chr1	962739	965185	Q6TDP4	0	+	962739	965185	255,102,0	1	2446	0	.	Interaction with F-actin.
chr1	965179	965188	Q6TDP4	0	+	965179	965188	255,102,0	1	9	0	.	Interaction with PDZK1.
chr1	1014436	1014451	P05161	0	+	1014436	1014451	255,102,0	1	15	0	.	Involved in the ligation of specific target proteins.
chr1	1217514	1217676	Q9BRK5	0	-	1217514	1217676	255,102,0	1	162	0	.	Necessary for intracellular retention in Golgi apparatus lumen.
chr1	1333510	1333540	Q7RTX0	0	+	1333510	1333540	255,102,0	1	30	0	.	Required for brazzein responsiveness.
chr1	1387524	1387835	Q96S94	0	-	1387524	1387835	255,102,0	1	311	0	.	RS.
chr1	1390476	1395396	Q96S94	0	-	1390476	1395396	255,102,0	1	4920	0	.	Cyclin-like 2.
chr1	1395432	1399060	Q96S94	0	-	1395432	1399060	255,102,0	1	3628	0	.	Cyclin-like 1.
chr1	1512271	1512418	Q9NVI7	0	+	1512271	1512418	255,102,0	1	147	0	.	Required for interaction with the inner surface of the mitochondrial outer membrane.
chr1	1522860	1523519	Q9NVI7	0	+	1522860	1523519	255,102,0	1	659	0	.	S100B-binding.
chr1	2056524	2144224	Q05513	0	+	2056524	2144224	255,102,0	1	87700	0	.	Interaction with SQSTM1.
chr1	2476588	2479927	O75038	0	+	2476588	2479927	255,102,0	1	3339	0	.	Necessary for plasma membrane localization.
chr1	3412231	3426055	Q9HAZ2	0	+	3412231	3426055	255,102,0	1	13824	0	.	Interaction with CTBP1, CTBP2 and ZNF516.
chr1	3412411	3433808	Q9HAZ2	0	+	3412411	3433808	255,102,0	1	21397	0	.	Mediates interaction with SKI and regulation of TGF-beta signaling. Pubmed:19049980
chr1	3468897	3476032	Q5VV41	0	+	3468897	3476032	255,102,0	1	7135	0	.	Required for RHOG activation and mediates interaction with EPHA2. Pubmed:20679435
chr1	3682365	3683132	O15350	0	+	3682365	3683132	255,102,0	1	767	0	.	Transactivation.
chr1	3707752	3727715	O15350	0	+	3707752	3727715	255,102,0	1	19963	0	.	DNA-binding.
chr1	3728175	3729392	O15350	0	+	3728175	3729392	255,102,0	1	1217	0	.	Interaction with HIPK2. Pubmed:11925430
chr1	3728175	3729410	O15350	0	+	3728175	3729410	255,102,0	1	1235	0	.	Oligomerization.
chr1	3775885	3775918	B2RUZ4	0	+	3775885	3775918	255,102,0	1	33	0	.	Displays the Vel antigen. Pubmed:26452714
chr1	4769929	4774496	Q9UKB5	0	+	4769929	4774496	255,102,0	1	4567	0	.	Targeting signals.
chr1	5863267	5887304	O75161	0	-	5863267	5887304	255,102,0	1	24037	0	.	Sufficient for basal bodies localization. Pubmed:26644512
chr1	6143906	6149380	Q8TDI0	0	-	6143906	6149380	255,102,0	1	5474	0	.	Histone-binding.
chr1	6621454	6621478	Q86YI8	0	+	6621454	6621478	255,102,0	1	24	0	.	Interaction with trimethylated histone H3 (H3K4).
chr1	7820142	7827233	P56645	0	+	7820142	7827233	255,102,0	1	7091	0	.	CSNK1E binding domain.
chr1	7829866	7830136	P56645	0	+	7829866	7830136	255,102,0	1	270	0	.	5 X 18 AA tandem repeats of S-[HP]-[AP]-T-[AT]-[GST]-[ATV]-L-S-[MT]-G-[LS]-P-P-[MRS]-[EKR]-[NST]-P.
chr1	7835940	7842752	P56645	0	+	7835940	7842752	255,102,0	1	6812	0	.	CRY binding domain.
chr1	7920837	7933201	Q07011	0	-	7920837	7933201	255,102,0	1	12364	0	.	Interaction with LRR-1.
chr1	8013509	8013599	Q9UJM3	0	-	8013509	8013599	255,102,0	1	90	0	.	Interaction with EGFR and ERBB2 and regulation of EGFR activation.
chr1	8861362	8862909	P06733	0	-	8861362	8862909	255,102,0	1	1547	0	.	Required for interaction with PLG.
chr1	8863291	8863303	A0A024R4F1	0	-	8863291	8863303	255,102,0	1	12	0	.	Substrate binding.
chr1	8863291	8863303	P06733	0	-	8863291	8863303	255,102,0	1	12	0	.	Substrate binding.
chr1	8865438	8868009	P06733	0	-	8865438	8868009	255,102,0	1	2571	0	.	Required for repression of c-myc promoter activity.
chr1	8870502	8871906	P06733	0	-	8870502	8871906	255,102,0	1	1404	0	.	Epitope recognized by CAR antibodies.
chr1	8871957	8871981	P06733	0	-	8871957	8871981	255,102,0	1	24	0	.	Epitope recognized by CAR and healthy patient antibodies.
chr1	8967744	8967750	P23280	0	+	8967744	8967750	255,102,0	1	6	0	.	Substrate binding.
chr1	9014683	9014704	Q6PXP3	0	-	9014683	9014704	255,102,0	1	21	0	.	Monosaccharide binding.
chr1	9037938	9037944	P22732	0	-	9037938	9037944	255,102,0	1	6	0	.	Fructose binding.
chr1	9039653	9039662	P22732	0	-	9039653	9039662	255,102,0	1	9	0	.	Fructose binding.
chr1	9244991	9264071	O95479	0	+	9244991	9264071	255,102,0	1	19080	0	.	Glucose 1-dehydrogenase.
chr1	9264071	9264113	O95479	0	+	9264071	9264113	255,102,0	1	42	0	.	Linker.
chr1	9264113	9264866	O95479	0	+	9264113	9264866	255,102,0	1	753	0	.	6-phosphogluconolactonase.
chr1	9975638	9975647	Q9HAN9	0	+	9975638	9975647	255,102,0	1	9	0	.	Substrate binding. Pubmed:11959140
chr1	9975749	9975761	Q9HAN9	0	+	9975749	9975761	255,102,0	1	12	0	.	Substrate binding. Pubmed:11788603, Pubmed:11959140
chr1	9982362	9982368	Q9HAN9	0	+	9982362	9982368	255,102,0	1	6	0	.	Substrate binding. Pubmed:11788603, Pubmed:11959140
chr1	10272249	10277998	O60333	0	+	10272249	10277998	255,102,0	1	5749	0	.	Interaction with KBP. Pubmed:16225668
chr1	10404214	10404223	P52209	0	+	10404214	10404223	255,102,0	1	9	0	.	Substrate binding.
chr1	10411456	10411462	P52209	0	+	10411456	10411462	255,102,0	1	6	0	.	Substrate binding.
chr1	11020530	11022651	Q13148	0	+	11020530	11022651	255,102,0	1	2121	0	.	Interaction with UBQLN2. Pubmed:23541532
chr1	11056610	11056622	P19623	0	-	11056610	11056622	255,102,0	1	12	0	.	Putrescine binding.
chr1	11056670	11056676	P19623	0	-	11056670	11056676	255,102,0	1	6	0	.	S-adenosylmethioninamine binding.
chr1	11121290	11122017	P42345	0	-	11121290	11122017	255,102,0	1	727	0	.	Interaction with MLST8.
chr1	11126715	11127806	P42345	0	-	11126715	11127806	255,102,0	1	1091	0	.	Sufficient for interaction with the FKBP1A/rapamycin complex.
chr1	11238450	11259409	P42345	0	-	11238450	11259409	255,102,0	1	20959	0	.	Interaction with NBN. Pubmed:23762398
chr1	11648747	11648753	Q9UK22	0	-	11648747	11648753	255,102,0	1	6	0	.	Carbohydrate binding.
chr1	11649206	11649215	Q9UK22	0	-	11649206	11649215	255,102,0	1	9	0	.	Carbohydrate binding.
chr1	11674777	11675711	Q9UI95	0	-	11674777	11675711	255,102,0	1	934	0	.	Mediates interaction with ipaB.
chr1	11675693	11680451	Q9UI95	0	-	11675693	11680451	255,102,0	1	4758	0	.	Mediates interaction with REV1 and REV3L and homodimerization.
chr1	11748573	11750078	Q6RW13	0	+	11748573	11750078	255,102,0	1	1505	0	.	Interaction with AGTR1.
chr1	12029763	12029895	Q5JXC2	0	+	12029763	12029895	255,102,0	1	132	0	.	Interaction with IGFBP2. Pubmed:14617774
chr1	13778674	13778743	Q13029	0	+	13778674	13778743	255,102,0	1	69	0	.	Retinoblastoma protein binding.
chr1	15034849	15060254	Q674X7	0	+	15034849	15060254	255,102,0	1	25405	0	.	Interaction with PPL. Pubmed:15337775
chr1	15661095	15661104	Q92681	0	+	15661095	15661104	255,102,0	1	9	0	.	Involved in post-transcriptional down-regulation of SLC5A1.
chr1	15684558	15725534	Q8IWE5	0	+	15684558	15725534	255,102,0	1	40976	0	.	Interaction with KIF5B. Pubmed:15905402
chr1	15730606	15732379	Q8IWE5	0	+	15730606	15732379	255,102,0	1	1773	0	.	Interaction with sifA.
chr1	15764983	15765193	Q8WUP2	0	+	15764983	15765193	255,102,0	1	210	0	.	Filamin-binding.
chr1	15764983	15767380	Q8WUP2	0	+	15764983	15767380	255,102,0	1	2397	0	.	Intrinsically disordered.
chr1	15774731	15784658	Q8WUP2	0	+	15774731	15784658	255,102,0	1	9927	0	.	FERMT2-binding.
chr1	15932627	15933632	Q96T58	0	+	15932627	15933632	255,102,0	1	1005	0	.	Interaction with MSX2.
chr1	15934364	15934850	Q96T58	0	+	15934364	15934850	255,102,0	1	486	0	.	Interaction with RBPSUH.
chr1	15941971	15942658	Q13105	0	-	15941971	15942658	255,102,0	1	687	0	.	Interaction with HCFC1. Pubmed:12244100
chr1	15942226	15942658	Q13105	0	-	15942226	15942658	255,102,0	1	432	0	.	Interaction with MYC.
chr1	15944939	15945059	Q13105	0	-	15944939	15945059	255,102,0	1	120	0	.	Interaction with MYC.
chr1	16017193	16017963	Q9UBY9	0	-	16017193	16017963	255,102,0	1	770	0	.	Required for localization to SC35 splicing speckles.
chr1	16125217	16130239	P29317	0	-	16125217	16130239	255,102,0	1	5022	0	.	Negatively regulates interaction with ARHGEF16. Pubmed:20679435
chr1	16129540	16133529	P29317	0	-	16129540	16133529	255,102,0	1	3989	0	.	Mediates interaction with ARHGEF16 and ELMO2. Pubmed:20679435
chr1	16148582	16155932	P29317	0	-	16148582	16155932	255,102,0	1	7350	0	.	Mediates interaction with CLDN4. Pubmed:16236711
chr1	16232050	16233729	Q9BU20	0	-	16232050	16233729	255,102,0	1	1679	0	.	Small GTPase-like.
chr1	18631681	18691797	P23759	0	+	18631681	18691797	255,102,0	1	60116	0	.	Sufficient to mediate interaction with PAXBP1.
chr1	19882720	19890391	Q5T2D3	0	+	19882720	19890391	255,102,0	1	7671	0	.	Cys-loop.
chr1	19894375	19894408	Q5T2D3	0	+	19894375	19894408	255,102,0	1	33	0	.	Variable-loop.
chr1	19897584	19897602	Q5T2D3	0	+	19897584	19897602	255,102,0	1	18	0	.	His-loop.
chr1	20483681	20485259	Q7Z7J9	0	-	20483681	20485259	255,102,0	1	1578	0	.	CAMK2 inhibitory domain.
chr1	20604932	20604953	P32320	0	+	20604932	20604953	255,102,0	1	21	0	.	Substrate binding.
chr1	20807321	20807366	O43432	0	-	20807321	20807366	255,102,0	1	45	0	.	Necessary but not sufficient for MKNK1-binding.
chr1	20807321	20817442	O43432	0	-	20807321	20817442	255,102,0	1	10121	0	.	EIF4A-binding.
chr1	20860403	20886362	O43432	0	-	20860403	20886362	255,102,0	1	25959	0	.	eIF3/EIF4A-binding.
chr1	20895442	20895478	O43432	0	-	20895442	20895478	255,102,0	1	36	0	.	EIF4E-binding.
chr1	20969533	20973025	O43432	0	-	20969533	20973025	255,102,0	1	3492	0	.	PABPC1-binding.
chr1	21823715	21824125	P98160	0	-	21823715	21824125	255,102,0	1	410	0	.	Mediates motor neuron attachment.
chr1	21828108	21828117	P98160	0	-	21828108	21828117	255,102,0	1	9	0	.	Mediates motor neuron attachment.
chr1	22595315	22596118	P29322	0	+	22595315	22596118	255,102,0	1	803	0	.	Mediates interaction with ANKS1A and ANKS1B.
chr1	22597310	22597677	P29322	0	+	22597310	22597677	255,102,0	1	367	0	.	Mediates interaction with PIK3CG and required for endocytosis.
chr1	23056005	23083361	O60341	0	+	23056005	23083361	255,102,0	1	27356	0	.	Demethylase activity.
chr1	23193265	23193280	P28221	0	-	23193265	23193280	255,102,0	1	15	0	.	Agonist binding.
chr1	23193850	23193880	P28221	0	-	23193850	23193880	255,102,0	1	30	0	.	Agonist binding.
chr1	23310654	23311017	O43390	0	-	23310654	23311017	255,102,0	1	363	0	.	RNA-binding RGG-box.
chr1	23310864	23310972	O43390	0	-	23310864	23310972	255,102,0	1	108	0	.	3 X 11 AA approximate repeats of D-D-Y-Y-G-Y-D-Y-H-D-Y.
chr1	23318118	23318481	O43390	0	-	23318118	23318481	255,102,0	1	363	0	.	RNA-binding RGG-box.
chr1	23318328	23318436	O43390	0	-	23318328	23318436	255,102,0	1	108	0	.	3 X 11 AA approximate repeats of D-D-Y-Y-G-Y-D-Y-H-D-Y.
chr1	23509882	23510119	Q14209	0	-	23509882	23510119	255,102,0	1	237	0	.	Transactivation.
chr1	23509912	23509966	Q14209	0	-	23509912	23509966	255,102,0	1	54	0	.	Retinoblastoma protein binding.
chr1	23516512	23521061	Q14209	0	-	23516512	23521061	255,102,0	1	4549	0	.	Dimerization.
chr1	23517346	23517583	Q14209	0	-	23517346	23517583	255,102,0	1	237	0	.	Transactivation.
chr1	23517376	23517430	Q14209	0	-	23517376	23517430	255,102,0	1	54	0	.	Retinoblastoma protein binding.
chr1	23521886	23521952	Q14209	0	-	23521886	23521952	255,102,0	1	66	0	.	Leucine-zipper.
chr1	23523976	23528525	Q14209	0	-	23523976	23528525	255,102,0	1	4549	0	.	Dimerization.
chr1	23524425	23530601	Q14209	0	-	23524425	23530601	255,102,0	1	6176	0	.	Cyclin A/CDK2 binding.
chr1	23529350	23529416	Q14209	0	-	23529350	23529416	255,102,0	1	66	0	.	Leucine-zipper.
chr1	23531889	23538065	Q14209	0	-	23531889	23538065	255,102,0	1	6176	0	.	Cyclin A/CDK2 binding.
chr1	23754125	23756344	Q14241	0	+	23754125	23756344	255,102,0	1	2219	0	.	Activation domain.
chr1	23754209	23754239	Q14241	0	+	23754209	23754239	255,102,0	1	30	0	.	BC-box.
chr1	23796229	23796241	Q14376	0	-	23796229	23796241	255,102,0	1	12	0	.	Substrate binding. Pubmed:11279032, Pubmed:11279193
chr1	23796906	23796915	Q14376	0	-	23796906	23796915	255,102,0	1	9	0	.	Substrate binding. Pubmed:10801319, Pubmed:11279032, Pubmed:11279193
chr1	23797051	23797060	Q14376	0	-	23797051	23797060	255,102,0	1	9	0	.	Substrate binding. Pubmed:10801319, Pubmed:11279032, Pubmed:11279193
chr1	23797114	23797123	Q14376	0	-	23797114	23797123	255,102,0	1	9	0	.	Substrate binding. Pubmed:11279032, Pubmed:11279193
chr1	23797820	23797829	Q14376	0	-	23797820	23797829	255,102,0	1	9	0	.	Substrate binding. Pubmed:15175331, Pubmed:10801319
chr1	24331495	24336500	Q8TE85	0	+	24331495	24336500	255,102,0	1	5005	0	.	Transcription activation. Pubmed:12549979
chr1	24643326	24650018	Q8IYB3	0	+	24643326	24650018	255,102,0	1	6692	0	.	Necessary for DNA and RNA-binding.
chr1	24643326	24650033	Q8IYB3	0	+	24643326	24650033	255,102,0	1	6707	0	.	Necessary for mRNA 3'-end cleavage and cytoplasmic accumulation.
chr1	24652605	24669447	Q8IYB3	0	+	24652605	24669447	255,102,0	1	16842	0	.	Necessary for speckles and matrix localization.
chr1	24745556	24814214	Q9Y696	0	+	24745556	24814214	255,102,0	1	68658	0	.	Required for insertion into the membrane.
chr1	25563788	25566893	Q5SW96	0	+	25563788	25566893	255,102,0	1	3105	0	.	AP-2 complex binding. Pubmed:12221107
chr1	25834995	25835508	Q9H7T9	0	-	25834995	25835508	255,102,0	1	513	0	.	Interaction with AURKA. Pubmed:20596670
chr1	26058566	26066380	Q969Q1	0	-	26058566	26066380	255,102,0	1	7814	0	.	Interaction with TTN. Pubmed:11243782
chr1	26255730	26259760	Q6P2H3	0	+	26255730	26259760	255,102,0	1	4030	0	.	Mediates interaction with NEK2 and is required for its function in the suppression of centrosome disjunction. Pubmed:26220856
chr1	26259760	26268569	Q6P2H3	0	+	26259760	26268569	255,102,0	1	8809	0	.	Required for centrosome localization and for its function in the suppression of centrosome disjunction. Pubmed:26220856
chr1	26282331	26282403	Q5T124	0	-	26282331	26282403	255,102,0	1	72	0	.	3 X 8 AA tandem repeats of P-G-P-G-P-G-P-S.
chr1	26425410	26425482	Q9H9Z2	0	+	26425410	26425482	255,102,0	1	72	0	.	Flexible linker.
chr1	26911934	26913772	Q15466	0	-	26911934	26913772	255,102,0	1	1838	0	.	Ligand-binding.
chr1	27102701	27103252	P19634	0	-	27102701	27103252	255,102,0	1	551	0	.	Interaction with CHP2.
chr1	27369358	27369364	O75636	0	-	27369358	27369364	255,102,0	1	6	0	.	Carbohydrate binding. Pubmed:17215869
chr1	27830835	27841168	Q12972	0	+	27830835	27841168	255,102,0	1	10333	0	.	Interaction with CDC5L, SF3B1 and MELK. Pubmed:10827081, Pubmed:12105215, Pubmed:14699119
chr1	27841168	27847062	Q12972	0	+	27841168	27847062	255,102,0	1	5894	0	.	Interaction with EED. Pubmed:12788942
chr1	27843263	27843293	Q12972	0	+	27843263	27843293	255,102,0	1	30	0	.	Involved in PP-1 inhibition.
chr1	27843290	27843302	Q12972	0	+	27843290	27843302	255,102,0	1	12	0	.	Involved in PP-1 binding.
chr1	27850317	27850377	Q12972	0	+	27850317	27850377	255,102,0	1	60	0	.	Interaction with EED. Pubmed:12788942
chr1	27850377	27850443	Q12972	0	+	27850377	27850443	255,102,0	1	66	0	.	RNA-binding.
chr1	27850380	27850401	Q12972	0	+	27850380	27850401	255,102,0	1	21	0	.	Involved in PP-1 inhibition.
chr1	27872571	27882038	Q5TEJ8	0	+	27872571	27882038	255,102,0	1	9467	0	.	CABIT 1.
chr1	27882038	27882866	Q5TEJ8	0	+	27882038	27882866	255,102,0	1	828	0	.	CABIT 2.
chr1	27892165	27894364	P15927	0	-	27892165	27894364	255,102,0	1	2199	0	.	Interaction with RAD52, TIPIN, UNG and XPA. Pubmed:11081631
chr1	28236258	28236429	Q9UII2	0	+	28236258	28236429	255,102,0	1	171	0	.	N-terminal inhibitory region.
chr1	28237876	28237975	Q9UII2	0	+	28237876	28237975	255,102,0	1	99	0	.	Antiparallel alpha-helical coiled coil region.
chr1	28271712	28272760	P58004	0	+	28271712	28272760	255,102,0	1	1048	0	.	N-terminal domain; mediates the alkylhydroperoxide reductase activity. Pubmed:26612684
chr1	28274059	28280799	P58004	0	+	28274059	28280799	255,102,0	1	6740	0	.	C-terminal domain; mediates TORC1 regulation. Pubmed:26612684
chr1	28274923	28274935	P58004	0	+	28274923	28274935	255,102,0	1	12	0	.	Leucine-binding. Pubmed:26586190
chr1	28737123	28743422	Q9Y5A9	0	+	28737123	28743422	255,102,0	1	6299	0	.	Localization to mRNA processing bodies (P-bodies). Pubmed:24284625
chr1	28743422	28768949	Q9Y5A9	0	+	28743422	28768949	255,102,0	1	25527	0	.	Interaction with m6A-containing mRNAs. Pubmed:24284625
chr1	28743515	28743524	Q9Y5A9	0	+	28743515	28743524	255,102,0	1	9	0	.	N6-methyladenosine binding. Pubmed:25412658
chr1	28743563	28743569	Q9Y5A9	0	+	28743563	28743569	255,102,0	1	6	0	.	N6-methyladenosine binding. Pubmed:25412658
chr1	29039269	29053309	P11171	0	+	29039269	29053309	255,102,0	1	14040	0	.	Hydrophilic.
chr1	29053309	29065113	P11171	0	+	29053309	29065113	255,102,0	1	11804	0	.	Spectrin--actin-binding.
chr1	29065113	29115794	P11171	0	+	29065113	29115794	255,102,0	1	50681	0	.	C-terminal (CTD).
chr1	29284861	29304009	Q92729	0	+	29284861	29304009	255,102,0	1	19148	0	.	Mediates interaction with CTNNB1.
chr1	29312701	29315387	Q92729	0	+	29312701	29315387	255,102,0	1	2686	0	.	Substrate binding.
chr1	30936693	30936708	Q14671	0	-	30936693	30936708	255,102,0	1	15	0	.	Uracil-nucleotide binding in RNA target. Pubmed:21397187, Pubmed:18328718
chr1	30936822	30941152	Q14671	0	-	30936822	30941152	255,102,0	1	4330	0	.	Guanine-nucleotide binding in RNA target. Pubmed:21397187, Pubmed:18328718
chr1	30941245	30941260	Q14671	0	-	30941245	30941260	255,102,0	1	15	0	.	Uracil-nucleotide binding in RNA target. Pubmed:21397187, Pubmed:18328718
chr1	30942078	30942093	Q14671	0	-	30942078	30942093	255,102,0	1	15	0	.	Adenine-nucleotide binding in RNA target. Pubmed:18328718
chr1	30945408	30945423	Q14671	0	-	30945408	30945423	255,102,0	1	15	0	.	Non-specific-nucleotide binding in RNA target. Pubmed:18328718
chr1	30950165	30950180	Q14671	0	-	30950165	30950180	255,102,0	1	15	0	.	Adenine-nucleotide binding in RNA target. Pubmed:18328718
chr1	30952245	30952260	Q14671	0	-	30952245	30952260	255,102,0	1	15	0	.	Uracil-nucleotide binding in RNA target. Pubmed:18328718
chr1	30952353	30953718	Q14671	0	-	30952353	30953718	255,102,0	1	1365	0	.	Adenine-nucleotide binding in RNA target. Pubmed:18328718
chr1	31619267	31619315	O43613	0	+	31619267	31619315	255,102,0	1	48	0	.	Required for response to orexin-A. Pubmed:26950369
chr1	31630615	31632510	Q9UBV8	0	-	31630615	31632510	255,102,0	1	1895	0	.	Required for interaction with PDCD6.
chr1	31633312	31635486	Q9UBV8	0	-	31633312	31635486	255,102,0	1	2174	0	.	9 X 9 AA approximate tandem repeat of [AP]-P-G-G-P-Y-G-G-P-P.
chr1	31652653	31652731	Q07092	0	-	31652653	31652731	255,102,0	1	78	0	.	Nonhelical region 1 (NC1).
chr1	31652731	31653984	Q07092	0	-	31652731	31653984	255,102,0	1	1253	0	.	Triple-helical region 1 (COL1) with 2 imperfections.
chr1	31653984	31654849	Q07092	0	-	31653984	31654849	255,102,0	1	865	0	.	Nonhelical region 2 (NC2).
chr1	31654849	31672487	Q07092	0	-	31654849	31672487	255,102,0	1	17638	0	.	Triple-helical region 2 (COL2) with 2 imperfections.
chr1	31672487	31672735	Q07092	0	-	31672487	31672735	255,102,0	1	248	0	.	Nonhelical region 3 (NC3).
chr1	31672735	31672780	Q07092	0	-	31672735	31672780	255,102,0	1	45	0	.	Triple-helical region 3 (COL3).
chr1	31672780	31675266	Q07092	0	-	31672780	31675266	255,102,0	1	2486	0	.	Nonhelical region 4 (NC4).
chr1	31675266	31680050	Q07092	0	-	31675266	31680050	255,102,0	1	4784	0	.	Triple-helical region 4 (COL4) with 2 imperfections.
chr1	31680050	31680083	Q07092	0	-	31680050	31680083	255,102,0	1	33	0	.	Nonhelical region 5 (NC5).
chr1	31680083	31684177	Q07092	0	-	31680083	31684177	255,102,0	1	4094	0	.	Triple-helical region 5 (COL5) with 3 imperfections.
chr1	31684177	31684222	Q07092	0	-	31684177	31684222	255,102,0	1	45	0	.	Nonhelical region 6 (NC6).
chr1	31684222	31685698	Q07092	0	-	31684222	31685698	255,102,0	1	1476	0	.	Triple-helical region 6 (COL6) with 1 imperfection.
chr1	31685698	31685761	Q07092	0	-	31685698	31685761	255,102,0	1	63	0	.	Nonhelical region 7 (NC7).
chr1	31685761	31688911	Q07092	0	-	31685761	31688911	255,102,0	1	3150	0	.	Triple-helical region 7 (COL7) with 1 imperfection.
chr1	31688911	31688962	Q07092	0	-	31688911	31688962	255,102,0	1	51	0	.	Nonhelical region 8 (NC8).
chr1	31688962	31689797	Q07092	0	-	31688962	31689797	255,102,0	1	835	0	.	Triple-helical region 8 (COL8) with 1 imperfection.
chr1	31689797	31689842	Q07092	0	-	31689797	31689842	255,102,0	1	45	0	.	Nonhelical region 9 (NC9).
chr1	31689842	31692633	Q07092	0	-	31689842	31692633	255,102,0	1	2791	0	.	Triple-helical region 9 (COL9) with 3 imperfections.
chr1	31692633	31697264	Q07092	0	-	31692633	31697264	255,102,0	1	4631	0	.	Nonhelical region 10 (NC10).
chr1	31911694	31911712	Q12974	0	-	31911694	31911712	255,102,0	1	18	0	.	Phosphate binding.
chr1	32014292	32036918	Q07666	0	+	32014292	32036918	255,102,0	1	22626	0	.	Involved in homodimerization. Pubmed:26758068
chr1	32037979	32042621	Q07666	0	+	32037979	32042621	255,102,0	1	4642	0	.	Interaction with HNRNPA1. Pubmed:17371836
chr1	32159411	32162016	O60684	0	+	32159411	32162016	255,102,0	1	2605	0	.	NLS binding site (major).
chr1	32163268	32167264	O60684	0	+	32163268	32167264	255,102,0	1	3996	0	.	NLS binding site (minor).
chr1	32274332	32275021	P06239	0	+	32274332	32275021	255,102,0	1	689	0	.	Interactions with CD4 and CD8.
chr1	32275650	32276431	P06239	0	+	32275650	32276431	255,102,0	1	781	0	.	Interaction with PTPRH. Pubmed:12837766
chr1	32292193	32330892	Q13547	0	+	32292193	32330892	255,102,0	1	38699	0	.	Histone deacetylase.
chr1	32334854	32334926	P49006	0	-	32334854	32334926	255,102,0	1	72	0	.	Effector domain involved in lipid-binding.
chr1	32334884	32334926	P49006	0	-	32334884	32334926	255,102,0	1	42	0	.	Calmodulin-binding (PSD).
chr1	32681852	32684073	Q9H7C4	0	-	32681852	32684073	255,102,0	1	2221	0	.	Tail.
chr1	32684073	32695050	Q9H7C4	0	-	32684073	32695050	255,102,0	1	10977	0	.	Coil 2.
chr1	32695050	32695170	Q9H7C4	0	-	32695050	32695170	255,102,0	1	120	0	.	Linker 2.
chr1	32695170	32695404	Q9H7C4	0	-	32695170	32695404	255,102,0	1	234	0	.	Coil 1b.
chr1	32695404	32695485	Q9H7C4	0	-	32695404	32695485	255,102,0	1	81	0	.	Linker 1.
chr1	32695485	32695590	Q9H7C4	0	-	32695485	32695590	255,102,0	1	105	0	.	Coil 1A.
chr1	32695590	32695614	Q9H7C4	0	-	32695590	32695614	255,102,0	1	24	0	.	Rod.
chr1	32695614	32702660	Q9H7C4	0	-	32695614	32702660	255,102,0	1	7046	0	.	Head.
chr1	33013366	33021371	A0A140VK93	0	-	33013366	33021371	255,102,0	1	8005	0	.	LID.
chr1	33013366	33021371	F8W1A4	0	-	33013366	33021371	255,102,0	1	8005	0	.	LID.
chr1	33013366	33021371	P54819	0	-	33013366	33021371	255,102,0	1	8005	0	.	LID.
chr1	33021700	33024528	A0A140VK93	0	-	33021700	33024528	255,102,0	1	2828	0	.	NMPbind.
chr1	33021700	33024528	F8W1A4	0	-	33021700	33024528	255,102,0	1	2828	0	.	NMPbind.
chr1	33021700	33024528	P54819	0	-	33021700	33024528	255,102,0	1	2828	0	.	NMPbind.
chr1	33092118	33092190	Q96A70	0	+	33092118	33092190	255,102,0	1	72	0	.	Necessary for polyamine uptake stimulation.
chr1	35192968	35193025	P23246	0	-	35192968	35193025	255,102,0	1	57	0	.	3 X 3 AA repeats of R-G-G.
chr1	35590002	35594598	Q6VUC0	0	+	35590002	35594598	255,102,0	1	4596	0	.	H-S-H (helix-span-helix), dimerization.
chr1	35895173	35895191	Q9UL18	0	+	35895173	35895191	255,102,0	1	18	0	.	Interaction with guide RNA.
chr1	35907100	35913951	Q9UL18	0	+	35907100	35913951	255,102,0	1	6851	0	.	Interaction with guide RNA.
chr1	35915521	35915539	Q9UL18	0	+	35915521	35915539	255,102,0	1	18	0	.	Impairs access of bound RNA to the active site.
chr1	35917685	35917700	Q9UL18	0	+	35917685	35917700	255,102,0	1	15	0	.	Interaction with guide RNA.
chr1	35918408	35919066	Q9UL18	0	+	35918408	35919066	255,102,0	1	658	0	.	Interaction with guide RNA.
chr1	35919150	35919228	Q9UL18	0	+	35919150	35919228	255,102,0	1	78	0	.	Interaction with guide RNA.
chr1	36097571	36098072	P25067	0	-	36097571	36098072	255,102,0	1	501	0	.	Nonhelical region (NC1).
chr1	36098072	36099452	P25067	0	-	36098072	36099452	255,102,0	1	1380	0	.	Triple-helical region.
chr1	36099452	36100158	P25067	0	-	36099452	36100158	255,102,0	1	706	0	.	Nonhelical region (NC2).
chr1	36282566	36286800	Q9Y2W1	0	+	36282566	36286800	255,102,0	1	4234	0	.	Required for mRNA splicing activation.
chr1	36289093	36304014	Q9Y2W1	0	+	36289093	36304014	255,102,0	1	14921	0	.	Required for mRNA decay activity.
chr1	36817074	36817083	Q13003	0	-	36817074	36817083	255,102,0	1	9	0	.	Glutamate binding.
chr1	37475619	37475757	Q5D1E8	0	+	37475619	37475757	255,102,0	1	138	0	.	Ubiquitin association domain.
chr1	37475736	37480296	Q5D1E8	0	+	37475736	37480296	255,102,0	1	4560	0	.	Necessary for interaction with TANK. Pubmed:25861989
chr1	37475829	37482506	Q5D1E8	0	+	37475829	37482506	255,102,0	1	6677	0	.	RNase. Pubmed:22561375
chr1	37481656	37481677	Q5D1E8	0	+	37481656	37481677	255,102,0	1	21	0	.	RNA binding. Pubmed:22561375
chr1	37482515	37483182	Q5D1E8	0	+	37482515	37483182	255,102,0	1	667	0	.	Necessary for interaction with ZC3H12D. Pubmed:26134560
chr1	37692690	37692984	Q53HL2	0	+	37692690	37692984	255,102,0	1	294	0	.	Required for interaction with INCENP. Pubmed:17956729
chr1	37692690	37695950	Q53HL2	0	+	37692690	37695950	255,102,0	1	3260	0	.	Required for centromere localization.
chr1	37692690	37700518	Q53HL2	0	+	37692690	37700518	255,102,0	1	7828	0	.	Required for interaction with SENP3. Pubmed:18946085
chr1	37692717	37698967	Q53HL2	0	+	37692717	37698967	255,102,0	1	6250	0	.	Required to form a minimal CPC core complex that localizes to the central spindle and midbody and properly executes the role of the CPC during cytokinesis.
chr1	37692747	37695920	Q53HL2	0	+	37692747	37695920	255,102,0	1	3173	0	.	Required for interaction with INCENP and BIRC5. Pubmed:17956729
chr1	37873010	37875629	P32019	0	-	37873010	37875629	255,102,0	1	2619	0	.	ASH.
chr1	37875629	37889570	P32019	0	-	37875629	37889570	255,102,0	1	13941	0	.	5-phosphatase.
chr1	37878310	37878319	P32019	0	-	37878310	37878319	255,102,0	1	9	0	.	Substrate binding.
chr1	37880116	37880122	P32019	0	-	37880116	37880122	255,102,0	1	6	0	.	Substrate binding.
chr1	37885816	37885822	P32019	0	-	37885816	37885822	255,102,0	1	6	0	.	Substrate binding.
chr1	39462010	39485791	Q9UPN3	0	+	39462010	39485791	255,102,0	1	23781	0	.	C-terminal tail.
chr1	39485563	39485611	Q9UPN3	0	+	39485563	39485611	255,102,0	1	48	0	.	4 X 4 AA tandem repeats of [GS]-S-R-[AR].
chr1	39627160	39632672	Q9NQ87	0	-	39627160	39632672	255,102,0	1	5512	0	.	Transcriptional repression and interaction with NCOR1 and SIN3A.
chr1	39847232	39847289	Q9H3H1	0	-	39847232	39847289	255,102,0	1	57	0	.	Interaction with substrate tRNA.
chr1	39847235	39847259	Q9H3H1	0	-	39847235	39847259	255,102,0	1	24	0	.	Interaction with substrate tRNA.
chr1	39847626	39847635	Q9H3H1	0	-	39847626	39847635	255,102,0	1	9	0	.	Interaction with substrate tRNA.
chr1	39848035	39850125	Q9H3H1	0	-	39848035	39850125	255,102,0	1	2090	0	.	Interaction with isopentenylpyrophosphate transferase.
chr1	39852729	39852744	Q9H3H1	0	-	39852729	39852744	255,102,0	1	15	0	.	Interaction with substrate tRNA.
chr1	39883317	39883329	Q9H3H1	0	-	39883317	39883329	255,102,0	1	12	0	.	Interaction with substrate tRNA.
chr1	39883380	39883398	Q9H3H1	0	-	39883380	39883398	255,102,0	1	18	0	.	Substrate binding.
chr1	39897383	39897470	P12524	0	-	39897383	39897470	255,102,0	1	87	0	.	Leucine-zipper.
chr1	40301184	40301259	Q14055	0	-	40301184	40301259	255,102,0	1	75	0	.	Nonhelical region 1 (NC1).
chr1	40301259	40301349	Q14055	0	-	40301259	40301349	255,102,0	1	90	0	.	Triple-helical region 1 (COL1).
chr1	40301349	40301355	Q14055	0	-	40301349	40301355	255,102,0	1	6	0	.	Nonhelical region 2 (NC2).
chr1	40301355	40302765	Q14055	0	-	40301355	40302765	255,102,0	1	1410	0	.	Triple-helical region 2 (COL2).
chr1	40302765	40303176	Q14055	0	-	40302765	40303176	255,102,0	1	411	0	.	Nonhelical region 3 (NC3).
chr1	40303176	40311265	Q14055	0	-	40303176	40311265	255,102,0	1	8089	0	.	Triple-helical region 3 (COL3).
chr1	40311265	40311529	Q14055	0	-	40311265	40311529	255,102,0	1	264	0	.	Nonhelical region 4 (NC4).
chr1	40311529	40315661	Q14055	0	-	40311529	40315661	255,102,0	1	4132	0	.	Triple-helical region 4 (COL4).
chr1	40413099	40416190	Q8WU79	0	+	40413099	40416190	255,102,0	1	3091	0	.	Interaction with clathrin heavy chains.
chr1	40416949	40422098	Q8WU79	0	+	40416949	40422098	255,102,0	1	5149	0	.	Interaction with PICALM.
chr1	40834988	40838385	P56696	0	+	40834988	40838385	255,102,0	1	3397	0	.	A-domain (Tetramerization).
chr1	41482476	41482524	P20800	0	-	41482476	41482524	255,102,0	1	48	0	.	Endothelin-like.
chr1	41511227	41513064	Q5T1R4	0	-	41511227	41513064	255,102,0	1	1837	0	.	6 X 4 AA tandem repeats of S-P-X-[RK].
chr1	41513604	41518423	Q5T1R4	0	-	41513604	41518423	255,102,0	1	4819	0	.	Acidic 3.
chr1	41518453	41524858	Q5T1R4	0	-	41518453	41524858	255,102,0	1	6405	0	.	ZAS2.
chr1	41581575	41584167	Q5T1R4	0	-	41581575	41584167	255,102,0	1	2592	0	.	No DNA binding activity or transactivation activity, but complete prevention of TRAF-dependent NF-Kappa-B activation; associates with TRAF2 and JUN.
chr1	41582148	41582214	Q5T1R4	0	-	41582148	41582214	255,102,0	1	66	0	.	Acidic 2.
chr1	41583936	41584008	Q5T1R4	0	-	41583936	41584008	255,102,0	1	72	0	.	Acidic 1.
chr1	41584071	41584224	Q5T1R4	0	-	41584071	41584224	255,102,0	1	153	0	.	ZAS1.
chr1	42682607	42683449	P67809	0	+	42682607	42683449	255,102,0	1	842	0	.	Interaction with ss-DNA.
chr1	42929595	42929616	P11166	0	-	42929595	42929616	255,102,0	1	21	0	.	Monosaccharide binding.
chr1	43386628	43386658	Q96G25	0	-	43386628	43386658	255,102,0	1	30	0	.	Interaction with the Elongin BC complex.
chr1	43553601	43553631	P10586	0	+	43553601	43553631	255,102,0	1	30	0	.	Heparin-binding.
chr1	43619197	43619303	P10586	0	+	43619197	43619303	255,102,0	1	106	0	.	Substrate binding.
chr1	43683737	43688972	O75164	0	+	43683737	43688972	255,102,0	1	5235	0	.	Interaction with NCOR1. Pubmed:16024779
chr1	43981822	43981837	O60909	0	+	43981822	43981837	255,102,0	1	15	0	.	UDP-alpha-D-galactose binding.
chr1	43984879	43984888	O60909	0	+	43984879	43984888	255,102,0	1	9	0	.	UDP-alpha-D-galactose binding.
chr1	43984963	43984969	O60909	0	+	43984963	43984969	255,102,0	1	6	0	.	UDP-alpha-D-galactose binding.
chr1	43985374	43985386	O60909	0	+	43985374	43985386	255,102,0	1	12	0	.	N-acetyl-D-glucosamine binding.
chr1	43985583	43985592	O60909	0	+	43985583	43985592	255,102,0	1	9	0	.	UDP-alpha-D-galactose binding.
chr1	44649754	44649894	Q5VTB9	0	+	44649754	44649894	255,102,0	1	140	0	.	Required for targeting to the cytoplasm.
chr1	44739935	44755931	Q99661	0	+	44739935	44755931	255,102,0	1	15996	0	.	Globular.
chr1	44753788	44754800	Q99661	0	+	44753788	44754800	255,102,0	1	1012	0	.	Negative regulator of microtubule-binding.
chr1	45012994	45013009	P06132	0	+	45012994	45013009	255,102,0	1	15	0	.	Substrate binding.
chr1	45508277	45508289	Q9Y4U1	0	+	45508277	45508289	255,102,0	1	12	0	.	Substrate binding. Pubmed:21697092, Pubmed:22642810
chr1	45508319	45508328	Q9Y4U1	0	+	45508319	45508328	255,102,0	1	9	0	.	Substrate binding. Pubmed:21697092, Pubmed:22642810
chr1	45606527	45606563	P49321	0	+	45606527	45606563	255,102,0	1	36	0	.	Histone-binding. Pubmed:8724350
chr1	45607541	45607643	P49321	0	+	45607541	45607643	255,102,0	1	102	0	.	Histone-binding. Pubmed:8724350
chr1	45608315	45614125	P49321	0	+	45608315	45614125	255,102,0	1	5810	0	.	Histone-binding. Pubmed:8724350
chr1	46248511	46248535	Q92698	0	+	46248511	46248535	255,102,0	1	24	0	.	Required for chromatin remodeling, strand pairing activities and coupling of ATPase activity.
chr1	46303160	46303190	Q15345	0	-	46303160	46303190	255,102,0	1	30	0	.	Interaction with Elongin BC complex.
chr1	46347023	46347044	Q96CB9	0	+	46347023	46347044	255,102,0	1	21	0	.	S-adenosyl-L-methionine binding.
chr1	46405720	46405732	O00519	0	+	46405720	46405732	255,102,0	1	12	0	.	Substrate binding.
chr1	46507010	46511054	Q8NFW5	0	+	46507010	46511054	255,102,0	1	4044	0	.	Interaction with OTX2 and is required for repressor activity.
chr1	47260311	47310319	Q15468	0	-	47260311	47310319	255,102,0	1	50008	0	.	Interaction with RBM14. Pubmed:25385835
chr1	47272115	47299915	Q15468	0	-	47272115	47299915	255,102,0	1	27800	0	.	Interaction with CENPJ. Pubmed:22020124, Pubmed:25385835
chr1	47272121	47280708	Q15468	0	-	47272121	47280708	255,102,0	1	8587	0	.	PIN1-binding.
chr1	47368489	47368582	B2R6S5	0	+	47368489	47368582	255,102,0	1	93	0	.	NMPbind.
chr1	47374929	47374962	B2R6S5	0	+	47374929	47374962	255,102,0	1	33	0	.	LID.
chr1	51361233	51402522	P42566	0	-	51361233	51402522	255,102,0	1	41289	0	.	15 X 3 AA repeats of D-P-F.
chr1	51440396	51519228	P42566	0	-	51440396	51519228	255,102,0	1	78832	0	.	Interaction with DAB2.
chr1	52266674	52268476	O95405	0	+	52266674	52268476	255,102,0	1	1802	0	.	SBD.
chr1	52373183	52385243	Q13415	0	-	52373183	52385243	255,102,0	1	12060	0	.	Necessary and sufficient for ORC complex assembly.
chr1	53211027	53211066	P23786	0	+	53211027	53211066	255,102,0	1	39	0	.	Coenzyme A binding.
chr1	53257279	53257456	Q14114	0	-	53257279	53257456	255,102,0	1	177	0	.	Clustered O-linked oligosaccharides.
chr1	54585863	54585872	Q8WXI4	0	+	54585863	54585872	255,102,0	1	9	0	.	Coenzyme A binding.
chr1	54592591	54592600	Q8WXI4	0	+	54592591	54592600	255,102,0	1	9	0	.	Coenzyme A binding.
chr1	54599341	54599350	Q8WXI4	0	+	54599341	54599350	255,102,0	1	9	0	.	Coenzyme A binding.
chr1	55058202	55063581	Q8NBP7	0	+	55058202	55063581	255,102,0	1	5379	0	.	C-terminal domain.
chr1	56704052	56704310	P54646	0	+	56704052	56704310	255,102,0	1	258	0	.	AIS.
chr1	58782146	58782233	P05412	0	-	58782146	58782233	255,102,0	1	87	0	.	Leucine-zipper.
chr1	58782233	58782317	P05412	0	-	58782233	58782317	255,102,0	1	84	0	.	Basic motif.
chr1	59815117	59865166	Q9UJC3	0	+	59815117	59865166	255,102,0	1	50049	0	.	Sufficient for interaction with microtubules.
chr1	59871062	59872962	Q9UJC3	0	+	59871062	59872962	255,102,0	1	1900	0	.	Sufficient for interaction with AKTIP and VPS18. Pubmed:18799622
chr1	62597614	62598061	Q9Y5C1	0	+	62597614	62598061	255,102,0	1	447	0	.	Sufficient to inhibit LPL lipase activity. Pubmed:12909640
chr1	62597614	62601096	Q9Y5C1	0	+	62597614	62601096	255,102,0	1	3482	0	.	Sufficient to inhibit LIPG/EL phospholipase activity. Pubmed:17110602
chr1	62597659	62597734	Q9Y5C1	0	+	62597659	62597734	255,102,0	1	75	0	.	Required for inhibition of LPL lipase activity. Pubmed:19318355
chr1	63490116	63490209	Q13352	0	-	63490116	63490209	255,102,0	1	93	0	.	DD1.
chr1	63629526	63629532	P36871	0	+	63629526	63629532	255,102,0	1	6	0	.	Substrate binding.
chr1	63636233	63636239	P36871	0	+	63636233	63636239	255,102,0	1	6	0	.	Substrate binding.
chr1	63638781	63638790	P36871	0	+	63638781	63638790	255,102,0	1	9	0	.	Substrate binding.
chr1	65148509	65190756	P27144	0	+	65148509	65190756	255,102,0	1	42247	0	.	NMPbind. Pubmed:19073142
chr1	65218860	65224799	P27144	0	+	65218860	65224799	255,102,0	1	5939	0	.	LID. Pubmed:19073142
chr1	65364717	65364753	O75061	0	+	65364717	65364753	255,102,0	1	36	0	.	3 X 4 AA approximate tandem repeats.
chr1	65601955	65605086	P48357	0	+	65601955	65605086	255,102,0	1	3131	0	.	Leptin-binding. Pubmed:22405007
chr1	65636193	65636211	P48357	0	+	65636193	65636211	255,102,0	1	18	0	.	Required for JAK2 activation.
chr1	65636208	65636235	P48357	0	+	65636208	65636235	255,102,0	1	27	0	.	Required for STAT3 phosphorylation.
chr1	66719343	66719364	Q9BQI5	0	+	66719343	66719364	255,102,0	1	21	0	.	Interaction with DPF motifs-containing proteins. Pubmed:26822536
chr1	66729297	66729306	Q9BQI5	0	+	66729297	66729306	255,102,0	1	9	0	.	Interaction with DPF motifs-containing proteins. Pubmed:26822536
chr1	66733793	66743092	Q9BQI5	0	+	66733793	66743092	255,102,0	1	9299	0	.	Necessary and sufficient to mediate interaction with CANX.
chr1	66733847	66733859	Q9BQI5	0	+	66733847	66733859	255,102,0	1	12	0	.	Interaction with DPF motifs-containing proteins. Pubmed:26822536
chr1	66741408	66741426	Q9BQI5	0	+	66741408	66741426	255,102,0	1	18	0	.	Interaction with DPF motifs-containing proteins. Pubmed:26822536
chr1	66959740	66972901	Q8N108	0	+	66959740	66972901	255,102,0	1	13161	0	.	Interaction with HDAC1. Pubmed:12482978
chr1	67395885	67395903	Q99665	0	+	67395885	67395903	255,102,0	1	18	0	.	Required for STAT4 binding.
chr1	67685494	67686028	P24522	0	+	67685494	67686028	255,102,0	1	534	0	.	Intrinsically disordered.
chr1	67686515	67686557	P24522	0	+	67686515	67686557	255,102,0	1	42	0	.	Intrinsically disordered.
chr1	68153623	68194033	Q5T9L3	0	-	68153623	68194033	255,102,0	1	40410	0	.	Interaction with Wnt proteins.
chr1	68479296	68481583	Q5TB30	0	-	68479296	68481583	255,102,0	1	2287	0	.	Interaction with ZNF224. Pubmed:20587513
chr1	70239458	70249988	Q05519	0	+	70239458	70249988	255,102,0	1	10530	0	.	10 X 8 AA approximate repeats of R-R-S-R-S-R-S-R.
chr1	71065094	71072183	O95218	0	-	71065094	71072183	255,102,0	1	7089	0	.	Required for nuclear targeting.
chr1	75749541	75749553	P11310	0	+	75749541	75749553	255,102,0	1	12	0	.	Substrate binding.
chr1	75791559	75791568	P53611	0	+	75791559	75791568	255,102,0	1	9	0	.	Geranylgeranyl diphosphate binding.
chr1	75792294	75794110	P53611	0	+	75792294	75794110	255,102,0	1	1816	0	.	Geranylgeranyl diphosphate binding.
chr1	77154471	77154504	Q92643	0	-	77154471	77154504	255,102,0	1	33	0	.	Essential for GPI attachment.
chr1	77293941	77411037	Q9Y6K8	0	+	77293941	77411037	255,102,0	1	117096	0	.	Adenylate kinase 1. Pubmed:19647735
chr1	77297626	77297722	Q9Y6K8	0	+	77297626	77297722	255,102,0	1	96	0	.	NMPbind 1.
chr1	77340442	77340475	Q9Y6K8	0	+	77340442	77340475	255,102,0	1	33	0	.	LID 1.
chr1	77486333	77558658	Q9Y6K8	0	+	77486333	77558658	255,102,0	1	72325	0	.	Adenylate kinase 2. Pubmed:19647735
chr1	77518631	77518721	Q9Y6K8	0	+	77518631	77518721	255,102,0	1	90	0	.	NMPbind 2.
chr1	77535912	77535945	Q9Y6K8	0	+	77535912	77535945	255,102,0	1	33	0	.	LID 2.
chr1	83921100	83921375	Q6ZT98	0	-	83921100	83921375	255,102,0	1	275	0	.	c-MTBD region. Pubmed:25959773
chr1	84496268	84496322	Q9H9Y2	0	+	84496268	84496322	255,102,0	1	54	0	.	RNA-binding.
chr1	85464808	85464814	O94760	0	-	85464808	85464814	255,102,0	1	6	0	.	Substrate binding.
chr1	85582615	85582841	O00622	0	+	85582615	85582841	255,102,0	1	226	0	.	Heparin-binding.
chr1	86424406	86432399	Q9UQC9	0	+	86424406	86432399	255,102,0	1	7993	0	.	Metalloprotease domain.
chr1	86469106	86482244	A8K7I4	0	+	86469106	86482244	255,102,0	1	13138	0	.	Metalloprotease domain. Pubmed:23112050
chr1	86547251	86565313	Q14CN2	0	+	86547251	86565313	255,102,0	1	18062	0	.	Metalloprotease domain.
chr1	86704899	86715741	Q9Y371	0	+	86704899	86715741	255,102,0	1	10842	0	.	Membrane-binding amphipathic helix.
chr1	86704899	86715762	Q9Y371	0	+	86704899	86715762	255,102,0	1	10863	0	.	Required for membrane binding. Pubmed:21068542
chr1	88784796	88804498	Q16513	0	+	88784796	88804498	255,102,0	1	19702	0	.	Necessary to rescue apical junction formation.
chr1	88833154	88833424	Q16513	0	+	88833154	88833424	255,102,0	1	270	0	.	Necessary for the catalytic activity.
chr1	88833424	88833445	Q16513	0	+	88833424	88833445	255,102,0	1	21	0	.	Negatively regulates the responsiveness of the catalytic activity by cardiolipin and is required for optimal activation by the GTP-bound RhoA.
chr1	89011968	89020721	Q9H0R5	0	-	89011968	89020721	255,102,0	1	8753	0	.	GTPase domain (Globular).
chr1	89057075	89063234	P32455	0	-	89057075	89063234	255,102,0	1	6159	0	.	GTPase domain (Globular).
chr1	89114237	89121966	P32456	0	-	89114237	89121966	255,102,0	1	7729	0	.	GTPase domain (Globular).
chr1	89149513	89171935	Q8N8V2	0	-	89149513	89171935	255,102,0	1	22422	0	.	GTPase domain (Globular).
chr1	89190259	89198834	Q96PP9	0	-	89190259	89198834	255,102,0	1	8575	0	.	GTPase domain (Globular).
chr1	89260706	89262282	Q96PP8	0	-	89260706	89262282	255,102,0	1	1576	0	.	Required for tetramerization, but not for dimerization. Pubmed:22461501
chr1	89264907	89269555	Q96PP8	0	-	89264907	89269555	255,102,0	1	4648	0	.	GTPase domain (Globular).
chr1	89264916	89269555	Q96PP8	0	-	89264916	89269555	255,102,0	1	4639	0	.	NLRP3-binding. Pubmed:22461501
chr1	89368551	89381752	Q6ZN66	0	+	89368551	89381752	255,102,0	1	13201	0	.	GTPase domain (Globular).
chr1	89995257	90007507	Q5BKZ1	0	+	89995257	90007507	255,102,0	1	12250	0	.	Mediates transcriptional activation.
chr1	91708696	91708741	Q03167	0	-	91708696	91708741	255,102,0	1	45	0	.	Interaction with TGF-beta ligand.
chr1	92480615	92480969	Q99684	0	-	92480615	92480969	255,102,0	1	354	0	.	Required for interaction with RELA. Pubmed:20547752
chr1	92483427	92483487	Q99684	0	-	92483427	92483487	255,102,0	1	60	0	.	SNAG domain.
chr1	92513658	92636222	O60447	0	-	92513658	92636222	255,102,0	1	122564	0	.	Interaction with AURKB and INCENP. Pubmed:16764853
chr1	92513658	92694301	O60447	0	-	92513658	92694301	255,102,0	1	180643	0	.	Targeting to the centrosomes.
chr1	92563680	92704644	O60447	0	-	92563680	92704644	255,102,0	1	140964	0	.	Dimerization.
chr1	92636231	92792394	O60447	0	-	92636231	92792394	255,102,0	1	156163	0	.	Interaction with alpha-tubulin, gamma-tubulin, BIRC5 and FBXO5. Pubmed:16439210, Pubmed:16764853
chr1	93533014	93549380	Q5T0N5	0	+	93533014	93549380	255,102,0	1	16366	0	.	Interaction with CDC42.
chr1	93549338	93552413	Q5T0N5	0	+	93549338	93552413	255,102,0	1	3075	0	.	Interaction with DNM1. Pubmed:16326391
chr1	93549395	93551086	Q5T0N5	0	+	93549395	93551086	255,102,0	1	1691	0	.	Interaction with DNM2 and WASL. Pubmed:16418535
chr1	93549395	93552413	Q5T0N5	0	+	93549395	93552413	255,102,0	1	3018	0	.	Interaction with DAAM1, DIAPH1 and DIAPH2. Pubmed:16630611
chr1	93873205	93876293	Q5QJE6	0	-	93873205	93876293	255,102,0	1	3088	0	.	TdBR region; mediates interaction with DNTT.
chr1	94173871	94173883	Q52LW3	0	-	94173871	94173883	255,102,0	1	12	0	.	Interaction with PTPN13/PTPL1. Pubmed:9305890
chr1	94418481	94473802	P28288	0	+	94418481	94473802	255,102,0	1	55321	0	.	Targeting to peroxisomes.
chr1	94418481	94475707	P28288	0	+	94418481	94475707	255,102,0	1	57226	0	.	Interaction with PEX19.
chr1	95234266	95234275	Q9Y3V2	0	+	95234266	95234275	255,102,0	1	9	0	.	Interaction with UBE2I/UBC9. Pubmed:25918163
chr1	95244422	95244431	Q9Y3V2	0	+	95244422	95244431	255,102,0	1	9	0	.	Interaction with UBE2I/UBC9. Pubmed:25918163
chr1	97305346	97305352	Q12882	0	-	97305346	97305352	255,102,0	1	6	0	.	Substrate binding.
chr1	97373608	97373617	Q12882	0	-	97373608	97373617	255,102,0	1	9	0	.	Substrate binding.
chr1	100352972	100442963	Q9UNH5	0	+	100352972	100442963	255,102,0	1	89991	0	.	A.
chr1	100442963	100455413	Q9UNH5	0	+	100442963	100455413	255,102,0	1	12450	0	.	Linker.
chr1	100455413	100484343	Q9UNH5	0	+	100455413	100484343	255,102,0	1	28930	0	.	B.
chr1	100874055	100874097	Q9UBQ6	0	-	100874055	100874097	255,102,0	1	42	0	.	Substrate binding.
chr1	100874199	100874214	Q9UBQ6	0	-	100874199	100874214	255,102,0	1	15	0	.	Substrate binding.
chr1	100876841	100876850	Q9UBQ6	0	-	100876841	100876850	255,102,0	1	9	0	.	Substrate binding.
chr1	100877506	100877524	Q9UBQ6	0	-	100877506	100877524	255,102,0	1	18	0	.	Substrate binding.
chr1	100912207	100913805	Q8NEW0	0	+	100912207	100913805	255,102,0	1	1598	0	.	His-rich loop.
chr1	101013739	101013745	Q9H2P9	0	-	101013739	101013745	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr1	101239341	101239347	P21453	0	+	101239341	101239347	255,102,0	1	6	0	.	Sphingosine 1-phosphate binding.
chr1	101239776	101239791	P21453	0	+	101239776	101239791	255,102,0	1	15	0	.	Sphingosine 1-phosphate binding.
chr1	102886975	102887038	P12107	0	-	102886975	102887038	255,102,0	1	63	0	.	Nonhelical region (C-terminal).
chr1	102887038	103012457	P12107	0	-	102887038	103012457	255,102,0	1	125419	0	.	Triple-helical region.
chr1	103012457	103014549	P12107	0	-	103012457	103014549	255,102,0	1	2092	0	.	Telopeptide.
chr1	103014549	103014558	P12107	0	-	103014549	103014558	255,102,0	1	9	0	.	Short nonhelical segment.
chr1	103014558	103021757	P12107	0	-	103014558	103021757	255,102,0	1	7199	0	.	Triple-helical region (interrupted).
chr1	103021757	103031208	P12107	0	-	103021757	103031208	255,102,0	1	9451	0	.	Nonhelical region.
chr1	103526070	103541353	Q96LT9	0	+	103526070	103541353	255,102,0	1	15283	0	.	Necessary for interaction with PDCD7. Pubmed:16096647
chr1	103537347	103545035	Q96LT9	0	+	103537347	103545035	255,102,0	1	7688	0	.	Necessary for binding to m(7)G-capped U12 snRNA.
chr1	107148830	107324308	Q9Y2I2	0	+	107148830	107324308	255,102,0	1	175478	0	.	NGL discriminant loop I.
chr1	107324656	107324677	Q9Y2I2	0	+	107324656	107324677	255,102,0	1	21	0	.	NGL discriminant loop II.
chr1	107324851	107324860	Q9Y2I2	0	+	107324851	107324860	255,102,0	1	9	0	.	NGL discriminant loop III.
chr1	107573333	107704577	Q9UKW4	0	-	107573333	107704577	255,102,0	1	131244	0	.	Sufficient for interaction with ROS1. Pubmed:11094073
chr1	108746737	108779366	O00186	0	+	108746737	108779366	255,102,0	1	32629	0	.	Mediates interaction with DOC2B.
chr1	108896870	108904133	P81274	0	+	108896870	108904133	255,102,0	1	7263	0	.	Important for interaction with NUMA1; INSC and FRMPD1.
chr1	109235272	109235281	P49591	0	+	109235272	109235281	255,102,0	1	9	0	.	Serine binding.
chr1	109281032	109281831	Q6PGN9	0	-	109281032	109281831	255,102,0	1	799	0	.	4 X 4 AA repeats of P-X-X-P.
chr1	109314045	109314694	Q99523	0	-	109314045	109314694	255,102,0	1	649	0	.	Golgi to endosome transport and interactions with GGA1 and GGA2.
chr1	109314760	109323122	Q99523	0	-	109314760	109323122	255,102,0	1	8362	0	.	Interactions with LRPAP1 and NGFB.
chr1	109397709	109397745	Q99523	0	-	109397709	109397745	255,102,0	1	36	0	.	Intrachain binding of the propeptide and the extracellular domain.
chr1	109628390	109628408	Q01433	0	+	109628390	109628408	255,102,0	1	18	0	.	Substrate binding.
chr1	109630379	109630391	Q01433	0	+	109630379	109630391	255,102,0	1	12	0	.	Substrate binding.
chr1	109656407	109656413	Q03013	0	+	109656407	109656413	255,102,0	1	6	0	.	Glutathione binding.
chr1	109657237	109657252	Q03013	0	+	109657237	109657252	255,102,0	1	15	0	.	Glutathione binding.
chr1	109657276	109657592	Q03013	0	+	109657276	109657592	255,102,0	1	316	0	.	Glutathione binding.
chr1	109657625	109657631	Q03013	0	+	109657625	109657631	255,102,0	1	6	0	.	Glutathione binding.
chr1	109668133	109668139	P28161	0	+	109668133	109668139	255,102,0	1	6	0	.	Glutathione binding. Pubmed:16549767, Pubmed:19808963
chr1	109668938	109668950	P28161	0	+	109668938	109668950	255,102,0	1	12	0	.	Glutathione binding. Pubmed:16549767, Pubmed:19808963
chr1	109668986	109669292	P28161	0	+	109668986	109669292	255,102,0	1	306	0	.	Glutathione binding. Pubmed:16549767, Pubmed:19808963
chr1	109669325	109669331	P28161	0	+	109669325	109669331	255,102,0	1	6	0	.	Glutathione binding. Pubmed:16549767, Pubmed:19808963
chr1	109687891	109687897	P09488	0	+	109687891	109687897	255,102,0	1	6	0	.	Glutathione binding. Pubmed:16548513
chr1	109688686	109688698	P09488	0	+	109688686	109688698	255,102,0	1	12	0	.	Glutathione binding. Pubmed:16548513
chr1	109688734	109689050	P09488	0	+	109688734	109689050	255,102,0	1	316	0	.	Glutathione binding. Pubmed:16548513
chr1	109689083	109689089	P09488	0	+	109689083	109689089	255,102,0	1	6	0	.	Glutathione binding. Pubmed:16548513
chr1	109712330	109712336	P46439	0	+	109712330	109712336	255,102,0	1	6	0	.	Glutathione binding.
chr1	109713141	109713156	P46439	0	+	109713141	109713156	255,102,0	1	15	0	.	Glutathione binding.
chr1	109713180	109713486	P46439	0	+	109713180	109713486	255,102,0	1	306	0	.	Glutathione binding.
chr1	109713519	109713525	P46439	0	+	109713519	109713525	255,102,0	1	6	0	.	Glutathione binding.
chr1	109738324	109738330	P21266	0	-	109738324	109738330	255,102,0	1	6	0	.	Glutathione binding.
chr1	109738363	109739431	P21266	0	-	109738363	109739431	255,102,0	1	1068	0	.	Glutathione binding.
chr1	109739455	109739470	P21266	0	-	109739455	109739470	255,102,0	1	15	0	.	Glutathione binding.
chr1	109740251	109740257	P21266	0	-	109740251	109740257	255,102,0	1	6	0	.	Glutathione binding.
chr1	109923836	109923899	P09603	0	+	109923836	109923899	255,102,0	1	63	0	.	O-glycosylated at one site.
chr1	110009105	110011257	O43865	0	+	110009105	110011257	255,102,0	1	2152	0	.	PEST. Pubmed:25237103
chr1	110016401	110019077	O43865	0	+	110016401	110019077	255,102,0	1	2676	0	.	NAD binding.
chr1	110020822	110021677	O43865	0	+	110020822	110021677	255,102,0	1	855	0	.	PDZ-binding.
chr1	110211499	110211583	Q03721	0	+	110211499	110211583	255,102,0	1	84	0	.	Inactivation gate.
chr1	110603807	110603849	P16389	0	-	110603807	110603849	255,102,0	1	42	0	.	S4-S5 linker.
chr1	110604407	110604782	P16389	0	-	110604407	110604782	255,102,0	1	375	0	.	Tetramerization domain.
chr1	111312341	111312347	Q9BZP6	0	+	111312341	111312347	255,102,0	1	6	0	.	Chitooligosaccharide binding.
chr1	111314570	111314582	Q9BZP6	0	+	111314570	111314582	255,102,0	1	12	0	.	Chitooligosaccharide binding.
chr1	111318007	111318019	Q9BZP6	0	+	111318007	111318019	255,102,0	1	12	0	.	Chitooligosaccharide binding.
chr1	111727321	111727453	Q9NTI7	0	-	111727321	111727453	255,102,0	1	132	0	.	Inka box.
chr1	111765789	111766068	Q9UHI6	0	+	111765789	111766068	255,102,0	1	279	0	.	SMN interacting.
chr1	111780224	111780272	Q9UK17	0	-	111780224	111780272	255,102,0	1	48	0	.	Mediates dendritic targeting.
chr1	111982666	111982723	Q9UK17	0	-	111982666	111982723	255,102,0	1	57	0	.	Interaction with KCNIP2.
chr1	112699944	112700315	Q9HCE1	0	+	112699944	112700315	255,102,0	1	371	0	.	Interaction with AGO2 and APOBEC3G. Pubmed:22791714
chr1	113968529	113973158	Q86Z02	0	+	113968529	113973158	255,102,0	1	4629	0	.	Interaction with TP53. Pubmed:12702766
chr1	113968547	113970178	Q86Z02	0	+	113968547	113970178	255,102,0	1	1631	0	.	Required for localization to nuclear speckles.
chr1	113968580	113969962	Q86Z02	0	+	113968580	113969962	255,102,0	1	1382	0	.	SUMO interaction motifs (SIM); required for nuclear localization and kinase activity.
chr1	114093788	114097798	Q5T7P8	0	-	114093788	114097798	255,102,0	1	4010	0	.	Necessary for cell membrane association (isoform 2).
chr1	114153658	114153739	Q5T7P8	0	-	114153658	114153739	255,102,0	1	81	0	.	Cysteine motif.
chr1	114427846	114463132	Q9UPN9	0	-	114427846	114463132	255,102,0	1	35286	0	.	Necessary for oligomerization.
chr1	114510635	114511076	Q9UPN9	0	-	114510635	114511076	255,102,0	1	441	0	.	Necessary for E3 ubiquitin-protein ligase activity and repression of SMAD4 signaling and transcriptional repression.
chr1	114673923	114673935	P23109	0	-	114673923	114673935	255,102,0	1	12	0	.	Substrate binding.
chr1	114677996	114678014	P23109	0	-	114677996	114678014	255,102,0	1	18	0	.	Substrate binding.
chr1	114708549	114708609	P01111	0	-	114708549	114708609	255,102,0	1	60	0	.	Hypervariable region.
chr1	116387347	116387356	P05023	0	+	116387347	116387356	255,102,0	1	9	0	.	Phosphoinositide-3 kinase binding.
chr1	116754749	116754794	P06729	0	+	116754749	116754794	255,102,0	1	45	0	.	LFA-3 (CD58) binding region 1.
chr1	116754884	116754929	P06729	0	+	116754884	116754929	255,102,0	1	45	0	.	LFA-3 (CD58) binding region 2.
chr1	119794683	119798503	Q9BYZ8	0	-	119794683	119798503	255,102,0	1	3820	0	.	Carbohydrate-binding.
chr1	119798596	119799736	Q9BYZ8	0	-	119798596	119799736	255,102,0	1	1140	0	.	Carbohydrate-binding.
chr1	119894008	119894143	Q9UKF2	0	-	119894008	119894143	255,102,0	1	135	0	.	5 X 9 AA approximate repeats.
chr1	119922417	119925543	Q04721	0	-	119922417	119925543	255,102,0	1	3126	0	.	Negative regulatory region (NRR).
chr1	145850838	145850871	Q9Y6X2	0	-	145850838	145850871	255,102,0	1	33	0	.	SUMO1-binding.
chr1	145855804	145858987	Q9Y6X2	0	-	145855804	145858987	255,102,0	1	3183	0	.	Interaction with CCAR2. Pubmed:25406032
chr1	145912163	145912310	O96011	0	-	145912163	145912310	255,102,0	1	147	0	.	Interaction with PEX19, PEX11G and FIS1 and peroxisome targeting. Pubmed:10704444, Pubmed:20826455
chr1	147614584	147615857	O00512	0	+	147614584	147615857	255,102,0	1	1273	0	.	Interaction with PYGO1.
chr1	147619226	147619277	O00512	0	+	147619226	147619277	255,102,0	1	51	0	.	Interaction with CTNNB1. Pubmed:17052462
chr1	149791325	149791388	P12314	0	+	149791325	149791388	255,102,0	1	63	0	.	Interaction with EPB41L2. Pubmed:18023480
chr1	149913669	149913840	Q7L0J3	0	-	149913669	149913840	255,102,0	1	171	0	.	Interaction with SYT1.
chr1	149947253	149967297	Q6GQQ9	0	-	149947253	149967297	255,102,0	1	20044	0	.	Catalytic.
chr1	149949003	149967342	Q6GQQ9	0	-	149949003	149967342	255,102,0	1	18339	0	.	TRAF-binding.
chr1	149965801	149965822	Q6GQQ9	0	-	149965801	149965822	255,102,0	1	21	0	.	Regulatory loop. Pubmed:27732584
chr1	150156988	150158872	Q53GL0	0	+	150156988	150158872	255,102,0	1	1884	0	.	Interaction with capping proteins (CPs).
chr1	150156997	150159217	Q53GL0	0	+	150156997	150159217	255,102,0	1	2220	0	.	Interaction with ATM, CKIP, IFP35 and NMI. Pubmed:17197158, Pubmed:16325375
chr1	150159214	150159520	Q53GL0	0	+	150159214	150159520	255,102,0	1	306	0	.	Negative regulator of AP-1 activity.
chr1	150220693	150226646	Q9BTT0	0	-	150220693	150226646	255,102,0	1	5953	0	.	ZID domain.
chr1	150263127	150263133	Q9ULX7	0	+	150263127	150263133	255,102,0	1	6	0	.	Substrate binding.
chr1	150340440	150346027	O43395	0	+	150340440	150346027	255,102,0	1	5587	0	.	Mediates interaction with SART3. Pubmed:15314151
chr1	150510937	150512483	Q16610	0	+	150510937	150512483	255,102,0	1	1546	0	.	2 X approximate repeats.
chr1	150579005	150579221	Q07820	0	-	150579005	150579221	255,102,0	1	216	0	.	PEST-like.
chr1	150648617	150648653	Q9H4A5	0	-	150648617	150648653	255,102,0	1	36	0	.	Beta-hairpin required for oligomerization.
chr1	150959283	150959292	Q15047	0	+	150959283	150959292	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr1	150963738	150963997	Q15047	0	+	150963738	150963997	255,102,0	1	259	0	.	S-adenosyl-L-methionine binding.
chr1	150997674	150998093	Q8N5J2	0	-	150997674	150998093	255,102,0	1	419	0	.	Ubiquitin-binding domain (UBD). Pubmed:27292798
chr1	151034048	151034132	Q86TP1	0	+	151034048	151034132	255,102,0	1	84	0	.	Essential for homodimerization.
chr1	151055108	151055126	Q9NRR8	0	-	151055108	151055126	255,102,0	1	18	0	.	Mediates phosphoinositide-binding.
chr1	151168306	151169082	Q9BWG6	0	+	151168306	151169082	255,102,0	1	776	0	.	Required for interaction with LUC7L2.
chr1	151265543	151266330	P55036	0	+	151265543	151266330	255,102,0	1	787	0	.	Interaction with UBQLN1. Pubmed:15147878
chr1	151265600	151266009	P55036	0	+	151265600	151266009	255,102,0	1	409	0	.	Essential for ubiquitin-binding.
chr1	151266402	151266417	P55036	0	+	151266402	151266417	255,102,0	1	15	0	.	Essential for ubiquitin-binding.
chr1	151344810	151346248	P48382	0	-	151344810	151346248	255,102,0	1	1438	0	.	N-terminal domain.
chr1	151345140	151345155	P48382	0	-	151345140	151345155	255,102,0	1	15	0	.	Leucine-rich region; critical for dimer formation and for interaction with RFXAP.
chr1	151406626	151407239	Q7Z3K3	0	-	151406626	151407239	255,102,0	1	613	0	.	Required for interaction with CBX5.
chr1	151662180	151668572	Q96L92	0	+	151662180	151668572	255,102,0	1	6392	0	.	FERM-like region F1.
chr1	151668602	151692458	Q96L92	0	+	151668602	151692458	255,102,0	1	23856	0	.	FERM-like region F2.
chr1	151692467	151693480	Q96L92	0	+	151692467	151693480	255,102,0	1	1013	0	.	FERM-like region F3.
chr1	151807474	151814919	P51449	0	-	151807474	151814919	255,102,0	1	7445	0	.	Ligand-binding.
chr1	151814919	151816673	P51449	0	-	151814919	151816673	255,102,0	1	1754	0	.	Hinge.
chr1	151817260	151831764	P51449	0	-	151817260	151831764	255,102,0	1	14504	0	.	Modulating.
chr1	151877061	151877067	Q5T1C6	0	-	151877061	151877067	255,102,0	1	6	0	.	Substrate binding.
chr1	151983243	151983279	P60903	0	-	151983243	151983279	255,102,0	1	36	0	.	Ancestral calcium site.
chr1	152107534	152109343	Q07283	0	-	152107534	152109343	255,102,0	1	1809	0	.	23 X 26 AA approximate tandem repeats.
chr1	152109604	152110501	Q07283	0	-	152109604	152110501	255,102,0	1	897	0	.	10 X 30 AA tandem repeats.
chr1	152111167	152111944	Q07283	0	-	152111167	152111944	255,102,0	1	777	0	.	9 X 28 AA approximate tandem repeats.
chr1	152111941	152112085	Q07283	0	-	152111941	152112085	255,102,0	1	144	0	.	8 X 6 AA tandem repeats of R-R-E-Q-Q-L.
chr1	152112085	152112277	Q07283	0	-	152112085	152112277	255,102,0	1	192	0	.	5 X 13 AA tandem repeats of R-R-E-Q-E-E-E-R-R-E-Q-Q-L.
chr1	152112943	152114080	Q07283	0	-	152112943	152114080	255,102,0	1	1137	0	.	S-100-like.
chr1	152156825	152157889	Q6XPR3	0	-	152156825	152157889	255,102,0	1	1064	0	.	S-100-like.
chr1	152221385	152223253	Q86YZ3	0	-	152221385	152223253	255,102,0	1	1868	0	.	S-100-like.
chr1	152357542	152358884	Q5D862	0	-	152357542	152358884	255,102,0	1	1342	0	.	S-100-like.
chr1	152884437	152884626	P49901	0	+	152884437	152884626	255,102,0	1	189	0	.	7 X 7 (OR 8) AA approximate repeats.
chr1	152910253	152911423	P07476	0	+	152910253	152911423	255,102,0	1	1170	0	.	39 X 10 AA approximate tandem repeats of [LP]-[EKG]-[LHVYQEK]-[PLSQE]-[EQDV]-[QHEKRGA]-Q-[EMVQLP]-[GKLE]-[QHVNLD].
chr1	152985236	152985317	P35321	0	+	152985236	152985317	255,102,0	1	81	0	.	2 X 12 AA approximate repeats.
chr1	152985320	152985464	P35321	0	+	152985320	152985464	255,102,0	1	144	0	.	6 X 8 AA approximate tandem repeats.
chr1	153003146	153003482	Q9UBC9	0	+	153003146	153003482	255,102,0	1	336	0	.	14 X 8 AA approximate tandem repeats.
chr1	153032351	153032432	P22528	0	+	153032351	153032432	255,102,0	1	81	0	.	2 X 12 AA approximate repeats.
chr1	153032435	153032579	P22528	0	+	153032435	153032579	255,102,0	1	144	0	.	6 X 8 AA approximate tandem repeats.
chr1	153040205	153040286	P22532	0	-	153040205	153040286	255,102,0	1	81	0	.	3 X 9 AA tandem repeats of P-K-C-P-[EQ]-P-C-P-[PS].
chr1	153056594	153056675	P35326	0	-	153056594	153056675	255,102,0	1	81	0	.	3 X 9 AA tandem repeats of P-K-C-P-[EQ]-P-C-P-P.
chr1	153070698	153070779	P35325	0	-	153070698	153070779	255,102,0	1	81	0	.	3 X 9 AA tandem repeats of P-K-C-P-[EQ]-P-C-P-P.
chr1	153093610	153093691	P22531	0	-	153093610	153093691	255,102,0	1	81	0	.	3 X 9 AA tandem repeats of P-K-C-P-[EQ]-P-C-P-P.
chr1	153112592	153112673	Q96RM1	0	-	153112592	153112673	255,102,0	1	81	0	.	3 X 9 AA tandem repeats of [PS]-K-C-P-[EQ]-[PS]-C-P-P.
chr1	153149969	153150050	Q9BYE4	0	-	153149969	153150050	255,102,0	1	81	0	.	3 X 9 AA approximate tandem repeats.
chr1	153299152	153299170	Q96LB9	0	-	153299152	153299170	255,102,0	1	18	0	.	Interaction with murein.
chr1	153330826	153330832	Q96LB8	0	-	153330826	153330832	255,102,0	1	6	0	.	Interaction with murein.
chr1	153337217	153337247	Q96LB8	0	-	153337217	153337247	255,102,0	1	30	0	.	Interaction with murein.
chr1	153373946	153374481	P80511	0	-	153373946	153374481	255,102,0	1	535	0	.	Hinge domain.
chr1	153643279	153645140	Q9Y3Y2	0	+	153643279	153645140	255,102,0	1	1861	0	.	Interaction with PRMT1.
chr1	153659503	153661298	O95295	0	+	153659503	153661298	255,102,0	1	1795	0	.	Interaction with TOR1A.
chr1	153812111	153816471	Q8WXI9	0	-	153812111	153816471	255,102,0	1	4360	0	.	CR2; histone tail-binding.
chr1	153818802	153818895	Q8WXI9	0	-	153818802	153818895	255,102,0	1	93	0	.	CR1; MBD2- and MBD3-binding.
chr1	153829342	153833702	Q8WXI9	0	-	153829342	153833702	255,102,0	1	4360	0	.	CR2; histone tail-binding.
chr1	153836033	153836126	Q8WXI9	0	-	153836033	153836126	255,102,0	1	93	0	.	CR1; MBD2- and MBD3-binding.
chr1	153960499	153960505	Q9NY26	0	-	153960499	153960505	255,102,0	1	6	0	.	Heavy metals binding.
chr1	153972989	153973079	Q8TEY5	0	+	153972989	153973079	255,102,0	1	90	0	.	Basic motif.
chr1	153973225	153973407	Q8TEY5	0	+	153973225	153973407	255,102,0	1	182	0	.	Leucine-zipper.
chr1	154272726	154273405	O00165	0	+	154272726	154273405	255,102,0	1	679	0	.	Required for localization in mitochondria.
chr1	154273796	154275698	O00165	0	+	154273796	154275698	255,102,0	1	1902	0	.	Involved in HCLS1 binding.
chr1	154274967	154275215	O00165	0	+	154274967	154275215	255,102,0	1	248	0	.	Involved in CASP9 binding.
chr1	154274970	154275470	O00165	0	+	154274970	154275470	255,102,0	1	500	0	.	Involved in GNA13 binding.
chr1	154274991	154275698	O00165	0	+	154274991	154275698	255,102,0	1	707	0	.	Required for localization in sarcoplasmic reticulum.
chr1	154274994	154275698	O00165	0	+	154274994	154275698	255,102,0	1	704	0	.	Involved in PKD2 binding.
chr1	154275203	154275404	O00165	0	+	154275203	154275404	255,102,0	1	201	0	.	Involved in PLN binding.
chr1	154275203	154275464	O00165	0	+	154275203	154275464	255,102,0	1	261	0	.	Involved in ATP2A2 binding.
chr1	154275668	154275698	O00165	0	+	154275668	154275698	255,102,0	1	30	0	.	Required for ITGB6 binding.
chr1	154965704	154966483	P29353	0	-	154965704	154966483	255,102,0	1	779	0	.	CH1.
chr1	154984033	154988347	Q8NFF5	0	+	154984033	154988347	255,102,0	1	4314	0	.	Molybdenum cofactor biosynthesis protein-like.
chr1	154989633	154992938	Q8NFF5	0	+	154989633	154992938	255,102,0	1	3305	0	.	FAD synthase.
chr1	155137978	155138278	Q9BRV3	0	+	155137978	155138278	255,102,0	1	300	0	.	Mediates interaction with TRPV2.
chr1	155277725	155277863	Q9P1Z3	0	+	155277725	155277863	255,102,0	1	138	0	.	Involved in subunit assembly.
chr1	155290604	155290622	P30613	0	-	155290604	155290622	255,102,0	1	18	0	.	Allosteric activator binding. Pubmed:11960989
chr1	155291933	155293190	P30613	0	-	155291933	155293190	255,102,0	1	1257	0	.	Allosteric activator binding. Pubmed:11960989
chr1	155293129	155293267	Q9P1Z3	0	+	155293129	155293267	255,102,0	1	138	0	.	Involved in subunit assembly.
chr1	155306008	155306026	P30613	0	-	155306008	155306026	255,102,0	1	18	0	.	Allosteric activator binding. Pubmed:11960989
chr1	155307337	155308594	P30613	0	-	155307337	155308594	255,102,0	1	1257	0	.	Allosteric activator binding. Pubmed:11960989
chr1	155324894	155325673	Q9BVN2	0	+	155324894	155325673	255,102,0	1	779	0	.	Interaction with TRAF6. Pubmed:19365808
chr1	155325864	155326734	Q9BVN2	0	+	155325864	155326734	255,102,0	1	870	0	.	Interaction with IKBKG. Pubmed:19365808
chr1	155357695	155378536	Q9NR48	0	-	155357695	155378536	255,102,0	1	20841	0	.	Catalytic domain.
chr1	155765455	155784080	Q3T8J9	0	-	155765455	155784080	255,102,0	1	18625	0	.	Required for interaction with YY1, SIN3A AND HDAC1, and transcriptional repression activity.
chr1	155965399	155965710	Q92974	0	-	155965399	155965710	255,102,0	1	311	0	.	Interaction with DYNLT1.
chr1	156055362	156055404	Q9Y2Q5	0	+	156055362	156055404	255,102,0	1	42	0	.	Required for location at endosomes.
chr1	156114918	156115017	P02545	0	+	156114918	156115017	255,102,0	1	99	0	.	Head.
chr1	156114918	156130650	P02545	0	+	156114918	156130650	255,102,0	1	15732	0	.	Interaction with MLIP. Pubmed:21498514
chr1	156115017	156115128	P02545	0	+	156115017	156115128	255,102,0	1	111	0	.	Coil 1A.
chr1	156115017	156136113	P02545	0	+	156115017	156136113	255,102,0	1	21096	0	.	Rod.
chr1	156115128	156115158	P02545	0	+	156115128	156115158	255,102,0	1	30	0	.	Linker 1.
chr1	156115158	156134819	P02545	0	+	156115158	156134819	255,102,0	1	19661	0	.	Coil 1B.
chr1	156134819	156134891	P02545	0	+	156134819	156134891	255,102,0	1	72	0	.	Linker 2.
chr1	156134891	156136113	P02545	0	+	156134891	156136113	255,102,0	1	1222	0	.	Coil 2.
chr1	156136113	156139103	P02545	0	+	156136113	156139103	255,102,0	1	2990	0	.	Tail.
chr1	156298784	156299030	Q6RSH7	0	-	156298784	156299030	255,102,0	1	246	0	.	Beta-domain.
chr1	156476493	156476514	Q14814	0	-	156476493	156476514	255,102,0	1	21	0	.	Beta domain.
chr1	156592427	156592442	Q8NCW5	0	+	156592427	156592442	255,102,0	1	15	0	.	NAD(P)HX.
chr1	156593455	156593476	Q8NCW5	0	+	156593455	156593476	255,102,0	1	21	0	.	NAD(P)HX.
chr1	156652507	156652540	Q96GW7	0	+	156652507	156652540	255,102,0	1	33	0	.	O-glycosylated at two sites.
chr1	156652567	156652585	Q96GW7	0	+	156652567	156652585	255,102,0	1	18	0	.	O-glycosylated at two sites.
chr1	156652654	156652675	Q96GW7	0	+	156652654	156652675	255,102,0	1	21	0	.	O-glycosylated at one site.
chr1	156669324	156673496	P48681	0	-	156669324	156673496	255,102,0	1	4172	0	.	Tail.
chr1	156673496	156676679	P48681	0	-	156673496	156676679	255,102,0	1	3183	0	.	Coil 2B.
chr1	156673496	156677243	P48681	0	-	156673496	156677243	255,102,0	1	3747	0	.	Rod.
chr1	156676679	156676688	P48681	0	-	156676679	156676688	255,102,0	1	9	0	.	Linker 2.
chr1	156676688	156676745	P48681	0	-	156676688	156676745	255,102,0	1	57	0	.	Coil 2A.
chr1	156676745	156676811	P48681	0	-	156676745	156676811	255,102,0	1	66	0	.	Linker 12.
chr1	156676811	156677099	P48681	0	-	156676811	156677099	255,102,0	1	288	0	.	Coil 1B.
chr1	156677099	156677135	P48681	0	-	156677099	156677135	255,102,0	1	36	0	.	Linker 1.
chr1	156677135	156677243	P48681	0	-	156677135	156677243	255,102,0	1	108	0	.	Coil 1A.
chr1	156677243	156677264	P48681	0	-	156677243	156677264	255,102,0	1	21	0	.	Head.
chr1	156700037	156700046	P29373	0	-	156700037	156700046	255,102,0	1	9	0	.	Retinoic acid binding.
chr1	156767771	156768071	Q92733	0	+	156767771	156768071	255,102,0	1	300	0	.	Mediates interaction with MAD2L2. Pubmed:11717438
chr1	156875569	156875635	P04629	0	+	156875569	156875635	255,102,0	1	66	0	.	Interaction with SQSTM1.
chr1	158182207	158182219	P15813	0	+	158182207	158182219	255,102,0	1	12	0	.	Glycolipid binding. Pubmed:16007090, Pubmed:17581592
chr1	158255292	158255307	P06126	0	+	158255292	158255307	255,102,0	1	15	0	.	Glycolipid binding. Pubmed:12833155
chr1	159018252	159032541	Q16666	0	+	159018252	159032541	255,102,0	1	14289	0	.	Interaction with TP53 C-terminus.
chr1	159051723	159054841	Q16666	0	+	159051723	159054841	255,102,0	1	3118	0	.	Interaction with TP53 core domain.
chr1	160123272	160123281	P50993	0	+	160123272	160123281	255,102,0	1	9	0	.	Interaction with phosphoinositide-3 kinase.
chr1	160155104	160155113	Q13733	0	+	160155104	160155113	255,102,0	1	9	0	.	Interaction with phosphoinositide-3 kinase.
chr1	160213228	160213258	Q15121	0	+	160213228	160213258	255,102,0	1	30	0	.	Microtubule-binding.
chr1	160213456	160213480	Q15121	0	+	160213456	160213480	255,102,0	1	24	0	.	Microtubule-binding.
chr1	160283016	160285121	P40855	0	-	160283016	160285121	255,102,0	1	2105	0	.	Necessary for PEX19 function on peroxisome biogenesis.
chr1	160283541	160285121	P40855	0	-	160283541	160285121	255,102,0	1	1580	0	.	Docking to the peroxisome membrane and binding to PEX3.
chr1	160751406	160752200	Q9NQ25	0	+	160751406	160752200	255,102,0	1	794	0	.	Interaction with FYN when phosphorylated at Tyr-284.
chr1	160879310	160879316	Q8WWA0	0	-	160879310	160879316	255,102,0	1	6	0	.	Carbohydrate binding. Pubmed:26148048
chr1	160947928	160947934	Q8WWU7	0	-	160947928	160947934	255,102,0	1	6	0	.	Carbohydrate binding.
chr1	161039976	161040234	P22415	0	-	161039976	161040234	255,102,0	1	258	0	.	Leucine-zipper.
chr1	161172255	161172264	O60512	0	-	161172255	161172264	255,102,0	1	9	0	.	UDP-alpha-D-galactose binding.
chr1	161173618	161173630	O60512	0	-	161173618	161173630	255,102,0	1	12	0	.	N-acetyl-D-glucosamine binding.
chr1	161173947	161173953	O60512	0	-	161173947	161173953	255,102,0	1	6	0	.	UDP-alpha-D-galactose binding.
chr1	161174025	161174034	O60512	0	-	161174025	161174034	255,102,0	1	9	0	.	UDP-alpha-D-galactose binding.
chr1	161175079	161175094	O60512	0	-	161175079	161175094	255,102,0	1	15	0	.	UDP-alpha-D-galactose binding.
chr1	161191140	161192096	O75173	0	-	161191140	161192096	255,102,0	1	956	0	.	Spacer.
chr1	161222973	161223009	P02652	0	-	161222973	161223009	255,102,0	1	36	0	.	O-glycosylated at one site.
chr1	161229008	161229092	Q969M1	0	+	161229008	161229092	255,102,0	1	84	0	.	Required for mitochondrial targeting.
chr1	161524664	161525822	P17066	0	+	161524664	161525822	255,102,0	1	1158	0	.	Nucleotide-binding domain (NBD).
chr1	161525843	161526191	P17066	0	+	161525843	161526191	255,102,0	1	348	0	.	Substrate-binding domain (SBD).
chr1	161751668	161751686	Q9UNI6	0	+	161751668	161751686	255,102,0	1	18	0	.	Substrate binding. Pubmed:24531476
chr1	161766360	161791503	P18850	0	+	161766360	161791503	255,102,0	1	25143	0	.	Transcription activation.
chr1	161819644	161819740	P18850	0	+	161819644	161819740	255,102,0	1	96	0	.	Basic motif.
chr1	161819764	161819788	P18850	0	+	161819764	161819788	255,102,0	1	24	0	.	Leucine-zipper.
chr1	161851803	161912343	P18850	0	+	161851803	161912343	255,102,0	1	60540	0	.	Interaction with THBS4. Pubmed:22682248
chr1	162367425	162367464	O75052	0	+	162367425	162367464	255,102,0	1	39	0	.	Interaction with NOS1.
chr1	162576817	162576829	Q16222	0	+	162576817	162576829	255,102,0	1	12	0	.	UTP binding.
chr1	163326051	163348975	Q9BZD4	0	+	163326051	163348975	255,102,0	1	22924	0	.	Interaction with the N-terminus of NDC80.
chr1	163348975	163355466	Q9BZD4	0	+	163348975	163355466	255,102,0	1	6491	0	.	Interaction with the C-terminus of NDC80 and the SPBC24-SPBC25 subcomplex.
chr1	165401265	165410951	P48443	0	-	165401265	165410951	255,102,0	1	9686	0	.	Ligand-binding.
chr1	165410951	165417050	P48443	0	-	165410951	165417050	255,102,0	1	6099	0	.	Hinge.
chr1	165419897	165444893	P48443	0	-	165419897	165444893	255,102,0	1	24996	0	.	Modulating.
chr1	168196546	168200043	O75663	0	+	168196546	168200043	255,102,0	1	3497	0	.	Interaction with PPP2CA.
chr1	168696596	168728967	Q07507	0	-	168696596	168728967	255,102,0	1	32371	0	.	3 X 6 AA repeats of D-R-[EQ]-W-[NQK]-[FY].
chr1	168696596	168729099	Q07507	0	-	168696596	168729099	255,102,0	1	32503	0	.	2 X 53-55 AA tandem repeats.
chr1	169130012	169131552	P05026	0	+	169130012	169131552	255,102,0	1	1540	0	.	immunoglobulin-like.
chr1	169387158	169387179	Q9H2G9	0	+	169387158	169387179	255,102,0	1	21	0	.	Essential for interaction with GORASP2. Pubmed:11739401
chr1	169540370	169543016	P12259	0	-	169540370	169543016	255,102,0	1	2646	0	.	B.
chr1	169540586	169541537	P12259	0	-	169540586	169541537	255,102,0	1	951	0	.	35 X 9 AA approximate tandem repeats of [TNP]-L-S-P-D-L-S-Q-T.
chr1	169542305	169542407	P12259	0	-	169542305	169542407	255,102,0	1	102	0	.	2 X 17 AA tandem repeats.
chr1	169853715	169854797	Q8IZE3	0	-	169853715	169854797	255,102,0	1	1082	0	.	Interaction with EZR. Pubmed:12651155
chr1	170166690	170166696	Q5VVY1	0	+	170166690	170166696	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr1	170544744	170552459	Q5T7V8	0	+	170544744	170552459	255,102,0	1	7715	0	.	Necessary for interaction with RCHY1. Pubmed:15781263
chr1	173530048	173534534	Q5TAH2	0	-	173530048	173534534	255,102,0	1	4486	0	.	Ion transport-like.
chr1	173837005	173837017	Q6PI48	0	+	173837005	173837017	255,102,0	1	12	0	.	Aspartate.
chr1	173982798	173983469	Q5TC82	0	-	173982798	173983469	255,102,0	1	671	0	.	ROQ.
chr1	175000183	175006749	Q9HB71	0	+	175000183	175006749	255,102,0	1	6566	0	.	Interaction with SIAH1.
chr1	175004814	175010076	Q9HB71	0	+	175004814	175010076	255,102,0	1	5262	0	.	Interaction with SKP1. Pubmed:11389839
chr1	175008635	175010076	Q9HB71	0	+	175008635	175010076	255,102,0	1	1441	0	.	Interaction with S100A6.
chr1	175988324	175988333	Q8NHY2	0	-	175988324	175988333	255,102,0	1	9	0	.	Interaction with TRIB1. Pubmed:27041596
chr1	176594927	176690261	Q9BXP8	0	+	176594927	176690261	255,102,0	1	95334	0	.	Metalloprotease.
chr1	177961704	177967882	Q96JE7	0	-	177961704	177967882	255,102,0	1	6178	0	.	Required for endoplasmic reticulum localization.
chr1	178893967	178916356	Q86X27	0	+	178893967	178916356	255,102,0	1	22389	0	.	Required for stimulation of nucleotide exchange by RALA.
chr1	179107720	179108209	P42684	0	-	179107720	179108209	255,102,0	1	489	0	.	F-actin-binding.
chr1	179108476	179109187	P42684	0	-	179108476	179109187	255,102,0	1	711	0	.	F-actin-binding.
chr1	179131383	179229394	P42684	0	-	179131383	179229394	255,102,0	1	98011	0	.	CAP.
chr1	179846073	179846778	Q8NFQ8	0	-	179846073	179846778	255,102,0	1	705	0	.	Interaction with TOR1A. Pubmed:23569223
chr1	179917552	179918236	Q5JTV8	0	+	179917552	179918236	255,102,0	1	684	0	.	Interaction with TOR1A.
chr1	180502047	180502062	Q9BR61	0	-	180502047	180502062	255,102,0	1	15	0	.	Acyl-CoA binding.
chr1	180806085	180806109	Q9UBH6	0	+	180806085	180806109	255,102,0	1	24	0	.	Important for inositol polyphosphate binding.
chr1	181049050	181049311	Q95460	0	+	181049050	181049311	255,102,0	1	261	0	.	Alpha-1.
chr1	181049050	181050285	Q95460	0	+	181049050	181050285	255,102,0	1	1235	0	.	Ligand-binding.
chr1	181050009	181050285	Q95460	0	+	181050009	181050285	255,102,0	1	276	0	.	Alpha-2.
chr1	181052233	181052509	Q95460	0	+	181052233	181052509	255,102,0	1	276	0	.	Alpha-3.
chr1	181053571	181053598	Q95460	0	+	181053571	181053598	255,102,0	1	27	0	.	Connecting peptide.
chr1	181711017	181715339	Q15878	0	+	181711017	181715339	255,102,0	1	4322	0	.	Binding to the beta subunit.
chr1	182585981	182586050	Q05823	0	-	182585981	182586050	255,102,0	1	69	0	.	2-5A binding (P-loop) 2.
chr1	182586080	182586122	Q05823	0	-	182586080	182586122	255,102,0	1	42	0	.	2-5A binding (P-loop) 1.
chr1	182806152	182806158	Q9BXD5	0	+	182806152	182806158	255,102,0	1	6	0	.	Substrate binding.
chr1	182842566	182858180	Q08211	0	+	182842566	182858180	255,102,0	1	15614	0	.	Interaction with CREBBP. Pubmed:9323138
chr1	182858117	182858807	Q08211	0	+	182858117	182858807	255,102,0	1	690	0	.	Interaction with BRCA1. Pubmed:9662397
chr1	182858822	182859117	Q08211	0	+	182858822	182859117	255,102,0	1	295	0	.	MTAD.
chr1	182884802	182887401	Q08211	0	+	182884802	182887401	255,102,0	1	2599	0	.	NTD.
chr1	183127368	183142787	P11047	0	+	183127368	183142787	255,102,0	1	15419	0	.	Domain II and I.
chr1	183231052	183243397	Q13753	0	+	183231052	183243397	255,102,0	1	12345	0	.	Domain II and I.
chr1	183278564	183278570	Q9BZQ4	0	-	183278564	183278570	255,102,0	1	6	0	.	Substrate binding.
chr1	183290163	183290175	Q9BZQ4	0	-	183290163	183290175	255,102,0	1	12	0	.	Substrate binding.
chr1	183293707	183293716	Q9BZQ4	0	-	183293707	183293716	255,102,0	1	9	0	.	Substrate binding.
chr1	185087556	185098144	Q99496	0	+	185087556	185098144	255,102,0	1	10588	0	.	Interaction with HIP2. Pubmed:11513855
chr1	185300987	185307530	Q9Y6Y0	0	-	185300987	185307530	255,102,0	1	6543	0	.	Sufficient for AHR interaction and signaling.
chr1	186332197	186333143	P12270	0	-	186332197	186333143	255,102,0	1	946	0	.	Sufficient and essential for mediating its nuclear import.
chr1	186341087	186343424	P12270	0	-	186341087	186343424	255,102,0	1	2337	0	.	Necessary for interaction with HSF1. Pubmed:17897941
chr1	186357581	186359879	P12270	0	-	186357581	186359879	255,102,0	1	2298	0	.	Necessary for association to the NPC.
chr1	186367961	186374989	P12270	0	-	186367961	186374989	255,102,0	1	7028	0	.	Necessary for interaction with HSF1. Pubmed:17897941
chr1	186374989	186375022	P12270	0	-	186374989	186375022	255,102,0	1	33	0	.	Sufficient for interaction with TPR.
chr1	186443981	186444389	P20941	0	-	186443981	186444389	255,102,0	1	408	0	.	Thioredoxin fold.
chr1	186854354	186911365	P47712	0	+	186854354	186911365	255,102,0	1	57011	0	.	Phospholipid binding.
chr1	192809164	192810253	P41220	0	+	192809164	192810253	255,102,0	1	1089	0	.	Necessary for membrane association. Pubmed:11278586
chr1	192810391	192811054	P41220	0	+	192810391	192811054	255,102,0	1	663	0	.	Necessary to inhibit protein synthesis. Pubmed:19736320
chr1	193016353	193021105	Q9Y5K5	0	-	193016353	193021105	255,102,0	1	4752	0	.	Interaction with ADRM1.
chr1	193069411	193076551	P10155	0	+	193069411	193076551	255,102,0	1	7140	0	.	RNA-binding.
chr1	193077044	193084728	P10155	0	+	193077044	193084728	255,102,0	1	7684	0	.	VWFA-like domain.
chr1	193141934	193147887	Q6P1J9	0	+	193141934	193147887	255,102,0	1	5953	0	.	Interaction with CTNNB1. Pubmed:16630820
chr1	193141934	193250709	Q6P1J9	0	+	193141934	193250709	255,102,0	1	108775	0	.	Interaction with POLR2A and PAF1.
chr1	198253039	198253081	Q8TDX7	0	+	198253039	198253081	255,102,0	1	42	0	.	NTE motif.
chr1	200048731	200111261	O00482	0	+	200048731	200111261	255,102,0	1	62530	0	.	Ligand-binding.
chr1	200120831	200120849	O00482	0	+	200120831	200120849	255,102,0	1	18	0	.	Lipid binding.
chr1	200553390	200592192	Q15058	0	-	200553390	200592192	255,102,0	1	38802	0	.	Required for CIT-binding.
chr1	200600444	200617658	Q15058	0	-	200600444	200617658	255,102,0	1	17214	0	.	Required for microtubule-binding with high affinity.
chr1	200617655	200618723	Q15058	0	-	200617655	200618723	255,102,0	1	1068	0	.	Required for PRC1-binding.
chr1	200988766	201003600	O75037	0	-	200988766	201003600	255,102,0	1	14834	0	.	Interaction with TRIM3.
chr1	201050420	201051088	Q13698	0	-	201050420	201051088	255,102,0	1	668	0	.	Dihydropyridine binding.
chr1	201050453	201051052	Q13698	0	-	201050453	201051052	255,102,0	1	599	0	.	Phenylalkylamine binding.
chr1	201061290	201062035	Q13698	0	-	201061290	201062035	255,102,0	1	745	0	.	Dihydropyridine binding.
chr1	201085463	201085517	Q13698	0	-	201085463	201085517	255,102,0	1	54	0	.	Binding to the beta subunit.
chr1	201386547	201386754	O00515	0	-	201386547	201386754	255,102,0	1	207	0	.	8 X SEK repeats.
chr1	201411458	201411524	P19237	0	-	201411458	201411524	255,102,0	1	66	0	.	Involved in binding TNC and actin.
chr1	201414562	201417790	P19237	0	-	201414562	201417790	255,102,0	1	3228	0	.	Involved in binding TNC.
chr1	201899431	201899491	P29536	0	-	201899431	201899491	255,102,0	1	60	0	.	5 X 4 AA approximate tandem repeats.
chr1	201900133	201900520	P29536	0	-	201900133	201900520	255,102,0	1	387	0	.	8 X approximate tandem repeats.
chr1	201997355	201997370	Q9H4A4	0	+	201997355	201997370	255,102,0	1	15	0	.	Substrate binding.
chr1	202150408	202152546	A0A024R963	0	-	202150408	202152546	255,102,0	1	2138	0	.	Substrate binding.
chr1	202150408	202152546	A0A024R9A7	0	-	202150408	202152546	255,102,0	1	2138	0	.	Substrate binding.
chr1	202150408	202152546	J3KR55	0	-	202150408	202152546	255,102,0	1	2138	0	.	Substrate binding.
chr1	202150408	202152546	P35236	0	-	202150408	202152546	255,102,0	1	2138	0	.	Substrate binding.
chr1	202158270	202159291	P35236	0	-	202158270	202159291	255,102,0	1	1021	0	.	Interaction with MAP kinases.
chr1	202596879	202603067	Q8N9I0	0	-	202596879	202603067	255,102,0	1	6188	0	.	Phospholipid binding.
chr1	202892535	202894672	Q53G59	0	-	202892535	202894672	255,102,0	1	2137	0	.	Interaction with DVL3. Pubmed:16547521
chr1	203179582	203179802	P36222	0	-	203179582	203179802	255,102,0	1	220	0	.	Important for AKT1 activation and IL8 production.
chr1	203181251	203181263	P36222	0	-	203181251	203181263	255,102,0	1	12	0	.	Chitooligosaccharide binding.
chr1	203184589	203184601	P36222	0	-	203184589	203184601	255,102,0	1	12	0	.	Chitooligosaccharide binding.
chr1	203185227	203185233	P36222	0	-	203185227	203185233	255,102,0	1	6	0	.	Chitooligosaccharide binding.
chr1	203222291	203222303	Q13231	0	-	203222291	203222303	255,102,0	1	12	0	.	Chitooligosaccharide binding.
chr1	203225061	203225073	Q13231	0	-	203225061	203225073	255,102,0	1	12	0	.	Chitooligosaccharide binding.
chr1	203225712	203225718	Q13231	0	-	203225712	203225718	255,102,0	1	6	0	.	Chitooligosaccharide binding.
chr1	203800117	203800366	P86452	0	+	203800117	203800366	255,102,0	1	249	0	.	HATC (Hobo-Ac-Tam3) domain.
chr1	204190537	204190567	Q15726	0	-	204190537	204190567	255,102,0	1	30	0	.	Essential for receptor binding and receptor activation.
chr1	204468908	204469799	O00750	0	-	204468908	204469799	255,102,0	1	891	0	.	Interaction with GRB2. Pubmed:11533253
chr1	204544597	204549205	O15151	0	+	204544597	204549205	255,102,0	1	4608	0	.	Region II.
chr1	204549385	204549679	O15151	0	+	204549385	204549679	255,102,0	1	294	0	.	Necessary for interaction with USP2. Pubmed:19838211
chr1	206479096	206493274	Q14164	0	+	206479096	206493274	255,102,0	1	14178	0	.	Interaction with DDX3X.
chr1	206480078	206480477	Q14164	0	+	206480078	206480477	255,102,0	1	399	0	.	Leucine-zipper.
chr1	206728844	206729038	P49137	0	+	206728844	206729038	255,102,0	1	194	0	.	Staurosporine binding.
chr1	206731841	206732607	P49137	0	+	206731841	206732607	255,102,0	1	766	0	.	Autoinhibitory helix.
chr1	206732610	206732685	P49137	0	+	206732610	206732685	255,102,0	1	75	0	.	p38 MAPK-binding site.
chr1	207049178	207049196	Q5VVQ6	0	-	207049178	207049196	255,102,0	1	18	0	.	S2 site. Pubmed:23827681
chr1	207049265	207049280	Q5VVQ6	0	-	207049265	207049280	255,102,0	1	15	0	.	His-loop. Pubmed:23827681
chr1	207049397	207049430	Q5VVQ6	0	-	207049397	207049430	255,102,0	1	33	0	.	Variable-loop. Pubmed:23827681
chr1	207049586	207049607	Q5VVQ6	0	-	207049586	207049607	255,102,0	1	21	0	.	Cys-loop. Pubmed:23827681
chr1	207049682	207050883	Q5VVQ6	0	-	207049682	207050883	255,102,0	1	1201	0	.	UBX-like. Pubmed:23827681
chr1	207054720	207067610	O60825	0	+	207054720	207067610	255,102,0	1	12890	0	.	6-phosphofructo-2-kinase.
chr1	207067610	207072368	O60825	0	+	207067610	207072368	255,102,0	1	4758	0	.	Fructose-2,6-bisphosphatase.
chr1	209611465	209611827	Q96NX5	0	+	209611465	209611827	255,102,0	1	362	0	.	Autoinhibitory domain.
chr1	209611525	209611830	Q96NX5	0	+	209611525	209611830	255,102,0	1	305	0	.	Calmodulin-binding.
chr1	209615279	209623089	Q13751	0	-	209615279	209623089	255,102,0	1	7810	0	.	Domain I.
chr1	209623089	209623507	Q13751	0	-	209623089	209623507	255,102,0	1	418	0	.	Domain alpha.
chr1	209623507	209625889	Q13751	0	-	209623507	209625889	255,102,0	1	2382	0	.	Domain II.
chr1	210623621	210623645	Q5VTY9	0	+	210623621	210623645	255,102,0	1	24	0	.	GTP-binding. Pubmed:11160356
chr1	210683358	210683481	O95259	0	-	210683358	210683481	255,102,0	1	123	0	.	CAD (involved in subunit assembly).
chr1	210683940	210775443	O95259	0	-	210683940	210775443	255,102,0	1	91503	0	.	Calmodulin-binding. Pubmed:10880439
chr1	210775356	210775365	O95259	0	-	210775356	210775365	255,102,0	1	9	0	.	Interaction with cyclic nucleotide-binding pocket.
chr1	211082851	211082887	O95259	0	-	211082851	211082887	255,102,0	1	36	0	.	Required for phosphatidylinositol bisphosphate binding. Pubmed:27005320
chr1	211371403	211372699	O00463	0	+	211371403	211372699	255,102,0	1	1296	0	.	Interaction with EIF2AK2/PKR. Pubmed:15121867
chr1	211578138	211578177	Q9Y6M5	0	-	211578138	211578177	255,102,0	1	39	0	.	6 X 2 AA approximate repeats of H-G.
chr1	211663428	211667232	P51955	0	-	211663428	211667232	255,102,0	1	3804	0	.	Necessary for interaction with MAD1L1. Pubmed:14978040
chr1	211663428	211669197	P51955	0	-	211663428	211669197	255,102,0	1	5769	0	.	Intearction with CEP85. Pubmed:26220856
chr1	211663428	211669308	P51955	0	-	211663428	211669308	255,102,0	1	5880	0	.	Interaction with PCNT. Pubmed:20599736
chr1	211663446	211663557	P51955	0	-	211663446	211663557	255,102,0	1	111	0	.	Interaction with SAV1 and STK3/MST2. Pubmed:21076410
chr1	211667106	211667220	P51955	0	-	211667106	211667220	255,102,0	1	114	0	.	Required for microtubule binding and for localization to the centrosomes.
chr1	211667214	211669182	P51955	0	-	211667214	211669182	255,102,0	1	1968	0	.	Leucine-zipper.
chr1	212618147	212618216	P18847	0	+	212618147	212618216	255,102,0	1	69	0	.	Basic motif.
chr1	212618225	212619435	P18847	0	+	212618225	212619435	255,102,0	1	1210	0	.	Leucine-zipper.
chr1	212686901	212696969	Q9NR55	0	-	212686901	212696969	255,102,0	1	10068	0	.	Leucine-zipper.
chr1	212696969	212697047	Q9NR55	0	-	212696969	212697047	255,102,0	1	78	0	.	Basic motif.
chr1	213996535	213996619	Q92786	0	+	213996535	213996619	255,102,0	1	84	0	.	Interaction with RORG.
chr1	214005167	214035825	Q92786	0	+	214005167	214035825	255,102,0	1	30658	0	.	Homeo-Prospero.
chr1	214035786	214035807	Q92786	0	+	214035786	214035807	255,102,0	1	21	0	.	Essential for nuclear localization, interaction with RORG, repression of RORG transcriptional activator activity.
chr1	214281302	214281311	Q9NRG4	0	+	214281302	214281311	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr1	214324652	214324661	Q9NRG4	0	+	214324652	214324661	255,102,0	1	9	0	.	Peptide substrate binding.
chr1	214327634	214327640	Q9NRG4	0	+	214327634	214327640	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr1	214330233	214330242	Q9NRG4	0	+	214330233	214330242	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr1	214364565	214364586	Q15678	0	-	214364565	214364586	255,102,0	1	21	0	.	Substrate binding.
chr1	215234923	215235142	O95069	0	+	215234923	215235142	255,102,0	1	219	0	.	Required for basal channel activity.
chr1	215234995	215235142	O95069	0	+	215234995	215235142	255,102,0	1	147	0	.	Essential for chloroform and halothane sensitivity.
chr1	219968808	219987161	P07814	0	-	219968808	219987161	255,102,0	1	18353	0	.	Proline--tRNA ligase.
chr1	219987206	219987305	P07814	0	-	219987206	219987305	255,102,0	1	99	0	.	Charged.
chr1	219987311	219997246	P07814	0	-	219987311	219997246	255,102,0	1	9935	0	.	3 X 57 AA approximate repeats.
chr1	219997246	220032425	P07814	0	-	219997246	220032425	255,102,0	1	35179	0	.	Glutamate--tRNA ligase.
chr1	220062834	220062846	O95861	0	-	220062834	220062846	255,102,0	1	12	0	.	Substrate binding.
chr1	220069399	220069411	O95861	0	-	220069399	220069411	255,102,0	1	12	0	.	Substrate binding.
chr1	221739099	221739150	Q9Y6W6	0	-	221739099	221739150	255,102,0	1	51	0	.	Interaction with MAP kinases.
chr1	222650290	222659981	Q5JRA6	0	+	222650290	222659981	255,102,0	1	9691	0	.	Mediates interaction with CTAGE5. Pubmed:21525241
chr1	222662320	222665616	Q5JRA6	0	+	222662320	222665616	255,102,0	1	3296	0	.	Proline-rich domain (PRD); mediates interaction with COPII coat subunits. Pubmed:19269366
chr1	222673355	222676219	Q96BJ3	0	-	222673355	222676219	255,102,0	1	2864	0	.	Axin-binding.
chr1	223616143	223619362	A6NHC0	0	-	223616143	223619362	255,102,0	1	3219	0	.	Domain III.
chr1	223752853	223761593	P17655	0	+	223752853	223761593	255,102,0	1	8740	0	.	Domain III.
chr1	223761593	223762206	P17655	0	+	223761593	223762206	255,102,0	1	613	0	.	Linker.
chr1	223762206	223774854	P17655	0	+	223762206	223774854	255,102,0	1	12648	0	.	Domain IV.
chr1	224305121	224330127	O15381	0	-	224305121	224330127	255,102,0	1	25006	0	.	Interaction with RPL5. Pubmed:15469983
chr1	225497786	225501012	Q8N8S7	0	-	225497786	225501012	255,102,0	1	3226	0	.	EVH2 block C.
chr1	225497786	225514643	Q8N8S7	0	-	225497786	225514643	255,102,0	1	16857	0	.	EVH2.
chr1	225512701	225512911	Q8N8S7	0	-	225512701	225512911	255,102,0	1	210	0	.	EVH2 block B.
chr1	225513001	225514643	Q8N8S7	0	-	225513001	225514643	255,102,0	1	1642	0	.	EVH2 block A.
chr1	225519399	225519534	Q8N8S7	0	-	225519399	225519534	255,102,0	1	135	0	.	9 X 5 AA tandem repeats of [LMQ]-E-[QR]-E-[QR].
chr1	226379612	226383078	P09874	0	-	226379612	226383078	255,102,0	1	3466	0	.	Automodification domain.
chr1	226641971	226641995	P27987	0	-	226641971	226641995	255,102,0	1	24	0	.	Substrate binding.
chr1	226642043	226642070	P27987	0	-	226642043	226642070	255,102,0	1	27	0	.	Calmodulin-binding.
chr1	230236041	230243418	Q10471	0	+	230236041	230243418	255,102,0	1	7377	0	.	Catalytic subdomain A.
chr1	230249263	230255294	Q10471	0	+	230249263	230255294	255,102,0	1	6031	0	.	Catalytic subdomain B.
chr1	230779030	230787566	O14815	0	+	230779030	230787566	255,102,0	1	8536	0	.	Domain III.
chr1	230787566	230801593	O14815	0	+	230787566	230801593	255,102,0	1	14027	0	.	Domain IV.
chr1	231421135	231421168	Q9GZT9	0	-	231421135	231421168	255,102,0	1	33	0	.	Beta(2)beta(3) 'finger-like' loop. Pubmed:18063574
chr1	231421828	231421873	Q9GZT9	0	-	231421828	231421873	255,102,0	1	45	0	.	Required for nuclear export.
chr1	231537307	231564656	Q99598	0	+	231537307	231564656	255,102,0	1	27349	0	.	Interaction with C1D. Pubmed:11801738
chr1	233354972	233362079	Q5TCX8	0	+	233354972	233362079	255,102,0	1	7107	0	.	Leucine-zipper 1.
chr1	233362118	233362184	Q5TCX8	0	+	233362118	233362184	255,102,0	1	66	0	.	Leucine-zipper 2.
chr1	233614519	233666605	O00180	0	+	233614519	233666605	255,102,0	1	52086	0	.	Selectivity filter 1. Pubmed:21653227, Pubmed:22282804
chr1	233666911	233666929	O00180	0	+	233666911	233666929	255,102,0	1	18	0	.	Selectivity filter 2. Pubmed:22282804
chr1	233671395	233671416	O00180	0	+	233671395	233671416	255,102,0	1	21	0	.	Important for intracellular retention in recycling endosomes. Pubmed:19959478
chr1	234391657	234391687	Q13395	0	-	234391657	234391687	255,102,0	1	30	0	.	S-adenosyl-L-methionine binding. Pubmed:18412263
chr1	234392477	234392486	Q13395	0	-	234392477	234392486	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding. Pubmed:18412263
chr1	234607250	234607385	Q7Z5L9	0	-	234607250	234607385	255,102,0	1	135	0	.	Cys-rich.
chr1	235177836	235177860	Q4LE39	0	-	235177836	235177860	255,102,0	1	24	0	.	Antigenic epitope.
chr1	235219956	235220316	Q4LE39	0	-	235219956	235220316	255,102,0	1	360	0	.	Antigenic epitope.
chr1	236544855	236544876	O00214	0	+	236544855	236544876	255,102,0	1	21	0	.	Beta-galactoside binding.
chr1	236874829	236874835	Q99707	0	+	236874829	236874835	255,102,0	1	6	0	.	Cobalamin-binding.
chr1	236897085	236897091	Q99707	0	+	236897085	236897091	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr1	237004189	237004285	P0DM35	0	-	237004189	237004285	255,102,0	1	96	0	.	Alpha.
chr1	237004285	237004372	P0DM35	0	-	237004285	237004372	255,102,0	1	87	0	.	Beta.
chr1	237503448	237674791	Q92736	0	+	237503448	237674791	255,102,0	1	171343	0	.	4 X approximate repeats.
chr1	237727101	237727191	Q92736	0	+	237727101	237727191	255,102,0	1	90	0	.	Interaction with CALM. Pubmed:18650434
chr1	239907892	239907907	P20309	0	+	239907892	239907907	255,102,0	1	15	0	.	Agonist binding.
chr1	239908969	239909041	P20309	0	+	239908969	239909041	255,102,0	1	72	0	.	Agonist binding.
chr1	240474127	240474151	Q9NZ56	0	+	240474127	240474151	255,102,0	1	24	0	.	Important for interaction with SPIRE1.
chr1	241508776	241508785	P07954	0	-	241508776	241508785	255,102,0	1	9	0	.	Substrate binding.
chr1	241511984	241511996	P07954	0	-	241511984	241511996	255,102,0	1	12	0	.	B site.
chr1	241850425	241853373	Q9UQ84	0	+	241850425	241853373	255,102,0	1	2948	0	.	N-domain.
chr1	241853460	241866949	Q9UQ84	0	+	241853460	241866949	255,102,0	1	13489	0	.	Interaction with MSH3. Pubmed:11427529
chr1	241857350	241858649	Q9UQ84	0	+	241857350	241858649	255,102,0	1	1299	0	.	I-domain.
chr1	241866949	241872234	Q9UQ84	0	+	241866949	241872234	255,102,0	1	5285	0	.	Interaction with MLH1.
chr1	241879031	241889597	Q9UQ84	0	+	241879031	241889597	255,102,0	1	10566	0	.	Interaction with MSH2.
chr1	241885460	241889597	Q9UQ84	0	+	241885460	241889597	255,102,0	1	4137	0	.	Interaction with MLH1.
chr1	243126451	243164623	Q5SW79	0	-	243126451	243164623	255,102,0	1	38172	0	.	Targeting to centrosomes.
chr1	243126451	243165403	Q5SW79	0	-	243126451	243165403	255,102,0	1	38952	0	.	Targeting to microtubules.
chr1	243293189	243499782	Q86SQ7	0	+	243293189	243499782	255,102,0	1	206593	0	.	Sufficient for homodimerization.
chr1	243378843	243499782	Q86SQ7	0	+	243378843	243499782	255,102,0	1	120939	0	.	Mediates interaction with OFD1. Pubmed:20835237
chr1	244054728	244055082	Q99592	0	+	244054728	244055082	255,102,0	1	354	0	.	Interaction with DNMT3A. Pubmed:11350943
chr1	244417689	244417710	A0A024R5Q7	0	-	244417689	244417710	255,102,0	1	21	0	.	Substrate binding.
chr1	244417689	244417710	P30520	0	-	244417689	244417710	255,102,0	1	21	0	.	Substrate binding.
chr1	244437747	244437759	A0A024R5Q7	0	-	244437747	244437759	255,102,0	1	12	0	.	IMP binding.
chr1	244437747	244437759	P30520	0	-	244437747	244437759	255,102,0	1	12	0	.	IMP binding.
chr1	244451688	244451700	A0A024R5Q7	0	-	244451688	244451700	255,102,0	1	12	0	.	IMP binding.
chr1	244451688	244451700	P30520	0	-	244451688	244451700	255,102,0	1	12	0	.	IMP binding.
chr1	244855558	244855931	Q00839	0	-	244855558	244855931	255,102,0	1	373	0	.	RNA-binding RGG-box. Pubmed:1628625
chr1	245749565	245863886	Q9H7B4	0	-	245749565	245863886	255,102,0	1	114321	0	.	C-terminal domain; essential for histone methyltransferase activity, nuclear localization and mediates interaction with HSP90AA1. Pubmed:25738358
chr1	245928014	245928020	Q9H7B4	0	-	245928014	245928020	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr1	246507169	246507178	Q9H7B4	0	-	246507169	246507178	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr10	248461	252377	Q15326	0	+	248461	252377	255,102,0	1	3916	0	.	Interaction with human adenovirus E1A.
chr10	1379155	1737084	Q9NS39	0	-	1379155	1737084	255,102,0	1	357929	0	.	R-domain (ssRNA-binding).
chr10	3067595	3113161	Q01813	0	+	3067595	3113161	255,102,0	1	45566	0	.	N-terminal catalytic PFK domain 1.
chr10	3103840	3103849	Q01813	0	+	3103840	3103849	255,102,0	1	9	0	.	Substrate binding.
chr10	3105142	3105151	Q01813	0	+	3105142	3105151	255,102,0	1	9	0	.	Substrate binding.
chr10	3108748	3108760	Q01813	0	+	3108748	3108760	255,102,0	1	12	0	.	Substrate binding.
chr10	3113161	3113380	Q01813	0	+	3113161	3113380	255,102,0	1	219	0	.	Interdomain linker.
chr10	3113380	3136576	Q01813	0	+	3113380	3136576	255,102,0	1	23196	0	.	C-terminal regulatory PFK domain 2.
chr10	3119972	3119987	Q01813	0	+	3119972	3119987	255,102,0	1	15	0	.	Allosteric activator fructose 2,6-bisphosphate binding.
chr10	3129881	3129890	Q01813	0	+	3129881	3129890	255,102,0	1	9	0	.	Allosteric activator fructose 2,6-bisphosphate binding.
chr10	3133302	3133314	Q01813	0	+	3133302	3133314	255,102,0	1	12	0	.	Allosteric activator fructose 2,6-bisphosphate binding.
chr10	5412692	5429196	Q7Z628	0	+	5412692	5429196	255,102,0	1	16504	0	.	Necessary for nuclear localization.
chr10	6203260	6220769	Q16875	0	+	6203260	6220769	255,102,0	1	17509	0	.	6-phosphofructo-2-kinase.
chr10	6220769	6232939	Q16875	0	+	6220769	6232939	255,102,0	1	12170	0	.	Fructose-2,6-bisphosphatase.
chr10	7738655	7738700	P19823	0	+	7738655	7738700	255,102,0	1	45	0	.	O-glycosylated at three sites.
chr10	7756088	7759991	O60870	0	-	7756088	7759991	255,102,0	1	3903	0	.	C-terminal subdomain B. Pubmed:17045609
chr10	7762472	7763791	O60870	0	-	7762472	7763791	255,102,0	1	1319	0	.	C-terminal subdomain A. Pubmed:17045609
chr10	7778915	7783139	O60870	0	-	7778915	7783139	255,102,0	1	4224	0	.	Winged helix-turn-helix (wHTH).
chr10	8064078	8069499	P23771	0	+	8064078	8069499	255,102,0	1	5421	0	.	Flexible linker.
chr10	11005387	11288446	O95319	0	+	11005387	11288446	255,102,0	1	283059	0	.	Necessary for RNA-binding, TNNT2 exon 5 and NMDA R1 exon 21 inclusion.
chr10	11314251	11329050	O95319	0	+	11314251	11329050	255,102,0	1	14799	0	.	Necessary for RNA-binding, TNNT2 exon 5 and NMDA R1 exon 21 inclusion.
chr10	11921300	11943093	Q9HAU5	0	-	11921300	11943093	255,102,0	1	21793	0	.	Sufficient for interaction with UPF1 C-terminus.
chr10	11921300	11959272	Q9HAU5	0	-	11921300	11959272	255,102,0	1	37972	0	.	Sufficient for interaction with EIF4A1 and EIF1. Pubmed:11073994
chr10	11931707	11936592	Q9HAU5	0	-	11931707	11936592	255,102,0	1	4885	0	.	Interaction with UPF1.
chr10	11931734	11942730	Q9HAU5	0	-	11931734	11942730	255,102,0	1	10996	0	.	Necessary for interaction with UPF1.
chr10	11936703	11942730	Q9HAU5	0	-	11936703	11942730	255,102,0	1	6027	0	.	Interaction with UPF1.
chr10	11955297	11964062	Q9HAU5	0	-	11955297	11964062	255,102,0	1	8765	0	.	Sufficient for interaction with UPF3A and UPF3B.
chr10	11955504	11956379	Q9HAU5	0	-	11955504	11956379	255,102,0	1	875	0	.	Binds to UPF3B.
chr10	12029490	12035144	Q9HAU5	0	-	12029490	12035144	255,102,0	1	5654	0	.	Sufficient for interaction with UPF1.
chr10	12179122	12179128	Q9UKK9	0	-	12179122	12179128	255,102,0	1	6	0	.	Substrate binding; shared with dimeric partner. Pubmed:21768126, Pubmed:18462755, Pubmed:17052728
chr10	12824465	12825608	Q8IU85	0	+	12824465	12825608	255,102,0	1	1143	0	.	Autoinhibitory domain.
chr10	12824525	12825611	Q8IU85	0	+	12824525	12825611	255,102,0	1	1086	0	.	Calmodulin-binding.
chr10	13164202	13172638	Q7L590	0	+	13164202	13172638	255,102,0	1	8436	0	.	N-terminal domain.
chr10	13175625	13186229	Q7L590	0	+	13175625	13186229	255,102,0	1	10604	0	.	OB-fold domain.
chr10	13186229	13188907	Q7L590	0	+	13186229	13188907	255,102,0	1	2678	0	.	Zinc finger-like 1.
chr10	13201525	13204269	Q7L590	0	+	13201525	13204269	255,102,0	1	2744	0	.	Zinc finger-like 2.
chr10	13204308	13209097	Q7L590	0	+	13204308	13209097	255,102,0	1	4789	0	.	Zinc finger-like 3.
chr10	13288506	13288515	O14832	0	-	13288506	13288515	255,102,0	1	9	0	.	Alpha-ketoglutarate binding.
chr10	14897448	14897457	Q9H5I1	0	+	14897448	14897457	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding. Pubmed:20084102
chr10	14899676	14899682	Q9H5I1	0	+	14899676	14899682	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding. Pubmed:20084102
chr10	15078950	15078965	Q8N6N7	0	-	15078950	15078965	255,102,0	1	15	0	.	Acyl-CoA binding.
chr10	15130245	15130260	O60551	0	-	15130245	15130260	255,102,0	1	15	0	.	Myristoyl-CoA binding. Pubmed:25255805
chr10	15130275	15130284	O60551	0	-	15130275	15130284	255,102,0	1	9	0	.	Myristoyl-CoA binding. Pubmed:25255805
chr10	15135298	15135307	O60551	0	-	15135298	15135307	255,102,0	1	9	0	.	Myristoyl-CoA binding. Pubmed:25255805
chr10	17174550	17174556	O14717	0	-	17174550	17174556	255,102,0	1	6	0	.	S-adenosyl-L-homocysteine binding. Pubmed:11139614
chr10	17201589	17201598	O14717	0	-	17201589	17201598	255,102,0	1	9	0	.	S-adenosyl-L-homocysteine binding. Pubmed:11139614
chr10	17229425	17229707	P08670	0	+	17229425	17229707	255,102,0	1	282	0	.	Head.
chr10	17229707	17229815	P08670	0	+	17229707	17229815	255,102,0	1	108	0	.	Coil 1A.
chr10	17229707	17235381	P08670	0	+	17229707	17235381	255,102,0	1	5674	0	.	Rod.
chr10	17229815	17229881	P08670	0	+	17229815	17229881	255,102,0	1	66	0	.	Linker 1.
chr10	17229881	17233784	P08670	0	+	17229881	17233784	255,102,0	1	3903	0	.	Coil 1B.
chr10	17233784	17233853	P08670	0	+	17233784	17233853	255,102,0	1	69	0	.	Linker 12.
chr10	17233853	17235381	P08670	0	+	17233853	17235381	255,102,0	1	1528	0	.	Coil 2.
chr10	17235381	17237268	P08670	0	+	17235381	17237268	255,102,0	1	1887	0	.	Tail.
chr10	17321102	17321111	P61647	0	-	17321102	17321111	255,102,0	1	9	0	.	Substrate binding.
chr10	17323078	17323087	P61647	0	-	17323078	17323087	255,102,0	1	9	0	.	Substrate binding.
chr10	18596240	18596261	Q8TEA1	0	-	18596240	18596261	255,102,0	1	21	0	.	S-adenosyl-L-methionine binding.
chr10	20787210	20812781	O76041	0	-	20787210	20812781	255,102,0	1	25571	0	.	Linker.
chr10	21538909	21670514	P55197	0	+	21538909	21670514	255,102,0	1	131605	0	.	Self-association.
chr10	21612362	21617207	P55197	0	+	21612362	21617207	255,102,0	1	4845	0	.	Interaction with FSTL3. Pubmed:17868029
chr10	21670583	21727887	P55197	0	+	21670583	21727887	255,102,0	1	57304	0	.	DNA-binding.
chr10	21730942	21733032	P55197	0	+	21730942	21733032	255,102,0	1	2090	0	.	Transactivation domain; required for DOT1L-binding.
chr10	21732927	21733014	P55197	0	+	21732927	21733014	255,102,0	1	87	0	.	Leucine-zipper.
chr10	22328617	22329245	P35226	0	+	22328617	22329245	255,102,0	1	628	0	.	Interaction with E4F1. Pubmed:16882984
chr10	23440396	23440417	Q5VV17	0	+	23440396	23440417	255,102,0	1	21	0	.	Cys-loop.
chr10	23440561	23440594	Q5VV17	0	+	23440561	23440594	255,102,0	1	33	0	.	His-loop.
chr10	23440732	23440750	Q5VV17	0	+	23440732	23440750	255,102,0	1	18	0	.	Variable-loop.
chr10	26223906	26223915	Q05329	0	+	26223906	26223915	255,102,0	1	9	0	.	Substrate binding.
chr10	26823185	26860812	Q8IZP0	0	-	26823185	26860812	255,102,0	1	37627	0	.	Required for binding to WASF1.
chr10	27235159	27235174	B7Z2R7	0	-	27235159	27235174	255,102,0	1	15	0	.	Acyl-CoA binding.
chr10	27235159	27235174	Q5T8D3	0	-	27235159	27235174	255,102,0	1	15	0	.	Acyl-CoA binding.
chr10	27235204	27240340	B7Z2R7	0	-	27235204	27240340	255,102,0	1	5136	0	.	Acyl-CoA binding.
chr10	27235204	27240340	Q5T8D3	0	-	27235204	27240340	255,102,0	1	5136	0	.	Acyl-CoA binding.
chr10	29481622	29488694	O95425	0	-	29481622	29488694	255,102,0	1	7072	0	.	Interaction with NEB. Pubmed:18639526
chr10	29550901	29555058	O95425	0	-	29550901	29555058	255,102,0	1	4157	0	.	Interaction with MYLK.
chr10	32015531	32017161	P33176	0	-	32015531	32017161	255,102,0	1	1630	0	.	Globular.
chr10	32901590	32901614	P05556	0	-	32901590	32901614	255,102,0	1	24	0	.	Interaction with ITGB1BP1.
chr10	32908397	32908415	P05556	0	-	32908397	32908415	255,102,0	1	18	0	.	Signal for sorting from recycling endosomes; interaction with ACAP1.
chr10	32911473	32919958	P05556	0	-	32911473	32919958	255,102,0	1	8485	0	.	Cysteine-rich tandem repeats.
chr10	32923584	32923644	P05556	0	-	32923584	32923644	255,102,0	1	60	0	.	CX3CL1-binding. Pubmed:24789099
chr10	32926017	32926038	P05556	0	-	32926017	32926038	255,102,0	1	21	0	.	CX3CL1-binding. Pubmed:23125415
chr10	34331150	34348049	Q8TEW0	0	-	34331150	34348049	255,102,0	1	16899	0	.	Interaction with PRKCI and PRKCZ.
chr10	35640973	35640991	Q9H461	0	-	35640973	35640991	255,102,0	1	18	0	.	Wnt-binding.
chr10	35641129	35641147	Q9H461	0	-	35641129	35641147	255,102,0	1	18	0	.	Wnt-binding.
chr10	35641195	35641219	Q9H461	0	-	35641195	35641219	255,102,0	1	24	0	.	Palmitate-binding groove.
chr10	43119550	43119559	P07949	0	+	43119550	43119559	255,102,0	1	9	0	.	Inhibitors binding.
chr10	43386804	43386822	P52597	0	-	43386804	43386822	255,102,0	1	18	0	.	Interaction with RNA.
chr10	43387332	43387350	P52597	0	-	43387332	43387350	255,102,0	1	18	0	.	Interaction with RNA.
chr10	43387626	43387644	P52597	0	-	43387626	43387644	255,102,0	1	18	0	.	Interaction with RNA.
chr10	44378692	44380764	P48061	0	-	44378692	44380764	255,102,0	1	2072	0	.	Receptor binding.
chr10	44380788	44380821	P48061	0	-	44380788	44380821	255,102,0	1	33	0	.	Heparin binding.
chr10	44380791	44380800	P48061	0	-	44380791	44380800	255,102,0	1	9	0	.	Receptor binding.
chr10	44380818	44380827	P48061	0	-	44380818	44380827	255,102,0	1	9	0	.	Receptor binding.
chr10	44380842	44380857	P48061	0	-	44380842	44380857	255,102,0	1	15	0	.	Receptor and heparin binding.
chr10	46987477	46987498	Q4JDL3	0	+	46987477	46987498	255,102,0	1	21	0	.	Substrate binding.
chr10	47348535	47357403	P10745	0	+	47348535	47357403	255,102,0	1	8868	0	.	4 X approximate tandem repeats.
chr10	49459012	49459099	Q03468	0	-	49459012	49459099	255,102,0	1	87	0	.	Ubiquitin-binding domain (UBD).
chr10	49612150	49612336	Q16572	0	+	49612150	49612336	255,102,0	1	186	0	.	Mediates interaction with SEC14L1.
chr10	49651929	49651968	P28329	0	+	49651929	49651968	255,102,0	1	39	0	.	Coenzyme A binding.
chr10	49832827	49832845	Q86W56	0	-	49832827	49832845	255,102,0	1	18	0	.	Substrate binding.
chr10	49843600	49885205	Q86W56	0	-	49843600	49885205	255,102,0	1	41605	0	.	Catalytic.
chr10	49861611	49861617	Q86W56	0	-	49861611	49861617	255,102,0	1	6	0	.	Substrate binding.
chr10	49932186	49941725	Q86W56	0	-	49932186	49941725	255,102,0	1	9539	0	.	A-domain.
chr10	50068005	50085534	Q641Q2	0	+	50068005	50085534	255,102,0	1	17529	0	.	Sufficient for interaction with WASHC3, WASHC4 and WASHC5; required for interaction with WASHC1.
chr10	50093329	50106396	Q641Q2	0	+	50093329	50106396	255,102,0	1	13067	0	.	Sufficient for interaction with CCDC93.
chr10	50093332	50132942	Q641Q2	0	+	50093332	50132942	255,102,0	1	39610	0	.	Interaction with VPS35.
chr10	50126176	50132942	Q641Q2	0	+	50126176	50132942	255,102,0	1	6766	0	.	Interaction with phospholipids.
chr10	50127792	50129472	Q641Q2	0	+	50127792	50129472	255,102,0	1	1680	0	.	Required for interaction with F-actin-capping protein subunit alpha (CAPZA1 or CAPZA2 or CAPZA3).
chr10	50187317	50187350	Q9NR71	0	-	50187317	50187350	255,102,0	1	33	0	.	Required for correct folding and localization.
chr10	50813976	50816069	Q9NQ94	0	-	50813976	50816069	255,102,0	1	2093	0	.	Required for nuclear localization. Pubmed:12896982
chr10	50991381	51153203	Q13976	0	+	50991381	51153203	255,102,0	1	161822	0	.	Required for dimerization.
chr10	50991402	50991510	Q13976	0	+	50991402	50991510	255,102,0	1	108	0	.	Leucine-zipper.
chr10	50991525	50991603	Q13976	0	+	50991525	50991603	255,102,0	1	78	0	.	Autoinhibitory domain.
chr10	51153203	51907513	Q13976	0	+	51153203	51907513	255,102,0	1	754310	0	.	cGMP-binding, high affinity.
chr10	51697902	51698037	Q9H0L4	0	-	51697902	51698037	255,102,0	1	135	0	.	9 X 5 AA tandem repeats of G-[AT]-G-[MI]-Q.
chr10	51698163	51698298	Q9H0L4	0	-	51698163	51698298	255,102,0	1	135	0	.	9 X 5 AA tandem repeats of M-E-T-R-[AG].
chr10	51907513	52161955	Q13976	0	+	51907513	52161955	255,102,0	1	254442	0	.	cGMP-binding, low affinity.
chr10	52314931	52316302	O94907	0	+	52314931	52316302	255,102,0	1	1371	0	.	DKK-type Cys-1.
chr10	52316570	52316795	O94907	0	+	52316570	52316795	255,102,0	1	225	0	.	DKK-type Cys-2.
chr10	56359490	56360036	O95229	0	-	56359490	56360036	255,102,0	1	546	0	.	Interaction with NDC80 and ZW10.
chr10	58216246	58216273	Q8NFU5	0	-	58216246	58216273	255,102,0	1	27	0	.	Substrate binding.
chr10	59812776	59852690	Q16204	0	-	59812776	59852690	255,102,0	1	39914	0	.	5 X 29 AA tandem repeats.
chr10	60082716	60085185	Q12955	0	-	60082716	60085185	255,102,0	1	2469	0	.	UPA domain.
chr10	60889037	60911542	O94844	0	-	60889037	60911542	255,102,0	1	22505	0	.	Rho-like.
chr10	67884724	67885138	Q96EB6	0	+	67884724	67885138	255,102,0	1	414	0	.	Interaction with CLOCK.
chr10	67884724	67891416	Q96EB6	0	+	67884724	67891416	255,102,0	1	6692	0	.	Interaction with HIST1H1E.
chr10	67885147	67912739	Q96EB6	0	+	67885147	67912739	255,102,0	1	27592	0	.	Interaction with CCAR2.
chr10	67889099	67889111	Q96EB6	0	+	67889099	67889111	255,102,0	1	12	0	.	Required for interaction with the sumoylated form of CCAR2. Pubmed:25406032
chr10	67912727	67912736	Q96EB6	0	+	67912727	67912736	255,102,0	1	9	0	.	Phosphorylated at one of three serine residues.
chr10	68121438	68165784	Q86TC9	0	+	68121438	68165784	255,102,0	1	44346	0	.	Interaction with CARP. Pubmed:11309420
chr10	68166637	68174123	Q86TC9	0	+	68166637	68174123	255,102,0	1	7486	0	.	Interaction with NEB. Pubmed:11309420
chr10	68189033	68210452	Q86TC9	0	+	68189033	68210452	255,102,0	1	21419	0	.	Interaction with ACTN.
chr10	68415041	68437099	P51530	0	-	68415041	68437099	255,102,0	1	22058	0	.	Helicase activity.
chr10	68437099	68469997	P51530	0	-	68437099	68469997	255,102,0	1	32898	0	.	Nuclease activity.
chr10	68573919	68644751	Q8NFU7	0	+	68573919	68644751	255,102,0	1	70832	0	.	Sufficient for binding to genomic CpG islands.
chr10	68672958	68673000	Q8NFU7	0	+	68672958	68673000	255,102,0	1	42	0	.	Interaction with DNA.
chr10	68691529	68691538	Q8NFU7	0	+	68691529	68691538	255,102,0	1	9	0	.	2-oxoglutarate binding.
chr10	68691547	68691556	Q8NFU7	0	+	68691547	68691556	255,102,0	1	9	0	.	Substrate binding.
chr10	68722504	68747487	Q8IX12	0	+	68722504	68747487	255,102,0	1	24983	0	.	Interaction with AR. Pubmed:23887938
chr10	68747248	68761066	Q8IX12	0	+	68747248	68761066	255,102,0	1	13818	0	.	Interaction with GATA2. Pubmed:23887938
chr10	68761012	68791263	Q8IX12	0	+	68761012	68791263	255,102,0	1	30251	0	.	Interaction with GATA1. Pubmed:24245781
chr10	68982629	68982704	Q9NR30	0	+	68982629	68982704	255,102,0	1	75	0	.	3 X 5 AA repeats.
chr10	69103922	69103976	P10124	0	+	69103922	69103976	255,102,0	1	54	0	.	9 X 2 AA tandem repeats of [SF]-G.
chr10	69208621	69209032	Q8IYB8	0	+	69208621	69209032	255,102,0	1	411	0	.	Interaction with LAMTOR5, important for protein stability.
chr10	69227359	69240681	Q2TB90	0	+	69227359	69240681	255,102,0	1	13322	0	.	Hexokinase small subdomain 1.
chr10	69233082	69239071	Q2TB90	0	+	69233082	69239071	255,102,0	1	5989	0	.	Glucose-binding.
chr10	69240681	69248499	Q2TB90	0	+	69240681	69248499	255,102,0	1	7818	0	.	Hexokinase large subdomain 1.
chr10	69248718	69257356	Q2TB90	0	+	69248718	69257356	255,102,0	1	8638	0	.	Hexokinase small subdomain 2.
chr10	69250601	69257065	Q2TB90	0	+	69250601	69257065	255,102,0	1	6464	0	.	Glucose-binding.
chr10	69257356	69266685	Q2TB90	0	+	69257356	69266685	255,102,0	1	9329	0	.	Hexokinase large subdomain 2.
chr10	69318947	69318983	P19367	0	+	69318947	69318983	255,102,0	1	36	0	.	Hydrophobic.
chr10	69318983	69382646	P19367	0	+	69318983	69382646	255,102,0	1	63663	0	.	Regulatory.
chr10	69343979	69369266	P19367	0	+	69343979	69369266	255,102,0	1	25287	0	.	Hexokinase small subdomain 1.
chr10	69359919	69359934	P19367	0	+	69359919	69359934	255,102,0	1	15	0	.	Glucose-6-phosphate 1 binding.
chr10	69368553	69368559	P19367	0	+	69368553	69368559	255,102,0	1	6	0	.	Substrate 1 binding.
chr10	69369266	69369272	P19367	0	+	69369266	69369272	255,102,0	1	6	0	.	Substrate 1 binding.
chr10	69369266	69382562	P19367	0	+	69369266	69382562	255,102,0	1	13296	0	.	Hexokinase large subdomain 1.
chr10	69369619	69376940	P19367	0	+	69369619	69376940	255,102,0	1	7321	0	.	Substrate 1 binding.
chr10	69380066	69380075	P19367	0	+	69380066	69380075	255,102,0	1	9	0	.	Glucose-6-phosphate 1 binding.
chr10	69382646	69401132	P19367	0	+	69382646	69401132	255,102,0	1	18486	0	.	Catalytic.
chr10	69382781	69389226	P19367	0	+	69382781	69389226	255,102,0	1	6445	0	.	Hexokinase small subdomain 2.
chr10	69384355	69384370	P19367	0	+	69384355	69384370	255,102,0	1	15	0	.	Glucose-6-phosphate 2 binding.
chr10	69384882	69384888	P19367	0	+	69384882	69384888	255,102,0	1	6	0	.	Substrate 2 binding.
chr10	69386340	69386346	P19367	0	+	69386340	69386346	255,102,0	1	6	0	.	Substrate 2 binding.
chr10	69389226	69389232	P19367	0	+	69389226	69389232	255,102,0	1	6	0	.	Substrate 2 binding.
chr10	69389226	69401066	P19367	0	+	69389226	69401066	255,102,0	1	11840	0	.	Hexokinase large subdomain 2.
chr10	69392132	69392138	P19367	0	+	69392132	69392138	255,102,0	1	6	0	.	Substrate 2 binding.
chr10	69398799	69398808	P19367	0	+	69398799	69398808	255,102,0	1	9	0	.	Glucose-6-phosphate 2 binding.
chr10	69802423	69822437	Q5TAT6	0	+	69802423	69822437	255,102,0	1	20014	0	.	Nonhelical region 1 (NC1).
chr10	69867796	69895567	Q5TAT6	0	+	69867796	69895567	255,102,0	1	27771	0	.	Triple-helical region 1 (COL1).
chr10	69895567	69902774	Q5TAT6	0	+	69895567	69902774	255,102,0	1	7207	0	.	Nonhelical region 2 (NC2).
chr10	69902774	69925830	Q5TAT6	0	+	69902774	69925830	255,102,0	1	23056	0	.	Triple-helical region 2 (COL2).
chr10	69925830	69927110	Q5TAT6	0	+	69925830	69927110	255,102,0	1	1280	0	.	Nonhelical region 3 (NC3).
chr10	69928936	69952953	Q5TAT6	0	+	69928936	69952953	255,102,0	1	24017	0	.	Triple-helical region 3 (COL3).
chr10	69952953	69957042	Q5TAT6	0	+	69952953	69957042	255,102,0	1	4089	0	.	Nonhelical region 4 (NC4).
chr10	70140031	70145632	Q2T9J0	0	-	70140031	70145632	255,102,0	1	5601	0	.	Serine protease.
chr10	70745230	70751588	Q8WXS8	0	+	70745230	70751588	255,102,0	1	6358	0	.	Spacer.
chr10	70884021	70884033	P61457	0	-	70884021	70884033	255,102,0	1	12	0	.	Substrate binding.
chr10	70885178	70885187	P61457	0	-	70885178	70885187	255,102,0	1	9	0	.	Substrate binding.
chr10	71293822	71297932	Q8IZJ1	0	+	71293822	71297932	255,102,0	1	4110	0	.	UPA domain.
chr10	71293876	71293933	Q8IZJ1	0	+	71293876	71293933	255,102,0	1	57	0	.	Interaction with DCC.
chr10	72368230	72368263	Q9BPX6	0	-	72368230	72368263	255,102,0	1	33	0	.	C-helix region. Pubmed:24514027
chr10	72562894	72562930	Q9BPX6	0	-	72562894	72562930	255,102,0	1	36	0	.	Polybasic region. Pubmed:27099988
chr10	72859178	72860526	Q8NE86	0	+	72859178	72860526	255,102,0	1	1348	0	.	N-terminal MCU domain. Pubmed:26341627
chr10	72868851	72871421	Q8NE86	0	+	72868851	72871421	255,102,0	1	2570	0	.	Outer juxtamembrane helix (OJMH).
chr10	72871565	72884280	Q8NE86	0	+	72871565	72884280	255,102,0	1	12715	0	.	Inner juxtamembrane helix (IJMH).
chr10	73134585	73139415	O95905	0	-	73134585	73139415	255,102,0	1	4830	0	.	Transcription activation. Pubmed:19919181
chr10	73136811	73136904	O95905	0	-	73136811	73136904	255,102,0	1	93	0	.	Acidic region required for transactivation activity. Pubmed:19919181
chr10	73136916	73138051	O95905	0	-	73136916	73138051	255,102,0	1	1135	0	.	Involved in nuclear export. Pubmed:19919181
chr10	73396524	73400856	P20073	0	-	73396524	73400856	255,102,0	1	4332	0	.	Repeat-rich region.
chr10	73398379	73400844	P20073	0	-	73398379	73400844	255,102,0	1	2465	0	.	3 X 5 AA tandem repeats of G-Y-P-P-X.
chr10	73438328	73438397	P16298	0	-	73438328	73438397	255,102,0	1	69	0	.	Inhibitory domain.
chr10	73446490	73446559	P16298	0	-	73446490	73446559	255,102,0	1	69	0	.	Calmodulin-binding.
chr10	73470738	73470756	P16298	0	-	73470738	73470756	255,102,0	1	18	0	.	Calcineurin B binding-site 2.
chr10	73470738	73495886	P16298	0	-	73470738	73495886	255,102,0	1	25148	0	.	Catalytic.
chr10	73471092	73471113	P16298	0	-	73471092	73471113	255,102,0	1	21	0	.	Calcineurin B binding-site 1.
chr10	73765495	73765573	P53992	0	+	73765495	73765573	255,102,0	1	78	0	.	Zinc finger-like.
chr10	73802453	73804824	P52849	0	-	73802453	73804824	255,102,0	1	2371	0	.	Heparan sulfate N-sulfotransferase 2.
chr10	73804824	73808268	P52849	0	-	73804824	73808268	255,102,0	1	3444	0	.	Heparan sulfate N-deacetylase 2.
chr10	73998210	74107300	P18206	0	+	73998210	74107300	255,102,0	1	109090	0	.	N-terminal globular head. Pubmed:20484056
chr10	74072731	74074744	P18206	0	+	74072731	74074744	255,102,0	1	2013	0	.	Talin-interaction.
chr10	74074894	74097227	P18206	0	+	74074894	74097227	255,102,0	1	22333	0	.	3 X 112 AA tandem repeats.
chr10	74105139	74105211	P18206	0	+	74105139	74105211	255,102,0	1	72	0	.	Interaction with ACTN4. Pubmed:15988023
chr10	74107300	74109045	P18206	0	+	74107300	74109045	255,102,0	1	1745	0	.	Linker (Pro-rich). Pubmed:20484056
chr10	74109045	74118166	P18206	0	+	74109045	74118166	255,102,0	1	9121	0	.	C-terminal tail. Pubmed:20484056
chr10	74114240	74114372	P18206	0	+	74114240	74114372	255,102,0	1	132	0	.	Facilitates phospholipid membrane insertion.
chr10	74118121	74118166	P18206	0	+	74118121	74118166	255,102,0	1	45	0	.	Facilitates phospholipid membrane insertion.
chr10	74975417	74979259	Q8WYB5	0	+	74975417	74979259	255,102,0	1	3842	0	.	Negatively regulates HAT activity.
chr10	74979259	75021883	Q8WYB5	0	+	74979259	75021883	255,102,0	1	42624	0	.	Catalytic.
chr10	74981808	75021883	Q8WYB5	0	+	74981808	75021883	255,102,0	1	40075	0	.	Interaction with BRPF1. Pubmed:18794358
chr10	74989048	74989063	Q8WYB5	0	+	74989048	74989063	255,102,0	1	15	0	.	Acetyl-CoA binding.
chr10	74989075	74989096	Q8WYB5	0	+	74989075	74989096	255,102,0	1	21	0	.	Acetyl-CoA binding.
chr10	75029501	75031043	Q8WYB5	0	+	75029501	75031043	255,102,0	1	1542	0	.	Interaction with RUNX1 and RUNX2. Pubmed:11965546
chr10	75038039	75038063	Q68J44	0	-	75038039	75038063	255,102,0	1	24	0	.	Substrate binding.
chr10	75235173	75235179	Q86VU5	0	-	75235173	75235179	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr10	76891710	76910019	Q12791	0	-	76891710	76910019	255,102,0	1	18309	0	.	Segment S10.
chr10	76949279	76949342	Q12791	0	-	76949279	76949342	255,102,0	1	63	0	.	Segment S9.
chr10	77012015	77012030	Q12791	0	-	77012015	77012030	255,102,0	1	15	0	.	Heme-binding motif.
chr10	77027851	77039550	Q12791	0	-	77027851	77039550	255,102,0	1	11699	0	.	Segment S8.
chr10	77073117	77073180	Q12791	0	-	77073117	77073180	255,102,0	1	63	0	.	Segment S7.
chr10	78000028	78000067	O14802	0	-	78000028	78000067	255,102,0	1	39	0	.	Bridging helix.
chr10	79201632	79277260	Q9ULJ6	0	+	79201632	79277260	255,102,0	1	75628	0	.	Sufficient for transactivation activity; sufficient for interaction with NOTCH1. Pubmed:26522984
chr10	79306184	79312746	Q9ULJ6	0	+	79306184	79312746	255,102,0	1	6562	0	.	Transactivation domain. Pubmed:26522984
chr10	80280709	80280748	Q00266	0	-	80280709	80280748	255,102,0	1	39	0	.	Flexible loop.
chr10	80420506	80425931	Q9BRX8	0	+	80420506	80425931	255,102,0	1	5425	0	.	Thioredoxin fold.
chr10	80509360	80516278	Q8NG11	0	+	80509360	80516278	255,102,0	1	6918	0	.	Necessary and sufficient for interaction with ADAM10. Pubmed:26668317
chr10	86472260	86518069	Q7Z5K2	0	-	86472260	86518069	255,102,0	1	45809	0	.	Mediates interaction with the cohesin complex.
chr10	86892214	86892223	P36894	0	+	86892214	86892223	255,102,0	1	9	0	.	Mediates specificity for BMP ligand.
chr10	86958754	86960038	O76070	0	+	86958754	86960038	255,102,0	1	1284	0	.	4 X 11 AA tandem repeats of [EGSA]-K-T-K-[EQ]-[GQ]-V-X(4).
chr10	87659981	87714990	O95340	0	+	87659981	87714990	255,102,0	1	55009	0	.	Adenylyl-sulfate kinase.
chr10	87713163	87713175	O95340	0	+	87713163	87713175	255,102,0	1	12	0	.	Adenylyl sulfate binding.
chr10	87713214	87713226	O95340	0	+	87713214	87713226	255,102,0	1	12	0	.	Adenylyl sulfate binding.
chr10	87713292	87713298	O95340	0	+	87713292	87713298	255,102,0	1	6	0	.	Adenylyl sulfate binding.
chr10	87714743	87714749	O95340	0	+	87714743	87714749	255,102,0	1	6	0	.	Adenylyl sulfate binding.
chr10	87715014	87745967	O95340	0	+	87715014	87745967	255,102,0	1	30953	0	.	Sulfate adenylyltransferase.
chr10	87965460	87965469	P60484	0	+	87965460	87965469	255,102,0	1	9	0	.	PDZ domain-binding.
chr10	88582239	88582245	Q5VYX0	0	-	88582239	88582245	255,102,0	1	6	0	.	FAD-binding.
chr10	89012063	89014393	P25445	0	+	89012063	89014393	255,102,0	1	2330	0	.	Interaction with HIPK3.
chr10	89014129	89014204	P25445	0	+	89014129	89014204	255,102,0	1	75	0	.	Interaction with CALM. Pubmed:24914971
chr10	89403040	89403061	P09914	0	+	89403040	89403061	255,102,0	1	21	0	.	Interaction with the 5'-triphosphate group of PPP-RNA.
chr10	89417958	89417979	Q13325	0	+	89417958	89417979	255,102,0	1	21	0	.	Interaction with the 5'-triphosphate group of PPP-RNA.
chr10	89737988	89738162	Q96Q89	0	+	89737988	89738162	255,102,0	1	174	0	.	Necessary and sufficient for interaction with SHTN1.
chr10	89758879	89774045	Q96Q89	0	+	89758879	89774045	255,102,0	1	15166	0	.	Interaction with PIN1. Pubmed:11470801
chr10	91630091	91630460	Q9UQK1	0	-	91630091	91630460	255,102,0	1	369	0	.	Interaction with EPM2A. Pubmed:14532330
chr10	91840665	91840692	Q9H2K2	0	+	91840665	91840692	255,102,0	1	27	0	.	HIF1AN-binding.
chr10	92508176	92508191	P14735	0	-	92508176	92508191	255,102,0	1	15	0	.	Substrate binding.
chr10	92508761	92508782	P14735	0	-	92508761	92508782	255,102,0	1	21	0	.	Substrate binding exosite.
chr10	93404022	93409617	Q9NZM1	0	-	93404022	93409617	255,102,0	1	5595	0	.	Necessary for interaction with EHD2. Pubmed:18502764
chr10	93506996	93516963	Q53EZ4	0	+	93506996	93516963	255,102,0	1	9967	0	.	Interaction with TSG101.
chr10	93507005	93515518	Q53EZ4	0	+	93507005	93515518	255,102,0	1	8513	0	.	Interaction with PDCD6IP.
chr10	93518945	93528150	Q53EZ4	0	+	93518945	93528150	255,102,0	1	9205	0	.	Required for localization to the interphase centrosome and to the midbody during cytokinesis.
chr10	94293527	94298503	Q9P212	0	+	94293527	94298503	255,102,0	1	4976	0	.	Required for activation by RHOA, RHOB, GNA12, GNA13 and G-beta gamma.
chr10	95606764	95626771	P54886	0	-	95606764	95626771	255,102,0	1	20007	0	.	Gamma-glutamyl phosphate reductase.
chr10	95626771	95653377	P54886	0	-	95626771	95653377	255,102,0	1	26606	0	.	Glutamate 5-kinase.
chr10	96319333	96338221	P04053	0	+	96319333	96338221	255,102,0	1	18888	0	.	Mediates interaction with DNTTIP2. Pubmed:12786946
chr10	96324286	96324301	P04053	0	+	96324286	96324301	255,102,0	1	15	0	.	Involved in DNA binding.
chr10	96327589	96328731	P04053	0	+	96327589	96328731	255,102,0	1	1142	0	.	Deoxynucleoside triphosphate binding.
chr10	96328740	96328752	P04053	0	+	96328740	96328752	255,102,0	1	12	0	.	Deoxynucleoside triphosphate binding.
chr10	96332578	96332584	P04053	0	+	96332578	96332584	255,102,0	1	6	0	.	Deoxynucleoside triphosphate binding.
chr10	96410472	96432879	Q9Y6L7	0	-	96410472	96432879	255,102,0	1	22407	0	.	Metalloprotease.
chr10	96656932	96709969	Q6ZUJ8	0	-	96656932	96709969	255,102,0	1	53037	0	.	Necessary and sufficient to mediate inhibition of NF-kappa-B downstream of activated TLRs; may mediate interaction with MYD88 and TIRAP.
chr10	97320044	97320113	Q92837	0	+	97320044	97320113	255,102,0	1	69	0	.	Involved in GSK-3 binding.
chr10	97333984	97334053	O75474	0	-	97333984	97334053	255,102,0	1	69	0	.	Involved in GSK-3 binding.
chr10	97426334	97426358	P18669	0	+	97426334	97426358	255,102,0	1	24	0	.	Substrate binding. Pubmed:23653202, Pubmed:15883004
chr10	97426373	97426379	P18669	0	+	97426373	97426379	255,102,0	1	6	0	.	Substrate binding. Pubmed:23653202, Pubmed:15883004
chr10	97430503	97430515	P18669	0	+	97430503	97430515	255,102,0	1	12	0	.	Substrate binding. Pubmed:15883004
chr10	97430584	97430590	P18669	0	+	97430584	97430590	255,102,0	1	6	0	.	Substrate binding. Pubmed:15883004
chr10	97431098	97431104	P18669	0	+	97431098	97431104	255,102,0	1	6	0	.	Substrate binding.
chr10	97572719	97578329	Q9GZV1	0	+	97572719	97578329	255,102,0	1	5610	0	.	May mediate interaction with PML, p53/TP53 and YBX1. Pubmed:15136035
chr10	97598791	97598797	Q86XE5	0	+	97598791	97598797	255,102,0	1	6	0	.	Substrate binding.
chr10	97650973	97650982	Q9BTU6	0	+	97650973	97650982	255,102,0	1	9	0	.	Important for substrate binding. Pubmed:24675427
chr10	97650997	97651039	Q9BTU6	0	+	97650997	97651039	255,102,0	1	42	0	.	Important for interaction with membranes. Pubmed:25168678, Pubmed:24675427
chr10	97656853	97656880	Q9BTU6	0	+	97656853	97656880	255,102,0	1	27	0	.	Important for interaction with membranes. Pubmed:24675427
chr10	97664974	97666457	Q9BTU6	0	+	97664974	97666457	255,102,0	1	1483	0	.	Important for interaction with membranes. Pubmed:24675427
chr10	97738477	97744736	Q5T4F4	0	+	97738477	97744736	255,102,0	1	6259	0	.	Sufficient for homooligomerization. Pubmed:23969831
chr10	97738477	97749537	Q5T4F4	0	+	97738477	97749537	255,102,0	1	11060	0	.	Sufficient for localization to endoplasmic reticulum tubular network and for interactions with REEP1, REEP5, ATL1, ATL2, ATL3 and SPAST. Pubmed:23969831, Pubmed:24668814
chr10	97738627	97738669	Q5T4F4	0	+	97738627	97738669	255,102,0	1	42	0	.	Necessary for interaction with RAB11A and function in neurite outgrowth. Pubmed:17082457
chr10	97751396	97757305	Q5T4F4	0	+	97751396	97757305	255,102,0	1	5909	0	.	Necessary for interaction with KIF5A. Pubmed:21976701
chr10	97751441	97751462	Q5T4F4	0	+	97751441	97751462	255,102,0	1	21	0	.	Necessary for interaction with VAPA and function in cell projections formation.
chr10	98248983	98253791	Q96JB6	0	-	98248983	98253791	255,102,0	1	4808	0	.	Lysyl-oxidase like.
chr10	100054437	100081565	P15169	0	-	100054437	100081565	255,102,0	1	27128	0	.	Catalytic.
chr10	100189606	100189624	O15111	0	-	100189606	100189624	255,102,0	1	18	0	.	NEMO-binding.
chr10	100204584	100204650	O15111	0	-	100204584	100204650	255,102,0	1	66	0	.	Leucine-zipper.
chr10	100289017	100290417	Q9P0L9	0	-	100289017	100290417	255,102,0	1	1400	0	.	Required for protein homotrimerization.
chr10	100535961	100536608	Q9NWT6	0	+	100535961	100536608	255,102,0	1	647	0	.	Interaction with VHL. Pubmed:11641274
chr10	100540745	100540754	Q9NWT6	0	+	100540745	100540754	255,102,0	1	9	0	.	Substrate binding. Pubmed:21177872
chr10	100544973	100544982	Q9NWT6	0	+	100544973	100544982	255,102,0	1	9	0	.	Substrate binding. Pubmed:21177872
chr10	100545084	100545090	Q9NWT6	0	+	100545084	100545090	255,102,0	1	6	0	.	Substrate binding. Pubmed:21177872
chr10	101002538	101004094	Q9BRK4	0	+	101002538	101004094	255,102,0	1	1556	0	.	Required for centrosomal localization.
chr10	101006496	101007165	Q9BRK4	0	+	101006496	101007165	255,102,0	1	669	0	.	Sufficient for interaction with CTNNB1. Pubmed:17000760
chr10	101006505	101007165	Q9BRK4	0	+	101006505	101007165	255,102,0	1	660	0	.	Sufficient for interaction with KATNB1 and for inhibition of katanin-mediated microtubule severing.
chr10	101521695	101521845	Q9Y297	0	+	101521695	101521845	255,102,0	1	150	0	.	Homodimerization domain D.
chr10	101526023	101526140	Q9Y297	0	+	101526023	101526140	255,102,0	1	117	0	.	Required for down-regulation of SNAI1.
chr10	101579665	101579785	Q9UGP5	0	-	101579665	101579785	255,102,0	1	120	0	.	DNA binding. Pubmed:14992725
chr10	101580323	101580353	Q9UGP5	0	-	101580323	101580353	255,102,0	1	30	0	.	Involved in primer binding.
chr10	101583528	101583540	Q9UGP5	0	-	101583528	101583540	255,102,0	1	12	0	.	DNA binding. Pubmed:14992725
chr10	101584655	101584700	Q9UGP5	0	-	101584655	101584700	255,102,0	1	45	0	.	DNA binding. Pubmed:14992725
chr10	101803930	101803939	O60502	0	-	101803930	101803939	255,102,0	1	9	0	.	Substrate binding.
chr10	101827355	101827397	Q9NS61	0	-	101827355	101827397	255,102,0	1	42	0	.	Interaction with KCND2.
chr10	102108206	102108323	Q86U70	0	-	102108206	102108323	255,102,0	1	117	0	.	LIM-binding domain (LID).
chr10	102139804	102139909	Q5VV67	0	+	102139804	102139909	255,102,0	1	105	0	.	Necessary for interaction with CREB1 and NRF1 and for transcriptional coactivation. Pubmed:16908542
chr10	102147126	102147342	Q5VV67	0	+	102147126	102147342	255,102,0	1	216	0	.	Necessary for interaction with CREB1 and NRF1. Pubmed:16908542
chr10	102157261	102161050	Q14978	0	+	102157261	102161050	255,102,0	1	3789	0	.	11 X 12 AA approximate repeats of an acidic serine cluster.
chr10	102159194	102160498	Q14978	0	+	102159194	102160498	255,102,0	1	1304	0	.	Interaction with RPA194.
chr10	102258938	102353648	Q92538	0	+	102258938	102353648	255,102,0	1	94710	0	.	DCB; DCB:DCB domain and DCB:HUS domain interaction.
chr10	102258938	102359398	Q92538	0	+	102258938	102359398	255,102,0	1	100460	0	.	Interaction with RAB1B. Pubmed:17429068
chr10	102361816	102361879	Q92538	0	+	102361816	102361879	255,102,0	1	63	0	.	HUS; DCB:HUS domain interaction.
chr10	102368233	102376625	Q92538	0	+	102368233	102376625	255,102,0	1	8392	0	.	Phosphatidylinositol-phosphate binding; required for translocation to the leading edge and for ARF1 activation upon GPCR signaling. Pubmed:22573891
chr10	102398782	102399301	Q00653	0	+	102398782	102399301	255,102,0	1	519	0	.	GRR.
chr10	102421915	102422897	Q9H469	0	+	102421915	102422897	255,102,0	1	982	0	.	Interaction with SMURF1. Pubmed:21572392
chr10	102597217	102615325	Q9UMX1	0	+	102597217	102615325	255,102,0	1	18108	0	.	Intrinsically disordered. Pubmed:24311597
chr10	103099928	103099955	P49902	0	-	103099928	103099955	255,102,0	1	27	0	.	Substrate binding.
chr10	103246431	103246443	Q2QD12	0	+	103246431	103246443	255,102,0	1	12	0	.	Substrate binding.
chr10	103246584	103246590	Q2QD12	0	+	103246584	103246590	255,102,0	1	6	0	.	Substrate binding.
chr10	103277211	103277472	Q16352	0	+	103277211	103277472	255,102,0	1	261	0	.	Head.
chr10	103277472	103277598	Q16352	0	+	103277472	103277598	255,102,0	1	126	0	.	Coil 1A.
chr10	103277472	103288393	Q16352	0	+	103277472	103288393	255,102,0	1	10921	0	.	Rod.
chr10	103277598	103277637	Q16352	0	+	103277598	103277637	255,102,0	1	39	0	.	Linker 1.
chr10	103277637	103277925	Q16352	0	+	103277637	103277925	255,102,0	1	288	0	.	Coil 1B.
chr10	103277925	103277997	Q16352	0	+	103277925	103277997	255,102,0	1	72	0	.	Linker 2.
chr10	103277997	103288393	Q16352	0	+	103277997	103288393	255,102,0	1	10396	0	.	Coil 2.
chr10	103288393	103288666	Q16352	0	+	103288393	103288666	255,102,0	1	273	0	.	Tail.
chr10	103882686	103889135	Q9H668	0	-	103882686	103889135	255,102,0	1	6449	0	.	Winged helix-turn-helix (wHTH) 2.
chr10	103889135	103898887	Q9H668	0	-	103889135	103898887	255,102,0	1	9752	0	.	Winged helix-turn-helix (wHTH) 1.
chr10	103898902	103917594	Q9H668	0	-	103898902	103917594	255,102,0	1	18692	0	.	Interaction with CTC1. Pubmed:23851344
chr10	104032237	104032282	Q9UMD9	0	-	104032237	104032282	255,102,0	1	45	0	.	Nonhelical region (NC1).
chr10	104032282	104055390	Q9UMD9	0	-	104032282	104055390	255,102,0	1	23108	0	.	Triple-helical region.
chr10	104055390	104080673	Q9UMD9	0	-	104055390	104080673	255,102,0	1	25283	0	.	Nonhelical region (NC16).
chr10	104064513	104072062	Q9UMD9	0	-	104064513	104072062	255,102,0	1	7549	0	.	Necessary for interaction with DST and for the recruitment of DST to hemidesmosome. Pubmed:12482924
chr10	104259684	104259690	P78417	0	+	104259684	104259690	255,102,0	1	6	0	.	Glutathione binding. Pubmed:10783391, Pubmed:21106529
chr10	104278002	104278008	Q9H4Y5	0	+	104278002	104278008	255,102,0	1	6	0	.	Glutathione binding. Pubmed:22522127
chr10	110133546	110133600	Q9UEY8	0	+	110133546	110133600	255,102,0	1	54	0	.	Interaction with calmodulin.
chr10	110590414	110596435	Q9UQE7	0	+	110590414	110596435	255,102,0	1	6021	0	.	Flexible hinge.
chr10	112950756	112950915	Q9NQB0	0	+	112950756	112950915	255,102,0	1	159	0	.	CTNNB1-binding.
chr10	113141231	113152356	Q9NQB0	0	+	113141231	113152356	255,102,0	1	11125	0	.	Mediates interaction with MAD2L2. Pubmed:19443654
chr10	113159924	113165627	Q9NQB0	0	+	113159924	113165627	255,102,0	1	5703	0	.	Promoter-specific activation domain.
chr10	113849262	113849919	Q6PJP8	0	-	113849262	113849919	255,102,0	1	657	0	.	Nuclear focus formation.
chr10	113850534	113853182	Q6PJP8	0	-	113850534	113853182	255,102,0	1	2648	0	.	Nuclear localization region.
chr10	117209741	117209759	Q7Z418	0	+	117209741	117209759	255,102,0	1	18	0	.	Interaction with calcineurin.
chr10	117209888	117209906	Q7Z418	0	+	117209888	117209906	255,102,0	1	18	0	.	Interaction with YWHAH.
chr10	118009000	118009144	Q7L804	0	-	118009000	118009144	255,102,0	1	144	0	.	Necessary for interaction with AP2A1, RAB11A, subcellular location, endocytosis activity and homooligomerization. Pubmed:12364336
chr10	118045857	118046121	Q7L804	0	-	118045857	118046121	255,102,0	1	264	0	.	Necessary for its cellular translocation to the plasma membrane.
chr10	118594134	118594152	P49683	0	-	118594134	118594152	255,102,0	1	18	0	.	Required for interaction with GRIP1, GRIP2 and PICK1. Pubmed:11641419
chr10	119029918	119029969	Q8WY41	0	+	119029918	119029969	255,102,0	1	51	0	.	Essential for its translational repressor activity.
chr10	119042003	119042747	Q14152	0	-	119042003	119042747	255,102,0	1	744	0	.	25 X 10 AA approximate tandem repeats of [DE]-[DE]-[DE]-R-[SEVGFPILV]-[HPSN]-[RSW]-[RL]-[DRGTIHN]-[EPMANLGDT].
chr10	119049953	119057028	Q14152	0	-	119049953	119057028	255,102,0	1	7075	0	.	Interaction with EIF3B.
chr10	119207917	119430396	P34947	0	+	119207917	119430396	255,102,0	1	222479	0	.	N-terminal.
chr10	119326520	119326580	P34947	0	+	119326520	119326580	255,102,0	1	60	0	.	Interaction with calmodulin.
chr10	119453237	119454989	P34947	0	+	119453237	119454989	255,102,0	1	1752	0	.	Sufficient for membrane localization.
chr10	119892782	119904277	Q9Y6Y8	0	+	119892782	119904277	255,102,0	1	11495	0	.	Interaction with SEC23A. Pubmed:10400679
chr10	120518879	120520980	Q5VZY2	0	+	120518879	120520980	255,102,0	1	2101	0	.	Phosphatase sequence motif I.
chr10	120521076	120521088	Q5VZY2	0	+	120521076	120521088	255,102,0	1	12	0	.	Phosphatase sequence motif II.
chr10	120575267	120575300	Q5VZY2	0	+	120575267	120575300	255,102,0	1	33	0	.	Phosphatase sequence motif III.
chr10	121551379	121551433	P21802	0	-	121551379	121551433	255,102,0	1	54	0	.	Heparin-binding.
chr10	122489458	122508742	Q92743	0	+	122489458	122508742	255,102,0	1	19284	0	.	Serine protease.
chr10	123043048	123043054	P45954	0	+	123043048	123043054	255,102,0	1	6	0	.	Substrate binding.
chr10	123044455	123044467	P45954	0	+	123044455	123044467	255,102,0	1	12	0	.	Substrate binding.
chr10	124461910	124461919	Q9H008	0	+	124461910	124461919	255,102,0	1	9	0	.	Substrate binding.
chr10	124484172	124484178	Q9H008	0	+	124484172	124484178	255,102,0	1	6	0	.	Substrate binding.
chr10	124801844	124826675	Q15018	0	+	124801844	124826675	255,102,0	1	24831	0	.	MPN-like.
chr10	124829456	124831351	Q15018	0	+	124829456	124831351	255,102,0	1	1895	0	.	Important for interaction with SHMT2. Pubmed:24075985
chr10	124829471	124831408	Q15018	0	+	124829471	124831408	255,102,0	1	1937	0	.	Important for interaction with BBRC36 and other subunits of the BRISC complex. Pubmed:26344097
chr10	124973661	124984788	Q9UGI0	0	+	124973661	124984788	255,102,0	1	11127	0	.	TRAF-binding.
chr10	125826599	125831509	Q9P287	0	+	125826599	125831509	255,102,0	1	4910	0	.	Interaction with BRCA2.
chr10	125831488	125836106	Q9P287	0	+	125831488	125836106	255,102,0	1	4618	0	.	Interaction with CDKN1A.
chr10	126425866	126461409	Q96M02	0	-	126425866	126461409	255,102,0	1	35543	0	.	ALMS motif.
chr10	126504527	126504854	Q96M02	0	-	126504527	126504854	255,102,0	1	327	0	.	Required for interaction with HDAC1.
chr10	127439087	127439114	Q14185	0	+	127439087	127439114	255,102,0	1	27	0	.	Phosphoinositide-binding.
chr10	127447419	127447500	Q14185	0	+	127447419	127447500	255,102,0	1	81	0	.	Interaction with NCK2 second and third SH3 domain (minor).
chr10	127447500	127451337	Q14185	0	+	127447500	127451337	255,102,0	1	3837	0	.	Interaction with NCK2 third SH3 domain (major).
chr10	127451337	127451385	Q14185	0	+	127451337	127451385	255,102,0	1	48	0	.	Interaction with NCK2 (minor).
chr10	128068281	128069707	P23469	0	+	128068281	128069707	255,102,0	1	1426	0	.	Substrate binding.
chr10	128103055	128108842	P46013	0	-	128103055	128108842	255,102,0	1	5787	0	.	16 X 122 AA approximate repeats. Pubmed:8227122
chr10	129873515	129873527	Q9H4W6	0	-	129873515	129873527	255,102,0	1	12	0	.	Interaction with DNA.
chr10	129877791	129877815	Q9H4W6	0	-	129877791	129877815	255,102,0	1	24	0	.	Interaction with DNA.
chr10	129963459	129963471	Q9H4W6	0	-	129963459	129963471	255,102,0	1	12	0	.	Interaction with DNA.
chr10	133231250	133231346	Q5T230	0	+	133231250	133231346	255,102,0	1	96	0	.	Leucine-zipper.
chr10	133370014	133370026	P30084	0	-	133370014	133370026	255,102,0	1	12	0	.	Substrate binding.
chr10	133533821	133533839	P05181	0	+	133533821	133533839	255,102,0	1	18	0	.	Substrate binding.
chr11	314984	315110	P13164	0	+	314984	315110	255,102,0	1	126	0	.	Interaction with CAV1. Pubmed:19499152
chr11	319840	319918	Q01628	0	-	319840	319918	255,102,0	1	78	0	.	Interaction with VAPA. Pubmed:23601107
chr11	319960	320636	Q01628	0	-	319960	320636	255,102,0	1	676	0	.	Interaction with SPP1. Pubmed:19901966
chr11	502129	502159	P13489	0	-	502129	502159	255,102,0	1	30	0	.	2 X 5 AA tandem repeats of S-L-D-I-Q.
chr11	532650	532710	P01112	0	-	532650	532710	255,102,0	1	60	0	.	Hypervariable region.
chr11	617353	618001	Q9HBB8	0	-	617353	618001	255,102,0	1	648	0	.	Mediates interaction with USH1C and MYO7B and is required for proper localization to microvilli tips and function in microvilli organization. Pubmed:24725409
chr11	618623	618941	Q9HBB8	0	-	618623	618941	255,102,0	1	318	0	.	4 X 31 AA approximate tandem repeats.
chr11	674604	678742	O75398	0	-	674604	678742	255,102,0	1	4138	0	.	Interaction with LMO4.
chr11	798177	798270	I0J062	0	+	798177	798270	255,102,0	1	93	0	.	Necessary for nucleolar localization. Pubmed:22094112
chr11	800344	801013	Q9HB75	0	-	800344	801013	255,102,0	1	669	0	.	UPA domain.
chr11	926033	970272	O94973	0	+	926033	970272	255,102,0	1	44239	0	.	Lipid-binding.
chr11	1016941	1017982	Q6W4X9	0	-	1016941	1017982	255,102,0	1	1041	0	.	Approximate repeats.
chr11	1182291	1192338	P98088	0	+	1182291	1192338	255,102,0	1	10047	0	.	9 X Cys-rich subdomain repeats.
chr11	1184913	1187745	P98088	0	+	1184913	1187745	255,102,0	1	2832	0	.	107 X 8 AA approximate tandem repeats of T-T-S-T-T-S-A-P.
chr11	1188231	1188639	P98088	0	+	1188231	1188639	255,102,0	1	408	0	.	17 X 8 AA approximate tandem repeats of T-T-S-T-T-S-A-P.
chr11	1189125	1189938	P98088	0	+	1189125	1189938	255,102,0	1	813	0	.	34 X 8 AA approximate tandem repeats of T-T-S-T-T-S-A-P.
chr11	1190421	1191930	P98088	0	+	1190421	1191930	255,102,0	1	1509	0	.	58 X 8 AA approximate tandem repeats of T-T-S-T-T-S-A-P.
chr11	1240876	1249564	Q9HC84	0	+	1240876	1249564	255,102,0	1	8688	0	.	7 X Cys-rich subdomain repeats.
chr11	1242547	1243477	Q9HC84	0	+	1242547	1243477	255,102,0	1	930	0	.	11 X approximate tandem repeats, Ser/Thr-rich.
chr11	1244134	1245148	Q9HC84	0	+	1244134	1245148	255,102,0	1	1014	0	.	11 X approximate tandem repeats, Ser/Thr-rich.
chr11	1245805	1247248	Q9HC84	0	+	1245805	1247248	255,102,0	1	1443	0	.	17 X approximate tandem repeats, Ser/Thr-rich.
chr11	1247905	1248919	Q9HC84	0	+	1247905	1248919	255,102,0	1	1014	0	.	11 X approximate tandem repeats, Ser/Thr-rich.
chr11	1249576	1251517	Q9HC84	0	+	1249576	1251517	255,102,0	1	1941	0	.	23 X approximate tandem repeats, Ser/Thr-rich.
chr11	1584436	1585126	Q6L8H4	0	-	1584436	1585126	255,102,0	1	690	0	.	8 X 4 AA repeats of C-C-X-P.
chr11	1584446	1585136	Q6L8H4	0	-	1584446	1585136	255,102,0	1	690	0	.	8 X 4 AA repeats of C-C-X-P.
chr11	1590146	1590836	Q6L8H4	0	-	1590146	1590836	255,102,0	1	690	0	.	8 X 4 AA repeats of C-C-X-P.
chr11	1597740	1598067	Q701N4	0	-	1597740	1598067	255,102,0	1	327	0	.	6 X 4 AA repeats of C-C-X-P.
chr11	1597756	1598083	Q701N4	0	-	1597756	1598083	255,102,0	1	327	0	.	6 X 4 AA repeats of C-C-X-P.
chr11	1603450	1603777	Q701N4	0	-	1603450	1603777	255,102,0	1	327	0	.	6 X 4 AA repeats of C-C-X-P.
chr11	1607692	1608283	Q6L8H2	0	-	1607692	1608283	255,102,0	1	591	0	.	11 X 4 AA repeats of C-C-X-P.
chr11	1607718	1608309	Q6L8H2	0	-	1607718	1608309	255,102,0	1	591	0	.	11 X 4 AA repeats of C-C-X-P.
chr11	1613402	1613993	Q6L8H2	0	-	1613402	1613993	255,102,0	1	591	0	.	11 X 4 AA repeats of C-C-X-P.
chr11	1621458	1622157	Q6L8H1	0	-	1621458	1622157	255,102,0	1	699	0	.	9 X 4 AA repeats of C-C-X-P.
chr11	1630023	1630530	Q701N2	0	+	1630023	1630530	255,102,0	1	507	0	.	8 X 4 AA repeats of C-C-X-P.
chr11	1635733	1636240	Q701N2	0	+	1635733	1636240	255,102,0	1	507	0	.	8 X 4 AA repeats of C-C-X-P.
chr11	1694545	1694800	Q6L8G9	0	+	1694545	1694800	255,102,0	1	255	0	.	6 X 4 AA repeats of C-C-X-P.
chr11	1697326	1697581	Q6L8G9	0	+	1697326	1697581	255,102,0	1	255	0	.	6 X 4 AA repeats of C-C-X-P.
chr11	1839699	1840614	P48788	0	+	1839699	1840614	255,102,0	1	915	0	.	Involved in binding TNC.
chr11	1841042	1841105	P48788	0	+	1841042	1841105	255,102,0	1	63	0	.	Involved in binding TNC and actin.
chr11	2133549	2133567	P01344	0	-	2133549	2133567	255,102,0	1	18	0	.	D.
chr11	2133567	2133630	P01344	0	-	2133567	2133630	255,102,0	1	63	0	.	A.
chr11	2133630	2133666	P01344	0	-	2133630	2133666	255,102,0	1	36	0	.	C.
chr11	2135367	2135451	P01344	0	-	2135367	2135451	255,102,0	1	84	0	.	B.
chr11	2775971	2777016	P51787	0	+	2775971	2777016	255,102,0	1	1045	0	.	Interaction with KCNE1 C-terminus. Pubmed:25037568
chr11	2778004	2847820	P51787	0	+	2778004	2847820	255,102,0	1	69816	0	.	Interaction with AKAP9. Pubmed:11799244
chr11	2778007	2847832	P51787	0	+	2778007	2847832	255,102,0	1	69825	0	.	C-terminal assembly domain. Pubmed:10654932
chr11	2884850	2885024	P49918	0	-	2884850	2885024	255,102,0	1	174	0	.	9 X 4 AA repeats of P-A-P-A.
chr11	3101687	3101693	Q9H0X9	0	-	3101687	3101693	255,102,0	1	6	0	.	Phosphatidylinositol 4-phosphate binding.
chr11	3102260	3102272	Q9H0X9	0	-	3102260	3102272	255,102,0	1	12	0	.	Phosphatidylinositol 4-phosphate binding.
chr11	3104269	3104287	Q9H0X9	0	-	3104269	3104287	255,102,0	1	18	0	.	Phosphatidylinositol 4-phosphate binding.
chr11	3104269	3104287	Q9H0X9	0	-	3104269	3104287	255,102,0	1	18	0	.	Phosphatidylserine binding.
chr11	3360278	3361890	O14628	0	-	3360278	3361890	255,102,0	1	1612	0	.	Spacer.
chr11	3744527	3771892	P52948	0	-	3744527	3771892	255,102,0	1	27365	0	.	FG repeats 2.
chr11	3771892	3775908	P52948	0	-	3771892	3775908	255,102,0	1	4016	0	.	GLEBS; interaction with RAE1. Pubmed:10209021
chr11	3775908	3782117	P52948	0	-	3775908	3782117	255,102,0	1	6209	0	.	FG repeats 1.
chr11	4082213	4083356	Q13586	0	+	4082213	4083356	255,102,0	1	1143	0	.	SOAR/CAD.
chr11	4102003	4102024	P23921	0	+	4102003	4102024	255,102,0	1	21	0	.	Allosteric activator binding.
chr11	4112060	4118323	P23921	0	+	4112060	4118323	255,102,0	1	6263	0	.	Substrate binding.
chr11	4119904	4119916	P23921	0	+	4119904	4119916	255,102,0	1	12	0	.	Allosteric effector binding, determines substrate specificity.
chr11	4123342	4123357	P23921	0	+	4123342	4123357	255,102,0	1	15	0	.	Substrate binding.
chr11	4132322	4132337	P23921	0	+	4132322	4132337	255,102,0	1	15	0	.	Substrate binding.
chr11	5678353	5678395	Q9C035	0	-	5678353	5678395	255,102,0	1	42	0	.	Required for interaction with GABARAP and for autophagy.
chr11	6440693	6440726	P02790	0	-	6440693	6440726	255,102,0	1	33	0	.	O-glycosylated at one site.
chr11	6456855	6465692	O75382	0	-	6456855	6465692	255,102,0	1	8837	0	.	Interaction with KIF21B.
chr11	6608052	6608759	Q13418	0	+	6608052	6608759	255,102,0	1	707	0	.	Interaction with LIMS1. Pubmed:12167643
chr11	6609075	6609316	Q13418	0	+	6609075	6609316	255,102,0	1	241	0	.	PH-like; mediates interaction with TGFB1I1.
chr11	7252210	7252279	Q86SS6	0	+	7252210	7252279	255,102,0	1	69	0	.	Cysteine motif.
chr11	8729948	8730089	P78524	0	-	8729948	8730089	255,102,0	1	141	0	.	Interaction with ABL1. Pubmed:9632734
chr11	9785306	9789153	Q86WG5	0	-	9785306	9789153	255,102,0	1	3847	0	.	Interaction with MTMR2. Pubmed:15998640
chr11	10494925	10494943	Q01432	0	+	10494925	10494943	255,102,0	1	18	0	.	Substrate binding.
chr11	10502867	10502879	Q01432	0	+	10502867	10502879	255,102,0	1	12	0	.	Substrate binding.
chr11	11340941	11377189	Q6P9A2	0	-	11340941	11377189	255,102,0	1	36248	0	.	Catalytic subdomain B.
chr11	11377357	11432759	Q6P9A2	0	-	11377357	11432759	255,102,0	1	55402	0	.	Catalytic subdomain A.
chr11	11964664	11967005	Q9UBP4	0	-	11964664	11967005	255,102,0	1	2341	0	.	DKK-type Cys-2.
chr11	11967041	11968484	Q9UBP4	0	-	11967041	11968484	255,102,0	1	1443	0	.	DKK-type Cys-1.
chr11	12008444	12008498	Q9UBP4	0	-	12008444	12008498	255,102,0	1	54	0	.	O-glycosylated at one site.
chr11	12162158	12223443	O94851	0	+	12162158	12223443	255,102,0	1	61285	0	.	Monooxygenase domain.
chr11	12293614	12293734	Q6ZW33	0	+	12293614	12293734	255,102,0	1	120	0	.	Interaction with MAPK1.
chr11	12349857	12358440	Q6ZW33	0	+	12349857	12358440	255,102,0	1	8583	0	.	RAB-binding domain (RBD). Pubmed:27552051
chr11	13378443	13386639	O00327	0	+	13378443	13386639	255,102,0	1	8196	0	.	Interaction with CIART.
chr11	13388833	13419608	Q9BSF8	0	-	13388833	13419608	255,102,0	1	30775	0	.	Interaction with AKT family members.
chr11	13492545	13492602	P01270	0	-	13492545	13492602	255,102,0	1	57	0	.	Important for receptor binding.
chr11	14644075	14644150	Q13370	0	+	14644075	14644150	255,102,0	1	75	0	.	Interaction with RAPGEF3. Pubmed:21393242
chr11	14789132	14789207	Q13370	0	+	14789132	14789207	255,102,0	1	75	0	.	Interaction with PIK3R6. Pubmed:21393242
chr11	14832763	14869537	Q13370	0	+	14832763	14869537	255,102,0	1	36774	0	.	Catalytic.
chr11	15175762	15175810	Q1MX18	0	+	15175762	15175810	255,102,0	1	48	0	.	Important for interaction with GPSM2. Pubmed:22074847
chr11	16803040	16817054	Q6IQ23	0	-	16803040	16817054	255,102,0	1	14014	0	.	Interaction with CTNND1. Pubmed:19041755
chr11	17092248	17092266	O00443	0	-	17092248	17092266	255,102,0	1	18	0	.	Interaction with PtdIns(4,5)P2-containing membranes.
chr11	17169315	17169738	O00443	0	-	17169315	17169738	255,102,0	1	423	0	.	Interaction with clathrin; sufficient to induce clathrin assemby.
chr11	17356754	17356766	Q68D85	0	+	17356754	17356766	255,102,0	1	12	0	.	Interaction with NCR3. Pubmed:19528259
chr11	17356958	17356970	Q68D85	0	+	17356958	17356970	255,102,0	1	12	0	.	Interaction with NCR3. Pubmed:19528259
chr11	17372017	17372434	Q68D85	0	+	17372017	17372434	255,102,0	1	417	0	.	Retroviral-Gag-like.
chr11	17494366	17526441	Q9Y6N9	0	-	17494366	17526441	255,102,0	1	32075	0	.	Mediates interaction with MYO7B. Pubmed:26812017, Pubmed:26812018
chr11	17531282	17544307	Q9Y6N9	0	-	17531282	17544307	255,102,0	1	13025	0	.	N-terminal domain. Pubmed:20142502
chr11	18506918	18509551	Q99816	0	-	18506918	18509551	255,102,0	1	2633	0	.	Interaction with CEP55.
chr11	18609863	18612489	Q68D10	0	-	18609863	18612489	255,102,0	1	2626	0	.	Important for interaction with histones. Pubmed:23378026
chr11	18614563	18634257	Q68D10	0	-	18614563	18634257	255,102,0	1	19694	0	.	Important for interaction with DNA. Pubmed:23378026
chr11	18729550	18729662	A8MXF1	0	-	18729550	18729662	255,102,0	1	112	0	.	Substrate binding.
chr11	18729550	18729662	E9PLZ4	0	-	18729550	18729662	255,102,0	1	112	0	.	Substrate binding.
chr11	18729550	18729662	P54829	0	-	18729550	18729662	255,102,0	1	112	0	.	Substrate binding.
chr11	19186314	19188137	P50461	0	-	19186314	19188137	255,102,0	1	1823	0	.	Interaction with CLF2 and isoform 2. Pubmed:24860983, Pubmed:19752190
chr11	19192433	19192448	P50461	0	-	19192433	19192448	255,102,0	1	15	0	.	Interaction with TCAP. Pubmed:12507422
chr11	22827829	22827868	Q8NHG7	0	-	22827829	22827868	255,102,0	1	39	0	.	VCP/p97-interacting motif (VIM). Pubmed:21896481
chr11	24914505	24976644	Q86TE4	0	+	24914505	24976644	255,102,0	1	62139	0	.	Leucine-zipper.
chr11	28211088	28211097	A6NJ78	0	+	28211088	28211097	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr11	30011253	30011295	P22459	0	-	30011253	30011295	255,102,0	1	42	0	.	S4-S5 linker.
chr11	32602303	32602396	Q7L2H7	0	+	32602303	32602396	255,102,0	1	93	0	.	Interaction with HSV-1 and HSV-2.
chr11	33348005	33351632	Q9H422	0	+	33348005	33351632	255,102,0	1	3627	0	.	Interaction with AR.
chr11	33348537	33349153	Q9H422	0	+	33348537	33349153	255,102,0	1	616	0	.	Interaction with FAS.
chr11	33348714	33351833	Q9H422	0	+	33348714	33351833	255,102,0	1	3119	0	.	Required for localization to nuclear speckles.
chr11	33348747	33349234	Q9H422	0	+	33348747	33349234	255,102,0	1	487	0	.	SUMO interaction motifs (SIM); required for nuclear localization and kinase activity.
chr11	33348759	33348792	Q9H422	0	+	33348759	33348792	255,102,0	1	33	0	.	Interaction with UBL1.
chr11	34086174	34086325	Q14444	0	+	34086174	34086325	255,102,0	1	151	0	.	G3BP1-binding.
chr11	34134559	34134568	A0A087WV29	0	+	34134559	34134568	255,102,0	1	9	0	.	Acetyl-CoA binding.
chr11	34134559	34134568	Q9H0A0	0	+	34134559	34134568	255,102,0	1	9	0	.	Acetyl-CoA binding.
chr11	34134580	34135189	A0A087WV29	0	+	34134580	34135189	255,102,0	1	609	0	.	Acetyl-CoA binding.
chr11	34134580	34135189	Q9H0A0	0	+	34134580	34135189	255,102,0	1	609	0	.	Acetyl-CoA binding.
chr11	34136716	34146189	Q9H0A0	0	+	34136716	34146189	255,102,0	1	9473	0	.	Required for localization to the nucleolus and midbody. Pubmed:19303003
chr11	35196747	35221655	P16070	0	+	35196747	35221655	255,102,0	1	24908	0	.	Stem.
chr11	36489840	36490344	Q9Y4K3	0	-	36489840	36490344	255,102,0	1	504	0	.	Interaction with TANK. Pubmed:25861989
chr11	36490344	36501515	Q9Y4K3	0	-	36490344	36501515	255,102,0	1	11171	0	.	Interaction with TAX1BP1. Pubmed:10920205
chr11	36573304	36574168	P15918	0	+	36573304	36574168	255,102,0	1	864	0	.	Interaction with importin alpha-1.
chr11	43312130	43328846	Q9BZZ5	0	+	43312130	43328846	255,102,0	1	16716	0	.	ARM-like and Heat-like helical repeats.
chr11	43328873	43330010	Q9BZZ5	0	+	43328873	43330010	255,102,0	1	1137	0	.	Leucine-zipper.
chr11	43892090	43892099	Q96Q83	0	+	43892090	43892099	255,102,0	1	9	0	.	Substrate binding.
chr11	43901590	43901599	Q96Q83	0	+	43901590	43901599	255,102,0	1	9	0	.	Alpha-ketoglutarate binding. Pubmed:16858410
chr11	43919953	43919974	Q96Q83	0	+	43919953	43919974	255,102,0	1	21	0	.	Alpha-ketoglutarate binding. Pubmed:16858410
chr11	44206845	44206863	Q93063	0	+	44206845	44206863	255,102,0	1	18	0	.	Substrate binding.
chr11	44206908	44206917	Q93063	0	+	44206908	44206917	255,102,0	1	9	0	.	Substrate binding.
chr11	44234177	44234192	Q93063	0	+	44234177	44234192	255,102,0	1	15	0	.	Substrate binding.
chr11	44236340	44236376	Q93063	0	+	44236340	44236376	255,102,0	1	36	0	.	Substrate binding.
chr11	45869790	45870450	Q49AN0	0	+	45869790	45870450	255,102,0	1	660	0	.	Required for inhibition of CLOCK-ARNTL-mediated transcription.
chr11	45900308	45902622	Q9UQF2	0	+	45900308	45902622	255,102,0	1	2314	0	.	JNK-binding domain (JBD).
chr11	45900398	45901985	Q9UQF2	0	+	45900398	45901985	255,102,0	1	1587	0	.	Minimal inhibitory domain (MID).
chr11	45902613	45903180	Q9UQF2	0	+	45902613	45903180	255,102,0	1	567	0	.	Interaction with MAP3K7. Pubmed:17709393
chr11	45903177	45905166	Q9UQF2	0	+	45903177	45905166	255,102,0	1	1989	0	.	Interaction with VRK2. Pubmed:18286207
chr11	45910256	45914349	Q9Y5Y5	0	-	45910256	45914349	255,102,0	1	4093	0	.	Interaction with PEX19.
chr11	45915818	45916256	Q9Y5Y5	0	-	45915818	45916256	255,102,0	1	438	0	.	Required for peroxisomal location.
chr11	45923475	45926549	Q8N3Y3	0	+	45923475	45926549	255,102,0	1	3074	0	.	Xylosyltransferase activity.
chr11	45926549	45928824	Q8N3Y3	0	+	45926549	45928824	255,102,0	1	2275	0	.	Glucuronyltransferase activity.
chr11	45933970	45938306	Q96BD5	0	-	45933970	45938306	255,102,0	1	4336	0	.	Required for transcriptional repression.
chr11	46278111	46300012	Q96BA8	0	+	46278111	46300012	255,102,0	1	21901	0	.	Required for transcriptional activation.
chr11	46312444	46312671	Q96BA8	0	+	46312444	46312671	255,102,0	1	227	0	.	Basic motif.
chr11	46312881	46316313	Q96BA8	0	+	46312881	46316313	255,102,0	1	3432	0	.	Leucine-zipper.
chr11	46371721	46371766	Q13574	0	+	46371721	46371766	255,102,0	1	45	0	.	MARCKS homology.
chr11	46372077	46373026	Q13574	0	+	46372077	46373026	255,102,0	1	949	0	.	Mediates interaction with RASGRP1.
chr11	46650237	46650261	O75143	0	+	46650237	46650261	255,102,0	1	24	0	.	Important for interaction with ATG101. Pubmed:26299944
chr11	46729557	46739112	P00734	0	+	46729557	46739112	255,102,0	1	9555	0	.	High affinity receptor-binding region which is also known as the TP508 peptide.
chr11	46744250	46744488	Q14008	0	-	46744250	46744488	255,102,0	1	238	0	.	Interaction with TACC3. Pubmed:25596274
chr11	46760721	46763591	Q14008	0	-	46760721	46763591	255,102,0	1	2870	0	.	TOG 5. Pubmed:24966168
chr11	46770041	46778476	Q14008	0	-	46770041	46778476	255,102,0	1	8435	0	.	TOG 4. Pubmed:24966168
chr11	46778581	46790472	Q14008	0	-	46778581	46790472	255,102,0	1	11891	0	.	TOG 3. Pubmed:24966168
chr11	46795737	46809462	Q14008	0	-	46795737	46809462	255,102,0	1	13725	0	.	TOG 2. Pubmed:24966168
chr11	46809835	46821231	Q14008	0	-	46809835	46821231	255,102,0	1	11396	0	.	TOG 1. Pubmed:24966168
chr11	47165484	47175289	Q8N6H7	0	-	47165484	47175289	255,102,0	1	9805	0	.	Required for interaction with coatomer.
chr11	47216409	47216445	Q92466	0	+	47216409	47216445	255,102,0	1	36	0	.	Required for interaction with DDB1.
chr11	47216466	47216887	Q92466	0	+	47216466	47216887	255,102,0	1	421	0	.	Required for interaction with DDB1.
chr11	47235388	47235397	Q92466	0	+	47235388	47235397	255,102,0	1	9	0	.	Photolesion recognition.
chr11	47259216	47260464	Q13133	0	+	47259216	47260464	255,102,0	1	1248	0	.	Transactivation AF-1; required for ligand-independent transactivation function. Pubmed:25661920
chr11	47261353	47268693	Q13133	0	+	47261353	47268693	255,102,0	1	7340	0	.	Transactivation AF-2; required for ligand-dependent transactivation function; mediates interaction with CCAR2. Pubmed:25661920
chr11	47261383	47268654	Q13133	0	+	47261383	47268654	255,102,0	1	7271	0	.	Ligand-binding.
chr11	48163613	48164395	Q12913	0	+	48163613	48164395	255,102,0	1	782	0	.	Substrate binding.
chr11	49146908	49146914	Q04609	0	-	49146908	49146914	255,102,0	1	6	0	.	Substrate binding. Pubmed:17372356, Pubmed:17567119
chr11	49154354	49185675	Q04609	0	-	49154354	49185675	255,102,0	1	31321	0	.	NAALADase.
chr11	49154456	49154462	Q04609	0	-	49154456	49154462	255,102,0	1	6	0	.	Substrate binding.
chr11	49156731	49156740	Q04609	0	-	49156731	49156740	255,102,0	1	9	0	.	Substrate binding. Pubmed:18234225, Pubmed:19053759
chr11	49156785	49156791	Q04609	0	-	49156785	49156791	255,102,0	1	6	0	.	Substrate binding.
chr11	57302191	57320179	Q9C0C2	0	-	57302191	57320179	255,102,0	1	17988	0	.	Acidic.
chr11	57302515	57302794	Q9C0C2	0	-	57302515	57302794	255,102,0	1	279	0	.	Tankyrase-binding.
chr11	57476590	57476629	Q86UN3	0	+	57476590	57476629	255,102,0	1	39	0	.	Important for interaction with MAG.
chr11	57550052	57550109	A8MU46	0	+	57550052	57550109	255,102,0	1	57	0	.	Calmodulin-binding.
chr11	57600079	57600184	P05155	0	+	57600079	57600184	255,102,0	1	105	0	.	7 X 4 AA tandem repeats of [QE]-P-T-[TQ].
chr11	58614252	58616717	Q96JP5	0	+	58614252	58616717	255,102,0	1	2465	0	.	Interaction with MAP3K14/NIK. Pubmed:20682767
chr11	59152673	59153501	Q96PZ2	0	+	59152673	59153501	255,102,0	1	828	0	.	Interaction with SV40 large T antigen.
chr11	59593712	59593718	P22059	0	-	59593712	59593718	255,102,0	1	6	0	.	Phosphatidylinositol 4-phosphate binding.
chr11	59594078	59594090	P22059	0	-	59594078	59594090	255,102,0	1	12	0	.	Phosphatidylinositol 4-phosphate binding.
chr11	59594195	59600591	P22059	0	-	59594195	59600591	255,102,0	1	6396	0	.	Sterol binding.
chr11	59610585	59615316	P22059	0	-	59610585	59615316	255,102,0	1	4731	0	.	Phosphatidylinositol 4-phosphate binding.
chr11	59638392	59652545	Q86TB9	0	-	59638392	59652545	255,102,0	1	14153	0	.	Region C.
chr11	59638392	59652948	Q86TB9	0	-	59638392	59652948	255,102,0	1	14556	0	.	Involved in nuclear spleckles localization.
chr11	59652545	59652975	Q86TB9	0	-	59652545	59652975	255,102,0	1	430	0	.	Region H.
chr11	59652948	59656555	Q86TB9	0	-	59652948	59656555	255,102,0	1	3607	0	.	Involved in RNA-binding.
chr11	59652948	59668895	Q86TB9	0	-	59652948	59668895	255,102,0	1	15947	0	.	Involved in nuclear foci localization.
chr11	59652975	59659344	Q86TB9	0	-	59652975	59659344	255,102,0	1	6369	0	.	Region N; interaction with decapping machinery.
chr11	59659344	59668895	Q86TB9	0	-	59659344	59668895	255,102,0	1	9551	0	.	Region A; interaction with DDX6/RCK.
chr11	59831684	59831714	P27352	0	-	59831684	59831714	255,102,0	1	30	0	.	Cobalamin binding.
chr11	59831759	59831777	P27352	0	-	59831759	59831777	255,102,0	1	18	0	.	Cobalamin binding.
chr11	59852977	59854776	P20061	0	-	59852977	59854776	255,102,0	1	1799	0	.	Globular C-terminal beta domain.
chr11	59853230	59853239	P20061	0	-	59853230	59853239	255,102,0	1	9	0	.	Cobalamin binding.
chr11	59854776	59855875	P20061	0	-	59854776	59855875	255,102,0	1	1099	0	.	Flexible linker.
chr11	59855875	59866401	P20061	0	-	59855875	59866401	255,102,0	1	10526	0	.	Globular N-terminal alpha domain.
chr11	59859265	59861539	P20061	0	-	59859265	59861539	255,102,0	1	2274	0	.	Cobalamin binding.
chr11	59861644	59861659	P20061	0	-	59861644	59861659	255,102,0	1	15	0	.	Cobalamin binding.
chr11	60463061	60463082	P11836	0	+	60463061	60463082	255,102,0	1	21	0	.	Epitope 1.
chr11	60466019	60466064	P11836	0	+	60466019	60466064	255,102,0	1	45	0	.	Epitope 2.
chr11	60466085	60466109	P11836	0	+	60466085	60466109	255,102,0	1	24	0	.	Epitope 3 (recognized by antibodies, including Rituximab).
chr11	60900902	60903503	Q9UMS4	0	-	60900902	60903503	255,102,0	1	2601	0	.	May mediate interaction with PSMC5.
chr11	60934758	60936583	Q24JP5	0	+	60934758	60936583	255,102,0	1	1825	0	.	Binds to HSPA5/GRP78.
chr11	60935425	60936904	Q24JP5	0	+	60935425	60936904	255,102,0	1	1479	0	.	Confers cellular localization similar to full-length form.
chr11	61300138	61310385	Q16531	0	-	61300138	61310385	255,102,0	1	10247	0	.	Interaction with CDT1 and CUL4A. Pubmed:15448697
chr11	61302342	61312029	Q16531	0	-	61302342	61312029	255,102,0	1	9687	0	.	WD repeat beta-propeller C.
chr11	61310391	61332965	Q16531	0	-	61310391	61332965	255,102,0	1	22574	0	.	Interaction with CDT1. Pubmed:15448697
chr11	61312029	61321646	Q16531	0	-	61312029	61321646	255,102,0	1	9617	0	.	WD repeat beta-propeller B; Interaction with CUL4A.
chr11	61322349	61332932	Q16531	0	-	61322349	61332932	255,102,0	1	10583	0	.	WD repeat beta-propeller A.
chr11	61338102	61338114	Q3LXA3	0	+	61338102	61338114	255,102,0	1	12	0	.	Dihydroxyacetone binding.
chr11	61795361	61795673	P39748	0	+	61795361	61795673	255,102,0	1	312	0	.	N-domain.
chr11	61795361	61795673	Q6FHX6	0	+	61795361	61795673	255,102,0	1	312	0	.	N-domain.
chr11	61795724	61796120	P39748	0	+	61795724	61796120	255,102,0	1	396	0	.	I-domain.
chr11	61795724	61796120	Q6FHX6	0	+	61795724	61796120	255,102,0	1	396	0	.	I-domain.
chr11	61796366	61796393	P39748	0	+	61796366	61796393	255,102,0	1	27	0	.	Interaction with PCNA. Pubmed:9305916
chr11	61796366	61796393	Q6FHX6	0	+	61796366	61796393	255,102,0	1	27	0	.	Interaction with PCNA.
chr11	62129896	62130271	Q9NQS7	0	+	62129896	62130271	255,102,0	1	375	0	.	Interaction with CBX5. Pubmed:21346195
chr11	62141041	62148750	Q9NQS7	0	+	62141041	62148750	255,102,0	1	7709	0	.	SAH.
chr11	62150128	62151910	Q9NQS7	0	+	62150128	62151910	255,102,0	1	1782	0	.	Interaction with AURKC. Pubmed:27332895
chr11	62150140	62151919	Q9NQS7	0	+	62150140	62151919	255,102,0	1	1779	0	.	IN box.
chr11	62389226	62389238	Q7L266	0	+	62389226	62389238	255,102,0	1	12	0	.	Substrate binding.
chr11	62391565	62391577	Q7L266	0	+	62391565	62391577	255,102,0	1	12	0	.	Substrate binding.
chr11	62616658	62616688	O94766	0	-	62616658	62616688	255,102,0	1	30	0	.	Interaction with galactose moiety of substrate glycoprotein.
chr11	62671811	62672072	Q6UW78	0	+	62671811	62672072	255,102,0	1	261	0	.	Mediates lipid-binding. Pubmed:25605331
chr11	62676592	62678588	Q04323	0	-	62676592	62678588	255,102,0	1	1996	0	.	Interaction with BRCA1. Pubmed:20351172
chr11	62801783	62805353	Q9UBU9	0	-	62801783	62805353	255,102,0	1	3570	0	.	Interaction with ALYREF/THOC4 and LUZP4. Pubmed:25662211
chr11	62803433	62803826	Q9UBU9	0	-	62803433	62803826	255,102,0	1	393	0	.	Major non-specific RNA-binding.
chr11	62803433	62805353	Q9UBU9	0	-	62803433	62805353	255,102,0	1	1920	0	.	RNA-binding (RBD).
chr11	62803826	62805353	Q9UBU9	0	-	62803826	62805353	255,102,0	1	1527	0	.	Minor non-specific RNA-binding.
chr11	63753672	63758198	O95197	0	+	63753672	63758198	255,102,0	1	4526	0	.	Interaction with FADD. Pubmed:17031492
chr11	63756114	63756123	O95197	0	+	63756114	63756123	255,102,0	1	9	0	.	Interaction with BACE1.
chr11	63952533	63952542	Q86UY6	0	+	63952533	63952542	255,102,0	1	9	0	.	Sustrate binding. Pubmed:25619998
chr11	63952762	63952771	Q86UY6	0	+	63952762	63952771	255,102,0	1	9	0	.	Acetyl-CoA binding. Pubmed:25619998
chr11	63952786	63952804	Q86UY6	0	+	63952786	63952804	255,102,0	1	18	0	.	Acetyl-CoA binding. Pubmed:25619998
chr11	63996905	63996932	Q96FW1	0	+	63996905	63996932	255,102,0	1	27	0	.	Ubiquitin-conjugating enzyme E2 binding. Pubmed:22325355
chr11	63997130	63997157	Q96FW1	0	+	63997130	63997157	255,102,0	1	27	0	.	Ubiquitin-conjugating enzyme E2 binding. Pubmed:22325355
chr11	63997190	63997211	Q96FW1	0	+	63997190	63997211	255,102,0	1	21	0	.	Free ubiquitin binding. Pubmed:22367539, Pubmed:22325355
chr11	63997241	63997369	Q96FW1	0	+	63997241	63997369	255,102,0	1	128	0	.	Ubiquitin-conjugating enzyme E2 binding. Pubmed:22367539, Pubmed:22325355
chr11	63997369	63997393	Q96FW1	0	+	63997369	63997393	255,102,0	1	24	0	.	Free ubiquitin binding. Pubmed:22367539, Pubmed:22325355
chr11	63997462	63997483	Q96FW1	0	+	63997462	63997483	255,102,0	1	21	0	.	Free ubiquitin binding. Pubmed:22367539, Pubmed:22325355
chr11	63999402	63999548	Q9BQ69	0	-	63999402	63999548	255,102,0	1	146	0	.	Substrate binding.
chr11	64000338	64015264	Q9BQ69	0	-	64000338	64015264	255,102,0	1	14926	0	.	Substrate binding.
chr11	64015276	64151242	Q9BQ69	0	-	64015276	64151242	255,102,0	1	135966	0	.	Substrate binding.
chr11	64151272	64151281	Q9BQ69	0	-	64151272	64151281	255,102,0	1	9	0	.	Substrate binding.
chr11	64267541	64267553	Q01970	0	+	64267541	64267553	255,102,0	1	12	0	.	Interaction with SHANK2.
chr11	64296994	64297129	Q9NYG8	0	+	64296994	64297129	255,102,0	1	135	0	.	Selectivity filter 1. Pubmed:23341632, Pubmed:25500157
chr11	64297625	64297643	Q9NYG8	0	+	64297625	64297643	255,102,0	1	18	0	.	Selectivity filter 2. Pubmed:23341632, Pubmed:25500157
chr11	64307179	64307407	P11474	0	+	64307179	64307407	255,102,0	1	228	0	.	Repressor domain.
chr11	64314784	64315900	P11474	0	+	64314784	64315900	255,102,0	1	1116	0	.	Ligand binding domain.
chr11	64315900	64315963	P11474	0	+	64315900	64315963	255,102,0	1	63	0	.	AF-2 domain.
chr11	64371333	64371477	O75676	0	+	64371333	64371477	255,102,0	1	144	0	.	Required for nuclear targeting and association with MAPK14.
chr11	64797124	64797338	Q12851	0	-	64797124	64797338	255,102,0	1	214	0	.	PEST3.
chr11	64798810	64799444	Q12851	0	-	64798810	64799444	255,102,0	1	634	0	.	PEST2.
chr11	64799656	64800144	Q12851	0	-	64799656	64800144	255,102,0	1	488	0	.	PEST1.
chr11	64805649	64807905	O00255	0	-	64805649	64807905	255,102,0	1	2256	0	.	Interaction with FANCD2. Pubmed:12874027
chr11	64989755	64994456	Q8N1L9	0	-	64989755	64994456	255,102,0	1	4701	0	.	Leucine-zipper.
chr11	64994465	64994531	Q8N1L9	0	-	64994465	64994531	255,102,0	1	66	0	.	Basic motif.
chr11	65046306	65054555	Q9UQQ1	0	-	65046306	65054555	255,102,0	1	8249	0	.	NAALADase.
chr11	65131145	65131326	Q86TM6	0	-	65131145	65131326	255,102,0	1	181	0	.	Interaction with p53/TP53. Pubmed:17170702
chr11	65133475	65133541	Q86TM6	0	-	65133475	65133541	255,102,0	1	66	0	.	Interaction with SEL1L.
chr11	65171465	65172731	Q5MJ68	0	+	65171465	65172731	255,102,0	1	1266	0	.	Speedy/Ringo box; Required for CDK-binding.
chr11	65188643	65206792	P07384	0	+	65188643	65206792	255,102,0	1	18149	0	.	Domain III.
chr11	65206792	65208075	P07384	0	+	65206792	65208075	255,102,0	1	1283	0	.	Linker.
chr11	65208075	65211280	P07384	0	+	65208075	65211280	255,102,0	1	3205	0	.	Domain IV.
chr11	65538515	65538563	Q96KG9	0	+	65538515	65538563	255,102,0	1	48	0	.	Interaction with COPB1.
chr11	65590101	65592233	Q8N3D4	0	+	65590101	65592233	255,102,0	1	2132	0	.	RAB-binding domain (RBD). Pubmed:27552051
chr11	65607381	65607447	Q16584	0	-	65607381	65607447	255,102,0	1	66	0	.	Leucine-zipper 2.
chr11	65607486	65607679	Q16584	0	-	65607486	65607679	255,102,0	1	193	0	.	Leucine-zipper 1.
chr11	65654656	65654791	Q04206	0	-	65654656	65654791	255,102,0	1	135	0	.	Activation domain.
chr11	65716918	65719178	Q92993	0	+	65716918	65719178	255,102,0	1	2260	0	.	Interaction with ATF2. Pubmed:18397884
chr11	65716924	65716933	Q92993	0	+	65716924	65716933	255,102,0	1	9	0	.	Acetyl-CoA binding.
chr11	65716945	65716966	Q92993	0	+	65716945	65716966	255,102,0	1	21	0	.	Acetyl-CoA binding.
chr11	65861967	65863191	Q96NY9	0	+	65861967	65863191	255,102,0	1	1224	0	.	Interaction with BLM. Pubmed:15805243
chr11	65893218	65894022	P15407	0	-	65893218	65894022	255,102,0	1	804	0	.	Leucine-zipper.
chr11	65894037	65894100	P15407	0	-	65894037	65894100	255,102,0	1	63	0	.	Basic motif.
chr11	66210418	66210442	Q6VY07	0	+	66210418	66210442	255,102,0	1	24	0	.	Involved in binding to AP-1.
chr11	66272370	66272430	Q9H0U4	0	+	66272370	66272430	255,102,0	1	60	0	.	Switch 2 region; required for interaction with REP1/CHM.
chr11	66332446	66334919	Q13671	0	-	66332446	66334919	255,102,0	1	2473	0	.	Ras and 14-3-3 protein binding region.
chr11	66421179	66421218	Q8IUM7	0	+	66421179	66421218	255,102,0	1	39	0	.	Basic motif; degenerate.
chr11	66421218	66421338	Q8IUM7	0	+	66421218	66421338	255,102,0	1	120	0	.	Helix-loop-helix motif.
chr11	66599469	66605732	O14618	0	+	66599469	66605732	255,102,0	1	6263	0	.	Superoxide dismutase-like.
chr11	66624794	66624938	Q96PK6	0	+	66624794	66624938	255,102,0	1	144	0	.	TRBP-interacting domain; interaction with STIL. Pubmed:25385835
chr11	66643622	66644129	Q9BWF3	0	+	66643622	66644129	255,102,0	1	507	0	.	Interaction with TNPO3. Pubmed:12628928
chr11	66668626	66669118	Q9BQ04	0	-	66668626	66669118	255,102,0	1	492	0	.	Interaction with TNPO3.
chr11	66852538	66852553	P11498	0	-	66852538	66852553	255,102,0	1	15	0	.	Substrate binding.
chr11	67266699	67281107	P25098	0	+	67266699	67281107	255,102,0	1	14408	0	.	N-terminal.
chr11	67392698	67393534	Q99638	0	+	67392698	67393534	255,102,0	1	836	0	.	Possesses 3'-5' exonuclease activity.
chr11	67396323	67397556	Q99638	0	+	67396323	67397556	255,102,0	1	1233	0	.	Sufficient for interaction with ABL1. Pubmed:11971963
chr11	67409628	67409751	Q8IV04	0	+	67409628	67409751	255,102,0	1	123	0	.	Interaction with calcineurin.
chr11	67584693	67584699	P09211	0	+	67584693	67584699	255,102,0	1	6	0	.	Glutathione binding. Pubmed:19396894, Pubmed:9012673, Pubmed:9351803
chr11	67584732	67584738	P09211	0	+	67584732	67584738	255,102,0	1	6	0	.	Glutathione binding. Pubmed:19396894, Pubmed:9012673, Pubmed:9351803
chr11	67642729	67645048	Q96HD9	0	-	67642729	67645048	255,102,0	1	2319	0	.	Shielding domain.
chr11	67645048	67647043	Q96HD9	0	-	67645048	67647043	255,102,0	1	1995	0	.	Hydrolytic domain.
chr11	67646830	67646836	Q96HD9	0	-	67646830	67646836	255,102,0	1	6	0	.	Substrate binding.
chr11	68097117	68097126	P35790	0	-	68097117	68097126	255,102,0	1	9	0	.	Substrate binding.
chr11	68347848	68363924	O75197	0	+	68347848	68363924	255,102,0	1	16076	0	.	Beta-propeller 1.
chr11	68386320	68406528	O75197	0	+	68386320	68406528	255,102,0	1	20208	0	.	Beta-propeller 2.
chr11	68406651	68413894	O75197	0	+	68406651	68413894	255,102,0	1	7243	0	.	Beta-propeller 3.
chr11	68416332	68426186	O75197	0	+	68416332	68426186	255,102,0	1	9854	0	.	Beta-propeller 4.
chr11	68773303	68773342	P50416	0	-	68773303	68773342	255,102,0	1	39	0	.	Coenzyme A binding.
chr11	68936391	68936835	P38935	0	+	68936391	68936835	255,102,0	1	444	0	.	SS DNA-binding.
chr11	71480853	71501349	Q6IA69	0	+	71480853	71501349	255,102,0	1	20496	0	.	Ligase.
chr11	71527402	71527774	Q6L8G8	0	+	71527402	71527774	255,102,0	1	372	0	.	7 X 4 AA repeats of C-C-X-P.
chr11	71538136	71538595	O75690	0	+	71538136	71538595	255,102,0	1	459	0	.	9 X 4 AA repeats of C-C-X-P.
chr11	71548759	71549143	P26371	0	+	71548759	71549143	255,102,0	1	384	0	.	8 X 4 AA repeats of C-C-X-P.
chr11	71565728	71566172	Q6L8G5	0	+	71565728	71566172	255,102,0	1	444	0	.	7 X 4 AA repeats of C-C-X-P.
chr11	71582390	71582735	Q6L8G4	0	-	71582390	71582735	255,102,0	1	345	0	.	6 X 4 AA repeats of C-C-X-P.
chr11	72003529	72008806	Q14980	0	-	72003529	72008806	255,102,0	1	5277	0	.	Tail (Globular).
chr11	72005253	72006131	Q14980	0	-	72005253	72006131	255,102,0	1	878	0	.	Interaction with microtubules. Pubmed:11956313
chr11	72005301	72005358	Q14980	0	-	72005301	72005358	255,102,0	1	57	0	.	Interaction with GPSM2. Pubmed:21816348
chr11	72018928	72035943	Q14980	0	-	72018928	72035943	255,102,0	1	17015	0	.	Head (Globular).
chr11	72097824	72098321	Q6IAA8	0	-	72097824	72098321	255,102,0	1	497	0	.	Interaction with LAMTOR2 and LAMTOR3.
chr11	72107978	72107984	Q8WZ04	0	+	72107978	72107984	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr11	72195623	72195638	P15328	0	+	72195623	72195638	255,102,0	1	15	0	.	Folate binding. Pubmed:23851396
chr11	72195722	72195740	P15328	0	+	72195722	72195740	255,102,0	1	18	0	.	Folate binding. Pubmed:23851396
chr11	72221187	72221202	P14207	0	+	72221187	72221202	255,102,0	1	15	0	.	Folate binding.
chr11	72221286	72221304	P14207	0	+	72221286	72221304	255,102,0	1	18	0	.	Folate binding.
chr11	72577536	72581902	O00408	0	-	72577536	72581902	255,102,0	1	4366	0	.	Catalytic.
chr11	72581421	72581436	O00408	0	-	72581421	72581436	255,102,0	1	15	0	.	Substrate binding.
chr11	73975042	73975111	P55851	0	-	73975042	73975111	255,102,0	1	69	0	.	Purine nucleotide binding.
chr11	74001447	74001516	P55916	0	-	74001447	74001516	255,102,0	1	69	0	.	Purine nucleotide binding.
chr11	74343326	74343335	Q6PCE3	0	-	74343326	74343335	255,102,0	1	9	0	.	Substrate binding.
chr11	74346757	74346763	Q6PCE3	0	-	74346757	74346763	255,102,0	1	6	0	.	Substrate binding.
chr11	74368518	74368524	Q6PCE3	0	-	74368518	74368524	255,102,0	1	6	0	.	Substrate binding.
chr11	74492323	74492332	A6NK58	0	-	74492323	74492332	255,102,0	1	9	0	.	Substrate binding.
chr11	74492362	74493244	A6NK58	0	-	74492362	74493244	255,102,0	1	882	0	.	Substrate binding.
chr11	74493427	74493451	A6NK58	0	-	74493427	74493451	255,102,0	1	24	0	.	Substrate binding.
chr11	74640730	74640763	Q15054	0	+	74640730	74640763	255,102,0	1	33	0	.	Interaction with PCNA. Pubmed:11595739, Pubmed:22148433
chr11	75266165	75272941	P49407	0	-	75266165	75272941	255,102,0	1	6776	0	.	Interaction with TRAF6. Pubmed:16378096
chr11	75278737	75351607	P49407	0	-	75278737	75351607	255,102,0	1	72870	0	.	Interaction with SRC.
chr11	75283382	75284259	P49407	0	-	75283382	75284259	255,102,0	1	877	0	.	Interaction with CHRM2.
chr11	75605929	75605974	Q96JE9	0	-	75605929	75605974	255,102,0	1	45	0	.	Calmodulin-binding.
chr11	75608114	75608159	Q96JE9	0	-	75608114	75608159	255,102,0	1	45	0	.	Calmodulin-binding.
chr11	75608264	75667478	Q96JE9	0	-	75608264	75667478	255,102,0	1	59214	0	.	Mn 3.
chr11	75608267	75608312	Q96JE9	0	-	75608267	75608312	255,102,0	1	45	0	.	Calmodulin-binding.
chr11	75667760	75667805	Q96JE9	0	-	75667760	75667805	255,102,0	1	45	0	.	Calmodulin-binding.
chr11	75667841	75667886	Q96JE9	0	-	75667841	75667886	255,102,0	1	45	0	.	Calmodulin-binding.
chr11	75667841	75667913	Q96JE9	0	-	75667841	75667913	255,102,0	1	72	0	.	Mn 2.
chr11	75667946	75668018	Q96JE9	0	-	75667946	75668018	255,102,0	1	72	0	.	Mn 1.
chr11	75667949	75667994	Q96JE9	0	-	75667949	75667994	255,102,0	1	45	0	.	Calmodulin-binding.
chr11	75961447	75983494	Q9P2Y5	0	+	75961447	75983494	255,102,0	1	22047	0	.	Sufficient for interaction with STX7; VTI1B AND STX8. Pubmed:24550300
chr11	75983494	76115944	Q9P2Y5	0	+	75983494	76115944	255,102,0	1	132450	0	.	Sufficient for interaction with VPS16, required for interaction with CEP63. Pubmed:22542840, Pubmed:18552835
chr11	76115944	76141410	Q9P2Y5	0	+	76115944	76141410	255,102,0	1	25466	0	.	Required for interaction with PRKDC, XRCC6 and XRCC5. Pubmed:22542840
chr11	76446938	76513456	Q7Z589	0	+	76446938	76513456	255,102,0	1	66518	0	.	Interaction with BRCA2. Pubmed:14651845
chr11	76458246	76458261	Q7Z589	0	+	76458246	76458261	255,102,0	1	15	0	.	Interaction with ZMYND11.
chr11	77118214	77120910	O15484	0	+	77118214	77120910	255,102,0	1	2696	0	.	Domain III.
chr11	77172843	77172867	Q13402	0	+	77172843	77172867	255,102,0	1	24	0	.	Actin-binding.
chr11	77179938	77181490	Q13402	0	+	77179938	77181490	255,102,0	1	1552	0	.	SAH. Pubmed:25122759
chr11	77353561	77379286	Q13153	0	-	77353561	77379286	255,102,0	1	25725	0	.	Interaction with CRIPAK. Pubmed:16278681
chr11	77379259	77379977	Q13153	0	-	77379259	77379977	255,102,0	1	718	0	.	Autoregulatory region.
chr11	77379364	77379962	Q13153	0	-	77379364	77379962	255,102,0	1	598	0	.	GTPase-binding.
chr11	77842511	77872312	Q9H7C9	0	+	77842511	77872312	255,102,0	1	29801	0	.	MTH138-like domain.
chr11	82839344	82850337	P42785	0	-	82839344	82850337	255,102,0	1	10993	0	.	SKS domain.
chr11	85661429	85661537	Q9NS37	0	-	85661429	85661537	255,102,0	1	108	0	.	Leucine-zipper.
chr11	85661552	85661576	Q9NS37	0	-	85661552	85661576	255,102,0	1	24	0	.	Basic motif.
chr11	85664074	85664182	Q9NS37	0	-	85664074	85664182	255,102,0	1	108	0	.	Leucine-zipper.
chr11	85664197	85664221	Q9NS37	0	-	85664197	85664221	255,102,0	1	24	0	.	Basic motif.
chr11	86003376	86011134	Q13492	0	-	86003376	86011134	255,102,0	1	7758	0	.	Interaction with FAM64A. Pubmed:16491119
chr11	86250421	86278522	O75530	0	+	86250421	86278522	255,102,0	1	28101	0	.	Interaction with EZH2.
chr11	86256404	86268504	O75530	0	+	86256404	86268504	255,102,0	1	12100	0	.	Required for interaction with the matrix protein MA of HIV-1.
chr11	86268495	86278522	O75530	0	+	86268495	86278522	255,102,0	1	10027	0	.	Required for interaction with the matrix protein MA of HIV-1.
chr11	88567255	88567270	P41594	0	-	88567255	88567270	255,102,0	1	15	0	.	Allosteric effector binding.
chr11	89047347	89047356	P41594	0	-	89047347	89047356	255,102,0	1	9	0	.	Glutamate binding.
chr11	89326767	89402430	Q9NPH5	0	-	89326767	89402430	255,102,0	1	75663	0	.	Mediates interaction with TLR4. Pubmed:15356101
chr11	90152477	90177990	Q9Y3Q0	0	+	90152477	90177990	255,102,0	1	25513	0	.	NAALADase.
chr11	90175987	90175993	Q9Y3Q0	0	+	90175987	90175993	255,102,0	1	6	0	.	Substrate binding. Pubmed:19678840
chr11	90176038	90176047	Q9Y3Q0	0	+	90176038	90176047	255,102,0	1	9	0	.	Substrate binding.
chr11	90177882	90177888	Q9Y3Q0	0	+	90177882	90177888	255,102,0	1	6	0	.	Substrate binding. Pubmed:19678840
chr11	90191588	90191594	Q9Y3Q0	0	+	90191588	90191594	255,102,0	1	6	0	.	Substrate binding. Pubmed:19678840
chr11	90202455	90214154	Q9UHD1	0	-	90202455	90214154	255,102,0	1	11699	0	.	Interaction with HSP90AA1 and HSP90AB1.
chr11	90214115	90222951	Q9UHD1	0	-	90214115	90222951	255,102,0	1	8836	0	.	Interaction with PPP5C.
chr11	93729645	93730266	Q9C0D2	0	+	93729645	93730266	255,102,0	1	621	0	.	ALMS motif.
chr11	94306557	94306617	A6ND01	0	+	94306557	94306617	255,102,0	1	60	0	.	Important for interaction with IZUMO1. Pubmed:27309808, Pubmed:27309818
chr11	95173257	95184429	P58005	0	-	95173257	95184429	255,102,0	1	11172	0	.	C-terminal domain; mediates TORC1 regulation.
chr11	95177798	95177810	P58005	0	-	95177798	95177810	255,102,0	1	12	0	.	Leucine-binding.
chr11	95799357	95821888	Q86XR8	0	+	95799357	95821888	255,102,0	1	22531	0	.	centrosome localization domain (CLD).
chr11	95822519	95831226	Q86XR8	0	+	95822519	95831226	255,102,0	1	8707	0	.	Mediates interaction with microtubules.
chr11	95845069	95845090	Q13614	0	-	95845069	95845090	255,102,0	1	21	0	.	Substrate binding. Pubmed:14690594
chr11	95847824	95847830	Q13614	0	-	95847824	95847830	255,102,0	1	6	0	.	Substrate binding. Pubmed:14690594
chr11	95847893	95849679	Q13614	0	-	95847893	95849679	255,102,0	1	1786	0	.	Substrate binding. Pubmed:14690594
chr11	101039118	101062600	P06401	0	-	101039118	101062600	255,102,0	1	23482	0	.	AF2; mediates transcriptional activation. Pubmed:1587864
chr11	101039118	101062618	P06401	0	-	101039118	101062618	255,102,0	1	23500	0	.	Steroid-binding.
chr11	101126097	101129070	P06401	0	-	101126097	101129070	255,102,0	1	2973	0	.	Modulating, Pro-Rich.
chr11	101127432	101127705	P06401	0	-	101127432	101127705	255,102,0	1	273	0	.	AF1; mediates transcriptional activation. Pubmed:1587864
chr11	101128155	101128578	P06401	0	-	101128155	101128578	255,102,0	1	423	0	.	Mediates transcriptional transrepression (in isoform A). Pubmed:9407067
chr11	101128578	101129070	P06401	0	-	101128578	101129070	255,102,0	1	492	0	.	AF3; mediates transcriptional activation (in isoform B). Pubmed:11546784
chr11	102205960	102229937	P46937	0	+	102205960	102229937	255,102,0	1	23977	0	.	Transactivation domain.
chr11	102691768	102691912	Q9H306	0	-	102691768	102691912	255,102,0	1	144	0	.	Required for retention in the endoplasmic reticulum. Pubmed:24548619
chr11	102795244	102797314	P03956	0	-	102795244	102797314	255,102,0	1	2070	0	.	Metalloprotease.
chr11	102944268	102950225	P45452	0	-	102944268	102950225	255,102,0	1	5957	0	.	Interaction with collagen.
chr11	102952072	102954267	P45452	0	-	102952072	102954267	255,102,0	1	2195	0	.	Interaction with TIMP2.
chr11	103109574	103168942	Q8NCM8	0	+	103109574	103168942	255,102,0	1	59368	0	.	Stem.
chr11	103168942	103174121	Q8NCM8	0	+	103168942	103174121	255,102,0	1	5179	0	.	AAA 1.
chr11	103176371	103184901	Q8NCM8	0	+	103176371	103184901	255,102,0	1	8530	0	.	AAA 2.
chr11	103186358	103191594	Q8NCM8	0	+	103186358	103191594	255,102,0	1	5236	0	.	AAA 3.
chr11	103199236	103211838	Q8NCM8	0	+	103199236	103211838	255,102,0	1	12602	0	.	AAA 4.
chr11	103211889	103234100	Q8NCM8	0	+	103211889	103234100	255,102,0	1	22211	0	.	Stalk.
chr11	103236449	103256198	Q8NCM8	0	+	103236449	103256198	255,102,0	1	19749	0	.	AAA 5.
chr11	103287577	103316610	Q8NCM8	0	+	103287577	103316610	255,102,0	1	29033	0	.	AAA 6.
chr11	104954831	104968525	P49662	0	-	104954831	104968525	255,102,0	1	13694	0	.	Required for LPS-binding.
chr11	105924419	105924428	P48058	0	+	105924419	105924428	255,102,0	1	9	0	.	Glutamate binding.
chr11	105926918	105926924	P48058	0	+	105926918	105926924	255,102,0	1	6	0	.	Glutamate binding.
chr11	106079538	106079556	Q9NRN7	0	+	106079538	106079556	255,102,0	1	18	0	.	Coenzyme A binding.
chr11	106079604	106079616	Q9NRN7	0	+	106079604	106079616	255,102,0	1	12	0	.	Coenzyme A binding.
chr11	106091324	106091339	Q9NRN7	0	+	106091324	106091339	255,102,0	1	15	0	.	Coenzyme A binding.
chr11	107504660	107522355	Q96BT7	0	-	107504660	107522355	255,102,0	1	17695	0	.	Methyltransferase domain.
chr11	107551820	107551829	Q96BT7	0	-	107551820	107551829	255,102,0	1	9	0	.	Alpha-ketoglutarate binding. Pubmed:22065580
chr11	108141645	108141654	A0A140VJX1	0	+	108141645	108141654	255,102,0	1	9	0	.	Coenzyme A binding.
chr11	108141645	108141654	P24752	0	+	108141645	108141654	255,102,0	1	9	0	.	Coenzyme A binding.
chr11	108161038	108161113	Q14207	0	-	108161038	108161113	255,102,0	1	75	0	.	Required for acceleration of G1 phase.
chr11	108161329	108161404	Q14207	0	-	108161329	108161404	255,102,0	1	75	0	.	Required for acceleration of G1 phase.
chr11	108161923	108161971	Q14207	0	-	108161923	108161971	255,102,0	1	48	0	.	Required for acceleration of G1 phase.
chr11	108172424	108172502	Q14207	0	-	108172424	108172502	255,102,0	1	78	0	.	Required for acceleration of G1 phase.
chr11	108173024	108173099	Q14207	0	-	108173024	108173099	255,102,0	1	75	0	.	Required for acceleration of G1 phase.
chr11	108176363	108185437	Q14207	0	-	108176363	108185437	255,102,0	1	9074	0	.	Mediates transcriptional activation.
chr11	108177042	108222536	Q14207	0	-	108177042	108222536	255,102,0	1	45494	0	.	Interaction with MIZF. Pubmed:15988025
chr11	108189226	108189301	Q14207	0	-	108189226	108189301	255,102,0	1	75	0	.	Required for activation of histone gene transcription and interaction with MIZF. Pubmed:15988025
chr11	108197382	108222524	Q14207	0	-	108197382	108222524	255,102,0	1	25142	0	.	Required for activation of histone gene transcription and interaction with MIZF. Pubmed:15988025
chr11	108288983	108289013	Q13315	0	+	108288983	108289013	255,102,0	1	30	0	.	Interaction with ABL1. Pubmed:9168117
chr11	110264781	110264793	P35241	0	-	110264781	110264793	255,102,0	1	12	0	.	Phosphatidylinositol binding.
chr11	111560296	111560431	Q6UX15	0	+	111560296	111560431	255,102,0	1	135	0	.	Interaction with NF2.
chr11	111560317	111560455	Q6UX15	0	+	111560317	111560455	255,102,0	1	138	0	.	Interaction with TLN1.
chr11	111560326	111560434	Q6UX15	0	+	111560326	111560434	255,102,0	1	108	0	.	3 X 5 AA repeats of E-S-G-X-V.
chr11	111560374	111560449	Q6UX15	0	+	111560374	111560449	255,102,0	1	75	0	.	2 X 4 AA repeats of N-X-I-Y.
chr11	111974084	111982469	Q155Q3	0	+	111974084	111982469	255,102,0	1	8385	0	.	Actin-binding.
chr11	112045188	112062532	P10515	0	+	112045188	112062532	255,102,0	1	17344	0	.	Catalytic.
chr11	113410876	113410903	P14416	0	-	113410876	113410903	255,102,0	1	27	0	.	Agonist binding.
chr11	113412574	113415513	P14416	0	-	113412574	113415513	255,102,0	1	2939	0	.	Interaction with PPP1R9B.
chr11	113415552	113415576	P14416	0	-	113415552	113415576	255,102,0	1	24	0	.	Agonist binding.
chr11	113748394	113773663	O43264	0	-	113748394	113773663	255,102,0	1	25269	0	.	Interaction with RINT1.
chr11	113760915	113773663	O43264	0	-	113760915	113773663	255,102,0	1	12748	0	.	Interaction with ZWINT.
chr11	113945951	113946050	O95264	0	+	113945951	113946050	255,102,0	1	99	0	.	HA-stretch.
chr11	113989565	113989676	P46098	0	+	113989565	113989676	255,102,0	1	111	0	.	HA-stretch.
chr11	114297982	114297988	P40261	0	+	114297982	114297988	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr11	114297982	114297988	Q6FH49	0	+	114297982	114297988	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr11	114312105	114312111	P40261	0	+	114312105	114312111	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr11	114312105	114312111	Q6FH49	0	+	114312105	114312111	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr11	116832785	116832881	P02656	0	+	116832785	116832881	255,102,0	1	96	0	.	Lipid-binding.
chr11	116835810	116836410	P02647	0	-	116835810	116836410	255,102,0	1	600	0	.	10 X approximate tandem repeats.
chr11	117338586	117362433	Q9UPV0	0	+	117338586	117362433	255,102,0	1	23847	0	.	Interaction with ATRIP. Pubmed:18283122
chr11	118521977	118521983	Q03164	0	+	118521977	118521983	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr11	118660908	118661161	O43280	0	-	118660908	118661161	255,102,0	1	253	0	.	Substrate binding.
chr11	118661457	118661466	O43280	0	-	118661457	118661466	255,102,0	1	9	0	.	Substrate binding.
chr11	118661725	118661891	O43280	0	-	118661725	118661891	255,102,0	1	166	0	.	Substrate binding.
chr11	118902143	118902833	Q86UU0	0	-	118902143	118902833	255,102,0	1	690	0	.	Necessary for interaction with CTNNB1.
chr11	119133196	119134495	Q9BQA5	0	+	119133196	119134495	255,102,0	1	1299	0	.	Interaction with NPAT. Pubmed:15988025
chr11	119133199	119134165	Q9BQA5	0	+	119133199	119134165	255,102,0	1	966	0	.	Required for activation of histone H4 transcription and contributes to DNA-binding.
chr11	119172982	119175271	Q86UT6	0	+	119172982	119175271	255,102,0	1	2289	0	.	Required for interaction with MAVS. Pubmed:18200010
chr11	119175268	119183433	Q86UT6	0	+	119175268	119183433	255,102,0	1	8165	0	.	Required for the repression of MAVS-induced interferon signaling.
chr11	119206417	119277820	P22681	0	+	119206417	119277820	255,102,0	1	71403	0	.	Sufficient for interaction with EPHB1. Pubmed:18034775
chr11	119206555	119271816	P22681	0	+	119206555	119271816	255,102,0	1	65261	0	.	4H.
chr11	119271816	119274021	P22681	0	+	119271816	119274021	255,102,0	1	2205	0	.	EF-hand-like.
chr11	119274021	119277802	P22681	0	+	119274021	119277802	255,102,0	1	3781	0	.	SH2-like.
chr11	119277802	119278210	P22681	0	+	119277802	119278210	255,102,0	1	408	0	.	Linker.
chr11	119287851	119299778	P22681	0	+	119287851	119299778	255,102,0	1	11927	0	.	Interaction with CD2AP. Pubmed:11067845
chr11	119357582	119358803	O75604	0	-	119357582	119358803	255,102,0	1	1221	0	.	Necessary for interaction with MDM4. Pubmed:19838211
chr11	119372880	119373480	O75604	0	-	119372880	119373480	255,102,0	1	600	0	.	Necessary for interaction with MDM4. Pubmed:19838211
chr11	119675264	119677109	Q15223	0	-	119675264	119677109	255,102,0	1	1845	0	.	Interaction with FGFR.
chr11	122796179	122809883	Q8TF42	0	+	122796179	122809883	255,102,0	1	13704	0	.	Protein tyrosine phosphatase.
chr11	123058479	123059202	P11142	0	-	123058479	123059202	255,102,0	1	723	0	.	Substrate-binding domain (SBD). Pubmed:27474739
chr11	123059223	123061321	P11142	0	-	123059223	123061321	255,102,0	1	2098	0	.	Nucleotide-binding domain (NBD). Pubmed:27474739
chr11	123059250	123060124	P11142	0	-	123059250	123060124	255,102,0	1	874	0	.	Interaction with BAG1.
chr11	125626768	125637525	O14757	0	+	125626768	125637525	255,102,0	1	10757	0	.	Interaction with CLSPN.
chr11	125644580	125655317	O14757	0	+	125644580	125655317	255,102,0	1	10737	0	.	Autoinhibitory region.
chr11	125677827	125678022	P26436	0	-	125677827	125678022	255,102,0	1	195	0	.	9 X 5 AA repeats of [SV]-G-E-Q-[PSA].
chr11	125677845	125678097	P26436	0	-	125677845	125678097	255,102,0	1	252	0	.	4 X 4 AA repeats of S-G-E-H.
chr11	125678064	125678154	P26436	0	-	125678064	125678154	255,102,0	1	90	0	.	3 X 5 AA repeats of S-E-H-[GA]-S.
chr11	126345400	126345436	Q96C86	0	+	126345400	126345436	255,102,0	1	36	0	.	Substrate binding.
chr11	128484823	128489305	P14921	0	-	128484823	128489305	255,102,0	1	4482	0	.	Activation domain; required for transcription activation.
chr11	128968909	128970118	A7KAX9	0	-	128968909	128970118	255,102,0	1	1209	0	.	Interaction with FYN. Pubmed:12788081
chr11	128970037	128971000	A7KAX9	0	-	128970037	128971000	255,102,0	1	963	0	.	Interaction with GAB2. Pubmed:12819203
chr11	129878334	129882169	Q6P4R8	0	-	129878334	129882169	255,102,0	1	3835	0	.	Winged-helix like domain.
chr11	130143400	130143445	Q06481	0	+	130143400	130143445	255,102,0	1	45	0	.	Interaction with DAB2.
chr11	130405734	130408495	Q9UP79	0	-	130405734	130408495	255,102,0	1	2761	0	.	Spacer.
chr11	130473068	130473482	Q8TE58	0	+	130473068	130473482	255,102,0	1	414	0	.	Spacer.
chr11	134261157	134261169	Q9UKU7	0	+	134261157	134261169	255,102,0	1	12	0	.	Substrate binding.
chr11	134382865	134382895	Q9P2W7	0	-	134382865	134382895	255,102,0	1	30	0	.	Interaction with galactose moiety of substrate glycoprotein.
chr11	134387644	134387653	Q9P2W7	0	-	134387644	134387653	255,102,0	1	9	0	.	Essential for transport from endoplasmic reticulum to Golgi apparatus and interaction with SAR1A.
chr12	285458	285662	P29375	0	-	285458	285662	255,102,0	1	204	0	.	Interaction with LMO2. Pubmed:9129143
chr12	916368	916703	P43351	0	-	916368	916703	255,102,0	1	335	0	.	Mediates interaction with RPA2. Pubmed:8702565
chr12	1593922	1594063	Q8N1E6	0	-	1593922	1594063	255,102,0	1	141	0	.	Required for down-regulation of SNAI1.
chr12	2800074	2801284	Q02790	0	+	2800074	2801284	255,102,0	1	1210	0	.	Interaction with tubulin.
chr12	2909553	2920873	O75386	0	+	2909553	2920873	255,102,0	1	11320	0	.	Required for association with the IFT complex A (IFT-A).
chr12	4558870	4558990	Q96B01	0	+	4558870	4558990	255,102,0	1	120	0	.	Interaction with RAD51.
chr12	4628490	4628532	O75969	0	-	4628490	4628532	255,102,0	1	42	0	.	PKA-RII subunit binding domain.
chr12	4739190	4745450	Q9NY28	0	+	4739190	4745450	255,102,0	1	6260	0	.	Catalytic subdomain A.
chr12	4745618	4761020	Q9NY28	0	+	4745618	4761020	255,102,0	1	15402	0	.	Catalytic subdomain B.
chr12	4811118	4811160	P17658	0	+	4811118	4811160	255,102,0	1	42	0	.	S4-S5 linker.
chr12	4852680	4852722	P17658	0	+	4852680	4852722	255,102,0	1	42	0	.	S4-S5 linker.
chr12	4911378	4911762	Q09470	0	+	4911378	4911762	255,102,0	1	384	0	.	Tetramerization domain.
chr12	4912305	4912347	Q09470	0	+	4912305	4912347	255,102,0	1	42	0	.	S4-S5 linker.
chr12	5044327	5044393	P22460	0	+	5044327	5044393	255,102,0	1	66	0	.	2 X 11 AA tandem repeat of D-[SP]-G-V-R-P-L-P-P-L-P.
chr12	5045398	5045440	P22460	0	+	5045398	5045440	255,102,0	1	42	0	.	S4-S5 linker.
chr12	5991833	5991971	P04275	0	-	5991833	5991971	255,102,0	1	138	0	.	E2.
chr12	6034813	6036458	P04275	0	-	6034813	6036458	255,102,0	1	1645	0	.	CX.
chr12	6036434	6044371	P04275	0	-	6036434	6044371	255,102,0	1	7937	0	.	E1.
chr12	6044371	6044443	P04275	0	-	6044371	6044443	255,102,0	1	72	0	.	Amino-terminal.
chr12	6329790	6329823	P19438	0	-	6329790	6329823	255,102,0	1	33	0	.	N-SMase activation domain (NSD).
chr12	6495098	6521892	Q15021	0	+	6495098	6521892	255,102,0	1	26794	0	.	Interactions with SMC2 and SMC4.
chr12	6534835	6537217	P04406	0	+	6534835	6537217	255,102,0	1	2382	0	.	Interaction with WARS. Pubmed:15628863
chr12	6537315	6537324	P04406	0	+	6537315	6537324	255,102,0	1	9	0	.	Glyceraldehyde 3-phosphate binding.
chr12	6537688	6537694	P04406	0	+	6537688	6537694	255,102,0	1	6	0	.	Glyceraldehyde 3-phosphate binding.
chr12	6561676	6561697	P46087	0	-	6561676	6561697	255,102,0	1	21	0	.	S-adenosyl-L-methionine binding.
chr12	6570678	6581341	Q14839	0	-	6570678	6581341	255,102,0	1	10663	0	.	Required for interaction with PCNT. Pubmed:17626165
chr12	6778312	6778384	P18627	0	+	6778312	6778384	255,102,0	1	72	0	.	12 X 2 AA tandem repeats of E-X.
chr12	6818846	6819317	P01730	0	+	6818846	6819317	255,102,0	1	471	0	.	HIV-1 Vpu-susceptibility domain.
chr12	6849748	6849838	Q99618	0	-	6849748	6849838	255,102,0	1	90	0	.	F-box-like.
chr12	6856782	6856794	A0A140VJZ1	0	+	6856782	6856794	255,102,0	1	12	0	.	Substrate binding.
chr12	6856782	6856794	P45974	0	+	6856782	6856794	255,102,0	1	12	0	.	Substrate binding.
chr12	6922095	6922107	P09104	0	+	6922095	6922107	255,102,0	1	12	0	.	Substrate binding.
chr12	6922095	6922107	Q6FHV6	0	+	6922095	6922107	255,102,0	1	12	0	.	Substrate binding.
chr12	6936815	6936968	P54259	0	+	6936815	6936968	255,102,0	1	153	0	.	Involved in binding BAIAP2.
chr12	6938597	6938645	P54259	0	+	6938597	6938645	255,102,0	1	48	0	.	Required for interaction with FAT1. Pubmed:19131340
chr12	6958068	6959942	P29350	0	+	6958068	6959942	255,102,0	1	1874	0	.	Substrate binding.
chr12	6967976	6968440	Q99623	0	-	6967976	6968440	255,102,0	1	464	0	.	Necessary for transcriptional repression. Pubmed:10359819
chr12	6970260	6970489	Q99623	0	-	6970260	6970489	255,102,0	1	229	0	.	Necessary for transcriptional repression. Pubmed:10359819
chr12	6975728	6975746	Q92979	0	+	6975728	6975746	255,102,0	1	18	0	.	S-adenosyl-L-methionine binding.
chr12	7794762	7794897	Q9H9S0	0	+	7794762	7794897	255,102,0	1	135	0	.	8 X repeats starting with a Trp in each unit.
chr12	7794762	7794897	Q9H9S0	0	+	7794762	7794897	255,102,0	1	135	0	.	Sufficient for transactivation activity.
chr12	7794897	7795092	Q9H9S0	0	+	7794897	7795092	255,102,0	1	195	0	.	Sufficient for strong transactivation activity.
chr12	7827497	7827518	Q8TDB8	0	-	7827497	7827518	255,102,0	1	21	0	.	Monosaccharide binding.
chr12	7929686	7929707	P11169	0	-	7929686	7929707	255,102,0	1	21	0	.	Monosaccharide binding. Pubmed:26176916
chr12	7929707	7929716	P11169	0	-	7929707	7929716	255,102,0	1	9	0	.	Important for selectivity against fructose. Pubmed:26176916
chr12	8605293	8605380	Q9GZX7	0	-	8605293	8605380	255,102,0	1	87	0	.	Required for interaction with RNF126. Pubmed:23277564
chr12	8606894	8606906	Q9GZX7	0	-	8606894	8606906	255,102,0	1	12	0	.	Important for interaction with CTNNBL1. Pubmed:18722174
chr12	8606942	8612764	Q9GZX7	0	-	8606942	8612764	255,102,0	1	5822	0	.	Interaction with SUPT6H. Pubmed:21518874
chr12	8849722	8850218	A8K2U0	0	+	8849722	8850218	255,102,0	1	496	0	.	Bait region.
chr12	9093499	9093517	P01023	0	-	9093499	9093517	255,102,0	1	18	0	.	Inhibitory.
chr12	9093520	9095030	P01023	0	-	9093520	9095030	255,102,0	1	1510	0	.	Bait region.
chr12	9093535	9093550	P01023	0	-	9093535	9093550	255,102,0	1	15	0	.	Inhibitory.
chr12	9093577	9094988	P01023	0	-	9093577	9094988	255,102,0	1	1411	0	.	Inhibitory.
chr12	9166104	9168923	P20742	0	-	9166104	9168923	255,102,0	1	2819	0	.	Bait region.
chr12	10160899	10169080	P78380	0	-	10160899	10169080	255,102,0	1	8181	0	.	Neck.
chr12	10213129	10213195	Q9H0R8	0	+	10213129	10213195	255,102,0	1	66	0	.	Interaction with beta-tubulin.
chr12	10218077	10220474	Q9H0R8	0	+	10218077	10220474	255,102,0	1	2397	0	.	Interaction with GABRG2.
chr12	10506043	10506067	Q2VIR3	0	+	10506043	10506067	255,102,0	1	24	0	.	G1.
chr12	10506127	10506142	Q2VIR3	0	+	10506127	10506142	255,102,0	1	15	0	.	G2.
chr12	10506301	10506313	Q2VIR3	0	+	10506301	10506313	255,102,0	1	12	0	.	G3.
chr12	10506469	10506481	Q2VIR3	0	+	10506469	10506481	255,102,0	1	12	0	.	G4.
chr12	10506574	10506583	Q2VIR3	0	+	10506574	10506583	255,102,0	1	9	0	.	G5.
chr12	12138325	12151033	O75581	0	-	12138325	12151033	255,102,0	1	12708	0	.	Beta-propeller 4.
chr12	12158949	12164434	O75581	0	-	12158949	12164434	255,102,0	1	5485	0	.	Beta-propeller 3.
chr12	12164557	12181434	O75581	0	-	12164557	12181434	255,102,0	1	16877	0	.	Beta-propeller 2.
chr12	12186941	12244653	O75581	0	-	12186941	12244653	255,102,0	1	57712	0	.	Beta-propeller 1.
chr12	12635845	12635941	O60519	0	+	12635845	12635941	255,102,0	1	96	0	.	Basic motif.
chr12	12635944	12635968	O60519	0	+	12635944	12635968	255,102,0	1	24	0	.	Leucine-zipper.
chr12	13563325	13563364	Q13224	0	-	13563325	13563364	255,102,0	1	39	0	.	Interaction with DAPK1.
chr12	14436143	14460787	Q6VMQ6	0	+	14436143	14460787	255,102,0	1	24644	0	.	Interaction with SETDB1.
chr12	14475919	14475952	Q6VMQ6	0	+	14475919	14475952	255,102,0	1	33	0	.	Interaction with SUMO. Pubmed:16757475
chr12	14497719	14498070	Q6VMQ6	0	+	14497719	14498070	255,102,0	1	351	0	.	Interaction with MBD1.
chr12	14791253	14791268	Q9Y2W2	0	-	14791253	14791268	255,102,0	1	15	0	.	Interaction with PP1.
chr12	14794594	14794609	Q9Y2W2	0	-	14794594	14794609	255,102,0	1	15	0	.	Interaction with PP1.
chr12	14799689	14801383	Q9Y2W2	0	-	14799689	14801383	255,102,0	1	1694	0	.	Required for nuclear import.
chr12	14915563	14915575	Q96DN0	0	-	14915563	14915575	255,102,0	1	12	0	.	PDIA3-binding site.
chr12	15587046	15589470	Q16827	0	+	15587046	15589470	255,102,0	1	2424	0	.	Substrate binding.
chr12	15621319	15631541	Q12929	0	-	15621319	15631541	255,102,0	1	10222	0	.	Effector region.
chr12	15623157	15623217	Q12929	0	-	15623157	15623217	255,102,0	1	60	0	.	Helix bundle 4.
chr12	15623211	15623229	Q12929	0	-	15623211	15623229	255,102,0	1	18	0	.	Helix bundle 3.
chr12	15623241	15623259	Q12929	0	-	15623241	15623259	255,102,0	1	18	0	.	Helix bundle 2.
chr12	15624237	15624300	Q12929	0	-	15624237	15624300	255,102,0	1	63	0	.	Helix bundle 1.
chr12	15624357	15631448	Q12929	0	-	15624357	15631448	255,102,0	1	7091	0	.	Amphipathic helix.
chr12	18081193	18089283	Q9H628	0	-	18081193	18089283	255,102,0	1	8090	0	.	Small GTPase-like.
chr12	19440323	19473250	Q6ZN18	0	+	19440323	19473250	255,102,0	1	32927	0	.	Interaction with RBBP4.
chr12	19493868	19518717	Q6ZN18	0	+	19493868	19518717	255,102,0	1	24849	0	.	Interaction with SUZ12.
chr12	20639887	20680103	Q14432	0	+	20639887	20680103	255,102,0	1	40216	0	.	Catalytic.
chr12	22201794	22201803	Q92185	0	-	22201794	22201803	255,102,0	1	9	0	.	Substrate binding.
chr12	22249019	22249028	Q92185	0	-	22249019	22249028	255,102,0	1	9	0	.	Substrate binding.
chr12	25215455	25215515	P01116	0	-	25215455	25215515	255,102,0	1	60	0	.	Hypervariable region.
chr12	26124092	26124107	Q9C0J9	0	-	26124092	26124107	255,102,0	1	15	0	.	Necessary for interaction with RXRA and repressor activity towards RXRA. Pubmed:19786558
chr12	26663690	26663699	Q14571	0	-	26663690	26663699	255,102,0	1	9	0	.	Inositol 1,4,5-trisphosphate binding.
chr12	26665930	26665942	Q14571	0	-	26665930	26665942	255,102,0	1	12	0	.	Inositol 1,4,5-trisphosphate binding.
chr12	26715346	26715361	Q14571	0	-	26715346	26715361	255,102,0	1	15	0	.	Inositol 1,4,5-trisphosphate binding.
chr12	27308338	27308416	Q9Y2H1	0	+	27308338	27308416	255,102,0	1	78	0	.	S100B binding.
chr12	27368365	27389295	Q8WYA1	0	+	27368365	27389295	255,102,0	1	20930	0	.	Interaction with PER2.
chr12	27963667	27963703	P12272	0	-	27963667	27963703	255,102,0	1	36	0	.	Important for receptor binding.
chr12	28257215	28259381	Q7Z6B0	0	+	28257215	28259381	255,102,0	1	2166	0	.	GGA1-binding motif.
chr12	28362488	28549086	Q7Z6B0	0	+	28362488	28549086	255,102,0	1	186598	0	.	Homodimerization.
chr12	32328441	32337655	Q96G01	0	+	32328441	32337655	255,102,0	1	9214	0	.	Interaction with RAB6A.
chr12	32576357	32582317	Q96M96	0	+	32576357	32582317	255,102,0	1	5960	0	.	Actin filament-binding.
chr12	32679363	32722583	O00429	0	+	32679363	32722583	255,102,0	1	43220	0	.	GTPase domain.
chr12	32722583	32733735	O00429	0	+	32722583	32733735	255,102,0	1	11152	0	.	Middle domain.
chr12	32731496	32742649	O00429	0	+	32731496	32742649	255,102,0	1	11153	0	.	Interaction with GSK3B.
chr12	32733771	32738296	O00429	0	+	32733771	32738296	255,102,0	1	4525	0	.	B domain.
chr12	32740483	32742598	O00429	0	+	32740483	32742598	255,102,0	1	2115	0	.	Important for homodimerization.
chr12	33439417	33439486	Q6XYQ8	0	-	33439417	33439486	255,102,0	1	69	0	.	Cysteine motif.
chr12	39618961	39619615	Q9UBJ2	0	-	39618961	39619615	255,102,0	1	654	0	.	Interaction with PEX19.
chr12	46370537	46371293	Q96QD8	0	-	46370537	46371293	255,102,0	1	756	0	.	Regulates protein turnover upon amino acid deprivation.
chr12	47748129	47748505	O95398	0	-	47748129	47748505	255,102,0	1	376	0	.	Interaction with PDE3B. Pubmed:21393242
chr12	47750370	47751067	O95398	0	-	47750370	47751067	255,102,0	1	697	0	.	Interaction with PDE3B. Pubmed:21393242
chr12	47783843	47785432	Q8WUI4	0	-	47783843	47785432	255,102,0	1	1589	0	.	Interaction with SIN3A.
chr12	47785465	47793378	Q8WUI4	0	-	47785465	47793378	255,102,0	1	7913	0	.	Histone deacetylase.
chr12	47791927	47796233	Q8WUI4	0	-	47791927	47796233	255,102,0	1	4306	0	.	Transcription repression 2.
chr12	47795752	47798925	Q8WUI4	0	-	47795752	47798925	255,102,0	1	3173	0	.	Transcription repression 1.
chr12	47797396	47798649	Q8WUI4	0	-	47797396	47798649	255,102,0	1	1253	0	.	Interaction with MEF2A.
chr12	47798157	47798925	Q8WUI4	0	-	47798157	47798925	255,102,0	1	768	0	.	Interaction with MEF2C.
chr12	47844748	47857138	P11473	0	-	47844748	47857138	255,102,0	1	12390	0	.	Ligand-binding.
chr12	47846729	47846753	P11473	0	-	47846729	47846753	255,102,0	1	24	0	.	Vitamin D3 binding.
chr12	47855673	47855706	P11473	0	-	47855673	47855706	255,102,0	1	33	0	.	Vitamin D3 binding.
chr12	47857138	47857677	P11473	0	-	47857138	47857677	255,102,0	1	539	0	.	Hinge.
chr12	47975479	47975560	P02458	0	-	47975479	47975560	255,102,0	1	81	0	.	Nonhelical region (C-terminal).
chr12	47975560	47996556	P02458	0	-	47975560	47996556	255,102,0	1	20996	0	.	Triple-helical region.
chr12	48046388	48063769	Q9P0U3	0	-	48046388	48063769	255,102,0	1	17381	0	.	Protease.
chr12	48074745	48101472	Q9P0U3	0	-	48074745	48101472	255,102,0	1	26727	0	.	Interaction with CCAR2. Pubmed:25406032
chr12	48122774	48139891	A0A024R0Y5	0	+	48122774	48139891	255,102,0	1	17117	0	.	N-terminal catalytic PFK domain 1.
chr12	48122777	48139891	P08237	0	+	48122777	48139891	255,102,0	1	17114	0	.	N-terminal catalytic PFK domain 1.
chr12	48133376	48133385	A0A024R0Y5	0	+	48133376	48133385	255,102,0	1	9	0	.	Substrate binding.
chr12	48133376	48133385	P08237	0	+	48133376	48133385	255,102,0	1	9	0	.	Substrate binding.
chr12	48134259	48134268	A0A024R0Y5	0	+	48134259	48134268	255,102,0	1	9	0	.	Substrate binding.
chr12	48134259	48134268	P08237	0	+	48134259	48134268	255,102,0	1	9	0	.	Substrate binding.
chr12	48135338	48135350	A0A024R0Y5	0	+	48135338	48135350	255,102,0	1	12	0	.	Substrate binding.
chr12	48135338	48135350	P08237	0	+	48135338	48135350	255,102,0	1	12	0	.	Substrate binding.
chr12	48139891	48140733	P08237	0	+	48139891	48140733	255,102,0	1	842	0	.	Interdomain linker.
chr12	48140733	48145705	A0A024R0Y5	0	+	48140733	48145705	255,102,0	1	4972	0	.	C-terminal regulatory PFK domain 2.
chr12	48140733	48145705	P08237	0	+	48140733	48145705	255,102,0	1	4972	0	.	C-terminal regulatory PFK domain 2.
chr12	48141994	48142009	A0A024R0Y5	0	+	48141994	48142009	255,102,0	1	15	0	.	Allosteric activator fructose 2,6-bisphosphate binding.
chr12	48141994	48142009	P08237	0	+	48141994	48142009	255,102,0	1	15	0	.	Allosteric activator fructose 2,6-bisphosphate binding.
chr12	48142844	48142853	A0A024R0Y5	0	+	48142844	48142853	255,102,0	1	9	0	.	Allosteric activator fructose 2,6-bisphosphate binding.
chr12	48142844	48142853	P08237	0	+	48142844	48142853	255,102,0	1	9	0	.	Allosteric activator fructose 2,6-bisphosphate binding.
chr12	48144145	48144157	A0A024R0Y5	0	+	48144145	48144157	255,102,0	1	12	0	.	Allosteric activator fructose 2,6-bisphosphate binding.
chr12	48144145	48144157	P08237	0	+	48144145	48144157	255,102,0	1	12	0	.	Allosteric activator fructose 2,6-bisphosphate binding.
chr12	48343494	48344650	Q96N77	0	-	48343494	48344650	255,102,0	1	1156	0	.	Transactivation.
chr12	48825442	48827018	P54284	0	+	48825442	48827018	255,102,0	1	1576	0	.	Mediates interaction with the alpha subunit.
chr12	48996748	48997654	O94850	0	-	48996748	48997654	255,102,0	1	906	0	.	Interaction with CD2AP and NPHS1.
chr12	48997567	48997855	O94850	0	-	48997567	48997855	255,102,0	1	288	0	.	Interaction with ACTN1. Pubmed:16464232
chr12	48998167	48998320	O94850	0	-	48998167	48998320	255,102,0	1	153	0	.	Interaction with MAGI2.
chr12	48998482	48998539	O94850	0	-	48998482	48998539	255,102,0	1	57	0	.	Nuclear localization.
chr12	49022138	49022144	O14686	0	-	49022138	49022144	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr12	49051678	49052368	O14686	0	-	49051678	49052368	255,102,0	1	690	0	.	15 X 5 AA repeats of S/P-P-P-E/P-E/A.
chr12	49104848	49110555	Q6UX01	0	-	49104848	49110555	255,102,0	1	5707	0	.	LCN1-binding.
chr12	49295200	49295497	P41219	0	+	49295200	49295497	255,102,0	1	297	0	.	Head.
chr12	49295497	49295596	P41219	0	+	49295497	49295596	255,102,0	1	99	0	.	Coil 1A.
chr12	49295497	49297575	P41219	0	+	49295497	49297575	255,102,0	1	2078	0	.	Rod.
chr12	49295596	49295629	P41219	0	+	49295596	49295629	255,102,0	1	33	0	.	Linker 1.
chr12	49295629	49296903	P41219	0	+	49295629	49296903	255,102,0	1	1274	0	.	Coil 1B.
chr12	49296903	49296972	P41219	0	+	49296903	49296972	255,102,0	1	69	0	.	Linker 2.
chr12	49296972	49297575	P41219	0	+	49296972	49297575	255,102,0	1	603	0	.	Coil 2.
chr12	49297575	49298350	P41219	0	+	49297575	49298350	255,102,0	1	775	0	.	Tail.
chr12	49330390	49330786	Q12815	0	+	49330390	49330786	255,102,0	1	396	0	.	4 X 33 AA approximate tandem repeats.
chr12	49999164	50005365	Q9H0H5	0	-	49999164	50005365	255,102,0	1	6201	0	.	Interaction with SLC26A8. Pubmed:11278976
chr12	50085495	50086848	Q96GM5	0	+	50085495	50086848	255,102,0	1	1353	0	.	Interaction with ESR1, NR1H4, NR3C1, PGR and SMARCA4. Pubmed:12917342
chr12	50086848	50098743	Q96GM5	0	+	50086848	50098743	255,102,0	1	11895	0	.	Interaction with SMARCC1 and SMARCC2. Pubmed:12917342
chr12	50087368	50098997	Q96GM5	0	+	50087368	50098997	255,102,0	1	11629	0	.	Necessary for GR/NR3C1-mediated remodeling and transcription from chromatin; required for GR/NR3C1 interaction with the BRG1/SMARCA4 complex in vivo.
chr12	50107758	50107764	A0A024R138	0	+	50107758	50107764	255,102,0	1	6	0	.	Substrate binding.
chr12	50107758	50107764	P21695	0	+	50107758	50107764	255,102,0	1	6	0	.	Substrate binding.
chr12	50427779	50427809	Q71RC2	0	+	50427779	50427809	255,102,0	1	30	0	.	Interaction with PABPC1. Pubmed:21098120
chr12	50430502	50453564	Q71RC2	0	+	50430502	50453564	255,102,0	1	23062	0	.	Interaction with the poly-A tract of mRNA. Pubmed:21098120
chr12	50814410	50819680	P18846	0	+	50814410	50819680	255,102,0	1	5270	0	.	Basic motif.
chr12	50819683	50819749	P18846	0	+	50819683	50819749	255,102,0	1	66	0	.	Leucine-zipper.
chr12	50925038	50925122	Q9H8H3	0	+	50925038	50925122	255,102,0	1	84	0	.	Targeting to lipid droplets.
chr12	51048356	51052147	Q6P1Q0	0	+	51048356	51052147	255,102,0	1	3791	0	.	Required and sufficient for mitochondrial import.
chr12	51099745	51116375	Q12800	0	-	51099745	51116375	255,102,0	1	16630	0	.	DNA-binding.
chr12	51359269	51364128	Q8NCL4	0	-	51359269	51364128	255,102,0	1	4859	0	.	Catalytic subdomain B.
chr12	51364314	51377333	Q8NCL4	0	-	51364314	51377333	255,102,0	1	13019	0	.	Catalytic subdomain A.
chr12	51913253	51913265	P37023	0	+	51913253	51913265	255,102,0	1	12	0	.	Mediates specificity for BMP ligand.
chr12	52013772	52014785	Q7Z6J2	0	+	52013772	52014785	255,102,0	1	1013	0	.	Interaction with PSCD3.
chr12	52057122	52057367	P22736	0	+	52057122	52057367	255,102,0	1	245	0	.	Ligand-binding.
chr12	52076986	52077001	Q9BSB4	0	+	52076986	52077001	255,102,0	1	15	0	.	Important for interaction with ATG13. Pubmed:26299944
chr12	52171400	52172205	Q6KB66	0	-	52171400	52172205	255,102,0	1	805	0	.	Tail.
chr12	52172205	52173677	Q6KB66	0	-	52172205	52173677	255,102,0	1	1472	0	.	Coil 2.
chr12	52172205	52191656	Q6KB66	0	-	52172205	52191656	255,102,0	1	19451	0	.	Rod.
chr12	52173677	52173749	Q6KB66	0	-	52173677	52173749	255,102,0	1	72	0	.	Linker 12.
chr12	52173749	52185482	Q6KB66	0	-	52173749	52185482	255,102,0	1	11733	0	.	Coil 1B.
chr12	52185482	52185533	Q6KB66	0	-	52185482	52185533	255,102,0	1	51	0	.	Linker 1.
chr12	52185533	52191659	Q6KB66	0	-	52185533	52191659	255,102,0	1	6126	0	.	Coil 1A.
chr12	52191656	52191902	Q6KB66	0	-	52191656	52191902	255,102,0	1	246	0	.	Head.
chr12	52233299	52233566	P08729	0	+	52233299	52233566	255,102,0	1	267	0	.	Head.
chr12	52233563	52235208	P08729	0	+	52233563	52235208	255,102,0	1	1645	0	.	Coil 1A.
chr12	52233566	52245624	P08729	0	+	52233566	52245624	255,102,0	1	12058	0	.	Rod.
chr12	52233569	52233587	P08729	0	+	52233569	52233587	255,102,0	1	18	0	.	Interaction with HPV16 E7. Pubmed:12072504
chr12	52235208	52235262	P08729	0	+	52235208	52235262	255,102,0	1	54	0	.	Linker 1.
chr12	52235262	52241486	P08729	0	+	52235262	52241486	255,102,0	1	6224	0	.	Coil 1B.
chr12	52241486	52241558	P08729	0	+	52241486	52241558	255,102,0	1	72	0	.	Linker 12.
chr12	52241558	52245624	P08729	0	+	52241558	52245624	255,102,0	1	4066	0	.	Coil 2.
chr12	52245624	52248757	P08729	0	+	52245624	52248757	255,102,0	1	3133	0	.	Tail.
chr12	52286257	52287109	Q14533	0	-	52286257	52287109	255,102,0	1	852	0	.	Tail.
chr12	52287109	52288076	Q14533	0	-	52287109	52288076	255,102,0	1	967	0	.	Coil 2.
chr12	52287109	52291147	Q14533	0	-	52287109	52291147	255,102,0	1	4038	0	.	Rod.
chr12	52288076	52288127	Q14533	0	-	52288076	52288127	255,102,0	1	51	0	.	Linker 12.
chr12	52288127	52290202	Q14533	0	-	52288127	52290202	255,102,0	1	2075	0	.	Coil 1B.
chr12	52290202	52290232	Q14533	0	-	52290202	52290232	255,102,0	1	30	0	.	Linker 1.
chr12	52290232	52291147	Q14533	0	-	52290232	52291147	255,102,0	1	915	0	.	Coil 1A.
chr12	52291147	52291465	Q14533	0	-	52291147	52291465	255,102,0	1	318	0	.	Head.
chr12	52301916	52302234	O43790	0	+	52301916	52302234	255,102,0	1	318	0	.	Head.
chr12	52302234	52303153	O43790	0	+	52302234	52303153	255,102,0	1	919	0	.	Coil 1A.
chr12	52302234	52306272	O43790	0	+	52302234	52306272	255,102,0	1	4038	0	.	Rod.
chr12	52303153	52303183	O43790	0	+	52303153	52303183	255,102,0	1	30	0	.	Linker 1.
chr12	52303183	52305260	O43790	0	+	52303183	52305260	255,102,0	1	2077	0	.	Coil 1B.
chr12	52305260	52305311	O43790	0	+	52305260	52305311	255,102,0	1	51	0	.	Linker 12.
chr12	52305311	52306272	O43790	0	+	52305311	52306272	255,102,0	1	961	0	.	Coil 2.
chr12	52306272	52308582	O43790	0	+	52306272	52308582	255,102,0	1	2310	0	.	Tail.
chr12	52314633	52315900	P78385	0	-	52314633	52315900	255,102,0	1	1267	0	.	Tail.
chr12	52315900	52316951	P78385	0	-	52315900	52316951	255,102,0	1	1051	0	.	Coil 2.
chr12	52315900	52321002	P78385	0	-	52315900	52321002	255,102,0	1	5102	0	.	Rod.
chr12	52316951	52317002	P78385	0	-	52316951	52317002	255,102,0	1	51	0	.	Linker 12.
chr12	52317002	52319280	P78385	0	-	52317002	52319280	255,102,0	1	2278	0	.	Coil 1B.
chr12	52319280	52319310	P78385	0	-	52319280	52319310	255,102,0	1	30	0	.	Linker 1.
chr12	52319310	52321002	P78385	0	-	52319310	52321002	255,102,0	1	1692	0	.	Coil 1A.
chr12	52321002	52321335	P78385	0	-	52321002	52321335	255,102,0	1	333	0	.	Head.
chr12	52360855	52362258	P78386	0	-	52360855	52362258	255,102,0	1	1403	0	.	Tail.
chr12	52362258	52363338	P78386	0	-	52362258	52363338	255,102,0	1	1080	0	.	Coil 2.
chr12	52362258	52367036	P78386	0	-	52362258	52367036	255,102,0	1	4778	0	.	Rod.
chr12	52363338	52363389	P78386	0	-	52363338	52363389	255,102,0	1	51	0	.	Linker 12.
chr12	52363389	52365086	P78386	0	-	52363389	52365086	255,102,0	1	1697	0	.	Coil 1B.
chr12	52365086	52365116	P78386	0	-	52365086	52365116	255,102,0	1	30	0	.	Linker 1.
chr12	52365116	52367036	P78386	0	-	52365116	52367036	255,102,0	1	1920	0	.	Coil 1A.
chr12	52367036	52367405	P78386	0	-	52367036	52367405	255,102,0	1	369	0	.	Head.
chr12	52378036	52380370	Q9NSB2	0	-	52378036	52380370	255,102,0	1	2334	0	.	Tail.
chr12	52380370	52381453	Q9NSB2	0	-	52380370	52381453	255,102,0	1	1083	0	.	Coil 2.
chr12	52380370	52385090	Q9NSB2	0	-	52380370	52385090	255,102,0	1	4720	0	.	Rod.
chr12	52381453	52381504	Q9NSB2	0	-	52381453	52381504	255,102,0	1	51	0	.	Linker 12.
chr12	52381504	52383714	Q9NSB2	0	-	52381504	52383714	255,102,0	1	2210	0	.	Coil 1B.
chr12	52383714	52383744	Q9NSB2	0	-	52383714	52383744	255,102,0	1	30	0	.	Linker 1.
chr12	52383744	52385090	Q9NSB2	0	-	52383744	52385090	255,102,0	1	1346	0	.	Coil 1A.
chr12	52385090	52385585	Q9NSB2	0	-	52385090	52385585	255,102,0	1	495	0	.	Head.
chr12	52394977	52396019	Q9NSB4	0	-	52394977	52396019	255,102,0	1	1042	0	.	Tail.
chr12	52396019	52400077	Q9NSB4	0	-	52396019	52400077	255,102,0	1	4058	0	.	Coil 2.
chr12	52396019	52405917	Q9NSB4	0	-	52396019	52405917	255,102,0	1	9898	0	.	Rod.
chr12	52400077	52400128	Q9NSB4	0	-	52400077	52400128	255,102,0	1	51	0	.	Linker 12.
chr12	52400128	52403825	Q9NSB4	0	-	52400128	52403825	255,102,0	1	3697	0	.	Coil 1B.
chr12	52403825	52403855	Q9NSB4	0	-	52403825	52403855	255,102,0	1	30	0	.	Linker 1.
chr12	52403855	52405917	Q9NSB4	0	-	52403855	52405917	255,102,0	1	2062	0	.	Coil 1A.
chr12	52405917	52406277	Q9NSB4	0	-	52405917	52406277	255,102,0	1	360	0	.	Head.
chr12	52424519	52428263	O95678	0	-	52424519	52428263	255,102,0	1	3744	0	.	Tail.
chr12	52428263	52430618	O95678	0	-	52428263	52430618	255,102,0	1	2355	0	.	Coil 2.
chr12	52428263	52433860	O95678	0	-	52428263	52433860	255,102,0	1	5597	0	.	Rod.
chr12	52430618	52430687	O95678	0	-	52430618	52430687	255,102,0	1	69	0	.	Linker 12.
chr12	52430687	52433141	O95678	0	-	52430687	52433141	255,102,0	1	2454	0	.	Coil 1B.
chr12	52433141	52433198	O95678	0	-	52433141	52433198	255,102,0	1	57	0	.	Linker 1.
chr12	52433198	52433860	O95678	0	-	52433198	52433860	255,102,0	1	662	0	.	Coil 1A.
chr12	52433860	52434304	O95678	0	-	52433860	52434304	255,102,0	1	444	0	.	Head.
chr12	52447192	52447785	P04259	0	-	52447192	52447785	255,102,0	1	593	0	.	Tail.
chr12	52447785	52449546	P04259	0	-	52447785	52449546	255,102,0	1	1761	0	.	Coil 2.
chr12	52447785	52451592	P04259	0	-	52447785	52451592	255,102,0	1	3807	0	.	Rod.
chr12	52449546	52449618	P04259	0	-	52449546	52449618	255,102,0	1	72	0	.	Linker 12.
chr12	52449618	52450509	P04259	0	-	52449618	52450509	255,102,0	1	891	0	.	Coil 1B.
chr12	52450509	52450566	P04259	0	-	52450509	52450566	255,102,0	1	57	0	.	Linker 1.
chr12	52450566	52451592	P04259	0	-	52450566	52451592	255,102,0	1	1026	0	.	Coil 1A.
chr12	52451592	52452075	P04259	0	-	52451592	52452075	255,102,0	1	483	0	.	Head.
chr12	52469064	52469677	P48668	0	-	52469064	52469677	255,102,0	1	613	0	.	Tail.
chr12	52469677	52471209	P48668	0	-	52469677	52471209	255,102,0	1	1532	0	.	Coil 2.
chr12	52469677	52473251	P48668	0	-	52469677	52473251	255,102,0	1	3574	0	.	Rod.
chr12	52471209	52471281	P48668	0	-	52471209	52471281	255,102,0	1	72	0	.	Linker 12.
chr12	52471281	52472169	P48668	0	-	52471281	52472169	255,102,0	1	888	0	.	Coil 1B.
chr12	52472169	52472226	P48668	0	-	52472169	52472226	255,102,0	1	57	0	.	Linker 1.
chr12	52472226	52473251	P48668	0	-	52472226	52473251	255,102,0	1	1025	0	.	Coil 1A.
chr12	52473251	52473734	P48668	0	-	52473251	52473734	255,102,0	1	483	0	.	Head.
chr12	52487722	52488335	P02538	0	-	52487722	52488335	255,102,0	1	613	0	.	Tail.
chr12	52488335	52490646	P02538	0	-	52488335	52490646	255,102,0	1	2311	0	.	Coil 2.
chr12	52488335	52492702	P02538	0	-	52488335	52492702	255,102,0	1	4367	0	.	Rod.
chr12	52490646	52490718	P02538	0	-	52490646	52490718	255,102,0	1	72	0	.	Linker 12.
chr12	52490718	52491625	P02538	0	-	52490718	52491625	255,102,0	1	907	0	.	Coil 1B.
chr12	52491625	52491682	P02538	0	-	52491625	52491682	255,102,0	1	57	0	.	Linker 1.
chr12	52491682	52492702	P02538	0	-	52491682	52492702	255,102,0	1	1020	0	.	Coil 1A.
chr12	52492702	52493185	P02538	0	-	52492702	52493185	255,102,0	1	483	0	.	Head.
chr12	52514944	52516644	P13647	0	-	52514944	52516644	255,102,0	1	1700	0	.	Tail.
chr12	52516644	52517667	P13647	0	-	52516644	52517667	255,102,0	1	1023	0	.	Coil 2.
chr12	52516644	52519795	P13647	0	-	52516644	52519795	255,102,0	1	3151	0	.	Rod.
chr12	52517667	52517736	P13647	0	-	52517667	52517736	255,102,0	1	69	0	.	Linker 12.
chr12	52517736	52519049	P13647	0	-	52517736	52519049	255,102,0	1	1313	0	.	Coil 1B.
chr12	52519049	52519106	P13647	0	-	52519049	52519106	255,102,0	1	57	0	.	Linker 1.
chr12	52519106	52519795	P13647	0	-	52519106	52519795	255,102,0	1	689	0	.	Coil 1A.
chr12	52519795	52520296	P13647	0	-	52519795	52520296	255,102,0	1	501	0	.	Head.
chr12	52544534	52546293	Q3SY84	0	-	52544534	52546293	255,102,0	1	1759	0	.	Tail.
chr12	52546293	52548229	Q3SY84	0	-	52546293	52548229	255,102,0	1	1936	0	.	Coil 2.
chr12	52546293	52552690	Q3SY84	0	-	52546293	52552690	255,102,0	1	6397	0	.	Rod.
chr12	52548229	52548301	Q3SY84	0	-	52548229	52548301	255,102,0	1	72	0	.	Linker 12.
chr12	52548301	52550132	Q3SY84	0	-	52548301	52550132	255,102,0	1	1831	0	.	Coil 1B.
chr12	52550132	52550189	Q3SY84	0	-	52550132	52550189	255,102,0	1	57	0	.	Linker 1.
chr12	52550189	52552690	Q3SY84	0	-	52550189	52552690	255,102,0	1	2501	0	.	Coil 1A.
chr12	52552690	52553077	Q3SY84	0	-	52552690	52553077	255,102,0	1	387	0	.	Head.
chr12	52566971	52568176	Q7RTS7	0	-	52566971	52568176	255,102,0	1	1205	0	.	Tail.
chr12	52568176	52570746	Q7RTS7	0	-	52568176	52570746	255,102,0	1	2570	0	.	Coil 2.
chr12	52568176	52573360	Q7RTS7	0	-	52568176	52573360	255,102,0	1	5184	0	.	Rod.
chr12	52570746	52570818	Q7RTS7	0	-	52570746	52570818	255,102,0	1	72	0	.	Linker 12.
chr12	52570818	52572556	Q7RTS7	0	-	52570818	52572556	255,102,0	1	1738	0	.	Coil 1B.
chr12	52572556	52572613	Q7RTS7	0	-	52572556	52572613	255,102,0	1	57	0	.	Linker 1.
chr12	52572613	52573360	Q7RTS7	0	-	52572613	52573360	255,102,0	1	747	0	.	Coil 1A.
chr12	52573360	52573777	Q7RTS7	0	-	52573360	52573777	255,102,0	1	417	0	.	Head.
chr12	52585984	52587638	Q14CN4	0	-	52585984	52587638	255,102,0	1	1654	0	.	Tail.
chr12	52587638	52591541	Q14CN4	0	-	52587638	52591541	255,102,0	1	3903	0	.	Coil 2.
chr12	52587638	52601080	Q14CN4	0	-	52587638	52601080	255,102,0	1	13442	0	.	Rod.
chr12	52591541	52591613	Q14CN4	0	-	52591541	52591613	255,102,0	1	72	0	.	Linker 12.
chr12	52591613	52599001	Q14CN4	0	-	52591613	52599001	255,102,0	1	7388	0	.	Coil 1B.
chr12	52599001	52599058	Q14CN4	0	-	52599001	52599058	255,102,0	1	57	0	.	Linker 1.
chr12	52599058	52601080	Q14CN4	0	-	52599058	52601080	255,102,0	1	2022	0	.	Coil 1A.
chr12	52601080	52601452	Q14CN4	0	-	52601080	52601452	255,102,0	1	372	0	.	Head.
chr12	52608198	52610622	Q86Y46	0	-	52608198	52610622	255,102,0	1	2424	0	.	Tail.
chr12	52610622	52613765	Q86Y46	0	-	52610622	52613765	255,102,0	1	3143	0	.	Coil 2.
chr12	52610622	52618131	Q86Y46	0	-	52610622	52618131	255,102,0	1	7509	0	.	Rod.
chr12	52613765	52613837	Q86Y46	0	-	52613765	52613837	255,102,0	1	72	0	.	Linker 12.
chr12	52613837	52616269	Q86Y46	0	-	52613837	52616269	255,102,0	1	2432	0	.	Coil 1B.
chr12	52616269	52616326	Q86Y46	0	-	52616269	52616326	255,102,0	1	57	0	.	Linker 1.
chr12	52616326	52618131	Q86Y46	0	-	52616326	52618131	255,102,0	1	1805	0	.	Coil 1A.
chr12	52618131	52618524	Q86Y46	0	-	52618131	52618524	255,102,0	1	393	0	.	Head.
chr12	52645021	52646747	P35908	0	-	52645021	52646747	255,102,0	1	1726	0	.	Tail.
chr12	52646747	52648250	P35908	0	-	52646747	52648250	255,102,0	1	1503	0	.	Coil 2.
chr12	52646747	52651611	P35908	0	-	52646747	52651611	255,102,0	1	4864	0	.	Rod.
chr12	52648250	52648322	P35908	0	-	52648250	52648322	255,102,0	1	72	0	.	Linker 12.
chr12	52648322	52650442	P35908	0	-	52648322	52650442	255,102,0	1	2120	0	.	Coil 1B.
chr12	52650442	52650499	P35908	0	-	52650442	52650499	255,102,0	1	57	0	.	Linker 1.
chr12	52650499	52651611	P35908	0	-	52650499	52651611	255,102,0	1	1112	0	.	Coil 1A.
chr12	52651611	52652142	P35908	0	-	52651611	52652142	255,102,0	1	531	0	.	Head.
chr12	52675195	52676282	P04264	0	-	52675195	52676282	255,102,0	1	1087	0	.	Tail.
chr12	52676282	52677393	P04264	0	-	52676282	52677393	255,102,0	1	1111	0	.	Coil 2.
chr12	52676282	52679811	P04264	0	-	52676282	52679811	255,102,0	1	3529	0	.	Rod.
chr12	52677393	52677465	P04264	0	-	52677393	52677465	255,102,0	1	72	0	.	Linker 12.
chr12	52677465	52678645	P04264	0	-	52677465	52678645	255,102,0	1	1180	0	.	Coil 1B.
chr12	52678645	52678702	P04264	0	-	52678645	52678702	255,102,0	1	57	0	.	Linker 1.
chr12	52678702	52679811	P04264	0	-	52678702	52679811	255,102,0	1	1109	0	.	Coil 1A.
chr12	52679811	52680345	P04264	0	-	52679811	52680345	255,102,0	1	534	0	.	Head.
chr12	52691167	52692425	Q7Z794	0	-	52691167	52692425	255,102,0	1	1258	0	.	Tail.
chr12	52692425	52694700	Q7Z794	0	-	52692425	52694700	255,102,0	1	2275	0	.	Coil 2.
chr12	52692425	52702945	Q7Z794	0	-	52692425	52702945	255,102,0	1	10520	0	.	Rod.
chr12	52694700	52694772	Q7Z794	0	-	52694700	52694772	255,102,0	1	72	0	.	Linker 12.
chr12	52694772	52697782	Q7Z794	0	-	52694772	52697782	255,102,0	1	3010	0	.	Coil 1B.
chr12	52697782	52697839	Q7Z794	0	-	52697782	52697839	255,102,0	1	57	0	.	Linker 1.
chr12	52697839	52702945	Q7Z794	0	-	52697839	52702945	255,102,0	1	5106	0	.	Coil 1A.
chr12	52702945	52703434	Q7Z794	0	-	52702945	52703434	255,102,0	1	489	0	.	Head.
chr12	52768715	52771006	Q01546	0	-	52768715	52771006	255,102,0	1	2291	0	.	Tail.
chr12	52771006	52772171	Q01546	0	-	52771006	52772171	255,102,0	1	1165	0	.	Coil 2.
chr12	52771006	52776745	Q01546	0	-	52771006	52776745	255,102,0	1	5739	0	.	Rod.
chr12	52772171	52772243	Q01546	0	-	52772171	52772243	255,102,0	1	72	0	.	Linker 12.
chr12	52772243	52775491	Q01546	0	-	52772243	52775491	255,102,0	1	3248	0	.	Coil 1B.
chr12	52775491	52775548	Q01546	0	-	52775491	52775548	255,102,0	1	57	0	.	Linker 1.
chr12	52775548	52776745	Q01546	0	-	52775548	52776745	255,102,0	1	1197	0	.	Coil 1A.
chr12	52776745	52777291	Q01546	0	-	52776745	52777291	255,102,0	1	546	0	.	Head.
chr12	52790044	52791213	P12035	0	-	52790044	52791213	255,102,0	1	1169	0	.	Tail.
chr12	52791213	52792316	P12035	0	-	52791213	52792316	255,102,0	1	1103	0	.	Coil 2.
chr12	52791213	52795451	P12035	0	-	52791213	52795451	255,102,0	1	4238	0	.	Rod.
chr12	52792316	52792388	P12035	0	-	52792316	52792388	255,102,0	1	72	0	.	Linker 12.
chr12	52792388	52794214	P12035	0	-	52792388	52794214	255,102,0	1	1826	0	.	Coil 1B.
chr12	52794214	52794277	P12035	0	-	52794214	52794277	255,102,0	1	63	0	.	Linker 1.
chr12	52794277	52795451	P12035	0	-	52794277	52795451	255,102,0	1	1174	0	.	Coil 1A.
chr12	52795451	52796042	P12035	0	-	52795451	52796042	255,102,0	1	591	0	.	Head.
chr12	52821874	52823023	Q5XKE5	0	-	52821874	52823023	255,102,0	1	1149	0	.	Tail.
chr12	52823023	52824275	Q5XKE5	0	-	52823023	52824275	255,102,0	1	1252	0	.	Coil 2.
chr12	52823023	52833837	Q5XKE5	0	-	52823023	52833837	255,102,0	1	10814	0	.	Rod.
chr12	52824275	52824347	Q5XKE5	0	-	52824275	52824347	255,102,0	1	72	0	.	Linker 12.
chr12	52824347	52831509	Q5XKE5	0	-	52824347	52831509	255,102,0	1	7162	0	.	Coil 1B.
chr12	52831509	52831572	Q5XKE5	0	-	52831509	52831572	255,102,0	1	63	0	.	Linker 1.
chr12	52831572	52833837	Q5XKE5	0	-	52831572	52833837	255,102,0	1	2265	0	.	Coil 1A.
chr12	52833837	52834260	Q5XKE5	0	-	52833837	52834260	255,102,0	1	423	0	.	Head.
chr12	52839115	52839768	Q8N1N4	0	-	52839115	52839768	255,102,0	1	653	0	.	Tail.
chr12	52839768	52844636	Q8N1N4	0	-	52839768	52844636	255,102,0	1	4868	0	.	Coil 2.
chr12	52839768	52848600	Q8N1N4	0	-	52839768	52848600	255,102,0	1	8832	0	.	Rod.
chr12	52844636	52844705	Q8N1N4	0	-	52844636	52844705	255,102,0	1	69	0	.	Linker 12.
chr12	52844705	52848010	Q8N1N4	0	-	52844705	52848010	255,102,0	1	3305	0	.	Coil 1B.
chr12	52848010	52848067	Q8N1N4	0	-	52848010	52848067	255,102,0	1	57	0	.	Linker 1.
chr12	52848067	52848600	Q8N1N4	0	-	52848067	52848600	255,102,0	1	533	0	.	Coil 1A.
chr12	52848600	52848930	Q8N1N4	0	-	52848600	52848930	255,102,0	1	330	0	.	Head.
chr12	52897430	52898686	P05787	0	-	52897430	52898686	255,102,0	1	1256	0	.	Tail.
chr12	52898686	52899978	P05787	0	-	52898686	52899978	255,102,0	1	1292	0	.	Coil 2.
chr12	52898686	52904711	P05787	0	-	52898686	52904711	255,102,0	1	6025	0	.	Rod.
chr12	52898734	52899975	P05787	0	-	52898734	52899975	255,102,0	1	1241	0	.	Necessary for interaction with PNN. Pubmed:10809736
chr12	52899978	52900050	P05787	0	-	52899978	52900050	255,102,0	1	72	0	.	Linker 12.
chr12	52900050	52901967	P05787	0	-	52900050	52901967	255,102,0	1	1917	0	.	Coil 1B.
chr12	52901967	52902018	P05787	0	-	52901967	52902018	255,102,0	1	51	0	.	Linker 1.
chr12	52902018	52904711	P05787	0	-	52902018	52904711	255,102,0	1	2693	0	.	Coil 1A.
chr12	52904711	52904981	P05787	0	-	52904711	52904981	255,102,0	1	270	0	.	Head.
chr12	52949176	52949410	P05783	0	+	52949176	52949410	255,102,0	1	234	0	.	Head.
chr12	52949380	52952289	P05783	0	+	52949380	52952289	255,102,0	1	2909	0	.	Necessary for interaction with PNN. Pubmed:10809736
chr12	52949401	52949557	P05783	0	+	52949401	52949557	255,102,0	1	156	0	.	Interaction with TRADD. Pubmed:11684708
chr12	52949410	52949518	P05783	0	+	52949410	52949518	255,102,0	1	108	0	.	Coil 1A.
chr12	52949410	52952331	P05783	0	+	52949410	52952331	255,102,0	1	2921	0	.	Rod.
chr12	52949518	52949569	P05783	0	+	52949518	52949569	255,102,0	1	51	0	.	Linker 1.
chr12	52949569	52951495	P05783	0	+	52949569	52951495	255,102,0	1	1926	0	.	Coil 1B.
chr12	52951495	52951567	P05783	0	+	52951495	52951567	255,102,0	1	72	0	.	Linker 12.
chr12	52951549	52952343	P05783	0	+	52951549	52952343	255,102,0	1	794	0	.	Interaction with DNAJB6. Pubmed:10954706
chr12	52951567	52952331	P05783	0	+	52951567	52952331	255,102,0	1	764	0	.	Coil 2.
chr12	52952331	52952839	P05783	0	+	52952331	52952839	255,102,0	1	508	0	.	Tail.
chr12	53192716	53193778	P26010	0	-	53192716	53193778	255,102,0	1	1062	0	.	Cysteine-rich tandem repeats.
chr12	53211777	53214478	P13631	0	-	53211777	53214478	255,102,0	1	2701	0	.	Ligand-binding.
chr12	53214478	53215302	P13631	0	-	53214478	53215302	255,102,0	1	824	0	.	Hinge.
chr12	53215711	53227545	P13631	0	-	53215711	53227545	255,102,0	1	11834	0	.	Modulating.
chr12	53380294	53382193	P08047	0	+	53380294	53382193	255,102,0	1	1899	0	.	Repressor domain.
chr12	53382382	53382700	P08047	0	+	53382382	53382700	255,102,0	1	318	0	.	Transactivation domain A (Gln-rich).
chr12	53382727	53383432	P08047	0	+	53382727	53383432	255,102,0	1	705	0	.	Transactivation domain B (Gln-rich).
chr12	53383432	53406739	P08047	0	+	53383432	53406739	255,102,0	1	23307	0	.	Transactivation domain C (highly charged).
chr12	53409371	53411237	P08047	0	+	53409371	53411237	255,102,0	1	1866	0	.	VZV IE62-binding.
chr12	53411003	53411237	P08047	0	+	53411003	53411237	255,102,0	1	234	0	.	Domain D.
chr12	53483470	53483656	Q12852	0	-	53483470	53483656	255,102,0	1	186	0	.	Leucine-zipper 2.
chr12	53483936	53484002	Q12852	0	-	53483936	53484002	255,102,0	1	66	0	.	Leucine-zipper 1.
chr12	53502024	53503118	Q15633	0	+	53502024	53503118	255,102,0	1	1094	0	.	Sufficient for interaction with PRKRA.
chr12	53504427	53505223	Q15633	0	+	53504427	53505223	255,102,0	1	796	0	.	Sufficient for interaction with PRKRA.
chr12	53505202	53506145	Q15633	0	+	53505202	53506145	255,102,0	1	943	0	.	Sufficient for interaction with DICER1.
chr12	53505765	53506145	Q15633	0	+	53505765	53506145	255,102,0	1	380	0	.	Sufficient for interaction with PRKRA.
chr12	53517139	53524716	P17544	0	-	53517139	53524716	255,102,0	1	7577	0	.	Essential for binding adenovirus 2 E1A.
chr12	53523345	53524611	P17544	0	-	53523345	53524611	255,102,0	1	1266	0	.	Leucine-zipper.
chr12	53524626	53524689	P17544	0	-	53524626	53524689	255,102,0	1	63	0	.	Basic motif.
chr12	53531815	53601000	P17544	0	-	53531815	53601000	255,102,0	1	69185	0	.	Transactivation domain.
chr12	53711946	53714223	Q9P1Z2	0	-	53711946	53714223	255,102,0	1	2277	0	.	C-terminal AD (CTNNB1 binding site); interaction with CCAR1.
chr12	53722063	53725242	Q9P1Z2	0	-	53722063	53725242	255,102,0	1	3179	0	.	N-terminal AD (CTNNB1 binding site).
chr12	53723667	53725110	Q9P1Z2	0	-	53723667	53725110	255,102,0	1	1443	0	.	Interaction with GATA1.
chr12	53725152	53725242	Q9P1Z2	0	-	53725152	53725242	255,102,0	1	90	0	.	p300 KIX-binding.
chr12	54182347	54182392	Q53HV7	0	-	54182347	54182392	255,102,0	1	45	0	.	DNA binding.
chr12	54241757	54246194	P45973	0	-	54241757	54246194	255,102,0	1	4437	0	.	Interaction with ASXL1. Pubmed:19880879
chr12	54280816	54282092	P09651	0	+	54280816	54282092	255,102,0	1	1276	0	.	Globular A domain.
chr12	54282092	54282458	P09651	0	+	54282092	54282458	255,102,0	1	366	0	.	Globular B domain.
chr12	54282640	54282843	P09651	0	+	54282640	54282843	255,102,0	1	203	0	.	RNA-binding RGG-box.
chr12	54283861	54284265	P09651	0	+	54283861	54284265	255,102,0	1	404	0	.	Nuclear targeting sequence (M9).
chr12	54292601	54292625	Q16621	0	-	54292601	54292625	255,102,0	1	24	0	.	Leucine-zipper.
chr12	54292634	54292694	Q16621	0	-	54292634	54292694	255,102,0	1	60	0	.	Basic motif.
chr12	54292877	54295248	Q16621	0	-	54292877	54295248	255,102,0	1	2371	0	.	Transactivation domain.
chr12	54293246	54295248	Q16621	0	-	54293246	54295248	255,102,0	1	2002	0	.	Required for interaction with MAPK8.
chr12	54370363	54371704	Q96PM9	0	-	54370363	54371704	255,102,0	1	1341	0	.	Necessary for binding to ITPR1, CEBPA and p53/TP53 mRNAs.
chr12	54396358	54397370	P08648	0	-	54396358	54397370	255,102,0	1	1012	0	.	Interaction with HPS5.
chr12	54549950	54567001	Q01064	0	+	54549950	54567001	255,102,0	1	17051	0	.	Calmodulin-binding.
chr12	54570351	54576682	Q01064	0	+	54570351	54576682	255,102,0	1	6331	0	.	Catalytic.
chr12	54856804	54856876	Q96DR8	0	+	54856804	54856876	255,102,0	1	72	0	.	3 X 8 AA tandem repeat of T-T-A-A-[APS]-T-T-A.
chr12	55685075	55685135	Q13683	0	-	55685075	55685135	255,102,0	1	60	0	.	3 X 4 AA repeats of D-X-H-P.
chr12	55901874	55902033	Q9BRP8	0	-	55901874	55902033	255,102,0	1	159	0	.	eIF2A-like.
chr12	55903418	55927761	Q9BRP8	0	-	55903418	55927761	255,102,0	1	24343	0	.	Required for interaction with MAGOH and RBM8A.
chr12	55956970	55957360	P40967	0	-	55956970	55957360	255,102,0	1	390	0	.	10 X 13 AA approximate tandem repeats, RPT domain.
chr12	56003881	56003911	P51687	0	+	56003881	56003911	255,102,0	1	30	0	.	Hinge.
chr12	56003911	56004592	P51687	0	+	56003911	56004592	255,102,0	1	681	0	.	Moco domain.
chr12	56004031	56004046	P51687	0	+	56004031	56004046	255,102,0	1	15	0	.	Molybdopterin-binding.
chr12	56004517	56004526	P51687	0	+	56004517	56004526	255,102,0	1	9	0	.	Molybdopterin-binding.
chr12	56004592	56005003	P51687	0	+	56004592	56005003	255,102,0	1	411	0	.	Homodimerization.
chr12	56032685	56035328	Q9H2S9	0	+	56032685	56035328	255,102,0	1	2643	0	.	Interaction with FOXP3.
chr12	56104740	56106643	Q9UQ80	0	+	56104740	56106643	255,102,0	1	1903	0	.	Necessary for nucleolar localization. Pubmed:15064750
chr12	56106634	56106661	Q9UQ80	0	+	56106634	56106661	255,102,0	1	27	0	.	RNA-binding. Pubmed:15064750
chr12	56111021	56112885	Q9UQ80	0	+	56111021	56112885	255,102,0	1	1864	0	.	Necessary for nucleolar localization. Pubmed:15064750
chr12	56111490	56112828	Q9UQ80	0	+	56111490	56112828	255,102,0	1	1338	0	.	Interaction with RNA.
chr12	56130605	56132287	Q9BSJ8	0	+	56130605	56132287	255,102,0	1	1682	0	.	Glycerophospholipid-binding barrel-like domain.
chr12	56143080	56143104	Q9BSJ8	0	+	56143080	56143104	255,102,0	1	24	0	.	Required for phosphatidylinositol 4,5-bisphosphate-dependent location at the cell membrane.
chr12	56417718	56418344	Q9UNS1	0	-	56417718	56418344	255,102,0	1	626	0	.	Required for nuclear localization.
chr12	56430263	56434170	Q9UNS1	0	-	56430263	56434170	255,102,0	1	3907	0	.	Required for homodimerization and for interaction with CRY1 and CHEK1.
chr12	56451360	56451393	P30301	0	-	56451360	56451393	255,102,0	1	33	0	.	Interaction with CALM.
chr12	56713593	56713641	Q13765	0	-	56713593	56713641	255,102,0	1	48	0	.	RNA/DNA-binding.
chr12	56713677	56714391	E9PAV3	0	-	56713677	56714391	255,102,0	1	714	0	.	Required for DNA-binding.
chr12	56713677	56714391	Q13765	0	-	56713677	56714391	255,102,0	1	714	0	.	Required for DNA-binding.
chr12	57038050	57038461	Q9UBC5	0	-	57038050	57038461	255,102,0	1	411	0	.	Actin-binding.
chr12	57059881	57060920	O14524	0	-	57059881	57060920	255,102,0	1	1039	0	.	Required for nuclear localization.
chr12	57059998	57060920	O14524	0	-	57059998	57060920	255,102,0	1	922	0	.	B; required for interaction with RAN-GTP.
chr12	57063207	57064729	O14524	0	-	57063207	57064729	255,102,0	1	1522	0	.	A; required for its colocalization with lamins at the nuclear envelope.
chr12	57091143	57091380	Q15742	0	+	57091143	57091380	255,102,0	1	237	0	.	NCD1.
chr12	57091839	57092558	Q15742	0	+	57091839	57092558	255,102,0	1	719	0	.	NCD2.
chr12	57092546	57093071	Q15742	0	+	57092546	57093071	255,102,0	1	525	0	.	Necessary for nuclear localization.
chr12	57212000	57212552	Q07954	0	+	57212000	57212552	255,102,0	1	552	0	.	Interaction with MAFB.
chr12	57224889	57225072	O95158	0	+	57224889	57225072	255,102,0	1	183	0	.	II.
chr12	57225072	57225309	O95158	0	+	57225072	57225309	255,102,0	1	237	0	.	III.
chr12	57225309	57225492	O95158	0	+	57225309	57225492	255,102,0	1	183	0	.	IV (linker domain).
chr12	57225492	57225744	O95158	0	+	57225492	57225744	255,102,0	1	252	0	.	V (Cys-rich).
chr12	57463691	57463751	P08151	0	+	57463691	57463751	255,102,0	1	60	0	.	SNAG domain.
chr12	57464836	57464851	P08151	0	+	57464836	57464851	255,102,0	1	15	0	.	Interaction with SUFU. Pubmed:24217340, Pubmed:24311597
chr12	57466323	57466350	P08151	0	+	57466323	57466350	255,102,0	1	27	0	.	Interaction with DNA. Pubmed:8378770
chr12	57467452	57467470	P08151	0	+	57467452	57467470	255,102,0	1	18	0	.	Interaction with DNA. Pubmed:8378770
chr12	57468038	57468059	P08151	0	+	57468038	57468059	255,102,0	1	21	0	.	Interaction with DNA. Pubmed:8378770
chr12	57516874	57516919	P35638	0	-	57516874	57516919	255,102,0	1	45	0	.	Leucine-zipper.
chr12	57516928	57517018	P35638	0	-	57516928	57517018	255,102,0	1	90	0	.	Basic motif.
chr12	57517328	57517379	P35638	0	-	57517328	57517379	255,102,0	1	51	0	.	N-terminal.
chr12	57517352	57517379	P35638	0	-	57517352	57517379	255,102,0	1	27	0	.	Interaction with TRIB3.
chr12	57567143	57569381	Q12840	0	+	57567143	57569381	255,102,0	1	2238	0	.	Microtubule-binding.
chr12	57569058	57569649	Q12840	0	+	57569058	57569649	255,102,0	1	591	0	.	Necessary for interaction with ZFYVE27.
chr12	57569622	57583176	Q12840	0	+	57569622	57583176	255,102,0	1	13554	0	.	Interaction with BICD2. Pubmed:20386726
chr12	57581135	57583176	Q12840	0	+	57581135	57583176	255,102,0	1	2041	0	.	Globular.
chr12	57614703	57614769	Q86VW2	0	+	57614703	57614769	255,102,0	1	66	0	.	Important for binding to Rho GTPases.
chr12	57615995	57616342	Q86VW2	0	+	57615995	57616342	255,102,0	1	347	0	.	Sufficient to bind activated GNAQ.
chr12	57751549	57751570	P11802	0	-	57751549	57751570	255,102,0	1	21	0	.	Required for binding D-type cyclins.
chr12	57769106	57769115	Q9UBP6	0	-	57769106	57769115	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr12	57769807	57769813	Q9UBP6	0	-	57769807	57769813	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr12	57769906	57769912	Q9UBP6	0	-	57769906	57769912	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr12	57773085	57773094	Q96AZ1	0	+	57773085	57773094	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr12	57797884	57801173	O75366	0	-	57797884	57801173	255,102,0	1	3289	0	.	Headpiece.
chr12	57801170	57816040	O75366	0	-	57801170	57816040	255,102,0	1	14870	0	.	Core.
chr12	57811036	57811063	O75366	0	-	57811036	57811063	255,102,0	1	27	0	.	Polyphosphoinositide binding.
chr12	57811117	57813240	O75366	0	-	57811117	57813240	255,102,0	1	2123	0	.	Polyphosphoinositide binding.
chr12	62260417	62325919	Q9Y4E8	0	+	62260417	62325919	255,102,0	1	65502	0	.	Mediates interaction with SART3. Pubmed:24526689
chr12	64410035	64423217	O43592	0	+	64410035	64423217	255,102,0	1	13182	0	.	Necessary for interaction with Ran, nuclear localization and nuclear import.
chr12	64425056	64448128	O43592	0	+	64425056	64448128	255,102,0	1	23072	0	.	Necessary for tRNA-binding, cytoplasmic localization and nuclear export.
chr12	64497048	64497187	Q9UHD2	0	+	64497048	64497187	255,102,0	1	139	0	.	Interaction with AZI2, TANK and TBKBP1. Pubmed:21931631
chr12	65240206	65246322	Q9Y2U8	0	+	65240206	65246322	255,102,0	1	6116	0	.	Interaction with SMAD1, SMAD2, SMAD3 and SMAD5. Pubmed:15647271
chr12	65828018	65828078	P52926	0	+	65828018	65828078	255,102,0	1	60	0	.	Interaction with E4F1. Pubmed:14645522
chr12	68650414	68654129	P61224	0	+	68650414	68654129	255,102,0	1	3715	0	.	Interaction with KRIT1. Pubmed:22577140
chr12	69251308	69256805	Q16630	0	+	69251308	69256805	255,102,0	1	5497	0	.	Necessary for interaction with NUDT21/CPSF5.
chr12	69262430	69262556	Q16630	0	+	69262430	69262556	255,102,0	1	126	0	.	Sufficient for nuclear targeting.
chr12	69370947	69390313	O95619	0	+	69370947	69390313	255,102,0	1	19366	0	.	Interaction with MLLT10. Pubmed:11756182
chr12	69370962	69390313	O95619	0	+	69370962	69390313	255,102,0	1	19351	0	.	Interaction with TACC1. Pubmed:11903063
chr12	70344145	70353912	Q9NZN8	0	+	70344145	70353912	255,102,0	1	9767	0	.	Repressor domain.
chr12	70532154	70534492	P23467	0	-	70532154	70534492	255,102,0	1	2338	0	.	Substrate binding.
chr12	70656801	70660944	Q15256	0	-	70656801	70660944	255,102,0	1	4143	0	.	Substrate binding.
chr12	72469786	72469801	Q9UKU6	0	+	72469786	72469801	255,102,0	1	15	0	.	Substrate binding.
chr12	75050678	75050696	Q96PR1	0	-	75050678	75050696	255,102,0	1	18	0	.	Selectivity filter.
chr12	76026734	76026848	Q8WV24	0	-	76026734	76026848	255,102,0	1	114	0	.	14 X 2 AA repeats of P-H.
chr12	76026863	76026971	Q8WV24	0	-	76026863	76026971	255,102,0	1	108	0	.	15 X 2 AA repeats of P-Q.
chr12	76028890	76029004	Q8WV24	0	-	76028890	76029004	255,102,0	1	114	0	.	14 X 2 AA repeats of P-H.
chr12	76029019	76029127	Q8WV24	0	-	76029019	76029127	255,102,0	1	108	0	.	15 X 2 AA repeats of P-Q.
chr12	76384338	76384344	Q9BZF1	0	-	76384338	76384344	255,102,0	1	6	0	.	Phosphatidylinositol 4-phosphate binding.
chr12	76386245	76386257	Q9BZF1	0	-	76386245	76386257	255,102,0	1	12	0	.	Phosphatidylinositol 4-phosphate binding.
chr12	76389721	76389739	Q9BZF1	0	-	76389721	76389739	255,102,0	1	18	0	.	Phosphatidylinositol 4-phosphate binding.
chr12	76389721	76389739	Q9BZF1	0	-	76389721	76389739	255,102,0	1	18	0	.	Phosphatidylserine binding.
chr12	76764266	76826925	Q8IUH5	0	+	76764266	76826925	255,102,0	1	62659	0	.	Necessary and sufficient for interaction with DNAJC5 and SNAP25.
chr12	79292061	79449001	P21579	0	+	79292061	79449001	255,102,0	1	156940	0	.	Phospholipid binding.
chr12	79592609	79594367	Q96IZ0	0	-	79592609	79594367	255,102,0	1	1758	0	.	Leucine-zipper.
chr12	79621114	79689812	Q96IZ0	0	-	79621114	79689812	255,102,0	1	68698	0	.	Selective for apoptosis induction in cancer cells (SAC).
chr12	79793919	79798541	O14974	0	-	79793919	79798541	255,102,0	1	4622	0	.	Interaction with ROCK2. Pubmed:19131646
chr12	81139163	81139175	Q9H6R3	0	+	81139163	81139175	255,102,0	1	12	0	.	Coenzyme A binding.
chr12	85286894	85301472	Q15699	0	+	85286894	85301472	255,102,0	1	14578	0	.	Transactivation domain.
chr12	88049186	88071409	O15078	0	-	88049186	88071409	255,102,0	1	22223	0	.	Self-association (with itself or N-terminus). Pubmed:18723859
chr12	88106803	88111825	O15078	0	-	88106803	88111825	255,102,0	1	5022	0	.	Interaction with IQCB1. Pubmed:18723859
chr12	88111825	88141307	O15078	0	-	88111825	88141307	255,102,0	1	29482	0	.	Self-association (with itself or C-terminus). Pubmed:18723859
chr12	89523454	89523643	Q8N4A0	0	-	89523454	89523643	255,102,0	1	189	0	.	Catalytic subdomain B.
chr12	89523820	89524150	Q8N4A0	0	-	89523820	89524150	255,102,0	1	330	0	.	Catalytic subdomain A.
chr12	93378373	93378382	Q9NZJ9	0	+	93378373	93378382	255,102,0	1	9	0	.	Substrate binding.
chr12	93398779	93398788	Q9NZJ9	0	+	93398779	93398788	255,102,0	1	9	0	.	Substrate binding.
chr12	95022231	95022291	P13056	0	-	95022231	95022291	255,102,0	1	60	0	.	Required for interaction with NRIP1.
chr12	95058319	95067384	P13056	0	-	95058319	95067384	255,102,0	1	9065	0	.	Required for interaction with KAT2B.
chr12	96002979	96002988	P09960	0	-	96002979	96002988	255,102,0	1	9	0	.	Substrate binding.
chr12	96018798	96018816	P09960	0	-	96018798	96018816	255,102,0	1	18	0	.	Substrate binding.
chr12	96027443	96027452	P09960	0	-	96027443	96027452	255,102,0	1	9	0	.	Substrate binding.
chr12	98515867	98547723	P42167	0	+	98515867	98547723	255,102,0	1	31856	0	.	Nucleoplasmic.
chr12	98516011	98527930	P42166	0	+	98516011	98527930	255,102,0	1	11919	0	.	Linker.
chr12	98516011	98527930	P42167	0	+	98516011	98527930	255,102,0	1	11919	0	.	Linker.
chr12	98531684	98544295	P42167	0	+	98531684	98544295	255,102,0	1	12611	0	.	NAKAP95-binding N.
chr12	98544965	98547606	P42167	0	+	98544965	98547606	255,102,0	1	2641	0	.	Binds lamins B.
chr12	98544968	98547615	P42167	0	+	98544968	98547615	255,102,0	1	2647	0	.	NAKAP95-binding C.
chr12	98708590	98708626	O14727	0	+	98708590	98708626	255,102,0	1	36	0	.	Interpropeller linker.
chr12	100337455	100339169	Q6P3W7	0	+	100337455	100339169	255,102,0	1	1714	0	.	Necessary for interaction with AP2 complex and clathrin, interaction with clathrin is necessary for its targeting to the TGN and endosomal membranes.
chr12	100536514	100563450	Q96RI1	0	+	100536514	100563450	255,102,0	1	26936	0	.	Ligand-binding.
chr12	100540733	100540760	Q96RI1	0	+	100540733	100540760	255,102,0	1	27	0	.	Agonist binding.
chr12	101728929	101728947	Q8IZU3	0	-	101728929	101728947	255,102,0	1	18	0	.	Important for oligomerization and fiber formation. Pubmed:24950965
chr12	101735006	101735018	Q8IZU3	0	-	101735006	101735018	255,102,0	1	12	0	.	Interaction with DNA. Pubmed:24950965
chr12	101737049	101737067	Q8IZU3	0	-	101737049	101737067	255,102,0	1	18	0	.	Important for oligomerization and fiber formation. Pubmed:24950965
chr12	101737260	101737278	Q8IZU3	0	-	101737260	101737278	255,102,0	1	18	0	.	Interaction with DNA. Pubmed:24950965
chr12	102419556	102419580	P05019	0	-	102419556	102419580	255,102,0	1	24	0	.	D.
chr12	102419580	102419643	P05019	0	-	102419580	102419643	255,102,0	1	63	0	.	A.
chr12	102419643	102419679	P05019	0	-	102419643	102419679	255,102,0	1	36	0	.	C.
chr12	102419679	102475718	P05019	0	-	102419679	102475718	255,102,0	1	56039	0	.	B.
chr12	103763512	103763545	Q8WWQ8	0	+	103763512	103763545	255,102,0	1	33	0	.	Interaction with TMSB4X. Pubmed:18519035
chr12	103793973	103796896	Q86UY8	0	-	103793973	103796896	255,102,0	1	2923	0	.	Substrate binding.
chr12	104119739	104123228	P25208	0	-	104119739	104123228	255,102,0	1	3489	0	.	C domain.
chr12	104123228	104126188	P25208	0	-	104123228	104126188	255,102,0	1	2960	0	.	B domain.
chr12	104123363	104123399	P25208	0	-	104123363	104123399	255,102,0	1	36	0	.	Subunit association domain (SAD).
chr12	104126188	104135453	P25208	0	-	104126188	104135453	255,102,0	1	9265	0	.	A domain.
chr12	105024426	105052907	Q3SY69	0	-	105024426	105052907	255,102,0	1	28481	0	.	Aldehyde dehydrogenase.
chr12	105066588	105073987	Q3SY69	0	-	105066588	105073987	255,102,0	1	7399	0	.	GART.
chr12	105144388	105166928	Q2M389	0	+	105144388	105166928	255,102,0	1	22540	0	.	Sufficient for interaction with WASHC5. Pubmed:20498093
chr12	105190112	105236012	Q8NEU8	0	-	105190112	105236012	255,102,0	1	45900	0	.	Required for RAB5A binding.
chr12	106711460	106732239	Q33E94	0	+	106711460	106732239	255,102,0	1	20779	0	.	Necessary for dimerization.
chr12	106997500	106997569	Q16526	0	-	106997500	106997569	255,102,0	1	69	0	.	Interaction with TIMELESS.
chr12	106997569	106999577	Q16526	0	-	106997569	106999577	255,102,0	1	2008	0	.	Required for inhibition of CLOCK-ARNTL/BMAL1-mediated transcription.
chr12	108523489	108532282	Q15020	0	-	108523489	108532282	255,102,0	1	8793	0	.	Necessary and sufficient for U6 snRNA binding. Pubmed:15314151
chr12	108526458	108530259	Q15020	0	-	108526458	108530259	255,102,0	1	3801	0	.	Required for nuclear localization. Pubmed:11959860
chr12	108532330	108535456	Q15020	0	-	108532330	108535456	255,102,0	1	3126	0	.	Required for interaction with USP4. Pubmed:20595234
chr12	108538942	108561151	Q15020	0	-	108538942	108561151	255,102,0	1	22209	0	.	Mediates interaction with PRPF3. Pubmed:15314151
chr12	108623524	108623944	Q14242	0	-	108623524	108623944	255,102,0	1	420	0	.	12 X 10 AA tandem repeats.
chr12	108787990	108788449	Q8WYL5	0	-	108787990	108788449	255,102,0	1	459	0	.	Interaction with YWHAG. Pubmed:15159416
chr12	109088229	109088250	Q6NS38	0	-	109088229	109088250	255,102,0	1	21	0	.	Alpha-ketoglutarate binding. Pubmed:18432238
chr12	109088508	109090013	Q6NS38	0	-	109088508	109090013	255,102,0	1	1505	0	.	Alpha-ketoglutarate binding. Pubmed:18432238
chr12	109090115	109090124	Q6NS38	0	-	109090115	109090124	255,102,0	1	9	0	.	Substrate binding. Pubmed:18432238
chr12	109090175	109090184	Q6NS38	0	-	109090175	109090184	255,102,0	1	9	0	.	Substrate binding. Pubmed:18432238
chr12	109097679	109097754	P13051	0	+	109097679	109097754	255,102,0	1	75	0	.	FAM72A-binding.
chr12	109242496	109265202	O00763	0	+	109242496	109265202	255,102,0	1	22706	0	.	Carboxyltransferase.
chr12	109783743	109784340	Q9HBA0	0	-	109783743	109784340	255,102,0	1	597	0	.	Interaction with calmodulin and ITPR3. Pubmed:18826956, Pubmed:12724311
chr12	109857623	109858712	Q9NZD2	0	-	109857623	109858712	255,102,0	1	1089	0	.	2 X 12 AA approximate tandem repeats.
chr12	109857656	109858703	Q9NZD2	0	-	109857656	109858703	255,102,0	1	1047	0	.	Glycolipid binding.
chr12	109903964	109916620	Q9BT92	0	+	109903964	109916620	255,102,0	1	12656	0	.	Interaction with keratin proteins. Pubmed:15731013
chr12	109908660	109914582	Q9BT92	0	+	109908660	109914582	255,102,0	1	5922	0	.	Trichohyalin/plectin homology domain. Pubmed:15731013
chr12	110127383	110129064	Q8WYA0	0	+	110127383	110129064	255,102,0	1	1681	0	.	CH (calponin-homology)-like region.
chr12	110332608	110333196	P16615	0	+	110332608	110333196	255,102,0	1	588	0	.	Interaction with phospholamban 1.
chr12	110339682	110340679	P16615	0	+	110339682	110340679	255,102,0	1	997	0	.	Interaction with HAX1. Pubmed:18971376
chr12	110343271	110343334	P16615	0	+	110343271	110343334	255,102,0	1	63	0	.	Interaction with phospholamban 2.
chr12	110343274	110346467	P16615	0	+	110343274	110346467	255,102,0	1	3193	0	.	Interaction with TMEM64 and PDIA3.
chr12	112486624	112488458	Q06124	0	+	112486624	112488458	255,102,0	1	1834	0	.	Substrate binding.
chr12	112907075	112907219	P00973	0	+	112907075	112907219	255,102,0	1	144	0	.	Interaction with dsRNA.
chr12	112911178	112911211	P00973	0	+	112911178	112911211	255,102,0	1	33	0	.	Interaction with dsRNA.
chr12	112938545	112948099	Q9Y6K5	0	+	112938545	112948099	255,102,0	1	9554	0	.	OAS domain 1.
chr12	112938563	112938701	Q9Y6K5	0	+	112938563	112938701	255,102,0	1	138	0	.	Interaction with dsRNA. Pubmed:25775560
chr12	112944570	112944615	Q9Y6K5	0	+	112944570	112944615	255,102,0	1	45	0	.	Interaction with dsRNA. Pubmed:25775560
chr12	112948860	112949061	Q9Y6K5	0	+	112948860	112949061	255,102,0	1	201	0	.	Linker.
chr12	112949061	112963454	Q9Y6K5	0	+	112949061	112963454	255,102,0	1	14393	0	.	OAS domain 2.
chr12	112964252	112969755	Q9Y6K5	0	+	112964252	112969755	255,102,0	1	5503	0	.	OAS domain 3.
chr12	112978638	112998407	P29728	0	+	112978638	112998407	255,102,0	1	19769	0	.	OAS domain 1.
chr12	113002949	113009240	P29728	0	+	113002949	113009240	255,102,0	1	6291	0	.	OAS domain 2.
chr12	113163271	113164192	Q8TDD1	0	-	113163271	113164192	255,102,0	1	921	0	.	Interaction with nuclear receptors.
chr12	113191388	113191475	Q96K30	0	+	113191388	113191475	255,102,0	1	87	0	.	Interaction with RBPJ/RBPSUH. Pubmed:21102556
chr12	113191472	113191814	Q96K30	0	+	113191472	113191814	255,102,0	1	342	0	.	Interaction with tubulin.
chr12	114671987	114674305	O15119	0	-	114671987	114674305	255,102,0	1	2318	0	.	Transcription repression.
chr12	115986400	115986466	Q71F56	0	-	115986400	115986466	255,102,0	1	66	0	.	Leucine-zipper.
chr12	117260509	117260569	P29475	0	-	117260509	117260569	255,102,0	1	60	0	.	Tetrahydrobiopterin-binding.
chr12	117260581	117263923	P29475	0	-	117260581	117263923	255,102,0	1	3342	0	.	Calmodulin-binding.
chr12	117311582	117330583	P29475	0	-	117311582	117330583	255,102,0	1	19001	0	.	PIN (nNOS-inhibiting protein) binding.
chr12	117330454	117331069	P29475	0	-	117330454	117331069	255,102,0	1	615	0	.	Interaction with NOSIP.
chr12	118139481	118144641	P30086	0	+	118139481	118144641	255,102,0	1	5160	0	.	Interaction with RAF1. Pubmed:18294816
chr12	118376694	118391275	Q9H7L9	0	+	118376694	118391275	255,102,0	1	14581	0	.	Mediates interaction with USP17L2. Pubmed:21239494
chr12	118400702	118401985	Q9H7L9	0	+	118400702	118401985	255,102,0	1	1283	0	.	Sin3 interaction domain (SID).
chr12	119672342	119674411	Q9Y478	0	+	119672342	119674411	255,102,0	1	2069	0	.	Glycogen-binding domain.
chr12	119718380	119730584	O14578	0	-	119718380	119730584	255,102,0	1	12204	0	.	Interaction with Rho/Rac.
chr12	120462084	120462123	Q13242	0	-	120462084	120462123	255,102,0	1	39	0	.	Interaction with SAFB1.
chr12	120498138	120498207	P63167	0	+	120498138	120498207	255,102,0	1	69	0	.	Interaction with ESR1. Pubmed:15891768
chr12	120510097	120510103	B4DP72	0	-	120510097	120510103	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr12	120510097	120510103	Q5HYK3	0	-	120510097	120510103	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr12	120546547	120552699	Q8N5U6	0	+	120546547	120552699	255,102,0	1	6152	0	.	Interaction with MEOX2. Pubmed:16335786
chr12	120738541	120738553	P16219	0	+	120738541	120738553	255,102,0	1	12	0	.	Substrate binding.
chr12	121245192	121248635	Q96RR4	0	-	121245192	121248635	255,102,0	1	3443	0	.	Calmodulin-binding.
chr12	121248626	121248644	Q96RR4	0	-	121248626	121248644	255,102,0	1	18	0	.	Autoinhibitory domain.
chr12	121263886	121268653	Q96RR4	0	-	121263886	121268653	255,102,0	1	4767	0	.	RP domain.
chr12	122079069	122130914	Q9HAP2	0	+	122079069	122130914	255,102,0	1	51845	0	.	Required for cytoplasmic localization. Pubmed:12446771
chr12	122130896	122133590	Q9HAP2	0	+	122130896	122133590	255,102,0	1	2694	0	.	Transactivation domain. Pubmed:12446771
chr12	122138471	122138537	Q9HAP2	0	+	122138471	122138537	255,102,0	1	66	0	.	Leucine-zipper.
chr12	122138923	122141695	Q9HAP2	0	+	122138923	122141695	255,102,0	1	2772	0	.	Mediates heterotypic interactions between MLXIP and MLX and is required for cytoplasmic localization. Pubmed:12446771
chr12	122377742	122377757	P30622	0	-	122377742	122377757	255,102,0	1	15	0	.	Important for tubulin binding. Pubmed:17889670
chr12	122860461	122860921	O75146	0	+	122860461	122860921	255,102,0	1	460	0	.	Important for actin binding.
chr12	122867463	122871025	Q9H9H4	0	-	122867463	122871025	255,102,0	1	3562	0	.	Interaction with IST1. Pubmed:19129479
chr12	123253842	123256893	Q9H3J6	0	+	123253842	123256893	255,102,0	1	3051	0	.	GGQ domain.
chr12	123265295	123271618	O14519	0	-	123265295	123271618	255,102,0	1	6323	0	.	intrinsically disordered.
chr12	123404901	123404910	A0A0C4DFR3	0	+	123404901	123404910	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr12	123404901	123404910	C9JKQ0	0	+	123404901	123404910	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr12	123407535	123407541	A0A0C4DFR3	0	+	123407535	123407541	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr12	123407535	123407541	C9JKQ0	0	+	123407535	123407541	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr12	123584636	123596666	Q15363	0	+	123584636	123596666	255,102,0	1	12030	0	.	Interaction with F2RL1. Pubmed:17693410
chr12	123586917	123590439	Q15363	0	+	123586917	123590439	255,102,0	1	3522	0	.	Required for TMED10 and TMED2 cis-Golgi network localization.
chr12	123762519	123846073	Q8IVF4	0	+	123762519	123846073	255,102,0	1	83554	0	.	Stem.
chr12	123846073	123853313	Q8IVF4	0	+	123846073	123853313	255,102,0	1	7240	0	.	AAA 1.
chr12	123857193	123867535	Q8IVF4	0	+	123857193	123867535	255,102,0	1	10342	0	.	AAA 2.
chr12	123870448	123877885	Q8IVF4	0	+	123870448	123877885	255,102,0	1	7437	0	.	AAA 3.
chr12	123881636	123897885	Q8IVF4	0	+	123881636	123897885	255,102,0	1	16249	0	.	AAA 4.
chr12	123897927	123913256	Q8IVF4	0	+	123897927	123913256	255,102,0	1	15329	0	.	Stalk.
chr12	123914524	123918684	Q8IVF4	0	+	123914524	123918684	255,102,0	1	4160	0	.	AAA 5.
chr12	123925169	123929687	Q8IVF4	0	+	123925169	123929687	255,102,0	1	4518	0	.	AAA 6.
chr12	130349868	130349877	Q96J94	0	+	130349868	130349877	255,102,0	1	9	0	.	Required for binding 2'-O-methylated 3'-end of piRNAs.
chr12	130357505	130362826	Q96J94	0	+	130357505	130362826	255,102,0	1	5321	0	.	RNA-binding.
chr12	131910710	131913837	O75385	0	+	131910710	131913837	255,102,0	1	3127	0	.	Interaction with GABARAP and GABARAPL2. Pubmed:11146101
chr12	131918651	131921358	O75385	0	+	131918651	131921358	255,102,0	1	2707	0	.	C-terminal domain; mediates interaction with SESN2. Pubmed:25040165
chr12	132621306	132621477	Q9UBL9	0	+	132621306	132621477	255,102,0	1	171	0	.	Pore-forming motif.
chr12	132714894	132714912	Q96HS1	0	+	132714894	132714912	255,102,0	1	18	0	.	Interaction with KEAP1.
chr12	132808297	132813312	Q08378	0	-	132808297	132813312	255,102,0	1	5015	0	.	Golgi-targeting domain.
chr12	132813402	132816585	Q08378	0	-	132813402	132816585	255,102,0	1	3183	0	.	Interaction with GOPC. Pubmed:15951434
chr13	19642138	19642162	Q99549	0	+	19642138	19642162	255,102,0	1	24	0	.	Histone H3K9me3 binding. Pubmed:21419134
chr13	19730322	19759402	Q8WXF1	0	-	19730322	19759402	255,102,0	1	29080	0	.	Sufficient for perinucleolar caps localization and interaction with NONO. Pubmed:16148043
chr13	19730322	19772543	Q8WXF1	0	-	19730322	19772543	255,102,0	1	42221	0	.	Sufficient for paraspeckles localization.
chr13	21146898	21147339	O00422	0	+	21146898	21147339	255,102,0	1	441	0	.	Involved in splicing regulation activity.
chr13	24284136	24286237	Q96N96	0	+	24284136	24286237	255,102,0	1	2101	0	.	ABR (APC-binding region) domain.
chr13	24297707	24302770	Q96N96	0	+	24297707	24302770	255,102,0	1	5063	0	.	C-terminal tail.
chr13	24421121	24434457	Q9UKK3	0	-	24421121	24434457	255,102,0	1	13336	0	.	Interaction with the major vault protein.
chr13	24883179	24905355	Q9HC77	0	-	24883179	24905355	255,102,0	1	22176	0	.	Interaction with STIL. Pubmed:22020124, Pubmed:25385835
chr13	24906855	24908037	Q9HC77	0	-	24906855	24908037	255,102,0	1	1182	0	.	Alpha/beta-tubulin binding. Pubmed:19131341
chr13	25257264	25257285	Q9Y217	0	-	25257264	25257285	255,102,0	1	21	0	.	Substrate binding.
chr13	25258596	25258602	Q9Y217	0	-	25258596	25258602	255,102,0	1	6	0	.	Substrate binding.
chr13	25258665	25258677	Q9Y217	0	-	25258665	25258677	255,102,0	1	12	0	.	Substrate binding.
chr13	25301791	25340071	Q9BVL2	0	+	25301791	25340071	255,102,0	1	38280	0	.	14 X 2 AA repeats of F-G.
chr13	26213826	26214063	Q9Y252	0	-	26213826	26214063	255,102,0	1	237	0	.	Required for polyubiquitination.
chr13	26254641	26254686	P49336	0	+	26254641	26254686	255,102,0	1	45	0	.	Interaction with CCNC.
chr13	27270992	27273488	Q6T310	0	+	27270992	27273488	255,102,0	1	2496	0	.	Small GTPase-like.
chr13	27792690	27792750	Q9H4S2	0	+	27792690	27792750	255,102,0	1	60	0	.	SNAG domain.
chr13	27920174	27920357	P52945	0	+	27920174	27920357	255,102,0	1	183	0	.	Transactivation domain.
chr13	27978258	27978273	A6NGE7	0	-	27978258	27978273	255,102,0	1	15	0	.	Substrate binding.
chr13	27978363	27978378	A6NGE7	0	-	27978363	27978378	255,102,0	1	15	0	.	Substrate binding.
chr13	28034127	28034148	P36888	0	-	28034127	28034148	255,102,0	1	21	0	.	Important for normal regulation of the kinase activity and for maintaining the kinase in an inactive state in the absence of bound ligand.
chr13	28138657	28266776	Q58A45	0	+	28138657	28266776	255,102,0	1	128119	0	.	Interaction with polyadenylate-binding protein. Pubmed:14583602
chr13	28266776	28292519	Q58A45	0	+	28266776	28292519	255,102,0	1	25743	0	.	Interaction with PAN2. Pubmed:23932717, Pubmed:14583602
chr13	28266785	28292519	A0A0C4DFZ9	0	+	28266785	28292519	255,102,0	1	25734	0	.	Interaction with PAN2.
chr13	30461455	30462561	P09429	0	-	30461455	30462561	255,102,0	1	1106	0	.	Binding to AGER/RAGE.
chr13	30462684	30463238	P09429	0	-	30462684	30463238	255,102,0	1	554	0	.	Cytokine-stimulating activity. Pubmed:12765338
chr13	30463211	30463677	P09429	0	-	30463211	30463677	255,102,0	1	466	0	.	Sufficient for interaction with HAVCR2.
chr13	30463214	30463265	P09429	0	-	30463214	30463265	255,102,0	1	51	0	.	LPS binding (Lipid A). Pubmed:21660935
chr13	30463635	30463674	P09429	0	-	30463635	30463674	255,102,0	1	39	0	.	LPS binding (delipidated). Pubmed:21660935
chr13	30463650	30463677	P09429	0	-	30463650	30463677	255,102,0	1	27	0	.	Heparin-binding.
chr13	30631311	30657562	Q5W0Q7	0	+	30631311	30657562	255,102,0	1	26251	0	.	SUMO-binding.
chr13	30735662	30744070	P20292	0	+	30735662	30744070	255,102,0	1	8408	0	.	Inhibitor binding.
chr13	30763953	30763989	P20292	0	+	30763953	30763989	255,102,0	1	36	0	.	Inhibitor binding.
chr13	33016608	33055234	Q9UEF7	0	+	33016608	33055234	255,102,0	1	38626	0	.	Glycosyl hydrolase-1 1.
chr13	33055258	33064006	Q9UEF7	0	+	33055258	33064006	255,102,0	1	8748	0	.	Glycosyl hydrolase-1 2.
chr13	36825466	36827744	O00287	0	+	36825466	36827744	255,102,0	1	2278	0	.	C-terminal domain.
chr13	37636905	37636914	Q9UBN4	0	-	37636905	37636914	255,102,0	1	9	0	.	PDZ-binding domain.
chr13	37636905	37655129	Q9UBN4	0	-	37636905	37655129	255,102,0	1	18224	0	.	Binds to ITPR1, ITPR2 and ITPR3.
chr13	37692320	37746074	Q9UBN4	0	-	37692320	37746074	255,102,0	1	53754	0	.	Multimerization domain.
chr13	37746317	37783075	Q9UBN4	0	-	37746317	37783075	255,102,0	1	36758	0	.	Multimerization domain.
chr13	40559801	40560644	Q12778	0	-	40559801	40560644	255,102,0	1	843	0	.	Sufficient for interaction with NLK.
chr13	40560113	40560404	Q12778	0	-	40560113	40560404	255,102,0	1	291	0	.	Required for interaction with RUNX2.
chr13	40560779	40560791	Q12778	0	-	40560779	40560791	255,102,0	1	12	0	.	DNA-binding.
chr13	40560836	40560860	Q12778	0	-	40560836	40560860	255,102,0	1	24	0	.	DNA-binding.
chr13	42303693	42303735	Q9UKA4	0	+	42303693	42303735	255,102,0	1	42	0	.	PKA-RII subunit binding domain.
chr13	44434766	44434832	Q15714	0	-	44434766	44434832	255,102,0	1	66	0	.	Leucine-zipper.
chr13	46058241	46058247	Q96IY4	0	-	46058241	46058247	255,102,0	1	6	0	.	Substrate binding.
chr13	46064672	46064678	Q96IY4	0	-	46064672	46064678	255,102,0	1	6	0	.	Substrate binding.
chr13	46073911	46073923	Q96IY4	0	-	46073911	46073923	255,102,0	1	12	0	.	Substrate binding.
chr13	46835232	46835247	P28223	0	-	46835232	46835247	255,102,0	1	15	0	.	Agonist binding.
chr13	46892522	46892540	P28223	0	-	46892522	46892540	255,102,0	1	18	0	.	Agonist binding.
chr13	47949564	47949573	E5KS60	0	-	47949564	47949573	255,102,0	1	9	0	.	Substrate binding; shared with subunit alpha.
chr13	47949564	47949573	Q9P2R7	0	-	47949564	47949573	255,102,0	1	9	0	.	Substrate binding; shared with subunit alpha.
chr13	48040986	48045796	Q9NV35	0	+	48040986	48045796	255,102,0	1	4810	0	.	Interaction with PCNA. Pubmed:19419956
chr13	48256233	48256332	Q9Y287	0	+	48256233	48256332	255,102,0	1	99	0	.	Necessary for interaction with APP and inhibitor effects on APP processing.
chr13	48368593	48453034	P06400	0	+	48368593	48453034	255,102,0	1	84441	0	.	Domain A.
chr13	48368593	48465099	P06400	0	+	48368593	48465099	255,102,0	1	96506	0	.	Pocket; binds T and E1A.
chr13	48453034	48456306	P06400	0	+	48453034	48456306	255,102,0	1	3272	0	.	Spacer.
chr13	48456306	48465099	P06400	0	+	48456306	48465099	255,102,0	1	8793	0	.	Domain B.
chr13	48465072	48480068	P06400	0	+	48465072	48480068	255,102,0	1	14996	0	.	Interaction with LIMD1. Pubmed:15542589
chr13	48465096	48480068	P06400	0	+	48465096	48480068	255,102,0	1	14972	0	.	Domain C; mediates interaction with E4F1. Pubmed:10869426
chr13	49481052	49481061	Q96T68	0	+	49481052	49481061	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr13	49488627	49490824	Q96T68	0	+	49488627	49490824	255,102,0	1	2197	0	.	S-adenosyl-L-methionine binding.
chr13	49706124	49709688	O00505	0	-	49706124	49709688	255,102,0	1	3564	0	.	NLS binding site (minor).
chr13	49721993	49725476	O00505	0	-	49721993	49725476	255,102,0	1	3483	0	.	NLS binding site (major).
chr13	52143936	52156191	P51956	0	-	52143936	52156191	255,102,0	1	12255	0	.	Interaction with VAV2. Pubmed:15618286
chr13	52642501	52642774	Q32P51	0	+	52642501	52642774	255,102,0	1	273	0	.	Globular A domain.
chr13	52642774	52643047	Q32P51	0	+	52642774	52643047	255,102,0	1	273	0	.	Globular B domain.
chr13	52643143	52643212	Q32P51	0	+	52643143	52643212	255,102,0	1	69	0	.	RNA-binding RGG-box.
chr13	52643293	52643407	Q32P51	0	+	52643293	52643407	255,102,0	1	114	0	.	Nuclear targeting sequence.
chr13	60567575	60567638	Q9H7E2	0	+	60567575	60567638	255,102,0	1	63	0	.	EBM motif; may mediate interaction with the EJC.
chr13	72783469	72795557	Q8WXW3	0	+	72783469	72795557	255,102,0	1	12088	0	.	Sufficient for NK inhibitory function. Pubmed:14634107
chr13	72783469	72854090	Q8WXW3	0	+	72783469	72854090	255,102,0	1	70621	0	.	Mediates modulation of Th2 dominant cytokine production. Pubmed:14634107
chr13	72827013	72827906	Q8WXW3	0	+	72827013	72827906	255,102,0	1	893	0	.	Required for interaction with PCM1. Pubmed:23110211
chr13	73062568	73062583	Q13887	0	+	73062568	73062583	255,102,0	1	15	0	.	Interaction with WWP1. Pubmed:15735697
chr13	75549841	75549859	P15374	0	+	75549841	75549859	255,102,0	1	18	0	.	Interaction with ubiquitin. Pubmed:15531586
chr13	75569486	75594917	P15374	0	+	75569486	75594917	255,102,0	1	25431	0	.	Interaction with ubiquitin. Pubmed:15531586
chr13	75605773	75605791	P15374	0	+	75605773	75605791	255,102,0	1	18	0	.	Interaction with ubiquitin. Pubmed:15531586
chr13	77000801	77000921	O75503	0	+	77000801	77000921	255,102,0	1	120	0	.	Membrane-anchoring. Pubmed:24038957
chr13	77139204	77168478	O75592	0	-	77139204	77168478	255,102,0	1	29274	0	.	RAE1 binding. Pubmed:22357847
chr13	77174309	77177912	O75592	0	-	77174309	77177912	255,102,0	1	3603	0	.	PHR domain 2.
chr13	77189043	77205485	O75592	0	-	77189043	77205485	255,102,0	1	16442	0	.	PHR domain 1.
chr13	77593571	77628007	O95171	0	+	77593571	77628007	255,102,0	1	34436	0	.	16 X approximate tandem repeats.
chr13	79520929	79520941	Q9NV92	0	+	79520929	79520941	255,102,0	1	12	0	.	Interaction with NEDD4.
chr13	95785985	95786042	Q13217	0	+	95785985	95786042	255,102,0	1	57	0	.	Flexible linker.
chr13	95801792	95860870	Q9NYU1	0	-	95801792	95860870	255,102,0	1	59078	0	.	Glucosyltransferase.
chr13	96091324	96091345	Q8IZP7	0	+	96091324	96091345	255,102,0	1	21	0	.	5'-phosphosulfate-binding.
chr13	96832514	96832541	Q8IZP7	0	+	96832514	96832541	255,102,0	1	27	0	.	3'-phosphate binding.
chr13	97997589	98002483	O00410	0	+	97997589	98002483	255,102,0	1	4894	0	.	Ran-GTP binding.
chr13	99295743	99295770	P32249	0	-	99295743	99295770	255,102,0	1	27	0	.	Interaction with G proteins.
chr13	99982361	99982829	O95409	0	+	99982361	99982829	255,102,0	1	468	0	.	Necessary for interaction with MDFIC and transcriptional activation or repression.
chr13	100532561	100532573	Q9BVM4	0	-	100532561	100532573	255,102,0	1	12	0	.	Substrate binding.
chr13	101453934	101715651	O95965	0	+	101453934	101715651	255,102,0	1	261717	0	.	Cysteine-rich tandem repeats.
chr13	102686973	102686982	Q5VZV1	0	-	102686973	102686982	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr13	102846266	102853777	P28715	0	+	102846266	102853777	255,102,0	1	7511	0	.	N-domain.
chr13	102866318	102868222	P28715	0	+	102866318	102868222	255,102,0	1	1904	0	.	I-domain.
chr13	102873319	102875369	P28715	0	+	102873319	102875369	255,102,0	1	2050	0	.	Interaction with PCNA. Pubmed:9305916
chr13	109100845	109140409	Q9Y6X6	0	+	109100845	109140409	255,102,0	1	39564	0	.	Involved in CYFIP1- and NCKAP1-binding.
chr13	109105513	109145077	Q9Y6X6	0	+	109105513	109145077	255,102,0	1	39564	0	.	Involved in CYFIP1- and NCKAP1-binding.
chr13	110430400	110506464	P08572	0	+	110430400	110506464	255,102,0	1	76064	0	.	Triple-helical region.
chr13	110634740	110634761	A0A024RDX4	0	+	110634740	110634761	255,102,0	1	21	0	.	NAD(P)HX.
chr13	113143894	113143957	P00742	0	+	113143894	113143957	255,102,0	1	63	0	.	O-glycosylated at one site.
chr13	113149475	113149505	P00742	0	+	113149475	113149505	255,102,0	1	30	0	.	O-glycosylated at one site.
chr13	113306507	113319488	P11279	0	+	113306507	113319488	255,102,0	1	12981	0	.	First lumenal domain.
chr13	113319488	113319587	P11279	0	+	113319488	113319587	255,102,0	1	99	0	.	Hinge.
chr13	113319587	113322313	P11279	0	+	113319587	113322313	255,102,0	1	2726	0	.	Second lumenal domain.
chr13	113633123	113633192	Q14186	0	+	113633123	113633192	255,102,0	1	69	0	.	Interaction with CEBPA. Pubmed:20176812
chr13	113634024	113636120	Q14186	0	+	113634024	113636120	255,102,0	1	2096	0	.	Dimerization.
chr13	113634545	113636675	Q14186	0	+	113634545	113636675	255,102,0	1	2130	0	.	Enhances binding of RB protein to E2F.
chr13	113634554	113636027	Q14186	0	+	113634554	113636027	255,102,0	1	1473	0	.	DCB1.
chr13	113636063	113636639	Q14186	0	+	113636063	113636639	255,102,0	1	576	0	.	DCB2.
chr13	113649376	113651703	P51164	0	-	113649376	113651703	255,102,0	1	2327	0	.	immunoglobulin-like.
chr13	113667386	113667953	Q15835	0	+	113667386	113667953	255,102,0	1	567	0	.	N-terminal.
chr13	113733054	113735360	Q15835	0	+	113733054	113735360	255,102,0	1	2306	0	.	C-terminal.
chr13	114281834	114282942	Q9H1J1	0	+	114281834	114282942	255,102,0	1	1108	0	.	Required for interaction with UPF2.
chr13	114301983	114302025	Q9H1J1	0	+	114301983	114302025	255,102,0	1	42	0	.	Required for association with EIF4A3 and ECJ core components CASC3, MAGOH and RBM8A.
chr13	114324652	114325312	Q96JM3	0	+	114324652	114325312	255,102,0	1	660	0	.	Mediates interaction with MAD2L2. Pubmed:21063390
chr13	114325192	114325612	Q96JM3	0	+	114325192	114325612	255,102,0	1	420	0	.	Mediates localization to the spindle and the kinetochore and is required for the attachment of spindle microtubules to the kinetochore.
chr13	114325612	114326278	Q96JM3	0	+	114325612	114326278	255,102,0	1	666	0	.	Mediates localization to the chromosome and the spindle and negatively regulates chromosome alignment.
chr14	20451982	20451997	Q9NPF4	0	-	20451982	20451997	255,102,0	1	15	0	.	Substrate binding.
chr14	20455648	20455954	P27695	0	+	20455648	20455954	255,102,0	1	306	0	.	Necessary for interaction with YBX1, binding to RNA, NPM1-dependent association with rRNA, endoribonuclease activity on abasic RNA and localization in the nucleoli. Pubmed:18809583
chr14	20455921	20455954	P27695	0	+	20455921	20455954	255,102,0	1	33	0	.	Necessary for interaction with NPM1 and for efficient rRNA binding.
chr14	20457415	20457505	P27695	0	+	20457415	20457505	255,102,0	1	90	0	.	Mitochondrial targeting sequence (MTS).
chr14	20474539	20474548	P00491	0	+	20474539	20474548	255,102,0	1	9	0	.	Phosphate binding.
chr14	20474539	20474548	V9HWH6	0	+	20474539	20474548	255,102,0	1	9	0	.	Phosphate binding.
chr14	20584117	20584132	Q8TAA1	0	-	20584117	20584132	255,102,0	1	15	0	.	Substrate binding.
chr14	20693753	20693768	P03950	0	+	20693753	20693768	255,102,0	1	15	0	.	Substrate binding.
chr14	20699572	20699587	P34096	0	+	20699572	20699587	255,102,0	1	15	0	.	Substrate binding.
chr14	20781879	20781894	Q93091	0	+	20781879	20781894	255,102,0	1	15	0	.	Substrate binding.
chr14	20801849	20801864	P07998	0	-	20801849	20801864	255,102,0	1	15	0	.	Substrate binding.
chr14	20891767	20891902	P12724	0	+	20891767	20891902	255,102,0	1	135	0	.	Required for nearly all of the bactericidal activity; partially involved in LPS-binding and bacterial membrane depolarization.
chr14	20891878	20891893	P12724	0	+	20891878	20891893	255,102,0	1	15	0	.	Substrate binding.
chr14	20955963	20955978	P10153	0	+	20955963	20955978	255,102,0	1	15	0	.	Substrate binding.
chr14	21001171	21001177	Q9NP94	0	+	21001171	21001177	255,102,0	1	6	0	.	Heavy metals binding.
chr14	21043187	21043202	Q9H1E1	0	+	21043187	21043202	255,102,0	1	15	0	.	Substrate binding.
chr14	21044334	21044349	Q9H1E1	0	+	21044334	21044349	255,102,0	1	15	0	.	Substrate binding.
chr14	21058084	21058099	Q8TDE3	0	+	21058084	21058099	255,102,0	1	15	0	.	Substrate binding.
chr14	21334636	21351198	Q96KN7	0	+	21334636	21351198	255,102,0	1	16562	0	.	Interaction with RPGR. Pubmed:24981858
chr14	21391621	21394937	Q9HCK8	0	-	21391621	21394937	255,102,0	1	3316	0	.	Interaction with FAM124B. Pubmed:23285124
chr14	21498350	21498356	Q86U44	0	-	21498350	21498356	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding. Pubmed:27373337, Pubmed:27281194
chr14	21499038	21499050	Q86U44	0	-	21499038	21499050	255,102,0	1	12	0	.	S-adenosyl-L-methionine binding. Pubmed:27373337, Pubmed:27281194
chr14	21499110	21499137	Q86U44	0	-	21499110	21499137	255,102,0	1	27	0	.	Gate loop 2. Pubmed:27281194
chr14	21499503	21499554	Q86U44	0	-	21499503	21499554	255,102,0	1	51	0	.	Interaction with METTL14. Pubmed:27281194
chr14	21499506	21499560	Q86U44	0	-	21499506	21499560	255,102,0	1	54	0	.	Interphase loop. Pubmed:27281194
chr14	21499509	21499551	Q86U44	0	-	21499509	21499551	255,102,0	1	42	0	.	Positively charged region required for RNA-binding. Pubmed:27281194
chr14	21499581	21499596	Q86U44	0	-	21499581	21499596	255,102,0	1	15	0	.	Interaction with METTL14. Pubmed:27281194
chr14	21500568	21500613	Q86U44	0	-	21500568	21500613	255,102,0	1	45	0	.	Gate loop 1. Pubmed:27281194
chr14	21500664	21500670	Q86U44	0	-	21500664	21500670	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding. Pubmed:27373337, Pubmed:27281194
chr14	22920906	22923143	O14744	0	-	22920906	22923143	255,102,0	1	2237	0	.	Beta barrel. Pubmed:23071334
chr14	22923053	22923074	O14744	0	-	22923053	22923074	255,102,0	1	21	0	.	Dimerization. Pubmed:23071334
chr14	22924122	22924128	O14744	0	-	22924122	22924128	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding. Pubmed:23071334
chr14	22924646	22924652	O14744	0	-	22924646	22924652	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding. Pubmed:23071334
chr14	22924941	22929325	O14744	0	-	22924941	22929325	255,102,0	1	4384	0	.	TIM barrel. Pubmed:23071334
chr14	22981261	22982266	Q96IF1	0	-	22981261	22982266	255,102,0	1	1005	0	.	PreLIM.
chr14	23059462	23061155	Q9UKV3	0	-	23059462	23061155	255,102,0	1	1693	0	.	Sufficient for interaction with RNPS1 and SAP18 and formation of th ASAP complex.
chr14	23117621	23117645	Q15744	0	-	23117621	23117645	255,102,0	1	24	0	.	Leucine-zipper.
chr14	23117648	23117711	Q15744	0	-	23117648	23117711	255,102,0	1	63	0	.	Basic motif.
chr14	23301507	23301534	Q9H7J1	0	-	23301507	23301534	255,102,0	1	27	0	.	Substrate-binding motif.
chr14	23301681	23301750	Q9H7J1	0	-	23301681	23301750	255,102,0	1	69	0	.	Glycogen-binding motif.
chr14	23321472	23322264	Q86U42	0	+	23321472	23322264	255,102,0	1	792	0	.	Interaction with SKIP. Pubmed:11371506
chr14	23322183	23322270	Q86U42	0	+	23322183	23322270	255,102,0	1	87	0	.	Stimulates PAPOLA.
chr14	23322291	23325283	Q86U42	0	+	23322291	23325283	255,102,0	1	2992	0	.	Necessary for homooligomerization.
chr14	23324263	23325283	Q86U42	0	+	23324263	23325283	255,102,0	1	1020	0	.	Interaction with PAPOLA.
chr14	23357447	23357600	O43281	0	-	23357447	23357600	255,102,0	1	153	0	.	Divergent helix-loop-helix motif.
chr14	23396393	23396711	P13533	0	-	23396393	23396711	255,102,0	1	318	0	.	Actin-binding.
chr14	23397182	23397251	P13533	0	-	23397182	23397251	255,102,0	1	69	0	.	Actin-binding.
chr14	23425391	23425712	P12883	0	-	23425391	23425712	255,102,0	1	321	0	.	Actin-binding.
chr14	23426789	23426858	P12883	0	-	23426789	23426858	255,102,0	1	69	0	.	Actin-binding.
chr14	23470953	23476130	Q8NEJ9	0	+	23470953	23476130	255,102,0	1	5177	0	.	Necessary for interaction with EIF4E.
chr14	23563810	23563843	O75843	0	-	23563810	23563843	255,102,0	1	33	0	.	Essential for ubiquitin-binding.
chr14	24064994	24065096	Q8ND23	0	+	24064994	24065096	255,102,0	1	102	0	.	Necessary for localization at the cell membrane. Pubmed:26578515
chr14	24075228	24075871	O95741	0	+	24075228	24075871	255,102,0	1	643	0	.	Linker region.
chr14	24081325	24081391	P54845	0	-	24081325	24081391	255,102,0	1	66	0	.	Leucine-zipper.
chr14	24081394	24081475	P54845	0	-	24081394	24081475	255,102,0	1	81	0	.	Basic motif.
chr14	24082569	24082761	P54845	0	-	24082569	24082761	255,102,0	1	192	0	.	Minimal transactivation domain (MTD).
chr14	24147698	24150855	Q96EP0	0	+	24147698	24150855	255,102,0	1	3157	0	.	Polyubiquitin-binding.
chr14	24151328	24151595	Q96EP0	0	+	24151328	24151595	255,102,0	1	267	0	.	Interaction with RBCK1.
chr14	24157897	24160570	Q96EP0	0	+	24157897	24160570	255,102,0	1	2673	0	.	LDD domain.
chr14	24209879	24210677	Q9BY43	0	-	24209879	24210677	255,102,0	1	798	0	.	Intramolecular interaction with N-terminus.
chr14	24210677	24213439	Q9BY43	0	-	24210677	24213439	255,102,0	1	2762	0	.	Intramolecular interaction with C-terminus.
chr14	24211425	24213439	Q9BY43	0	-	24211425	24213439	255,102,0	1	2014	0	.	Interaction with phosphoinosides.
chr14	24217156	24217165	Q15843	0	-	24217156	24217165	255,102,0	1	9	0	.	Interaction with UBE1C.
chr14	24237519	24237528	A0A087WWM4	0	+	24237519	24237528	255,102,0	1	9	0	.	GMP binding.
chr14	24237519	24237528	F8WAN9	0	+	24237519	24237528	255,102,0	1	9	0	.	GMP binding.
chr14	24237519	24237528	H0YLV5	0	+	24237519	24237528	255,102,0	1	9	0	.	GMP binding.
chr14	24237519	24237528	H0YMB3	0	+	24237519	24237528	255,102,0	1	9	0	.	GMP binding.
chr14	24237519	24237528	H0YNJ6	0	+	24237519	24237528	255,102,0	1	9	0	.	GMP binding.
chr14	24237519	24237528	Q9P2T1	0	+	24237519	24237528	255,102,0	1	9	0	.	GMP binding.
chr14	24238271	24238277	A0A087WWM4	0	+	24238271	24238277	255,102,0	1	6	0	.	GMP binding.
chr14	24238271	24238277	F8WAN9	0	+	24238271	24238277	255,102,0	1	6	0	.	GMP binding.
chr14	24238271	24238277	H0YLV5	0	+	24238271	24238277	255,102,0	1	6	0	.	GMP binding.
chr14	24238271	24238277	H0YMB3	0	+	24238271	24238277	255,102,0	1	6	0	.	GMP binding.
chr14	24238271	24238277	H0YNJ6	0	+	24238271	24238277	255,102,0	1	6	0	.	GMP binding.
chr14	24238271	24238277	Q9P2T1	0	+	24238271	24238277	255,102,0	1	6	0	.	GMP binding.
chr14	24238349	24238358	A0A087WWM4	0	+	24238349	24238358	255,102,0	1	9	0	.	GMP binding.
chr14	24238349	24238358	F8WAN9	0	+	24238349	24238358	255,102,0	1	9	0	.	GMP binding.
chr14	24238349	24238358	H0YLV5	0	+	24238349	24238358	255,102,0	1	9	0	.	GMP binding.
chr14	24238349	24238358	H0YMB3	0	+	24238349	24238358	255,102,0	1	9	0	.	GMP binding.
chr14	24238349	24238358	H0YNJ6	0	+	24238349	24238358	255,102,0	1	9	0	.	GMP binding.
chr14	24238349	24238358	Q9P2T1	0	+	24238349	24238358	255,102,0	1	9	0	.	GMP binding.
chr14	24238403	24238601	A0A087WWM4	0	+	24238403	24238601	255,102,0	1	198	0	.	GMP binding.
chr14	24238403	24238601	F8WAN9	0	+	24238403	24238601	255,102,0	1	198	0	.	GMP binding.
chr14	24238403	24238601	H0YLV5	0	+	24238403	24238601	255,102,0	1	198	0	.	GMP binding.
chr14	24238403	24238601	H0YMB3	0	+	24238403	24238601	255,102,0	1	198	0	.	GMP binding.
chr14	24238403	24238601	Q9P2T1	0	+	24238403	24238601	255,102,0	1	198	0	.	GMP binding.
chr14	24262052	24262352	P22735	0	-	24262052	24262352	255,102,0	1	300	0	.	Membrane anchorage region.
chr14	24369737	24369755	Q14934	0	+	24369737	24369755	255,102,0	1	18	0	.	Calcineurin-binding.
chr14	24370034	24370277	Q14934	0	+	24370034	24370277	255,102,0	1	243	0	.	2 approximate SP repeats.
chr14	24427791	24428841	Q6UW01	0	-	24427791	24428841	255,102,0	1	1050	0	.	Necessary for interaction with CBLN3, and homotrimerization.
chr14	24608323	24608332	P20718	0	-	24608323	24608332	255,102,0	1	9	0	.	Mediates the preference for acidic residues at the P3' and P4' sites.
chr14	28768425	28768497	P55316	0	+	28768425	28768497	255,102,0	1	72	0	.	Interaction with KDM5B. Pubmed:12657635
chr14	30947256	30950909	Q13033	0	-	30947256	30950909	255,102,0	1	3653	0	.	Calmodulin-binding.
chr14	31025948	31025975	Q13033	0	-	31025948	31025975	255,102,0	1	27	0	.	Caveolin-binding.
chr14	32823999	32824041	Q13023	0	+	32823999	32824041	255,102,0	1	42	0	.	PKA-RII subunit binding domain.
chr14	33950440	33950491	Q9H6Z9	0	-	33950440	33950491	255,102,0	1	51	0	.	Required for interaction with ADRB2. Pubmed:19584355
chr14	33950533	33950569	Q9H6Z9	0	-	33950533	33950569	255,102,0	1	36	0	.	Beta(2)beta(3) 'finger-like' loop.
chr14	34713132	34713402	Q9Y281	0	-	34713132	34713402	255,102,0	1	270	0	.	Interaction with CSRP3. Pubmed:19752190
chr14	34713399	34713561	Q9Y281	0	-	34713399	34713561	255,102,0	1	162	0	.	Interaction with CSRP3. Pubmed:19752190
chr14	34775952	34783231	Q9NRL2	0	-	34775952	34783231	255,102,0	1	7279	0	.	Interaction with SMARCA5.
chr14	34826149	34874604	Q9NRL2	0	-	34826149	34874604	255,102,0	1	48455	0	.	Required for interaction with NCOR1. Pubmed:17519354
chr14	34862051	34874604	Q9NRL2	0	-	34862051	34874604	255,102,0	1	12553	0	.	Required for association with the CHRAC1/POLE3 complex.
chr14	34996709	35013901	P61011	0	+	34996709	35013901	255,102,0	1	17192	0	.	G-domain.
chr14	35014742	35029149	P61011	0	+	35014742	35029149	255,102,0	1	14407	0	.	M-domain.
chr14	35534252	35534312	Q96T92	0	+	35534252	35534312	255,102,0	1	60	0	.	SNAG domain.
chr14	35548536	35654477	Q6GYQ0	0	-	35548536	35654477	255,102,0	1	105941	0	.	Minimal domain that binds to TCF3/E12.
chr14	36299085	36314569	Q9NS73	0	-	36299085	36314569	255,102,0	1	15484	0	.	Interaction with MAP3K12.
chr14	36299130	36299178	Q9NS73	0	-	36299130	36299178	255,102,0	1	48	0	.	Leucine-zipper 2.
chr14	36308124	36308169	Q9NS73	0	-	36308124	36308169	255,102,0	1	45	0	.	Leucine-zipper 1.
chr14	36663393	36663459	P55771	0	+	36663393	36663459	255,102,0	1	66	0	.	Interaction with KDM5B. Pubmed:12657635
chr14	39277050	39346022	O15320	0	+	39277050	39346022	255,102,0	1	68972	0	.	Mediates interaction with MIA3. Pubmed:21525241
chr14	39346022	39350261	O15320	0	+	39346022	39350261	255,102,0	1	4239	0	.	Proline-rich domain (PRD); probably mediates interaction with COPII coat subunits. Pubmed:21525241
chr14	44962700	44963357	Q9Y4F4	0	+	44962700	44963357	255,102,0	1	657	0	.	TOG 1.
chr14	44963474	44964209	Q9Y4F4	0	+	44963474	44964209	255,102,0	1	735	0	.	TOG 2.
chr14	45032329	45052556	Q9Y4F4	0	+	45032329	45052556	255,102,0	1	20227	0	.	TOG 3.
chr14	45066626	45073558	Q9Y4F4	0	+	45066626	45073558	255,102,0	1	6932	0	.	TOG 4.
chr14	45167141	45175154	Q8IYD8	0	+	45167141	45175154	255,102,0	1	8013	0	.	Interaction with CENPS/CENPSX. Pubmed:20347428
chr14	45189200	45200005	Q8IYD8	0	+	45189200	45200005	255,102,0	1	10805	0	.	Interaction with FAAP24. Pubmed:17289582
chr14	50116321	50116330	Q9H867	0	-	50116321	50116330	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr14	50313020	50322586	Q99766	0	+	50313020	50322586	255,102,0	1	9566	0	.	N-terminal domain.
chr14	50628252	50632336	Q8WXF7	0	+	50628252	50632336	255,102,0	1	4084	0	.	Sufficient for membrane association.
chr14	52778364	52778373	Q96EK6	0	-	52778364	52778373	255,102,0	1	9	0	.	Acetyl-CoA binding. Pubmed:18601654
chr14	52778409	52778415	Q96EK6	0	-	52778409	52778415	255,102,0	1	6	0	.	Substrate binding. Pubmed:18675810, Pubmed:18601654
chr14	52780680	52780698	Q96EK6	0	-	52780680	52780698	255,102,0	1	18	0	.	Acetyl-CoA binding. Pubmed:18601654
chr14	52780719	52780728	Q96EK6	0	-	52780719	52780728	255,102,0	1	9	0	.	Substrate binding. Pubmed:18675810, Pubmed:18601654
chr14	52781795	52781807	Q96EK6	0	-	52781795	52781807	255,102,0	1	12	0	.	Substrate binding. Pubmed:18675810, Pubmed:18601654
chr14	52919270	52950451	Q96AC1	0	-	52919270	52950451	255,102,0	1	31181	0	.	Interaction with membranes containing phosphatidylinositol phosphate.
chr14	54397068	54401533	Q16667	0	+	54397068	54401533	255,102,0	1	4465	0	.	Interaction with CDK2.
chr14	55138131	55138353	P17931	0	+	55138131	55138353	255,102,0	1	222	0	.	8 X 9 AA tandem repeats of Y-P-G-X(3)-P-G-A.
chr14	55142692	55142713	P17931	0	+	55142692	55142713	255,102,0	1	21	0	.	Beta-galactoside binding.
chr14	55369621	55369861	Q6ZNE5	0	-	55369621	55369861	255,102,0	1	240	0	.	BATS.
chr14	55411648	55411696	Q6ZNE5	0	-	55411648	55411696	255,102,0	1	48	0	.	Cysteine repeats.
chr14	58364939	58364981	P29374	0	+	58364939	58364981	255,102,0	1	42	0	.	Retinoblastoma protein binding.
chr14	58457839	58459893	Q9BVV6	0	+	58457839	58459893	255,102,0	1	2054	0	.	Required for centrosomal localization.
chr14	58638475	58640858	Q9NYF0	0	+	58638475	58640858	255,102,0	1	2383	0	.	Required for self-association.
chr14	59340151	59340181	Q9Y4D1	0	+	59340151	59340181	255,102,0	1	30	0	.	Actin-binding.
chr14	59475982	59475988	Q96EM0	0	-	59475982	59475988	255,102,0	1	6	0	.	Substrate binding.
chr14	59483998	59484004	Q96EM0	0	-	59483998	59484004	255,102,0	1	6	0	.	Substrate binding.
chr14	61695804	61737063	Q16665	0	+	61695804	61737063	255,102,0	1	41259	0	.	Interaction with TSGA10.
chr14	61736997	61738088	Q16665	0	+	61736997	61738088	255,102,0	1	1091	0	.	N-terminal VHL recognition site.
chr14	61737060	61740904	Q16665	0	+	61737060	61740904	255,102,0	1	3844	0	.	ODD.
chr14	61740558	61740820	Q16665	0	+	61740558	61740820	255,102,0	1	262	0	.	NTAD.
chr14	61740760	61740811	Q16665	0	+	61740760	61740811	255,102,0	1	51	0	.	C-terminal VHL recognition site.
chr14	61740820	61746959	Q16665	0	+	61740820	61746959	255,102,0	1	6139	0	.	ID.
chr14	61746959	61747082	Q16665	0	+	61746959	61747082	255,102,0	1	123	0	.	CTAD.
chr14	61762460	61768710	Q16533	0	+	61762460	61768710	255,102,0	1	6250	0	.	SNAPC3-binding.
chr14	61768695	61778889	Q16533	0	+	61768695	61778889	255,102,0	1	10194	0	.	SNAPC4-binding.
chr14	62707630	62707750	Q8NCM2	0	-	62707630	62707750	255,102,0	1	120	0	.	CAD (involved in subunit assembly).
chr14	62708329	62708365	Q8NCM2	0	-	62708329	62708365	255,102,0	1	36	0	.	Calmodulin-binding.
chr14	64225481	64225523	Q8WXH0	0	+	64225481	64225523	255,102,0	1	42	0	.	Sufficient for interaction with SUN2. Pubmed:22632968
chr14	64233139	64268804	Q92731	0	-	64233139	64268804	255,102,0	1	35665	0	.	Steroid-binding.
chr14	64280071	64282985	Q92731	0	-	64280071	64282985	255,102,0	1	2914	0	.	Modulating.
chr14	64468394	64468904	P24588	0	+	64468394	64468904	255,102,0	1	510	0	.	Essential to the intracellular anchoring function.
chr14	64469567	64469609	P24588	0	+	64469567	64469609	255,102,0	1	42	0	.	PKA-RII subunit binding domain.
chr14	64540852	64542016	P54652	0	+	64540852	64542016	255,102,0	1	1164	0	.	Nucleotide-binding domain (NBD).
chr14	64542037	64542385	P54652	0	+	64542037	64542385	255,102,0	1	348	0	.	Substrate-binding domain (SBD).
chr14	65040838	65040850	P49356	0	+	65040838	65040850	255,102,0	1	12	0	.	Farnesyl diphosphate binding.
chr14	65044358	65044370	P49356	0	+	65044358	65044370	255,102,0	1	12	0	.	Farnesyl diphosphate binding.
chr14	65044385	65044397	P49356	0	+	65044385	65044397	255,102,0	1	12	0	.	Farnesyl diphosphate binding.
chr14	65076652	65077967	P61244	0	-	65076652	65077967	255,102,0	1	1315	0	.	Leucine-zipper.
chr14	65724156	65724162	Q9BYC5	0	+	65724156	65724162	255,102,0	1	6	0	.	Important for donor substrate binding.
chr14	66508566	66922707	Q9NQX3	0	+	66508566	66922707	255,102,0	1	414141	0	.	MPT Mo-transferase.
chr14	66916030	67058689	Q9NQX3	0	+	66916030	67058689	255,102,0	1	142659	0	.	Interaction with GABARAP.
chr14	67058716	67180934	Q9NQX3	0	+	67058716	67180934	255,102,0	1	122218	0	.	MPT adenylyltransferase.
chr14	67279230	67292563	Q8N3R9	0	+	67279230	67292563	255,102,0	1	13333	0	.	Interaction with PARD6B.
chr14	67292683	67302046	Q8N3R9	0	+	67292683	67302046	255,102,0	1	9363	0	.	Interaction with LIN7C.
chr14	67645712	67645727	P78540	0	+	67645712	67645727	255,102,0	1	15	0	.	Substrate binding. Pubmed:12859189
chr14	67645745	67645754	P78540	0	+	67645745	67645754	255,102,0	1	9	0	.	Substrate binding. Pubmed:12859189
chr14	67659877	67659892	Q9UEU0	0	-	67659877	67659892	255,102,0	1	15	0	.	Interaction with CLINT1. Pubmed:18033301
chr14	67674420	67674486	Q9UEU0	0	-	67674420	67674486	255,102,0	1	66	0	.	Interaction with CLINT1. Pubmed:18033301
chr14	67823543	67835106	O15315	0	+	67823543	67835106	255,102,0	1	11563	0	.	Interaction with RAD51C.
chr14	68789535	68789997	Q07352	0	-	68789535	68789997	255,102,0	1	462	0	.	Necessary for mRNA decay activation. Pubmed:15687258
chr14	68790216	68792938	Q07352	0	-	68790216	68792938	255,102,0	1	2722	0	.	Necessary and sufficient for the association with mRNA decay enzymes and mRNA decay activation. Pubmed:15687258
chr14	68880042	68893690	P12814	0	-	68880042	68893690	255,102,0	1	13648	0	.	Interaction with DDN. Pubmed:16464232
chr14	69324719	69328562	Q8N428	0	+	69324719	69328562	255,102,0	1	3843	0	.	Catalytic subdomain A.
chr14	69333161	69338727	Q8N428	0	+	69333161	69338727	255,102,0	1	5566	0	.	Catalytic subdomain B.
chr14	70167606	70167666	P57103	0	-	70167606	70167666	255,102,0	1	60	0	.	Putative calmodulin-binding region.
chr14	70742459	70742525	P80192	0	-	70742459	70742525	255,102,0	1	66	0	.	Leucine-zipper 2.
chr14	70742564	70748867	P80192	0	-	70742564	70748867	255,102,0	1	6303	0	.	Leucine-zipper 1.
chr14	73099735	73111070	P49756	0	+	73099735	73111070	255,102,0	1	11335	0	.	Necessary for nuclear speckle localization.
chr14	73211776	73219235	P49768	0	+	73211776	73219235	255,102,0	1	7459	0	.	Required for interaction with CTNNB1. Pubmed:9738936
chr14	73211926	73217193	P49768	0	+	73211926	73217193	255,102,0	1	5267	0	.	Required for interaction with CTNND2. Pubmed:10037471
chr14	73219274	73219286	P49768	0	+	73219274	73219286	255,102,0	1	12	0	.	Interaction with MTCH1. Pubmed:10551805
chr14	73874160	73874166	Q8N8N7	0	+	73874160	73874166	255,102,0	1	6	0	.	Substrate binding.
chr14	73881214	73881223	Q8N8N7	0	+	73881214	73881223	255,102,0	1	9	0	.	Substrate binding.
chr14	74500886	74502908	Q14767	0	-	74500886	74502908	255,102,0	1	2022	0	.	C-terminal domain. Pubmed:17293099
chr14	74553021	74553054	Q14767	0	-	74553021	74553054	255,102,0	1	33	0	.	Heparin-binding.
chr14	74585936	74585990	Q14767	0	-	74585936	74585990	255,102,0	1	54	0	.	Heparin-binding.
chr14	74611599	74611665	Q14767	0	-	74611599	74611665	255,102,0	1	66	0	.	Heparin-binding.
chr14	74946377	74946764	P49763	0	-	74946377	74946764	255,102,0	1	387	0	.	Heparin-binding.
chr14	75087161	75095411	Q8TD19	0	-	75087161	75095411	255,102,0	1	8250	0	.	Interaction with NEK6. Pubmed:19001501
chr14	75134887	75134926	P49755	0	-	75134887	75134926	255,102,0	1	39	0	.	Interaction with ARF1. Pubmed:11726511
chr14	75134887	75134935	P49755	0	-	75134887	75134935	255,102,0	1	48	0	.	Interaction with COPG1.
chr14	75135763	75135859	P49755	0	-	75135763	75135859	255,102,0	1	96	0	.	Required for TMED10 and TMED2 cis-Golgi network localization.
chr14	75135871	75176579	P49755	0	-	75135871	75176579	255,102,0	1	40708	0	.	Required for interaction with STX17. Pubmed:21545355
chr14	75280580	75280643	P01100	0	+	75280580	75280643	255,102,0	1	63	0	.	Basic motif; required for the activation of phospholipid synthesis, but not for CDS1-binding.
chr14	75280658	75280860	P01100	0	+	75280658	75280860	255,102,0	1	202	0	.	Leucine-zipper.
chr14	75461443	75461512	Q8WYK2	0	+	75461443	75461512	255,102,0	1	69	0	.	Basic motif.
chr14	75461521	75469367	Q8WYK2	0	+	75461521	75469367	255,102,0	1	7846	0	.	Leucine-zipper.
chr14	75525101	75525170	Q16520	0	+	75525101	75525170	255,102,0	1	69	0	.	Basic motif.
chr14	75525179	75546518	Q16520	0	+	75525179	75546518	255,102,0	1	21339	0	.	Leucine-zipper.
chr14	75579044	75579188	Q9UPI3	0	+	75579044	75579188	255,102,0	1	144	0	.	8 X 6 AA tandem repeats of P-S-[VS]-S-[VIAG]-[HNP].
chr14	75733995	75745558	Q6EMB2	0	+	75733995	75745558	255,102,0	1	11563	0	.	c-MTBD region. Pubmed:25959773
chr14	76778000	76779015	Q7L8A9	0	+	76778000	76779015	255,102,0	1	1015	0	.	Involved in heparin-binding and antiangiogenic activity.
chr14	77266544	77270937	Q9NPG2	0	-	77266544	77270937	255,102,0	1	4393	0	.	Globin.
chr14	77673814	77704405	Q13686	0	-	77673814	77704405	255,102,0	1	30591	0	.	tRNA-binding. Pubmed:27745969
chr14	77673949	77673970	Q13686	0	-	77673949	77673970	255,102,0	1	21	0	.	Alpha-ketoglutarate binding.
chr14	77675729	77675738	Q13686	0	-	77675729	77675738	255,102,0	1	9	0	.	Alpha-ketoglutarate binding.
chr14	77679894	77679903	Q13686	0	-	77679894	77679903	255,102,0	1	9	0	.	Substrate binding.
chr14	77731003	77738791	Q13573	0	-	77731003	77738791	255,102,0	1	7788	0	.	SNW.
chr14	77751411	77751474	Q13573	0	-	77751411	77751474	255,102,0	1	63	0	.	Interaction with PPIL1. Pubmed:16595688
chr14	81476974	81477145	Q9UBV2	0	-	81476974	81477145	255,102,0	1	171	0	.	Mediates retention in the endoplasmic reticulum.
chr14	81477145	81533681	Q9UBV2	0	-	81477145	81533681	255,102,0	1	56536	0	.	Interaction with ERLEC1, OS9 and SYVN1.
chr14	81479617	81484344	Q9UBV2	0	-	81479617	81484344	255,102,0	1	4727	0	.	Interaction with SYVN1.
chr14	81487410	81497966	Q9UBV2	0	-	81487410	81497966	255,102,0	1	10556	0	.	Important for homodimerization and oligomerization.
chr14	88468969	88468990	Q16825	0	-	88468969	88468990	255,102,0	1	21	0	.	Substrate binding.
chr14	89988970	89988982	Q9NUW8	0	+	89988970	89988982	255,102,0	1	12	0	.	Interaction with DNA. Pubmed:12470949
chr14	91272627	91272636	Q9P219	0	-	91272627	91272636	255,102,0	1	9	0	.	DVL1-binding.
chr14	92652807	92659330	Q8TB24	0	+	92652807	92659330	255,102,0	1	6523	0	.	Interaction with RAB5B. Pubmed:12972505
chr14	92926631	92926688	P10645	0	+	92926631	92926688	255,102,0	1	57	0	.	O-glycosylated at one site only in cerebrospinal fluid.
chr14	92931434	92931467	P10645	0	+	92931434	92931467	255,102,0	1	33	0	.	O-glycosylated at one site only in cerebrospinal fluid.
chr14	93183627	93183639	Q96BY2	0	-	93183627	93183639	255,102,0	1	12	0	.	RASSF1-binding.
chr14	93183861	93183885	Q96BY2	0	-	93183861	93183885	255,102,0	1	24	0	.	BH3-like.
chr14	94290134	94290188	Q9UK55	0	-	94290134	94290188	255,102,0	1	54	0	.	Heparin-binding.
chr14	94378529	94378604	P01009	0	-	94378529	94378604	255,102,0	1	75	0	.	RCL.
chr14	94487401	94487458	Q8IW75	0	-	94487401	94487458	255,102,0	1	57	0	.	RCL.
chr14	94623646	94623724	P01011	0	+	94623646	94623724	255,102,0	1	78	0	.	RCL.
chr14	94623682	94623709	P01011	0	+	94623682	94623709	255,102,0	1	27	0	.	O-glycosylated at one site.
chr14	95115788	95126717	Q9UPY3	0	-	95115788	95126717	255,102,0	1	10929	0	.	Required for interaction with PRKRA and TARBP2.
chr14	95535377	95543954	Q86SX6	0	+	95535377	95543954	255,102,0	1	8577	0	.	Glutathione binding. Pubmed:21029046
chr14	95544014	95544020	Q86SX6	0	+	95544014	95544020	255,102,0	1	6	0	.	Glutathione binding. Pubmed:21029046
chr14	96385606	96385681	Q9P0R6	0	+	96385606	96385681	255,102,0	1	75	0	.	Interaction with GSK3B. Pubmed:16981698
chr14	96456346	96483081	Q96M32	0	+	96456346	96483081	255,102,0	1	26735	0	.	Adenylate kinase. Pubmed:21080915
chr14	96456436	96471485	Q96M32	0	+	96456436	96471485	255,102,0	1	15049	0	.	NMPbind.
chr14	96478517	96478550	Q96M32	0	+	96478517	96478550	255,102,0	1	33	0	.	LID.
chr14	96486957	96488340	Q96M32	0	+	96486957	96488340	255,102,0	1	1383	0	.	DPY-30. Pubmed:21080915
chr14	96552479	96556338	P51003	0	+	96552479	96556338	255,102,0	1	3859	0	.	Ser/Thr-rich.
chr14	96560672	96565047	P51003	0	+	96560672	96565047	255,102,0	1	4375	0	.	Required for interaction with NUDT21.
chr14	99891205	99940109	O00423	0	+	99891205	99940109	255,102,0	1	48904	0	.	Tandem atypical propeller in EMLs.
chr14	100128700	100129577	Q9UI08	0	+	100128700	100129577	255,102,0	1	877	0	.	EVH2 block A.
chr14	100128700	100143726	Q9UI08	0	+	100128700	100143726	255,102,0	1	15026	0	.	EVH2.
chr14	100129643	100132731	Q9UI08	0	+	100129643	100132731	255,102,0	1	3088	0	.	EVH2 block B.
chr14	100141225	100143726	Q9UI08	0	+	100141225	100143726	255,102,0	1	2501	0	.	EVH2 block C.
chr14	100149495	100149510	Q6QHC5	0	-	100149495	100149510	255,102,0	1	15	0	.	Required for C4-hydroxylase activity.
chr14	100239244	100239754	P25490	0	+	100239244	100239754	255,102,0	1	510	0	.	Interaction with the SMAD1/SMAD4 complex.
chr14	100262392	100276609	P25490	0	+	100262392	100276609	255,102,0	1	14217	0	.	Involved in nuclear matrix association.
chr14	100274737	100277597	P25490	0	+	100274737	100277597	255,102,0	1	2860	0	.	Binding to DNA.
chr14	100276582	100277468	P25490	0	+	100276582	100277468	255,102,0	1	886	0	.	Involved in repression of activated transcription.
chr14	100277465	100277546	P25490	0	+	100277465	100277546	255,102,0	1	81	0	.	Involved in masking transactivation domain.
chr14	101964847	102006055	Q14204	0	+	101964847	102006055	255,102,0	1	41208	0	.	Stem.
chr14	101983489	101986334	Q14204	0	+	101983489	101986334	255,102,0	1	2845	0	.	Interaction with DYNC1I2.
chr14	101986175	101986631	Q14204	0	+	101986175	101986631	255,102,0	1	456	0	.	Interaction with DYNC1LI2.
chr14	102006055	102010351	Q14204	0	+	102006055	102010351	255,102,0	1	4296	0	.	AAA 1.
chr14	102010871	102015969	Q14204	0	+	102010871	102015969	255,102,0	1	5098	0	.	AAA 2.
chr14	102016816	102019964	Q14204	0	+	102016816	102019964	255,102,0	1	3148	0	.	AAA 3.
chr14	102026630	102029574	Q14204	0	+	102026630	102029574	255,102,0	1	2944	0	.	AAA 4.
chr14	102029634	102034062	Q14204	0	+	102029634	102034062	255,102,0	1	4428	0	.	Stalk.
chr14	102034354	102039140	Q14204	0	+	102034354	102039140	255,102,0	1	4786	0	.	AAA 5.
chr14	102041644	102044024	Q14204	0	+	102041644	102044024	255,102,0	1	2380	0	.	AAA 6.
chr14	102081714	102081726	P07900	0	-	102081714	102081726	255,102,0	1	12	0	.	Essential for interaction with SGTA and TTC1. Pubmed:15708368
chr14	102081714	102081729	P07900	0	-	102081714	102081729	255,102,0	1	15	0	.	Essential for interaction with SMYD3. Pubmed:25738358
chr14	102081714	102082156	P07900	0	-	102081714	102082156	255,102,0	1	442	0	.	Required for homodimerization. Pubmed:8289821
chr14	102081714	102084812	P07900	0	-	102081714	102084812	255,102,0	1	3098	0	.	Interaction with FLCN and FNIP1. Pubmed:27353360
chr14	102082339	102084812	P07900	0	-	102082339	102084812	255,102,0	1	2473	0	.	Interaction with FNIP2. Pubmed:27353360
chr14	102593117	102708575	Q9UKL0	0	+	102593117	102708575	255,102,0	1	115458	0	.	Interaction with HDAC1. Pubmed:11516394
chr14	102714449	102721340	Q9UKL0	0	+	102714449	102721340	255,102,0	1	6891	0	.	Interaction with KDM1A. Pubmed:16885027
chr14	103530035	103530044	Q96FX7	0	+	103530035	103530044	255,102,0	1	9	0	.	Substrate. Pubmed:26470919
chr14	103530080	103530104	Q96FX7	0	+	103530080	103530104	255,102,0	1	24	0	.	Substrate. Pubmed:26470919
chr14	103530167	103530173	Q96FX7	0	+	103530167	103530173	255,102,0	1	6	0	.	Substrate. Pubmed:26470919
chr14	103530230	103530245	Q96FX7	0	+	103530230	103530245	255,102,0	1	15	0	.	Substrate. Pubmed:26470919
chr14	103530305	103532601	Q96FX7	0	+	103530305	103532601	255,102,0	1	2296	0	.	Substrate. Pubmed:26470919
chr14	103532589	103532598	Q96FX7	0	+	103532589	103532598	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding. Pubmed:26470919
chr14	103532736	103532742	Q96FX7	0	+	103532736	103532742	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding. Pubmed:26470919
chr14	103532787	103532799	Q96FX7	0	+	103532787	103532799	255,102,0	1	12	0	.	Substrate. Pubmed:26470919
chr14	103534563	103534587	Q96FX7	0	+	103534563	103534587	255,102,0	1	24	0	.	Substrate. Pubmed:26470919
chr14	103727874	103733015	Q9BQ24	0	+	103727874	103733015	255,102,0	1	5141	0	.	PH-like.
chr14	104092670	104104735	Q86U10	0	+	104092670	104104735	255,102,0	1	12065	0	.	Asparaginase.
chr14	104093548	104093557	Q86U10	0	+	104093548	104093557	255,102,0	1	9	0	.	Substrate binding.
chr14	104095572	104095578	Q86U10	0	+	104095572	104095578	255,102,0	1	6	0	.	Substrate binding.
chr14	104724396	104724408	Q8N142	0	+	104724396	104724408	255,102,0	1	12	0	.	IMP binding.
chr14	104735028	104735040	Q8N142	0	+	104735028	104735040	255,102,0	1	12	0	.	IMP binding.
chr14	104743108	104743129	Q8N142	0	+	104743108	104743129	255,102,0	1	21	0	.	Substrate binding.
chr14	104753306	104755676	O15304	0	+	104753306	104755676	255,102,0	1	2370	0	.	Interaction with BCL2L1 isoform Bcl-x(L) and inhibition of BCL2L1 anti-apoptotic activity.
chr14	104756602	104756659	O15304	0	+	104756602	104756659	255,102,0	1	57	0	.	Interaction with coxsackievirus B3 VP2.
chr14	104773923	104773932	P31749	0	-	104773923	104773932	255,102,0	1	9	0	.	Inhibitor binding.
chr14	104780187	104780196	P31749	0	-	104780187	104780196	255,102,0	1	9	0	.	Inositol-(1,3,4,5)-tetrakisphosphate binding.
chr14	104780205	104792604	P31749	0	-	104780205	104792604	255,102,0	1	12399	0	.	Inositol-(1,3,4,5)-tetrakisphosphate binding.
chr14	105624478	105624799	P01861	0	-	105624478	105624799	255,102,0	1	321	0	.	CH3.
chr14	105624896	105625226	P01861	0	-	105624896	105625226	255,102,0	1	330	0	.	CH2.
chr14	105625249	105625570	P01861	0	-	105625249	105625570	255,102,0	1	321	0	.	CH3.
chr14	105625344	105625380	P01861	0	-	105625344	105625380	255,102,0	1	36	0	.	Hinge.
chr14	105625667	105625997	P01861	0	-	105625667	105625997	255,102,0	1	330	0	.	CH2.
chr14	105625772	105626066	P01861	0	-	105625772	105626066	255,102,0	1	294	0	.	CH1.
chr14	105626115	105626151	P01861	0	-	105626115	105626151	255,102,0	1	36	0	.	Hinge.
chr14	105626543	105626837	P01861	0	-	105626543	105626837	255,102,0	1	294	0	.	CH1.
chr14	105643205	105643526	P01859	0	-	105643205	105643526	255,102,0	1	321	0	.	CH3.
chr14	105643623	105643950	P01859	0	-	105643623	105643950	255,102,0	1	327	0	.	CH2.
chr14	105643976	105644297	P01859	0	-	105643976	105644297	255,102,0	1	321	0	.	CH3.
chr14	105644068	105644104	P01859	0	-	105644068	105644104	255,102,0	1	36	0	.	Hinge.
chr14	105644394	105644721	P01859	0	-	105644394	105644721	255,102,0	1	327	0	.	CH2.
chr14	105644496	105644790	P01859	0	-	105644496	105644790	255,102,0	1	294	0	.	CH1.
chr14	105644839	105644875	P01859	0	-	105644839	105644875	255,102,0	1	36	0	.	Hinge.
chr14	105645267	105645561	P01859	0	-	105645267	105645561	255,102,0	1	294	0	.	CH1.
chr14	105741475	105741796	P01857	0	-	105741475	105741796	255,102,0	1	321	0	.	CH3.
chr14	105741893	105742350	P01857	0	-	105741893	105742350	255,102,0	1	457	0	.	CH2.
chr14	105742246	105742567	P01857	0	-	105742246	105742567	255,102,0	1	321	0	.	CH3.
chr14	105742350	105742386	P01857	0	-	105742350	105742386	255,102,0	1	36	0	.	Hinge.
chr14	105742664	105743121	P01857	0	-	105742664	105743121	255,102,0	1	457	0	.	CH2.
chr14	105742777	105743071	P01857	0	-	105742777	105743071	255,102,0	1	294	0	.	CH1.
chr14	105743121	105743157	P01857	0	-	105743121	105743157	255,102,0	1	36	0	.	Hinge.
chr14	105743548	105743842	P01857	0	-	105743548	105743842	255,102,0	1	294	0	.	CH1.
chr14	106373662	106373956	P06331	0	-	106373662	106373956	255,102,0	1	294	0	.	V region.
chr14	106398343	106398637	P06331	0	-	106398343	106398637	255,102,0	1	294	0	.	V region.
chr15	23566577	23566661	Q13064	0	+	23566577	23566661	255,102,0	1	84	0	.	Makorin-type Cys-His.
chr15	24977879	24978429	P63162	0	+	24977879	24978429	255,102,0	1	550	0	.	Repeat-rich region.
chr15	25370631	25370931	Q05086	0	-	25370631	25370931	255,102,0	1	300	0	.	Interaction with HCV core protein.
chr15	25370928	25370982	Q05086	0	-	25370928	25370982	255,102,0	1	54	0	.	E6-binding.
chr15	26561078	26561144	P28472	0	-	26561078	26561144	255,102,0	1	66	0	.	Allosteric effector binding.
chr15	26580454	26583338	P28472	0	-	26580454	26583338	255,102,0	1	2884	0	.	Agonist binding.
chr15	26621408	26621417	P28472	0	-	26621408	26621417	255,102,0	1	9	0	.	Agonist binding.
chr15	29054436	29054694	Q99767	0	+	29054436	29054694	255,102,0	1	258	0	.	STXBP1-binding.
chr15	29195107	29195365	Q99767	0	+	29195107	29195365	255,102,0	1	258	0	.	STXBP1-binding.
chr15	29268793	29269474	Q96MG7	0	-	29268793	29269474	255,102,0	1	681	0	.	Interaction with NSMCE1.
chr15	29410057	29410738	Q96MG7	0	-	29410057	29410738	255,102,0	1	681	0	.	Interaction with NSMCE1.
chr15	31487196	31558972	Q8TE49	0	-	31487196	31558972	255,102,0	1	71776	0	.	Catalytic.
chr15	31487486	31559017	Q8TE49	0	-	31487486	31559017	255,102,0	1	71531	0	.	TRAF-binding.
chr15	32499914	32684289	Q68DA7	0	-	32499914	32684289	255,102,0	1	184375	0	.	Mediates interaction with alpha-catenin.
chr15	32683788	32685654	Q68DA7	0	-	32683788	32685654	255,102,0	1	1866	0	.	Microtubule-binding.
chr15	32969174	33153549	Q68DA7	0	-	32969174	33153549	255,102,0	1	184375	0	.	Mediates interaction with alpha-catenin.
chr15	33153048	33154914	Q68DA7	0	-	33153048	33154914	255,102,0	1	1866	0	.	Microtubule-binding.
chr15	33623966	33755125	Q15413	0	+	33623966	33755125	255,102,0	1	131159	0	.	4 X approximate repeats.
chr15	33726436	33726478	Q15413	0	+	33726436	33726478	255,102,0	1	42	0	.	Interaction with FKBP1A. Pubmed:22100703
chr15	33813481	33813571	Q15413	0	+	33813481	33813571	255,102,0	1	90	0	.	Interaction with CALM.
chr15	34381413	34381839	A7E2F4	0	-	34381413	34381839	255,102,0	1	426	0	.	Golgi-targeting domain.
chr15	34527634	34528060	A8MQT2	0	-	34527634	34528060	255,102,0	1	426	0	.	Golgi-targeting domain.
chr15	36892175	36896646	O14770	0	-	36892175	36896646	255,102,0	1	4471	0	.	Transcriptional activation domain.
chr15	37093646	37098001	O14770	0	-	37093646	37098001	255,102,0	1	4355	0	.	Required for interaction with PBX1.
chr15	38490556	38494489	O95267	0	-	38490556	38494489	255,102,0	1	3933	0	.	PT region; mediates the BCR-dependent translocation to plasma membrane.
chr15	38494558	38494585	O95267	0	-	38494558	38494585	255,102,0	1	27	0	.	Suppress the PT region-mediated translocation to plasma membrane.
chr15	38519367	38559872	O95267	0	-	38519367	38559872	255,102,0	1	40505	0	.	Ras exchanger motif region; required for transforming activity.
chr15	39582263	39582410	P07996	0	+	39582263	39582410	255,102,0	1	147	0	.	Heparin-binding.
chr15	40001128	40026066	Q9P2K8	0	+	40001128	40026066	255,102,0	1	24938	0	.	Histidyl-tRNA synthetase-like.
chr15	40105861	40105888	Q96LC9	0	-	40105861	40105888	255,102,0	1	27	0	.	Interaction with DLC2.
chr15	40176545	40176647	O60566	0	+	40176545	40176647	255,102,0	1	102	0	.	Necessary for interaction with KNL1. Pubmed:17981135
chr15	40264860	40272583	Q9NQU5	0	+	40264860	40272583	255,102,0	1	7723	0	.	Linker.
chr15	40387195	40393594	Q9Y448	0	+	40387195	40393594	255,102,0	1	6399	0	.	Interaction with SPAG5. Pubmed:21402792
chr15	40602931	40622370	Q8NG31	0	+	40602931	40622370	255,102,0	1	19439	0	.	Interaction with BUB1 and BUB1B. Pubmed:17981135
chr15	40622748	40623789	Q8NG31	0	+	40622748	40623789	255,102,0	1	1041	0	.	2 X 104 AA approximate repeats.
chr15	40628114	40662107	Q8NG31	0	+	40628114	40662107	255,102,0	1	33993	0	.	Necessary for kinetochore localization and for interaction with NSL1 and DSN1. Pubmed:17981135
chr15	40728729	40729631	Q06609	0	+	40728729	40729631	255,102,0	1	902	0	.	Interaction with PALB2.
chr15	40828566	40828581	Q9NXH3	0	-	40828566	40828581	255,102,0	1	15	0	.	Interaction with protein phosphatase 1.
chr15	40931660	40931669	Q9NR61	0	+	40931660	40931669	255,102,0	1	9	0	.	Interaction with Notch1.
chr15	40931678	40931693	Q9NR61	0	+	40931678	40931693	255,102,0	1	15	0	.	Interaction with Notch1.
chr15	40953685	40953703	Q9BUX1	0	+	40953685	40953703	255,102,0	1	18	0	.	Substrate binding.
chr15	40980225	41071893	Q9ULG1	0	-	40980225	41071893	255,102,0	1	91668	0	.	Assembles INO80 complex module consisting of conserved components INO80B, INO80C, ACTR5, RVBL1, RVBL2.
chr15	41071875	41087586	Q9ULG1	0	-	41071875	41087586	255,102,0	1	15711	0	.	Assembles INO80 complex module consisting of conserved components ACTR8, ACTL6A and YY1.
chr15	41085443	41096310	Q9ULG1	0	-	41085443	41096310	255,102,0	1	10867	0	.	Assembles INO80 complex module with putative regulatory components INO80E, INO80F, UCHL5, NFRKB, MCRS1 and IN80D.
chr15	41278781	41279356	Q99653	0	+	41278781	41279356	255,102,0	1	575	0	.	Necessary for nuclear export signal.
chr15	41365449	41377218	Q9BXS6	0	+	41365449	41377218	255,102,0	1	11769	0	.	Interaction with microtubules.
chr15	41502051	41502078	P23677	0	+	41502051	41502078	255,102,0	1	27	0	.	Calmodulin-binding.
chr15	41502126	41502150	P23677	0	+	41502126	41502150	255,102,0	1	24	0	.	Substrate binding. Pubmed:15350214
chr15	42399549	42403753	P20807	0	+	42399549	42403753	255,102,0	1	4204	0	.	Domain III.
chr15	42403753	42409335	P20807	0	+	42403753	42409335	255,102,0	1	5582	0	.	Linker.
chr15	42409335	42411770	P20807	0	+	42409335	42411770	255,102,0	1	2435	0	.	Domain IV.
chr15	42736023	42736309	Q8IWY9	0	-	42736023	42736309	255,102,0	1	286	0	.	Interaction with ASF1A/B. Pubmed:22407294
chr15	43185501	43191015	O95273	0	+	43185501	43191015	255,102,0	1	5514	0	.	Interaction with TCF3. Pubmed:10915743
chr15	43185501	43191033	O95273	0	+	43185501	43191033	255,102,0	1	5532	0	.	Interaction with RPLP0. Pubmed:17621266
chr15	43185501	43191439	O95273	0	+	43185501	43191439	255,102,0	1	5938	0	.	Required for interaction with CCND1.
chr15	43190343	43194838	O95273	0	+	43190343	43194838	255,102,0	1	4495	0	.	Interaction with TCF3. Pubmed:10915743
chr15	43191532	43194838	O95273	0	+	43191532	43194838	255,102,0	1	3306	0	.	Interaction with RPLP0. Pubmed:17621266
chr15	43216346	43216373	P16452	0	-	43216346	43216373	255,102,0	1	27	0	.	Band 3 binding.
chr15	43330003	43330009	O60294	0	-	43330003	43330009	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr15	43416273	43420521	Q12888	0	-	43416273	43420521	255,102,0	1	4248	0	.	Tudor-like. Pubmed:17190600
chr15	43420401	43420488	Q12888	0	-	43420401	43420488	255,102,0	1	87	0	.	Interaction with dimethylated histone H4. Pubmed:17190600
chr15	43522715	43523096	P78559	0	+	43522715	43523096	255,102,0	1	381	0	.	9 X 3 AA repeats of K-K-[DE].
chr15	43577698	43579038	Q6PFW1	0	-	43577698	43579038	255,102,0	1	1340	0	.	Polyphosphoinositide-binding domain. Pubmed:21222653
chr15	43581042	43581054	Q6PFW1	0	-	43581042	43581054	255,102,0	1	12	0	.	Substrate binding.
chr15	43582094	43582100	Q6PFW1	0	-	43582094	43582100	255,102,0	1	6	0	.	Substrate binding.
chr15	43583551	43583557	Q6PFW1	0	-	43583551	43583557	255,102,0	1	6	0	.	Substrate binding.
chr15	43594335	43595014	P12532	0	+	43594335	43595014	255,102,0	1	679	0	.	Cardiolipin-binding.
chr15	43694167	43694846	P12532	0	+	43694167	43694846	255,102,0	1	679	0	.	Cardiolipin-binding.
chr15	44537197	44551435	O75822	0	+	44537197	44551435	255,102,0	1	14238	0	.	Sufficient for interaction with EIF3B.
chr15	44561098	44561146	A0A024R5S5	0	+	44561098	44561146	255,102,0	1	48	0	.	Promotes stable association with the 40S ribosome.
chr15	44561098	44561146	O75822	0	+	44561098	44561146	255,102,0	1	48	0	.	Promotes stable association with the 40S ribosome.
chr15	44736704	44755349	Q86WT6	0	+	44736704	44755349	255,102,0	1	18645	0	.	Necessary for nuclear localization.
chr15	45097349	45101248	Q9NRD8	0	-	45097349	45101248	255,102,0	1	3899	0	.	Interaction with TXNDC11.
chr15	45106874	45113059	Q9NRD8	0	-	45106874	45113059	255,102,0	1	6185	0	.	Peroxidase-like; mediates peroxidase activity.
chr15	45133880	45142069	Q9NRD9	0	+	45133880	45142069	255,102,0	1	8189	0	.	Peroxidase-like; mediates peroxidase activity.
chr15	45150678	45160878	Q9NRD9	0	+	45150678	45160878	255,102,0	1	10200	0	.	Interaction with TXNDC11.
chr15	48336050	48336059	P33316	0	+	48336050	48336059	255,102,0	1	9	0	.	Substrate binding.
chr15	48341290	48341302	P33316	0	+	48341290	48341302	255,102,0	1	12	0	.	Substrate binding.
chr15	48342054	48342060	P33316	0	+	48342054	48342060	255,102,0	1	6	0	.	Substrate binding.
chr15	48797958	48805649	O94986	0	-	48797958	48805649	255,102,0	1	7691	0	.	Interaction with PLK4. Pubmed:24997597
chr15	48834930	48856087	Q6S5L8	0	-	48834930	48856087	255,102,0	1	21157	0	.	CH1.
chr15	48878335	48878536	Q9Y6B2	0	+	48878335	48878536	255,102,0	1	201	0	.	Interaction with NR0B2.
chr15	48962460	48963015	Q6S5L8	0	-	48962460	48963015	255,102,0	1	555	0	.	CH2.
chr15	49133998	49155578	P61201	0	-	49133998	49155578	255,102,0	1	21580	0	.	Mediates interaction with NIF3L1.
chr15	49217191	49217203	Q01415	0	+	49217191	49217203	255,102,0	1	12	0	.	Substrate binding.
chr15	49282040	49282052	Q01415	0	+	49282040	49282052	255,102,0	1	12	0	.	Substrate binding.
chr15	50286121	50289630	Q06547	0	-	50286121	50289630	255,102,0	1	3509	0	.	Transcription activation and HCFC1 interaction.
chr15	51057883	51058435	Q5GJ75	0	-	51057883	51058435	255,102,0	1	552	0	.	Binding to phosphoinositides.
chr15	52383107	52383176	Q9Y4I1	0	-	52383107	52383176	255,102,0	1	69	0	.	Actin-binding.
chr15	55360848	55389424	Q9ULG6	0	-	55360848	55389424	255,102,0	1	28576	0	.	Interaction with MCF2L and SRC.
chr15	55491218	55498311	Q8WXU2	0	-	55491218	55498311	255,102,0	1	7093	0	.	Mediates interaction with ESR1 and STUB1. Pubmed:19423554
chr15	55546109	55546166	Q9Y3Y4	0	-	55546109	55546166	255,102,0	1	57	0	.	Interaction with BCL9. Pubmed:18498752
chr15	55546118	55546262	Q9Y3Y4	0	-	55546118	55546262	255,102,0	1	144	0	.	Interaction with H3K4me2.
chr15	55842085	55869611	P46934	0	-	55842085	55869611	255,102,0	1	27526	0	.	Mediates interaction with TNIK.
chr15	57166430	57192187	Q99081	0	+	57166430	57192187	255,102,0	1	25757	0	.	Leucine-zipper.
chr15	57197789	57231160	Q99081	0	+	57197789	57231160	255,102,0	1	33371	0	.	Interaction with RUNX1T1. Pubmed:23812588
chr15	57273249	57282503	Q99081	0	+	57273249	57282503	255,102,0	1	9254	0	.	Class A specific domain.
chr15	57437999	57440436	Q0VF96	0	+	57437999	57440436	255,102,0	1	2437	0	.	Head.
chr15	57547367	57547487	Q0VF96	0	+	57547367	57547487	255,102,0	1	120	0	.	Tail.
chr15	58542617	58545746	P11150	0	+	58542617	58545746	255,102,0	1	3129	0	.	Heparin-binding.
chr15	58847446	58851905	Q8NBR6	0	+	58847446	58851905	255,102,0	1	4459	0	.	Ubiquitin-binding domain (UBD). Pubmed:27292798
chr15	59031542	59058396	Q6ZNA4	0	+	59031542	59058396	255,102,0	1	26854	0	.	Interaction with AXIN1. Pubmed:16601693
chr15	59091133	59091142	Q6ZNA4	0	+	59091133	59091142	255,102,0	1	9	0	.	Ubiquitin binding.
chr15	59094783	59094798	Q6ZNA4	0	+	59094783	59094798	255,102,0	1	15	0	.	Ubiquitin binding.
chr15	59195492	59195525	Q12965	0	-	59195492	59195525	255,102,0	1	33	0	.	Actin-binding.
chr15	60382417	60386072	P07355	0	-	60382417	60386072	255,102,0	1	3655	0	.	S100A10-binding site.
chr15	60497457	60511232	P35398	0	-	60497457	60511232	255,102,0	1	13775	0	.	Ligand-binding.
chr15	60511232	60514625	P35398	0	-	60511232	60514625	255,102,0	1	3393	0	.	Hinge.
chr15	62675297	62694318	Q9Y4G6	0	+	62675297	62694318	255,102,0	1	19021	0	.	Interaction with PIP5K1C.
chr15	63340353	63340359	O43570	0	-	63340353	63340359	255,102,0	1	6	0	.	Substrate binding.
chr15	63911907	63924845	Q9UIK4	0	-	63911907	63924845	255,102,0	1	12938	0	.	Calmodulin-binding.
chr15	63912152	63912182	Q9UIK4	0	-	63912152	63912182	255,102,0	1	30	0	.	Autoinhibitory domain.
chr15	64129948	64130002	Q13596	0	+	64129948	64130002	255,102,0	1	54	0	.	Membrane-binding amphipathic helix. Pubmed:19816406
chr15	64397797	64409685	Q15650	0	+	64397797	64409685	255,102,0	1	11888	0	.	Mediates interaction with DDRGK1. Pubmed:25219498
chr15	64409682	64418570	Q15650	0	+	64409682	64418570	255,102,0	1	8888	0	.	Mediates interaction with UFL1. Pubmed:25219498
chr15	64751572	64751605	Q6ZRY4	0	-	64751572	64751605	255,102,0	1	33	0	.	Important for homodimerization. Pubmed:25064856
chr15	64816300	64823837	Q9H611	0	-	64816300	64823837	255,102,0	1	7537	0	.	Hydrolyzes ATP in the presence of both magnesium and single-stranded DNA; weak activity in the presence of RNA or double-stranded DNA; No unwinding activity.
chr15	64823795	64824335	Q9H611	0	-	64823795	64824335	255,102,0	1	540	0	.	PINT.
chr15	66349105	66352142	Q9BVW5	0	-	66349105	66352142	255,102,0	1	3037	0	.	Interaction with TIMELESS.
chr15	66435174	66435180	Q02750	0	+	66435174	66435180	255,102,0	1	6	0	.	Inhibitor binding.
chr15	66436883	66436892	Q02750	0	+	66436883	66436892	255,102,0	1	9	0	.	Inhibitor binding.
chr15	66481807	66481822	Q02750	0	+	66481807	66481822	255,102,0	1	15	0	.	Inhibitor binding.
chr15	66485103	66487253	Q02750	0	+	66485103	66487253	255,102,0	1	2150	0	.	RAF1-binding.
chr15	67165260	67181275	P84022	0	+	67165260	67181275	255,102,0	1	16015	0	.	Linker.
chr15	67181392	67184827	P84022	0	+	67181392	67184827	255,102,0	1	3435	0	.	Sufficient for interaction with XPO4. Pubmed:16449645
chr15	67543386	67543410	Q13163	0	+	67543386	67543410	255,102,0	1	24	0	.	Interaction with MAPK7.
chr15	67563287	67563302	Q13163	0	+	67563287	67563302	255,102,0	1	15	0	.	Interaction with MAP3K2/MAP3K3.
chr15	67585915	67586875	Q13163	0	+	67585915	67586875	255,102,0	1	960	0	.	Interaction with MAPK7.
chr15	68176556	68176592	O75925	0	+	68176556	68176592	255,102,0	1	36	0	.	SUMO1-binding.
chr15	68181287	68187724	O75925	0	+	68181287	68187724	255,102,0	1	6437	0	.	4 X 4 AA repeats of N-T-S-L.
chr15	68780083	68784430	P39687	0	-	68780083	68784430	255,102,0	1	4347	0	.	Interaction with E4F1.
chr15	68784400	68784475	P39687	0	-	68784400	68784475	255,102,0	1	75	0	.	Necessary for tumor-suppressive function.
chr15	69014735	69031699	Q96PH1	0	+	69014735	69031699	255,102,0	1	16964	0	.	N-terminal regulatory region; interacts with the C-terminal catalytic region in a calcium-dependent manner.
chr15	69037183	69047415	Q96PH1	0	+	69037183	69047415	255,102,0	1	10232	0	.	C-terminal catalytic region.
chr15	69444789	69446301	Q02241	0	+	69444789	69446301	255,102,0	1	1512	0	.	Interaction with ARF6. Pubmed:22522702
chr15	70055279	70058776	Q04726	0	-	70055279	70058776	255,102,0	1	3497	0	.	SP domain.
chr15	70058776	70060646	Q04726	0	-	70058776	70060646	255,102,0	1	1870	0	.	CcN domain.
chr15	70060646	70066197	Q04726	0	-	70060646	70066197	255,102,0	1	5551	0	.	GP domain.
chr15	70066197	70096798	Q04726	0	-	70066197	70096798	255,102,0	1	30601	0	.	Q domain.
chr15	71826693	71899016	B2RTY4	0	-	71826693	71899016	255,102,0	1	72323	0	.	Tail.
chr15	71899016	71901280	B2RTY4	0	-	71899016	71901280	255,102,0	1	2264	0	.	Neck or regulatory domain.
chr15	71904937	71904973	B2RTY4	0	-	71904937	71904973	255,102,0	1	36	0	.	Actin-binding.
chr15	72139653	72140145	Q96LD8	0	+	72139653	72140145	255,102,0	1	492	0	.	Protease.
chr15	72199652	72207195	P14618	0	-	72199652	72207195	255,102,0	1	7543	0	.	Interaction with POU5F1. Pubmed:18191611
chr15	72199682	72199700	P14618	0	-	72199682	72199700	255,102,0	1	18	0	.	D-fructose 1,6-bisphosphate binding; part of allosteric site. Pubmed:15996096, Pubmed:23530218
chr15	72200651	72202467	P14618	0	-	72200651	72202467	255,102,0	1	1816	0	.	D-fructose 1,6-bisphosphate binding; part of allosteric site. Pubmed:15996096, Pubmed:23530218
chr15	72202461	72202596	P14618	0	-	72202461	72202596	255,102,0	1	135	0	.	Intersubunit contact.
chr15	72346584	72346590	P06865	0	-	72346584	72346590	255,102,0	1	6	0	.	Critical for hydrolyzis GM2 gangliosides.
chr15	72474951	72544835	Q9Y4X5	0	+	72474951	72544835	255,102,0	1	69884	0	.	UBA-like. Pubmed:23707686
chr15	72580736	72583289	Q9Y4X5	0	+	72580736	72583289	255,102,0	1	2553	0	.	Ariadne domain. Pubmed:23707686
chr15	72686227	72712285	Q96RK4	0	+	72686227	72712285	255,102,0	1	26058	0	.	Required for localization to centrosomes.
chr15	72715370	72731701	Q96RK4	0	+	72715370	72731701	255,102,0	1	16331	0	.	Interaction with PCM1. Pubmed:15107855
chr15	72731701	72737584	Q96RK4	0	+	72731701	72737584	255,102,0	1	5883	0	.	Required for localization to centrosomes.
chr15	73367490	73367646	Q9Y3Q4	0	-	73367490	73367646	255,102,0	1	156	0	.	Involved in subunit assembly.
chr15	73592093	73592132	Q9Y639	0	-	73592093	73592132	255,102,0	1	39	0	.	Narpin; mediates binding with FGFR1 and has antidepressant-like activity.
chr15	73942858	73951834	Q08397	0	+	73942858	73951834	255,102,0	1	8976	0	.	Lysyl-oxidase like.
chr15	74032658	74034485	P29590	0	+	74032658	74034485	255,102,0	1	1827	0	.	Interaction with PER2. Pubmed:22274616
chr15	74034485	74034506	P29590	0	+	74034485	74034506	255,102,0	1	21	0	.	Sumo interaction motif (SIM).
chr15	74415979	74416577	O75326	0	-	74415979	74416577	255,102,0	1	598	0	.	Interaction with integrins.
chr15	74572915	74591364	Q8IVW6	0	+	74572915	74591364	255,102,0	1	18449	0	.	Interaction with RB1. Pubmed:10446990
chr15	74593181	74595627	Q8IVW6	0	+	74593181	74595627	255,102,0	1	2446	0	.	Interaction with ARID3A. Pubmed:17400556
chr15	74640551	74655982	Q96F86	0	-	74640551	74655982	255,102,0	1	15431	0	.	Required for interaction with DDX6.
chr15	74671701	74675124	Q96F86	0	-	74671701	74675124	255,102,0	1	3423	0	.	Required for P-body targeting and interaction with DCP1A.
chr15	74798623	74798906	P41240	0	+	74798623	74798906	255,102,0	1	283	0	.	Interaction with PTPN22.
chr15	74848679	74850539	O15127	0	-	74848679	74850539	255,102,0	1	1860	0	.	Interaction with SLC9A7. Pubmed:15840657
chr15	75389771	75392431	Q96ST3	0	-	75389771	75392431	255,102,0	1	2660	0	.	Interaction with OGT. Pubmed:12150998
chr15	75392542	75400900	Q96ST3	0	-	75392542	75400900	255,102,0	1	8358	0	.	Interaction with NCOR1.
chr15	75392605	75396292	Q96ST3	0	-	75392605	75396292	255,102,0	1	3687	0	.	Interaction with HDAC1 and ARID4B. Pubmed:12724404
chr15	75396373	75400897	Q96ST3	0	-	75396373	75400897	255,102,0	1	4524	0	.	Interaction with SUDS3 and SAP130. Pubmed:12724404
chr15	75400891	75407090	Q96ST3	0	-	75400891	75407090	255,102,0	1	6199	0	.	Interaction with SAP30.
chr15	75401937	75412906	Q96ST3	0	-	75401937	75412906	255,102,0	1	10969	0	.	Interaction with REST.
chr15	75412930	75422658	Q96ST3	0	-	75412930	75422658	255,102,0	1	9728	0	.	Interaction with HCFC1. Pubmed:12670868
chr15	75469795	75469816	P43378	0	-	75469795	75469816	255,102,0	1	21	0	.	Substrate binding.
chr15	75598456	75605206	O95149	0	-	75598456	75605206	255,102,0	1	6750	0	.	Necessary for binding to the m3G-cap structure. Pubmed:9670026
chr15	75609582	75621051	O95149	0	-	75609582	75621051	255,102,0	1	11469	0	.	Necessary for interaction with XPO1. Pubmed:10209022
chr15	75609910	75609919	O95149	0	-	75609910	75609919	255,102,0	1	9	0	.	Interaction with m3G-cap structure. Pubmed:15920472
chr15	75617515	75621051	O95149	0	-	75617515	75621051	255,102,0	1	3536	0	.	Necessary for interaction with KPNB1 and m3G-cap U1 and U5 snRNP import receptor activity. Pubmed:18187419, Pubmed:9670026
chr15	75675855	75682631	Q6UVK1	0	-	75675855	75682631	255,102,0	1	6776	0	.	Cysteine-containing.
chr15	75675855	75682634	Q6UVK1	0	-	75675855	75682634	255,102,0	1	6779	0	.	Neurite growth inhibition.
chr15	75684846	75689174	Q6UVK1	0	-	75684846	75689174	255,102,0	1	4328	0	.	Interaction with COL5A1.
chr15	75687944	75689345	Q6UVK1	0	-	75687944	75689345	255,102,0	1	1401	0	.	Interaction with COL6A2.
chr15	75689147	75693234	Q6UVK1	0	-	75689147	75693234	255,102,0	1	4087	0	.	Globular or compact configuration stabilized by disulfide bonds.
chr15	75689147	75693234	Q6UVK1	0	-	75689147	75693234	255,102,0	1	4087	0	.	Neurite growth inhibition.
chr15	76216561	76285688	P13804	0	-	76216561	76285688	255,102,0	1	69127	0	.	Domain II. Pubmed:8962055
chr15	76285688	76295719	P13804	0	-	76285688	76295719	255,102,0	1	10031	0	.	Domain I. Pubmed:8962055
chr15	76341151	76341241	Q96A47	0	+	76341151	76341241	255,102,0	1	90	0	.	LIM-binding domain (LID).
chr15	78347956	78347965	P29762	0	+	78347956	78347965	255,102,0	1	9	0	.	Retinoic acid binding.
chr15	78771252	78773122	Q9UKP4	0	-	78771252	78773122	255,102,0	1	1870	0	.	Spacer.
chr15	78878247	78884997	Q9UBU8	0	+	78878247	78884997	255,102,0	1	6750	0	.	Interaction with KAT8. Pubmed:12397079
chr15	78887305	78894109	Q9UBU8	0	+	78887305	78894109	255,102,0	1	6804	0	.	Sufficient for interaction with SIN3A. Pubmed:12391155
chr15	78891506	78893571	Q9UBU8	0	+	78891506	78893571	255,102,0	1	2065	0	.	Interaction with RB1-1.
chr15	78892217	78897004	Q9UBU8	0	+	78892217	78897004	255,102,0	1	4787	0	.	Sufficient for interaction with PHF12. Pubmed:12391155
chr15	78894866	78897010	Q9UBU8	0	+	78894866	78897010	255,102,0	1	2144	0	.	Interaction with RB1-2.
chr15	79845365	79845380	P49914	0	-	79845365	79845380	255,102,0	1	15	0	.	Substrate binding.
chr15	80888714	80909282	Q8WUJ3	0	+	80888714	80909282	255,102,0	1	20568	0	.	Necessary for its endoplasmic reticulum (ER) retention and interaction with HSPA5. Pubmed:23990668
chr15	80979311	80979431	Q14696	0	-	80979311	80979431	255,102,0	1	120	0	.	Escort domain.
chr15	80979431	80989791	Q14696	0	-	80979431	80989791	255,102,0	1	10360	0	.	Chaperone domain.
chr15	81265783	81290476	Q14005	0	+	81265783	81290476	255,102,0	1	24693	0	.	Interaction with GRIN2A. Pubmed:12923170
chr15	81300425	81303584	Q14005	0	+	81300425	81303584	255,102,0	1	3159	0	.	Interaction with HTLV-1 tax.
chr15	81301509	81306093	Q14005	0	+	81301509	81306093	255,102,0	1	4584	0	.	Interaction with PPP1R12A, PPP1R12B and PPP1R12C. Pubmed:12923170
chr15	82809726	82813273	Q8TF30	0	+	82809726	82813273	255,102,0	1	3547	0	.	Mediates association with membranes. Pubmed:18614018
chr15	82813273	82830847	Q8TF30	0	+	82813273	82830847	255,102,0	1	17574	0	.	Mediates interaction with microtubules. Pubmed:23027905
chr15	82830847	82833533	Q8TF30	0	+	82830847	82833533	255,102,0	1	2686	0	.	Mediates actin nucleation. Pubmed:18614018
chr15	82989021	82989183	Q9BTL3	0	+	82989021	82989183	255,102,0	1	162	0	.	Interaction with RNMT. Pubmed:22099306
chr15	82989183	82990064	Q9BTL3	0	+	82989183	82990064	255,102,0	1	881	0	.	RNA-binding.
chr15	83264503	83264533	Q01954	0	-	83264503	83264533	255,102,0	1	30	0	.	Hydrophobic.
chr15	83447533	83559270	Q99963	0	+	83447533	83559270	255,102,0	1	111737	0	.	Membrane-binding amphipathic helix.
chr15	83565196	83568602	Q99963	0	+	83565196	83568602	255,102,0	1	3406	0	.	Required for dimerization upon membrane association.
chr15	83587009	83588695	Q99963	0	+	83587009	83588695	255,102,0	1	1686	0	.	Interaction with ARC.
chr15	85115447	85115471	O60658	0	+	85115447	85115471	255,102,0	1	24	0	.	Involved in RAF1-binding. Pubmed:23509299
chr15	85117695	85137852	O60658	0	+	85117695	85137852	255,102,0	1	20157	0	.	Catalytic.
chr15	85579547	85579616	Q12802	0	+	85579547	85579616	255,102,0	1	69	0	.	Important for interaction with PRKAR2A.
chr15	85658543	85682201	Q12802	0	+	85658543	85682201	255,102,0	1	23658	0	.	Important for interaction with MAP2K3. Pubmed:21224381
chr15	85717308	85744674	Q12802	0	+	85717308	85744674	255,102,0	1	27366	0	.	Interaction with ESR1. Pubmed:9627117
chr15	89642271	89647619	Q2M1P5	0	-	89642271	89647619	255,102,0	1	5348	0	.	Sufficient for interaction with NPHP1. Pubmed:21633164
chr15	89667607	89667694	O60240	0	-	89667607	89667694	255,102,0	1	87	0	.	Required for interaction with CIDEC.
chr15	89683403	89683463	O75192	0	-	89683403	89683463	255,102,0	1	60	0	.	Required for homodimerization, interaction with PEX11G, and peroxisomal localization. Pubmed:20826455
chr15	89750676	89750688	Q9BRJ9	0	-	89750676	89750688	255,102,0	1	12	0	.	2 X 2 AA tandem repeats of G-Q.
chr15	89776891	89776969	Q0VG99	0	+	89776891	89776969	255,102,0	1	78	0	.	13 X 2 AA tandem repeats of G-Q.
chr15	89785351	89806379	P15144	0	-	89785351	89806379	255,102,0	1	21028	0	.	Metalloprotease.
chr15	89804363	89804378	P15144	0	-	89804363	89804378	255,102,0	1	15	0	.	Substrate binding. Pubmed:22932899
chr15	89805089	89805113	P15144	0	-	89805089	89805113	255,102,0	1	24	0	.	Necessary and sufficient to mediate interaction with HCoV-229E. Pubmed:8887485, Pubmed:1350662
chr15	89806379	89806487	P15144	0	-	89806379	89806487	255,102,0	1	108	0	.	Cytosolic Ser/Thr-rich junction.
chr15	89901797	89903257	Q7Z6K5	0	-	89901797	89903257	255,102,0	1	1460	0	.	Necessary and sufficient for interaction with ARPC2. Pubmed:24132237
chr15	90088700	90088721	P48735	0	-	90088700	90088721	255,102,0	1	21	0	.	Substrate binding.
chr15	90476743	90484253	P46940	0	+	90476743	90484253	255,102,0	1	7510	0	.	C1.
chr15	90484256	90500105	P46940	0	+	90484256	90500105	255,102,0	1	15849	0	.	C2.
chr15	90530071	90593713	Q6UUV7	0	+	90530071	90593713	255,102,0	1	63642	0	.	Required for interaction with HTLV-1 TAX.
chr15	90751887	90761173	P54132	0	+	90751887	90761173	255,102,0	1	9286	0	.	Necessary for interaction with SPIDR. Pubmed:23509288
chr15	90881767	90881779	P09958	0	+	90881767	90881779	255,102,0	1	12	0	.	Cell surface signal.
chr15	90885045	90889610	P07332	0	+	90885045	90889610	255,102,0	1	4565	0	.	Important for interaction with membranes containing phosphoinositides.
chr15	90967133	90974198	O43663	0	-	90967133	90974198	255,102,0	1	7065	0	.	Unstructured, Arg/Lys rich.
chr15	90974198	90979241	O43663	0	-	90974198	90979241	255,102,0	1	5043	0	.	Spectrin-fold.
chr15	90979241	90994417	O43663	0	-	90979241	90994417	255,102,0	1	15176	0	.	Dimerization.
chr15	92444702	92444711	Q92186	0	+	92444702	92444711	255,102,0	1	9	0	.	Substrate binding.
chr15	92464136	92464145	Q92186	0	+	92464136	92464145	255,102,0	1	9	0	.	Substrate binding.
chr15	92464241	92464247	Q92186	0	+	92464241	92464247	255,102,0	1	6	0	.	Substrate binding.
chr15	96332453	96337619	P24468	0	+	96332453	96337619	255,102,0	1	5166	0	.	Interaction with ZFPM2.
chr15	96334179	96337619	P24468	0	+	96334179	96337619	255,102,0	1	3440	0	.	Ligand-binding.
chr15	96337385	96337619	P24468	0	+	96337385	96337619	255,102,0	1	234	0	.	Important for dimerization.
chr15	100051689	100096389	Q8TE56	0	-	100051689	100096389	255,102,0	1	44700	0	.	Spacer.
chr15	101275302	101275341	Q9BQE4	0	-	101275302	101275341	255,102,0	1	39	0	.	VCP/p97-interacting motif (VIM). Pubmed:21896481
chr15	101307234	101326474	P29122	0	-	101307234	101326474	255,102,0	1	19240	0	.	CRM (Cys-rich motif).
chr16	289534	297783	O15169	0	-	289534	297783	255,102,0	1	8249	0	.	Interaction with PPP2CA. Pubmed:9920888
chr16	291212	297987	O15169	0	-	291212	297987	255,102,0	1	6775	0	.	Interaction with RNF111. Pubmed:16601693
chr16	291227	293645	O15169	0	-	291227	293645	255,102,0	1	2418	0	.	Interaction with HIPK2.
chr16	297999	298206	O15169	0	-	297999	298206	255,102,0	1	207	0	.	Interaction with CTNNB1.
chr16	298206	310047	O15169	0	-	298206	310047	255,102,0	1	11841	0	.	Interaction with GSK3B.
chr16	314547	346401	O15169	0	-	314547	346401	255,102,0	1	31854	0	.	Interaction with TP53.
chr16	410280	410289	Q9NUI1	0	+	410280	410289	255,102,0	1	9	0	.	Substrate binding.
chr16	505577	519795	O75154	0	+	505577	519795	255,102,0	1	14218	0	.	ARF-binding domain (ABD).
chr16	509123	523317	O75154	0	+	509123	523317	255,102,0	1	14194	0	.	ARF-binding domain (ABD).
chr16	765605	765753	Q13421	0	+	765605	765753	255,102,0	1	148	0	.	Required for megakaryocyte-potentiating factor activity.
chr16	1314066	1314084	P63279	0	+	1314066	1314084	255,102,0	1	18	0	.	Interaction with SUMO1.
chr16	1809309	1809321	Q16775	0	-	1809309	1809321	255,102,0	1	12	0	.	Substrate binding. Pubmed:10508780
chr16	1816970	1816979	Q16775	0	-	1816970	1816979	255,102,0	1	9	0	.	Substrate binding. Pubmed:10508780
chr16	1817233	1817242	Q16775	0	-	1817233	1817242	255,102,0	1	9	0	.	Substrate binding. Pubmed:10508780
chr16	1911955	1911961	Q96QI5	0	-	1911955	1911961	255,102,0	1	6	0	.	Substrate binding.
chr16	1912150	1912162	Q96QI5	0	-	1912150	1912162	255,102,0	1	12	0	.	Substrate binding.
chr16	1913979	1913985	Q96QI5	0	-	1913979	1913985	255,102,0	1	6	0	.	Substrate binding.
chr16	1914174	1914186	Q96QI5	0	-	1914174	1914186	255,102,0	1	12	0	.	Substrate binding.
chr16	1917939	1917960	Q96QI5	0	-	1917939	1917960	255,102,0	1	21	0	.	Substrate binding.
chr16	1919963	1919984	Q96QI5	0	-	1919963	1919984	255,102,0	1	21	0	.	Substrate binding.
chr16	1979171	1979201	Q8NFA2	0	-	1979171	1979201	255,102,0	1	30	0	.	Proline-rich region; mediates mutually exclusive interactions with itself and NOXA1.
chr16	2048615	2061951	P49815	0	+	2048615	2061951	255,102,0	1	13336	0	.	Required for interaction with TSC1.
chr16	2184785	2185334	Q8WXD9	0	-	2184785	2185334	255,102,0	1	549	0	.	CASK-binding.
chr16	2223733	2228469	Q66K89	0	+	2223733	2228469	255,102,0	1	4736	0	.	Required for ubiquitin ligase activity.
chr16	2232304	2232814	Q66K89	0	+	2232304	2232814	255,102,0	1	510	0	.	Mediates dimerization, DNA-binding, transcription repression of CCNA2 and interaction with HMGA2. Pubmed:14645522
chr16	2233485	2234687	Q66K89	0	+	2233485	2234687	255,102,0	1	1202	0	.	Mediates interaction with CDKN2A.
chr16	2233917	2234863	Q66K89	0	+	2233917	2234863	255,102,0	1	946	0	.	Interaction with BMI1. Pubmed:16882984
chr16	2234355	2234729	Q66K89	0	+	2234355	2234729	255,102,0	1	374	0	.	Mediates interaction with TP53.
chr16	2234711	2234780	Q66K89	0	+	2234711	2234780	255,102,0	1	69	0	.	Mediates interaction with RASSF1. Pubmed:14729613
chr16	2244516	2244531	P42126	0	-	2244516	2244531	255,102,0	1	15	0	.	Substrate binding. Pubmed:15351645
chr16	2253966	2255691	Q15287	0	-	2253966	2255691	255,102,0	1	1725	0	.	Necessary for interaction with TRA2B, nuclear localization and exon-skipping. Pubmed:14729963
chr16	2255670	2262787	Q15287	0	-	2255670	2262787	255,102,0	1	7117	0	.	Interaction with SAP18 and ACIN1. Pubmed:20966198
chr16	2255676	2262796	Q15287	0	-	2255676	2262796	255,102,0	1	7120	0	.	Necessary for interaction with PNN and exon-skipping.
chr16	2262293	2264643	Q15287	0	-	2262293	2264643	255,102,0	1	2350	0	.	Necessary for interaction with the cleaved p110 isoform of CDC2L1.
chr16	2262778	2264643	Q15287	0	-	2262778	2264643	255,102,0	1	1865	0	.	Necessary for interaction with SRP54, nuclear localization and exon-skipping. Pubmed:14729963
chr16	2263151	2264198	Q15287	0	-	2263151	2264198	255,102,0	1	1047	0	.	Necessary for interactions with UPF2 and UPF3B and UPF2-dependent NMD.
chr16	2455422	2456957	P41002	0	+	2455422	2456957	255,102,0	1	1535	0	.	PEST.
chr16	2527816	2527822	Q9Y303	0	+	2527816	2527822	255,102,0	1	6	0	.	Substrate binding.
chr16	2528133	2528139	Q9Y303	0	+	2528133	2528139	255,102,0	1	6	0	.	Substrate binding.
chr16	2528322	2528334	Q9Y303	0	+	2528322	2528334	255,102,0	1	12	0	.	Substrate binding.
chr16	2528660	2528669	Q9Y303	0	+	2528660	2528669	255,102,0	1	9	0	.	Substrate binding.
chr16	2561778	2565557	O15530	0	+	2561778	2565557	255,102,0	1	3779	0	.	PIF-pocket. Pubmed:22999883
chr16	2758542	2759605	Q9UQ35	0	+	2758542	2759605	255,102,0	1	1063	0	.	Sufficient for RNA-binding.
chr16	2972955	2974001	Q99640	0	-	2972955	2974001	255,102,0	1	1046	0	.	Interaction with CDC2-CCNB1.
chr16	2972955	2974118	Q99640	0	-	2972955	2974118	255,102,0	1	1163	0	.	Interaction with PIN1.
chr16	3015361	3015367	P56747	0	-	3015361	3015367	255,102,0	1	6	0	.	Interactions with TJP1, TJP2 and TJP3.
chr16	3023276	3023288	Q9NWW0	0	-	3023276	3023288	255,102,0	1	12	0	.	Interaction with HCFC1. Pubmed:12235138
chr16	3244266	3249433	O15553	0	-	3244266	3249433	255,102,0	1	5167	0	.	Required for homotrimerization and induction of pyroptosomes.
chr16	3254227	3254272	O15553	0	-	3254227	3254272	255,102,0	1	45	0	.	Interaction with RELA. Pubmed:18577712
chr16	3482561	3482570	Q9H7X0	0	+	3482561	3482570	255,102,0	1	9	0	.	Acetyl-CoA binding. Pubmed:27320834, Pubmed:27550639
chr16	3482585	3483367	Q9H7X0	0	+	3482585	3483367	255,102,0	1	782	0	.	Acetyl-CoA binding. Pubmed:27320834, Pubmed:27550639
chr16	3483472	3483484	Q9H7X0	0	+	3483472	3483484	255,102,0	1	12	0	.	Acetyl-CoA binding. Pubmed:27320834, Pubmed:27550639
chr16	3483508	3483544	Q9H7X0	0	+	3483508	3483544	255,102,0	1	36	0	.	Required for homodimerization. Pubmed:27320834
chr16	3582344	3583356	Q8IY92	0	-	3582344	3583356	255,102,0	1	1012	0	.	Interaction with SLX1.
chr16	3582344	3594563	Q8IY92	0	-	3582344	3594563	255,102,0	1	12219	0	.	Interaction with PLK1 and TERF2-TERF2IP. Pubmed:19596235
chr16	3583305	3589656	Q8IY92	0	-	3583305	3589656	255,102,0	1	6351	0	.	Interaction with MUS81.
chr16	3595610	3608964	Q8IY92	0	-	3595610	3608964	255,102,0	1	13354	0	.	Interaction with SLX4IP, ERCC4 and MSH2. Pubmed:19596235
chr16	3729373	3738575	Q92793	0	-	3729373	3738575	255,102,0	1	9202	0	.	Interaction with TRERF1. Pubmed:11349124
chr16	3738611	3738617	I3L466	0	-	3738611	3738617	255,102,0	1	6	0	.	Acetyl-CoA binding.
chr16	3738611	3738617	Q92793	0	-	3738611	3738617	255,102,0	1	6	0	.	Acetyl-CoA binding.
chr16	3738644	3738653	I3L466	0	-	3738644	3738653	255,102,0	1	9	0	.	Acetyl-CoA binding.
chr16	3738644	3738653	Q92793	0	-	3738644	3738653	255,102,0	1	9	0	.	Acetyl-CoA binding.
chr16	3738647	3738656	Q92793	0	-	3738647	3738656	255,102,0	1	9	0	.	Interaction with histone.
chr16	3757877	3757934	Q92793	0	-	3757877	3757934	255,102,0	1	57	0	.	Interaction with ASF1A. Pubmed:24616510
chr16	3757907	3758048	Q92793	0	-	3757907	3758048	255,102,0	1	141	0	.	Interaction with histone. Pubmed:24361270
chr16	3792080	3850416	Q92793	0	-	3792080	3850416	255,102,0	1	58336	0	.	Interaction with SRCAP. Pubmed:10347196
chr16	4260583	4261853	Q01664	0	-	4260583	4261853	255,102,0	1	1270	0	.	Leucine-zipper 2.
chr16	4261943	4262380	Q01664	0	-	4261943	4262380	255,102,0	1	437	0	.	Leucine-zipper 1.
chr16	4332382	4334977	Q9BZE0	0	+	4332382	4334977	255,102,0	1	2595	0	.	Interaction with CTNND1.
chr16	4333384	4334866	Q9BZE0	0	+	4333384	4334866	255,102,0	1	1482	0	.	Transcription activation.
chr16	4334896	4334968	Q9BZE0	0	+	4334896	4334968	255,102,0	1	72	0	.	Transcription repression.
chr16	4340366	4341421	Q9Y3D7	0	-	4340366	4341421	255,102,0	1	1055	0	.	J-like.
chr16	4463812	4466225	Q9HBL8	0	-	4463812	4466225	255,102,0	1	2413	0	.	Interaction with ASS1.
chr16	4465771	4468184	Q9HBL8	0	-	4465771	4468184	255,102,0	1	2413	0	.	Interaction with ASS1.
chr16	4694175	4695158	Q9BRJ7	0	+	4694175	4695158	255,102,0	1	983	0	.	Interaction with PXN.
chr16	4777799	4779741	Q8IYM1	0	-	4777799	4779741	255,102,0	1	1942	0	.	Self-association (via N-terminus) to polymerize octomeric septin 12-7-6-2/4-2/4-6-7-12 filaments.
chr16	4777916	4787510	Q8IYM1	0	-	4777916	4787510	255,102,0	1	9594	0	.	Interaction with SEPT7. Pubmed:25588830
chr16	4852917	4859090	Q9NPG3	0	+	4852917	4859090	255,102,0	1	6173	0	.	Sufficient for interaction with HIRA. Pubmed:19029251
chr16	5025546	5025570	Q9UK23	0	-	5025546	5025570	255,102,0	1	24	0	.	Mediates the interaction with AP4M1. Pubmed:26544806
chr16	5090324	5090333	Q96G04	0	-	5090324	5090333	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr16	8764779	8764785	P80404	0	+	8764779	8764785	255,102,0	1	6	0	.	Pyridoxal phosphate binding.
chr16	8899663	8902458	Q93009	0	-	8899663	8902458	255,102,0	1	2795	0	.	Interaction with ICP0/VMW110. Pubmed:16160161
chr16	8919126	8930320	Q93009	0	-	8919126	8930320	255,102,0	1	11194	0	.	Interaction with p53/TP53, MDM2 and EBNA1. Pubmed:14506283
chr16	8919126	8963285	Q93009	0	-	8919126	8963285	255,102,0	1	44159	0	.	Interaction with TSPYL5. Pubmed:21170034
chr16	8919135	8923390	Q93009	0	-	8919135	8923390	255,102,0	1	4255	0	.	Necessary for nuclear localization.
chr16	9822361	9822367	Q12879	0	-	9822361	9822367	255,102,0	1	6	0	.	Glutamate binding.
chr16	9840758	9840767	Q12879	0	-	9840758	9840767	255,102,0	1	9	0	.	Glutamate binding.
chr16	11254932	11254962	O15524	0	-	11254932	11254962	255,102,0	1	30	0	.	Interaction with Elongin BC complex.
chr16	11255244	11255280	O15524	0	-	11255244	11255280	255,102,0	1	36	0	.	Extended SH2 subdomain (ESS).
chr16	11255280	11255316	O15524	0	-	11255280	11255316	255,102,0	1	36	0	.	Kinase inhibitory region (KIR).
chr16	11886517	11886526	P15170	0	-	11886517	11886526	255,102,0	1	9	0	.	G5.
chr16	11886805	11886817	P15170	0	-	11886805	11886817	255,102,0	1	12	0	.	G4.
chr16	11887629	11887641	P15170	0	-	11887629	11887641	255,102,0	1	12	0	.	G3.
chr16	11887689	11887704	P15170	0	-	11887689	11887704	255,102,0	1	15	0	.	G2.
chr16	11894973	11896567	P15170	0	-	11894973	11896567	255,102,0	1	1594	0	.	G1.
chr16	12665080	12781335	Q9BRF8	0	-	12665080	12781335	255,102,0	1	116255	0	.	Catalytic.
chr16	13920165	13935303	Q92889	0	+	13920165	13935303	255,102,0	1	15138	0	.	Helicase-like.
chr16	13928139	13928205	Q92889	0	+	13928139	13928205	255,102,0	1	66	0	.	Leucine-zipper 1.
chr16	13930724	13930811	Q92889	0	+	13930724	13930811	255,102,0	1	87	0	.	Leucine-zipper 2.
chr16	13944789	13948035	Q92889	0	+	13944789	13948035	255,102,0	1	3246	0	.	Nuclease.
chr16	13948104	13948311	Q92889	0	+	13948104	13948311	255,102,0	1	207	0	.	HhH2, dimerization with ERCC1.
chr16	15028587	15035076	Q9NYV6	0	+	15028587	15035076	255,102,0	1	6489	0	.	Interaction with TWISTNB. Pubmed:12393749
chr16	15031565	15035076	Q9NYV6	0	+	15031565	15035076	255,102,0	1	3511	0	.	Interaction with EIF3L. Pubmed:12393749
chr16	15061746	15065256	Q9NYV6	0	-	15061746	15065256	255,102,0	1	3510	0	.	Interaction with EIF3L. Pubmed:12393749
chr16	15061746	15068224	Q9NYV6	0	-	15061746	15068224	255,102,0	1	6478	0	.	Interaction with TWISTNB. Pubmed:12393749
chr16	15395942	15396062	Q2QL34	0	+	15395942	15396062	255,102,0	1	120	0	.	Targeting to peroxisomes.
chr16	15481048	15481168	Q2QL34	0	+	15481048	15481168	255,102,0	1	120	0	.	Targeting to peroxisomes.
chr16	15703993	15704107	P35749	0	-	15703993	15704107	255,102,0	1	114	0	.	C-terminal.
chr16	15747652	15747697	P35749	0	-	15747652	15747697	255,102,0	1	45	0	.	Actin-binding.
chr16	15750146	15750215	P35749	0	-	15750146	15750215	255,102,0	1	69	0	.	Actin-binding.
chr16	15789147	15789261	P35749	0	-	15789147	15789261	255,102,0	1	114	0	.	C-terminal.
chr16	15832806	15832851	P35749	0	-	15832806	15832851	255,102,0	1	45	0	.	Actin-binding.
chr16	15835300	15835369	P35749	0	-	15835300	15835369	255,102,0	1	69	0	.	Actin-binding.
chr16	15879802	15888585	Q96NB1	0	-	15879802	15888585	255,102,0	1	8783	0	.	Necessary and sufficient for homooligomerization and localization to centrosomes and pericentriolar satellites.
chr16	15964940	15973729	Q96NB1	0	-	15964940	15973729	255,102,0	1	8789	0	.	Necessary and sufficient for homooligomerization and localization to centrosomes and pericentriolar satellites.
chr16	18847517	18926041	Q96Q15	0	-	18847517	18926041	255,102,0	1	78524	0	.	Interaction with SMG8 and SMG9. Pubmed:21245168
chr16	19071995	19078155	Q99807	0	+	19071995	19078155	255,102,0	1	6160	0	.	2 X approximate tandem repeats.
chr16	19527881	19536338	O43303	0	+	19527881	19536338	255,102,0	1	8457	0	.	CEP97 binding.
chr16	19532463	19532520	O43303	0	+	19532463	19532520	255,102,0	1	57	0	.	Calmodulin-binding.
chr16	19532472	19532520	O43303	0	+	19532472	19532520	255,102,0	1	48	0	.	Required for interaction with CEP290. Pubmed:18694559
chr16	19536716	19537364	O43303	0	+	19536716	19537364	255,102,0	1	648	0	.	Interaction with CEP76. Pubmed:19460342
chr16	19542733	19542973	O43303	0	+	19542733	19542973	255,102,0	1	240	0	.	Calmodulin-binding.
chr16	19545837	19545885	O43303	0	+	19545837	19545885	255,102,0	1	48	0	.	Calmodulin-binding.
chr16	19706912	19714120	Q1ED39	0	-	19706912	19714120	255,102,0	1	7208	0	.	Interaction with ZNF106.
chr16	20336646	20336676	P07911	0	-	20336646	20336676	255,102,0	1	30	0	.	Regulates polymerization into filaments. Pubmed:19005207
chr16	20336700	20336712	P07911	0	-	20336700	20336712	255,102,0	1	12	0	.	Essential for cleavage by HPN. Pubmed:26811476, Pubmed:19005207, Pubmed:26673890
chr16	20341308	20344067	P07911	0	-	20341308	20344067	255,102,0	1	2759	0	.	Important for secretion and polymerization into filaments. Pubmed:26811476
chr16	20480695	20480825	Q08AH3	0	+	20480695	20480825	255,102,0	1	130	0	.	Coenzyme A binding. Pubmed:19345228
chr16	20483165	20483174	Q08AH3	0	+	20483165	20483174	255,102,0	1	9	0	.	Coenzyme A binding. Pubmed:19345228
chr16	20540656	20540665	Q68CK6	0	-	20540656	20540665	255,102,0	1	9	0	.	Coenzyme A binding.
chr16	20543009	20543139	Q68CK6	0	-	20543009	20543139	255,102,0	1	130	0	.	Coenzyme A binding.
chr16	20952484	20963422	Q8TD57	0	-	20952484	20963422	255,102,0	1	10938	0	.	AAA 6.
chr16	20964058	20964751	Q8TD57	0	-	20964058	20964751	255,102,0	1	693	0	.	AAA 5.
chr16	20965003	20979425	Q8TD57	0	-	20965003	20979425	255,102,0	1	14422	0	.	Stalk.
chr16	20979467	20985559	Q8TD57	0	-	20979467	20985559	255,102,0	1	6092	0	.	AAA 4.
chr16	20987722	21003124	Q8TD57	0	-	20987722	21003124	255,102,0	1	15402	0	.	AAA 3.
chr16	21022037	21036785	Q8TD57	0	-	21022037	21036785	255,102,0	1	14748	0	.	AAA 2.
chr16	21037874	21051737	Q8TD57	0	-	21037874	21051737	255,102,0	1	13863	0	.	AAA 1.
chr16	21051737	21159441	Q8TD57	0	-	21051737	21159441	255,102,0	1	107704	0	.	Stem.
chr16	21201736	21201805	Q05996	0	-	21201736	21201805	255,102,0	1	69	0	.	Disordered.
chr16	21233737	21250322	Q8N8V4	0	+	21233737	21250322	255,102,0	1	16585	0	.	Mediates localization to microvilli. Pubmed:26812018
chr16	21250322	21250604	Q8N8V4	0	+	21250322	21250604	255,102,0	1	282	0	.	Mediates interaction with MYO7B. Pubmed:26812018
chr16	22273640	22273691	O00418	0	+	22273640	22273691	255,102,0	1	51	0	.	Calmodulin-binding.
chr16	22273688	22273742	O00418	0	+	22273688	22273742	255,102,0	1	54	0	.	Pseudosubstrate/autoinhibitory domain.
chr16	22815045	22815066	Q9Y278	0	+	22815045	22815066	255,102,0	1	21	0	.	Substrate binding.
chr16	22914986	22914998	Q9Y278	0	+	22914986	22914998	255,102,0	1	12	0	.	Substrate binding.
chr16	22915190	22915196	Q9Y278	0	+	22915190	22915196	255,102,0	1	6	0	.	Substrate binding.
chr16	23474904	23480705	Q9UJY4	0	-	23474904	23480705	255,102,0	1	5801	0	.	Unstructured hinge.
chr16	23535149	23535164	Q5JPH6	0	-	23535149	23535164	255,102,0	1	15	0	.	Glutamate binding.
chr16	23557217	23557226	Q5JPH6	0	-	23557217	23557226	255,102,0	1	9	0	.	Glutamate binding.
chr16	23603461	23629233	Q86YC2	0	-	23603461	23629233	255,102,0	1	25772	0	.	Interaction with RAD51, BRCA2 and POLH. Pubmed:24485656
chr16	23603461	23629831	Q86YC2	0	-	23603461	23629831	255,102,0	1	26370	0	.	Required for interaction with POLH and POLH DNA synthesis stimulation. Pubmed:24485656
chr16	23630416	23641157	Q86YC2	0	-	23630416	23641157	255,102,0	1	10741	0	.	DNA-binding (with the preference D loop > dsDNA > ssDNA).
chr16	23635207	23635363	Q86YC2	0	-	23635207	23635363	255,102,0	1	156	0	.	ChAM (Chromatin-association motif); required for chromatin association, mediates nucleosome association.
chr16	23635588	23641157	Q86YC2	0	-	23635588	23641157	255,102,0	1	5569	0	.	Interaction with BRCA1. Pubmed:19369211
chr16	23635945	23641157	Q86YC2	0	-	23635945	23641157	255,102,0	1	5212	0	.	Interaction with RAD51.
chr16	23636065	23641157	Q86YC2	0	-	23636065	23641157	255,102,0	1	5092	0	.	Required for its oligomerization and is important for its focal concentration at DNA damage sites.
chr16	23680915	23680999	P53350	0	+	23680915	23680999	255,102,0	1	84	0	.	Activation loop.
chr16	23689544	23689589	P53350	0	+	23689544	23689589	255,102,0	1	45	0	.	Linker.
chr16	23689862	23689871	P53350	0	+	23689862	23689871	255,102,0	1	9	0	.	Important for interaction with phosphorylated proteins.
chr16	24569633	24570107	Q7Z6E9	0	+	24569633	24570107	255,102,0	1	474	0	.	Interaction with RB1.
chr16	24571362	24571698	Q7Z6E9	0	+	24571362	24571698	255,102,0	1	336	0	.	Interaction with p53.
chr16	24729841	24791438	Q8NDV7	0	+	24729841	24791438	255,102,0	1	61597	0	.	Interaction with argonaute family proteins.
chr16	24789401	24790151	Q8NDV7	0	+	24789401	24790151	255,102,0	1	750	0	.	Sufficient for interaction with AGO1, AGO3 and AGO4.
chr16	24789449	24789680	Q8NDV7	0	+	24789449	24789680	255,102,0	1	231	0	.	Sufficient for interaction with AGO2.
chr16	24789593	24789839	Q8NDV7	0	+	24789593	24789839	255,102,0	1	246	0	.	Sufficient for interaction with AGO2.
chr16	24789659	24789959	Q8NDV7	0	+	24789659	24789959	255,102,0	1	300	0	.	Sufficient for interaction with AGO2.
chr16	24789866	24790127	Q8NDV7	0	+	24789866	24790127	255,102,0	1	261	0	.	Sufficient for interaction with AGO2.
chr16	24790145	24790895	Q8NDV7	0	+	24790145	24790895	255,102,0	1	750	0	.	Sufficient for interaction with AGO2.
chr16	24790337	24805058	Q8NDV7	0	+	24790337	24805058	255,102,0	1	14721	0	.	Sufficient for interaction with AGO1 and AGO4.
chr16	24793516	24794623	Q8NDV7	0	+	24793516	24794623	255,102,0	1	1107	0	.	Sufficient for interaction with AGO2.
chr16	24815283	24816850	Q8NDV7	0	+	24815283	24816850	255,102,0	1	1567	0	.	PABPC1-interacting motif-2 (PAM2).
chr16	24818627	24823804	Q8NDV7	0	+	24818627	24823804	255,102,0	1	5177	0	.	Sufficient for interaction with AGO2.
chr16	25161145	25161151	Q9UIC8	0	+	25161145	25161151	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr16	25693101	25693122	Q9Y661	0	+	25693101	25693122	255,102,0	1	21	0	.	Substrate binding.
chr16	26135654	26135666	Q9Y661	0	+	26135654	26135666	255,102,0	1	12	0	.	Substrate binding.
chr16	26135858	26135864	Q9Y661	0	+	26135858	26135864	255,102,0	1	6	0	.	Substrate binding.
chr16	27234217	27257570	Q8WV22	0	-	27234217	27257570	255,102,0	1	23353	0	.	Interaction with NSMCE3.
chr16	27362660	27363023	P24394	0	+	27362660	27363023	255,102,0	1	363	0	.	Required for IRS1 activation and IL4-induced cell growth.
chr16	27363023	27363323	P24394	0	+	27363023	27363323	255,102,0	1	300	0	.	Required for IL4-induced gene expression.
chr16	28590643	28590652	Q96ES7	0	+	28590643	28590652	255,102,0	1	9	0	.	Histone H3K4me3 N-terminus binding.
chr16	28590887	28590899	Q96ES7	0	+	28590887	28590899	255,102,0	1	12	0	.	Histone H3K4me3 N-terminus binding.
chr16	28591613	28591622	Q96ES7	0	+	28591613	28591622	255,102,0	1	9	0	.	Histone H3K4me3 binding.
chr16	28595414	28595423	P50226	0	-	28595414	28595423	255,102,0	1	9	0	.	Substrate binding.
chr16	28608338	28608347	P50225	0	-	28608338	28608347	255,102,0	1	9	0	.	Substrate binding.
chr16	28823550	28825650	Q8WWM7	0	+	28823550	28825650	255,102,0	1	2100	0	.	Interaction with MPL. Pubmed:11784712
chr16	28866094	28872341	Q9NRF2	0	+	28866094	28872341	255,102,0	1	6247	0	.	Interaction with JAK2 (low-affinity binding; independent of JAK2 phosphorylation).
chr16	28866163	28866349	Q9NRF2	0	+	28866163	28866349	255,102,0	1	186	0	.	Required for self-association.
chr16	28866346	28866682	Q9NRF2	0	+	28866346	28866682	255,102,0	1	336	0	.	Interaction with RAC1.
chr16	28866391	28866823	Q9NRF2	0	+	28866391	28866823	255,102,0	1	432	0	.	Required for NGF signaling.
chr16	28866763	28866793	Q9NRF2	0	+	28866763	28866793	255,102,0	1	30	0	.	Required for nuclear localization.
chr16	28894166	28894520	O14983	0	+	28894166	28894520	255,102,0	1	354	0	.	Interaction with phospholamban 1.
chr16	28902223	28902286	O14983	0	+	28902223	28902286	255,102,0	1	63	0	.	Interaction with phospholamban 2.
chr16	28986709	28986805	O43561	0	+	28986709	28986805	255,102,0	1	96	0	.	Interaction with PLCG1.
chr16	28989543	28989555	O43561	0	+	28989543	28989555	255,102,0	1	12	0	.	Interaction with GRB2, GRAP2 and PIK3R1. Pubmed:10811803
chr16	28989787	28989799	O43561	0	+	28989787	28989799	255,102,0	1	12	0	.	Interaction with GRB2, GRAP2 and PIK3R1. Pubmed:10811803
chr16	29461893	29461902	P0DMM9	0	+	29461893	29461902	255,102,0	1	9	0	.	Substrate binding.
chr16	29461893	29461902	P0DMN0	0	+	29461893	29461902	255,102,0	1	9	0	.	Substrate binding.
chr16	29695058	29695067	Q15274	0	+	29695058	29695067	255,102,0	1	9	0	.	Substrate binding.
chr16	29697258	29697267	Q15274	0	+	29697258	29697267	255,102,0	1	9	0	.	Substrate binding.
chr16	29697321	29697330	Q15274	0	+	29697321	29697330	255,102,0	1	9	0	.	Substrate binding.
chr16	29816870	29817005	Q9BTK6	0	+	29816870	29817005	255,102,0	1	135	0	.	Sufficient for interaction with NCOA1. Pubmed:19039327
chr16	29817005	29819751	Q9BTK6	0	+	29817005	29819751	255,102,0	1	2746	0	.	Sufficient for interaction with ESR1. Pubmed:19039327
chr16	29897919	29897943	Q6UXD5	0	-	29897919	29897943	255,102,0	1	24	0	.	O-glycosylated at one site.
chr16	30006188	30007184	Q14183	0	-	30006188	30007184	255,102,0	1	996	0	.	Interaction with UNC13D. Pubmed:18354201
chr16	30009552	30010222	Q14183	0	-	30009552	30010222	255,102,0	1	670	0	.	Interaction with UNC13D and DYNLT1. Pubmed:9804756, Pubmed:18354201
chr16	30201236	30201245	P0DMM9	0	+	30201236	30201245	255,102,0	1	9	0	.	Substrate binding.
chr16	30201236	30201245	P0DMN0	0	+	30201236	30201245	255,102,0	1	9	0	.	Substrate binding.
chr16	30429115	30429130	Q9H773	0	-	30429115	30429130	255,102,0	1	15	0	.	Substrate binding.
chr16	30756703	30756866	P15735	0	+	30756703	30756866	255,102,0	1	163	0	.	Calmodulin-binding (domain-N).
chr16	30756911	30756986	P15735	0	+	30756911	30756986	255,102,0	1	75	0	.	Calmodulin-binding (domain-C).
chr16	30980028	30980136	O15047	0	+	30980028	30980136	255,102,0	1	108	0	.	Interaction with CFP1.
chr16	30980133	30980768	O15047	0	+	30980133	30980768	255,102,0	1	635	0	.	Interaction with ASH2L, RBBP5 and WDR5. Pubmed:17998332
chr16	31038006	31039800	Q12846	0	+	31038006	31039800	255,102,0	1	1794	0	.	Interaction with CENPF.
chr16	31127191	31131256	Q9H7Z6	0	+	31127191	31131256	255,102,0	1	4065	0	.	Sufficient for interaction with KANSL1.
chr16	31130302	31130311	Q9H7Z6	0	+	31130302	31130311	255,102,0	1	9	0	.	Acetyl-CoA binding. Pubmed:21217699
chr16	31130323	31130344	Q9H7Z6	0	+	31130323	31130344	255,102,0	1	21	0	.	Acetyl-CoA binding. Pubmed:21217699
chr16	31472188	31474643	O43294	0	+	31472188	31474643	255,102,0	1	2455	0	.	Transcription activation.
chr16	31472188	31476017	O43294	0	+	31472188	31476017	255,102,0	1	3829	0	.	Interaction with PTK2B/PYK2.
chr16	31473898	31474234	O43294	0	+	31473898	31474234	255,102,0	1	336	0	.	Interaction with PTK2/FAK1.
chr16	46660474	46672321	Q96QK1	0	-	46660474	46672321	255,102,0	1	11847	0	.	Interaction with SLC11A2. Pubmed:24344282
chr16	46661849	46671731	Q96QK1	0	-	46661849	46671731	255,102,0	1	9882	0	.	Interaction with IGF2R cytoplasmic domain. Pubmed:15078903
chr16	46679017	46679050	Q96QK1	0	-	46679017	46679050	255,102,0	1	33	0	.	Interaction with SNX3. Pubmed:24344282
chr16	46682145	46683537	Q96QK1	0	-	46682145	46683537	255,102,0	1	1392	0	.	Interaction with SNX3. Pubmed:24344282
chr16	47461368	47497409	Q93100	0	+	47461368	47497409	255,102,0	1	36041	0	.	Calmodulin-binding.
chr16	47663699	47664933	Q93100	0	+	47663699	47664933	255,102,0	1	1234	0	.	Calmodulin-binding.
chr16	47689167	47693465	Q93100	0	+	47689167	47693465	255,102,0	1	4298	0	.	Calmodulin-binding.
chr16	48355662	48356241	Q8IUQ4	0	-	48355662	48356241	255,102,0	1	579	0	.	SBD.
chr16	48361582	48362161	Q8IUQ4	0	-	48361582	48362161	255,102,0	1	579	0	.	SBD.
chr16	49279406	49281282	P23435	0	-	49279406	49281282	255,102,0	1	1876	0	.	Necessary for interaction with CBLN3, and homotrimerization.
chr16	50625490	50630293	Q969G9	0	+	50625490	50630293	255,102,0	1	4803	0	.	Interaction with DVL1, DVL2 and DVL3.
chr16	50710631	50710733	Q9HC29	0	+	50710631	50710733	255,102,0	1	102	0	.	Required for CARD9 binding. Pubmed:24960071
chr16	50750013	50782419	Q9NQC7	0	+	50750013	50782419	255,102,0	1	32406	0	.	Interaction with TRIP. Pubmed:14676304
chr16	50779705	50779933	Q9NQC7	0	+	50779705	50779933	255,102,0	1	228	0	.	Interaction with TRAF2.
chr16	50779933	50781389	Q9NQC7	0	+	50779933	50781389	255,102,0	1	1456	0	.	Interaction with IKBKG/NEMO. Pubmed:15341735
chr16	53307893	53314903	Q3L8U1	0	+	53307893	53314903	255,102,0	1	7010	0	.	Binds A/T-rich DNA.
chr16	53314438	53314462	Q3L8U1	0	+	53314438	53314462	255,102,0	1	24	0	.	A.T hook-like.
chr16	53459519	53465587	Q08999	0	+	53459519	53465587	255,102,0	1	6068	0	.	Domain A.
chr16	53459519	53480757	Q08999	0	+	53459519	53480757	255,102,0	1	21238	0	.	Pocket; binds E1A.
chr16	53465587	53470618	Q08999	0	+	53465587	53470618	255,102,0	1	5031	0	.	Spacer.
chr16	53470618	53480757	Q08999	0	+	53470618	53480757	255,102,0	1	10139	0	.	Domain B.
chr16	53810187	53879849	Q9C0B1	0	+	53810187	53879849	255,102,0	1	69662	0	.	Fe2OG dioxygenase domain.
chr16	53826376	53826412	Q9C0B1	0	+	53826376	53826412	255,102,0	1	36	0	.	Loop L1; predicted to block binding of double-stranded DNA or RNA.
chr16	53826430	53826442	Q9C0B1	0	+	53826430	53826442	255,102,0	1	12	0	.	Substrate binding.
chr16	53873835	53873844	Q9C0B1	0	+	53873835	53873844	255,102,0	1	9	0	.	Alpha-ketoglutarate binding.
chr16	55483082	55485608	P08253	0	+	55483082	55485608	255,102,0	1	2526	0	.	Collagenase-like 1.
chr16	55485608	55491808	P08253	0	+	55485608	55491808	255,102,0	1	6200	0	.	Collagen-binding.
chr16	55491808	55493216	P08253	0	+	55491808	55493216	255,102,0	1	1408	0	.	Collagenase-like 2.
chr16	55491859	55505439	P08253	0	+	55491859	55505439	255,102,0	1	13580	0	.	Required for inhibitor TIMP2 binding.
chr16	56362920	56362977	Q9UKV5	0	-	56362920	56362977	255,102,0	1	57	0	.	VCP/p97-interacting motif (VIM). Pubmed:21914798
chr16	56434820	56447865	O43809	0	-	56434820	56447865	255,102,0	1	13045	0	.	Necessary for interactions with PAPOLA and PABPN1.
chr16	56439686	56451199	O43809	0	-	56439686	56451199	255,102,0	1	11513	0	.	Necessary for RNA-binding.
chr16	56447793	56447802	O43809	0	-	56447793	56447802	255,102,0	1	9	0	.	Interaction with RNA.
chr16	56589590	56589928	P25713	0	+	56589590	56589928	255,102,0	1	338	0	.	Beta.
chr16	56589928	56590946	P25713	0	+	56589928	56590946	255,102,0	1	1018	0	.	Alpha.
chr16	56608655	56609050	P02795	0	+	56608655	56609050	255,102,0	1	395	0	.	Beta.
chr16	56609050	56609351	P02795	0	+	56609050	56609351	255,102,0	1	301	0	.	Alpha.
chr16	56625851	56626524	P04732	0	+	56625851	56626524	255,102,0	1	673	0	.	Beta.
chr16	56626524	56626968	P04732	0	+	56626524	56626968	255,102,0	1	444	0	.	Alpha.
chr16	56632731	56633398	Q8N339	0	+	56632731	56633398	255,102,0	1	667	0	.	Beta.
chr16	56633398	56633839	Q8N339	0	+	56633398	56633839	255,102,0	1	441	0	.	Alpha.
chr16	56638738	56639322	P04731	0	+	56638738	56639322	255,102,0	1	584	0	.	Beta.
chr16	56639322	56639947	P04731	0	+	56639322	56639947	255,102,0	1	625	0	.	Alpha.
chr16	56651953	56652629	P07438	0	+	56651953	56652629	255,102,0	1	676	0	.	Beta.
chr16	56652629	56653062	P07438	0	+	56652629	56653062	255,102,0	1	433	0	.	Alpha.
chr16	56658058	56658733	P04733	0	+	56658058	56658733	255,102,0	1	675	0	.	Beta.
chr16	56658733	56659161	P04733	0	+	56658733	56659161	255,102,0	1	428	0	.	Alpha.
chr16	56666881	56667318	P13640	0	-	56666881	56667318	255,102,0	1	437	0	.	Alpha.
chr16	56667321	56667993	P13640	0	-	56667321	56667993	255,102,0	1	672	0	.	Beta.
chr16	56669884	56670564	P80294	0	+	56669884	56670564	255,102,0	1	680	0	.	Beta.
chr16	56670564	56670986	P80294	0	+	56670564	56670986	255,102,0	1	422	0	.	Alpha.
chr16	56682540	56683223	P80297	0	+	56682540	56683223	255,102,0	1	683	0	.	Beta.
chr16	56683223	56684046	P80297	0	+	56683223	56684046	255,102,0	1	823	0	.	Alpha.
chr16	56936728	56939940	Q15011	0	+	56936728	56939940	255,102,0	1	3212	0	.	Interaction with UBQLN1. Pubmed:18307982
chr16	57121149	57123458	Q96FN4	0	+	57121149	57123458	255,102,0	1	2309	0	.	Linker region.
chr16	57379635	57382138	P78423	0	+	57379635	57382138	255,102,0	1	2503	0	.	Chemokine and involved in interaction with ITGAV:ITGB3 and ITGA4:ITGB1. Pubmed:23125415
chr16	57382138	57382861	P78423	0	+	57382138	57382861	255,102,0	1	723	0	.	Mucin-like stalk.
chr16	57429172	57431227	Q6FI81	0	-	57429172	57431227	255,102,0	1	2055	0	.	Intrinsically disordered.
chr16	57431227	57434083	Q6FI81	0	-	57431227	57434083	255,102,0	1	2856	0	.	Linker.
chr16	57434083	57440928	Q6FI81	0	-	57434083	57440928	255,102,0	1	6845	0	.	N-terminal domain.
chr16	57459573	57459585	O75208	0	+	57459573	57459585	255,102,0	1	12	0	.	Lipid binding. Pubmed:25339443
chr16	57651210	57651234	Q9Y653	0	+	57651210	57651234	255,102,0	1	24	0	.	Heparin-binding. Pubmed:27068534
chr16	57653282	57653315	Q9Y653	0	+	57653282	57653315	255,102,0	1	33	0	.	Heparin-binding. Pubmed:27068534
chr16	57737243	57752925	Q9BVA0	0	+	57737243	57752925	255,102,0	1	15682	0	.	Interaction with dynein.
chr16	57737243	57753121	Q9BVA0	0	+	57737243	57753121	255,102,0	1	15878	0	.	Interaction with centrosomes.
chr16	57752925	57755124	Q9BVA0	0	+	57752925	57755124	255,102,0	1	2199	0	.	Interaction with PAFAH1B1.
chr16	57755118	57756943	Q9BVA0	0	+	57755118	57756943	255,102,0	1	1825	0	.	Interaction with KATNA1 and NDEL1.
chr16	58392601	58392649	Q9BRX5	0	+	58392601	58392649	255,102,0	1	48	0	.	Not essential for folding and stability of GINS complex, but may regulate accessibility to the central complex pore.
chr16	58539944	58551206	A5YKK6	0	-	58539944	58551206	255,102,0	1	11262	0	.	Interaction with CNOT6, CNOT6L, CNOT7 and CNOT8. Pubmed:22977175
chr16	58551744	58556928	A5YKK6	0	-	58551744	58556928	255,102,0	1	5184	0	.	Interaction with ZFP36.
chr16	66758782	66770015	Q8NA31	0	-	66758782	66770015	255,102,0	1	11233	0	.	Interaction with TERF1.
chr16	66813565	66813607	Q13564	0	-	66813565	66813607	255,102,0	1	42	0	.	Interaction with UBA3.
chr16	66852795	66852801	P43166	0	+	66852795	66852801	255,102,0	1	6	0	.	Substrate binding.
chr16	66909300	66910431	O75309	0	-	66909300	66910431	255,102,0	1	1131	0	.	Ectodomain G.
chr16	66922111	66922171	P55042	0	-	66922111	66922171	255,102,0	1	60	0	.	Calmodulin-binding.
chr16	67154720	67154924	Q15628	0	-	67154720	67154924	255,102,0	1	204	0	.	Interaction with KRT14 and KRT18. Pubmed:11684708
chr16	67165969	67166605	Q9ULV5	0	+	67165969	67166605	255,102,0	1	636	0	.	Hydrophobic repeat HR-A/B.
chr16	67167477	67167831	Q9ULV5	0	+	67167477	67167831	255,102,0	1	354	0	.	Interactions with DUSP26, MAPK1 and MAPK2.
chr16	67168837	67168915	Q9ULV5	0	+	67168837	67168915	255,102,0	1	78	0	.	Hydrophobic repeat HR-C.
chr16	67187068	67189676	Q86VI1	0	-	67187068	67189676	255,102,0	1	2608	0	.	Mediates interaction with EXOC2, EXOC4 and EXOC5.
chr16	67192353	67192820	Q16254	0	+	67192353	67192820	255,102,0	1	467	0	.	Leucine-zipper.
chr16	67193018	67194715	Q16254	0	+	67193018	67194715	255,102,0	1	1697	0	.	Dimerization.
chr16	67195981	67198120	Q16254	0	+	67195981	67198120	255,102,0	1	2139	0	.	Transactivation.
chr16	67198048	67198102	Q16254	0	+	67198048	67198102	255,102,0	1	54	0	.	Interaction with RBL1 and RBL2.
chr16	67231513	67233869	Q9Y613	0	-	67231513	67233869	255,102,0	1	2356	0	.	Interaction with ROCK1. Pubmed:18694941
chr16	67436787	67436802	P80365	0	+	67436787	67436802	255,102,0	1	15	0	.	Essential for protein stability.
chr16	67482695	67482704	O00253	0	-	67482695	67482704	255,102,0	1	9	0	.	Interaction with melanocortin receptors.
chr16	67649281	67649887	Q6F5E8	0	+	67649281	67649887	255,102,0	1	606	0	.	Tropomodulin-like.
chr16	67654368	67654452	Q6F5E8	0	+	67654368	67654452	255,102,0	1	84	0	.	Necessary for localization at the cell membrane. Pubmed:26578515
chr16	67658630	67659250	Q96AP0	0	-	67658630	67659250	255,102,0	1	620	0	.	Interaction with POT1.
chr16	67661038	67661954	Q9NPB6	0	+	67661038	67661954	255,102,0	1	916	0	.	Interaction with PRKCI and PRKCZ.
chr16	67661981	67662365	Q9NPB6	0	+	67661981	67662365	255,102,0	1	384	0	.	Interaction with PARD3 and CDC42.
chr16	67829439	67832240	Q96BT3	0	-	67829439	67832240	255,102,0	1	2801	0	.	Flexible stalk domain.
chr16	67881364	67881509	Q6P2E9	0	+	67881364	67881509	255,102,0	1	145	0	.	Sufficient for nuclear localization.
chr16	68122207	68122225	Q12968	0	+	68122207	68122225	255,102,0	1	18	0	.	Calcineurin-binding.
chr16	68122501	68122807	Q12968	0	+	68122501	68122807	255,102,0	1	306	0	.	3 X SP repeats.
chr16	68828280	68829665	P12830	0	+	68828280	68829665	255,102,0	1	1385	0	.	Required for binding CTNND1 and PSEN1.
chr16	68829788	68833496	P12830	0	+	68829788	68833496	255,102,0	1	3708	0	.	Required for binding alpha, beta and gamma catenins.
chr16	69300852	69300921	Q13425	0	+	69300852	69300921	255,102,0	1	69	0	.	Calmodulin-binding.
chr16	69311511	69316343	Q9UN37	0	+	69311511	69316343	255,102,0	1	4832	0	.	Interaction with CHMP1B.
chr16	69330045	69330078	Q9HBH1	0	-	69330045	69330078	255,102,0	1	33	0	.	Hydrophobic dimerization interface.
chr16	69339829	69340326	Q9Y221	0	+	69339829	69340326	255,102,0	1	497	0	.	N-terminal domain.
chr16	69340326	69341649	Q9Y221	0	+	69340326	69341649	255,102,0	1	1323	0	.	C-terminal domain.
chr16	69368461	69385722	Q15554	0	-	69368461	69385722	255,102,0	1	17261	0	.	TRFH dimerization.
chr16	69714996	69715005	P15559	0	-	69714996	69715005	255,102,0	1	9	0	.	Substrate binding.
chr16	70299300	70329945	Q9UMR2	0	+	70299300	70329945	255,102,0	1	30645	0	.	N-terminal lobe.
chr16	70315970	70316012	Q9UMR2	0	+	70315970	70316012	255,102,0	1	42	0	.	N-terminal helix.
chr16	70329945	70333579	Q9UMR2	0	+	70329945	70333579	255,102,0	1	3634	0	.	C-terminal lobe.
chr16	70346994	70366738	Q9NUU7	0	+	70346994	70366738	255,102,0	1	19744	0	.	N-terminal lobe.
chr16	70356113	70356155	Q9NUU7	0	+	70356113	70356155	255,102,0	1	42	0	.	N-terminal helix.
chr16	70366738	70371983	Q9NUU7	0	+	70366738	70371983	255,102,0	1	5245	0	.	C-terminal lobe.
chr16	70687945	70687960	Q08AM6	0	-	70687945	70687960	255,102,0	1	15	0	.	Mediates interaction with the PDZ domain of NOS1.
chr16	71849797	71850331	P0C7T5	0	+	71849797	71850331	255,102,0	1	534	0	.	Interaction with NCOR2 and ATXN1. Pubmed:16121196
chr16	71849797	71850331	P0C7T5	0	+	71849797	71850331	255,102,0	1	534	0	.	Self-association.
chr16	71930156	71933509	Q7Z443	0	-	71930156	71933509	255,102,0	1	3353	0	.	Channel pore-region.
chr16	72014667	72017033	Q02127	0	+	72014667	72017033	255,102,0	1	2366	0	.	Substrate binding.
chr16	72021236	72021254	Q02127	0	+	72021236	72021254	255,102,0	1	18	0	.	Substrate binding.
chr16	72023191	72023197	Q02127	0	+	72023191	72023197	255,102,0	1	6	0	.	Substrate binding.
chr16	72060620	72060638	P00738	0	+	72060620	72060638	255,102,0	1	18	0	.	Interaction with CD163.
chr16	74999674	74999701	Q8ND25	0	+	74999674	74999701	255,102,0	1	27	0	.	Required for endosomal and lysosomal localization and myristoylation.
chr16	75229735	75229888	P56945	0	-	75229735	75229888	255,102,0	1	153	0	.	Divergent helix-loop-helix motif.
chr16	75235650	75242760	P56945	0	-	75235650	75242760	255,102,0	1	7110	0	.	Substrate for kinases.
chr16	75395088	75395208	Q9UEE9	0	-	75395088	75395208	255,102,0	1	120	0	.	Hydrophilic.
chr16	75566486	75566883	P60520	0	+	75566486	75566883	255,102,0	1	397	0	.	Interaction with beta-tubulin.
chr16	75568051	75568150	P60520	0	+	75568051	75568150	255,102,0	1	99	0	.	Interaction with GABRG2.
chr16	77300308	77321118	Q8TE60	0	-	77300308	77321118	255,102,0	1	20810	0	.	Spacer.
chr16	78115117	79211793	Q9NZC7	0	+	78115117	79211793	255,102,0	1	1096676	0	.	Interaction with MAPT.
chr16	78424888	78432515	Q9NZC7	0	+	78424888	78432515	255,102,0	1	7627	0	.	Mediates targeting to the mitochondria.
chr16	79598783	79599527	O75444	0	-	79598783	79599527	255,102,0	1	744	0	.	Represses ARE-mediated transcription.
chr16	79598891	79598957	O75444	0	-	79598891	79598957	255,102,0	1	66	0	.	Leucine-zipper.
chr16	79598963	79599041	O75444	0	-	79598963	79599041	255,102,0	1	78	0	.	Basic motif.
chr16	81043164	81043824	O43313	0	+	81043164	81043824	255,102,0	1	660	0	.	Required for formation of RAD51 foci.
chr16	83899261	83907028	O95822	0	+	83899261	83907028	255,102,0	1	7767	0	.	Alpha-helical domain.
chr16	83907028	83915486	O95822	0	+	83907028	83915486	255,102,0	1	8458	0	.	Catalytic domain.
chr16	83912313	83912334	O95822	0	+	83912313	83912334	255,102,0	1	21	0	.	Malonyl-CoA binding.
chr16	84130405	84131318	Q3SXM5	0	-	84130405	84131318	255,102,0	1	913	0	.	Required for mitochondria translocation.
chr16	84590197	84590227	Q14019	0	-	84590197	84590227	255,102,0	1	30	0	.	Flexible and important for F-actin binding.
chr16	84700093	84744781	Q14694	0	+	84700093	84744781	255,102,0	1	44688	0	.	Interaction with p53/TP53. Pubmed:20096447
chr16	87891864	87891870	P35218	0	-	87891864	87891870	255,102,0	1	6	0	.	Substrate binding.
chr16	88004409	88027637	Q8N9N5	0	+	88004409	88027637	255,102,0	1	23228	0	.	Interaction with CUX1 and HDAC1.
chr16	88027568	88033116	Q8N9N5	0	+	88027568	88033116	255,102,0	1	5548	0	.	Necessary and sufficient for TP53 activation.
chr16	88027634	88035334	Q8N9N5	0	+	88027634	88035334	255,102,0	1	7700	0	.	DNA-binding.
chr16	88532654	88532690	Q8IX07	0	+	88532654	88532690	255,102,0	1	36	0	.	Interaction with TACC3.
chr16	88534337	88534358	Q8IX07	0	+	88534337	88534358	255,102,0	1	21	0	.	Interaction with CTBP2.
chr16	88686346	88686406	Q3KNW1	0	-	88686346	88686406	255,102,0	1	60	0	.	SNAG domain.
chr16	88804857	88805521	Q9H211	0	+	88804857	88805521	255,102,0	1	664	0	.	Interaction with GMNN.
chr16	88807355	88808275	Q9H211	0	+	88807355	88808275	255,102,0	1	920	0	.	Interaction with LRWD1. Pubmed:22645314
chr16	88826703	88856799	P34059	0	-	88826703	88856799	255,102,0	1	30096	0	.	Catalytic domain.
chr16	88879332	88880738	O75081	0	-	88879332	88880738	255,102,0	1	1406	0	.	Nervy homology region 3 (NHR3); essential for down-regulation of PFKFB3, PFKFB4 and PDK1 expression. Pubmed:23840896
chr16	88879413	88880738	O75081	0	-	88879413	88880738	255,102,0	1	1325	0	.	Mediates interaction with PRKAR2A. Pubmed:11823486
chr16	88881387	88976807	O75081	0	-	88881387	88976807	255,102,0	1	95420	0	.	Mediates localization to the nucleus.
chr16	88881402	88976807	O75081	0	-	88881402	88976807	255,102,0	1	95405	0	.	Mediates interaction with PDE7A (in isoform 2).
chr16	88881456	88882699	O75081	0	-	88881456	88882699	255,102,0	1	1243	0	.	Nervy homology region 2 (NHR2); essential for down-regulation of PFKFB3, PFKFB4 and PDK1 expression. Pubmed:23840896
chr16	88886049	88892339	O75081	0	-	88886049	88892339	255,102,0	1	6290	0	.	Interaction with HIF1A. Pubmed:25974097
chr16	88886127	88892432	O75081	0	-	88886127	88892432	255,102,0	1	6305	0	.	Interaction with ZBTB33. Pubmed:23251453
chr16	88892483	88976807	O75081	0	-	88892483	88976807	255,102,0	1	84324	0	.	Required for nucleolar targeting (in isoform 1).
chr16	89268480	89279437	Q6UB99	0	-	89268480	89279437	255,102,0	1	10957	0	.	Important for protein degradation. Pubmed:25413698
chr16	89863499	89863562	Q8WWL2	0	+	89863499	89863562	255,102,0	1	63	0	.	Spir-box.
chr16	90022721	90032771	O95995	0	+	90022721	90032771	255,102,0	1	10050	0	.	Regulates microtubule-binding.
chr16	90032771	90037249	O95995	0	+	90032771	90037249	255,102,0	1	4478	0	.	Microtubule-binding.
chr17	745837	745903	P57678	0	-	745837	745903	255,102,0	1	66	0	.	Leucine-zipper.
chr17	1495825	1497938	Q9BT40	0	-	1495825	1497938	255,102,0	1	2113	0	.	Required for ruffle localization.
chr17	1497944	1513978	Q9BT40	0	-	1497944	1513978	255,102,0	1	16034	0	.	Catalytic.
chr17	1646934	1648357	Q96NA2	0	-	1646934	1648357	255,102,0	1	1423	0	.	Necessary for interaction with RAB7A and RAB34, lysosomal distribution and morphology.
chr17	1650804	1650909	Q6P2Q9	0	-	1650804	1650909	255,102,0	1	105	0	.	Required for interaction with EFTUD2 and SNRNP200. Pubmed:17317632
chr17	1653901	1659490	Q6P2Q9	0	-	1653901	1659490	255,102,0	1	5589	0	.	Involved in interaction with pre-mRNA 5' splice site.
chr17	1653943	1658603	Q6P2Q9	0	-	1653943	1658603	255,102,0	1	4660	0	.	RNase H homology domain.
chr17	1658645	1660476	Q6P2Q9	0	-	1658645	1660476	255,102,0	1	1831	0	.	Restriction endonuclease homology domain.
chr17	1660485	1662018	Q6P2Q9	0	-	1660485	1662018	255,102,0	1	1533	0	.	Linker.
chr17	1660757	1660799	Q6P2Q9	0	-	1660757	1660799	255,102,0	1	42	0	.	Important for branch point selection.
chr17	1662018	1676325	Q6P2Q9	0	-	1662018	1676325	255,102,0	1	14307	0	.	Reverse transcriptase homology domain.
chr17	1777299	1777338	P36955	0	+	1777299	1777338	255,102,0	1	39	0	.	O-glycosylated at one site.
chr17	1787521	1787527	Q8IYR2	0	-	1787521	1787527	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr17	1804652	1804661	Q8IYR2	0	-	1804652	1804661	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr17	2057092	2057578	Q14526	0	+	2057092	2057578	255,102,0	1	486	0	.	Mediates HDAC-dependent transcriptional repression.
chr17	2057353	2057374	Q14526	0	+	2057353	2057374	255,102,0	1	21	0	.	Interaction with CTBP1.
chr17	2299243	2300413	Q86US8	0	-	2299243	2300413	255,102,0	1	1170	0	.	Interaction with telomeric DNA.
chr17	2300293	2300356	Q86US8	0	-	2300293	2300356	255,102,0	1	63	0	.	EJC-binding motif 2; mediates interaction with the EJC.
chr17	2300575	2300638	Q86US8	0	-	2300575	2300638	255,102,0	1	63	0	.	EJC-binding motif 1; mediates interaction with the EJC.
chr17	2323252	2323258	Q9GZT4	0	+	2323252	2323258	255,102,0	1	6	0	.	Substrate binding.
chr17	2387959	2388046	Q99583	0	-	2387959	2388046	255,102,0	1	87	0	.	Leucine-zipper.
chr17	2638288	2665453	P43034	0	+	2638288	2665453	255,102,0	1	27165	0	.	Required for self-association and interaction with PAFAH1B2 and PAFAH1B3.
chr17	2638288	2666997	P43034	0	+	2638288	2666997	255,102,0	1	28709	0	.	Interaction with NDE1.
chr17	2638288	2667105	P43034	0	+	2638288	2667105	255,102,0	1	28817	0	.	Interaction with NDEL1.
chr17	2667045	2681799	P43034	0	+	2667045	2681799	255,102,0	1	14754	0	.	Interaction with dynein and dynactin.
chr17	2680259	2681796	P43034	0	+	2680259	2681796	255,102,0	1	1537	0	.	Interaction with DCX. Pubmed:11001923
chr17	2681730	2681799	P43034	0	+	2681730	2681799	255,102,0	1	69	0	.	Interaction with NDEL1.
chr17	3476366	3476372	P45381	0	+	3476366	3476372	255,102,0	1	6	0	.	Substrate binding.
chr17	3476366	3476372	Q6FH48	0	+	3476366	3476372	255,102,0	1	6	0	.	Substrate binding.
chr17	3483555	3483570	P45381	0	+	3483555	3483570	255,102,0	1	15	0	.	Substrate binding.
chr17	3483555	3483570	Q6FH48	0	+	3483555	3483570	255,102,0	1	15	0	.	Substrate binding.
chr17	3566928	3571569	Q8NER1	0	-	3566928	3571569	255,102,0	1	4641	0	.	Interaction with calmodulin.
chr17	3566955	3571539	Q8NER1	0	-	3566955	3571539	255,102,0	1	4584	0	.	Required for PIP2-mediated channel inhibition.
chr17	3572213	3573683	Q8NER1	0	-	3572213	3573683	255,102,0	1	1470	0	.	AD.
chr17	3591289	3591295	Q8NER1	0	-	3591289	3591295	255,102,0	1	6	0	.	Important for channel activation by agonists and heat.
chr17	3761013	3761178	P38570	0	-	3761013	3761178	255,102,0	1	165	0	.	X-domain (extra domain).
chr17	3826135	3829348	Q53F19	0	-	3826135	3829348	255,102,0	1	3213	0	.	RNA recognition motif (RRM) domain. Pubmed:26382858
chr17	3865963	3869516	Q8N5S9	0	-	3865963	3869516	255,102,0	1	3553	0	.	Calmodulin-binding.
chr17	3869507	3869525	Q8N5S9	0	-	3869507	3869525	255,102,0	1	18	0	.	Autoinhibitory domain.
chr17	3883122	3883444	Q8N5S9	0	-	3883122	3883444	255,102,0	1	322	0	.	RP domain.
chr17	3898501	3898525	P51575	0	-	3898501	3898525	255,102,0	1	24	0	.	Pore-forming motif.
chr17	3936366	3936429	Q93084	0	-	3936366	3936429	255,102,0	1	63	0	.	Interaction with phospholamban 2.
chr17	3944790	3945136	Q93084	0	-	3944790	3945136	255,102,0	1	346	0	.	Interaction with phospholamban 1.
chr17	4179840	4183402	Q9P2R3	0	-	4179840	4183402	255,102,0	1	3562	0	.	Interaction with RHOD and RAB5A. Pubmed:24102721
chr17	4539417	4539951	Q9BQG0	0	-	4539417	4539951	255,102,0	1	534	0	.	Required for nuclear and nucleolar localization.
chr17	4548035	4555324	Q9BQG0	0	-	4548035	4555324	255,102,0	1	7289	0	.	Interaction with MYB.
chr17	4718622	4721036	P32121	0	+	4718622	4721036	255,102,0	1	2414	0	.	Interaction with TRAF6. Pubmed:16378096
chr17	4720590	4721036	P32121	0	+	4720590	4721036	255,102,0	1	446	0	.	Interaction with AP2B1.
chr17	4815799	4819484	O14939	0	+	4815799	4819484	255,102,0	1	3685	0	.	Catalytic.
chr17	4894018	4897284	Q8N4C8	0	+	4894018	4897284	255,102,0	1	3266	0	.	Mediates interaction with RAP2A. Pubmed:18930710
chr17	4956612	4956624	P13929	0	+	4956612	4956624	255,102,0	1	12	0	.	Substrate binding.
chr17	5433352	5433743	Q07021	0	-	5433352	5433743	255,102,0	1	391	0	.	Interaction with MAVS. Pubmed:19164550
chr17	5438226	5438848	Q07021	0	-	5438226	5438848	255,102,0	1	622	0	.	C1q binding.
chr17	5515512	5530703	Q9C000	0	-	5515512	5530703	255,102,0	1	15191	0	.	FIIND.
chr17	6579749	6589912	Q2KHM9	0	-	6579749	6589912	255,102,0	1	10163	0	.	Necessary and sufficient for FOPNL-binding. Pubmed:26643951
chr17	7220179	7224157	P49748	0	+	7220179	7224157	255,102,0	1	3978	0	.	Catalytic.
chr17	7222799	7222811	P49748	0	+	7222799	7222811	255,102,0	1	12	0	.	Substrate binding.
chr17	7224018	7224024	P49748	0	+	7224018	7224024	255,102,0	1	6	0	.	Substrate binding.
chr17	7224157	7224336	P49748	0	+	7224157	7224336	255,102,0	1	179	0	.	Membrane-anchoring.
chr17	7228013	7229447	O14641	0	-	7228013	7229447	255,102,0	1	1434	0	.	Required for interaction with FOXK2. Pubmed:25805136
chr17	7240856	7241664	O95166	0	-	7240856	7241664	255,102,0	1	808	0	.	Interaction with GPHN.
chr17	7241425	7241664	O95166	0	-	7241425	7241664	255,102,0	1	239	0	.	Interaction with GABRG2.
chr17	7242264	7242330	O95166	0	-	7242264	7242330	255,102,0	1	66	0	.	Interaction with beta-tubulin.
chr17	7260376	7260382	O95471	0	-	7260376	7260382	255,102,0	1	6	0	.	Interactions with TJP1, TJP2 and TJP3.
chr17	7281952	7283250	P14672	0	+	7281952	7283250	255,102,0	1	1298	0	.	SRFBP1-binding.
chr17	7284648	7284669	P14672	0	+	7284648	7284669	255,102,0	1	21	0	.	Monosaccharide binding.
chr17	7288790	7290346	Q9Y2T7	0	-	7288790	7290346	255,102,0	1	1556	0	.	Required for mRNA-binding.
chr17	7290487	7294242	Q9Y2T7	0	-	7290487	7294242	255,102,0	1	3755	0	.	Required for cytoplasmic retention.
chr17	7309692	7311122	P63241	0	+	7309692	7311122	255,102,0	1	1430	0	.	DOHH-binding.
chr17	7336734	7347045	Q15027	0	+	7336734	7347045	255,102,0	1	10311	0	.	Required for formation of endosomal tubules when overexpressed with PIP5K1C.
chr17	7347111	7351392	Q15027	0	+	7347111	7351392	255,102,0	1	4281	0	.	Required for interaction with GULP1.
chr17	7348369	7349014	Q15027	0	+	7348369	7349014	255,102,0	1	645	0	.	Prevents interaction with ITGB1 when S-554 is not phosphorylated.
chr17	7393672	7394110	Q9NRY6	0	-	7393672	7394110	255,102,0	1	438	0	.	Proline-rich domain (PRD).
chr17	7465757	7466246	Q9P1Z0	0	-	7465757	7466246	255,102,0	1	489	0	.	Interaction with CBFA2T3. Pubmed:23251453
chr17	7565527	7571387	Q9H4L4	0	+	7565527	7571387	255,102,0	1	5860	0	.	Protease.
chr17	7579826	7580180	P34810	0	+	7579826	7580180	255,102,0	1	354	0	.	Mucin-like.
chr17	7579967	7580147	P34810	0	+	7579967	7580147	255,102,0	1	180	0	.	2 X 30 AA tandem repeats.
chr17	7626554	7626563	Q96F10	0	-	7626554	7626563	255,102,0	1	9	0	.	Acetyl-CoA binding.
chr17	7626776	7626794	Q96F10	0	-	7626776	7626794	255,102,0	1	18	0	.	Acetyl-CoA binding.
chr17	7626958	7626967	Q96F10	0	-	7626958	7626967	255,102,0	1	9	0	.	Acetyl-CoA binding.
chr17	7627396	7627402	Q96F10	0	-	7627396	7627402	255,102,0	1	6	0	.	Substrate binding.
chr17	7654651	7655892	P14415	0	+	7654651	7655892	255,102,0	1	1241	0	.	immunoglobulin-like.
chr17	7669611	7673722	P04637	0	-	7669611	7673722	255,102,0	1	4111	0	.	Interaction with CARM1. Pubmed:15186775
chr17	7669629	7669689	P04637	0	-	7669629	7669689	255,102,0	1	60	0	.	Basic (repression of DNA-binding).
chr17	7669680	7676071	P04637	0	-	7669680	7676071	255,102,0	1	6391	0	.	Interaction with HIPK1.
chr17	7670619	7670634	P04637	0	-	7670619	7670634	255,102,0	1	15	0	.	Interaction with USP7.
chr17	7670628	7673573	P04637	0	-	7670628	7673573	255,102,0	1	2945	0	.	Interaction with HIPK2.
chr17	7670640	7673555	P04637	0	-	7670640	7673555	255,102,0	1	2915	0	.	Oligomerization.
chr17	7673567	7676594	P04637	0	-	7673567	7676594	255,102,0	1	3027	0	.	Interaction with CCAR2. Pubmed:25732823
chr17	7673719	7676071	P04637	0	-	7673719	7676071	255,102,0	1	2352	0	.	Required for interaction with ZNF385A. Pubmed:17719541
chr17	7673737	7674197	P04637	0	-	7673737	7674197	255,102,0	1	460	0	.	Interaction with E4F1. Pubmed:10644996
chr17	7673743	7676023	P04637	0	-	7673743	7676023	255,102,0	1	2280	0	.	Interaction with AXIN1.
chr17	7673779	7673803	P04637	0	-	7673779	7673803	255,102,0	1	24	0	.	Interaction with DNA.
chr17	7674218	7674242	P04637	0	-	7674218	7674242	255,102,0	1	24	0	.	Interaction with the 53BP2 SH3 domain.
chr17	7674254	7676032	P04637	0	-	7674254	7676032	255,102,0	1	1778	0	.	Required for interaction with FBXO42. Pubmed:19509332
chr17	7676038	7676173	P04637	0	-	7676038	7676173	255,102,0	1	135	0	.	Interaction with WWOX.
chr17	7676119	7676594	P04637	0	-	7676119	7676594	255,102,0	1	475	0	.	Interaction with HRMT1L2. Pubmed:15186775
chr17	7676236	7676594	P04637	0	-	7676236	7676594	255,102,0	1	358	0	.	Transcription activation (acidic).
chr17	7719734	7778121	Q9P225	0	+	7719734	7778121	255,102,0	1	58387	0	.	Stem.
chr17	7778121	7780737	Q9P225	0	+	7778121	7780737	255,102,0	1	2616	0	.	AAA 1.
chr17	7786129	7788163	Q9P225	0	+	7786129	7788163	255,102,0	1	2034	0	.	AAA 2.
chr17	7792329	7797187	Q9P225	0	+	7792329	7797187	255,102,0	1	4858	0	.	AAA 3.
chr17	7797762	7801967	Q9P225	0	+	7797762	7801967	255,102,0	1	4205	0	.	AAA 4.
chr17	7802009	7816657	Q9P225	0	+	7802009	7816657	255,102,0	1	14648	0	.	Stalk.
chr17	7817611	7819012	Q9P225	0	+	7817611	7819012	255,102,0	1	1401	0	.	AAA 5.
chr17	7823913	7830681	Q9P225	0	+	7823913	7830681	255,102,0	1	6768	0	.	AAA 6.
chr17	7907154	7911480	Q12873	0	+	7907154	7911480	255,102,0	1	4326	0	.	Required for interaction with PCNT. Pubmed:17626165
chr17	7939677	7949507	Q8N137	0	+	7939677	7949507	255,102,0	1	9830	0	.	Required for centrosome localization.
chr17	8141070	8142273	O15534	0	-	8141070	8142273	255,102,0	1	1203	0	.	CRY binding domain.
chr17	8144766	8146715	O15534	0	-	8144766	8146715	255,102,0	1	1949	0	.	Required for phosphorylation by CSNK1E.
chr17	8150046	8150706	O15534	0	-	8150046	8150706	255,102,0	1	660	0	.	Interaction with BTRC. Pubmed:15917222
chr17	8445789	8448658	Q9GZM8	0	+	8445789	8448658	255,102,0	1	2869	0	.	Self-association.
chr17	8445813	8450820	Q9GZM8	0	+	8445813	8450820	255,102,0	1	5007	0	.	Interaction with KATNB1.
chr17	8446852	8448559	Q9GZM8	0	+	8446852	8448559	255,102,0	1	1707	0	.	Required for interaction with PAFAH1B1.
chr17	8448682	8467020	Q9GZM8	0	+	8448682	8467020	255,102,0	1	18338	0	.	Interaction with CENPF. Pubmed:17600710
chr17	8450817	8454863	Q9GZM8	0	+	8450817	8454863	255,102,0	1	4046	0	.	Interaction with YWHAE.
chr17	8450823	8467020	Q9GZM8	0	+	8450823	8467020	255,102,0	1	16197	0	.	Interaction with NEFL.
chr17	8450835	8454863	Q9GZM8	0	+	8450835	8454863	255,102,0	1	4028	0	.	Interaction with KATNA1.
chr17	8454815	8460056	Q9GZM8	0	+	8454815	8460056	255,102,0	1	5241	0	.	Interaction with DISC1.
chr17	8454860	8460089	Q9GZM8	0	+	8454860	8460089	255,102,0	1	5229	0	.	Required for localization to the centrosome and interaction with dynein, dynactin, tubulin gamma, PCM1 and PCNT. Pubmed:16291865
chr17	8881827	8886554	Q8WYR1	0	-	8881827	8886554	255,102,0	1	4727	0	.	Interaction with beta-gamma G protein dimers.
chr17	8904885	8911422	Q8WYR1	0	-	8904885	8911422	255,102,0	1	6537	0	.	Heterodimerization.
chr17	10330496	10332116	Q9UKX3	0	-	10330496	10332116	255,102,0	1	1620	0	.	Actin-binding.
chr17	10340162	10340231	Q9UKX3	0	-	10340162	10340231	255,102,0	1	69	0	.	Actin-binding.
chr17	10406150	10406291	P13535	0	-	10406150	10406291	255,102,0	1	141	0	.	Actin-binding.
chr17	10406904	10406973	P13535	0	-	10406904	10406973	255,102,0	1	69	0	.	Actin-binding.
chr17	10455050	10455189	Q9Y623	0	-	10455050	10455189	255,102,0	1	139	0	.	Actin-binding.
chr17	10455826	10455895	Q9Y623	0	-	10455826	10455895	255,102,0	1	69	0	.	Actin-binding.
chr17	10505272	10505405	P12882	0	-	10505272	10505405	255,102,0	1	133	0	.	Actin-binding.
chr17	10506024	10506093	P12882	0	-	10506024	10506093	255,102,0	1	69	0	.	Actin-binding.
chr17	10533394	10533526	Q9UKX2	0	-	10533394	10533526	255,102,0	1	132	0	.	Actin-binding.
chr17	10535290	10535359	Q9UKX2	0	-	10535290	10535359	255,102,0	1	69	0	.	Actin-binding.
chr17	10640442	10640580	P11055	0	-	10640442	10640580	255,102,0	1	138	0	.	Actin-binding.
chr17	10641297	10641366	P11055	0	-	10641297	10641366	255,102,0	1	69	0	.	Actin-binding.
chr17	10692932	10695753	O75880	0	-	10692932	10695753	255,102,0	1	2821	0	.	Important for dimerization.
chr17	11598498	11705126	Q9NYC9	0	+	11598498	11705126	255,102,0	1	106628	0	.	Stem.
chr17	11705126	11744844	Q9NYC9	0	+	11705126	11744844	255,102,0	1	39718	0	.	AAA 1.
chr17	11745021	11763446	Q9NYC9	0	+	11745021	11763446	255,102,0	1	18425	0	.	AAA 2.
chr17	11768599	11793505	Q9NYC9	0	+	11768599	11793505	255,102,0	1	24906	0	.	AAA 3.
chr17	11797731	11822896	Q9NYC9	0	+	11797731	11822896	255,102,0	1	25165	0	.	AAA 4.
chr17	11822938	11869223	Q9NYC9	0	+	11822938	11869223	255,102,0	1	46285	0	.	Stalk.
chr17	11874990	11883747	Q9NYC9	0	+	11874990	11883747	255,102,0	1	8757	0	.	AAA 5.
chr17	11902907	11932184	Q9NYC9	0	+	11902907	11932184	255,102,0	1	29277	0	.	AAA 6.
chr17	12020994	12054929	P45985	0	+	12020994	12054929	255,102,0	1	33935	0	.	D domain.
chr17	12141149	12141221	P45985	0	+	12141149	12141221	255,102,0	1	72	0	.	DVD domain.
chr17	12736201	12739226	Q8IZQ8	0	+	12736201	12739226	255,102,0	1	3025	0	.	HDAC5-binding.
chr17	12984781	12990168	Q17R89	0	+	12984781	12990168	255,102,0	1	5387	0	.	Interaction with BST2. Pubmed:19273615
chr17	13496307	13496319	Q9Y663	0	-	13496307	13496319	255,102,0	1	12	0	.	Substrate binding.
chr17	13496565	13496571	Q9Y663	0	-	13496565	13496571	255,102,0	1	6	0	.	Substrate binding.
chr17	13496640	13496655	Q9Y663	0	-	13496640	13496655	255,102,0	1	15	0	.	Substrate binding.
chr17	13496763	13496775	Q9Y663	0	-	13496763	13496775	255,102,0	1	12	0	.	Substrate binding.
chr17	13600559	13600580	Q9Y663	0	-	13600559	13600580	255,102,0	1	21	0	.	Substrate binding.
chr17	14302022	14302043	Q9Y662	0	+	14302022	14302043	255,102,0	1	21	0	.	Substrate binding.
chr17	14345070	14345082	Q9Y662	0	+	14345070	14345082	255,102,0	1	12	0	.	Substrate binding.
chr17	14345274	14345280	Q9Y662	0	+	14345274	14345280	255,102,0	1	6	0	.	Substrate binding.
chr17	15974859	15974889	P29275	0	+	15974859	15974889	255,102,0	1	30	0	.	Agonist binding.
chr17	15975081	15975105	P29275	0	+	15975081	15975105	255,102,0	1	24	0	.	Agonist binding.
chr17	15975138	15975171	P29275	0	+	15975138	15975171	255,102,0	1	33	0	.	Agonist binding.
chr17	16032298	16070177	O75376	0	-	16032298	16070177	255,102,0	1	37879	0	.	Interaction with C1D.
chr17	16039568	16046996	O75376	0	-	16039568	16046996	255,102,0	1	7428	0	.	ID2.
chr17	16057560	16057981	O75376	0	-	16057560	16057981	255,102,0	1	421	0	.	ID1.
chr17	16057924	16057936	O75376	0	-	16057924	16057936	255,102,0	1	12	0	.	Required for interaction with RARA in the absence of its ligand.
chr17	16061833	16091917	O75376	0	-	16061833	16091917	255,102,0	1	30084	0	.	Interaction with ETO.
chr17	16143659	16194569	O75376	0	-	16143659	16194569	255,102,0	1	50910	0	.	Interaction with ZBTB33 and HEXIM1. Pubmed:17452463, Pubmed:14527417
chr17	16146521	16153368	O75376	0	-	16146521	16153368	255,102,0	1	6847	0	.	Interaction with SIN3A/B.
chr17	16417668	16426790	Q9Y5S1	0	+	16417668	16426790	255,102,0	1	9122	0	.	Required for interaction with SLC50A1.
chr17	17042848	17143669	Q6WCQ1	0	+	17042848	17143669	255,102,0	1	100821	0	.	Interaction with F-actin.
chr17	17158591	17173958	Q6WCQ1	0	+	17158591	17173958	255,102,0	1	15367	0	.	Interaction with RHOA. Pubmed:14506264
chr17	17173955	17175340	Q6WCQ1	0	+	17173955	17175340	255,102,0	1	1385	0	.	Interaction with PPP1R12A.
chr17	17206169	17206286	Q8N2A8	0	-	17206169	17206286	255,102,0	1	117	0	.	Required for mitochondrial localization.
chr17	17506225	17506231	Q9UBM1	0	-	17506225	17506231	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding. Pubmed:12842883
chr17	17512563	17512572	Q9UBM1	0	-	17512563	17512572	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding. Pubmed:12842883
chr17	17817370	17819549	P36956	0	-	17817370	17819549	255,102,0	1	2179	0	.	Interaction with LMNA.
chr17	17818260	17818326	P36956	0	-	17818260	17818326	255,102,0	1	66	0	.	Leucine-zipper.
chr17	17820432	17836817	P36956	0	-	17820432	17836817	255,102,0	1	16385	0	.	Transcriptional activation (acidic).
chr17	18140799	18140823	Q9UKN7	0	+	18140799	18140823	255,102,0	1	24	0	.	Actin-binding.
chr17	18142090	18143910	Q9UKN7	0	+	18142090	18143910	255,102,0	1	1820	0	.	Neck or regulatory domain.
chr17	18143910	18178867	Q9UKN7	0	+	18143910	18178867	255,102,0	1	34957	0	.	Tail.
chr17	18184819	18184828	Q6P6C2	0	+	18184819	18184828	255,102,0	1	9	0	.	Alpha-ketoglutarate binding. Pubmed:24778178
chr17	18247662	18251378	Q13045	0	-	18247662	18251378	255,102,0	1	3716	0	.	Interaction with ACTL6A. Pubmed:14966289
chr17	18251781	18258690	Q13045	0	-	18251781	18258690	255,102,0	1	6909	0	.	Interaction with LRRFIP1 and LRRFIP2.
chr17	18277732	18278068	Q13472	0	-	18277732	18278068	255,102,0	1	336	0	.	2 X 27 AA approximate repeats.
chr17	18486045	18486066	Q6DKI2	0	+	18486045	18486066	255,102,0	1	21	0	.	Beta-galactoside binding 1.
chr17	18492796	18492817	Q6DKI2	0	+	18492796	18492817	255,102,0	1	21	0	.	Beta-galactoside binding 2.
chr17	19313185	19334245	O95208	0	+	19313185	19334245	255,102,0	1	21060	0	.	6 X 3 AA repeats of [DE]-P-W.
chr17	19332049	19334245	O95208	0	+	19332049	19334245	255,102,0	1	2196	0	.	3 X 3 AA repeats of N-P-F.
chr17	19378903	19379131	Q13164	0	+	19378903	19379131	255,102,0	1	228	0	.	Required for cytoplasmic targeting.
chr17	19379780	19380626	Q13164	0	+	19379780	19380626	255,102,0	1	846	0	.	Required for binding to MAP2K5.
chr17	19380626	19381427	Q13164	0	+	19380626	19381427	255,102,0	1	801	0	.	Necessary for oligomerization.
chr17	19381427	19383198	Q13164	0	+	19381427	19383198	255,102,0	1	1771	0	.	May not be required for kinase activity; required to stimulate MEF2C activity.
chr17	19776351	19783723	Q8IYT8	0	-	19776351	19783723	255,102,0	1	7372	0	.	CTD-like region.
chr17	19909222	19909264	O43572	0	-	19909222	19909264	255,102,0	1	42	0	.	PKA-RII subunit binding.
chr17	20451522	20451543	Q3B8N2	0	-	20451522	20451543	255,102,0	1	21	0	.	Beta-galactoside binding 2.
chr17	20458251	20458272	Q3B8N2	0	-	20458251	20458272	255,102,0	1	21	0	.	Beta-galactoside binding 1.
chr17	27640683	27640704	O00182	0	+	27640683	27640704	255,102,0	1	21	0	.	Beta-galactoside binding 1.
chr17	27647369	27647390	O00182	0	+	27647369	27647390	255,102,0	1	21	0	.	Beta-galactoside binding 2.
chr17	27772424	27773195	P35228	0	-	27772424	27773195	255,102,0	1	771	0	.	Calmodulin-binding.
chr17	28042873	28043248	Q9UBE8	0	+	28042873	28043248	255,102,0	1	375	0	.	Sufficient for interaction with DAPK3. Pubmed:21454679
chr17	28042873	28168522	Q9UBE8	0	+	28042873	28168522	255,102,0	1	125649	0	.	Required for interaction with TAB2.
chr17	28043242	28191032	Q9UBE8	0	+	28043242	28191032	255,102,0	1	147790	0	.	Sufficient for interaction with DAPK3. Pubmed:21454679
chr17	28191065	28194633	Q9UBE8	0	+	28191065	28194633	255,102,0	1	3568	0	.	Required for homodimerization and kinase activation and localization to the nucleus.
chr17	28191083	28194633	Q9UBE8	0	+	28191083	28194633	255,102,0	1	3550	0	.	Required for interaction with TAB2.
chr17	28328654	28330448	Q8IY31	0	-	28328654	28330448	255,102,0	1	1794	0	.	IFT57-binding.
chr17	28367853	28367955	P04004	0	-	28367853	28367955	255,102,0	1	102	0	.	Heparin-binding.
chr17	28547299	28548075	Q13432	0	-	28547299	28548075	255,102,0	1	776	0	.	Required for centrosome localization.
chr17	28552380	28552557	Q13432	0	-	28552380	28552557	255,102,0	1	177	0	.	Required for midbody localization.
chr17	28583645	28586493	Q96R06	0	-	28583645	28586493	255,102,0	1	2848	0	.	Interaction with KNSTRN. Pubmed:21402792
chr17	28673404	28681361	Q7KZ85	0	+	28673404	28681361	255,102,0	1	7957	0	.	Interaction with IWS1.
chr17	28673404	28687135	Q7KZ85	0	+	28673404	28687135	255,102,0	1	13731	0	.	Interaction with PAAF1. Pubmed:22316138
chr17	28677765	28695477	Q7KZ85	0	+	28677765	28695477	255,102,0	1	17712	0	.	Interaction with KDM6A.
chr17	28701030	28701622	Q7KZ85	0	+	28701030	28701622	255,102,0	1	592	0	.	Interaction with histone H2B and H3. Pubmed:10933715
chr17	28717333	28717690	P0DI83	0	-	28717333	28717690	255,102,0	1	357	0	.	13 x 9 AA approximate tandem-repeats of P-R-V-I-V-G-(S/T)-P-R.
chr17	28911214	28919214	Q96QT6	0	-	28911214	28919214	255,102,0	1	8000	0	.	Interaction with SIN3A. Pubmed:11390640
chr17	28921704	28927008	Q96QT6	0	-	28921704	28927008	255,102,0	1	5304	0	.	Interaction with SIN3A. Pubmed:11390640
chr17	28924239	28926999	Q96QT6	0	-	28924239	28926999	255,102,0	1	2760	0	.	PBR.
chr17	28981905	28981920	Q53EL9	0	-	28981905	28981920	255,102,0	1	15	0	.	O-glycosylated at two sites.
chr17	28981953	28981983	Q53EL9	0	-	28981953	28981983	255,102,0	1	30	0	.	O-glycosylated at two sites.
chr17	29121850	29166940	Q92614	0	-	29121850	29166940	255,102,0	1	45090	0	.	Mediates nucleotide-independent binding to F-actin and interaction with GOLPH3.
chr17	29246863	29249200	P05813	0	+	29246863	29249200	255,102,0	1	2337	0	.	N-terminal arm.
chr17	29252199	29253651	P05813	0	+	29252199	29253651	255,102,0	1	1452	0	.	Connecting peptide.
chr17	29574704	29575388	Q9Y2X7	0	-	29574704	29575388	255,102,0	1	684	0	.	Interaction with PXN and TGFB1I1.
chr17	29576656	29581348	Q9Y2X7	0	-	29576656	29581348	255,102,0	1	4692	0	.	PTK2/FAK1-binding.
chr17	29576988	29581339	Q9Y2X7	0	-	29576988	29581339	255,102,0	1	4351	0	.	ARHGEF6-binding.
chr17	30179104	30180909	Q9H0G5	0	+	30179104	30180909	255,102,0	1	1805	0	.	Necessary for alternative splicing activity.
chr17	30198458	30198518	P31645	0	-	30198458	30198518	255,102,0	1	60	0	.	Required for serotonin uptake activity. Pubmed:19270731
chr17	30198476	30198503	P31645	0	-	30198476	30198503	255,102,0	1	27	0	.	Interaction with RAB4A.
chr17	30379073	30422845	O75976	0	+	30379073	30422845	255,102,0	1	43772	0	.	Carboxypeptidase-like 1.
chr17	30422845	30445838	O75976	0	+	30422845	30445838	255,102,0	1	22993	0	.	Carboxypeptidase-like 2.
chr17	30445838	30462450	O75976	0	+	30445838	30462450	255,102,0	1	16612	0	.	Carboxypeptidase-like 3.
chr17	31265241	31327741	P21359	0	+	31265241	31327741	255,102,0	1	62500	0	.	Lipid binding.
chr17	31431896	31531729	Q86YS3	0	+	31431896	31531729	255,102,0	1	99833	0	.	Necessary for interaction with RAB11A, subcellular location, homo- or heterooligomerization.
chr17	31995654	31998700	Q15022	0	+	31995654	31998700	255,102,0	1	3046	0	.	VEFS-box.
chr17	32350285	32358610	O43670	0	+	32350285	32358610	255,102,0	1	8325	0	.	Microtubule-binding region. Pubmed:24462186
chr17	32367972	32369351	O43670	0	+	32367972	32369351	255,102,0	1	1379	0	.	GLEBS. Pubmed:24462186, Pubmed:24462187
chr17	34989602	34989614	P49916	0	+	34989602	34989614	255,102,0	1	12	0	.	Interaction with DNA. Pubmed:20518483
chr17	34991024	34991042	P49916	0	+	34991024	34991042	255,102,0	1	18	0	.	Interaction with DNA. Pubmed:20518483
chr17	34991790	34991802	P49916	0	+	34991790	34991802	255,102,0	1	12	0	.	Interaction with DNA. Pubmed:20518483
chr17	34992009	34992030	P49916	0	+	34992009	34992030	255,102,0	1	21	0	.	Interaction with DNA. Pubmed:20518483
chr17	35118514	35119613	O75771	0	-	35118514	35119613	255,102,0	1	1099	0	.	preferentially binds ssDNA.
chr17	35552920	35554591	P0C7P3	0	-	35552920	35554591	255,102,0	1	1671	0	.	Required for ribosome binding. Pubmed:25996083
chr17	35554591	35557447	P0C7P3	0	-	35554591	35557447	255,102,0	1	2856	0	.	Required for endoribonuclease activity. Pubmed:25996083
chr17	35710256	35723696	P63010	0	+	35710256	35723696	255,102,0	1	13440	0	.	Interaction with ARRB1.
chr17	35735184	35741302	Q96S79	0	+	35735184	35741302	255,102,0	1	6118	0	.	Small GTPase-like.
chr17	35844517	35845024	Q92804	0	+	35844517	35845024	255,102,0	1	507	0	.	21 X approximate tandem repeats of D-R-[S,G](0,3)-G-G-Y-G-G.
chr17	35925514	35930084	Q8NG50	0	-	35925514	35930084	255,102,0	1	4570	0	.	Necessary for nuclear and nucleolar localization.
chr17	35930075	35930727	Q8NG50	0	-	35930075	35930727	255,102,0	1	652	0	.	Necessary for nuclear localization and for nucleolar accumulation in response to heat shock.
chr17	36496253	36498538	Q96H55	0	-	36496253	36498538	255,102,0	1	2285	0	.	Mitochondrial targeting.
chr17	36496625	36498910	Q96H55	0	-	36496625	36498910	255,102,0	1	2285	0	.	Mitochondrial targeting.
chr17	36953891	36986729	Q9NY61	0	+	36953891	36986729	255,102,0	1	32838	0	.	POLR2J binding.
chr17	36955724	36988561	Q9NY61	0	+	36955724	36988561	255,102,0	1	32837	0	.	POLR2J binding.
chr17	36986729	36988687	Q9NY61	0	+	36986729	36988687	255,102,0	1	1958	0	.	RB1 binding.
chr17	36988561	36990519	Q9NY61	0	+	36988561	36990519	255,102,0	1	1958	0	.	RB1 binding.
chr17	36988687	37019022	Q9NY61	0	+	36988687	37019022	255,102,0	1	30335	0	.	RB1 and SP1 binding.
chr17	36990519	37020854	Q9NY61	0	+	36990519	37020854	255,102,0	1	30335	0	.	RB1 and SP1 binding.
chr17	37097073	37181296	Q13085	0	-	37097073	37181296	255,102,0	1	84223	0	.	Carboxyltransferase.
chr17	37098541	37182770	Q13085	0	-	37098541	37182770	255,102,0	1	84229	0	.	Carboxyltransferase.
chr17	37553364	37561519	Q9UMZ2	0	-	37553364	37561519	255,102,0	1	8155	0	.	Interaction with A1P1G1 and A1P1G2.
chr17	37557999	37566154	Q9UMZ2	0	-	37557999	37566154	255,102,0	1	8155	0	.	Interaction with A1P1G1 and A1P1G2.
chr17	37744791	37744884	P35680	0	-	37744791	37744884	255,102,0	1	93	0	.	Dimerization.
chr17	37749315	37749408	P35680	0	-	37749315	37749408	255,102,0	1	93	0	.	Dimerization.
chr17	38153029	38178195	O14512	0	+	38153029	38178195	255,102,0	1	25166	0	.	Mediates interaction with SORBS3. Pubmed:15242778
chr17	38352613	38377835	O14512	0	+	38352613	38377835	255,102,0	1	25222	0	.	Mediates interaction with SORBS3. Pubmed:15242778
chr17	38475138	38475168	A6NHQ4	0	-	38475138	38475168	255,102,0	1	30	0	.	BC-box.
chr17	38674351	38674381	A6NHQ4	0	-	38674351	38674381	255,102,0	1	30	0	.	BC-box.
chr17	39407957	39408476	Q15648	0	-	39407957	39408476	255,102,0	1	519	0	.	Interaction with TP53. Pubmed:9444950
chr17	39409022	39410255	Q15648	0	-	39409022	39410255	255,102,0	1	1233	0	.	Interaction with ESR1.
chr17	39409853	39410597	Q15648	0	-	39409853	39410597	255,102,0	1	744	0	.	Interaction with VDR.
chr17	39410075	39410180	Q15648	0	-	39410075	39410180	255,102,0	1	105	0	.	Interaction with GATA1. Pubmed:24245781
chr17	39410117	39410357	Q15648	0	-	39410117	39410357	255,102,0	1	240	0	.	Interaction with PPARGC1A and THRA. Pubmed:14636573
chr17	39410210	39451062	Q15648	0	-	39410210	39451062	255,102,0	1	40852	0	.	Interaction with the Mediator complex and THRA.
chr17	39410288	39419801	Q15648	0	-	39410288	39419801	255,102,0	1	9513	0	.	Interaction with THRA.
chr17	39410450	39447884	Q15648	0	-	39410450	39447884	255,102,0	1	37434	0	.	Interaction with ESR1.
chr17	39419843	39431121	Q15648	0	-	39419843	39431121	255,102,0	1	11278	0	.	Interaction with the Mediator complex.
chr17	39431127	39440463	Q15648	0	-	39431127	39440463	255,102,0	1	9336	0	.	Interaction with the Mediator complex.
chr17	39669660	39669666	P11086	0	+	39669660	39669666	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr17	39670011	39670017	P11086	0	+	39670011	39670017	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr17	39723397	39723439	P04626	0	+	39723397	39723439	255,102,0	1	42	0	.	Required for interaction with KPNB1 and EEA1. Pubmed:16314522
chr17	39727858	39727867	P04626	0	+	39727858	39727867	255,102,0	1	9	0	.	Interaction with PIK3C2B.
chr17	39965687	39974274	Q96QA5	0	+	39965687	39974274	255,102,0	1	8587	0	.	Triggers pyroptosis. Pubmed:27281216
chr17	40074488	40077542	P10827	0	+	40074488	40077542	255,102,0	1	3054	0	.	Modulating.
chr17	40084806	40089333	P10827	0	+	40084806	40089333	255,102,0	1	4527	0	.	Ligand-binding.
chr17	40093085	40095839	P20393	0	-	40093085	40095839	255,102,0	1	2754	0	.	Ligand-binding.
chr17	40095839	40096076	P20393	0	-	40095839	40096076	255,102,0	1	237	0	.	Hinge.
chr17	40095839	40097290	P20393	0	-	40095839	40097290	255,102,0	1	1451	0	.	Crucial for activation of GJA1.
chr17	40096765	40100094	P20393	0	-	40096765	40100094	255,102,0	1	3329	0	.	Modulating.
chr17	40123278	40123323	Q68DK7	0	+	40123278	40123323	255,102,0	1	45	0	.	Interaction with MSL2.
chr17	40133044	40133107	Q68DK7	0	+	40133044	40133107	255,102,0	1	63	0	.	Interaction with KAT8.
chr17	40133624	40134297	Q68DK7	0	+	40133624	40134297	255,102,0	1	673	0	.	Sufficient for interaction with MSL3 MRG domain.
chr17	40161863	40163544	O15234	0	+	40161863	40163544	255,102,0	1	1681	0	.	Necessary for RNA-binding, interaction with MAGOH and localization in nucleus speckles. Pubmed:15166247
chr17	40161863	40163544	O15234	0	+	40161863	40163544	255,102,0	1	1681	0	.	Sufficient to form the EJC.
chr17	40163823	40169618	O15234	0	+	40163823	40169618	255,102,0	1	5795	0	.	Necessary for localization in cytoplasmic stress granules.
chr17	40260615	40260627	Q8TF74	0	+	40260615	40260627	255,102,0	1	12	0	.	Binds actin.
chr17	40331218	40348398	P10276	0	+	40331218	40348398	255,102,0	1	17180	0	.	Modulating.
chr17	40349915	40352037	P10276	0	+	40349915	40352037	255,102,0	1	2122	0	.	Hinge.
chr17	40352037	40356094	P10276	0	+	40352037	40356094	255,102,0	1	4057	0	.	Ligand-binding.
chr17	40356046	40356094	P10276	0	+	40356046	40356094	255,102,0	1	48	0	.	Required for binding corepressor NCOR1.
chr17	40400211	40400241	P11388	0	-	40400211	40400241	255,102,0	1	30	0	.	Interaction with DNA. Pubmed:22841979
chr17	40411386	40411395	P11388	0	-	40411386	40411395	255,102,0	1	9	0	.	Interaction with DNA. Pubmed:23022727
chr17	40698239	40699448	Q2M2I5	0	-	40698239	40699448	255,102,0	1	1209	0	.	Tail.
chr17	40699448	40700299	Q2M2I5	0	-	40699448	40700299	255,102,0	1	851	0	.	Coil 2.
chr17	40699448	40703276	Q2M2I5	0	-	40699448	40703276	255,102,0	1	3828	0	.	Rod.
chr17	40700299	40700368	Q2M2I5	0	-	40700299	40700368	255,102,0	1	69	0	.	Linker 12.
chr17	40700368	40703099	Q2M2I5	0	-	40700368	40703099	255,102,0	1	2731	0	.	Coil 1B.
chr17	40703099	40703168	Q2M2I5	0	-	40703099	40703168	255,102,0	1	69	0	.	Linker 1.
chr17	40703168	40703276	Q2M2I5	0	-	40703168	40703276	255,102,0	1	108	0	.	Coil 1A.
chr17	40703276	40703693	Q2M2I5	0	-	40703276	40703693	255,102,0	1	417	0	.	Head.
chr17	40748279	40750384	Q7Z3Z0	0	-	40748279	40750384	255,102,0	1	2105	0	.	Tail.
chr17	40750384	40751242	Q7Z3Z0	0	-	40750384	40751242	255,102,0	1	858	0	.	Coil 2.
chr17	40750384	40755037	Q7Z3Z0	0	-	40750384	40755037	255,102,0	1	4653	0	.	Rod.
chr17	40751242	40751311	Q7Z3Z0	0	-	40751242	40751311	255,102,0	1	69	0	.	Linker 12.
chr17	40751311	40754863	Q7Z3Z0	0	-	40751311	40754863	255,102,0	1	3552	0	.	Coil 1B.
chr17	40754863	40754929	Q7Z3Z0	0	-	40754863	40754929	255,102,0	1	66	0	.	Linker 1.
chr17	40754929	40755037	Q7Z3Z0	0	-	40754929	40755037	255,102,0	1	108	0	.	Coil 1A.
chr17	40755037	40755271	Q7Z3Z0	0	-	40755037	40755271	255,102,0	1	234	0	.	Head.
chr17	40766526	40768883	Q7Z3Y9	0	-	40766526	40768883	255,102,0	1	2357	0	.	Tail.
chr17	40768883	40770038	Q7Z3Y9	0	-	40768883	40770038	255,102,0	1	1155	0	.	Coil 2.
chr17	40768883	40771867	Q7Z3Y9	0	-	40768883	40771867	255,102,0	1	2984	0	.	Rod.
chr17	40770038	40770107	Q7Z3Y9	0	-	40770038	40770107	255,102,0	1	69	0	.	Linker 12.
chr17	40770107	40771693	Q7Z3Y9	0	-	40770107	40771693	255,102,0	1	1586	0	.	Coil 1B.
chr17	40771693	40771759	Q7Z3Y9	0	-	40771693	40771759	255,102,0	1	66	0	.	Linker 1.
chr17	40771759	40771867	Q7Z3Y9	0	-	40771759	40771867	255,102,0	1	108	0	.	Coil 1A.
chr17	40771867	40772113	Q7Z3Y9	0	-	40771867	40772113	255,102,0	1	246	0	.	Head.
chr17	40777001	40777519	Q7Z3Y8	0	-	40777001	40777519	255,102,0	1	518	0	.	Tail.
chr17	40777519	40779777	Q7Z3Y8	0	-	40777519	40779777	255,102,0	1	2258	0	.	Coil 2.
chr17	40777519	40782244	Q7Z3Y8	0	-	40777519	40782244	255,102,0	1	4725	0	.	Rod.
chr17	40779777	40779846	Q7Z3Y8	0	-	40779777	40779846	255,102,0	1	69	0	.	Linker 12.
chr17	40779846	40782070	Q7Z3Y8	0	-	40779846	40782070	255,102,0	1	2224	0	.	Coil 1B.
chr17	40782070	40782136	Q7Z3Y8	0	-	40782070	40782136	255,102,0	1	66	0	.	Linker 1.
chr17	40782136	40782244	Q7Z3Y8	0	-	40782136	40782244	255,102,0	1	108	0	.	Coil 1A.
chr17	40782244	40782493	Q7Z3Y8	0	-	40782244	40782493	255,102,0	1	249	0	.	Head.
chr17	40792429	40793833	Q7Z3Y7	0	-	40792429	40793833	255,102,0	1	1404	0	.	Tail.
chr17	40793833	40797197	Q7Z3Y7	0	-	40793833	40797197	255,102,0	1	3364	0	.	Coil 2.
chr17	40793833	40799638	Q7Z3Y7	0	-	40793833	40799638	255,102,0	1	5805	0	.	Rod.
chr17	40797197	40797266	Q7Z3Y7	0	-	40797197	40797266	255,102,0	1	69	0	.	Linker 12.
chr17	40797266	40799464	Q7Z3Y7	0	-	40797266	40799464	255,102,0	1	2198	0	.	Coil 1B.
chr17	40799464	40799530	Q7Z3Y7	0	-	40799464	40799530	255,102,0	1	66	0	.	Linker 1.
chr17	40799530	40799638	Q7Z3Y7	0	-	40799530	40799638	255,102,0	1	108	0	.	Coil 1A.
chr17	40799638	40799893	Q7Z3Y7	0	-	40799638	40799893	255,102,0	1	255	0	.	Head.
chr17	40818478	40819521	P13645	0	-	40818478	40819521	255,102,0	1	1043	0	.	Tail.
chr17	40819521	40820339	P13645	0	-	40819521	40820339	255,102,0	1	818	0	.	Coil 2.
chr17	40819521	40822150	P13645	0	-	40819521	40822150	255,102,0	1	2629	0	.	Rod.
chr17	40820339	40820408	P13645	0	-	40820339	40820408	255,102,0	1	69	0	.	Linker 12.
chr17	40820408	40821979	P13645	0	-	40820408	40821979	255,102,0	1	1571	0	.	Coil 1B.
chr17	40821979	40822042	P13645	0	-	40821979	40822042	255,102,0	1	63	0	.	Linker 1.
chr17	40822042	40822150	P13645	0	-	40822042	40822150	255,102,0	1	108	0	.	Coil 1A.
chr17	40822150	40822585	P13645	0	-	40822150	40822585	255,102,0	1	435	0	.	Head.
chr17	40861663	40863133	Q99456	0	-	40861663	40863133	255,102,0	1	1470	0	.	Tail.
chr17	40863133	40863780	Q99456	0	-	40863133	40863780	255,102,0	1	647	0	.	Coil 2.
chr17	40863133	40866814	Q99456	0	-	40863133	40866814	255,102,0	1	3681	0	.	Rod.
chr17	40863780	40863849	Q99456	0	-	40863780	40863849	255,102,0	1	69	0	.	Linker 12.
chr17	40863849	40866640	Q99456	0	-	40863849	40866640	255,102,0	1	2791	0	.	Coil 1B.
chr17	40866640	40866697	Q99456	0	-	40866640	40866697	255,102,0	1	57	0	.	Linker 1.
chr17	40866706	40866814	Q99456	0	-	40866706	40866814	255,102,0	1	108	0	.	Coil 1A.
chr17	40866814	40867186	Q99456	0	-	40866814	40867186	255,102,0	1	372	0	.	Head.
chr17	40876363	40878152	P35900	0	-	40876363	40878152	255,102,0	1	1789	0	.	Tail.
chr17	40878152	40880177	P35900	0	-	40878152	40880177	255,102,0	1	2025	0	.	Coil 2.
chr17	40878152	40884978	P35900	0	-	40878152	40884978	255,102,0	1	6826	0	.	Rod.
chr17	40880177	40880246	P35900	0	-	40880177	40880246	255,102,0	1	69	0	.	Linker 12.
chr17	40880246	40884816	P35900	0	-	40880246	40884816	255,102,0	1	4570	0	.	Coil 1B.
chr17	40884816	40884870	P35900	0	-	40884816	40884870	255,102,0	1	54	0	.	Linker 1.
chr17	40884870	40884978	P35900	0	-	40884870	40884978	255,102,0	1	108	0	.	Coil 1A.
chr17	40884978	40885185	P35900	0	-	40884978	40885185	255,102,0	1	207	0	.	Head.
chr17	40922991	40925361	Q9C075	0	-	40922991	40925361	255,102,0	1	2370	0	.	Rod-like helical tail.
chr17	40925361	40928523	Q9C075	0	-	40925361	40928523	255,102,0	1	3162	0	.	Coil 2.
chr17	40925361	40936390	Q9C075	0	-	40925361	40936390	255,102,0	1	11029	0	.	Rod.
chr17	40928523	40928592	Q9C075	0	-	40928523	40928592	255,102,0	1	69	0	.	Linker 12.
chr17	40928592	40936228	Q9C075	0	-	40928592	40936228	255,102,0	1	7636	0	.	Coil 1B.
chr17	40936228	40936282	Q9C075	0	-	40936228	40936282	255,102,0	1	54	0	.	Linker 1.
chr17	40936282	40936390	Q9C075	0	-	40936282	40936390	255,102,0	1	108	0	.	Coil 1A.
chr17	40936390	40936603	Q9C075	0	-	40936390	40936603	255,102,0	1	213	0	.	Head.
chr17	40958603	40960288	Q6A163	0	-	40958603	40960288	255,102,0	1	1685	0	.	Tail.
chr17	40958730	40960415	Q6A163	0	-	40958730	40960415	255,102,0	1	1685	0	.	Tail.
chr17	40960288	40962494	Q6A163	0	-	40960288	40962494	255,102,0	1	2206	0	.	Coil 2.
chr17	40960288	40966568	Q6A163	0	-	40960288	40966568	255,102,0	1	6280	0	.	Rod.
chr17	40960415	40962621	Q6A163	0	-	40960415	40962621	255,102,0	1	2206	0	.	Coil 2.
chr17	40960415	40966695	Q6A163	0	-	40960415	40966695	255,102,0	1	6280	0	.	Rod.
chr17	40962494	40962542	Q6A163	0	-	40962494	40962542	255,102,0	1	48	0	.	Linker 12.
chr17	40962542	40966430	Q6A163	0	-	40962542	40966430	255,102,0	1	3888	0	.	Coil 1B.
chr17	40962621	40962669	Q6A163	0	-	40962621	40962669	255,102,0	1	48	0	.	Linker 12.
chr17	40962669	40966557	Q6A163	0	-	40962669	40966557	255,102,0	1	3888	0	.	Coil 1B.
chr17	40966430	40966463	Q6A163	0	-	40966430	40966463	255,102,0	1	33	0	.	Linker 1.
chr17	40966463	40966568	Q6A163	0	-	40966463	40966568	255,102,0	1	105	0	.	Coil 1A.
chr17	40966557	40966590	Q6A163	0	-	40966557	40966590	255,102,0	1	33	0	.	Linker 1.
chr17	40966568	40966856	Q6A163	0	-	40966568	40966856	255,102,0	1	288	0	.	Head.
chr17	40966590	40966695	Q6A163	0	-	40966590	40966695	255,102,0	1	105	0	.	Coil 1A.
chr17	40966695	40966983	Q6A163	0	-	40966695	40966983	255,102,0	1	288	0	.	Head.
chr17	40978199	40978811	Q6A162	0	-	40978199	40978811	255,102,0	1	612	0	.	Tail.
chr17	40978326	40978938	Q6A162	0	-	40978326	40978938	255,102,0	1	612	0	.	Tail.
chr17	40978811	40981082	Q6A162	0	-	40978811	40981082	255,102,0	1	2271	0	.	Coil 2.
chr17	40978811	40984006	Q6A162	0	-	40978811	40984006	255,102,0	1	5195	0	.	Rod.
chr17	40978938	40981209	Q6A162	0	-	40978938	40981209	255,102,0	1	2271	0	.	Coil 2.
chr17	40978938	40984133	Q6A162	0	-	40978938	40984133	255,102,0	1	5195	0	.	Rod.
chr17	40981082	40981130	Q6A162	0	-	40981082	40981130	255,102,0	1	48	0	.	Linker 12.
chr17	40981130	40983868	Q6A162	0	-	40981130	40983868	255,102,0	1	2738	0	.	Coil 1B.
chr17	40981209	40981257	Q6A162	0	-	40981209	40981257	255,102,0	1	48	0	.	Linker 12.
chr17	40981257	40983995	Q6A162	0	-	40981257	40983995	255,102,0	1	2738	0	.	Coil 1B.
chr17	40983868	40983901	Q6A162	0	-	40983868	40983901	255,102,0	1	33	0	.	Linker 1.
chr17	40983901	40984006	Q6A162	0	-	40983901	40984006	255,102,0	1	105	0	.	Coil 1A.
chr17	40983995	40984028	Q6A162	0	-	40983995	40984028	255,102,0	1	33	0	.	Linker 1.
chr17	40984006	40984273	Q6A162	0	-	40984006	40984273	255,102,0	1	267	0	.	Head.
chr17	40984028	40984133	Q6A162	0	-	40984028	40984133	255,102,0	1	105	0	.	Coil 1A.
chr17	40984133	40984400	Q6A162	0	-	40984133	40984400	255,102,0	1	267	0	.	Head.
chr17	40993920	40994091	Q9BYR6	0	-	40993920	40994091	255,102,0	1	171	0	.	3 X 5 AA repeats of C-C-X(3).
chr17	40994047	40994218	Q9BYR6	0	-	40994047	40994218	255,102,0	1	171	0	.	3 X 5 AA repeats of C-C-X(3).
chr17	40999676	40999847	Q9BYR7	0	-	40999676	40999847	255,102,0	1	171	0	.	3 X 5 AA repeats of C-C-X(3).
chr17	40999803	40999974	Q9BYR7	0	-	40999803	40999974	255,102,0	1	171	0	.	3 X 5 AA repeats of C-C-X(3).
chr17	41008897	41009068	Q9BYR8	0	-	41008897	41009068	255,102,0	1	171	0	.	4 X 5 AA repeats of C-C-X(3).
chr17	41009024	41009195	Q9BYR8	0	-	41009024	41009195	255,102,0	1	171	0	.	4 X 5 AA repeats of C-C-X(3).
chr17	41026639	41027149	Q9BYS1	0	-	41026639	41027149	255,102,0	1	510	0	.	15 X 5 AA repeats of C-C-[QEPVRC]-[TPIVLE]-[SRHVP].
chr17	41026766	41027276	Q9BYS1	0	-	41026766	41027276	255,102,0	1	510	0	.	15 X 5 AA repeats of C-C-[QEPVRC]-[TPIVLE]-[SRHVP].
chr17	41046931	41047255	Q9BYU5	0	-	41046931	41047255	255,102,0	1	324	0	.	10 X 5 AA repeats of C-C-[CDPQRWG]-[APRS]-[CIPSTVD].
chr17	41047056	41047380	Q9BYU5	0	-	41047056	41047380	255,102,0	1	324	0	.	10 X 5 AA repeats of C-C-[CDPQRWG]-[APRS]-[CIPSTVD].
chr17	41054875	41055199	Q9BYT5	0	-	41054875	41055199	255,102,0	1	324	0	.	11 X 5 AA repeats of C-C-[CDPQRWG]-[APRS]-[CIPSTVD].
chr17	41055000	41055429	Q9BYT5	0	-	41055000	41055429	255,102,0	1	429	0	.	11 X 5 AA repeats of C-C-[CDPQRWG]-[APRS]-[CIPSTVD].
chr17	41055105	41055429	Q9BYU5	0	-	41055105	41055429	255,102,0	1	324	0	.	10 X 5 AA repeats of C-C-[CDPQRWG]-[APRS]-[CIPSTVD].
chr17	41059714	41060038	P0C7H8	0	-	41059714	41060038	255,102,0	1	324	0	.	10 X 5 AA repeats of C-C-[CDPQRWG]-[APRS]-[CIPSTVD].
chr17	41059714	41060038	Q9BYR9	0	-	41059714	41060038	255,102,0	1	324	0	.	10 X 5 AA repeats of C-C-[CDPQRW]-[ADPRS]-[CIPSTV].
chr17	41059944	41060268	P0C7H8	0	-	41059944	41060268	255,102,0	1	324	0	.	10 X 5 AA repeats of C-C-[CDPQRWG]-[APRS]-[CIPSTVD].
chr17	41059944	41060268	Q9BYR9	0	-	41059944	41060268	255,102,0	1	324	0	.	10 X 5 AA repeats of C-C-[CDPQRW]-[ADPRS]-[CIPSTV].
chr17	41065509	41065833	P0C7H8	0	-	41065509	41065833	255,102,0	1	324	0	.	10 X 5 AA repeats of C-C-[CDPQRWG]-[APRS]-[CIPSTVD].
chr17	41065509	41065833	Q9BYR9	0	-	41065509	41065833	255,102,0	1	324	0	.	10 X 5 AA repeats of C-C-[CDPQRW]-[ADPRS]-[CIPSTV].
chr17	41065739	41066063	P0C7H8	0	-	41065739	41066063	255,102,0	1	324	0	.	10 X 5 AA repeats of C-C-[CDPQRWG]-[APRS]-[CIPSTVD].
chr17	41065739	41066063	Q9BYR9	0	-	41065739	41066063	255,102,0	1	324	0	.	10 X 5 AA repeats of C-C-[CDPQRW]-[ADPRS]-[CIPSTV].
chr17	41097592	41098045	Q9BYQ9	0	-	41097592	41098045	255,102,0	1	453	0	.	25 X 5 AA repeats of C-C-[IKRQVHEC]-[SPRT]-[STCVQPR].
chr17	41105457	41105922	Q9BYQ8	0	+	41105457	41105922	255,102,0	1	465	0	.	29 X 5 AA repeats of C-C-[RQVHIEK]-[SPTR]-[VSTQCRNP].
chr17	41117826	41118303	Q9BYQ6	0	-	41117826	41118303	255,102,0	1	477	0	.	27 X 5 AA repeats of C-C-[GIKRQVHEL]-[SPTR]-[STVQRMC].
chr17	41123615	41124110	Q9BQ66	0	-	41123615	41124110	255,102,0	1	495	0	.	31 X 5 AA repeats of C-C-[GRQVIL]-[SPTR]-[VSTQPC].
chr17	41124083	41124578	Q9BQ66	0	-	41124083	41124578	255,102,0	1	495	0	.	31 X 5 AA repeats of C-C-[GRQVIL]-[SPTR]-[VSTQPC].
chr17	41139968	41140430	Q9BYQ5	0	-	41139968	41140430	255,102,0	1	462	0	.	30 X 5 AA repeats of C-C-[IRQVEL]-[SPTR]-[STVQRCP].
chr17	41149305	41149755	Q9BYR2	0	-	41149305	41149755	255,102,0	1	450	0	.	26 X 5 AA repeats of C-C-[GRQVCHIEK]-[SPTR]-[VSTQYC].
chr17	41160229	41160679	Q9BYR3	0	-	41160229	41160679	255,102,0	1	450	0	.	26 X 5 AA repeats of C-C-[GRQVCH]-[SPT]-[VSTQR].
chr17	41167593	41168073	Q9BYR4	0	-	41167593	41168073	255,102,0	1	480	0	.	29 X 5 AA repeats of C-C-[GIKRQVH]-[SPT]-[STA].
chr17	41177777	41178152	Q9BYR5	0	-	41177777	41178152	255,102,0	1	375	0	.	20 X 5 AA repeats OF C-C-[GRQVS]-[SPT]-[VSTQ].
chr17	41184419	41184842	Q9BYQ7	0	-	41184419	41184842	255,102,0	1	423	0	.	18 X 5 AA repeats of C-C-[GRQC]-[SPT]-[VSTL].
chr17	41189907	41190630	A8MXZ3	0	+	41189907	41190630	255,102,0	1	723	0	.	30 X 5 AA repeats of C-C-[CGSVRQH]-[SQTNP]-[PTSI].
chr17	41226654	41244516	Q9BYP9	0	+	41226654	41244516	255,102,0	1	17862	0	.	14 X 5 AA repeats of C-C-[RQVGE]-[SPSTNQ]-[TASL].
chr17	41226675	41227170	Q9BYQ4	0	+	41226675	41227170	255,102,0	1	495	0	.	17 X 5 AA repeats of C-C-[RQVSGE]-[SPTQ]-[TASP].
chr17	41232521	41232971	Q9BYQ3	0	+	41232521	41232971	255,102,0	1	450	0	.	16 X 5 AA repeats of C-C-[RQVSHE]-[SPTN]-[TASPI].
chr17	41232522	41232972	Q9BYQ3	0	+	41232522	41232972	255,102,0	1	450	0	.	16 X 5 AA repeats of C-C-[RQVSHE]-[SPTN]-[TASPI].
chr17	41238072	41238522	Q9BYQ0	0	+	41238072	41238522	255,102,0	1	450	0	.	15 X 5 AA repeats of C-C-[RQVSGE]-[SPSNQ]-[TASPI].
chr17	41238371	41238806	Q9BYQ2	0	+	41238371	41238806	255,102,0	1	435	0	.	15 X 5 AA repeats of C-C-[RQVGE]-[SPTN]-[TASPF].
chr17	41249741	41250176	Q9BYQ2	0	+	41249741	41250176	255,102,0	1	435	0	.	15 X 5 AA repeats of C-C-[RQVGE]-[SPTN]-[TASPF].
chr17	41254016	41254481	A8MVA2	0	+	41254016	41254481	255,102,0	1	465	0	.	16 X 5 AA repeats of C-C-[GSVRQ]-[QTSPHN]-[TPSGYC].
chr17	41255341	41255836	Q9BYP9	0	+	41255341	41255836	255,102,0	1	495	0	.	14 X 5 AA repeats of C-C-[RQVGE]-[SPSTNQ]-[TASL].
chr17	41264348	41264828	A8MTY7	0	+	41264348	41264828	255,102,0	1	480	0	.	17 X 5 AA repeats of C-C-[VGSREQH]-[SQTPN]-[STPAI].
chr17	41265386	41265851	A8MVA2	0	+	41265386	41265851	255,102,0	1	465	0	.	16 X 5 AA repeats of C-C-[GSVRQ]-[QTSPHN]-[TPSGYC].
chr17	41275718	41276198	A8MTY7	0	+	41275718	41276198	255,102,0	1	480	0	.	17 X 5 AA repeats of C-C-[VGSREQH]-[SQTPN]-[STPAI].
chr17	41290548	41291469	A8MX34	0	-	41290548	41291469	255,102,0	1	921	0	.	7 X 5 AA repeats of C-C-X(3).
chr17	41291596	41292517	A8MX34	0	-	41291596	41292517	255,102,0	1	921	0	.	7 X 5 AA repeats of C-C-X(3).
chr17	41301918	41302839	A8MX34	0	-	41301918	41302839	255,102,0	1	921	0	.	7 X 5 AA repeats of C-C-X(3).
chr17	41308332	41309037	A8MUX0	0	-	41308332	41309037	255,102,0	1	705	0	.	11 X 5 AA repeats of C-C-X(3).
chr17	41346121	41346455	O76009	0	-	41346121	41346455	255,102,0	1	334	0	.	Tail.
chr17	41346455	41347153	O76009	0	-	41346455	41347153	255,102,0	1	698	0	.	Coil 2.
chr17	41346455	41350599	O76009	0	-	41346455	41350599	255,102,0	1	4144	0	.	Rod.
chr17	41347153	41347201	O76009	0	-	41347153	41347201	255,102,0	1	48	0	.	Linker 12.
chr17	41347201	41350461	O76009	0	-	41347201	41350461	255,102,0	1	3260	0	.	Coil 1B.
chr17	41350461	41350494	O76009	0	-	41350461	41350494	255,102,0	1	33	0	.	Linker 1.
chr17	41350494	41350599	O76009	0	-	41350494	41350599	255,102,0	1	105	0	.	Coil 1A.
chr17	41350599	41350767	O76009	0	-	41350599	41350767	255,102,0	1	168	0	.	Head.
chr17	41363838	41364786	Q14525	0	-	41363838	41364786	255,102,0	1	948	0	.	Tail.
chr17	41364786	41365484	Q14525	0	-	41364786	41365484	255,102,0	1	698	0	.	Coil 2.
chr17	41364786	41369582	Q14525	0	-	41364786	41369582	255,102,0	1	4796	0	.	Rod.
chr17	41365484	41365532	Q14525	0	-	41365484	41365532	255,102,0	1	48	0	.	Linker 12.
chr17	41365532	41369444	Q14525	0	-	41365532	41369444	255,102,0	1	3912	0	.	Coil 1B.
chr17	41369444	41369477	Q14525	0	-	41369444	41369477	255,102,0	1	33	0	.	Linker 1.
chr17	41369477	41369582	Q14525	0	-	41369477	41369582	255,102,0	1	105	0	.	Coil 1A.
chr17	41369582	41369750	Q14525	0	-	41369582	41369750	255,102,0	1	168	0	.	Head.
chr17	41378061	41378963	O76011	0	-	41378061	41378963	255,102,0	1	902	0	.	Tail.
chr17	41378963	41379662	O76011	0	-	41378963	41379662	255,102,0	1	699	0	.	Coil 2.
chr17	41378963	41382078	O76011	0	-	41378963	41382078	255,102,0	1	3115	0	.	Rod.
chr17	41379662	41379710	O76011	0	-	41379662	41379710	255,102,0	1	48	0	.	Linker 12.
chr17	41379710	41381940	O76011	0	-	41379710	41381940	255,102,0	1	2230	0	.	Coil 1B.
chr17	41381940	41381973	O76011	0	-	41381940	41381973	255,102,0	1	33	0	.	Linker 1.
chr17	41381973	41382078	O76011	0	-	41381973	41382078	255,102,0	1	105	0	.	Coil 1A.
chr17	41382078	41382372	O76011	0	-	41382078	41382372	255,102,0	1	294	0	.	Head.
chr17	41394018	41394855	Q15323	0	-	41394018	41394855	255,102,0	1	837	0	.	Tail.
chr17	41394855	41395554	Q15323	0	-	41394855	41395554	255,102,0	1	699	0	.	Coil 2.
chr17	41394855	41397371	Q15323	0	-	41394855	41397371	255,102,0	1	2516	0	.	Rod.
chr17	41395554	41395602	Q15323	0	-	41395554	41395602	255,102,0	1	48	0	.	Linker 12.
chr17	41395602	41397233	Q15323	0	-	41395602	41397233	255,102,0	1	1631	0	.	Coil 1B.
chr17	41397233	41397266	Q15323	0	-	41397233	41397266	255,102,0	1	33	0	.	Linker 1.
chr17	41397266	41397371	Q15323	0	-	41397266	41397371	255,102,0	1	105	0	.	Coil 1A.
chr17	41397371	41397539	Q15323	0	-	41397371	41397539	255,102,0	1	168	0	.	Head.
chr17	41401318	41402155	Q15323	0	-	41401318	41402155	255,102,0	1	837	0	.	Tail.
chr17	41402155	41402854	Q15323	0	-	41402155	41402854	255,102,0	1	699	0	.	Coil 2.
chr17	41402155	41404671	Q15323	0	-	41402155	41404671	255,102,0	1	2516	0	.	Rod.
chr17	41402854	41402902	Q15323	0	-	41402854	41402902	255,102,0	1	48	0	.	Linker 12.
chr17	41402902	41404533	Q15323	0	-	41402902	41404533	255,102,0	1	1631	0	.	Coil 1B.
chr17	41404533	41404566	Q15323	0	-	41404533	41404566	255,102,0	1	33	0	.	Linker 1.
chr17	41404566	41404671	Q15323	0	-	41404566	41404671	255,102,0	1	105	0	.	Coil 1A.
chr17	41404671	41404839	Q15323	0	-	41404671	41404839	255,102,0	1	168	0	.	Head.
chr17	41420880	41420982	O76014	0	-	41420880	41420982	255,102,0	1	102	0	.	Tail.
chr17	41421374	41422365	O76014	0	-	41421374	41422365	255,102,0	1	991	0	.	Coil 2.
chr17	41421374	41424211	O76014	0	-	41421374	41424211	255,102,0	1	2837	0	.	Rod.
chr17	41422365	41422413	O76014	0	-	41422365	41422413	255,102,0	1	48	0	.	Linker 12.
chr17	41422413	41424073	O76014	0	-	41422413	41424073	255,102,0	1	1660	0	.	Coil 1B.
chr17	41424073	41424106	O76014	0	-	41424073	41424106	255,102,0	1	33	0	.	Linker 1.
chr17	41424106	41424211	O76014	0	-	41424106	41424211	255,102,0	1	105	0	.	Coil 1A.
chr17	41424211	41424523	O76014	0	-	41424211	41424523	255,102,0	1	312	0	.	Head.
chr17	41428205	41428307	O76014	0	-	41428205	41428307	255,102,0	1	102	0	.	Tail.
chr17	41428699	41429690	O76014	0	-	41428699	41429690	255,102,0	1	991	0	.	Coil 2.
chr17	41428699	41431536	O76014	0	-	41428699	41431536	255,102,0	1	2837	0	.	Rod.
chr17	41429690	41429738	O76014	0	-	41429690	41429738	255,102,0	1	48	0	.	Linker 12.
chr17	41429738	41431398	O76014	0	-	41429738	41431398	255,102,0	1	1660	0	.	Coil 1B.
chr17	41431398	41431431	O76014	0	-	41431398	41431431	255,102,0	1	33	0	.	Linker 1.
chr17	41431431	41431536	O76014	0	-	41431431	41431536	255,102,0	1	105	0	.	Coil 1A.
chr17	41431536	41431848	O76014	0	-	41431536	41431848	255,102,0	1	312	0	.	Head.
chr17	41437414	41438100	O76015	0	-	41437414	41438100	255,102,0	1	686	0	.	Tail.
chr17	41438100	41438789	O76015	0	-	41438100	41438789	255,102,0	1	689	0	.	Coil 2.
chr17	41438100	41440609	O76015	0	-	41438100	41440609	255,102,0	1	2509	0	.	Rod.
chr17	41438789	41438837	O76015	0	-	41438789	41438837	255,102,0	1	48	0	.	Linker 12.
chr17	41438837	41440471	O76015	0	-	41438837	41440471	255,102,0	1	1634	0	.	Coil 1B.
chr17	41440471	41440504	O76015	0	-	41440471	41440504	255,102,0	1	33	0	.	Linker 1.
chr17	41440504	41440609	O76015	0	-	41440504	41440609	255,102,0	1	105	0	.	Coil 1A.
chr17	41440609	41440921	O76015	0	-	41440609	41440921	255,102,0	1	312	0	.	Head.
chr17	41460112	41462837	Q14532	0	-	41460112	41462837	255,102,0	1	2725	0	.	Tail.
chr17	41462837	41464374	Q14532	0	-	41462837	41464374	255,102,0	1	1537	0	.	Coil 2.
chr17	41462837	41467037	Q14532	0	-	41462837	41467037	255,102,0	1	4200	0	.	Rod.
chr17	41464374	41464422	Q14532	0	-	41464374	41464422	255,102,0	1	48	0	.	Linker 12.
chr17	41464422	41466899	Q14532	0	-	41464422	41466899	255,102,0	1	2477	0	.	Coil 1B.
chr17	41466899	41466932	Q14532	0	-	41466899	41466932	255,102,0	1	33	0	.	Linker 1.
chr17	41466932	41467037	Q14532	0	-	41466932	41467037	255,102,0	1	105	0	.	Coil 1A.
chr17	41467037	41467325	Q14532	0	-	41467037	41467325	255,102,0	1	288	0	.	Head.
chr17	41477058	41477525	Q92764	0	-	41477058	41477525	255,102,0	1	467	0	.	Tail.
chr17	41477525	41478926	Q92764	0	-	41477525	41478926	255,102,0	1	1401	0	.	Coil 2.
chr17	41477525	41480806	Q92764	0	-	41477525	41480806	255,102,0	1	3281	0	.	Rod.
chr17	41478926	41478974	Q92764	0	-	41478926	41478974	255,102,0	1	48	0	.	Linker 12.
chr17	41478974	41480668	Q92764	0	-	41478974	41480668	255,102,0	1	1694	0	.	Coil 1B.
chr17	41480668	41480701	Q92764	0	-	41480668	41480701	255,102,0	1	33	0	.	Linker 1.
chr17	41480701	41480806	Q92764	0	-	41480701	41480806	255,102,0	1	105	0	.	Coil 1A.
chr17	41480806	41481097	Q92764	0	-	41480806	41481097	255,102,0	1	291	0	.	Head.
chr17	41486378	41486957	O76013	0	-	41486378	41486957	255,102,0	1	579	0	.	Tail.
chr17	41486957	41487668	O76013	0	-	41486957	41487668	255,102,0	1	711	0	.	Coil 2.
chr17	41486957	41489585	O76013	0	-	41486957	41489585	255,102,0	1	2628	0	.	Rod.
chr17	41487668	41487716	O76013	0	-	41487668	41487716	255,102,0	1	48	0	.	Linker 12.
chr17	41487716	41489447	O76013	0	-	41487716	41489447	255,102,0	1	1731	0	.	Coil 1B.
chr17	41489447	41489480	O76013	0	-	41489447	41489480	255,102,0	1	33	0	.	Linker 1.
chr17	41489480	41489585	O76013	0	-	41489480	41489585	255,102,0	1	105	0	.	Coil 1A.
chr17	41489585	41489864	O76013	0	-	41489585	41489864	255,102,0	1	279	0	.	Head.
chr17	41501258	41502381	P13646	0	-	41501258	41502381	255,102,0	1	1123	0	.	Tail.
chr17	41502381	41503014	P13646	0	-	41502381	41503014	255,102,0	1	633	0	.	Coil 2.
chr17	41502381	41505241	P13646	0	-	41502381	41505241	255,102,0	1	2860	0	.	Rod.
chr17	41503014	41503083	P13646	0	-	41503014	41503083	255,102,0	1	69	0	.	Linker 12.
chr17	41503083	41505076	P13646	0	-	41503083	41505076	255,102,0	1	1993	0	.	Coil 1B.
chr17	41505076	41505133	P13646	0	-	41505076	41505133	255,102,0	1	57	0	.	Linker 1.
chr17	41505133	41505241	P13646	0	-	41505133	41505241	255,102,0	1	108	0	.	Coil 1A.
chr17	41505241	41505550	P13646	0	-	41505241	41505550	255,102,0	1	309	0	.	Head.
chr17	41514025	41515479	P19012	0	-	41514025	41515479	255,102,0	1	1454	0	.	Tail.
chr17	41515479	41516190	P19012	0	-	41515479	41516190	255,102,0	1	711	0	.	Coil 2.
chr17	41515479	41518515	P19012	0	-	41515479	41518515	255,102,0	1	3036	0	.	Rod.
chr17	41516190	41516250	P19012	0	-	41516190	41516250	255,102,0	1	60	0	.	Linker 12.
chr17	41516250	41518350	P19012	0	-	41516250	41518350	255,102,0	1	2100	0	.	Coil 1B.
chr17	41518350	41518407	P19012	0	-	41518350	41518407	255,102,0	1	57	0	.	Linker 1.
chr17	41518407	41518515	P19012	0	-	41518407	41518515	255,102,0	1	108	0	.	Coil 1A.
chr17	41518515	41518827	P19012	0	-	41518515	41518827	255,102,0	1	312	0	.	Head.
chr17	41523745	41523784	P08727	0	-	41523745	41523784	255,102,0	1	39	0	.	Rod-like helical tail.
chr17	41523775	41524471	P08727	0	-	41523775	41524471	255,102,0	1	696	0	.	Necessary for interaction with PNN. Pubmed:10809736
chr17	41523784	41524456	P08727	0	-	41523784	41524456	255,102,0	1	672	0	.	Coil 2.
chr17	41523784	41528010	P08727	0	-	41523784	41528010	255,102,0	1	4226	0	.	Rod.
chr17	41524456	41524525	P08727	0	-	41524456	41524525	255,102,0	1	69	0	.	Linker 12.
chr17	41524525	41527848	P08727	0	-	41524525	41527848	255,102,0	1	3323	0	.	Coil 1B.
chr17	41527848	41527902	P08727	0	-	41527848	41527902	255,102,0	1	54	0	.	Linker 1.
chr17	41527902	41528010	P08727	0	-	41527902	41528010	255,102,0	1	108	0	.	Coil 1A.
chr17	41528010	41528247	P08727	0	-	41528010	41528247	255,102,0	1	237	0	.	Head.
chr17	41567275	41568172	P35527	0	-	41567275	41568172	255,102,0	1	897	0	.	Tail.
chr17	41568172	41569503	P35527	0	-	41568172	41569503	255,102,0	1	1331	0	.	Coil 2.
chr17	41568172	41571536	P35527	0	-	41568172	41571536	255,102,0	1	3364	0	.	Rod.
chr17	41569503	41569572	P35527	0	-	41569503	41569572	255,102,0	1	69	0	.	Linker 12.
chr17	41569572	41571371	P35527	0	-	41569572	41571371	255,102,0	1	1799	0	.	Coil 1B.
chr17	41571371	41571428	P35527	0	-	41571371	41571428	255,102,0	1	57	0	.	Linker 1.
chr17	41571428	41571536	P35527	0	-	41571428	41571536	255,102,0	1	108	0	.	Coil 1A.
chr17	41571536	41571992	P35527	0	-	41571536	41571992	255,102,0	1	456	0	.	Head.
chr17	41582437	41583236	P02533	0	-	41582437	41583236	255,102,0	1	799	0	.	Interaction with Type I keratins and keratin filaments.
chr17	41582437	41583242	P02533	0	-	41582437	41583242	255,102,0	1	805	0	.	Tail.
chr17	41583242	41583837	P02533	0	-	41583242	41583837	255,102,0	1	595	0	.	Coil 2.
chr17	41583242	41586492	P02533	0	-	41583242	41586492	255,102,0	1	3250	0	.	Rod.
chr17	41583837	41583906	P02533	0	-	41583837	41583906	255,102,0	1	69	0	.	Linker 12.
chr17	41583906	41586330	P02533	0	-	41583906	41586330	255,102,0	1	2424	0	.	Coil 1B.
chr17	41586330	41586384	P02533	0	-	41586330	41586384	255,102,0	1	54	0	.	Linker 1.
chr17	41586384	41586492	P02533	0	-	41586384	41586492	255,102,0	1	108	0	.	Coil 1A.
chr17	41586492	41586834	P02533	0	-	41586492	41586834	255,102,0	1	342	0	.	Head.
chr17	41609937	41610338	P08779	0	-	41609937	41610338	255,102,0	1	401	0	.	Tail.
chr17	41610338	41611146	P08779	0	-	41610338	41611146	255,102,0	1	808	0	.	Coil 2.
chr17	41610338	41612340	P08779	0	-	41610338	41612340	255,102,0	1	2002	0	.	Rod.
chr17	41611146	41611215	P08779	0	-	41611146	41611215	255,102,0	1	69	0	.	Linker 12.
chr17	41611215	41612178	P08779	0	-	41611215	41612178	255,102,0	1	963	0	.	Coil 1B.
chr17	41612178	41612232	P08779	0	-	41612178	41612232	255,102,0	1	54	0	.	Linker 1.
chr17	41612232	41612340	P08779	0	-	41612232	41612340	255,102,0	1	108	0	.	Coil 1A.
chr17	41612340	41612688	P08779	0	-	41612340	41612688	255,102,0	1	348	0	.	Head.
chr17	41619596	41620663	Q04695	0	-	41619596	41620663	255,102,0	1	1067	0	.	Tail.
chr17	41620663	41621676	Q04695	0	-	41620663	41621676	255,102,0	1	1013	0	.	Coil 2.
chr17	41620663	41624260	Q04695	0	-	41620663	41624260	255,102,0	1	3597	0	.	Rod.
chr17	41620801	41620846	Q04695	0	-	41620801	41620846	255,102,0	1	45	0	.	Peptide epitope S4; induces T-cell and keratinocyte proliferation and IFN-gamma production.
chr17	41621676	41621736	Q04695	0	-	41621676	41621736	255,102,0	1	60	0	.	Linker 12.
chr17	41621736	41624095	Q04695	0	-	41621736	41624095	255,102,0	1	2359	0	.	Coil 1B.
chr17	41622963	41623008	Q04695	0	-	41622963	41623008	255,102,0	1	45	0	.	Peptide epitope S2; induces T-cell proliferation and IFN-gamma production.
chr17	41624095	41624149	Q04695	0	-	41624095	41624149	255,102,0	1	54	0	.	Linker 1.
chr17	41624149	41624260	Q04695	0	-	41624149	41624260	255,102,0	1	111	0	.	Coil 1A.
chr17	41624161	41624206	Q04695	0	-	41624161	41624206	255,102,0	1	45	0	.	Peptide epitope S1; induces T-cell and keratinocyte proliferation and IFN-gamma production.
chr17	41624260	41624509	Q04695	0	-	41624260	41624509	255,102,0	1	249	0	.	Head.
chr17	41757477	41758452	P14923	0	-	41757477	41758452	255,102,0	1	975	0	.	Interaction with DSC1.
chr17	41767396	41769492	P14923	0	-	41767396	41769492	255,102,0	1	2096	0	.	Interaction with DSC1 and DSG1.
chr17	41828885	41828891	Q969T7	0	-	41828885	41828891	255,102,0	1	6	0	.	Substrate binding.
chr17	41878822	41878855	P53396	0	-	41878822	41878855	255,102,0	1	33	0	.	CoA-binding.
chr17	42021577	42023890	Q9NYR9	0	+	42021577	42023890	255,102,0	1	2313	0	.	Small GTPase-like.
chr17	42101832	42103648	Q96C10	0	-	42101832	42103648	255,102,0	1	1816	0	.	RNA-binding.
chr17	42115737	42115749	Q92830	0	-	42115737	42115749	255,102,0	1	12	0	.	Acetyl-CoA binding. Pubmed:17410582
chr17	42115821	42117043	Q92830	0	-	42115821	42117043	255,102,0	1	1222	0	.	Acetyl-CoA binding. Pubmed:17410582
chr17	42117055	42117064	Q92830	0	-	42117055	42117064	255,102,0	1	9	0	.	Acetyl-CoA binding. Pubmed:17410582
chr17	42218748	42219451	P51692	0	-	42218748	42219451	255,102,0	1	703	0	.	Required for interaction with NMI. Pubmed:9989503
chr17	42563159	42564735	Q13057	0	+	42563159	42564735	255,102,0	1	1576	0	.	Phosphopantetheine adenylyltransferase.
chr17	42568922	42569245	Q9UH92	0	+	42568922	42569245	255,102,0	1	323	0	.	Leucine-zipper.
chr17	42573157	42573609	Q9P2W1	0	-	42573157	42573609	255,102,0	1	452	0	.	DNA binding.
chr17	42810762	42810840	Q14457	0	-	42810762	42810840	255,102,0	1	78	0	.	Required for membrane-association. Pubmed:23878393
chr17	42818554	42818804	Q14457	0	-	42818554	42818804	255,102,0	1	250	0	.	Interaction with BCL2 and BCL2L1 isoform Bcl-X(L). Pubmed:17446862
chr17	42845757	42845790	O75106	0	+	42845757	42845790	255,102,0	1	33	0	.	Substrate binding.
chr17	42846009	42846027	O75106	0	+	42846009	42846027	255,102,0	1	18	0	.	Substrate binding.
chr17	42849216	42849240	O75106	0	+	42849216	42849240	255,102,0	1	24	0	.	Heparin-binding.
chr17	42852492	42852525	Q16853	0	+	42852492	42852525	255,102,0	1	33	0	.	Substrate binding.
chr17	42852744	42852762	Q16853	0	+	42852744	42852762	255,102,0	1	18	0	.	Substrate binding.
chr17	43006959	43012235	P80217	0	+	43006959	43012235	255,102,0	1	5276	0	.	Leucine-zipper.
chr17	43082488	43082572	P38398	0	-	43082488	43082572	255,102,0	1	84	0	.	Interaction with PALB2. Pubmed:19369211
chr17	43194448	43196988	Q14596	0	+	43194448	43196988	255,102,0	1	2540	0	.	ATG8 family protein-binding.
chr17	43200318	43200354	Q14596	0	+	43200318	43200354	255,102,0	1	36	0	.	ATG8 family protein-binding.
chr17	44004717	44007354	Q8N159	0	+	44004717	44007354	255,102,0	1	2637	0	.	Amino-acid kinase domain (AAK).
chr17	44007741	44007759	Q8N159	0	+	44007741	44007759	255,102,0	1	18	0	.	Substrate binding.
chr17	44078873	44085156	Q9UQL6	0	-	44078873	44085156	255,102,0	1	6283	0	.	Histone deacetylase.
chr17	44255206	44255798	P02730	0	-	44255206	44255798	255,102,0	1	592	0	.	Involved in anion transport.
chr17	44258428	44258590	P02730	0	-	44258428	44258590	255,102,0	1	162	0	.	Dimerization arm.
chr17	44259168	44261580	P02730	0	-	44259168	44261580	255,102,0	1	2412	0	.	Globular.
chr17	44259862	44259892	P02730	0	-	44259862	44259892	255,102,0	1	30	0	.	Interaction with ANK1.
chr17	44308832	44315550	Q59EK9	0	+	44308832	44315550	255,102,0	1	6718	0	.	Interaction with RAP2A.
chr17	44907349	44910654	P14136	0	-	44907349	44910654	255,102,0	1	3305	0	.	Tail.
chr17	44910654	44913280	P14136	0	-	44910654	44913280	255,102,0	1	2626	0	.	Coil 2B.
chr17	44910654	44915270	P14136	0	-	44910654	44915270	255,102,0	1	4616	0	.	Rod.
chr17	44913280	44913292	P14136	0	-	44913280	44913292	255,102,0	1	12	0	.	Linker 2.
chr17	44913292	44913358	P14136	0	-	44913292	44913358	255,102,0	1	66	0	.	Coil 2A.
chr17	44913358	44913406	P14136	0	-	44913358	44913406	255,102,0	1	48	0	.	Linker 12.
chr17	44913406	44915141	P14136	0	-	44913406	44915141	255,102,0	1	1735	0	.	Coil 1B.
chr17	44915141	44915174	P14136	0	-	44915141	44915174	255,102,0	1	33	0	.	Linker 1.
chr17	44915174	44915270	P14136	0	-	44915174	44915270	255,102,0	1	96	0	.	Coil 1A.
chr17	44915270	44915486	P14136	0	-	44915270	44915486	255,102,0	1	216	0	.	Head.
chr17	45086618	45086627	P30419	0	+	45086618	45086627	255,102,0	1	9	0	.	Myristoyl-CoA binding. Pubmed:25255805
chr17	45098409	45098418	P30419	0	+	45098409	45098418	255,102,0	1	9	0	.	Myristoyl-CoA binding. Pubmed:25255805
chr17	45098433	45098448	P30419	0	+	45098433	45098448	255,102,0	1	15	0	.	Myristoyl-CoA binding. Pubmed:25255805
chr17	45121232	45121319	Q8N3E9	0	-	45121232	45121319	255,102,0	1	87	0	.	Substrate binding.
chr17	45136210	45136507	Q8NC06	0	+	45136210	45136507	255,102,0	1	297	0	.	Acyl-CoA binding.
chr17	45136537	45136552	Q8NC06	0	+	45136537	45136552	255,102,0	1	15	0	.	Acyl-CoA binding.
chr17	45149637	45149721	O94992	0	+	45149637	45149721	255,102,0	1	84	0	.	Basic region; mediates nuclear localization and interaction with 7SK snRNA and NR3C1. Pubmed:15941832
chr17	45149793	45149805	O94992	0	+	45149793	45149805	255,102,0	1	12	0	.	Interaction with P-TEFb.
chr17	45149817	45149940	O94992	0	+	45149817	45149940	255,102,0	1	123	0	.	Autoinhibitory acidic region; in absence of 7SK snRNA interacts with the basic region preventing interaction with P-TEFb and modulating subcellular localization.
chr17	45150045	45150132	O94992	0	+	45150045	45150132	255,102,0	1	87	0	.	Mediates interaction with CCNT1.
chr17	45150117	45150255	O94992	0	+	45150117	45150255	255,102,0	1	138	0	.	Required for inhibition of ESR1-dependent transcription.
chr17	45169365	45169377	Q96MH2	0	+	45169365	45169377	255,102,0	1	12	0	.	Interaction with P-TEFb.
chr17	45169623	45169806	Q96MH2	0	+	45169623	45169806	255,102,0	1	183	0	.	Interaction with CCNT1, HEXIM1 and HEXIM2. Pubmed:15713661, Pubmed:15994294
chr17	45270425	45284901	Q99558	0	-	45270425	45284901	255,102,0	1	14476	0	.	Interaction with ZFP91. Pubmed:20682767
chr17	45437792	45453826	Q9Y4G2	0	-	45437792	45453826	255,102,0	1	16034	0	.	Interaction with RAB7A. Pubmed:25500191
chr17	45437860	45453892	Q9Y4G2	0	-	45437860	45453892	255,102,0	1	16032	0	.	Interaction with RAB7A. Pubmed:25500191
chr17	45437862	45453547	Q9Y4G2	0	-	45437862	45453547	255,102,0	1	15685	0	.	Interaction with RAB7A. Pubmed:25500191
chr17	45821407	45821437	P34998	0	+	45821407	45821437	255,102,0	1	30	0	.	Important for peptide agonist binding.
chr17	45833026	45833056	P34998	0	+	45833026	45833056	255,102,0	1	30	0	.	Important for peptide agonist binding.
chr17	45833204	45833478	P34998	0	+	45833204	45833478	255,102,0	1	274	0	.	Important for antagonist binding.
chr17	45844823	45845097	P34998	0	+	45844823	45845097	255,102,0	1	274	0	.	Important for antagonist binding.
chr17	46264169	46264443	P34998	0	-	46264169	46264443	255,102,0	1	274	0	.	Important for antagonist binding.
chr17	46276249	46276279	P34998	0	-	46276249	46276279	255,102,0	1	30	0	.	Important for peptide agonist binding.
chr17	47284687	47286275	P05106	0	+	47284687	47286275	255,102,0	1	1588	0	.	Involved in CX3CL1-, NRG1-, FGF1- and IGF1-binding. Pubmed:20682778, Pubmed:23125415
chr17	47287168	47287231	P05106	0	+	47287168	47287231	255,102,0	1	63	0	.	CX3CL1-binding. Pubmed:24789099
chr17	47292264	47299504	P05106	0	+	47292264	47299504	255,102,0	1	7240	0	.	Cysteine-rich tandem repeats.
chr17	47586363	47586378	P55786	0	+	47586363	47586378	255,102,0	1	15	0	.	Substrate binding.
chr17	47665143	47668212	Q14974	0	+	47665143	47668212	255,102,0	1	3069	0	.	IAB-binding.
chr17	47668185	47669710	Q14974	0	+	47668185	47669710	255,102,0	1	1525	0	.	Ran-GTP binding.
chr17	47696112	47699662	A7MCY6	0	+	47696112	47699662	255,102,0	1	3550	0	.	Homodimerization.
chr17	47699662	47708508	A7MCY6	0	+	47699662	47708508	255,102,0	1	8846	0	.	Interaction with TBK1 and IKBKE.
chr17	47941786	47941798	V9HW45	0	+	47941786	47941798	255,102,0	1	12	0	.	Substrate binding.
chr17	47941798	47941810	Q9NVS9	0	+	47941798	47941810	255,102,0	1	12	0	.	Pyridoxal 5'-phosphate binding.
chr17	47946668	47946677	Q9NVS9	0	+	47946668	47946677	255,102,0	1	9	0	.	Pyridoxal 5'-phosphate binding.
chr17	47946668	47946677	V9HW45	0	+	47946668	47946677	255,102,0	1	9	0	.	Substrate binding.
chr17	47976717	47981499	Q96JB5	0	+	47976717	47981499	255,102,0	1	4782	0	.	Required for interaction with UFL1 and mediates interaction with CHEK1. Pubmed:19223857, Pubmed:20228063
chr17	48059287	48059347	Q14494	0	+	48059287	48059347	255,102,0	1	60	0	.	Basic motif.
chr17	48059365	48059410	Q14494	0	+	48059365	48059410	255,102,0	1	45	0	.	Leucine-zipper.
chr17	48119049	48119064	Q9Y5W9	0	+	48119049	48119064	255,102,0	1	15	0	.	Important for membrane trafficking.
chr17	48162561	48170618	Q86WV1	0	-	48162561	48170618	255,102,0	1	8057	0	.	Interaction with FYB.
chr17	48860415	48860448	Q13137	0	+	48860415	48860448	255,102,0	1	33	0	.	Interaction with LGALS8. Pubmed:23386746, Pubmed:23511477
chr17	48862846	48863002	Q13137	0	+	48862846	48863002	255,102,0	1	156	0	.	Interaction with MYO6. Pubmed:17635994
chr17	49038324	49049420	Q9NZI8	0	+	49038324	49049420	255,102,0	1	11096	0	.	Necessary for interaction with ELAVL4 and binding to TAU mRNA.
chr17	49041486	49042272	Q9NZI8	0	+	49041486	49042272	255,102,0	1	786	0	.	Sufficient for nuclear export.
chr17	49045946	49045979	Q9NZI8	0	+	49045946	49045979	255,102,0	1	33	0	.	Sufficient for nuclear export.
chr17	49298415	49298742	Q9Y2D9	0	-	49298415	49298742	255,102,0	1	327	0	.	Mediates interaction with CBFA2T3. Pubmed:16966434
chr17	49512045	49512748	P08138	0	+	49512045	49512748	255,102,0	1	703	0	.	Mediates interaction with KIDINS220.
chr17	49578607	49578766	O95157	0	+	49578607	49578766	255,102,0	1	159	0	.	II.
chr17	49578766	49579012	O95157	0	+	49578766	49579012	255,102,0	1	246	0	.	III.
chr17	49579012	49579039	O95157	0	+	49579012	49579039	255,102,0	1	27	0	.	IV (linker domain).
chr17	49579039	49579297	O95157	0	+	49579039	49579297	255,102,0	1	258	0	.	V (Cys-rich).
chr17	49600437	49601956	O43791	0	-	49600437	49601956	255,102,0	1	1519	0	.	Important for homodimerization.
chr17	49611286	49611382	O43791	0	-	49611286	49611382	255,102,0	1	96	0	.	Important for homodimerization.
chr17	49611364	49619375	O43791	0	-	49611364	49619375	255,102,0	1	8011	0	.	Required for nuclear localization.
chr17	49619061	49619094	O43791	0	-	49619061	49619094	255,102,0	1	33	0	.	Important for binding substrate proteins.
chr17	49823237	49823246	O95251	0	+	49823237	49823246	255,102,0	1	9	0	.	Acetyl-CoA binding.
chr17	49823258	49823279	O95251	0	+	49823258	49823279	255,102,0	1	21	0	.	Acetyl-CoA binding.
chr17	50087866	50088242	P26006	0	+	50087866	50088242	255,102,0	1	376	0	.	Interaction with HPS5.
chr17	50479904	50479910	Q9HA92	0	+	50479904	50479910	255,102,0	1	6	0	.	S-adenosyl-L-methionine 2 binding.
chr17	50540315	50541031	Q9H201	0	+	50540315	50541031	255,102,0	1	716	0	.	5 X 3 AA repeats of [DE]-P-W.
chr17	50541678	50542151	Q9H201	0	+	50541678	50542151	255,102,0	1	473	0	.	3 X 3 AA repeats of N-P-F.
chr17	50863363	50863537	P50616	0	-	50863363	50863537	255,102,0	1	174	0	.	Required for interaction with CPEB3. Pubmed:21336257
chr17	50863741	50863774	P50616	0	-	50863741	50863774	255,102,0	1	33	0	.	Important for nuclear localization.
chr17	51166830	51168313	P22392	0	+	51166830	51168313	255,102,0	1	1483	0	.	Interaction with AKAP13. Pubmed:15249197
chr17	54947303	54949520	O75674	0	+	54947303	54949520	255,102,0	1	2217	0	.	Interaction with GRB2.
chr17	54950079	54950091	O75674	0	+	54950079	54950091	255,102,0	1	12	0	.	Interaction with PIK3R1.
chr17	55320669	55320732	Q16534	0	+	55320669	55320732	255,102,0	1	63	0	.	Basic motif.
chr17	55320732	55320756	Q16534	0	+	55320732	55320756	255,102,0	1	24	0	.	Leucine-zipper.
chr17	56895355	56913451	Q14258	0	-	56895355	56913451	255,102,0	1	18096	0	.	Interaction with influenza A virus NS1.
chr17	56942121	56950086	P38432	0	-	56942121	56950086	255,102,0	1	7965	0	.	2 X 4 AA repeats of S-L-P-A.
chr17	56949981	56950005	P38432	0	-	56949981	56950005	255,102,0	1	24	0	.	4 X 2 AA tandem repeats of R-G.
chr17	56949981	56950068	P38432	0	-	56949981	56950068	255,102,0	1	87	0	.	Required for interaction with SMN. Pubmed:11641277
chr17	56950428	56950575	P38432	0	-	56950428	56950575	255,102,0	1	147	0	.	2 X 4 AA repeats of A-R-N-S.
chr17	57106493	57106535	Q92667	0	+	57106493	57106535	255,102,0	1	42	0	.	PKA-RII subunit binding domain.
chr17	57974583	57974859	Q14119	0	-	57974583	57974859	255,102,0	1	276	0	.	4 X 7 AA repeats of P-[LV]-T-[IL]-T-[ST]-P.
chr17	58005411	58005561	Q07955	0	-	58005411	58005561	255,102,0	1	150	0	.	Interaction with SAFB1.
chr17	58351457	58352132	P63272	0	-	58351457	58352132	255,102,0	1	675	0	.	Interaction with SUPT5H.
chr17	58504838	58504859	Q9NYA4	0	-	58504838	58504859	255,102,0	1	21	0	.	Substrate binding.
chr17	58505536	58505542	Q9NYA4	0	-	58505536	58505542	255,102,0	1	6	0	.	Substrate binding.
chr17	58506764	58506776	Q9NYA4	0	-	58506764	58506776	255,102,0	1	12	0	.	Substrate binding.
chr17	58692643	58695163	O43502	0	+	58692643	58695163	255,102,0	1	2520	0	.	Required for Holliday junction resolution activity.
chr17	58695019	58696696	O43502	0	+	58695019	58696696	255,102,0	1	1677	0	.	Interaction with RAD51B, RAD51D and XRCC3. Pubmed:14704354
chr17	59620134	59663910	Q00610	0	+	59620134	59663910	255,102,0	1	43776	0	.	Globular terminal domain.
chr17	59644302	59644434	Q00610	0	+	59644302	59644434	255,102,0	1	132	0	.	WD40-like repeat 1.
chr17	59644434	59647468	Q00610	0	+	59644434	59647468	255,102,0	1	3034	0	.	WD40-like repeat 2.
chr17	59647468	59647594	Q00610	0	+	59647468	59647594	255,102,0	1	126	0	.	WD40-like repeat 3.
chr17	59647594	59648305	Q00610	0	+	59647594	59648305	255,102,0	1	711	0	.	WD40-like repeat 4.
chr17	59648305	59651292	Q00610	0	+	59648305	59651292	255,102,0	1	2987	0	.	WD40-like repeat 5.
chr17	59651292	59655961	Q00610	0	+	59651292	59655961	255,102,0	1	4669	0	.	WD40-like repeat 6.
chr17	59655961	59660411	Q00610	0	+	59655961	59660411	255,102,0	1	4450	0	.	WD40-like repeat 7.
chr17	59661619	59663868	Q00610	0	+	59661619	59663868	255,102,0	1	2249	0	.	Binding site for the uncoating ATPase, involved in lattice disassembly.
chr17	59663841	59663994	Q00610	0	+	59663841	59663994	255,102,0	1	153	0	.	Involved in spindle localization and interaction with TACC3. Pubmed:23918938
chr17	59663910	59664834	Q00610	0	+	59663910	59664834	255,102,0	1	924	0	.	Flexible linker.
chr17	59664834	59666599	Q00610	0	+	59664834	59666599	255,102,0	1	1765	0	.	Distal segment.
chr17	59664834	59693849	Q00610	0	+	59664834	59693849	255,102,0	1	29015	0	.	Heavy chain arm.
chr17	59666611	59693849	Q00610	0	+	59666611	59693849	255,102,0	1	27238	0	.	Proximal segment.
chr17	59682664	59685187	Q00610	0	+	59682664	59685187	255,102,0	1	2523	0	.	Involved in binding clathrin light chain.
chr17	59685628	59693849	Q00610	0	+	59685628	59693849	255,102,0	1	8221	0	.	Trimerization.
chr17	59945447	59946785	P23443	0	+	59945447	59946785	255,102,0	1	1338	0	.	Autoinhibitory domain.
chr17	60158374	60158380	P22748	0	+	60158374	60158380	255,102,0	1	6	0	.	Substrate binding.
chr17	60600414	60600717	O15297	0	+	60600414	60600717	255,102,0	1	303	0	.	Interaction with CHEK1. Pubmed:15870257
chr17	61405701	61408170	Q13207	0	+	61405701	61408170	255,102,0	1	2469	0	.	Repression domain 1 (RD1).
chr17	63477181	63484510	P12821	0	+	63477181	63484510	255,102,0	1	7329	0	.	Peptidase M2 1.
chr17	63484510	63497141	P12821	0	+	63484510	63497141	255,102,0	1	12631	0	.	Peptidase M2 2.
chr17	63817792	63818080	Q86XP3	0	+	63817792	63818080	255,102,0	1	288	0	.	Necessary for interaction with TP53BP2. Pubmed:19377511
chr17	63830811	63831966	P62195	0	+	63830811	63831966	255,102,0	1	1155	0	.	May mediate interaction with PRPF9.
chr17	64499925	64500561	P17844	0	-	64499925	64500561	255,102,0	1	636	0	.	Transactivation domain.
chr17	66212135	66214648	P02749	0	-	66212135	66214648	255,102,0	1	2513	0	.	Sushi-like.
chr17	67875608	67891848	Q12830	0	+	67875608	67891848	255,102,0	1	16240	0	.	Interaction with KEAP1. Pubmed:15379550
chr17	67893450	67893699	Q12830	0	+	67893450	67893699	255,102,0	1	249	0	.	Interaction with MAZ. Pubmed:10727212
chr17	68042205	68043147	P52292	0	+	68042205	68043147	255,102,0	1	942	0	.	NLS binding site (major).
chr17	68043849	68044365	P52292	0	+	68043849	68044365	255,102,0	1	516	0	.	NLS binding site (minor).
chr17	68515399	68523784	P10644	0	+	68515399	68523784	255,102,0	1	8385	0	.	Dimerization and phosphorylation.
chr17	69414993	69505820	P52564	0	+	69414993	69505820	255,102,0	1	90827	0	.	D domain.
chr17	69541678	69541750	P52564	0	+	69541678	69541750	255,102,0	1	72	0	.	DVD domain.
chr17	75239375	75241451	Q9NZ52	0	-	75239375	75241451	255,102,0	1	2076	0	.	Unstructured hinge.
chr17	75241406	75261587	Q9NZ52	0	-	75241406	75261587	255,102,0	1	20181	0	.	Binds to ARF1 (in long isoform).
chr17	75629247	75629469	O94762	0	-	75629247	75629469	255,102,0	1	222	0	.	Interaction with RAD51.
chr17	75629794	75631230	O94762	0	-	75629794	75631230	255,102,0	1	1436	0	.	Interaction with POLR2A.
chr17	75729277	75729295	P16144	0	+	75729277	75729295	255,102,0	1	18	0	.	Involved in NRG1- and IGF1-binding. Pubmed:20682778, Pubmed:22351760
chr17	75731961	75736383	P16144	0	+	75731961	75736383	255,102,0	1	4422	0	.	Cysteine-rich tandem repeats.
chr17	75737617	75739698	P16144	0	+	75737617	75739698	255,102,0	1	2081	0	.	Palmitoylated on several cysteines.
chr17	75763066	75763078	P51570	0	-	75763066	75763078	255,102,0	1	12	0	.	Substrate binding.
chr17	75764998	75765010	P51570	0	-	75764998	75765010	255,102,0	1	12	0	.	Substrate binding.
chr17	75835744	75840542	Q70J99	0	-	75835744	75840542	255,102,0	1	4798	0	.	Interaction with RAB27A.
chr17	76007105	76008185	Q92817	0	-	76007105	76008185	255,102,0	1	1080	0	.	Globular 2.
chr17	76008185	76011816	Q92817	0	-	76008185	76011816	255,102,0	1	3631	0	.	Central fibrous rod domain.
chr17	76011816	76027198	Q92817	0	-	76011816	76027198	255,102,0	1	15382	0	.	Globular 1.
chr17	76027114	76027165	Q92817	0	-	76027114	76027165	255,102,0	1	51	0	.	4 X 4 AA tandem repeats of K-G-S-P.
chr17	76386291	76386303	Q9NYA1	0	+	76386291	76386303	255,102,0	1	12	0	.	Substrate binding.
chr17	76469715	76469724	Q16613	0	+	76469715	76469724	255,102,0	1	9	0	.	Acetyl-CoA binding.
chr17	76469739	76469757	Q16613	0	+	76469739	76469757	255,102,0	1	18	0	.	Acetyl-CoA binding.
chr17	76469847	76469856	Q16613	0	+	76469847	76469856	255,102,0	1	9	0	.	Acetyl-CoA binding.
chr17	76531016	76537494	Q8WWM9	0	-	76531016	76537494	255,102,0	1	6478	0	.	Globin.
chr17	77143596	77209395	Q92503	0	+	77143596	77209395	255,102,0	1	65799	0	.	Required for interaction and inhibitory function toward DDX58. Pubmed:23843640
chr17	78049062	78067923	Q9HCJ0	0	+	78049062	78067923	255,102,0	1	18861	0	.	Sufficient for interaction with argonaute family proteins.
chr17	78087068	78104842	Q9HCJ0	0	+	78087068	78104842	255,102,0	1	17774	0	.	Silencing domain; interaction with CNOT1 and PAN3. Pubmed:21981923
chr17	78093072	78093708	Q9HCJ0	0	+	78093072	78093708	255,102,0	1	636	0	.	Required for interaction with PABPC1.
chr17	78093072	78104842	Q9HCJ0	0	+	78093072	78104842	255,102,0	1	11770	0	.	Sufficient for translational repression when tethered to a target mRNA.
chr17	78093102	78093654	Q9HCJ0	0	+	78093102	78093654	255,102,0	1	552	0	.	PABPC1-interacting motif-2 (PAM2).
chr17	78104557	78104842	Q9HCJ0	0	+	78104557	78104842	255,102,0	1	285	0	.	Interaction with the CCR4-NOT complex.
chr17	78174935	78174950	P04183	0	-	78174935	78174950	255,102,0	1	15	0	.	Substrate binding. Pubmed:15733844, Pubmed:15611477, Pubmed:22385435
chr17	78358960	78358996	O14543	0	-	78358960	78358996	255,102,0	1	36	0	.	Extended SH2 subdomain (ESS).
chr17	78358996	78359032	O14543	0	-	78358996	78359032	255,102,0	1	36	0	.	Kinase inhibitory region (KIR).
chr17	78676099	78676126	Q15438	0	-	78676099	78676126	255,102,0	1	27	0	.	C-terminal autoinhibitory region.
chr17	78692476	78698275	Q15438	0	-	78692476	78698275	255,102,0	1	5799	0	.	Phosphatidylinositol 3,4,5-trisphosphate binding.
chr17	78870949	78870955	P16035	0	-	78870949	78870955	255,102,0	1	6	0	.	Involved in metalloproteinase-binding.
chr17	78924995	78925010	P16035	0	-	78924995	78925010	255,102,0	1	15	0	.	Involved in metalloproteinase-binding.
chr17	79833961	79834024	O00257	0	-	79833961	79834024	255,102,0	1	63	0	.	Interaction with RNF2.
chr17	79834024	79839251	O00257	0	-	79834024	79839251	255,102,0	1	5227	0	.	Interaction with BMI1.
chr17	80998377	80998413	Q96FZ7	0	+	80998377	80998413	255,102,0	1	36	0	.	Interaction with VPS4A.
chr17	81693512	81696669	O14964	0	+	81693512	81696669	255,102,0	1	3157	0	.	Interaction with SNX1.
chr17	81695938	81696669	O14964	0	+	81695938	81696669	255,102,0	1	731	0	.	Interaction with SNAP25 and TRAK2.
chr17	81695965	81696832	O14964	0	+	81695965	81696832	255,102,0	1	867	0	.	Interaction with STAM.
chr17	81696400	81701615	O14964	0	+	81696400	81701615	255,102,0	1	5215	0	.	Interaction with NF2. Pubmed:10861283
chr17	81922814	81922859	O15525	0	-	81922814	81922859	255,102,0	1	45	0	.	Leucine-zipper.
chr17	81922865	81922937	O15525	0	-	81922865	81922937	255,102,0	1	72	0	.	Basic motif.
chr17	82009051	82009537	Q9BZE9	0	+	82009051	82009537	255,102,0	1	486	0	.	Interaction with GLUT4.
chr17	82079145	82080899	P49327	0	-	82079145	82080899	255,102,0	1	1754	0	.	Thioesterase.
chr17	82081652	82083091	P49327	0	-	82081652	82083091	255,102,0	1	1439	0	.	Beta-ketoacyl reductase.
chr17	82083091	82084250	P49327	0	-	82083091	82084250	255,102,0	1	1159	0	.	Enoyl reductase.
chr17	82088531	82091429	P49327	0	-	82088531	82091429	255,102,0	1	2898	0	.	Acyl and malonyl transferases.
chr17	82091471	82096445	P49327	0	-	82091471	82096445	255,102,0	1	4974	0	.	Beta-ketoacyl synthase.
chr17	82248979	82251432	P48730	0	-	82248979	82251432	255,102,0	1	2453	0	.	Centrosomal localization signal (CLS).
chr17	82249461	82249539	P48730	0	-	82249461	82249539	255,102,0	1	78	0	.	Autoinhibitory.
chr17	82316266	82316374	P09564	0	-	82316266	82316374	255,102,0	1	108	0	.	4 X 9 AA tandem repeats, potential spacer function.
chr17	82520272	82563447	Q01167	0	+	82520272	82563447	255,102,0	1	43175	0	.	Required for interaction with DVL2 and SUDS3. Pubmed:25805136
chr17	82571858	82582785	Q01167	0	+	82571858	82582785	255,102,0	1	10927	0	.	DNA-binding; major groove.
chr17	82582812	82582827	Q01167	0	+	82582812	82582827	255,102,0	1	15	0	.	DNA-binding; minor groove.
chr17	82582872	82582890	Q01167	0	+	82582872	82582890	255,102,0	1	18	0	.	DNA-binding; minor groove.
chr18	677421	677430	Q7L5Y1	0	-	677421	677430	255,102,0	1	9	0	.	Substrate binding.
chr18	712509	712518	Q7L5Y1	0	-	712509	712518	255,102,0	1	9	0	.	Substrate binding.
chr18	909551	909578	P18509	0	+	909551	909578	255,102,0	1	27	0	.	Important for receptor binding.
chr18	2572985	2587910	O14777	0	+	2572985	2587910	255,102,0	1	14925	0	.	Nuclear localization.
chr18	2572985	2599132	O14777	0	+	2572985	2599132	255,102,0	1	26147	0	.	Interaction with the N-terminus of CDCA1.
chr18	2578046	2587913	O14777	0	+	2578046	2587913	255,102,0	1	9867	0	.	Interaction with RB1.
chr18	2587910	2599090	O14777	0	+	2587910	2599090	255,102,0	1	11180	0	.	Interaction with SMC1A.
chr18	2587910	2616499	O14777	0	+	2587910	2616499	255,102,0	1	28589	0	.	Interaction with NEK2 and ZWINT. Pubmed:16732327
chr18	2595480	2608783	O14777	0	+	2595480	2608783	255,102,0	1	13303	0	.	Interaction with PSMC2 and SMC1A.
chr18	2599132	2616571	O14777	0	+	2599132	2616571	255,102,0	1	17439	0	.	Interaction with the C-terminus of CDCA1 and the SPBC24-SPBC25 subcomplex.
chr18	2920812	2925259	Q92539	0	-	2920812	2925259	255,102,0	1	4447	0	.	C-LIP.
chr18	2951320	2960840	Q92539	0	-	2951320	2960840	255,102,0	1	9520	0	.	N-LIP.
chr18	3188867	3188975	P52179	0	-	3188867	3188975	255,102,0	1	108	0	.	6 X 6 AA tandem repeats.
chr18	3567497	3567533	O14490	0	-	3567497	3567533	255,102,0	1	36	0	.	Interaction with DYL2.
chr18	3567563	3581892	O14490	0	-	3567563	3581892	255,102,0	1	14329	0	.	Interaction with DYL2.
chr18	5145672	5145723	P0CW23	0	-	5145672	5145723	255,102,0	1	51	0	.	PKA-RII subunit binding domain.
chr18	5394697	5397318	Q9Y2J2	0	-	5394697	5397318	255,102,0	1	2621	0	.	C-terminal (CTD).
chr18	5397318	5416345	Q9Y2J2	0	-	5397318	5416345	255,102,0	1	19027	0	.	Spectrin--actin-binding.
chr18	5416345	5423537	Q9Y2J2	0	-	5416345	5423537	255,102,0	1	7192	0	.	Hydrophilic.
chr18	6976077	6997882	P25391	0	-	6976077	6997882	255,102,0	1	21805	0	.	Domain II and I.
chr18	8376195	8376477	P28827	0	+	8376195	8376477	255,102,0	1	282	0	.	Substrate binding.
chr18	8705660	8706407	Q9Y4B5	0	+	8705660	8706407	255,102,0	1	747	0	.	Necessary for colocalization and binding with microtubules.
chr18	8705660	8783556	Q9Y4B5	0	+	8705660	8783556	255,102,0	1	77896	0	.	Necessary for self-assembly, microtubule bundling activity and apicobasal microtubule organization.
chr18	8813209	8821499	Q9Y4B5	0	+	8813209	8821499	255,102,0	1	8290	0	.	Necessary for interaction with MARK2 and apicobasal microtubule bundle formation in polarized epithelial cells. Pubmed:23902687
chr18	8825584	8825872	Q9Y4B5	0	+	8825584	8825872	255,102,0	1	288	0	.	Necessary for colocalization and binding with microtubules.
chr18	9524746	9533376	Q15311	0	+	9524746	9533376	255,102,0	1	8630	0	.	Interaction with RalA.
chr18	9886815	9887805	Q86VQ3	0	+	9886815	9887805	255,102,0	1	990	0	.	22 X 15 AA approximate tandem repeat of Q-P-K-X-G-D-I-P-K-S-[PS]-E-[KE]-X-I.
chr18	11851904	11851979	Q7LBR1	0	+	11851904	11851979	255,102,0	1	75	0	.	Interaction with IST1.
chr18	11852030	11852108	Q7LBR1	0	+	11852030	11852108	255,102,0	1	78	0	.	Interaction with SPAST. Pubmed:15537668
chr18	11852048	11852099	Q7LBR1	0	+	11852048	11852099	255,102,0	1	51	0	.	Interaction with VPS4A, MITD1 and STAMBP. Pubmed:19129480
chr18	11852048	11852108	Q7LBR1	0	+	11852048	11852108	255,102,0	1	60	0	.	Interaction with VTA1.
chr18	11852057	11852108	Q7LBR1	0	+	11852057	11852108	255,102,0	1	51	0	.	Interaction with VPS4B.
chr18	12009958	12009970	O14732	0	+	12009958	12009970	255,102,0	1	12	0	.	Substrate binding.
chr18	12028854	12028863	O14732	0	+	12028854	12028863	255,102,0	1	9	0	.	Substrate binding.
chr18	12454393	12454456	Q08AE8	0	-	12454393	12454456	255,102,0	1	63	0	.	Spir-box.
chr18	12546862	12546886	Q08AE8	0	-	12546862	12546886	255,102,0	1	24	0	.	Important for interaction with FMN2.
chr18	12794280	12794400	P17706	0	-	12794280	12794400	255,102,0	1	120	0	.	Mediates interaction with STX17. Pubmed:23006999
chr18	12794280	12801974	P17706	0	-	12794280	12801974	255,102,0	1	7694	0	.	Endoplasmic reticulum location.
chr18	12817194	12817215	A8K3N4	0	-	12817194	12817215	255,102,0	1	21	0	.	Substrate binding.
chr18	12817194	12817215	K7EQG9	0	-	12817194	12817215	255,102,0	1	21	0	.	Substrate binding.
chr18	12817194	12817215	P17706	0	-	12817194	12817215	255,102,0	1	21	0	.	Substrate binding.
chr18	13734571	13734577	O43148	0	+	13734571	13734577	255,102,0	1	6	0	.	mRNA cap binding.
chr18	13740267	13740273	K7EP06	0	+	13740267	13740273	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr18	13740267	13740273	O43148	0	+	13740267	13740273	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr18	13741566	13741575	K7EP06	0	+	13741566	13741575	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr18	13741566	13741575	O43148	0	+	13741566	13741575	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr18	20953576	20966926	Q13464	0	-	20953576	20966926	255,102,0	1	13350	0	.	Auto-inhibitory.
chr18	20967913	20968783	Q13464	0	-	20967913	20968783	255,102,0	1	870	0	.	RHOA binding.
chr18	20987072	21028885	Q13464	0	-	20987072	21028885	255,102,0	1	41813	0	.	Interaction with FHOD1. Pubmed:18694941
chr18	21612429	21623896	P62314	0	+	21612429	21623896	255,102,0	1	11467	0	.	Sufficient for interaction with CLNS1A. Pubmed:11747828
chr18	22936914	22946469	Q99708	0	+	22936914	22946469	255,102,0	1	9555	0	.	Essential for binding to the MRN complex and for RPA focus formation on DNA damage.
chr18	22993351	22993498	Q99708	0	+	22993351	22993498	255,102,0	1	147	0	.	Damage-recruitment motif.
chr18	23135762	23136089	Q8TDN4	0	+	23135762	23136089	255,102,0	1	327	0	.	Interaction with TDRD7.
chr18	23136296	23252989	Q8TDN4	0	+	23136296	23252989	255,102,0	1	116693	0	.	Interaction with CDK3.
chr18	23561375	23561468	O15118	0	-	23561375	23561468	255,102,0	1	93	0	.	Important for cholesterol binding and cholesterol transfer from NPC1 to liposomes.
chr18	24318621	24377533	Q9BXW6	0	-	24318621	24377533	255,102,0	1	58912	0	.	Interaction with RAB7A. Pubmed:16176980
chr18	26032521	26035071	Q15532	0	-	26032521	26035071	255,102,0	1	2550	0	.	2 X 13 AA imperfect tandem repeats.
chr18	26052672	26090566	Q15532	0	-	26052672	26090566	255,102,0	1	37894	0	.	Transcriptional activation.
chr18	26286439	26292254	Q92750	0	+	26286439	26292254	255,102,0	1	5815	0	.	Required for interaction with P65/RELA.
chr18	26389910	26390009	Q92750	0	+	26389910	26390009	255,102,0	1	99	0	.	Required for interaction with TAF12. Pubmed:15601843
chr18	31598633	31598648	P02766	0	+	31598633	31598648	255,102,0	1	15	0	.	Thyroid hormone binding.
chr18	31626311	31626317	Q9UBX8	0	-	31626311	31626317	255,102,0	1	6	0	.	UDP-alpha-D-galactose binding.
chr18	31627012	31627024	Q9UBX8	0	-	31627012	31627024	255,102,0	1	12	0	.	N-acetyl-D-glucosamine binding.
chr18	31631044	31631050	Q9UBX8	0	-	31631044	31631050	255,102,0	1	6	0	.	UDP-alpha-D-galactose binding.
chr18	31631122	31631131	Q9UBX8	0	-	31631122	31631131	255,102,0	1	9	0	.	UDP-alpha-D-galactose binding.
chr18	31638730	31638745	Q9UBX8	0	-	31638730	31638745	255,102,0	1	15	0	.	UDP-alpha-D-galactose binding.
chr18	32018989	32018998	Q96EQ8	0	+	32018989	32018998	255,102,0	1	9	0	.	Interaction with the C2HC RNF-type zinc finger. Pubmed:27411375
chr18	32042184	32042199	Q96EQ8	0	+	32042184	32042199	255,102,0	1	15	0	.	Interaction with the RING-type zinc finger. Pubmed:27411375
chr18	32042217	32042244	Q96EQ8	0	+	32042217	32042244	255,102,0	1	27	0	.	Linker region. Pubmed:27411375
chr18	32068312	32068357	Q96EQ8	0	+	32068312	32068357	255,102,0	1	45	0	.	Required for interaction with ubiquitin and for autoubiquitination. Pubmed:17990982
chr18	32195424	32208129	Q16820	0	+	32195424	32208129	255,102,0	1	12705	0	.	Metalloprotease.
chr18	32217013	32217052	Q16820	0	+	32217013	32217052	255,102,0	1	39	0	.	Required for proteolytic processing.
chr18	32270299	32287105	Q9H706	0	-	32270299	32287105	255,102,0	1	16806	0	.	Necessary for interaction with GRB2. Pubmed:19509291
chr18	32287636	32470395	Q9H706	0	-	32287636	32470395	255,102,0	1	182759	0	.	CABIT.
chr18	34755976	34818318	Q9Y4J8	0	+	34755976	34818318	255,102,0	1	62342	0	.	Interaction with MAGEE1.
chr18	34838769	34848380	Q9Y4J8	0	+	34838769	34848380	255,102,0	1	9611	0	.	Syntrophin-binding region.
chr18	35102107	35140366	Q15555	0	+	35102107	35140366	255,102,0	1	38259	0	.	DCTN1-binding.
chr18	35132055	35132187	Q15555	0	+	35132055	35132187	255,102,0	1	132	0	.	APC-binding.
chr18	35337435	35337588	P17028	0	-	35337435	35337588	255,102,0	1	153	0	.	Necessary and sufficient for nuclear localization.
chr18	35677618	35683584	Q10472	0	+	35677618	35683584	255,102,0	1	5966	0	.	Catalytic subdomain A.
chr18	35687178	35691074	Q10472	0	+	35687178	35691074	255,102,0	1	3896	0	.	Catalytic subdomain B.
chr18	37273070	37565641	Q9BZC1	0	-	37273070	37565641	255,102,0	1	292571	0	.	Sufficient for RNA-binding and MSE-dependent splicing activity.
chr18	37274337	37274397	Q9BZC1	0	-	37274337	37274397	255,102,0	1	60	0	.	Necessary for TNNT2 exon 5 inclusion.
chr18	43271790	43273990	Q9H2B2	0	-	43271790	43273990	255,102,0	1	2200	0	.	Phospholipid binding.
chr18	45063464	45063536	Q9Y6X0	0	+	45063464	45063536	255,102,0	1	72	0	.	3 X 8 AA tandem repeats of P-P-L-P-P-P-P-P.
chr18	46450778	46450787	Q6ZSG1	0	+	46450778	46450787	255,102,0	1	9	0	.	Ubiquitin binding. Pubmed:26656854
chr18	46456519	46456534	Q6ZSG1	0	+	46456519	46456534	255,102,0	1	15	0	.	Ubiquitin binding. Pubmed:26656854
chr18	46680266	46680275	O15466	0	-	46680266	46680275	255,102,0	1	9	0	.	Substrate binding.
chr18	46681985	46681994	O15466	0	-	46681985	46681994	255,102,0	1	9	0	.	Substrate binding.
chr18	46828047	46828068	O75928	0	-	46828047	46828068	255,102,0	1	21	0	.	SUMO1-binding.
chr18	46963007	46963487	A6NLF2	0	-	46963007	46963487	255,102,0	1	480	0	.	Activation domain.
chr18	46963373	46963403	A6NLF2	0	-	46963373	46963403	255,102,0	1	30	0	.	BC-box.
chr18	46963373	46963403	A6NLF2	0	-	46963373	46963403	255,102,0	1	30	0	.	Interaction with elongin BC.
chr18	47022892	47022922	Q3SY89	0	-	47022892	47022922	255,102,0	1	30	0	.	BC-box.
chr18	47028441	47028921	Q8NG57	0	-	47028441	47028921	255,102,0	1	480	0	.	Activation domain.
chr18	47028807	47028837	Q8NG57	0	-	47028807	47028837	255,102,0	1	30	0	.	BC-box.
chr18	47028807	47028837	Q8NG57	0	-	47028807	47028837	255,102,0	1	30	0	.	Interaction with elongin BC.
chr18	47033287	47033767	Q8IYF1	0	-	47033287	47033767	255,102,0	1	480	0	.	Activation domain.
chr18	47033653	47033683	Q8IYF1	0	-	47033653	47033683	255,102,0	1	30	0	.	BC-box.
chr18	47033653	47033683	Q8IYF1	0	-	47033653	47033683	255,102,0	1	30	0	.	Interacting with Elongin BC complex.
chr18	47134664	47134670	Q9H0R4	0	-	47134664	47134670	255,102,0	1	6	0	.	Substrate binding.
chr18	47136394	47136403	Q9H0R4	0	-	47136394	47136403	255,102,0	1	9	0	.	Substrate binding.
chr18	48619565	48758249	O43310	0	+	48619565	48758249	255,102,0	1	138684	0	.	Interaction with NCBP1/CBP80. Pubmed:19648179
chr18	48948399	48948429	O15105	0	-	48948399	48948429	255,102,0	1	30	0	.	Important for interaction with SMURF2.
chr18	49581593	49581632	Q9Y5X9	0	+	49581593	49581632	255,102,0	1	39	0	.	Heparin-binding.
chr18	49936268	49936337	Q9ULV0	0	-	49936268	49936337	255,102,0	1	69	0	.	Actin-binding.
chr18	50272678	50272955	Q9UIS9	0	-	50272678	50272955	255,102,0	1	277	0	.	TRD.
chr18	50385297	50392244	Q96BD8	0	+	50385297	50392244	255,102,0	1	6947	0	.	Microtubule binding. Pubmed:23085020
chr18	51058374	51065427	Q13485	0	+	51058374	51065427	255,102,0	1	7053	0	.	SAD.
chr18	53530602	53530626	P43146	0	+	53530602	53530626	255,102,0	1	24	0	.	Interaction with MYO10. Pubmed:21642953
chr18	54224112	54224559	Q9UBB5	0	-	54224112	54224559	255,102,0	1	447	0	.	Necessary for interaction with DHX9. Pubmed:12665568
chr18	54283012	54283942	Q9UNA4	0	+	54283012	54283942	255,102,0	1	930	0	.	DNA binding.
chr18	54287314	54287371	Q9UNA4	0	+	54287314	54287371	255,102,0	1	57	0	.	DNA binding.
chr18	55228302	55228859	P15884	0	-	55228302	55228859	255,102,0	1	557	0	.	Class A specific domain.
chr18	55254646	55257326	P15884	0	-	55254646	55257326	255,102,0	1	2680	0	.	Leucine-zipper.
chr18	55461073	55587116	P15884	0	-	55461073	55587116	255,102,0	1	126043	0	.	Essential for MYOD1 inhibition.
chr18	57357240	57357249	O43173	0	+	57357240	57357249	255,102,0	1	9	0	.	Substrate binding. Pubmed:26192331
chr18	57360031	57360040	O43173	0	+	57360031	57360040	255,102,0	1	9	0	.	Substrate binding. Pubmed:26192331
chr18	57360139	57360145	O43173	0	+	57360139	57360145	255,102,0	1	6	0	.	Substrate binding. Pubmed:26192331
chr18	58723070	58741947	Q9UDY8	0	+	58723070	58741947	255,102,0	1	18877	0	.	Caspase-like.
chr18	59349116	59349125	P49257	0	-	59349116	59349125	255,102,0	1	9	0	.	Carbohydrate binding.
chr18	59902708	59902738	Q13794	0	+	59902708	59902738	255,102,0	1	30	0	.	Required for mitochondrial location.
chr18	61815968	61816148	Q8N8N0	0	-	61815968	61816148	255,102,0	1	180	0	.	Necessary for interaction with RRAGA. Pubmed:25936802
chr18	62945172	62972568	O60346	0	+	62945172	62972568	255,102,0	1	27396	0	.	Interaction with SLC9A3R1. Pubmed:21804599
chr18	74510851	74510857	Q96KP4	0	+	74510851	74510857	255,102,0	1	6	0	.	Substrate binding.
chr18	76441761	76443054	Q92618	0	-	76441761	76443054	255,102,0	1	1293	0	.	Mediates promoter DNA-binding and activation of transcription.
chr18	76984876	76988509	P02686	0	-	76984876	76988509	255,102,0	1	3633	0	.	Induces experimental autoimmune encephalomyelitis (EAE) 2.
chr18	76989970	77016873	P02686	0	-	76989970	77016873	255,102,0	1	26903	0	.	Induces experimental autoimmune encephalomyelitis (EAE) 1.
chr18	79410626	79410644	O95644	0	+	79410626	79410644	255,102,0	1	18	0	.	Calcineurin-binding.
chr18	79410650	79410929	O95644	0	+	79410650	79410929	255,102,0	1	279	0	.	Trans-activation domain A (TAD-A).
chr18	79410881	79411169	O95644	0	+	79410881	79411169	255,102,0	1	288	0	.	3 X SP repeats.
chr18	79486261	79527574	O95644	0	+	79486261	79527574	255,102,0	1	41313	0	.	Trans-activation domain B (TAD-B).
chr18	80160139	80160523	Q9BYG4	0	-	80160139	80160523	255,102,0	1	384	0	.	Interaction with PARD3 and CDC42.
chr19	422307	434831	P98077	0	-	422307	434831	255,102,0	1	12524	0	.	CH1.
chr19	501676	504767	Q13477	0	+	501676	504767	255,102,0	1	3091	0	.	Mucin-like.
chr19	501682	501814	Q13477	0	+	501682	501814	255,102,0	1	132	0	.	5.5 X 8 AA tandem repeats of [PS]-P-D-T-T-S-[QP]-E.
chr19	541408	541549	P49427	0	+	541408	541549	255,102,0	1	141	0	.	SCF-binding.
chr19	590416	590572	Q9UL51	0	+	590416	590572	255,102,0	1	156	0	.	Involved in subunit assembly.
chr19	617276	621294	O00411	0	-	617276	621294	255,102,0	1	4018	0	.	Mediates interaction with TEFM. Pubmed:21278163
chr19	828306	828381	P20160	0	+	828306	828381	255,102,0	1	75	0	.	Possesses antibiotic activity. Pubmed:8506327
chr19	929882	932517	Q99856	0	+	929882	932517	255,102,0	1	2635	0	.	Acidic.
chr19	966705	966837	Q99856	0	+	966705	966837	255,102,0	1	132	0	.	Important for nuclear localization.
chr19	966840	968448	Q99856	0	+	966840	968448	255,102,0	1	1608	0	.	Homodimerization.
chr19	971891	971954	Q99856	0	+	971891	971954	255,102,0	1	63	0	.	Important for cytoplasmic localization.
chr19	1207045	1207183	Q15831	0	+	1207045	1207183	255,102,0	1	138	0	.	Sufficient for interaction with SIRT1. Pubmed:18687677
chr19	1398969	1398975	Q14353	0	-	1398969	1398975	255,102,0	1	6	0	.	Substrate binding.
chr19	1398969	1398975	V9HWB2	0	-	1398969	1398975	255,102,0	1	6	0	.	Substrate binding.
chr19	1399560	1399566	Q14353	0	-	1399560	1399566	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr19	1399560	1399566	V9HWB2	0	-	1399560	1399566	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr19	1399843	1399852	Q14353	0	-	1399843	1399852	255,102,0	1	9	0	.	S-adenosyl-L-methionine.
chr19	1399843	1399852	V9HWB2	0	-	1399843	1399852	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr19	1399897	1399915	Q14353	0	-	1399897	1399915	255,102,0	1	18	0	.	S-adenosyl-L-methionine binding.
chr19	1399897	1399915	V9HWB2	0	-	1399897	1399915	255,102,0	1	18	0	.	S-adenosyl-L-methionine binding.
chr19	1466472	1468062	O95996	0	+	1466472	1468062	255,102,0	1	1590	0	.	5 X 20 AA approximate repeat of F-X-V-E-X-T-P-X-C-F-S-R-X-S-S-L-S-S-L-S.
chr19	1466472	1468062	O95996	0	+	1466472	1468062	255,102,0	1	1590	0	.	Interaction with CTNNB1. Pubmed:9823329
chr19	1468761	1469001	O95996	0	+	1468761	1469001	255,102,0	1	240	0	.	Required for localization to microtubules and function in microtubule stabilization. Pubmed:25753423
chr19	1469499	1469733	O95996	0	+	1469499	1469733	255,102,0	1	234	0	.	Interaction with MAPRE1 and MAPRE3. Pubmed:10644998
chr19	1619366	1619782	P15923	0	-	1619366	1619782	255,102,0	1	416	0	.	Leucine-zipper.
chr19	1827057	1827297	Q8N1G1	0	-	1827057	1827297	255,102,0	1	240	0	.	Interaction with ELOA. Pubmed:12943681
chr19	2043130	2043139	Q9HBH9	0	-	2043130	2043139	255,102,0	1	9	0	.	Staurosporine binding.
chr19	2254220	2255308	Q96MG2	0	-	2254220	2255308	255,102,0	1	1088	0	.	Mediates interaction with CACNA1S.
chr19	2430913	2434296	Q03252	0	-	2430913	2434296	255,102,0	1	3383	0	.	Tail.
chr19	2434296	2435087	Q03252	0	-	2434296	2435087	255,102,0	1	791	0	.	Coil 2.
chr19	2434296	2456789	Q03252	0	-	2434296	2456789	255,102,0	1	22493	0	.	Rod.
chr19	2435087	2435168	Q03252	0	-	2435087	2435168	255,102,0	1	81	0	.	Linker 2.
chr19	2435168	2444519	Q03252	0	-	2435168	2444519	255,102,0	1	9351	0	.	Coil 1B.
chr19	2444519	2456684	Q03252	0	-	2444519	2456684	255,102,0	1	12165	0	.	Linker 1.
chr19	2456684	2456789	Q03252	0	-	2456684	2456789	255,102,0	1	105	0	.	Coil 1A.
chr19	2456789	2456933	Q03252	0	-	2456789	2456933	255,102,0	1	144	0	.	Head.
chr19	3006650	3013779	Q04725	0	-	3006650	3013779	255,102,0	1	7129	0	.	SP domain.
chr19	3013779	3015757	Q04725	0	-	3013779	3015757	255,102,0	1	1978	0	.	CcN domain.
chr19	3015757	3019451	Q04725	0	-	3015757	3019451	255,102,0	1	3694	0	.	GP domain.
chr19	3019451	3028904	Q04725	0	-	3019451	3028904	255,102,0	1	9453	0	.	Q domain.
chr19	3053821	3053917	Q08117	0	-	3053821	3053917	255,102,0	1	96	0	.	CCN domain.
chr19	3633436	3633520	O60331	0	-	3633436	3633520	255,102,0	1	84	0	.	Mediates interaction with TLN2. Pubmed:12422219
chr19	3905639	3907735	Q86WG3	0	+	3905639	3907735	255,102,0	1	2096	0	.	Required for interaction with KLC1.
chr19	3908290	3924589	Q86WG3	0	+	3908290	3924589	255,102,0	1	16299	0	.	Mediates interaction with GLS. Pubmed:16899818
chr19	3936650	3936662	Q9NPI5	0	+	3936650	3936662	255,102,0	1	12	0	.	Substrate binding.
chr19	3937281	3937287	Q9NPI5	0	+	3937281	3937287	255,102,0	1	6	0	.	Substrate binding.
chr19	3941080	3941086	Q9NPI5	0	+	3941080	3941086	255,102,0	1	6	0	.	Substrate binding.
chr19	3959142	3959187	O43293	0	-	3959142	3959187	255,102,0	1	45	0	.	Leucine-zipper. Pubmed:9488481
chr19	3963659	3964316	O43293	0	-	3963659	3964316	255,102,0	1	657	0	.	Activation segment.
chr19	4168368	4168458	Q68CJ9	0	+	4168368	4168458	255,102,0	1	90	0	.	Basic motif.
chr19	4170170	4171118	Q68CJ9	0	+	4170170	4171118	255,102,0	1	948	0	.	Leucine-zipper.
chr19	4362702	4363446	Q99961	0	-	4362702	4363446	255,102,0	1	744	0	.	Interaction with ARC.
chr19	4365551	4366510	Q99961	0	-	4365551	4366510	255,102,0	1	959	0	.	Required for dimerization upon membrane association.
chr19	4366976	4400368	Q99961	0	-	4366976	4400368	255,102,0	1	33392	0	.	Membrane-binding amphipathic helix.
chr19	4453987	4454026	Q9BZV1	0	-	4453987	4454026	255,102,0	1	39	0	.	VCP/p97-interacting motif (VIM). Pubmed:21896481
chr19	4510962	4513635	Q96Q06	0	-	4510962	4513635	255,102,0	1	2673	0	.	27 X 33 AA approximate tandem repeat.
chr19	4523530	4523590	Q00G26	0	-	4523530	4523590	255,102,0	1	60	0	.	Recruits mitochondria at the lipid droplet surface.
chr19	4523530	4525800	Q00G26	0	-	4523530	4525800	255,102,0	1	2270	0	.	Interaction with PNPLA2 and ABHD5.
chr19	4529073	4534074	Q00G26	0	-	4529073	4534074	255,102,0	1	5001	0	.	Essential for lipid droplet targeting.
chr19	4529798	4534074	Q00G26	0	-	4529798	4534074	255,102,0	1	4276	0	.	Interaction with LIPE.
chr19	4816241	4816844	Q8IUC6	0	-	4816241	4816844	255,102,0	1	603	0	.	Sufficient to induce apoptosis.
chr19	4817918	4818377	Q8IUC6	0	-	4817918	4818377	255,102,0	1	459	0	.	TRIF-NTD. Pubmed:24311583
chr19	4929464	4932798	Q96T88	0	+	4929464	4932798	255,102,0	1	3334	0	.	Tudor-like 1.
chr19	4932816	4941591	Q96T88	0	+	4932816	4941591	255,102,0	1	8775	0	.	Tudor-like 2.
chr19	4941743	4941761	Q96T88	0	+	4941743	4941761	255,102,0	1	18	0	.	Linker.
chr19	4941854	4941869	Q96T88	0	+	4941854	4941869	255,102,0	1	15	0	.	Histone H3R2me0 binding.
chr19	4941914	4941923	Q96T88	0	+	4941914	4941923	255,102,0	1	9	0	.	Histone H3R2me0 binding.
chr19	4945887	4945893	Q96T88	0	+	4945887	4945893	255,102,0	1	6	0	.	Required to promote base flipping.
chr19	4945941	4945947	Q96T88	0	+	4945941	4945947	255,102,0	1	6	0	.	Methylcytosine binding.
chr19	4945950	4945962	Q96T88	0	+	4945950	4945962	255,102,0	1	12	0	.	Required for formation of a 5-methylcytosine-binding pocket.
chr19	4947125	4947137	Q96T88	0	+	4947125	4947137	255,102,0	1	12	0	.	Required for formation of a 5-methylcytosine-binding pocket.
chr19	5212234	5212341	Q13332	0	-	5212234	5212341	255,102,0	1	107	0	.	Substrate binding.
chr19	5587245	5595482	Q14151	0	-	5587245	5595482	255,102,0	1	8237	0	.	Interaction with SAFB1.
chr19	5654115	5667087	Q15424	0	+	5654115	5667087	255,102,0	1	12972	0	.	Interaction with POLR2A. Pubmed:9671816
chr19	5657279	5668288	Q15424	0	+	5657279	5668288	255,102,0	1	11009	0	.	Interaction with SAFB2.
chr19	6374895	6374904	Q9BT30	0	+	6374895	6374904	255,102,0	1	9	0	.	Alpha-ketoglutarate binding. Pubmed:25122757
chr19	6415215	6415711	Q92945	0	-	6415215	6415711	255,102,0	1	496	0	.	4 X 12 AA imperfect repeats.
chr19	6680245	6682021	P01024	0	-	6680245	6682021	255,102,0	1	1776	0	.	Properdin-binding.
chr19	6739761	6743199	Q15642	0	+	6739761	6743199	255,102,0	1	3438	0	.	Required for podosome formation and interaction with AKAP9 and microtubules. Pubmed:15047863
chr19	6739761	6743199	Q15642	0	+	6739761	6743199	255,102,0	1	3438	0	.	Required for translocation to the plasma membrane in response to insulin.
chr19	6744886	6750587	Q15642	0	+	6744886	6750587	255,102,0	1	5701	0	.	Interaction with CDC42.
chr19	6744886	6751208	Q15642	0	+	6744886	6751208	255,102,0	1	6322	0	.	Interaction with PDE6G.
chr19	6750306	6751208	Q15642	0	+	6750306	6751208	255,102,0	1	902	0	.	Required for interaction with FASLG and localization to lysosomes. Pubmed:16318909
chr19	6750354	6750599	Q15642	0	+	6750354	6750599	255,102,0	1	245	0	.	Interaction with DNM2 and WASL.
chr19	6750560	6751208	Q15642	0	+	6750560	6751208	255,102,0	1	648	0	.	Interaction with DNM1 and WASL. Pubmed:16326391
chr19	6750587	6751208	Q15642	0	+	6750587	6751208	255,102,0	1	621	0	.	Required for podosome formation.
chr19	6750605	6751208	Q15642	0	+	6750605	6751208	255,102,0	1	603	0	.	Interaction with WAS. Pubmed:10713100
chr19	6750611	6751208	Q15642	0	+	6750611	6751208	255,102,0	1	597	0	.	Interaction with ARHGAP17, DAAM1, DIAPH1 and DIAPH2. Pubmed:11431473, Pubmed:16630611
chr19	7117112	7117124	P06213	0	-	7117112	7117124	255,102,0	1	12	0	.	PIK3R1-binding.
chr19	7126599	7126602	P06213	0	-	7126599	7126602	255,102,0	1	3	0	.	Important for interaction with IRS1, SHC1 and STAT5B. Pubmed:9428692
chr19	7152733	7152760	P06213	0	-	7152733	7152760	255,102,0	1	27	0	.	Insulin-binding.
chr19	7745069	7745980	Q9NNX6	0	-	7745069	7745980	255,102,0	1	911	0	.	7 X approximate tandem repeats.
chr19	7765744	7766678	Q9H2X3	0	+	7765744	7766678	255,102,0	1	934	0	.	7 X approximate tandem repeats.
chr19	7904052	7909801	O14733	0	+	7904052	7909801	255,102,0	1	5749	0	.	D domain.
chr19	7912299	7912371	O14733	0	+	7912299	7912371	255,102,0	1	72	0	.	DVD domain.
chr19	8485625	8486252	P52272	0	+	8485625	8486252	255,102,0	1	627	0	.	27 X 6 AA repeats of [GEVSTPAN]-[ILMV]-[DE]-[RH]-[MLVI]-[GAV].
chr19	8536980	8537013	O00160	0	-	8536980	8537013	255,102,0	1	33	0	.	Actin-binding.
chr19	8842678	8842990	Q8WWY6	0	+	8842678	8842990	255,102,0	1	312	0	.	Transcription repressor.
chr19	8876593	8923062	Q8WXI7	0	-	8876593	8923062	255,102,0	1	46469	0	.	12 X approximate tandem repeats. Pubmed:11786729
chr19	9966737	9998010	P25940	0	-	9966737	9998010	255,102,0	1	31273	0	.	Triple-helical region.
chr19	9998010	10004109	P25940	0	-	9998010	10004109	255,102,0	1	6099	0	.	Nonhelical region.
chr19	10089966	10091315	Q9NUL5	0	+	10089966	10091315	255,102,0	1	1349	0	.	Interaction with PABPC1. Pubmed:26735137
chr19	10133669	10140841	P26358	0	-	10133669	10140841	255,102,0	1	7172	0	.	Catalytic.
chr19	10133669	10140895	P26358	0	-	10133669	10140895	255,102,0	1	7226	0	.	Interaction with the PRC2/EED-EZH2 complex.
chr19	10140230	10140236	P26358	0	-	10140230	10140236	255,102,0	1	6	0	.	S-adenosyl-L-homocysteine binding.
chr19	10140296	10140302	P26358	0	-	10140296	10140302	255,102,0	1	6	0	.	S-adenosyl-L-homocysteine binding. Pubmed:21163962
chr19	10140802	10140808	P26358	0	-	10140802	10140808	255,102,0	1	6	0	.	S-adenosyl-L-homocysteine binding.
chr19	10140895	10141126	P26358	0	-	10140895	10141126	255,102,0	1	231	0	.	6 X 2 AA tandem repeats of K-G.
chr19	10149923	10151538	P26358	0	-	10149923	10151538	255,102,0	1	1615	0	.	Autoinhibitory linker.
chr19	10151523	10154313	P26358	0	-	10151523	10154313	255,102,0	1	2790	0	.	Required for activity.
chr19	10154445	10162705	P26358	0	-	10154445	10162705	255,102,0	1	8260	0	.	Interaction with the PRC2/EED-EZH2 complex.
chr19	10154719	10160388	P26358	0	-	10154719	10160388	255,102,0	1	5669	0	.	DNA replication foci-targeting sequence.
chr19	10154994	10162699	P26358	0	-	10154994	10162699	255,102,0	1	7705	0	.	Homodimerization.
chr19	10160050	10194899	P26358	0	-	10160050	10194899	255,102,0	1	34849	0	.	Interaction with the PRC2/EED-EZH2 complex.
chr19	10173158	10177368	P26358	0	-	10173158	10177368	255,102,0	1	4210	0	.	Interaction with DNMT3B. Pubmed:12145218
chr19	10177290	10177326	P26358	0	-	10177290	10177326	255,102,0	1	36	0	.	Interaction with PCNA. Pubmed:9302295
chr19	10180350	10194899	P26358	0	-	10180350	10194899	255,102,0	1	14549	0	.	Interaction with DNMT3A. Pubmed:12145218
chr19	10180434	10194899	P26358	0	-	10180434	10194899	255,102,0	1	14465	0	.	Interaction with DMAP1. Pubmed:10888872
chr19	10321606	10323404	Q8IY67	0	-	10321606	10323404	255,102,0	1	1798	0	.	Interaction with PTBP1.
chr19	10457988	10467129	P27815	0	+	10457988	10467129	255,102,0	1	9141	0	.	Catalytic.
chr19	10544279	10544856	Q86TL0	0	+	10544279	10544856	255,102,0	1	577	0	.	Cryptic mitochondrial signal peptide.
chr19	10683515	10689309	Q12906	0	+	10683515	10689309	255,102,0	1	5794	0	.	Interaction with PRMT1. Pubmed:10749851
chr19	10702115	10702130	Q9BXR0	0	+	10702115	10702130	255,102,0	1	15	0	.	Substrate binding.
chr19	10712291	10712565	Q9BXR0	0	+	10712291	10712565	255,102,0	1	274	0	.	RNA binding.
chr19	10712616	10712760	Q9BXR0	0	+	10712616	10712760	255,102,0	1	144	0	.	RNA binding; important for wobble base 34 recognition.
chr19	10920903	10921754	Q86X55	0	+	10920903	10921754	255,102,0	1	851	0	.	Transactivation domain.
chr19	10984151	10986990	P51532	0	+	10984151	10986990	255,102,0	1	2839	0	.	Necessary for interaction with SS18L1/CREST.
chr19	11123193	11123337	P01130	0	+	11123193	11123337	255,102,0	1	144	0	.	Clustered O-linked oligosaccharides.
chr19	11129553	11131313	P01130	0	+	11129553	11131313	255,102,0	1	1760	0	.	Required for MYLIP-triggered down-regulation of LDLR. Pubmed:19520913
chr19	11166608	11174536	Q63ZY3	0	-	11166608	11174536	255,102,0	1	7928	0	.	Interaction with NCOA1. Pubmed:17476305
chr19	11193863	11194511	Q63ZY3	0	-	11193863	11194511	255,102,0	1	648	0	.	Interaction with AIFM1. Pubmed:22371500
chr19	11378142	11378151	P19235	0	-	11378142	11378151	255,102,0	1	9	0	.	Required for high-affinity SOCS3 binding.
chr19	12676043	12676064	P49366	0	-	12676043	12676064	255,102,0	1	21	0	.	Spermidine binding.
chr19	12676082	12676091	P49366	0	-	12676082	12676091	255,102,0	1	9	0	.	Spermidine binding.
chr19	12679883	12679889	P49366	0	-	12679883	12679889	255,102,0	1	6	0	.	Spermidine binding.
chr19	12763284	12764891	Q96ED9	0	-	12763284	12764891	255,102,0	1	1607	0	.	Sufficient for interaction with CNTRL. Pubmed:17140400
chr19	12763284	12765929	Q96ED9	0	-	12763284	12765929	255,102,0	1	2645	0	.	Required for localization to the centrosome and induction of aggresome formation.
chr19	12765077	12775449	Q96ED9	0	-	12765077	12775449	255,102,0	1	10372	0	.	Sufficient for interaction with microtubules.
chr19	12772225	12775449	Q96ED9	0	-	12772225	12775449	255,102,0	1	3224	0	.	Required for localization to the centrosome and induction of aggresome formation.
chr19	12792572	12792656	P17275	0	+	12792572	12792656	255,102,0	1	84	0	.	Basic motif.
chr19	12792656	12792743	P17275	0	+	12792656	12792743	255,102,0	1	87	0	.	Leucine-zipper.
chr19	12893559	12893565	Q92947	0	+	12893559	12893565	255,102,0	1	6	0	.	Substrate binding.
chr19	12896915	12896939	Q92947	0	+	12896915	12896939	255,102,0	1	24	0	.	Substrate binding.
chr19	12924711	12924720	Q9Y285	0	-	12924711	12924720	255,102,0	1	9	0	.	L-phenylalanine binding. Pubmed:20223217
chr19	12938730	12940341	P27797	0	+	12938730	12940341	255,102,0	1	1611	0	.	N-domain.
chr19	12940320	12940603	P27797	0	+	12940320	12940603	255,102,0	1	283	0	.	4 X approximate repeats.
chr19	12940341	12940851	P27797	0	+	12940341	12940851	255,102,0	1	510	0	.	P-domain.
chr19	12940546	12940648	P27797	0	+	12940546	12940648	255,102,0	1	102	0	.	Interaction with PPIB.
chr19	12940612	12940818	P27797	0	+	12940612	12940818	255,102,0	1	206	0	.	3 X approximate repeats.
chr19	12940851	12943910	P27797	0	+	12940851	12943910	255,102,0	1	3059	0	.	C-domain.
chr19	12952829	12953046	P54725	0	+	12952829	12953046	255,102,0	1	217	0	.	HIV-1 vpr binding.
chr19	13962697	13963989	P22670	0	-	13962697	13963989	255,102,0	1	1292	0	.	Necessary for dimerization.
chr19	14120599	14136456	Q9NVP2	0	-	14120599	14136456	255,102,0	1	15857	0	.	Interaction with histone H3.
chr19	14120602	14136456	Q9NVP2	0	-	14120602	14136456	255,102,0	1	15854	0	.	Interaction with CHAF1B.
chr19	14170715	14170727	O94910	0	-	14170715	14170727	255,102,0	1	12	0	.	Carbohydrate binding.
chr19	14446491	14446506	Q16512	0	+	14446491	14446506	255,102,0	1	15	0	.	Important for interaction with bacterial SspH1 and SspH1-mediated polyubiquitination. Pubmed:24248594
chr19	15115635	15116215	A1L0T0	0	-	15115635	15116215	255,102,0	1	580	0	.	Thiamine pyrophosphate binding.
chr19	15238379	15242930	O60885	0	-	15238379	15242930	255,102,0	1	4551	0	.	C-terminal (CTD) region.
chr19	15256077	15256245	O60885	0	-	15256077	15256245	255,102,0	1	168	0	.	BID region.
chr19	15257005	15257065	O60885	0	-	15257005	15257065	255,102,0	1	60	0	.	NPS region.
chr19	15355214	15355268	O43823	0	-	15355214	15355268	255,102,0	1	54	0	.	Required for interaction with MYCBP.
chr19	15355226	15355280	O43823	0	-	15355226	15355280	255,102,0	1	54	0	.	RII-binding.
chr19	15355286	15359017	O43823	0	-	15355286	15359017	255,102,0	1	3731	0	.	Involved in condensin complex recruitment. Pubmed:11964380
chr19	15361774	15368236	O43823	0	-	15361774	15368236	255,102,0	1	6462	0	.	Involved in chromatin-binding. Pubmed:11964380
chr19	15373081	15379731	O43823	0	-	15373081	15379731	255,102,0	1	6650	0	.	Interaction with DPY30. Pubmed:23995757
chr19	15373108	15373832	O43823	0	-	15373108	15373832	255,102,0	1	724	0	.	Interaction with DDX5.
chr19	15373126	15379731	O43823	0	-	15373126	15379731	255,102,0	1	6605	0	.	Interaction with MCM2. Pubmed:12740381
chr19	16325470	16325944	Q9Y5W3	0	+	16325470	16325944	255,102,0	1	474	0	.	Interaction with WWP1.
chr19	16361859	16395407	Q9UBC2	0	-	16361859	16395407	255,102,0	1	33548	0	.	15 X 3 AA repeats of D-P-F.
chr19	16417950	16442210	Q9UBC2	0	-	16417950	16442210	255,102,0	1	24260	0	.	Interaction with DAB2.
chr19	16479133	16482485	Q96L12	0	-	16479133	16482485	255,102,0	1	3352	0	.	C-domain.
chr19	16482485	16484016	Q96L12	0	-	16482485	16484016	255,102,0	1	1531	0	.	P-domain.
chr19	16482518	16482719	Q96L12	0	-	16482518	16482719	255,102,0	1	201	0	.	3 X approximate repeats.
chr19	16482728	16484037	Q96L12	0	-	16482728	16484037	255,102,0	1	1309	0	.	4 X approximate repeats.
chr19	16484016	16496072	Q96L12	0	-	16484016	16496072	255,102,0	1	12056	0	.	N-domain.
chr19	16829420	16853143	O75182	0	+	16829420	16853143	255,102,0	1	23723	0	.	Interaction with CRY1.
chr19	16829844	16831581	O75182	0	+	16829844	16831581	255,102,0	1	1737	0	.	Interaction with REST.
chr19	16853068	16865550	O75182	0	+	16853068	16865550	255,102,0	1	12482	0	.	Interaction with NCOR1.
chr19	16862466	16866427	O75182	0	+	16862466	16866427	255,102,0	1	3961	0	.	Interaction with SUDS3 and HDAC1.
chr19	17232354	17232588	P10588	0	-	17232354	17232588	255,102,0	1	234	0	.	Important for dimerization.
chr19	17232354	17235928	P10588	0	-	17232354	17235928	255,102,0	1	3574	0	.	Ligand-binding.
chr19	17269088	17278952	Q9NWV8	0	+	17269088	17278952	255,102,0	1	9864	0	.	VWFA-like.
chr19	17423732	17424990	Q96EY5	0	+	17423732	17424990	255,102,0	1	1258	0	.	Interaction with TSG101, VPS37B and VPS28. Pubmed:18005716
chr19	17487181	17500586	Q6PCB7	0	+	17487181	17500586	255,102,0	1	13405	0	.	Sufficient for oligomerization.
chr19	17719502	17727775	Q66K74	0	+	17719502	17727775	255,102,0	1	8273	0	.	Necessary for the microtubule-organizing center localization.
chr19	17727379	17734425	Q66K74	0	+	17727379	17734425	255,102,0	1	7046	0	.	Necessary for interaction with RASSF1 isoform A and isoform C.
chr19	17727523	17733302	Q66K74	0	+	17727523	17733302	255,102,0	1	5779	0	.	Necessary for association with microtubules.
chr19	17733281	17734425	Q66K74	0	+	17733281	17734425	255,102,0	1	1144	0	.	Necessary for association with actin.
chr19	17733302	17733377	Q66K74	0	+	17733302	17733377	255,102,0	1	75	0	.	Necessary for the mitochondrial aggregation and genome destruction.
chr19	17755164	17774273	O14526	0	+	17755164	17774273	255,102,0	1	19109	0	.	Mediates membrane-binding.
chr19	17774246	17778203	O14526	0	+	17774246	17778203	255,102,0	1	3957	0	.	Mediates interaction with the adaptor protein complex AP-2.
chr19	17781535	17788303	O14526	0	+	17781535	17788303	255,102,0	1	6768	0	.	Mediates interaction with AGFG1, CALM, DAB2, EPS15, EPS15R, ITSN1 and clathrin. Pubmed:22484487
chr19	17842507	17844417	P52333	0	-	17842507	17844417	255,102,0	1	1910	0	.	Interaction with cytokine/interferon/growth hormone receptors.
chr19	17988504	17998163	Q92952	0	+	17988504	17998163	255,102,0	1	9659	0	.	Calmodulin-binding.
chr19	18280512	18280599	P17535	0	-	18280512	18280599	255,102,0	1	87	0	.	Leucine-zipper.
chr19	18280599	18280683	P17535	0	-	18280599	18280683	255,102,0	1	84	0	.	Basic motif.
chr19	18782917	18785762	P49747	0	-	18782917	18785762	255,102,0	1	2845	0	.	Mediates cell survival and induction of the IAP family of survival proteins.
chr19	18790073	18791206	P49747	0	-	18790073	18791206	255,102,0	1	1133	0	.	COMP N-terminal.
chr19	18832209	18854656	Q92900	0	+	18832209	18854656	255,102,0	1	22447	0	.	Sufficient for interaction with RENT2.
chr19	19227741	19227756	O14594	0	+	19227741	19227756	255,102,0	1	15	0	.	O-glycosylated at one site.
chr19	19320859	19336172	Q9Y6X3	0	+	19320859	19336172	255,102,0	1	15313	0	.	Sufficient for interaction with NIPBL.
chr19	19492607	19492712	Q86YP4	0	+	19492607	19492712	255,102,0	1	105	0	.	CR1; MBD2-binding.
chr19	19498535	19501356	Q86YP4	0	+	19498535	19501356	255,102,0	1	2821	0	.	CR2; histone tail-binding.
chr19	19527758	19528123	Q9P0J0	0	+	19527758	19528123	255,102,0	1	365	0	.	Important for inducing cell death.
chr19	32607769	32615759	Q96NW4	0	-	32607769	32615759	255,102,0	1	7990	0	.	Sufficient for interaction with VPS29. Pubmed:24856514
chr19	32607817	32628152	Q96NW4	0	-	32607817	32628152	255,102,0	1	20335	0	.	Interaction with RAB32.
chr19	32615711	32619295	Q96NW4	0	-	32615711	32619295	255,102,0	1	3584	0	.	Required for interaction with VAMP7. Pubmed:23104059, Pubmed:19745841
chr19	32622448	32628152	Q96NW4	0	-	32622448	32628152	255,102,0	1	5704	0	.	Interaction with RAB38. Pubmed:18477474
chr19	32628122	32631425	Q96NW4	0	-	32628122	32631425	255,102,0	1	3303	0	.	Sufficient for interaction with VPS29. Pubmed:24856514
chr19	32639355	32659015	Q96NW4	0	-	32639355	32659015	255,102,0	1	19660	0	.	Sufficient for GEF activity towards RAB21. Pubmed:16525121
chr19	32676719	32676863	Q6ZS82	0	+	32676719	32676863	255,102,0	1	144	0	.	SNARE-like.
chr19	32976511	32976679	Q9BTP7	0	+	32976511	32976679	255,102,0	1	168	0	.	RuvA domain 2-like.
chr19	33026619	33044298	Q8IUC4	0	-	33026619	33044298	255,102,0	1	17679	0	.	Interaction with Rho.
chr19	33301340	33301685	P49715	0	-	33301340	33301685	255,102,0	1	345	0	.	Interaction with FOXO1.
chr19	33301379	33301466	P49715	0	-	33301379	33301466	255,102,0	1	87	0	.	Leucine-zipper.
chr19	33301475	33301559	P49715	0	-	33301475	33301559	255,102,0	1	84	0	.	Basic motif.
chr19	33301802	33302033	P49715	0	-	33301802	33302033	255,102,0	1	231	0	.	Required to induce adipocyte differentiation.
chr19	33301820	33301871	P49715	0	-	33301820	33301871	255,102,0	1	51	0	.	Required to functionally cooperate with SREBF1 in promoter activation.
chr19	33302198	33302255	P49715	0	-	33302198	33302255	255,102,0	1	57	0	.	Required for interaction with TRIB1. Pubmed:26455797
chr19	33302204	33302414	P49715	0	-	33302204	33302414	255,102,0	1	210	0	.	Required to repress E2F1:TFDP1-mediated transcription, to inhibit cell cycle and to induce adipocyte differentiation.
chr19	33379434	33379518	P53567	0	+	33379434	33379518	255,102,0	1	84	0	.	Basic motif.
chr19	33379527	33379593	P53567	0	+	33379527	33379593	255,102,0	1	66	0	.	Leucine-zipper.
chr19	35279041	35279199	Q15853	0	+	35279041	35279199	255,102,0	1	158	0	.	Leucine-zipper.
chr19	35295623	35302452	P20916	0	+	35295623	35302452	255,102,0	1	6829	0	.	Interaction with RTN4R and RTN4RL2.
chr19	35295758	35295767	P20916	0	+	35295758	35295767	255,102,0	1	9	0	.	Ganglioside GT1b binding.
chr19	35295935	35295950	P20916	0	+	35295935	35295950	255,102,0	1	15	0	.	Ganglioside GT1b binding.
chr19	35313301	35313451	P20916	0	+	35313301	35313451	255,102,0	1	150	0	.	Required for normal axon myelination in the central nervous system.
chr19	35351809	35351824	O14842	0	+	35351809	35351824	255,102,0	1	15	0	.	Agonist binding. Pubmed:25043059
chr19	35533527	35536964	O14556	0	+	35533527	35536964	255,102,0	1	3437	0	.	Testis-specific N-terminal extension.
chr19	35542951	35542960	O14556	0	+	35542951	35542960	255,102,0	1	9	0	.	Glyceraldehyde 3-phosphate binding.
chr19	35543444	35543450	O14556	0	+	35543444	35543450	255,102,0	1	6	0	.	Glyceraldehyde 3-phosphate binding.
chr19	35633707	35637551	Q9BTD8	0	+	35633707	35637551	255,102,0	1	3844	0	.	Necessary for interaction with HNRNPK.
chr19	35738362	35738368	Q9UMN6	0	+	35738362	35738368	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr19	35755876	35757008	O14558	0	-	35755876	35757008	255,102,0	1	1132	0	.	Involved in stabilization of the HSPB1:HSBP6 heterodimer. Pubmed:27717639
chr19	35826516	35831056	O60500	0	-	35826516	35831056	255,102,0	1	4540	0	.	Binds to NPHS2.
chr19	35904133	35904142	Q9UBK5	0	+	35904133	35904142	255,102,0	1	9	0	.	GRB2 binding site.
chr19	35904133	35904145	Q9UBK5	0	+	35904133	35904145	255,102,0	1	12	0	.	PIK3R1 binding site.
chr19	36009334	36009355	Q3KRA9	0	-	36009334	36009355	255,102,0	1	21	0	.	Alpha-ketoglutarate binding.
chr19	36010914	36010923	Q3KRA9	0	-	36010914	36010923	255,102,0	1	9	0	.	Alpha-ketoglutarate binding.
chr19	36016160	36017440	Q96DZ5	0	-	36016160	36017440	255,102,0	1	1280	0	.	GoLD.
chr19	36237073	36237316	Q15072	0	+	36237073	36237316	255,102,0	1	243	0	.	Interaction with TERF2IP. Pubmed:15838871
chr19	36609914	36626212	Q96SR6	0	+	36609914	36626212	255,102,0	1	16298	0	.	Mediates interaction with TRIM28.
chr19	36609926	36610052	Q96SR6	0	+	36609926	36610052	255,102,0	1	126	0	.	Represses transcription.
chr19	36610717	36626530	Q96SR6	0	+	36610717	36626530	255,102,0	1	15813	0	.	Represses transcription.
chr19	36626782	36627547	Q96SR6	0	+	36626782	36627547	255,102,0	1	765	0	.	Required for transcriptional repression activity; probably mediates sequence-specific DNA-binding.
chr19	38251401	38256237	Q96A00	0	-	38251401	38256237	255,102,0	1	4836	0	.	Inhibitory.
chr19	38384414	38385791	Q86UU5	0	-	38384414	38385791	255,102,0	1	1377	0	.	Interactions with ZNF403/GGNBP2 and OAZ3.
chr19	38385803	38386895	Q86UU5	0	-	38385803	38386895	255,102,0	1	1092	0	.	Interaction with GGNBP1.
chr19	38460534	38507772	P21817	0	+	38460534	38507772	255,102,0	1	47238	0	.	6 X approximate repeats.
chr19	38528320	38528410	P21817	0	+	38528320	38528410	255,102,0	1	90	0	.	Interaction with CALM. Pubmed:18650434
chr19	38647778	38647823	O43707	0	+	38647778	38647823	255,102,0	1	45	0	.	Interaction with VCL. Pubmed:15988023
chr19	38647862	38700620	O43707	0	+	38647862	38700620	255,102,0	1	52758	0	.	Interaction with VCL. Pubmed:15988023
chr19	38701045	38701102	O43707	0	+	38701045	38701102	255,102,0	1	57	0	.	Interaction with VCL. Pubmed:15988023
chr19	38706087	38708120	O43707	0	+	38706087	38708120	255,102,0	1	2033	0	.	Polyphosphoinositide (PIP2)-binding.
chr19	38726971	38729429	O43707	0	+	38726971	38729429	255,102,0	1	2458	0	.	Mediates interaction with MICALL2.
chr19	38730854	38735507	Q6ZSI9	0	-	38730854	38735507	255,102,0	1	4653	0	.	Domain IV.
chr19	38735507	38737580	Q6ZSI9	0	-	38735507	38737580	255,102,0	1	2073	0	.	Domain III.
chr19	38771897	38771918	P47929	0	-	38771897	38771918	255,102,0	1	21	0	.	Beta-galactoside binding.
chr19	38790800	38790821	P47929	0	+	38790800	38790821	255,102,0	1	21	0	.	Beta-galactoside binding.
chr19	38802030	38802051	P56470	0	-	38802030	38802051	255,102,0	1	21	0	.	Beta-galactoside binding.
chr19	38817564	38831081	Q13011	0	-	38817564	38831081	255,102,0	1	13517	0	.	Substrate binding.
chr19	38879675	38881153	Q8IXJ6	0	-	38879675	38881153	255,102,0	1	1478	0	.	Peptide inhibitor binding.
chr19	38889869	38889884	Q8IXJ6	0	-	38889869	38889884	255,102,0	1	15	0	.	Peptide inhibitor binding.
chr19	38918434	38918443	Q9NP81	0	-	38918434	38918443	255,102,0	1	9	0	.	Serine binding.
chr19	39169625	39173872	O96013	0	+	39169625	39173872	255,102,0	1	4247	0	.	Linker.
chr19	39173803	39173881	O96013	0	+	39173803	39173881	255,102,0	1	78	0	.	GEF-interaction domain (GID).
chr19	39459559	39464983	O00267	0	+	39459559	39464983	255,102,0	1	5424	0	.	Interaction with SUPT4H1.
chr19	39466539	39469284	O00267	0	+	39466539	39469284	255,102,0	1	2745	0	.	Interaction with RNA polymerase II.
chr19	39473203	39473480	O00267	0	+	39473203	39473480	255,102,0	1	277	0	.	9 X 7 AA approximate tandem repeats of G-S-[QR]-T-P-X-[YQ], motif CTR1.
chr19	39473999	39474544	O00267	0	+	39473999	39474544	255,102,0	1	545	0	.	10 X 8 AA approximate tandem repeats of P-[TS]-P-S-P-[QA]-[SG]-Y, motif CTR2.
chr19	39826044	39826260	Q9Y463	0	-	39826044	39826260	255,102,0	1	216	0	.	Interaction with RANBP9. Pubmed:14500717
chr19	39834690	39834789	P22087	0	-	39834690	39834789	255,102,0	1	99	0	.	Helical.
chr19	39836633	39836645	P22087	0	-	39836633	39836645	255,102,0	1	12	0	.	S-adenosyl-L-methionine binding.
chr19	39837741	39837747	P22087	0	-	39837741	39837747	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr19	39837816	39837822	P22087	0	-	39837816	39837822	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr19	39839064	39839070	P22087	0	-	39839064	39839070	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr19	40205257	40205937	Q02779	0	+	40205257	40205937	255,102,0	1	680	0	.	Leucine-zipper 1.
chr19	40205976	40206042	Q02779	0	+	40205976	40206042	255,102,0	1	66	0	.	Leucine-zipper 2.
chr19	40236337	40236343	P31751	0	-	40236337	40236343	255,102,0	1	6	0	.	Inhibitor binding.
chr19	40236379	40237971	P31751	0	-	40236379	40237971	255,102,0	1	1592	0	.	Inhibitor binding.
chr19	40238916	40238925	P31751	0	-	40238916	40238925	255,102,0	1	9	0	.	Inhibitor binding.
chr19	40396002	40397061	Q9BXM0	0	-	40396002	40397061	255,102,0	1	1059	0	.	55 X 5 AA approximate tandem repeats of [LVMAG]-[PSREQC]-[EDKL]-[LIVMAP]-[AQKHRPE]; that may have a tripeptide spacer of [LV]-P-[KER].
chr19	40733208	40733229	Q96DU7	0	+	40733208	40733229	255,102,0	1	21	0	.	Substrate binding.
chr19	40733214	40733241	Q96DU7	0	+	40733214	40733241	255,102,0	1	27	0	.	Calmodulin-binding.
chr19	40733289	40733313	Q96DU7	0	+	40733289	40733313	255,102,0	1	24	0	.	Substrate binding.
chr19	40801244	40801277	Q96KS0	0	+	40801244	40801277	255,102,0	1	33	0	.	Beta(2)beta(3) 'finger-like' loop.
chr19	41264503	41268236	Q9BUJ2	0	+	41264503	41268236	255,102,0	1	3733	0	.	Necessary for interaction with HRMT1L1.
chr19	41274045	41306562	Q9BUJ2	0	+	41274045	41306562	255,102,0	1	32517	0	.	Necessary for interaction with TP53. Pubmed:15907477
chr19	41294436	41302759	Q9BUJ2	0	+	41294436	41302759	255,102,0	1	8323	0	.	Necessary for interaction with BRD7 and transcriptional activation. Pubmed:12489984
chr19	41302810	41303973	Q9BUJ2	0	+	41302810	41303973	255,102,0	1	1163	0	.	5 X 3 AA repeats of R-G-G.
chr19	41302810	41303973	Q9BUJ2	0	+	41302810	41303973	255,102,0	1	1163	0	.	Necessary for transcription repression.
chr19	41414141	41414150	P12694	0	+	41414141	41414150	255,102,0	1	9	0	.	Thiamine pyrophosphate binding.
chr19	41956848	41956881	Q9UI14	0	-	41956848	41956881	255,102,0	1	33	0	.	Homodimerization.
chr19	41956848	41956881	Q9UI14	0	-	41956848	41956881	255,102,0	1	33	0	.	Required for interaction with prenylated RAB3A and VAMP2.
chr19	41956848	41956911	Q9UI14	0	-	41956848	41956911	255,102,0	1	63	0	.	Required for interaction with GDI1.
chr19	41958842	41958917	Q9UI14	0	-	41958842	41958917	255,102,0	1	75	0	.	Required for interaction with prenylated RAB3A and VAMP2.
chr19	41988070	41988079	P13637	0	-	41988070	41988079	255,102,0	1	9	0	.	Interaction with phosphoinositide-3 kinase.
chr19	42092238	42093862	P09086	0	-	42092238	42093862	255,102,0	1	1624	0	.	Leucine-zipper.
chr19	42286784	42286841	Q96RK0	0	+	42286784	42286841	255,102,0	1	57	0	.	Interaction with ATXN1.
chr19	42509111	42509225	P13688	0	-	42509111	42509225	255,102,0	1	114	0	.	Required for interaction with PTPN11 and PTPN6 and for control of phosphorylation level.
chr19	42509111	42512372	P13688	0	-	42509111	42512372	255,102,0	1	3261	0	.	Interaction with FLNA.
chr19	42509120	42509132	P13688	0	-	42509120	42509132	255,102,0	1	12	0	.	Essential for interaction with PTPN11 and PTPN6.
chr19	42511618	42512378	P13688	0	-	42511618	42512378	255,102,0	1	760	0	.	Interaction with calmodulin.
chr19	42522200	42527350	P13688	0	-	42522200	42527350	255,102,0	1	5150	0	.	Required for homophilic binding.
chr19	43769449	43769793	O15554	0	-	43769449	43769793	255,102,0	1	344	0	.	Calmodulin-binding.
chr19	44010276	44010540	Q9UIE0	0	+	44010276	44010540	255,102,0	1	264	0	.	KRNB.
chr19	44156286	44156457	Q14588	0	+	44156286	44156457	255,102,0	1	171	0	.	KRNB.
chr19	44777949	44780986	Q9ULV8	0	+	44777949	44780986	255,102,0	1	3037	0	.	4H.
chr19	44780986	44781360	Q9ULV8	0	+	44780986	44781360	255,102,0	1	374	0	.	EF-hand-like.
chr19	44781360	44790049	Q9ULV8	0	+	44781360	44790049	255,102,0	1	8689	0	.	SH2-like.
chr19	44790049	44792427	Q9ULV8	0	+	44790049	44792427	255,102,0	1	2378	0	.	Linker.
chr19	44792427	44800440	Q9ULV8	0	+	44792427	44800440	255,102,0	1	8013	0	.	Interaction with RET. Pubmed:18753381
chr19	44814606	44814618	P50895	0	+	44814606	44814618	255,102,0	1	12	0	.	Interaction with laminin alpha5.
chr19	44908533	44909061	P02649	0	+	44908533	44909061	255,102,0	1	528	0	.	8 X 22 AA approximate tandem repeats.
chr19	44908767	44908800	P02649	0	+	44908767	44908800	255,102,0	1	33	0	.	LDL receptor binding. Pubmed:2063194
chr19	44908779	44908791	P02649	0	+	44908779	44908791	255,102,0	1	12	0	.	Heparin-binding. Pubmed:3947350
chr19	44908980	44909004	P02649	0	+	44908980	44909004	255,102,0	1	24	0	.	Heparin-binding. Pubmed:3947350
chr19	44948711	44948759	P02655	0	+	44948711	44948759	255,102,0	1	48	0	.	O-glycosylated at one site.
chr19	44948840	44949165	P02655	0	+	44948840	44949165	255,102,0	1	325	0	.	Lipid binding. Pubmed:6772077
chr19	44949174	44949246	P02655	0	+	44949174	44949246	255,102,0	1	72	0	.	Lipoprotein lipase cofactor. Pubmed:6772077, Pubmed:1555583
chr19	45002959	45011976	Q01201	0	+	45002959	45011976	255,102,0	1	9017	0	.	Leucine-zipper.
chr19	45352640	45357539	P18074	0	-	45352640	45357539	255,102,0	1	4899	0	.	Mediates interaction with MMS19.
chr19	45409677	45414905	P07992	0	-	45409677	45414905	255,102,0	1	5228	0	.	HhH2, dimerization with ERCC4.
chr19	45471214	45471292	P53539	0	+	45471214	45471292	255,102,0	1	78	0	.	Basic motif.
chr19	45471292	45472628	P53539	0	+	45471292	45472628	255,102,0	1	1336	0	.	Leucine-zipper.
chr19	45522533	45522732	P50552	0	+	45522533	45522732	255,102,0	1	199	0	.	EVH2 block A.
chr19	45522533	45526165	P50552	0	+	45522533	45526165	255,102,0	1	3632	0	.	EVH2.
chr19	45522771	45523656	P50552	0	+	45522771	45523656	255,102,0	1	885	0	.	EVH2 block B.
chr19	45524639	45526165	P50552	0	+	45524639	45526165	255,102,0	1	1526	0	.	EVH2 block C.
chr19	45524642	45526153	P50552	0	+	45524642	45526153	255,102,0	1	1511	0	.	2 X 15 AA tandem repeats of L-[EQ]-[KR]-[MV]-K-[EQ]-E-[IL]-[IL]-E-[AEV]-[FV]-[KRV]-[KQ]-E.
chr19	45609665	45638866	O95834	0	-	45609665	45638866	255,102,0	1	29201	0	.	Tandem atypical propeller in EMLs.
chr19	45745198	45745240	C9JSJ3	0	+	45745198	45745240	255,102,0	1	42	0	.	Basic motif; degenerate.
chr19	45745240	45750716	C9JSJ3	0	+	45745240	45750716	255,102,0	1	5476	0	.	Helix-loop-helix motif.
chr19	45848803	45854495	Q92797	0	-	45848803	45854495	255,102,0	1	5692	0	.	Interaction with HSF1. Pubmed:14707147
chr19	45884124	45884268	Q8IU81	0	-	45884124	45884268	255,102,0	1	144	0	.	Cys-rich.
chr19	46305255	46305327	Q9Y2N7	0	+	46305255	46305327	255,102,0	1	72	0	.	Nuclear localization signal.
chr19	46309276	46312212	Q9Y2N7	0	+	46309276	46312212	255,102,0	1	2936	0	.	Nuclear export signal.
chr19	46325552	46331186	Q9Y2N7	0	+	46325552	46331186	255,102,0	1	5634	0	.	ODD.
chr19	46325558	46329284	Q9Y2N7	0	+	46325558	46329284	255,102,0	1	3726	0	.	NTAD.
chr19	46376490	46390343	P53041	0	+	46376490	46390343	255,102,0	1	13853	0	.	Catalytic.
chr19	46387094	46387100	P53041	0	+	46387094	46387100	255,102,0	1	6	0	.	Substrate binding. Pubmed:15155720
chr19	46390328	46390343	P53041	0	+	46390328	46390343	255,102,0	1	15	0	.	Required for autoinhibition.
chr19	46733229	46736869	Q9NRL3	0	-	46733229	46736869	255,102,0	1	3640	0	.	Calmodulin-binding.
chr19	46746193	46746220	Q9NRL3	0	-	46746193	46746220	255,102,0	1	27	0	.	Caveolin-binding.
chr19	46918675	46919473	Q9NRY4	0	+	46918675	46919473	255,102,0	1	798	0	.	Has GTPase activity, required for proper localization.
chr19	46922311	46937290	Q9NRY4	0	+	46922311	46937290	255,102,0	1	14979	0	.	Required for phospholipid binding and regulation of the substrate preference. Pubmed:19673492
chr19	47319804	47319831	P21730	0	+	47319804	47319831	255,102,0	1	27	0	.	Required for CHIPS binding. Pubmed:15542591
chr19	47319837	47319867	P21730	0	+	47319837	47319867	255,102,0	1	30	0	.	Involved in C5a binding. Pubmed:9553099
chr19	47457468	47457528	Q9UPR5	0	-	47457468	47457528	255,102,0	1	60	0	.	Putative calmodulin-binding region.
chr19	47736410	47736473	Q9NZN4	0	+	47736410	47736473	255,102,0	1	63	0	.	Mediates membrane-binding.
chr19	48127909	48127918	P18858	0	-	48127909	48127918	255,102,0	1	9	0	.	Interaction with target DNA.
chr19	48136082	48136112	P18858	0	-	48136082	48136112	255,102,0	1	30	0	.	Interaction with target DNA.
chr19	48620514	48627705	Q9NRA0	0	+	48620514	48627705	255,102,0	1	7191	0	.	Required for binding to sulfatide and phosphoinositides and for membrane localization.
chr19	48628045	48628057	Q9NRA0	0	+	48628045	48628057	255,102,0	1	12	0	.	Substrate binding.
chr19	48630923	48630968	Q10586	0	-	48630923	48630968	255,102,0	1	45	0	.	Leucine-zipper.
chr19	48630977	48631046	Q10586	0	-	48630977	48631046	255,102,0	1	69	0	.	Basic motif.
chr19	48713269	48714446	Q6ZN01	0	-	48713269	48714446	255,102,0	1	1177	0	.	Transcription activation.
chr19	48743463	48743502	Q8IYV9	0	-	48743463	48743502	255,102,0	1	39	0	.	Important for interaction with IZUMO1R. Pubmed:27309818
chr19	48873233	48873413	O75807	0	+	48873233	48873413	255,102,0	1	180	0	.	Required for localization in the endoplasmic reticulum.
chr19	48874241	48874763	O75807	0	+	48874241	48874763	255,102,0	1	522	0	.	4 X 34 AA approximate repeats.
chr19	48874241	48874763	O75807	0	+	48874241	48874763	255,102,0	1	522	0	.	Interaction with SMAD7. Pubmed:14718519
chr19	48874679	48874898	O75807	0	+	48874679	48874898	255,102,0	1	219	0	.	Interaction with KMT2A/MLL1.
chr19	48874838	48875697	O75807	0	+	48874838	48875697	255,102,0	1	859	0	.	Interaction with SMARCB1.
chr19	48900919	48904364	Q02818	0	+	48900919	48904364	255,102,0	1	3445	0	.	O-glycosylated at one site.
chr19	48913488	48919247	Q02818	0	+	48913488	48919247	255,102,0	1	5759	0	.	Binds to GNAI2 and GNAI3.
chr19	48965826	48965850	P02792	0	+	48965826	48965850	255,102,0	1	24	0	.	Catalytic site for iron oxidation.
chr19	49152010	49153284	P23327	0	-	49152010	49153284	255,102,0	1	1274	0	.	Metal-binding.
chr19	49154142	49154922	P23327	0	-	49154142	49154922	255,102,0	1	780	0	.	4 X tandem repeats, acidic.
chr19	49154211	49154922	P23327	0	-	49154211	49154922	255,102,0	1	711	0	.	6 X approximate tandem repeats.
chr19	49210302	49211081	Q8TD43	0	+	49210302	49211081	255,102,0	1	779	0	.	Calmodulin-binding.
chr19	49210786	49210804	Q8TD43	0	+	49210786	49210804	255,102,0	1	18	0	.	Mediates modulation by decavanadate and PIP2-binding.
chr19	49341326	49355161	Q15562	0	-	49341326	49355161	255,102,0	1	13835	0	.	Transcriptional activation.
chr19	49513469	49514215	P55899	0	+	49513469	49514215	255,102,0	1	746	0	.	Alpha-1. Pubmed:10933786
chr19	49514215	49514485	P55899	0	+	49514215	49514485	255,102,0	1	270	0	.	Alpha-2. Pubmed:10933786
chr19	49524505	49524775	P55899	0	+	49524505	49524775	255,102,0	1	270	0	.	Alpha-3. Pubmed:10933786
chr19	49525455	49525476	P55899	0	+	49525455	49525476	255,102,0	1	21	0	.	Connecting peptide.
chr19	49558929	49559947	Q9Y314	0	-	49558929	49559947	255,102,0	1	1018	0	.	U-box-like.
chr19	49654810	49658396	Q9H7N4	0	+	49654810	49658396	255,102,0	1	3586	0	.	Necessary for interaction with the CTD domain of POLR2A.
chr19	49660730	49662428	Q14653	0	-	49660730	49662428	255,102,0	1	1698	0	.	Involved in HERC5 binding.
chr19	49710406	49710445	Q8TCG5	0	+	49710406	49710445	255,102,0	1	39	0	.	Coenzyme A binding.
chr19	49818341	49829938	Q71SY5	0	+	49818341	49829938	255,102,0	1	11597	0	.	Interaction with the Mediator complex.
chr19	49831395	49835132	Q71SY5	0	+	49831395	49835132	255,102,0	1	3737	0	.	Interaction with VP16.
chr19	49831413	49835138	Q71SY5	0	+	49831413	49835138	255,102,0	1	3725	0	.	Interaction with CREBBP. Pubmed:17641689
chr19	49835548	49835939	Q71SY5	0	+	49835548	49835939	255,102,0	1	391	0	.	Interaction with RARA. Pubmed:17641689
chr19	49835897	49836381	Q71SY5	0	+	49835897	49836381	255,102,0	1	484	0	.	Interaction with RARA. Pubmed:17641689
chr19	49855068	49860276	Q86YD1	0	+	49855068	49860276	255,102,0	1	5208	0	.	Interaction with FLOT1. Pubmed:15713644
chr19	49861265	49862379	Q96T60	0	-	49861265	49862379	255,102,0	1	1114	0	.	Kinase.
chr19	49862388	49865189	Q96T60	0	-	49862388	49865189	255,102,0	1	2801	0	.	Phosphatase.
chr19	49909378	49909792	P37198	0	-	49909378	49909792	255,102,0	1	414	0	.	5 X 2 AA repeats of F-G.
chr19	49930850	49930913	Q9Y2D1	0	+	49930850	49930913	255,102,0	1	63	0	.	Required for protein stabilization induced by IL1B. Pubmed:24379400
chr19	49932597	49932894	Q9Y2D1	0	+	49932597	49932894	255,102,0	1	297	0	.	Interaction with PTP4A1.
chr19	49932870	49932933	Q9Y2D1	0	+	49932870	49932933	255,102,0	1	63	0	.	Basic motif.
chr19	49932948	49932993	Q9Y2D1	0	+	49932948	49932993	255,102,0	1	45	0	.	Leucine-zipper.
chr19	50045376	50046099	Q8WTR7	0	+	50045376	50046099	255,102,0	1	723	0	.	Interaction with SLBP/pre-mRNA complex.
chr19	50328848	50329082	Q14003	0	-	50328848	50329082	255,102,0	1	234	0	.	Important for normal N-type inactivation. Pubmed:26997484
chr19	50377605	50378222	P55055	0	+	50377605	50378222	255,102,0	1	617	0	.	Transactivation AF-1; required for ligand-independent transactivation function. Pubmed:25661920
chr19	50378703	50382599	P55055	0	+	50378703	50382599	255,102,0	1	3896	0	.	Transactivation AF-2; required for ligand-dependent transactivation function; mediates interaction with CCAR2. Pubmed:25661920
chr19	50378736	50382599	P55055	0	+	50378736	50382599	255,102,0	1	3863	0	.	Ligand-binding.
chr19	50418962	50422514	Q01892	0	+	50418962	50422514	255,102,0	1	3552	0	.	TAD1 (Acidic).
chr19	50422541	50422881	Q01892	0	+	50422541	50422881	255,102,0	1	340	0	.	TAD2.
chr19	50637309	50637384	Q9BQG1	0	-	50637309	50637384	255,102,0	1	75	0	.	Cysteine motif.
chr19	51142759	51142774	Q9Y286	0	+	51142759	51142774	255,102,0	1	15	0	.	Sialic acid binding. Pubmed:16623661, Pubmed:16895906, Pubmed:12438315
chr19	51345363	51346950	P38117	0	-	51345363	51346950	255,102,0	1	1587	0	.	Recognition loop. Pubmed:15159392, Pubmed:25023281
chr19	52190117	52219759	P30153	0	+	52190117	52219759	255,102,0	1	29642	0	.	PP2A subunit B binding.
chr19	52202003	52216044	P30153	0	+	52202003	52216044	255,102,0	1	14041	0	.	Polyoma small and medium T antigens Binding.
chr19	52206045	52213020	P30153	0	+	52206045	52213020	255,102,0	1	6975	0	.	SV40 small T antigen binding.
chr19	52219759	52225978	P30153	0	+	52219759	52225978	255,102,0	1	6219	0	.	PP2A subunit C binding.
chr19	54152942	54155404	O75175	0	+	54152942	54155404	255,102,0	1	2462	0	.	Repressor domain.
chr19	54153425	54155887	O75175	0	+	54153425	54155887	255,102,0	1	2462	0	.	Repressor domain.
chr19	54153425	54155888	O75175	0	+	54153425	54155888	255,102,0	1	2463	0	.	Repressor domain.
chr19	55154131	55154194	P19429	0	-	55154131	55154194	255,102,0	1	63	0	.	Involved in binding TNC and actin.
chr19	55156245	55157064	P19429	0	-	55156245	55157064	255,102,0	1	819	0	.	Involved in binding TNC.
chr19	55241031	55247076	Q9UPN7	0	-	55241031	55247076	255,102,0	1	6045	0	.	Interaction with PPP6C.
chr19	55347095	55347365	Q86Y97	0	+	55347095	55347365	255,102,0	1	270	0	.	Required for heterochromatin localization.
chr19	55366036	55366063	P20809	0	-	55366036	55366063	255,102,0	1	27	0	.	Important for interaction with IL11RA and for the stimulation of cell proliferation.
chr19	55483644	55483785	Q5EBL2	0	+	55483644	55483785	255,102,0	1	141	0	.	4 X approximate tandem repeats.
chr19	55655107	55660564	P26368	0	+	55655107	55660564	255,102,0	1	5457	0	.	Required for interaction with PRPF19. Pubmed:21536736
chr19	55691810	55692756	Q9Y6I3	0	+	55691810	55692756	255,102,0	1	946	0	.	8 X 3 AA repeats of [ED]-P-W.
chr19	55694964	55695347	Q9Y6I3	0	+	55694964	55695347	255,102,0	1	383	0	.	3 X 3 AA repeats of N-P-F.
chr19	56814112	56814190	Q9GZU2	0	-	56814112	56814190	255,102,0	1	78	0	.	4 X 5 AA repeat of P-X-G-E-A.
chr19	56814190	56814253	Q9GZU2	0	-	56814190	56814253	255,102,0	1	63	0	.	3 X 7 AA repeat of P-E-V-E-A-A-E.
chr19	57235360	57235414	Q9UQB9	0	+	57235360	57235414	255,102,0	1	54	0	.	Interaction with BIRC5. Pubmed:27332895
chr19	58544949	58548320	Q13263	0	+	58544949	58548320	255,102,0	1	3371	0	.	RBCC domain.
chr19	58547609	58548320	Q13263	0	+	58547609	58548320	255,102,0	1	711	0	.	Leucine zipper alpha helical coiled-coil region.
chr19	58547612	58548320	Q13263	0	+	58547612	58548320	255,102,0	1	708	0	.	Interaction with MAGEC2.
chr19	58548174	58548302	Q13263	0	+	58548174	58548302	255,102,0	1	128	0	.	Involved in binding PPP1CA.
chr19	58549003	58549117	Q13263	0	+	58549003	58549117	255,102,0	1	114	0	.	HP1 box.
chr19	58551651	58551669	O43633	0	-	58551651	58551669	255,102,0	1	18	0	.	Interaction with VTA1.
chr19	58551651	58554047	O43633	0	-	58551651	58554047	255,102,0	1	2396	0	.	Interaction with VPS4B.
chr19	58557095	58558381	P61081	0	-	58557095	58558381	255,102,0	1	1286	0	.	Interaction with UBA3.
chr2	669582	669666	Q96B42	0	-	669582	669666	255,102,0	1	84	0	.	DNA-binding.
chr2	8730722	8730737	Q9ULH0	0	-	8730722	8730737	255,102,0	1	15	0	.	Mediates interaction with SNTA1.
chr2	8750249	8750261	Q9ULH0	0	-	8750249	8750261	255,102,0	1	12	0	.	Mediates interaction with CRKL.
chr2	9407556	9407565	O14713	0	-	9407556	9407565	255,102,0	1	9	0	.	Interaction with ITGB1.
chr2	9407562	9407574	O14713	0	-	9407562	9407574	255,102,0	1	12	0	.	Interaction with KRIT1.
chr2	9492966	9494744	P78536	0	-	9492966	9494744	255,102,0	1	1778	0	.	Crambin-like.
chr2	9849372	9849459	Q53T94	0	+	9849372	9849459	255,102,0	1	87	0	.	B-reader.
chr2	9851539	9851554	Q53T94	0	+	9851539	9851554	255,102,0	1	15	0	.	B-linker.
chr2	9851554	9882781	Q53T94	0	+	9851554	9882781	255,102,0	1	31227	0	.	N-terminal cyclin fold.
chr2	9882781	9910896	Q53T94	0	+	9882781	9910896	255,102,0	1	28115	0	.	C-terminal cyclin fold.
chr2	9951833	9958851	Q9NZI5	0	+	9951833	9958851	255,102,0	1	7018	0	.	Transcription activation.
chr2	10441846	10441852	P11926	0	-	10441846	10441852	255,102,0	1	6	0	.	Substrate binding.
chr2	10442093	10442105	P11926	0	-	10442093	10442105	255,102,0	1	12	0	.	Pyridoxal phosphate binding. Pubmed:17407445, Pubmed:26305948, Pubmed:26443277
chr2	11197663	11198750	O75116	0	-	11197663	11198750	255,102,0	1	1087	0	.	RHOA binding.
chr2	11208298	11222095	O75116	0	-	11208298	11222095	255,102,0	1	13797	0	.	Interaction with PPP1R12A.
chr2	11221196	11221340	O75116	0	-	11221196	11221340	255,102,0	1	144	0	.	Interaction with NPM1. Pubmed:17015463
chr2	11446479	11451670	O75461	0	-	11446479	11451670	255,102,0	1	5191	0	.	Transcription repression.
chr2	11447759	11451799	O75461	0	-	11447759	11451799	255,102,0	1	4040	0	.	Dimerization.
chr2	11451694	11451760	O75461	0	-	11451694	11451760	255,102,0	1	66	0	.	Leucine-zipper.
chr2	11765541	11771407	Q14693	0	+	11765541	11771407	255,102,0	1	5866	0	.	N-LIP.
chr2	11802997	11820491	Q14693	0	+	11802997	11820491	255,102,0	1	17494	0	.	C-LIP.
chr2	15167050	15396441	A2RRP1	0	-	15167050	15396441	255,102,0	1	229391	0	.	Interaction with ZW10 and RINT1. Pubmed:20462495, Pubmed:19369418
chr2	15396441	15561304	A2RRP1	0	-	15396441	15561304	255,102,0	1	164863	0	.	Interaction with USE1L. Pubmed:19369418
chr2	15591933	15607242	Q92499	0	+	15591933	15607242	255,102,0	1	15309	0	.	Necessary for interaction with HNRNPK. Pubmed:12183465
chr2	15591933	15623563	Q92499	0	+	15591933	15623563	255,102,0	1	31630	0	.	Necessary for interaction with RELA. Pubmed:19058135
chr2	15623560	15630903	Q92499	0	+	15623560	15630903	255,102,0	1	7343	0	.	Necessary for interaction with HNRNPK. Pubmed:12183465
chr2	15627064	15629619	Q92499	0	+	15627064	15629619	255,102,0	1	2555	0	.	Necessary for interaction with replicase polyprotein 1ab nsp14 of IBV.
chr2	15945998	15946064	P04198	0	+	15945998	15946064	255,102,0	1	66	0	.	Leucine-zipper.
chr2	17510806	17510953	Q09MP3	0	-	17510806	17510953	255,102,0	1	147	0	.	Interaction with RAD51. Pubmed:16990250
chr2	17707247	17716257	Q96SB8	0	-	17707247	17716257	255,102,0	1	9010	0	.	Flexible hinge.
chr2	17759943	17761522	Q17RS7	0	+	17759943	17761522	255,102,0	1	1579	0	.	N-domain.
chr2	17764911	17766689	Q17RS7	0	+	17764911	17766689	255,102,0	1	1778	0	.	I-domain.
chr2	24037859	24037880	Q9H6R7	0	-	24037859	24037880	255,102,0	1	21	0	.	Interaction with HCK. Pubmed:25469238
chr2	24074137	24074179	Q9Y3B4	0	-	24074137	24074179	255,102,0	1	42	0	.	Interaction with pre-mRNA branch site.
chr2	24705216	24707171	Q15788	0	+	24705216	24707171	255,102,0	1	1955	0	.	Interaction with STAT3. Pubmed:11773079
chr2	24707810	24729578	Q15788	0	+	24707810	24729578	255,102,0	1	21768	0	.	Interaction with CREBBP.
chr2	24971850	24971904	Q9NZQ0	0	-	24971850	24971904	255,102,0	1	54	0	.	Required for interaction with MAPK1.
chr2	25234338	25234347	Q9Y6K1	0	-	25234338	25234347	255,102,0	1	9	0	.	S-adenosyl-L-homocysteine binding. Pubmed:17713477
chr2	25241579	25241588	Q9Y6K1	0	-	25241579	25241588	255,102,0	1	9	0	.	S-adenosyl-L-homocysteine binding. Pubmed:17713477
chr2	25243898	25243913	Q9Y6K1	0	-	25243898	25243913	255,102,0	1	15	0	.	S-adenosyl-L-homocysteine binding. Pubmed:17713477
chr2	25244247	25245327	Q9Y6K1	0	-	25244247	25245327	255,102,0	1	1080	0	.	Interaction with the PRC2/EED-EZH2 complex.
chr2	25246689	25274985	Q9Y6K1	0	-	25246689	25274985	255,102,0	1	28296	0	.	Interaction with DNMT1 and DNMT3B. Pubmed:12145218
chr2	25433908	25451610	O60941	0	-	25433908	25451610	255,102,0	1	17702	0	.	Syntrophin-binding region.
chr2	26173253	26184865	Q75VX8	0	+	26173253	26184865	255,102,0	1	11612	0	.	CABIT.
chr2	26792144	26792192	P49450	0	+	26792144	26792192	255,102,0	1	48	0	.	Important for flexibility of DNA ends that protrude from nucleosomes. Pubmed:27499292
chr2	26792767	26793204	P49450	0	+	26792767	26793204	255,102,0	1	437	0	.	CATD. Pubmed:7962047, Pubmed:15282608
chr2	27025903	27026282	Q9UPY8	0	+	27025903	27026282	255,102,0	1	379	0	.	APC-binding.
chr2	27025903	27026345	Q9UPY8	0	+	27025903	27026345	255,102,0	1	442	0	.	DCTN1-binding.
chr2	27217554	27224016	P27708	0	+	27217554	27224016	255,102,0	1	6462	0	.	GATase (Glutamine amidotransferase).
chr2	27224016	27224418	P27708	0	+	27224016	27224418	255,102,0	1	402	0	.	Linker.
chr2	27224418	27232601	P27708	0	+	27224418	27232601	255,102,0	1	8183	0	.	CPSase A.
chr2	27224418	27236799	P27708	0	+	27224418	27236799	255,102,0	1	12381	0	.	CPSase (Carbamoyl-phosphate synthase).
chr2	27232601	27236799	P27708	0	+	27232601	27236799	255,102,0	1	4198	0	.	CPSase B.
chr2	27236799	27239441	P27708	0	+	27236799	27239441	255,102,0	1	2642	0	.	DHOase (dihydroorotase).
chr2	27239441	27241170	P27708	0	+	27239441	27241170	255,102,0	1	1729	0	.	Linker.
chr2	27241170	27243515	P27708	0	+	27241170	27243515	255,102,0	1	2345	0	.	ATCase (Aspartate transcarbamylase).
chr2	27299404	27305607	Q9BYV2	0	+	27299404	27305607	255,102,0	1	6203	0	.	Mediates microtubule-binding and homooligomerization.
chr2	27373881	27376517	Q15036	0	+	27373881	27376517	255,102,0	1	2636	0	.	FERM-like.
chr2	27375538	27376517	Q15036	0	+	27375538	27376517	255,102,0	1	979	0	.	PTB-like F3 module.
chr2	27581348	27582377	Q68DN1	0	+	27581348	27582377	255,102,0	1	1029	0	.	27 X 8 AA approximative tandem repeat of P-S-E-R-S-H-H-S.
chr2	27858489	27858504	Q9H477	0	-	27858489	27858504	255,102,0	1	15	0	.	Substrate binding.
chr2	27890264	27890273	Q9H477	0	-	27890264	27890273	255,102,0	1	9	0	.	Substrate binding.
chr2	27894643	28025366	Q9NXR7	0	+	27894643	28025366	255,102,0	1	130723	0	.	UEV-like 1.
chr2	28241364	28338453	Q9NXR7	0	+	28241364	28338453	255,102,0	1	97089	0	.	UEV-like 2.
chr2	28408779	28408788	P15408	0	+	28408779	28408788	255,102,0	1	9	0	.	Basic motif.
chr2	28408788	28408812	P15408	0	+	28408788	28408812	255,102,0	1	24	0	.	Leucine-zipper.
chr2	28516866	28642890	Q6P1J6	0	+	28516866	28642890	255,102,0	1	126024	0	.	4 X 308-326 AA approximate repeats.
chr2	28642890	28643019	Q6P1J6	0	+	28642890	28643019	255,102,0	1	129	0	.	Necessary for membrane localization.
chr2	28816215	28840219	Q5MJ70	0	+	28816215	28840219	255,102,0	1	24004	0	.	Speedy/Ringo box; Required for CDK-binding.
chr2	28851288	28852421	Q9BVS5	0	-	28851288	28852421	255,102,0	1	1133	0	.	Substrate.
chr2	28852481	28852493	Q9BVS5	0	-	28852481	28852493	255,102,0	1	12	0	.	Substrate.
chr2	28861273	28861279	Q9BVS5	0	-	28861273	28861279	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr2	28865038	28865062	Q9BVS5	0	-	28865038	28865062	255,102,0	1	24	0	.	Substrate.
chr2	28869581	28869596	Q9BVS5	0	-	28869581	28869596	255,102,0	1	15	0	.	Substrate.
chr2	28869656	28869662	Q9BVS5	0	-	28869656	28869662	255,102,0	1	6	0	.	Substrate.
chr2	28869740	28869881	Q9BVS5	0	-	28869740	28869881	255,102,0	1	141	0	.	Substrate.
chr2	28870040	28870049	Q9BVS5	0	-	28870040	28870049	255,102,0	1	9	0	.	Substrate.
chr2	29220753	29220762	Q9UM73	0	-	29220753	29220762	255,102,0	1	9	0	.	Inhibitor binding.
chr2	30932117	30944865	Q96FL9	0	-	30932117	30944865	255,102,0	1	12748	0	.	Catalytic subdomain B.
chr2	30955626	30966274	Q96FL9	0	-	30955626	30966274	255,102,0	1	10648	0	.	Catalytic subdomain A.
chr2	31174686	31187793	A8MX76	0	-	31174686	31187793	255,102,0	1	13107	0	.	Domain IV.
chr2	31187793	31188338	A8MX76	0	-	31187793	31188338	255,102,0	1	545	0	.	Linker.
chr2	31188338	31193236	A8MX76	0	-	31188338	31193236	255,102,0	1	4898	0	.	Domain III.
chr2	32063831	32063981	Q9UBP0	0	+	32063831	32063981	255,102,0	1	150	0	.	Required for nuclear localization. Pubmed:15147984
chr2	32063831	32064071	Q9UBP0	0	+	32063831	32064071	255,102,0	1	240	0	.	Required for interaction with ATL1. Pubmed:16815977, Pubmed:16339213
chr2	32063831	32089601	Q9UBP0	0	+	32063831	32089601	255,102,0	1	25770	0	.	Required for midbody localization. Pubmed:18997780
chr2	32063831	32115731	Q9UBP0	0	+	32063831	32115731	255,102,0	1	51900	0	.	Required for interaction with RTN1. Pubmed:16602018
chr2	32063978	32064092	Q9UBP0	0	+	32063978	32064092	255,102,0	1	114	0	.	Required for interaction with SSNA1 and microtubules. Pubmed:15269182
chr2	32064164	32098797	Q9UBP0	0	+	32064164	32098797	255,102,0	1	34633	0	.	Sufficient for interaction with CHMP1B. Pubmed:18997780
chr2	32064170	32098809	Q9UBP0	0	+	32064170	32098809	255,102,0	1	34639	0	.	Required for interaction with microtubules. Pubmed:15269182
chr2	32114636	32154493	Q9UBP0	0	+	32114636	32154493	255,102,0	1	39857	0	.	Sufficient for microtubule severing. Pubmed:15269182
chr2	32114762	32115815	Q9UBP0	0	+	32114762	32115815	255,102,0	1	1053	0	.	Required for interaction with microtubules and microtubule severing. Pubmed:15269182
chr2	32115758	32115767	Q9UBP0	0	+	32115758	32115767	255,102,0	1	9	0	.	Required for interaction with microtubules. Pubmed:23272056
chr2	32250474	32250798	Q9NPP4	0	-	32250474	32250798	255,102,0	1	324	0	.	Winged-helix domain (WHD).
chr2	32250969	32251581	Q9NPP4	0	-	32250969	32251581	255,102,0	1	612	0	.	Nucleotide-binding domain (NBD).
chr2	33364334	33398542	Q14766	0	+	33364334	33398542	255,102,0	1	34208	0	.	C-terminal domain. Pubmed:17293099
chr2	36902744	36905586	O43815	0	-	36902744	36905586	255,102,0	1	2842	0	.	Calmodulin-binding.
chr2	36966274	36966301	O43815	0	-	36966274	36966301	255,102,0	1	27	0	.	Caveolin-binding.
chr2	37107275	37126401	P19525	0	-	37107275	37126401	255,102,0	1	19126	0	.	Interaction with TRAF5. Pubmed:15121867
chr2	37120135	37122582	P19525	0	-	37120135	37122582	255,102,0	1	2447	0	.	2 X 13 AA approximate repeats.
chr2	38675961	38675967	Q96C23	0	+	38675961	38675967	255,102,0	1	6	0	.	Substrate binding.
chr2	38745171	38748583	Q16629	0	-	38745171	38748583	255,102,0	1	3412	0	.	6 X 8 AA repeats of R-R-S-R-S-X-S-X.
chr2	38749620	38749674	Q16629	0	-	38749620	38749674	255,102,0	1	54	0	.	Sufficient for interaction with NXF1.
chr2	40429461	40429521	P32418	0	-	40429461	40429521	255,102,0	1	60	0	.	Putative calmodulin-binding region.
chr2	42767439	42769811	P46952	0	-	42767439	42769811	255,102,0	1	2372	0	.	Domain B.
chr2	42769811	42770146	P46952	0	-	42769811	42770146	255,102,0	1	335	0	.	Linker.
chr2	42770146	42792536	P46952	0	-	42770146	42792536	255,102,0	1	22390	0	.	Domain A (catalytic).
chr2	43225170	43225296	P47974	0	-	43225170	43225296	255,102,0	1	126	0	.	RNA-binding. Pubmed:20506496, Pubmed:14981510
chr2	43888602	43905695	P42704	0	-	43888602	43905695	255,102,0	1	17093	0	.	RNA-binding.
chr2	44942317	44942461	O95343	0	+	44942317	44942461	255,102,0	1	144	0	.	Interaction with AES.
chr2	44942797	44942806	O95343	0	+	44942797	44942806	255,102,0	1	9	0	.	Bind to RHO promoter.
chr2	46378698	46380298	Q99814	0	+	46378698	46380298	255,102,0	1	1600	0	.	NTAD.
chr2	46384534	46384657	Q99814	0	+	46384534	46384657	255,102,0	1	123	0	.	CTAD.
chr2	46624203	46624224	Q9P021	0	+	46624203	46624224	255,102,0	1	21	0	.	Sufficient for interaction with DLG4. Pubmed:17474715
chr2	46624212	46624224	Q9P021	0	+	46624212	46624224	255,102,0	1	12	0	.	PDZ3-binding.
chr2	46758530	46758680	O75159	0	+	46758530	46758680	255,102,0	1	150	0	.	Required for interaction with IL4R.
chr2	47475065	47476374	P43246	0	+	47475065	47476374	255,102,0	1	1309	0	.	Interaction with EXO1.
chr2	53767892	53767910	Q8WUX2	0	+	53767892	53767910	255,102,0	1	18	0	.	Substrate binding.
chr2	53869424	53874491	Q14997	0	-	53869424	53874491	255,102,0	1	5067	0	.	Bromodomain-like (BRDL).
chr2	54646295	54659189	Q01082	0	+	54646295	54659189	255,102,0	1	12894	0	.	Interaction with ANK2. Pubmed:15262991
chr2	54664476	54664563	Q01082	0	+	54664476	54664563	255,102,0	1	87	0	.	Mediates interaction with CAMSAP1. Pubmed:24117850
chr2	55249397	55249406	P46199	0	-	55249397	55249406	255,102,0	1	9	0	.	G5.
chr2	55249502	55249514	P46199	0	-	55249502	55249514	255,102,0	1	12	0	.	G4.
chr2	55252606	55252618	P46199	0	-	55252606	55252618	255,102,0	1	12	0	.	G3.
chr2	55254056	55254071	P46199	0	-	55254056	55254071	255,102,0	1	15	0	.	G2.
chr2	55254122	55254146	P46199	0	-	55254122	55254146	255,102,0	1	24	0	.	G1.
chr2	55308971	55309166	Q3V6T2	0	-	55308971	55309166	255,102,0	1	195	0	.	Phosphoinositide-binding. Pubmed:16139227
chr2	55867075	55876728	Q12805	0	-	55867075	55876728	255,102,0	1	9653	0	.	Mediates interaction with TIMP3. Pubmed:15123717
chr2	58159354	58159690	Q86Y07	0	+	58159354	58159690	255,102,0	1	336	0	.	Interaction with MAP3K7. Pubmed:17709393
chr2	58162886	58222006	Q9NW38	0	-	58162886	58222006	255,102,0	1	59120	0	.	UBC-RWD region (URD).
chr2	60462281	60553270	Q9H165	0	-	60462281	60553270	255,102,0	1	90989	0	.	Required for nuclear body formation and for SUMO1 recruitment.
chr2	60948122	60948170	Q3MIT2	0	-	60948122	60948170	255,102,0	1	48	0	.	RNA binding thumb loop.
chr2	60960440	60960482	Q3MIT2	0	-	60960440	60960482	255,102,0	1	42	0	.	RNA binding forefinger loop.
chr2	61031758	61032025	Q92968	0	+	61031758	61032025	255,102,0	1	267	0	.	Targeting to peroxisomes.
chr2	61031848	61031914	Q92968	0	+	61031848	61031914	255,102,0	1	66	0	.	Interaction with PEX19.
chr2	61485815	61485878	O14980	0	-	61485815	61485878	255,102,0	1	63	0	.	Interaction with HIV-1 Rev.
chr2	61488756	61533897	O14980	0	-	61488756	61533897	255,102,0	1	45141	0	.	Necessary for HTLV-1 Rex-mediated mRNA export.
chr2	61492689	61493908	O14980	0	-	61492689	61493908	255,102,0	1	1219	0	.	Interaction with RANBP3.
chr2	61492948	61495523	O14980	0	-	61492948	61495523	255,102,0	1	2575	0	.	Interaction with Ran and nuclear export complex formation.
chr2	61493896	61493908	O14980	0	-	61493896	61493908	255,102,0	1	12	0	.	Necessary for HTLV-1 Rex multimerization.
chr2	61905681	62000889	Q8N668	0	+	61905681	62000889	255,102,0	1	95208	0	.	Sufficient for interaction with SLC12A2. Pubmed:23515529
chr2	62000892	62135938	Q8N668	0	+	62000892	62135938	255,102,0	1	135046	0	.	Required for binding to PtdIns(4,5)P2. Pubmed:18940794
chr2	62996657	63045440	Q8NDI1	0	+	62996657	63045440	255,102,0	1	48783	0	.	RAB-binding domain (RBD). Pubmed:27552051
chr2	63882546	63882558	Q16851	0	+	63882546	63882558	255,102,0	1	12	0	.	UTP binding.
chr2	63882552	63882558	Q16851	0	+	63882552	63882558	255,102,0	1	6	0	.	Substrate binding. Pubmed:25860585
chr2	63885763	63885772	Q16851	0	+	63885763	63885772	255,102,0	1	9	0	.	Substrate binding. Pubmed:25860585
chr2	63890134	63891224	Q16851	0	+	63890134	63891224	255,102,0	1	1090	0	.	Oligomerization.
chr2	63891203	63891209	Q16851	0	+	63891203	63891209	255,102,0	1	6	0	.	Critical for end-to-end subunit interaction.
chr2	64635938	64636169	Q14140	0	-	64635938	64636169	255,102,0	1	231	0	.	Required for transactivation activity.
chr2	66567489	66569105	O00470	0	+	66567489	66569105	255,102,0	1	1616	0	.	Required for transcriptional activation.
chr2	68042891	68043017	Q13901	0	-	68042891	68043017	255,102,0	1	126	0	.	Interaction with NCOR1 and NCOR2.
chr2	68043014	68046401	Q13901	0	-	68043014	68046401	255,102,0	1	3387	0	.	Interaction with NR1D1.
chr2	68043014	68047310	Q13901	0	-	68043014	68047310	255,102,0	1	4296	0	.	Required for transcriptional repression.
chr2	68545241	68545274	Q8IW19	0	+	68545241	68545274	255,102,0	1	33	0	.	Flexible linker.
chr2	69073068	69073089	Q9H6X2	0	+	69073068	69073089	255,102,0	1	21	0	.	Interaction with PA.
chr2	69326928	69348243	Q06210	0	-	69326928	69348243	255,102,0	1	21315	0	.	Isomerase.
chr2	69338445	69338454	Q06210	0	-	69338445	69338454	255,102,0	1	9	0	.	Substrate-binding. Pubmed:19059404
chr2	69342169	69342175	Q06210	0	-	69342169	69342175	255,102,0	1	6	0	.	Substrate-binding. Pubmed:19059404
chr2	69396287	69406050	Q9UMS0	0	-	69396287	69406050	255,102,0	1	9763	0	.	NifU.
chr2	70663442	70663496	P35612	0	-	70663442	70663496	255,102,0	1	54	0	.	Interaction with calmodulin.
chr2	70678754	70678814	P35612	0	-	70678754	70678814	255,102,0	1	60	0	.	Interaction with calmodulin.
chr2	71072669	71072675	Q9UJ70	0	+	71072669	71072675	255,102,0	1	6	0	.	Substrate binding. Pubmed:17010375
chr2	71072717	71072726	Q9UJ70	0	+	71072717	71072726	255,102,0	1	9	0	.	Substrate binding. Pubmed:17010375
chr2	71363186	71364248	Q14966	0	+	71363186	71364248	255,102,0	1	1062	0	.	Involved in localization to nuclear speckles.
chr2	72888477	72888483	P35270	0	+	72888477	72888483	255,102,0	1	6	0	.	Substrate binding.
chr2	73830856	73847392	O95630	0	+	73830856	73847392	255,102,0	1	16536	0	.	Interaction with CHMP3.
chr2	73847689	73847704	O95630	0	+	73847689	73847704	255,102,0	1	15	0	.	Interaction with STAM.
chr2	74361501	74366273	Q14203	0	-	74361501	74366273	255,102,0	1	4772	0	.	Interaction with HPS6. Pubmed:25189619
chr2	74464663	74465022	Q13724	0	-	74464663	74465022	255,102,0	1	359	0	.	Required for endoplasmic reticulum targeting.
chr2	74505157	74505983	Q9BSM1	0	-	74505157	74505983	255,102,0	1	826	0	.	Sufficient for interaction with BCOR and BCORL1. Pubmed:23523425
chr2	74505181	74506828	Q9BSM1	0	-	74505181	74506828	255,102,0	1	1647	0	.	Required for repressor activity.
chr2	74530501	74531683	O43464	0	+	74530501	74531683	255,102,0	1	1182	0	.	Serine protease.
chr2	74533671	74534769	P58215	0	-	74533671	74534769	255,102,0	1	1098	0	.	Lysyl-oxidase like.
chr2	74834580	74834616	P52789	0	+	74834580	74834616	255,102,0	1	36	0	.	Hydrophobic.
chr2	74834616	74880424	P52789	0	+	74834616	74880424	255,102,0	1	45808	0	.	Regulatory.
chr2	74854445	74873873	P52789	0	+	74854445	74873873	255,102,0	1	19428	0	.	Hexokinase small subdomain 1.
chr2	74867658	74867673	P52789	0	+	74867658	74867673	255,102,0	1	15	0	.	Glucose-6-phosphate 1 binding.
chr2	74872386	74872392	P52789	0	+	74872386	74872392	255,102,0	1	6	0	.	Substrate 1 binding.
chr2	74873293	74873299	P52789	0	+	74873293	74873299	255,102,0	1	6	0	.	Substrate 1 binding.
chr2	74873873	74873879	P52789	0	+	74873873	74873879	255,102,0	1	6	0	.	Substrate 1 binding.
chr2	74873873	74880340	P52789	0	+	74873873	74880340	255,102,0	1	6467	0	.	Hexokinase large subdomain 1.
chr2	74874444	74877172	P52789	0	+	74874444	74877172	255,102,0	1	2728	0	.	Substrate 1 binding.
chr2	74878892	74878901	P52789	0	+	74878892	74878901	255,102,0	1	9	0	.	Glucose-6-phosphate 1 binding.
chr2	74880424	74890938	P52789	0	+	74880424	74890938	255,102,0	1	10514	0	.	Catalytic.
chr2	74880559	74886323	P52789	0	+	74880559	74886323	255,102,0	1	5764	0	.	Hexokinase small subdomain 2.
chr2	74881733	74881748	P52789	0	+	74881733	74881748	255,102,0	1	15	0	.	Glucose-6-phosphate 2 binding.
chr2	74882206	74882212	P52789	0	+	74882206	74882212	255,102,0	1	6	0	.	Substrate 2 binding.
chr2	74885511	74885517	P52789	0	+	74885511	74885517	255,102,0	1	6	0	.	Substrate 2 binding.
chr2	74886323	74886329	P52789	0	+	74886323	74886329	255,102,0	1	6	0	.	Substrate 2 binding.
chr2	74886323	74890872	P52789	0	+	74886323	74890872	255,102,0	1	4549	0	.	Hexokinase large subdomain 2.
chr2	74886497	74886503	P52789	0	+	74886497	74886503	255,102,0	1	6	0	.	Substrate 2 binding.
chr2	74886668	74887909	P52789	0	+	74886668	74887909	255,102,0	1	1241	0	.	Substrate 2 binding.
chr2	74889449	74889458	P52789	0	+	74889449	74889458	255,102,0	1	9	0	.	Glucose-6-phosphate 2 binding.
chr2	75493514	75518140	Q9H8M9	0	-	75493514	75518140	255,102,0	1	24626	0	.	Necessary for the localization and biological activity.
chr2	84441342	84441351	P53597	0	-	84441342	84441351	255,102,0	1	9	0	.	Coenzyme A binding.
chr2	84449648	84449660	P53597	0	-	84449648	84449660	255,102,0	1	12	0	.	Coenzyme A binding.
chr2	84517826	84624566	Q9C0G6	0	+	84517826	84624566	255,102,0	1	106740	0	.	Stem.
chr2	84624566	84640573	Q9C0G6	0	+	84624566	84640573	255,102,0	1	16007	0	.	AAA 1.
chr2	84653382	84658378	Q9C0G6	0	+	84653382	84658378	255,102,0	1	4996	0	.	AAA 2.
chr2	84669375	84685327	Q9C0G6	0	+	84669375	84685327	255,102,0	1	15952	0	.	AAA 3.
chr2	84688522	84701255	Q9C0G6	0	+	84688522	84701255	255,102,0	1	12733	0	.	AAA 4.
chr2	84701303	84707551	Q9C0G6	0	+	84701303	84707551	255,102,0	1	6248	0	.	Stalk.
chr2	84709417	84722648	Q9C0G6	0	+	84709417	84722648	255,102,0	1	13231	0	.	AAA 5.
chr2	84762766	84787253	Q9C0G6	0	+	84762766	84787253	255,102,0	1	24487	0	.	AAA 6.
chr2	85133684	85133906	Q9HCS4	0	+	85133684	85133906	255,102,0	1	222	0	.	CTNNB1-binding.
chr2	85541676	85541715	P31153	0	+	85541676	85541715	255,102,0	1	39	0	.	Flexible loop.
chr2	85754876	85754918	Q96SQ7	0	+	85754876	85754918	255,102,0	1	42	0	.	Basic motif; degenerate.
chr2	85754918	85764068	Q96SQ7	0	+	85754918	85764068	255,102,0	1	9150	0	.	Helix-loop-helix motif.
chr2	86045327	86045622	O95602	0	-	86045327	86045622	255,102,0	1	295	0	.	Bridging helix.
chr2	86505806	86505812	Q9Y3E7	0	-	86505806	86505812	255,102,0	1	6	0	.	Interaction with STAMBP.
chr2	86505806	86507551	Q9Y3E7	0	-	86505806	86507551	255,102,0	1	1745	0	.	Interaction with VPS4A.
chr2	86505812	86507551	Q9Y3E7	0	-	86505812	86507551	255,102,0	1	1739	0	.	Intramolecular interaction with N-terminus.
chr2	86505851	86505866	Q9Y3E7	0	-	86505851	86505866	255,102,0	1	15	0	.	Interaction with STAMBP.
chr2	86507494	86507500	Q9Y3E7	0	-	86507494	86507500	255,102,0	1	6	0	.	Important for autoinhibitory function.
chr2	86510426	86563345	Q9Y3E7	0	-	86510426	86563345	255,102,0	1	52919	0	.	Intramolecular interaction with C-terminus.
chr2	86529311	86529329	Q9Y3E7	0	-	86529311	86529329	255,102,0	1	18	0	.	Important for autoinhibitory function.
chr2	88067912	88067921	Q8NB12	0	+	88067912	88067921	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr2	88091095	88091101	Q8NB12	0	+	88091095	88091101	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr2	88096703	88096712	Q8NB12	0	+	88096703	88096712	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr2	88885850	88885919	P06312	0	+	88885850	88885919	255,102,0	1	69	0	.	Framework-1. Pubmed:2997712
chr2	88885919	88885970	P06312	0	+	88885919	88885970	255,102,0	1	51	0	.	Complementarity-determining-1. Pubmed:2997712
chr2	88885970	88886015	P06312	0	+	88885970	88886015	255,102,0	1	45	0	.	Framework-2. Pubmed:2997712
chr2	88886015	88886036	P06312	0	+	88886015	88886036	255,102,0	1	21	0	.	Complementarity-determining-2. Pubmed:2997712
chr2	88886036	88886132	P06312	0	+	88886036	88886132	255,102,0	1	96	0	.	Framework-3. Pubmed:2997712
chr2	88886132	88886153	P06312	0	+	88886132	88886153	255,102,0	1	21	0	.	Complementarity-determining-3. Pubmed:2997712
chr2	88897499	88897568	P06315	0	+	88897499	88897568	255,102,0	1	69	0	.	Framework-1. Pubmed:3925437
chr2	88897568	88897601	P06315	0	+	88897568	88897601	255,102,0	1	33	0	.	Complementarity-determining-1. Pubmed:3925437
chr2	88897601	88897646	P06315	0	+	88897601	88897646	255,102,0	1	45	0	.	Framework-2. Pubmed:3925437
chr2	88897646	88897667	P06315	0	+	88897646	88897667	255,102,0	1	21	0	.	Complementarity-determining-2. Pubmed:3925437
chr2	88897667	88897763	P06315	0	+	88897667	88897763	255,102,0	1	96	0	.	Framework-3. Pubmed:3925437
chr2	88897763	88897784	P06315	0	+	88897763	88897784	255,102,0	1	21	0	.	Complementarity-determining-3. Pubmed:3925437
chr2	88947321	88947417	P01602	0	-	88947321	88947417	255,102,0	1	96	0	.	Framework-3. Pubmed:6779204
chr2	88947417	88947438	P01602	0	-	88947417	88947438	255,102,0	1	21	0	.	Complementarity-determining-2. Pubmed:6779204
chr2	88947438	88947483	P01602	0	-	88947438	88947483	255,102,0	1	45	0	.	Framework-2. Pubmed:6779204
chr2	88947483	88947516	P01602	0	-	88947483	88947516	255,102,0	1	33	0	.	Complementarity-determining-1. Pubmed:6779204
chr2	88947516	88947585	P01602	0	-	88947516	88947585	255,102,0	1	69	0	.	Framework-1. Pubmed:6779204
chr2	89027170	89027191	P04433	0	-	89027170	89027191	255,102,0	1	21	0	.	Complementarity-determining-3. Pubmed:6440122
chr2	89027191	89027287	P04433	0	-	89027191	89027287	255,102,0	1	96	0	.	Framework-3. Pubmed:6440122
chr2	89027287	89027308	P04433	0	-	89027287	89027308	255,102,0	1	21	0	.	Complementarity-determining-2. Pubmed:6440122
chr2	89027308	89027353	P04433	0	-	89027308	89027353	255,102,0	1	45	0	.	Framework-2. Pubmed:6440122
chr2	89027353	89027386	P04433	0	-	89027353	89027386	255,102,0	1	33	0	.	Complementarity-determining-1. Pubmed:6440122
chr2	89027386	89027455	P04433	0	-	89027386	89027455	255,102,0	1	69	0	.	Framework-1. Pubmed:6440122
chr2	89085197	89085293	P01624	0	-	89085197	89085293	255,102,0	1	96	0	.	Framework-3. Pubmed:3083417
chr2	89085293	89085314	P01624	0	-	89085293	89085314	255,102,0	1	21	0	.	Complementarity-determining-2. Pubmed:3083417
chr2	89085314	89085359	P01624	0	-	89085314	89085359	255,102,0	1	45	0	.	Framework-2. Pubmed:3083417
chr2	89085359	89085392	P01624	0	-	89085359	89085392	255,102,0	1	33	0	.	Complementarity-determining-1. Pubmed:3083417
chr2	89085392	89085461	P01624	0	-	89085392	89085461	255,102,0	1	69	0	.	Framework-1. Pubmed:3083417
chr2	89099879	89099975	P04430	0	-	89099879	89099975	255,102,0	1	96	0	.	Framework-3.
chr2	89099975	89099996	P04430	0	-	89099975	89099996	255,102,0	1	21	0	.	Complementarity-determining-2.
chr2	89099996	89100041	P04430	0	-	89099996	89100041	255,102,0	1	45	0	.	Framework-2.
chr2	89100041	89100074	P04430	0	-	89100041	89100074	255,102,0	1	33	0	.	Complementarity-determining-1.
chr2	89100074	89100143	P04430	0	-	89100074	89100143	255,102,0	1	69	0	.	Framework-1.
chr2	89117362	89117458	P01599	0	-	89117362	89117458	255,102,0	1	96	0	.	Framework-3.
chr2	89117458	89117479	P01599	0	-	89117458	89117479	255,102,0	1	21	0	.	Complementarity-determining-2.
chr2	89117479	89117524	P01599	0	-	89117479	89117524	255,102,0	1	45	0	.	Framework-2.
chr2	89117524	89117557	P01599	0	-	89117524	89117557	255,102,0	1	33	0	.	Complementarity-determining-1.
chr2	89117557	89117626	P01599	0	-	89117557	89117626	255,102,0	1	69	0	.	Framework-1.
chr2	89142594	89142690	P01619	0	-	89142594	89142690	255,102,0	1	96	0	.	Framework-3. Pubmed:2997711
chr2	89142690	89142711	P01619	0	-	89142690	89142711	255,102,0	1	21	0	.	Complementarity-determining-2. Pubmed:2997711
chr2	89142711	89142756	P01619	0	-	89142711	89142756	255,102,0	1	45	0	.	Framework-2. Pubmed:2997711
chr2	89142756	89142792	P01619	0	-	89142756	89142792	255,102,0	1	36	0	.	Complementarity-determining-1. Pubmed:2997711
chr2	89142792	89142861	P01619	0	-	89142792	89142861	255,102,0	1	69	0	.	Framework-1. Pubmed:2997711
chr2	89221718	89221814	P01615	0	-	89221718	89221814	255,102,0	1	96	0	.	Framework-3. Pubmed:6325927
chr2	89221814	89221835	P01615	0	-	89221814	89221835	255,102,0	1	21	0	.	Complementarity-determining-2. Pubmed:6325927
chr2	89221835	89221880	P01615	0	-	89221835	89221880	255,102,0	1	45	0	.	Framework-2. Pubmed:6325927
chr2	89221880	89221928	P01615	0	-	89221880	89221928	255,102,0	1	48	0	.	Complementarity-determining-1. Pubmed:6325927
chr2	89221928	89221997	P01615	0	-	89221928	89221997	255,102,0	1	69	0	.	Framework-1. Pubmed:6325927
chr2	89244801	89244897	P06310	0	-	89244801	89244897	255,102,0	1	96	0	.	Framework-3. Pubmed:2997711
chr2	89244897	89244918	P06310	0	-	89244897	89244918	255,102,0	1	21	0	.	Complementarity-determining-2. Pubmed:2997711
chr2	89244918	89244963	P06310	0	-	89244918	89244963	255,102,0	1	45	0	.	Framework-2. Pubmed:2997711
chr2	89244963	89245011	P06310	0	-	89244963	89245011	255,102,0	1	48	0	.	Complementarity-determining-1. Pubmed:2997711
chr2	89245011	89245080	P06310	0	-	89245011	89245080	255,102,0	1	69	0	.	Framework-1. Pubmed:2997711
chr2	89268000	89268021	P01593	0	-	89268000	89268021	255,102,0	1	21	0	.	Complementarity-determining-3.
chr2	89268021	89268117	P01593	0	-	89268021	89268117	255,102,0	1	96	0	.	Framework-3.
chr2	89268021	89268117	P01594	0	-	89268021	89268117	255,102,0	1	96	0	.	Framework-3.
chr2	89268117	89268138	P01593	0	-	89268117	89268138	255,102,0	1	21	0	.	Complementarity-determining-2.
chr2	89268117	89268138	P01594	0	-	89268117	89268138	255,102,0	1	21	0	.	Complementarity-determining-2.
chr2	89268138	89268183	P01593	0	-	89268138	89268183	255,102,0	1	45	0	.	Framework-2.
chr2	89268138	89268183	P01594	0	-	89268138	89268183	255,102,0	1	45	0	.	Framework-2.
chr2	89268183	89268216	P01593	0	-	89268183	89268216	255,102,0	1	33	0	.	Complementarity-determining-1.
chr2	89268183	89268216	P01594	0	-	89268183	89268216	255,102,0	1	33	0	.	Complementarity-determining-1.
chr2	89268216	89268285	P01593	0	-	89268216	89268285	255,102,0	1	69	0	.	Framework-1.
chr2	89268216	89268285	P01594	0	-	89268216	89268285	255,102,0	1	69	0	.	Framework-1.
chr2	89319645	89319741	P01597	0	-	89319645	89319741	255,102,0	1	96	0	.	Framework-3. Pubmed:6091049
chr2	89319645	89319741	P04432	0	-	89319645	89319741	255,102,0	1	96	0	.	Framework-3. Pubmed:6091049
chr2	89319741	89319762	P01597	0	-	89319741	89319762	255,102,0	1	21	0	.	Complementarity-determining-2. Pubmed:6091049
chr2	89319741	89319762	P04432	0	-	89319741	89319762	255,102,0	1	21	0	.	Complementarity-determining-2. Pubmed:6091049
chr2	89319762	89319807	P01597	0	-	89319762	89319807	255,102,0	1	45	0	.	Framework-2. Pubmed:6091049
chr2	89319762	89319807	P04432	0	-	89319762	89319807	255,102,0	1	45	0	.	Framework-2. Pubmed:6091049
chr2	89319807	89319840	P01597	0	-	89319807	89319840	255,102,0	1	33	0	.	Complementarity-determining-1. Pubmed:6091049
chr2	89319807	89319840	P04432	0	-	89319807	89319840	255,102,0	1	33	0	.	Complementarity-determining-1. Pubmed:6091049
chr2	89319840	89319909	P01597	0	-	89319840	89319909	255,102,0	1	69	0	.	Framework-1. Pubmed:6091049
chr2	89319840	89319909	P04432	0	-	89319840	89319909	255,102,0	1	69	0	.	Framework-1. Pubmed:6091049
chr2	89862694	89862763	P01597	0	+	89862694	89862763	255,102,0	1	69	0	.	Framework-1. Pubmed:6091049
chr2	89862694	89862763	P04432	0	+	89862694	89862763	255,102,0	1	69	0	.	Framework-1. Pubmed:6091049
chr2	89862763	89862796	P01597	0	+	89862763	89862796	255,102,0	1	33	0	.	Complementarity-determining-1. Pubmed:6091049
chr2	89862763	89862796	P04432	0	+	89862763	89862796	255,102,0	1	33	0	.	Complementarity-determining-1. Pubmed:6091049
chr2	89862796	89862841	P01597	0	+	89862796	89862841	255,102,0	1	45	0	.	Framework-2. Pubmed:6091049
chr2	89862796	89862841	P04432	0	+	89862796	89862841	255,102,0	1	45	0	.	Framework-2. Pubmed:6091049
chr2	89862841	89862862	P01597	0	+	89862841	89862862	255,102,0	1	21	0	.	Complementarity-determining-2. Pubmed:6091049
chr2	89862841	89862862	P04432	0	+	89862841	89862862	255,102,0	1	21	0	.	Complementarity-determining-2. Pubmed:6091049
chr2	89862862	89862958	P01597	0	+	89862862	89862958	255,102,0	1	96	0	.	Framework-3. Pubmed:6091049
chr2	89862862	89862958	P04432	0	+	89862862	89862958	255,102,0	1	96	0	.	Framework-3. Pubmed:6091049
chr2	89914260	89914329	P01593	0	+	89914260	89914329	255,102,0	1	69	0	.	Framework-1.
chr2	89914260	89914329	P01594	0	+	89914260	89914329	255,102,0	1	69	0	.	Framework-1.
chr2	89914329	89914362	P01593	0	+	89914329	89914362	255,102,0	1	33	0	.	Complementarity-determining-1.
chr2	89914329	89914362	P01594	0	+	89914329	89914362	255,102,0	1	33	0	.	Complementarity-determining-1.
chr2	89914362	89914407	P01593	0	+	89914362	89914407	255,102,0	1	45	0	.	Framework-2.
chr2	89914362	89914407	P01594	0	+	89914362	89914407	255,102,0	1	45	0	.	Framework-2.
chr2	89914407	89914428	P01593	0	+	89914407	89914428	255,102,0	1	21	0	.	Complementarity-determining-2.
chr2	89914407	89914428	P01594	0	+	89914407	89914428	255,102,0	1	21	0	.	Complementarity-determining-2.
chr2	89914428	89914524	P01593	0	+	89914428	89914524	255,102,0	1	96	0	.	Framework-3.
chr2	89914428	89914524	P01594	0	+	89914428	89914524	255,102,0	1	96	0	.	Framework-3.
chr2	89914524	89914545	P01593	0	+	89914524	89914545	255,102,0	1	21	0	.	Complementarity-determining-3.
chr2	89960448	89960517	P01615	0	+	89960448	89960517	255,102,0	1	69	0	.	Framework-1. Pubmed:6325927
chr2	89960517	89960565	P01615	0	+	89960517	89960565	255,102,0	1	48	0	.	Complementarity-determining-1. Pubmed:6325927
chr2	89960565	89960610	P01615	0	+	89960565	89960610	255,102,0	1	45	0	.	Framework-2. Pubmed:6325927
chr2	89960610	89960631	P01615	0	+	89960610	89960631	255,102,0	1	21	0	.	Complementarity-determining-2. Pubmed:6325927
chr2	89960631	89960727	P01615	0	+	89960631	89960727	255,102,0	1	96	0	.	Framework-3. Pubmed:6325927
chr2	90100453	90100522	P01601	0	+	90100453	90100522	255,102,0	1	69	0	.	Framework-1. Pubmed:6779204
chr2	90100522	90100555	P01601	0	+	90100522	90100555	255,102,0	1	33	0	.	Complementarity-determining-1. Pubmed:6779204
chr2	90100555	90100600	P01601	0	+	90100555	90100600	255,102,0	1	45	0	.	Framework-2. Pubmed:6779204
chr2	90100600	90100621	P01601	0	+	90100600	90100621	255,102,0	1	21	0	.	Complementarity-determining-2. Pubmed:6779204
chr2	90100621	90100717	P01601	0	+	90100621	90100717	255,102,0	1	96	0	.	Framework-3. Pubmed:6779204
chr2	90160050	90160119	P01611	0	+	90160050	90160119	255,102,0	1	69	0	.	Framework-1.
chr2	90160119	90160152	P01611	0	+	90160119	90160152	255,102,0	1	33	0	.	Complementarity-determining-1.
chr2	90160152	90160197	P01611	0	+	90160152	90160197	255,102,0	1	45	0	.	Framework-2.
chr2	90160197	90160218	P01611	0	+	90160197	90160218	255,102,0	1	21	0	.	Complementarity-determining-2.
chr2	90160218	90160314	P01611	0	+	90160218	90160314	255,102,0	1	96	0	.	Framework-3.
chr2	95384004	95384046	Q9Y2W7	0	+	95384004	95384046	255,102,0	1	42	0	.	Interaction with KCND2.
chr2	96026735	96028038	Q6NUI2	0	-	96026735	96028038	255,102,0	1	1303	0	.	Acyltransferase.
chr2	96711659	96711668	Q9H0V9	0	-	96711659	96711668	255,102,0	1	9	0	.	Carbohydrate binding.
chr2	96733536	96733545	Q9H0V9	0	-	96733536	96733545	255,102,0	1	9	0	.	Carbohydrate binding.
chr2	96840270	96840324	Q86SG2	0	-	96840270	96840324	255,102,0	1	54	0	.	Interaction with TTN. Pubmed:14583192
chr2	96861870	96866405	Q9C0C4	0	-	96861870	96866405	255,102,0	1	4535	0	.	Dominant negative effect on myogenic differentiation.
chr2	97724342	97725175	P43403	0	+	97724342	97725175	255,102,0	1	833	0	.	Interdomain A.
chr2	97733184	97734641	P43403	0	+	97733184	97734641	255,102,0	1	1457	0	.	Interdomain B.
chr2	99018204	99020431	Q9BZW7	0	-	99018204	99020431	255,102,0	1	2227	0	.	Interaction with HIF1A.
chr2	99169431	99170628	Q8WV92	0	-	99169431	99170628	255,102,0	1	1197	0	.	Important for association with membranes.
chr2	99379087	99379111	O60841	0	+	99379087	99379111	255,102,0	1	24	0	.	G1.
chr2	99379353	99379368	O60841	0	+	99379353	99379368	255,102,0	1	15	0	.	G2.
chr2	99382200	99382212	O60841	0	+	99382200	99382212	255,102,0	1	12	0	.	G3.
chr2	99382915	99389723	O60841	0	+	99382915	99389723	255,102,0	1	6808	0	.	G4.
chr2	99390284	99390293	O60841	0	+	99390284	99390293	255,102,0	1	9	0	.	G5.
chr2	99401249	99402737	Q9UBZ9	0	-	99401249	99402737	255,102,0	1	1488	0	.	Protein interaction domain; mediates interaction with DNA polymerase zeta.
chr2	99412751	99412778	Q9UBZ9	0	-	99412751	99412778	255,102,0	1	27	0	.	Interaction with target DNA.
chr2	99412934	99412946	Q9UBZ9	0	-	99412934	99412946	255,102,0	1	12	0	.	Interaction with target DNA.
chr2	99438727	99438760	Q9UBZ9	0	-	99438727	99438760	255,102,0	1	33	0	.	Interaction with target DNA.
chr2	100569623	100576493	Q9H2J4	0	+	100569623	100576493	255,102,0	1	6870	0	.	Thioredoxin fold.
chr2	100904754	100932911	Q99743	0	+	100904754	100932911	255,102,0	1	28157	0	.	Sufficient for heterodimer formation with ARNTL/BMAL1, E-box binding and for the effect of NADPH.
chr2	101873700	101888935	O95819	0	+	101873700	101888935	255,102,0	1	15235	0	.	Mediates interaction with RAP2A. Pubmed:14966141
chr2	102026207	102026252	P27930	0	+	102026207	102026252	255,102,0	1	45	0	.	Contains proteolytic cleavage site.
chr2	102340809	102342245	Q01638	0	+	102340809	102342245	255,102,0	1	1436	0	.	Flexible linker.
chr2	108010621	108010858	Q9GZV3	0	+	108010621	108010858	255,102,0	1	237	0	.	Mediates interaction with SEC14L1.
chr2	108253385	108253394	Q6IMI6	0	+	108253385	108253394	255,102,0	1	9	0	.	Substrate binding.
chr2	108300878	108300887	O00338	0	+	108300878	108300887	255,102,0	1	9	0	.	Substrate binding.
chr2	108382425	108382434	O75897	0	+	108382425	108382434	255,102,0	1	9	0	.	Substrate binding.
chr2	108497046	108499609	Q8IWJ2	0	+	108497046	108499609	255,102,0	1	2563	0	.	Mediates interaction with RAB6A.
chr2	108497046	108507627	Q8IWJ2	0	+	108497046	108507627	255,102,0	1	10581	0	.	Mediates interaction with RAB9A.
chr2	108766977	108767400	P49792	0	+	108766977	108767400	255,102,0	1	423	0	.	Interaction with BICD2. Pubmed:20386726
chr2	108771741	108771756	P49792	0	+	108771741	108771756	255,102,0	1	15	0	.	Interaction with sumoylated RANGAP1.
chr2	108771747	108772523	P49792	0	+	108771747	108772523	255,102,0	1	776	0	.	Interaction with UBE2I.
chr2	108771747	108772884	P49792	0	+	108771747	108772884	255,102,0	1	1137	0	.	Required for E3 SUMO-ligase activity.
chr2	108771747	108773037	P49792	0	+	108771747	108773037	255,102,0	1	1290	0	.	2 X 50 AA approximate repeats.
chr2	108772523	108773037	P49792	0	+	108772523	108773037	255,102,0	1	514	0	.	Interaction with SUMO1. Pubmed:15608651
chr2	110658497	110658647	O43683	0	-	110658497	110658647	255,102,0	1	150	0	.	Essential for loading of BUBR1, MAD1L1 and MAD2L1 to kinetochores.
chr2	110667557	110667641	O43683	0	-	110667557	110667641	255,102,0	1	84	0	.	Necessary for interaction with BUB3.
chr2	110670552	110677995	O43683	0	-	110670552	110677995	255,102,0	1	7443	0	.	Necessary for kinetochore localization.
chr2	110672686	110672788	O43683	0	-	110672686	110672788	255,102,0	1	102	0	.	Necessary for interaction with KNL1. Pubmed:17981135
chr2	112660426	112660453	Q8WUM9	0	+	112660426	112660453	255,102,0	1	27	0	.	A.
chr2	114442778	115309346	Q8N608	0	+	114442778	115309346	255,102,0	1	866568	0	.	Mediates effects on KCND2.
chr2	117920345	117945537	Q567U6	0	-	117920345	117945537	255,102,0	1	25192	0	.	Sufficient for interaction with WASHC2C. Pubmed:25355947
chr2	117946816	118013995	Q567U6	0	-	117946816	118013995	255,102,0	1	67179	0	.	Sufficient for interaction with CCDC22. Pubmed:25355947
chr2	119368262	119368277	P07108	0	+	119368262	119368277	255,102,0	1	15	0	.	Acyl-CoA binding.
chr2	119615697	119625675	Q4G0U5	0	+	119615697	119625675	255,102,0	1	9978	0	.	Interaction with calmodulin.
chr2	119965640	119967852	A0A024RAE8	0	+	119965640	119967852	255,102,0	1	2212	0	.	Substrate binding.
chr2	119965640	119967852	P29074	0	+	119965640	119967852	255,102,0	1	2212	0	.	Substrate binding.
chr2	121281177	121285109	Q9NZI6	0	-	121281177	121285109	255,102,0	1	3932	0	.	Mediate transcriptional repression.
chr2	121340863	121367708	Q7Z460	0	-	121340863	121367708	255,102,0	1	26845	0	.	Localization to kinetochores.
chr2	121340863	121367714	Q7Z460	0	-	121340863	121367714	255,102,0	1	26851	0	.	Interaction with CLIP2.
chr2	121340863	121367714	Q7Z460	0	-	121340863	121367714	255,102,0	1	26851	0	.	Interaction with PHLDB2 and RSN. Pubmed:16824950
chr2	121410934	121430106	Q7Z460	0	-	121410934	121430106	255,102,0	1	19172	0	.	Interaction with microtubules, MAPRE1 and MAPRE3. Pubmed:15631994
chr2	121727798	121728305	Q9BYG3	0	-	121727798	121728305	255,102,0	1	507	0	.	Interaction with MKI67.
chr2	121758804	121761421	Q15631	0	+	121758804	121761421	255,102,0	1	2617	0	.	DNA/RNA binding.
chr2	121765208	121765274	Q15631	0	+	121765208	121765274	255,102,0	1	66	0	.	Leucine-zipper.
chr2	127053421	127054012	O00499	0	-	127053421	127054012	255,102,0	1	591	0	.	Clathrin-binding.
chr2	127070039	127106940	O00499	0	-	127070039	127106940	255,102,0	1	36901	0	.	Interaction with BIN2. Pubmed:10903846
chr2	127481046	127496147	Q96ST2	0	-	127481046	127496147	255,102,0	1	15101	0	.	Interaction with SUPT6H and ALYREF. Pubmed:17234882
chr2	127505014	127505200	Q96ST2	0	-	127505014	127505200	255,102,0	1	186	0	.	3 X approximate tandem repeats.
chr2	127608809	127629724	Q6PIF6	0	+	127608809	127629724	255,102,0	1	20915	0	.	Mediates interaction with ANKS4B. Pubmed:24725409
chr2	127628489	127637414	Q6PIF6	0	+	127628489	127637414	255,102,0	1	8925	0	.	Mediates interaction with CDHR2, CDHR5 and USH1C. Pubmed:26812017, Pubmed:24725409
chr2	127942011	127950298	Q9H0E3	0	-	127942011	127950298	255,102,0	1	8287	0	.	Interactions with SIN3A and HDAC1.
chr2	128178483	128189739	Q9NYU2	0	+	128178483	128189739	255,102,0	1	11256	0	.	Glucosyltransferase.
chr2	128268818	128268845	O60243	0	-	128268818	128268845	255,102,0	1	27	0	.	3'-phosphate binding.
chr2	128318257	128318278	O60243	0	-	128318257	128318278	255,102,0	1	21	0	.	5'-phosphosulfate-binding.
chr2	129980115	129980637	Q9H0N0	0	+	129980115	129980637	255,102,0	1	522	0	.	Required for centrosome localization.
chr2	130074246	130075368	A5A3E0	0	-	130074246	130075368	255,102,0	1	1122	0	.	Actin-like.
chr2	130370185	130370572	Q99952	0	+	130370185	130370572	255,102,0	1	387	0	.	Substrate binding.
chr2	130462818	130463937	P0CG38	0	-	130462818	130463937	255,102,0	1	1119	0	.	Actin-like.
chr2	130656755	130657874	P0CG39	0	+	130656755	130657874	255,102,0	1	1119	0	.	Actin-like.
chr2	130931173	130946586	Q9NR80	0	+	130931173	130946586	255,102,0	1	15413	0	.	ABR (APC-binding region) domain.
chr2	131263558	131264680	Q6S8J3	0	+	131263558	131264680	255,102,0	1	1122	0	.	Actin-like.
chr2	134918854	134953355	O60583	0	+	134918854	134953355	255,102,0	1	34501	0	.	Interaction with MDFIC and MDFI. Pubmed:17289077
chr2	134952684	134953355	O60583	0	+	134952684	134953355	255,102,0	1	671	0	.	Interaction with POLR2A. Pubmed:15563843
chr2	135200344	135202942	Q5FWF4	0	-	135200344	135202942	255,102,0	1	2598	0	.	Endonuclease activity.
chr2	135265629	135504354	Q5FWF4	0	-	135265629	135504354	255,102,0	1	238725	0	.	DNA annealing helicase activity.
chr2	135741929	135761909	Q92575	0	+	135741929	135761909	255,102,0	1	19980	0	.	Interaction with UBQLN1. Pubmed:19822669
chr2	135789610	135836911	P09848	0	-	135789610	135836911	255,102,0	1	47301	0	.	4 X approximate repeats.
chr2	135911478	135911493	P14868	0	-	135911478	135911493	255,102,0	1	15	0	.	Binding site for the 3'-end of tRNA.
chr2	135922832	135922844	P14868	0	-	135922832	135922844	255,102,0	1	12	0	.	Aspartate.
chr2	136115123	136115132	P61073	0	-	136115123	136115132	255,102,0	1	9	0	.	Involved in dimerization.
chr2	136115297	136115357	P61073	0	-	136115297	136115357	255,102,0	1	60	0	.	Involved in dimerization.
chr2	136115357	136115372	P61073	0	-	136115357	136115372	255,102,0	1	15	0	.	Chemokine binding, important for signaling and HIV-1 coreceptor activity.
chr2	136115486	136115525	P61073	0	-	136115486	136115525	255,102,0	1	39	0	.	Involved in dimerization; when bound to chemokine.
chr2	136115576	136115591	P61073	0	-	136115576	136115591	255,102,0	1	15	0	.	Chemokine binding.
chr2	136115636	136115648	P61073	0	-	136115636	136115648	255,102,0	1	12	0	.	Chemokine binding.
chr2	136115864	136118060	P61073	0	-	136115864	136118060	255,102,0	1	2196	0	.	Important for chemokine binding, signaling and HIV-1 coreceptor activity.
chr2	138670924	138671182	O95156	0	-	138670924	138671182	255,102,0	1	258	0	.	V (Cys-rich).
chr2	138671182	138671209	O95156	0	-	138671182	138671209	255,102,0	1	27	0	.	IV (linker domain).
chr2	138671209	138671446	O95156	0	-	138671209	138671446	255,102,0	1	237	0	.	III.
chr2	138671446	138671650	O95156	0	-	138671446	138671650	255,102,0	1	204	0	.	II.
chr2	142956259	142956271	Q16719	0	+	142956259	142956271	255,102,0	1	12	0	.	Pyridoxal phosphate binding.
chr2	144399725	144399878	O60315	0	-	144399725	144399878	255,102,0	1	153	0	.	SMAD-MH2 binding domain.
chr2	148942690	148950439	O60282	0	+	148942690	148950439	255,102,0	1	7749	0	.	Microtubule-binding.
chr2	149010158	149011670	O60282	0	+	149010158	149011670	255,102,0	1	1512	0	.	Globular.
chr2	151465289	151475068	Q5UIP0	0	+	151465289	151475068	255,102,0	1	9779	0	.	Interaction with condensed chromosomes in telophase.
chr2	151489970	151492218	P20929	0	-	151489970	151492218	255,102,0	1	2248	0	.	Interaction with SVIL. Pubmed:18639526
chr2	152126300	152132139	O75886	0	-	152126300	152132139	255,102,0	1	5839	0	.	Interaction with HGS.
chr2	152143870	152143876	O75886	0	-	152143870	152143876	255,102,0	1	6	0	.	Interaction with USP8.
chr2	154242057	154242891	Q8IUC8	0	+	154242057	154242891	255,102,0	1	834	0	.	Catalytic subdomain A.
chr2	154245974	154301471	Q8IUC8	0	+	154245974	154301471	255,102,0	1	55497	0	.	Catalytic subdomain B.
chr2	156326312	156326854	P43354	0	-	156326312	156326854	255,102,0	1	542	0	.	Ligand-binding.
chr2	157284309	157295733	Q7Z7M9	0	+	157284309	157295733	255,102,0	1	11424	0	.	Catalytic subdomain A.
chr2	157296505	157300738	Q7Z7M9	0	+	157296505	157300738	255,102,0	1	4233	0	.	Catalytic subdomain B.
chr2	157321273	157321333	Q8TAM6	0	-	157321273	157321333	255,102,0	1	60	0	.	Binds actin.
chr2	157418571	157427401	O60759	0	-	157418571	157427401	255,102,0	1	8830	0	.	Interaction with CYTH1.
chr2	160101828	160107756	P18564	0	-	160101828	160107756	255,102,0	1	5928	0	.	Interaction with HAX1. Pubmed:17545607
chr2	160126404	160137728	P18564	0	-	160126404	160137728	255,102,0	1	11324	0	.	Cysteine-rich tandem repeats.
chr2	161179662	161179755	Q92844	0	+	161179662	161179755	255,102,0	1	93	0	.	Necessary for interaction with ZC3H12A. Pubmed:25861989
chr2	161204673	161231023	Q92844	0	+	161204673	161231023	255,102,0	1	26350	0	.	Necessary for interaction with TRAF6. Pubmed:25861989
chr2	161223983	161224742	Q92844	0	+	161223983	161224742	255,102,0	1	759	0	.	Interaction with TBK1 and IKBKE.
chr2	161224739	161231023	Q92844	0	+	161224739	161231023	255,102,0	1	6284	0	.	TRAF family member interaction.
chr2	165757184	165759343	Q14435	0	-	165757184	165759343	255,102,0	1	2159	0	.	Catalytic subdomain B.
chr2	165759529	165765022	Q14435	0	-	165759529	165765022	255,102,0	1	5493	0	.	Catalytic subdomain A.
chr2	165992366	165992420	P35498	0	-	165992366	165992420	255,102,0	1	54	0	.	S3b-S4 loop of repeat IV.
chr2	165994284	165994317	P35498	0	-	165994284	165994317	255,102,0	1	33	0	.	S1-S2 loop of repeat IV.
chr2	168871433	168876090	Q9HBM1	0	-	168871433	168876090	255,102,0	1	4657	0	.	Interaction with the C-terminus of SPBC24.
chr2	168876090	168889519	Q9HBM1	0	-	168876090	168889519	255,102,0	1	13429	0	.	Interaction with the N-terminus of SPBC24.
chr2	168888425	168893079	Q9HBM1	0	-	168888425	168893079	255,102,0	1	4654	0	.	Interaction with the C-terminus of SPBC24.
chr2	168889256	168889519	Q9HBM1	0	-	168889256	168889519	255,102,0	1	263	0	.	Interaction with the NDC80-NUF2 subcomplex.
chr2	168893079	168906508	Q9HBM1	0	-	168893079	168906508	255,102,0	1	13429	0	.	Interaction with the N-terminus of SPBC24.
chr2	168906245	168906508	Q9HBM1	0	-	168906245	168906508	255,102,0	1	263	0	.	Interaction with the NDC80-NUF2 subcomplex.
chr2	168968485	168969410	O95342	0	-	168968485	168969410	255,102,0	1	925	0	.	Interaction with HAX1.
chr2	169128824	169129048	P98164	0	-	169128824	169129048	255,102,0	1	224	0	.	Interaction with DAB2.
chr2	170836812	170836821	Q99259	0	+	170836812	170836821	255,102,0	1	9	0	.	Substrate binding.
chr2	170954662	170954680	Q9H8Y8	0	+	170954662	170954680	255,102,0	1	18	0	.	Important for membrane binding.
chr2	172498097	172504108	P23229	0	+	172498097	172504108	255,102,0	1	6011	0	.	Interaction with HPS5.
chr2	173217121	173217187	Q9NYL2	0	+	173217121	173217187	255,102,0	1	66	0	.	Leucine-zipper.
chr2	173363868	173364842	Q9BWT1	0	+	173363868	173364842	255,102,0	1	974	0	.	Interaction with MYC. Pubmed:23166294
chr2	173365532	173367661	Q9BWT1	0	+	173365532	173367661	255,102,0	1	2129	0	.	Mediates transcriptional activity.
chr2	173913238	173954912	Q02447	0	-	173913238	173954912	255,102,0	1	41674	0	.	Repressor domain.
chr2	173955014	173955464	Q02447	0	-	173955014	173955464	255,102,0	1	450	0	.	Transactivation domain (Gln-rich).
chr2	173955800	173956100	Q02447	0	-	173955800	173956100	255,102,0	1	300	0	.	Transactivation domain (Gln-rich).
chr2	174349153	174350727	Q86X95	0	-	174349153	174350727	255,102,0	1	1574	0	.	Interaction with RP9.
chr2	174380204	174395622	Q86X95	0	-	174380204	174395622	255,102,0	1	15418	0	.	Interaction with RBPJ. Pubmed:9874765
chr2	174581346	174581358	O43516	0	-	174581346	174581358	255,102,0	1	12	0	.	Binds actin.
chr2	175080726	175093108	P15336	0	-	175080726	175093108	255,102,0	1	12382	0	.	Leucine-zipper.
chr2	175093123	175093186	P15336	0	-	175093123	175093186	255,102,0	1	63	0	.	Basic motif.
chr2	175097524	175097536	P15336	0	-	175097524	175097536	255,102,0	1	12	0	.	Essential for its histone acetyltransferase activity.
chr2	177230814	177230832	Q16236	0	-	177230814	177230832	255,102,0	1	18	0	.	Mediates interaction with CHD6 and is necessary to activate transcription.
chr2	177231015	177231039	Q16236	0	-	177231015	177231039	255,102,0	1	24	0	.	Leucine-zipper.
chr2	177231048	177231108	Q16236	0	-	177231048	177231108	255,102,0	1	60	0	.	Basic motif.
chr2	177523792	177523801	O00116	0	+	177523792	177523801	255,102,0	1	9	0	.	Important for enzyme activity.
chr2	177629493	177728043	Q9HCR9	0	-	177629493	177728043	255,102,0	1	98550	0	.	Catalytic.
chr2	178432099	178441636	O75569	0	-	178432099	178441636	255,102,0	1	9537	0	.	Sufficient for self-association and interaction with TARBP2.
chr2	178441633	178447518	O75569	0	-	178441633	178447518	255,102,0	1	5885	0	.	Sufficient for self-association and interaction with TARBP2.
chr2	178447512	178451030	O75569	0	-	178447512	178451030	255,102,0	1	3518	0	.	Sufficient for self-association and interaction with TARBP2.
chr2	178777863	178777956	Q8WZ42	0	-	178777863	178777956	255,102,0	1	93	0	.	ZIS5.
chr2	178795143	178799644	Q8WZ42	0	-	178795143	178799644	255,102,0	1	4501	0	.	ZIS1.
chr2	179443252	179544943	Q569K4	0	-	179443252	179544943	255,102,0	1	101691	0	.	Interaction with p53/TP53. Pubmed:22945289
chr2	179544943	179769755	Q569K4	0	-	179544943	179769755	255,102,0	1	224812	0	.	Required for induction of apoptosis.
chr2	182185910	182231020	P54750	0	-	182185910	182231020	255,102,0	1	45110	0	.	Catalytic.
chr2	182264383	182522307	P54750	0	-	182264383	182522307	255,102,0	1	257924	0	.	Calmodulin-binding.
chr2	182729916	182740361	Q8IXB1	0	+	182729916	182740361	255,102,0	1	10445	0	.	Trxb 1.
chr2	182740352	182751740	Q8IXB1	0	+	182740352	182751740	255,102,0	1	11388	0	.	Trxb 2.
chr2	186504202	186505513	Q8WU90	0	+	186504202	186505513	255,102,0	1	1311	0	.	Required for interaction with DRG1.
chr2	188985775	188987112	P02461	0	+	188985775	188987112	255,102,0	1	1337	0	.	Nonhelical region (N-terminal).
chr2	188987112	189008986	P02461	0	+	188987112	189008986	255,102,0	1	21874	0	.	Triple-helical region.
chr2	189008986	189009013	P02461	0	+	189008986	189009013	255,102,0	1	27	0	.	Nonhelical region (C-terminal).
chr2	189752952	189752958	Q9H4B0	0	-	189752952	189752958	255,102,0	1	6	0	.	Substrate binding.
chr2	189755262	189755277	Q9H4B0	0	-	189755262	189755277	255,102,0	1	15	0	.	Substrate binding.
chr2	190200025	190200082	Q9BSF0	0	+	190200025	190200082	255,102,0	1	57	0	.	PKA-RI-binding.
chr2	190366891	190369110	P49441	0	+	190366891	190369110	255,102,0	1	2219	0	.	Substrate binding.
chr2	190659185	190659422	Q13506	0	+	190659185	190659422	255,102,0	1	237	0	.	NCD1.
chr2	190659836	190670436	Q13506	0	+	190659836	190670436	255,102,0	1	10600	0	.	NCD2.
chr2	190670424	190683746	Q13506	0	+	190670424	190683746	255,102,0	1	13322	0	.	Necessary for nuclear localization.
chr2	191953746	191953800	Q9UIK5	0	-	191953746	191953800	255,102,0	1	54	0	.	Required for shedding.
chr2	195787027	195799460	Q8WXX0	0	-	195787027	195799460	255,102,0	1	12433	0	.	AAA 6.
chr2	195816836	195845087	Q8WXX0	0	-	195816836	195845087	255,102,0	1	28251	0	.	AAA 5.
chr2	195853504	195861739	Q8WXX0	0	-	195853504	195861739	255,102,0	1	8235	0	.	Stalk.
chr2	195861787	195864751	Q8WXX0	0	-	195861787	195864751	255,102,0	1	2964	0	.	AAA 4.
chr2	195872315	195881944	Q8WXX0	0	-	195872315	195881944	255,102,0	1	9629	0	.	AAA 3.
chr2	195888257	195895161	Q8WXX0	0	-	195888257	195895161	255,102,0	1	6904	0	.	AAA 2.
chr2	195900296	195922155	Q8WXX0	0	-	195900296	195922155	255,102,0	1	21859	0	.	AAA 1.
chr2	195922155	196068711	Q8WXX0	0	-	195922155	196068711	255,102,0	1	146556	0	.	Stem.
chr2	196274054	196318681	Q9P2P5	0	-	196274054	196318681	255,102,0	1	44627	0	.	Interaction with TP73. Pubmed:12890487
chr2	197403599	197403719	O75533	0	-	197403599	197403719	255,102,0	1	120	0	.	Interaction with SF3B14.
chr2	197405141	197410007	O75533	0	-	197405141	197410007	255,102,0	1	4866	0	.	Interaction with PPP1R8. Pubmed:12105215
chr2	197408459	197416839	O75533	0	-	197408459	197416839	255,102,0	1	8380	0	.	U2AF homology region; mediates interaction with RBM39. Pubmed:24795046
chr2	198083763	198084183	Q15111	0	+	198083763	198084183	255,102,0	1	420	0	.	Interaction with PPP1C.
chr2	198085143	198085218	Q15111	0	+	198085143	198085218	255,102,0	1	75	0	.	Interaction with GABA A beta subunit.
chr2	200897078	200903675	Q9GZT8	0	+	200897078	200903675	255,102,0	1	6597	0	.	Mediates interaction with COPS2.
chr2	201129865	201140418	O15519	0	+	201129865	201140418	255,102,0	1	10553	0	.	Interaction with caspase-8.
chr2	201129865	201149022	O15519	0	+	201129865	201149022	255,102,0	1	19157	0	.	Interaction with FADD.
chr2	201129865	201160553	O15519	0	+	201129865	201160553	255,102,0	1	30688	0	.	Interaction with caspase-8 propeptide.
chr2	201129865	201160943	O15519	0	+	201129865	201160943	255,102,0	1	31078	0	.	Not proteolytically processed and involved in apoptosis inhibition.
chr2	201140406	201160943	O15519	0	+	201140406	201160943	255,102,0	1	20537	0	.	Interaction with caspase-3.
chr2	201140406	201163970	O15519	0	+	201140406	201163970	255,102,0	1	23564	0	.	Interaction with TRAF1 and TRAF2.
chr2	201145419	201163970	O15519	0	+	201145419	201163970	255,102,0	1	18551	0	.	Interaction with caspase-8 subunits p18 and p10.
chr2	201149828	201160712	O15519	0	+	201149828	201160712	255,102,0	1	10884	0	.	Caspase.
chr2	201160745	201163970	O15519	0	+	201160745	201163970	255,102,0	1	3225	0	.	Interaction with caspase-8.
chr2	201387871	201392947	O60296	0	-	201387871	201392947	255,102,0	1	5076	0	.	Interaction with HGS.
chr2	202880862	202899577	Q9GZL7	0	-	202880862	202899577	255,102,0	1	18715	0	.	Sufficient for nucleolar localization.
chr2	203870611	203870626	P16410	0	+	203870611	203870626	255,102,0	1	15	0	.	Homodimerization.
chr2	203870923	203871385	P16410	0	+	203870923	203871385	255,102,0	1	462	0	.	Homodimerization.
chr2	206573144	206573162	O75077	0	+	206573144	206573162	255,102,0	1	18	0	.	May bind the integrin receptor.
chr2	207577623	207596959	P16220	0	+	207577623	207596959	255,102,0	1	19336	0	.	Basic motif.
chr2	207596962	207597028	P16220	0	+	207596962	207597028	255,102,0	1	66	0	.	Leucine-zipper.
chr2	207621839	207621848	Q8WXB1	0	-	207621839	207621848	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr2	208121936	208124114	P07320	0	-	208121936	208124114	255,102,0	1	2178	0	.	Connecting peptide.
chr2	208128466	208129443	P07315	0	-	208128466	208129443	255,102,0	1	977	0	.	Connecting peptide.
chr2	208142901	208145776	P07316	0	-	208142901	208145776	255,102,0	1	2875	0	.	Connecting peptide.
chr2	208161067	208163206	P11844	0	-	208161067	208163206	255,102,0	1	2139	0	.	Connecting peptide.
chr2	208248482	208248503	O75874	0	-	208248482	208248503	255,102,0	1	21	0	.	Substrate binding.
chr2	208248482	208248503	V9HWJ2	0	-	208248482	208248503	255,102,0	1	21	0	.	Substrate binding.
chr2	208350859	208355302	Q9Y2I7	0	+	208350859	208355302	255,102,0	1	4443	0	.	Catalytic.
chr2	209696699	209696930	P11137	0	+	209696699	209696930	255,102,0	1	231	0	.	Calmodulin-binding.
chr2	210016599	210016611	C9IZU8	0	+	210016599	210016611	255,102,0	1	12	0	.	Substrate binding.
chr2	210016599	210016611	C9J9T0	0	+	210016599	210016611	255,102,0	1	12	0	.	Substrate binding.
chr2	210016599	210016611	Q96AT9	0	+	210016599	210016611	255,102,0	1	12	0	.	Substrate binding.
chr2	210019692	210019698	Q96AT9	0	+	210019692	210019698	255,102,0	1	6	0	.	Substrate binding.
chr2	210435408	210435420	O43813	0	-	210435408	210435420	255,102,0	1	12	0	.	Glutathione binding.
chr2	210556847	210588090	P31327	0	+	210556847	210588090	255,102,0	1	31243	0	.	Anthranilate phosphoribosyltransferase homolog.
chr2	214752449	214752464	Q99728	0	-	214752449	214752464	255,102,0	1	15	0	.	Flexible linker.
chr2	214792303	214809494	Q99728	0	-	214792303	214809494	255,102,0	1	17191	0	.	Interaction with BRCA1.
chr2	215326908	215326914	P31939	0	+	215326908	215326914	255,102,0	1	6	0	.	AICAR binding.
chr2	215362046	215367992	P02751	0	-	215362046	215367992	255,102,0	1	5946	0	.	Fibrin-binding 2.
chr2	215372043	215372376	P02751	0	-	215372043	215372376	255,102,0	1	333	0	.	Connecting strand 3 (CS-3) (V region).
chr2	215373322	215376675	P02751	0	-	215373322	215376675	255,102,0	1	3353	0	.	Binds to FBLN1.
chr2	215373322	215379318	P02751	0	-	215373322	215379318	255,102,0	1	5996	0	.	Heparin-binding 2.
chr2	215384020	215391812	P02751	0	-	215384020	215391812	255,102,0	1	7792	0	.	Cell-attachment.
chr2	215414953	215425208	P02751	0	-	215414953	215425208	255,102,0	1	10255	0	.	Collagen-binding.
chr2	215422205	215423353	P02751	0	-	215422205	215423353	255,102,0	1	1148	0	.	Critical for collagen binding.
chr2	215428207	215434819	P02751	0	-	215428207	215434819	255,102,0	1	6612	0	.	Fibrin- and heparin-binding 1.
chr2	216119085	216122065	P13010	0	+	216119085	216122065	255,102,0	1	2980	0	.	Leucine-zipper.
chr2	216414707	216414794	Q9NZC9	0	+	216414707	216414794	255,102,0	1	87	0	.	Mediates interaction with RPA2.
chr2	218344456	218344465	Q8N490	0	+	218344456	218344465	255,102,0	1	9	0	.	Substrate binding.
chr2	218344948	218344960	Q8N490	0	+	218344948	218344960	255,102,0	1	12	0	.	Substrate binding.
chr2	218423781	218427995	P09327	0	+	218423781	218427995	255,102,0	1	4214	0	.	Necessary for homodimerization.
chr2	218423781	218438699	P09327	0	+	218423781	218438699	255,102,0	1	14918	0	.	Core.
chr2	218425797	218427974	P09327	0	+	218425797	218427974	255,102,0	1	2177	0	.	LPA/PIP2-binding site 1.
chr2	218428028	218428055	P09327	0	+	218428028	218428055	255,102,0	1	27	0	.	LPA/PIP2-binding site 2.
chr2	218438699	218449333	P09327	0	+	218438699	218449333	255,102,0	1	10634	0	.	Headpiece.
chr2	218449297	218449324	P09327	0	+	218449297	218449324	255,102,0	1	27	0	.	LPA/PIP2-binding site 3.
chr2	218615956	218616040	Q9BRC7	0	+	218615956	218616040	255,102,0	1	84	0	.	Substrate binding.
chr2	218750024	218752873	Q14679	0	+	218750024	218752873	255,102,0	1	2849	0	.	c-MTBD region. Pubmed:25959773
chr2	218814152	218814389	Q02318	0	+	218814152	218814389	255,102,0	1	237	0	.	Sterol-binding.
chr2	218981669	218981999	Q99581	0	-	218981669	218981999	255,102,0	1	330	0	.	May mediate active transcriptional repression.
chr2	218990982	218992107	P53672	0	-	218990982	218992107	255,102,0	1	1125	0	.	Connecting peptide.
chr2	218993143	218993176	P53672	0	-	218993143	218993176	255,102,0	1	33	0	.	N-terminal arm.
chr2	219147780	219158362	Q9H9Q4	0	-	219147780	219158362	255,102,0	1	10582	0	.	Globular head.
chr2	219208024	219208274	Q8WV99	0	+	219208024	219208274	255,102,0	1	250	0	.	VCP/p97-interacting motif (VIM). Pubmed:21896481
chr2	219235863	219236036	Q9H8Y5	0	+	219235863	219236036	255,102,0	1	173	0	.	VCP/p97-interacting motif (VIM). Pubmed:21896481
chr2	219247469	219247706	O75716	0	+	219247469	219247706	255,102,0	1	237	0	.	Activation loop.
chr2	219297024	219297971	Q16849	0	-	219297024	219297971	255,102,0	1	947	0	.	Sufficient for dimerization of proICA512.
chr2	219298046	219300076	Q16849	0	-	219298046	219300076	255,102,0	1	2030	0	.	Sufficient for dimerization of proICA512. Pubmed:25561468
chr2	219302821	219309230	Q16849	0	-	219302821	219309230	255,102,0	1	6409	0	.	RESP18 homology domain.
chr2	219418462	219418786	P17661	0	+	219418462	219418786	255,102,0	1	324	0	.	Head.
chr2	219418786	219418885	P17661	0	+	219418786	219418885	255,102,0	1	99	0	.	Coil 1A.
chr2	219418786	219421552	P17661	0	+	219418786	219421552	255,102,0	1	2766	0	.	Rod.
chr2	219418885	219418915	P17661	0	+	219418885	219418915	255,102,0	1	30	0	.	Linker 1.
chr2	219418915	219420515	P17661	0	+	219418915	219420515	255,102,0	1	1600	0	.	Coil 1B.
chr2	219420515	219420563	P17661	0	+	219420515	219420563	255,102,0	1	48	0	.	Linker 12.
chr2	219420563	219420620	P17661	0	+	219420563	219420620	255,102,0	1	57	0	.	Coil 2A.
chr2	219420620	219420644	P17661	0	+	219420620	219420644	255,102,0	1	24	0	.	Linker 2.
chr2	219420644	219421552	P17661	0	+	219420644	219421552	255,102,0	1	908	0	.	Coil 2B.
chr2	219421552	219425987	P17661	0	+	219421552	219425987	255,102,0	1	4435	0	.	Tail.
chr2	219570950	219570980	O75147	0	-	219570950	219570980	255,102,0	1	30	0	.	Interaction with TTN.
chr2	219571175	219571184	O75147	0	-	219571175	219571184	255,102,0	1	9	0	.	Interaction with TTN.
chr2	219635824	219641725	P48751	0	+	219635824	219641725	255,102,0	1	5901	0	.	Membrane (anion exchange).
chr2	223598682	223598739	P13521	0	-	223598682	223598739	255,102,0	1	57	0	.	O-glycosylated at one site.
chr2	225513596	225513632	Q9P242	0	+	225513596	225513632	255,102,0	1	36	0	.	Involved in CYFIP1- and NCKAP1-binding.
chr2	226732535	226732544	P35568	0	-	226732535	226732544	255,102,0	1	9	0	.	GRB2-binding.
chr2	226734818	226735223	P35568	0	-	226734818	226735223	255,102,0	1	405	0	.	Mediates interaction with PHIP.
chr2	226914299	226914347	Q8TEB9	0	+	226914299	226914347	255,102,0	1	48	0	.	Ubiquitin-binding domain (UBD).
chr2	226995474	226995519	Q8TEB9	0	+	226995474	226995519	255,102,0	1	45	0	.	VCP/p97-interacting motif (VIM).
chr2	227010457	227121148	P53420	0	-	227010457	227121148	255,102,0	1	110691	0	.	Triple-helical region.
chr2	227140160	227140238	P53420	0	-	227140160	227140238	255,102,0	1	78	0	.	7S domain.
chr2	227164810	227238006	Q01955	0	+	227164810	227238006	255,102,0	1	73196	0	.	7S domain.
chr2	227238006	227307771	Q01955	0	+	227238006	227307771	255,102,0	1	69765	0	.	Triple-helical region.
chr2	227307735	227307789	Q01955	0	+	227307735	227307789	255,102,0	1	54	0	.	Epitope recognized by Goodpasture antibodies.
chr2	227307891	227309234	Q01955	0	+	227307891	227309234	255,102,0	1	1343	0	.	Required for the anti-angiogenic activity of tumstatin.
chr2	227310847	227310904	Q01955	0	+	227310847	227310904	255,102,0	1	57	0	.	Required for the anti-tumor cell activity of tumstatin.
chr2	228018015	228018069	Q2M3C7	0	-	228018015	228018069	255,102,0	1	54	0	.	PKA-RII subunit binding domain.
chr2	229366934	229366946	Q8NFT8	0	-	229366934	229366946	255,102,0	1	12	0	.	Interaction with AP1G1 and somatodendritic targeting.
chr2	229591765	229714294	Q8NFT8	0	-	229591765	229714294	255,102,0	1	122529	0	.	Interaction with NOTCH1.
chr2	229787564	229788925	Q14669	0	-	229787564	229788925	255,102,0	1	1361	0	.	K-box.
chr2	230177540	230177555	Q9HB58	0	-	230177540	230177555	255,102,0	1	15	0	.	Nuclear hormone receptor interaction.
chr2	230462457	230473328	P23497	0	+	230462457	230473328	255,102,0	1	10871	0	.	Sufficient to mediate interaction with ETS1.
chr2	231108939	231108954	P41595	0	-	231108939	231108954	255,102,0	1	15	0	.	Agonist binding.
chr2	231113861	231113879	P41595	0	-	231113861	231113879	255,102,0	1	18	0	.	Agonist binding.
chr2	231461747	231461981	P19338	0	-	231461747	231461981	255,102,0	1	234	0	.	8 X 8 AA tandem repeats of X-T-P-X-K-K-X-X.
chr2	231732954	231732975	O43924	0	-	231732954	231732975	255,102,0	1	21	0	.	Required for association with membranes. Pubmed:9712853
chr2	232557907	232557919	O60573	0	+	232557907	232557919	255,102,0	1	12	0	.	EIF4EBP1/2/3 binding.
chr2	232557979	232557985	O60573	0	+	232557979	232557985	255,102,0	1	6	0	.	7-methylguanosine-containing mRNA cap binding.
chr2	232564258	232564273	O60573	0	+	232564258	232564273	255,102,0	1	15	0	.	EIF4EBP1/2/3 binding.
chr2	232564345	232564351	O60573	0	+	232564345	232564351	255,102,0	1	6	0	.	7-methylguanosine-containing mRNA cap binding.
chr2	232566900	232566924	O60573	0	+	232566900	232566924	255,102,0	1	24	0	.	EIF4EBP1/2/3 binding.
chr2	232566972	232567086	O60573	0	+	232566972	232567086	255,102,0	1	114	0	.	7-methylguanosine-containing mRNA cap binding.
chr2	232567212	232568951	O60573	0	+	232567212	232568951	255,102,0	1	1739	0	.	7-methylguanosine-containing mRNA cap binding.
chr2	232806489	232806540	Q6Y7W6	0	+	232806489	232806540	255,102,0	1	51	0	.	Required for GRB10-binding.
chr2	232920292	232974890	Q8N5V2	0	-	232920292	232974890	255,102,0	1	54598	0	.	Regulatory region; modulates activity toward RHOA, RAC1 and CDC42.
chr2	233204195	233204240	Q92835	0	+	233204195	233204240	255,102,0	1	45	0	.	Interaction with DAB2.
chr2	233251863	233256115	Q676U5	0	+	233251863	233256115	255,102,0	1	4252	0	.	Interaction with ATG5. Pubmed:25484072
chr2	233265120	233270050	Q676U5	0	+	233265120	233270050	255,102,0	1	4930	0	.	WIPI2-binding. Pubmed:24954904
chr2	233270047	233272984	Q676U5	0	+	233270047	233272984	255,102,0	1	2937	0	.	RB1CC1-binding. Pubmed:24954904, Pubmed:23392225
chr2	233942607	233942634	Q7Z2W7	0	+	233942607	233942634	255,102,0	1	27	0	.	Epitope; activates specific cytotoxic T lymphocytes.
chr2	235709210	235799393	Q9UPQ3	0	+	235709210	235799393	255,102,0	1	90183	0	.	Small GTPase-like.
chr2	236581434	236581551	P25106	0	+	236581434	236581551	255,102,0	1	117	0	.	C-terminal cytoplasmic tail.
chr2	237324776	237345094	P12111	0	-	237324776	237345094	255,102,0	1	20318	0	.	Nonhelical region.
chr2	237345180	237361780	P12111	0	-	237345180	237361780	255,102,0	1	16600	0	.	Triple-helical region.
chr2	237361780	237396742	P12111	0	-	237361780	237396742	255,102,0	1	34962	0	.	Nonhelical region.
chr2	237763165	237763465	Q32MZ4	0	+	237763165	237763465	255,102,0	1	300	0	.	DNA-binding.
chr2	237973107	237973194	Q969M7	0	+	237973107	237973194	255,102,0	1	87	0	.	Interaction with UBA3. Pubmed:19250909
chr2	238246377	238250555	O15055	0	-	238246377	238250555	255,102,0	1	4178	0	.	CRY binding domain.
chr2	238251659	238253361	O15055	0	-	238251659	238253361	255,102,0	1	1702	0	.	Interaction with PPARG.
chr2	238255663	238258603	O15055	0	-	238255663	238258603	255,102,0	1	2940	0	.	CSNK1E binding domain.
chr2	238260917	238260932	O15055	0	-	238260917	238260932	255,102,0	1	15	0	.	Important for protein stability.
chr2	238320662	238332877	Q8TDR0	0	+	238320662	238332877	255,102,0	1	12215	0	.	Abolishes microtubules-binding when missing.
chr2	238329093	238398916	Q8TDR0	0	+	238329093	238398916	255,102,0	1	69823	0	.	DISC1-interaction domain.
chr2	239053099	239108184	P56524	0	-	239053099	239108184	255,102,0	1	55085	0	.	Histone deacetylase.
chr2	239139722	239176551	P56524	0	-	239139722	239176551	255,102,0	1	36829	0	.	Interaction with MEF2A. Pubmed:10487761
chr2	240576692	240576707	Q9HAU8	0	+	240576692	240576707	255,102,0	1	15	0	.	Substrate binding.
chr2	240594675	240596522	Q9HC96	0	+	240594675	240596522	255,102,0	1	1847	0	.	Domain III 1.
chr2	240596735	240598370	Q9HC96	0	+	240596735	240598370	255,102,0	1	1635	0	.	Domain III 2.
chr2	241096162	241096216	Q7Z6M4	0	-	241096162	241096216	255,102,0	1	54	0	.	Dimerization with NSUN4.
chr2	241343832	241343865	Q15019	0	+	241343832	241343865	255,102,0	1	33	0	.	Important for dimerization.
chr2	241559525	241559618	Q9UMX3	0	+	241559525	241559618	255,102,0	1	93	0	.	Interactions with ITPR1.
chr2	241559690	241562361	Q9UMX3	0	+	241559690	241562361	255,102,0	1	2671	0	.	Nuclear export signal. Pubmed:16302269
chr20	145416	145545	Q9BYW3	0	+	145416	145545	255,102,0	1	129	0	.	In vitro binds to LPS, mediates antimicrobial activity and inhibits LPS-mediated inflammation. Pubmed:23229569
chr20	388010	391376	Q96RU7	0	+	388010	391376	255,102,0	1	3366	0	.	Interaction with DDIT3/CHOP.
chr20	408757	419635	Q9BYM8	0	+	408757	419635	255,102,0	1	10878	0	.	Interaction with IRF3. Pubmed:18711448
chr20	408757	420924	Q9BYM8	0	+	408757	420924	255,102,0	1	12167	0	.	Interaction with TAB2. Pubmed:17449468
chr20	417562	417863	Q9BYM8	0	+	417562	417863	255,102,0	1	301	0	.	Interaction with RNF31. Pubmed:22430200
chr20	505207	505225	P68400	0	-	505207	505225	255,102,0	1	18	0	.	Interaction with beta subunit.
chr20	675541	675601	Q9NQ03	0	-	675541	675601	255,102,0	1	60	0	.	SNAG domain.
chr20	1118776	1135205	Q92530	0	+	1118776	1135205	255,102,0	1	16429	0	.	Important for homodimerization and interaction with FBXO7. Pubmed:18495667
chr20	2461770	2463125	P14678	0	-	2461770	2463125	255,102,0	1	1355	0	.	Repeat-rich region.
chr20	2705628	2705640	Q9BQW3	0	+	2705628	2705640	255,102,0	1	12	0	.	Interaction with DNA.
chr20	2748582	2748606	Q9BQW3	0	+	2748582	2748606	255,102,0	1	24	0	.	Interaction with DNA.
chr20	2749469	2749481	Q9BQW3	0	+	2749469	2749481	255,102,0	1	12	0	.	Interaction with DNA.
chr20	2864651	2865432	Q9H269	0	+	2864651	2865432	255,102,0	1	781	0	.	Interaction with VPS33A. Pubmed:23901104
chr20	3190655	3194856	Q96HY6	0	-	3190655	3194856	255,102,0	1	4201	0	.	Mediates interaction with UFL1. Pubmed:25219498
chr20	3194853	3200398	Q96HY6	0	-	3194853	3200398	255,102,0	1	5545	0	.	Mediates interaction with TRIP4. Pubmed:25219498
chr20	3200407	3204627	Q96HY6	0	-	3200407	3204627	255,102,0	1	4220	0	.	Mediates interaction with CDK5RAP3. Pubmed:20228063
chr20	3209590	3209608	Q9BY32	0	+	3209590	3209608	255,102,0	1	18	0	.	Substrate binding.
chr20	3214008	3214014	Q9BY32	0	+	3214008	3214014	255,102,0	1	6	0	.	Substrate binding.
chr20	3221873	3221885	Q9BY32	0	+	3221873	3221885	255,102,0	1	12	0	.	Substrate binding.
chr20	3223405	3223411	Q9BY32	0	+	3223405	3223411	255,102,0	1	6	0	.	Substrate binding.
chr20	3227789	3231023	Q8NBS3	0	-	3227789	3231023	255,102,0	1	3234	0	.	Membrane (bicarbonate transporter).
chr20	3706377	3706392	Q9BZZ2	0	-	3706377	3706392	255,102,0	1	15	0	.	Sialic acid binding.
chr20	3784686	3784878	P07199	0	-	3784686	3784878	255,102,0	1	192	0	.	Homodimerization.
chr20	3854651	3857748	Q7Z434	0	+	3854651	3857748	255,102,0	1	3097	0	.	Required for interaction with NLRX1. Pubmed:18200010
chr20	3861465	3861480	Q7Z434	0	+	3861465	3861480	255,102,0	1	15	0	.	Interaction with TRAF2. Pubmed:16153868
chr20	3861495	3862262	Q7Z434	0	+	3861495	3862262	255,102,0	1	767	0	.	Interaction with TRAF6.
chr20	3865886	3865904	Q7Z434	0	+	3865886	3865904	255,102,0	1	18	0	.	Interaction with TRAF6.
chr20	4699286	4699334	P04156	0	+	4699286	4699334	255,102,0	1	48	0	.	Interaction with ADGRG6.
chr20	4699286	4699910	P04156	0	+	4699286	4699910	255,102,0	1	624	0	.	Interaction with GRB2, ERI3 and SYN1.
chr20	4699370	4699493	P04156	0	+	4699370	4699493	255,102,0	1	123	0	.	5 X 8 AA tandem repeats of P-H-G-G-G-W-G-Q.
chr20	4724629	4724701	Q9UKY0	0	+	4724629	4724701	255,102,0	1	72	0	.	Flexible tail.
chr20	4724701	4725007	Q9UKY0	0	+	4724701	4725007	255,102,0	1	306	0	.	Globular.
chr20	5118787	5119780	P12004	0	-	5118787	5119780	255,102,0	1	993	0	.	Interaction with NUDT15. Pubmed:19419956
chr20	5586233	5586239	Q9NPB8	0	-	5586233	5586239	255,102,0	1	6	0	.	Substrate binding.
chr20	5922489	5922504	P05060	0	+	5922489	5922504	255,102,0	1	15	0	.	O-glycosylated at one site.
chr20	5938705	5941055	Q9UJA5	0	-	5938705	5941055	255,102,0	1	2350	0	.	Substrate. Pubmed:26470919
chr20	5941085	5941112	Q9UJA5	0	-	5941085	5941112	255,102,0	1	27	0	.	Substrate. Pubmed:26470919
chr20	5943679	5943967	Q9UJA5	0	-	5943679	5943967	255,102,0	1	288	0	.	Substrate. Pubmed:26470919
chr20	5944027	5944187	Q9UJA5	0	-	5944027	5944187	255,102,0	1	160	0	.	Substrate. Pubmed:26470919
chr20	5944858	5944891	Q9UJA5	0	-	5944858	5944891	255,102,0	1	33	0	.	Substrate. Pubmed:26470919
chr20	9566030	9644256	Q9P286	0	-	9566030	9644256	255,102,0	1	78226	0	.	Linker.
chr20	10275491	10293222	P60880	0	+	10275491	10293222	255,102,0	1	17731	0	.	Interaction with CENPF.
chr20	10408678	10412923	Q9NPJ1	0	-	10408678	10412923	255,102,0	1	4245	0	.	Substrate-binding apical domain.
chr20	10658540	10658567	P78504	0	-	10658540	10658567	255,102,0	1	27	0	.	Important for interaction with NOTCH1. Pubmed:18660822
chr20	14327305	14327395	Q9NZU0	0	-	14327305	14327395	255,102,0	1	90	0	.	Interaction with ADGRL3. Pubmed:26235030
chr20	17494076	17497019	Q12934	0	-	17494076	17497019	255,102,0	1	2943	0	.	Tail.
chr20	17497019	17511999	Q12934	0	-	17497019	17511999	255,102,0	1	14980	0	.	Coil 2.
chr20	17497019	17531209	Q12934	0	-	17497019	17531209	255,102,0	1	34190	0	.	Rod.
chr20	17511999	17512050	Q12934	0	-	17511999	17512050	255,102,0	1	51	0	.	Linker 12.
chr20	17512050	17531077	Q12934	0	-	17512050	17531077	255,102,0	1	19027	0	.	Coil 1B.
chr20	17531077	17531104	Q12934	0	-	17531077	17531104	255,102,0	1	27	0	.	Linker 1.
chr20	17531104	17531209	Q12934	0	-	17531104	17531209	255,102,0	1	105	0	.	Coil 1A.
chr20	17531209	17531329	Q12934	0	-	17531209	17531329	255,102,0	1	120	0	.	Head.
chr20	17950139	17952595	Q9Y5X3	0	-	17950139	17952595	255,102,0	1	2456	0	.	Interaction with DOCK1. Pubmed:18596235
chr20	17951508	17951562	Q9Y5X3	0	-	17951508	17951562	255,102,0	1	54	0	.	Membrane-binding amphipathic helix. Pubmed:23085988
chr20	17954036	17954048	Q9Y5X3	0	-	17954036	17954048	255,102,0	1	12	0	.	Phosphatidylinositol bisphosphate binding.
chr20	17954069	17954090	Q9Y5X3	0	-	17954069	17954090	255,102,0	1	21	0	.	Phosphatidylinositol bisphosphate binding.
chr20	17956950	17956971	Q9Y5X3	0	-	17956950	17956971	255,102,0	1	21	0	.	Phosphatidylinositol bisphosphate binding.
chr20	18493995	18494040	O75884	0	-	18493995	18494040	255,102,0	1	45	0	.	Retinoblastoma protein binding.
chr20	20039752	20045361	Q9BZJ0	0	-	20039752	20045361	255,102,0	1	5609	0	.	Mediates interaction with HSP90.
chr20	20368267	20368327	Q01101	0	+	20368267	20368327	255,102,0	1	60	0	.	SNAG domain.
chr20	20368393	20368441	Q01101	0	+	20368393	20368441	255,102,0	1	48	0	.	Necessary for interaction with CCND1.
chr20	22581852	22582143	Q9Y261	0	-	22581852	22582143	255,102,0	1	291	0	.	Transactivation domain 2.
chr20	22582944	22584221	Q9Y261	0	-	22582944	22584221	255,102,0	1	1277	0	.	Transactivation domain 1.
chr20	23047959	23048064	P07204	0	-	23047959	23048064	255,102,0	1	105	0	.	Involved in alpha-L/beta-2 and alpha-M/beta-2 integrin binding. Pubmed:27055590
chr20	23985888	23985894	Q9BX51	0	-	23985888	23985894	255,102,0	1	6	0	.	Glutamate binding.
chr20	23985954	23985960	Q9BX51	0	-	23985954	23985960	255,102,0	1	6	0	.	Glutamate binding.
chr20	25023591	25023603	Q9NUB1	0	-	25023591	25023603	255,102,0	1	12	0	.	Coenzyme A binding.
chr20	25292464	25292470	P11216	0	+	25292464	25292470	255,102,0	1	6	0	.	Pyridoxal 5'-phosphate. Pubmed:27402852
chr20	25616275	25616281	Q8TBE9	0	-	25616275	25616281	255,102,0	1	6	0	.	Substrate binding.
chr20	25623906	25623915	Q8TBE9	0	-	25623906	25623915	255,102,0	1	9	0	.	Substrate binding.
chr20	31484334	31484394	O75628	0	+	31484334	31484394	255,102,0	1	60	0	.	Calmodulin-binding.
chr20	31833725	31833764	Q9H1R3	0	+	31833725	31833764	255,102,0	1	39	0	.	Calmodulin-binding.
chr20	32210075	32210084	Q9H488	0	+	32210075	32210084	255,102,0	1	9	0	.	Substrate binding.
chr20	32228431	32228440	Q9H488	0	+	32228431	32228440	255,102,0	1	9	0	.	Substrate binding.
chr20	32234559	32234565	Q9H488	0	+	32234559	32234565	255,102,0	1	6	0	.	Substrate binding.
chr20	32316863	32331316	O15066	0	+	32316863	32331316	255,102,0	1	14453	0	.	Globular.
chr20	32780323	32791681	Q9UBC3	0	+	32780323	32791681	255,102,0	1	11358	0	.	Interaction with DNMT1 and DNMT3A. Pubmed:12145218
chr20	32796794	32798550	Q9UBC3	0	+	32796794	32798550	255,102,0	1	1756	0	.	Interaction with the PRC2/EED-EZH2 complex.
chr20	32799312	32799327	Q9UBC3	0	+	32799312	32799327	255,102,0	1	15	0	.	S-adenosyl-L-homocysteine binding.
chr20	32800271	32800280	Q9UBC3	0	+	32800271	32800280	255,102,0	1	9	0	.	S-adenosyl-L-homocysteine binding.
chr20	32807834	32807843	Q9UBC3	0	+	32807834	32807843	255,102,0	1	9	0	.	S-adenosyl-L-homocysteine binding.
chr20	32836735	32848725	Q15691	0	+	32836735	32848725	255,102,0	1	11990	0	.	Interaction with MTUS2/TIP150. Pubmed:19543227
chr20	32839811	32848725	Q15691	0	+	32839811	32848725	255,102,0	1	8914	0	.	Interaction with CDK5RAP2. Pubmed:19553473
chr20	32846641	32848725	Q15691	0	+	32846641	32848725	255,102,0	1	2084	0	.	DCTN1-binding.
chr20	32846677	32846746	Q15691	0	+	32846677	32846746	255,102,0	1	69	0	.	APC-binding.
chr20	33359090	33370510	Q96SZ6	0	-	33359090	33370510	255,102,0	1	11420	0	.	CDK5R1-binding.
chr20	33392214	33397001	Q96SZ6	0	-	33392214	33397001	255,102,0	1	4787	0	.	CDK5 activation inhibition.
chr20	33408509	33408578	Q13424	0	-	33408509	33408578	255,102,0	1	69	0	.	Calmodulin-binding.
chr20	33611206	33623222	O43439	0	+	33611206	33623222	255,102,0	1	12016	0	.	Interaction with PRDM14.
chr20	33628366	33629790	O43439	0	+	33628366	33629790	255,102,0	1	1424	0	.	Nervy homology region 2 (NHR2).
chr20	33636686	33640468	O43439	0	+	33636686	33640468	255,102,0	1	3782	0	.	Nervy homology region 3 (NHR3).
chr20	33676734	33676944	Q01094	0	-	33676734	33676944	255,102,0	1	210	0	.	Transactivation.
chr20	33676767	33676821	Q01094	0	-	33676767	33676821	255,102,0	1	54	0	.	RB1 binding. Pubmed:12598654
chr20	33676899	33678352	Q01094	0	-	33676899	33678352	255,102,0	1	1453	0	.	Required for interaction with TRIM28. Pubmed:17704056
chr20	33677318	33678343	Q01094	0	-	33677318	33678343	255,102,0	1	1025	0	.	Dimerization.
chr20	33679753	33680413	Q01094	0	-	33679753	33680413	255,102,0	1	660	0	.	Interaction with BIRC2/c-IAP1. Pubmed:21653699
chr20	33679804	33679870	Q01094	0	-	33679804	33679870	255,102,0	1	66	0	.	Leucine-zipper.
chr20	33680353	33686066	Q01094	0	-	33680353	33686066	255,102,0	1	5713	0	.	Cyclin A:CDK2 binding. Pubmed:8033208
chr20	34077047	34077128	Q9UKM9	0	+	34077047	34077128	255,102,0	1	81	0	.	Epitope (recognized by BKRF1 antibodies).
chr20	34445380	34457469	Q96J02	0	+	34445380	34457469	255,102,0	1	12089	0	.	Required for interaction with FYN. Pubmed:16387660
chr20	34477798	34477828	Q96J02	0	+	34477798	34477828	255,102,0	1	30	0	.	MAP kinase docking site.
chr20	34559394	34559409	Q9H492	0	+	34559394	34559409	255,102,0	1	15	0	.	Important for interaction with ATG13 and for autophagosome formation. Pubmed:24290141
chr20	34585495	34585558	Q9H490	0	-	34585495	34585558	255,102,0	1	63	0	.	May be involved in recognition of long-chain fatty acids in GPI.
chr20	34715324	34741335	Q14686	0	-	34715324	34741335	255,102,0	1	26011	0	.	EP300/CRSP3-binding region.
chr20	34742325	34782355	Q14686	0	-	34742325	34782355	255,102,0	1	40030	0	.	NCOA1-binding region.
chr20	34743084	34782355	Q14686	0	-	34743084	34782355	255,102,0	1	39271	0	.	CREBBP-binding region.
chr20	34749410	34782355	Q14686	0	-	34749410	34782355	255,102,0	1	32945	0	.	TBP/GTF2A-binding region.
chr20	34749413	34749878	Q14686	0	-	34749413	34749878	255,102,0	1	465	0	.	NCOA6IP-binding region.
chr20	34914106	34914118	Q9NR19	0	+	34914106	34914118	255,102,0	1	12	0	.	Coenzyme A binding.
chr20	34928866	34928872	P48637	0	-	34928866	34928872	255,102,0	1	6	0	.	Substrate binding.
chr20	34935599	34935611	P48637	0	-	34935599	34935611	255,102,0	1	12	0	.	Substrate binding.
chr20	34936983	34936992	P48637	0	-	34936983	34936992	255,102,0	1	9	0	.	Substrate binding.
chr20	34942525	34942537	P48637	0	-	34942525	34942537	255,102,0	1	12	0	.	Substrate binding.
chr20	35021207	35092778	Q8TEL6	0	-	35021207	35092778	255,102,0	1	71571	0	.	Interaction with TNFRSF1A.
chr20	35680755	35680764	Q9Y697	0	-	35680755	35680764	255,102,0	1	9	0	.	Pyridoxal phosphate binding.
chr20	35696400	35696406	Q9Y697	0	-	35696400	35696406	255,102,0	1	6	0	.	Pyridoxal phosphate binding.
chr20	35699755	35700846	P60602	0	+	35699755	35700846	255,102,0	1	1091	0	.	Sufficient for antibacterial activity.
chr20	35704483	35709233	Q14498	0	-	35704483	35709233	255,102,0	1	4750	0	.	Interaction with NCOA6.
chr20	35709230	35714218	Q14498	0	-	35709230	35714218	255,102,0	1	4988	0	.	Interaction with ESR1 and ESR2.
chr20	35709230	35716760	Q14498	0	-	35709230	35716760	255,102,0	1	7530	0	.	Interaction with JUN.
chr20	35714215	35716760	Q14498	0	-	35714215	35716760	255,102,0	1	2545	0	.	Activating domain.
chr20	36194357	36197996	Q9H4G0	0	+	36194357	36197996	255,102,0	1	3639	0	.	Spectrin--actin-binding.
chr20	36214407	36229337	Q9H4G0	0	+	36214407	36229337	255,102,0	1	14930	0	.	C-terminal (CTD).
chr20	36591023	36591428	Q9GZN2	0	+	36591023	36591428	255,102,0	1	405	0	.	Repressive function.
chr20	36613868	36614387	Q9H6Q3	0	-	36613868	36614387	255,102,0	1	519	0	.	SLA C-terminal.
chr20	36912489	36912507	Q9Y3Z3	0	-	36912489	36912507	255,102,0	1	18	0	.	Substrate binding.
chr20	36916956	36916977	Q9Y3Z3	0	-	36916956	36916977	255,102,0	1	21	0	.	Substrate binding.
chr20	37007434	37032706	P28749	0	-	37007434	37032706	255,102,0	1	25272	0	.	Domain B.
chr20	37007434	37061200	P28749	0	-	37007434	37061200	255,102,0	1	53766	0	.	Pocket; binds T and E1A.
chr20	37032706	37044103	P28749	0	-	37032706	37044103	255,102,0	1	11397	0	.	Spacer.
chr20	37044103	37061200	P28749	0	-	37044103	37061200	255,102,0	1	17097	0	.	Domain A.
chr20	38304238	38311904	P17213	0	+	38304238	38311904	255,102,0	1	7666	0	.	N-terminal barrel. Pubmed:10843855
chr20	38311904	38326336	P17213	0	+	38311904	38326336	255,102,0	1	14432	0	.	Central sheet. Pubmed:10843855
chr20	38320223	38320241	P17213	0	+	38320223	38320241	255,102,0	1	18	0	.	Cleavage sites for elastase.
chr20	38323878	38334435	P17213	0	+	38323878	38334435	255,102,0	1	10557	0	.	C-terminal barrel. Pubmed:10843855
chr20	38951779	38952517	Q9H4H8	0	+	38951779	38952517	255,102,0	1	738	0	.	Required for interaction with KIF22 and function in chromosome congression. Pubmed:18485706
chr20	40687989	40688055	Q9Y5Q3	0	-	40687989	40688055	255,102,0	1	66	0	.	Leucine-zipper.
chr20	40688061	40688139	Q9Y5Q3	0	-	40688061	40688139	255,102,0	1	78	0	.	Basic motif.
chr20	41101317	41101323	P11387	0	+	41101317	41101323	255,102,0	1	6	0	.	Interaction with DNA.
chr20	41113978	41113996	P11387	0	+	41113978	41113996	255,102,0	1	18	0	.	Interaction with DNA.
chr20	41116322	41116331	P11387	0	+	41116322	41116331	255,102,0	1	9	0	.	Interaction with DNA.
chr20	41203251	41203428	Q9H4I2	0	-	41203251	41203428	255,102,0	1	177	0	.	Required for nuclear localization.
chr20	41203410	41204010	Q9H4I2	0	-	41203410	41204010	255,102,0	1	600	0	.	Required for repressor activity.
chr20	41203452	41204193	Q9H4I2	0	-	41203452	41204193	255,102,0	1	741	0	.	Required for homodimerization and interaction with NFYA. Pubmed:12659632
chr20	41204595	41204916	Q9H4I2	0	-	41204595	41204916	255,102,0	1	321	0	.	Required for nuclear localization.
chr20	41345803	41348654	Q9BQK8	0	+	41345803	41348654	255,102,0	1	2851	0	.	N-LIP.
chr20	41355998	41358507	Q9BQK8	0	+	41355998	41358507	255,102,0	1	2509	0	.	C-LIP.
chr20	41484367	41551337	Q8TD26	0	-	41484367	41551337	255,102,0	1	66970	0	.	Required for DNA-dependent ATPase activity.
chr20	42106905	42110337	O14522	0	-	42106905	42110337	255,102,0	1	3432	0	.	Substrate binding.
chr20	44006579	44006696	Q96NM4	0	+	44006579	44006696	255,102,0	1	117	0	.	Required for transcriptional activation.
chr20	44625617	44625671	P00813	0	-	44625617	44625671	255,102,0	1	54	0	.	Required for binding to DDP4. Pubmed:15016824
chr20	45175865	45175997	P19957	0	+	45175865	45175997	255,102,0	1	132	0	.	2 X tandem repeats of SVP-1 like motif.
chr20	45207504	45208614	P04279	0	+	45207504	45208614	255,102,0	1	1110	0	.	Repeat-rich region.
chr20	45207786	45208146	P04279	0	+	45207786	45208146	255,102,0	1	360	0	.	Interaction with EPPIN. Pubmed:15590901
chr20	45208077	45208437	P04279	0	+	45208077	45208437	255,102,0	1	360	0	.	2 X 60 AA tandem repeats, type 1.
chr20	45221839	45223309	Q02383	0	+	45221839	45223309	255,102,0	1	1470	0	.	Repeat-rich region.
chr20	45222412	45223132	Q02383	0	+	45222412	45223132	255,102,0	1	720	0	.	4 X 60 AA tandem repeats, type I.
chr20	45252417	45253146	P03973	0	-	45252417	45253146	255,102,0	1	729	0	.	Elastase inhibitory domain.
chr20	45542146	45542742	O95925	0	-	45542146	45542742	255,102,0	1	596	0	.	Interaction with LTF. Pubmed:22699487
chr20	45542146	45542787	O95925	0	-	45542146	45542787	255,102,0	1	641	0	.	Interaction with SEMG1.
chr20	45792736	45801142	Q9H147	0	+	45792736	45801142	255,102,0	1	8406	0	.	Important for dimerization. Pubmed:25653165
chr20	45803363	45811153	Q9H147	0	+	45803363	45811153	255,102,0	1	7790	0	.	Important for DNA and nucleosome binding. Pubmed:25653165
chr20	46062302	46062668	Q9HCD5	0	-	46062302	46062668	255,102,0	1	366	0	.	Transcription activation.
chr20	46068529	46079424	Q9HCD5	0	-	46068529	46079424	255,102,0	1	10895	0	.	Transcription repression.
chr20	47210763	47210883	Q9ULU4	0	-	47210763	47210883	255,102,0	1	120	0	.	Interaction with PRKCB1.
chr20	47276515	47298899	Q9ULU4	0	-	47276515	47298899	255,102,0	1	22384	0	.	Interaction with histone H3K14ac. Pubmed:27477906
chr20	47283588	47298899	Q9ULU4	0	-	47283588	47298899	255,102,0	1	15311	0	.	Interaction with histone H3K4me0. Pubmed:27477906
chr20	47640037	47647099	Q9Y6Q9	0	+	47640037	47647099	255,102,0	1	7062	0	.	Interaction with CREBBP. Pubmed:9346901
chr20	47647108	47651242	Q9Y6Q9	0	+	47647108	47651242	255,102,0	1	4134	0	.	Acetyltransferase.
chr20	48921892	48953624	Q9Y6D5	0	+	48921892	48953624	255,102,0	1	31732	0	.	DCB; DCB:DCB domain and DCB:HUS domain interaction.
chr20	48972421	48973203	Q9Y6D5	0	+	48972421	48973203	255,102,0	1	782	0	.	HUS; DCB:HUS domain interaction.
chr20	49374116	49374218	Q14721	0	-	49374116	49374218	255,102,0	1	102	0	.	Self-association.
chr20	49482255	49482306	Q14721	0	-	49482255	49482306	255,102,0	1	51	0	.	Self-association.
chr20	49637369	49637375	O43286	0	-	49637369	49637375	255,102,0	1	6	0	.	UDP-alpha-D-galactose binding.
chr20	49639691	49639703	O43286	0	-	49639691	49639703	255,102,0	1	12	0	.	N-acetyl-D-glucosamine binding.
chr20	49640563	49640569	O43286	0	-	49640563	49640569	255,102,0	1	6	0	.	UDP-alpha-D-galactose binding.
chr20	49640641	49640650	O43286	0	-	49640641	49640650	255,102,0	1	9	0	.	UDP-alpha-D-galactose binding.
chr20	49642554	49642569	O43286	0	-	49642554	49642569	255,102,0	1	15	0	.	UDP-alpha-D-galactose binding.
chr20	49983059	49983119	O95863	0	+	49983059	49983119	255,102,0	1	60	0	.	SNAG domain.
chr20	49983086	49983861	O95863	0	+	49983086	49983861	255,102,0	1	775	0	.	LATS2 binding.
chr20	49984098	49984194	O95863	0	+	49984098	49984194	255,102,0	1	96	0	.	Required for FBXL14-triggered degradation.
chr20	49984191	49988053	O95863	0	+	49984191	49988053	255,102,0	1	3862	0	.	Required for nuclear localization and interaction with KPNB1, NOTCH1 and PARP1. Pubmed:21577210, Pubmed:22128911
chr20	50191033	50191105	P17676	0	+	50191033	50191105	255,102,0	1	72	0	.	Required for Lys-174 sumoylation.
chr20	50191102	50191438	P17676	0	+	50191102	50191438	255,102,0	1	336	0	.	Required for MYC transcriptional repression.
chr20	50191855	50191918	P17676	0	+	50191855	50191918	255,102,0	1	63	0	.	Basic motif.
chr20	50191921	50191945	P17676	0	+	50191921	50191945	255,102,0	1	24	0	.	Leucine-zipper.
chr20	50578569	50578590	A8K3M3	0	+	50578569	50578590	255,102,0	1	21	0	.	Substrate binding.
chr20	50578569	50578590	B4DSN5	0	+	50578569	50578590	255,102,0	1	21	0	.	Substrate binding.
chr20	50578569	50578590	P18031	0	+	50578569	50578590	255,102,0	1	21	0	.	Substrate binding.
chr20	50749744	50750128	Q9BYG5	0	+	50749744	50750128	255,102,0	1	384	0	.	Interaction with PARD3 and CDC42.
chr20	50893630	50893654	Q9H2P0	0	-	50893630	50893654	255,102,0	1	24	0	.	Neuroprotective peptide (NAP). Pubmed:19091000
chr20	51523382	51523691	Q13469	0	-	51523382	51523691	255,102,0	1	309	0	.	3 X approximate SP repeats.
chr20	51523643	51523886	Q13469	0	-	51523643	51523886	255,102,0	1	243	0	.	Trans-activation domain A (TAD-A).
chr20	51523715	51523760	Q13469	0	-	51523715	51523760	255,102,0	1	45	0	.	Required for cytoplasmic retention of the phosphorylated form.
chr20	51523892	51523910	Q13469	0	-	51523892	51523910	255,102,0	1	18	0	.	Calcineurin-binding.
chr20	56395591	56395657	Q05048	0	+	56395591	56395657	255,102,0	1	66	0	.	Hydrophobic.
chr20	56634222	56637932	Q92754	0	+	56634222	56637932	255,102,0	1	3710	0	.	H-S-H (helix-span-helix), dimerization.
chr20	57563119	57563128	P35558	0	+	57563119	57563128	255,102,0	1	9	0	.	Substrate binding. Pubmed:14552798, Pubmed:17532214, Pubmed:11851336
chr20	57564501	57564510	P35558	0	+	57564501	57564510	255,102,0	1	9	0	.	Substrate binding. Pubmed:14552798, Pubmed:17532214, Pubmed:11851336
chr20	59321125	59321170	P14138	0	+	59321125	59321170	255,102,0	1	45	0	.	Endothelin-like.
chr20	59806177	59841502	Q96KR7	0	+	59806177	59841502	255,102,0	1	35325	0	.	Required for PP1CA binding and inhibition of PP1 activity.
chr20	62143820	62162819	O75177	0	+	62143820	62162819	255,102,0	1	18999	0	.	N-terminal auto-inhibitory domain; necessary for interaction with SMARCA4/BRG1.
chr20	62162819	62163597	O75177	0	+	62162819	62163597	255,102,0	1	778	0	.	Methionine-rich intra-molecular domain.
chr20	62164158	62172716	O75177	0	+	62164158	62172716	255,102,0	1	8558	0	.	MFD domain.
chr20	62172764	62179205	O75177	0	+	62172764	62179205	255,102,0	1	6441	0	.	Necessary for nuclear localization.
chr20	62174638	62179205	O75177	0	+	62174638	62179205	255,102,0	1	4567	0	.	Necessary for interaction with CREBBP and for the recruitment of CREBBP to the nuclear bodies.
chr20	62193462	62201074	Q9H4K7	0	+	62193462	62201074	255,102,0	1	7612	0	.	Localized in the mitochondria.
chr20	62193507	62201074	Q9H4K7	0	+	62193507	62201074	255,102,0	1	7567	0	.	Not localized in the mitochondria.
chr20	62303631	62306256	Q16186	0	+	62303631	62306256	255,102,0	1	2625	0	.	Pru (pleckstrin-like receptor for ubiquitin) domain. Pubmed:18497817
chr20	62307728	62308758	Q16186	0	+	62307728	62308758	255,102,0	1	1030	0	.	Interaction with UCHL5. Pubmed:20471946
chr20	62314716	62320888	O15230	0	-	62314716	62320888	255,102,0	1	6172	0	.	Domain II and I.
chr20	62328979	62334553	O15230	0	-	62328979	62334553	255,102,0	1	5574	0	.	Domain IV 1 (domain IV B).
chr20	62758309	62760042	P30989	0	+	62758309	62760042	255,102,0	1	1733	0	.	Neurotensin binding.
chr20	62813163	62813583	Q9NZT2	0	+	62813163	62813583	255,102,0	1	420	0	.	7 X 20 AA approximate tandem repeats of [ST]-P-S-E-T-P-G-P-[SR]-P-A-G-P-[AT]-[GR]-D-E-P-A-[EK].
chr20	62817572	62836486	Q14050	0	+	62817572	62836486	255,102,0	1	18914	0	.	Triple-helical region 3 (COL3).
chr20	62836486	62837129	Q14050	0	+	62836486	62837129	255,102,0	1	643	0	.	Nonhelical region 3 (NC3).
chr20	62837129	62840567	Q14050	0	+	62837129	62840567	255,102,0	1	3438	0	.	Triple-helical region 2 (COL2).
chr20	62840567	62840573	Q14050	0	+	62840567	62840573	255,102,0	1	6	0	.	Nonhelical region 2 (NC2).
chr20	62840573	62840660	Q14050	0	+	62840573	62840660	255,102,0	1	87	0	.	Triple-helical region 1 (COL1).
chr20	62840660	62840729	Q14050	0	+	62840660	62840729	255,102,0	1	69	0	.	Nonhelical region 1 (NC1).
chr20	62841977	62842037	Q9UL49	0	-	62841977	62842037	255,102,0	1	60	0	.	R1 epitope (recognized by Chagas's antibodies).
chr20	62857564	62857594	Q9UL49	0	-	62857564	62857594	255,102,0	1	30	0	.	R3 epitope (recognized by Chagas's antibodies).
chr20	63202703	63202709	Q9BYJ9	0	-	63202703	63202709	255,102,0	1	6	0	.	N6-methyladenosine binding. Pubmed:26318451
chr20	63202748	63202757	Q9BYJ9	0	-	63202748	63202757	255,102,0	1	9	0	.	N6-methyladenosine binding. Pubmed:26318451
chr20	63494837	63494846	Q05639	0	-	63494837	63494846	255,102,0	1	9	0	.	G5.
chr20	63494957	63494969	Q05639	0	-	63494957	63494969	255,102,0	1	12	0	.	G4.
chr20	63495897	63495909	Q05639	0	-	63495897	63495909	255,102,0	1	12	0	.	G3.
chr20	63495957	63495972	Q05639	0	-	63495957	63495972	255,102,0	1	15	0	.	G2.
chr20	63497700	63497724	Q05639	0	-	63497700	63497724	255,102,0	1	24	0	.	G1.
chr20	63533650	63534157	Q13882	0	-	63533650	63534157	255,102,0	1	507	0	.	Linker.
chr20	63547310	63547463	Q9H3Y6	0	-	63547310	63547463	255,102,0	1	153	0	.	N-terminal.
chr20	63559248	63562198	Q9BYK8	0	-	63559248	63562198	255,102,0	1	2950	0	.	Interaction with THRAP3. Pubmed:23525231
chr20	63565644	63568401	Q9BYK8	0	-	63565644	63568401	255,102,0	1	2757	0	.	Interaction with THRAP3. Pubmed:23525231
chr20	63738346	63738358	Q9H400	0	+	63738346	63738358	255,102,0	1	12	0	.	Interaction with GRB2.
chr20	63738412	63738424	Q9H400	0	+	63738412	63738424	255,102,0	1	12	0	.	Interaction with CSK. Pubmed:14610046
chr20	63738609	63738621	Q9H400	0	+	63738609	63738621	255,102,0	1	12	0	.	Interaction with CSK. Pubmed:14610046
chr20	63738714	63738726	Q9H400	0	+	63738714	63738726	255,102,0	1	12	0	.	Interaction with LCK and PIK3R1.
chr20	63738771	63738783	Q9H400	0	+	63738771	63738783	255,102,0	1	12	0	.	Interaction with LCK, PLCG2 and PIK3R1.
chr20	64073855	64073888	P49795	0	-	64073855	64073888	255,102,0	1	33	0	.	Interaction with GIPC.
chr21	6455625	6455640	P0DN79	0	-	6455625	6455640	255,102,0	1	15	0	.	Pyridoxal phosphate binding.
chr21	6455625	6455640	P35520	0	-	6455625	6455640	255,102,0	1	15	0	.	Pyridoxal phosphate binding. Pubmed:11483494, Pubmed:12173932
chr21	14964718	14964841	P48552	0	-	14964718	14964841	255,102,0	1	123	0	.	Repression domain 4.
chr21	14964718	14965936	P48552	0	-	14964718	14965936	255,102,0	1	1218	0	.	Interaction with ZNF366. Pubmed:17085477
chr21	14965537	14965990	P48552	0	-	14965537	14965990	255,102,0	1	453	0	.	Repression domain 3.
chr21	14966092	14966965	P48552	0	-	14966092	14966965	255,102,0	1	873	0	.	Repression domain 2.
chr21	14966776	14966902	P48552	0	-	14966776	14966902	255,102,0	1	126	0	.	Required for targeting to small nuclear foci.
chr21	14966947	14968192	P48552	0	-	14966947	14968192	255,102,0	1	1245	0	.	Interaction with ZNF366. Pubmed:17085477
chr21	14967193	14967961	P48552	0	-	14967193	14967961	255,102,0	1	768	0	.	Repression domain 1.
chr21	15766101	15777941	Q9UHP3	0	+	15766101	15777941	255,102,0	1	11840	0	.	SUMO interaction domain (SIM).
chr21	25881729	25891739	P05067	0	-	25881729	25891739	255,102,0	1	10010	0	.	Interaction with G(o)-alpha.
chr21	25954656	25955647	P05067	0	-	25954656	25955647	255,102,0	1	991	0	.	Collagen-binding.
chr21	25955647	25955743	P05067	0	-	25955647	25955743	255,102,0	1	96	0	.	Heparin-binding.
chr21	25975983	25982397	P05067	0	-	25975983	25982397	255,102,0	1	6414	0	.	Heparin-binding.
chr21	26051097	26051121	P05067	0	-	26051097	26051121	255,102,0	1	24	0	.	Zinc-binding.
chr21	26089967	26090012	P05067	0	-	26089967	26090012	255,102,0	1	45	0	.	Heparin-binding.
chr21	26837935	26838470	Q9UHI8	0	-	26837935	26838470	255,102,0	1	535	0	.	Spacer.
chr21	26924223	26929917	Q9UNA0	0	-	26924223	26929917	255,102,0	1	5694	0	.	Spacer.
chr21	29329600	29329651	O14867	0	+	29329600	29329651	255,102,0	1	51	0	.	Basic motif.
chr21	29329660	29329684	O14867	0	+	29329660	29329684	255,102,0	1	24	0	.	Leucine-zipper.
chr21	29576978	29576984	P39086	0	-	29576978	29576984	255,102,0	1	6	0	.	Glutamate binding.
chr21	29587559	29587568	P39086	0	-	29587559	29587568	255,102,0	1	9	0	.	Glutamate binding.
chr21	30215250	30215256	P56748	0	-	30215250	30215256	255,102,0	1	6	0	.	Interactions with TJP1, TJP2 and TJP3.
chr21	30282176	30282356	Q3LI83	0	-	30282176	30282356	255,102,0	1	180	0	.	6 X 10 AA repeats of Y-[ILR]-[SVPC]-[NRTS]-[SNTG]-X-[QHRP]-[PSY]-[QSL]-[SRK].
chr21	30371910	30372078	Q52LG2	0	-	30371910	30372078	255,102,0	1	168	0	.	5 X 10 AA approximate repeats.
chr21	30396221	30396389	Q8IUC0	0	+	30396221	30396389	255,102,0	1	168	0	.	5 X 10 AA approximate repeats.
chr21	30425609	30425777	Q3SY46	0	-	30425609	30425777	255,102,0	1	168	0	.	5 X 10 AA approximate repeats.
chr21	30430395	30430533	Q3LI77	0	+	30430395	30430533	255,102,0	1	138	0	.	4 X 10 AA approximate repeats.
chr21	30480065	30480305	Q8IUB9	0	-	30480065	30480305	255,102,0	1	240	0	.	26 X 2 AA repeats of G-[YCGS].
chr21	30813058	30813187	Q8IUC2	0	-	30813058	30813187	255,102,0	1	129	0	.	12 X 2 AA repeats of G-[YCGS].
chr21	30829446	30829572	Q8IUC3	0	-	30829446	30829572	255,102,0	1	126	0	.	11 X 2 AA repeats of G-[YCGS].
chr21	30881074	30881194	Q8IUC1	0	-	30881074	30881194	255,102,0	1	120	0	.	4 X 10 AA approximate repeats.
chr21	32582271	32582337	Q8TDR4	0	-	32582271	32582337	255,102,0	1	66	0	.	Leucine-zipper.
chr21	32750965	32759838	Q9Y5B6	0	-	32750965	32759838	255,102,0	1	8873	0	.	Necessary and sufficient for interaction with PAX7.
chr21	33355345	33355375	P17181	0	+	33355345	33355375	255,102,0	1	30	0	.	Important for interaction with TYK2. Pubmed:24704786
chr21	33504126	33509807	P22102	0	-	33504126	33509807	255,102,0	1	5681	0	.	GART.
chr21	33504216	33504228	P22102	0	-	33504216	33504228	255,102,0	1	12	0	.	5'-phosphoribosylglycinamide binding.
chr21	33504303	33504414	P22102	0	-	33504303	33504414	255,102,0	1	111	0	.	10-formyltetrahydrofolate binding.
chr21	33505588	33505600	P22102	0	-	33505588	33505600	255,102,0	1	12	0	.	10-formyltetrahydrofolate binding.
chr21	33506096	33506105	P22102	0	-	33506096	33506105	255,102,0	1	9	0	.	5'-phosphoribosylglycinamide binding.
chr21	33509807	33522281	P22102	0	-	33509807	33522281	255,102,0	1	12474	0	.	AIRS.
chr21	33551406	33551916	P18583	0	+	33551406	33551916	255,102,0	1	510	0	.	17 X 10 AA tandem repeats of L-A-[ST]-[NSG]-[TS]-MDSQM.
chr21	33551964	33552195	P18583	0	+	33551964	33552195	255,102,0	1	231	0	.	11 X 7 AA tandem repeats of [DR]-P-Y-R-[LI][AG][QHP].
chr21	33552246	33552609	P18583	0	+	33552246	33552609	255,102,0	1	363	0	.	14 X 6 AA repeats of [ED]-R-S-M-M-S.
chr21	33552669	33552768	P18583	0	+	33552669	33552768	255,102,0	1	99	0	.	3 X 11 AA tandem repats of P-P-L-P-P-E-E-P-P-[TME]-[MTG].
chr21	33553305	33553401	P18583	0	+	33553305	33553401	255,102,0	1	96	0	.	4 X 8 AA tandem repeats of V-L-E-SS-[AVT]-VT.
chr21	33555003	33555213	P18583	0	+	33555003	33555213	255,102,0	1	210	0	.	7 X 7 AA repeats of P-S-R-R-S-R-[TS].
chr21	33555030	33555270	P18583	0	+	33555030	33555270	255,102,0	1	240	0	.	2 X 19 AA repeats of P-S-R-R-R-R-S-R-S-V-V-R-R-R-S-F-S-I-S.
chr21	33555267	33555348	P18583	0	+	33555267	33555348	255,102,0	1	81	0	.	3 X tandem repeats of [ST]-P-[VLI]-R-[RL]-[RK]-[RF]-S-R.
chr21	33767761	33797532	Q15811	0	+	33767761	33797532	255,102,0	1	29771	0	.	KLERQ.
chr21	34449247	34449310	P15382	0	-	34449247	34449310	255,102,0	1	63	0	.	interaction with KCNQ1 C-terminus. Pubmed:25037568
chr21	34669856	34670234	Q96NY7	0	+	34669856	34670234	255,102,0	1	378	0	.	13 X 10 AA tandem repeat of G-D-[SNG]-[VIM]-[DEQ]-A-[EAG]-[GDVE]-[PRG]-[LAVP].
chr21	34792290	34792413	Q01196	0	-	34792290	34792413	255,102,0	1	123	0	.	Interaction with FOXP3. Pubmed:17377532
chr21	34792296	34792578	Q01196	0	-	34792296	34792578	255,102,0	1	282	0	.	Interaction with KAT6B.
chr21	34792383	34799316	Q01196	0	-	34792383	34799316	255,102,0	1	6933	0	.	Interaction with KAT6A. Pubmed:11742995
chr21	34859474	34859504	Q01196	0	-	34859474	34859504	255,102,0	1	30	0	.	Interaction with DNA.
chr21	34859576	34880581	Q01196	0	-	34859576	34880581	255,102,0	1	21005	0	.	Interaction with DNA.
chr21	34886860	34886875	Q01196	0	-	34886860	34886875	255,102,0	1	15	0	.	Interaction with DNA.
chr21	36070397	36070951	P16152	0	+	36070397	36070951	255,102,0	1	554	0	.	Glutathione binding.
chr21	36072624	36072630	P16152	0	+	36072624	36072630	255,102,0	1	6	0	.	Glutathione binding.
chr21	36345001	36349364	Q14149	0	+	36345001	36349364	255,102,0	1	4363	0	.	Nuclear matrix binding. Pubmed:11927593
chr21	36364137	36369141	Q14149	0	+	36364137	36369141	255,102,0	1	5004	0	.	RNA binding. Pubmed:11927593
chr21	37013607	37017970	P57055	0	+	37013607	37017970	255,102,0	1	4363	0	.	Ripply homology domain.
chr21	39390709	39391791	O00258	0	+	39390709	39391791	255,102,0	1	1082	0	.	Interaction with ASNA1/TRC40.
chr21	41435935	41445459	P20591	0	+	41435935	41445459	255,102,0	1	9524	0	.	GTPase domain (Globular).
chr21	41445459	41445537	P20591	0	+	41445459	41445537	255,102,0	1	78	0	.	Bundle signaling element (BSE).
chr21	41445534	41452710	P20591	0	+	41445534	41452710	255,102,0	1	7176	0	.	Middle domain.
chr21	41445537	41458665	P20591	0	+	41445537	41458665	255,102,0	1	13128	0	.	Stalk.
chr21	41452770	41452782	P20591	0	+	41452770	41452782	255,102,0	1	12	0	.	Critical for lipid-binding.
chr21	41993807	41994008	Q9ULJ3	0	-	41993807	41994008	255,102,0	1	201	0	.	Mediates homodimerization.
chr21	42432114	42447191	P57075	0	+	42432114	42447191	255,102,0	1	15077	0	.	Phosphatase-like.
chr21	42759049	42770762	O76083	0	+	42759049	42770762	255,102,0	1	11713	0	.	Catalytic.
chr21	43063947	43063962	P0DN79	0	-	43063947	43063962	255,102,0	1	15	0	.	Pyridoxal phosphate binding.
chr21	43063947	43063962	P35520	0	-	43063947	43063962	255,102,0	1	15	0	.	Pyridoxal phosphate binding. Pubmed:11483494, Pubmed:12173932
chr21	43417688	43417769	P57059	0	-	43417688	43417769	255,102,0	1	81	0	.	RK-rich region.
chr21	44291097	44291109	O43918	0	+	44291097	44291109	255,102,0	1	12	0	.	Interaction with histone H3 not methylated at 'Lys-4'.
chr21	44291124	44291151	O43918	0	+	44291124	44291151	255,102,0	1	27	0	.	Interaction with histone H3 not methylated at 'Lys-4'.
chr21	44291205	44292311	O43918	0	+	44291205	44292311	255,102,0	1	1106	0	.	Interaction with histone H3 not methylated at 'Lys-4'.
chr21	44300108	44320126	P17858	0	+	44300108	44320126	255,102,0	1	20018	0	.	N-terminal catalytic PFK domain 1.
chr21	44313039	44313048	P17858	0	+	44313039	44313048	255,102,0	1	9	0	.	Substrate binding.
chr21	44313665	44313674	P17858	0	+	44313665	44313674	255,102,0	1	9	0	.	Substrate binding.
chr21	44316479	44316491	P17858	0	+	44316479	44316491	255,102,0	1	12	0	.	Substrate binding.
chr21	44320126	44321737	P17858	0	+	44320126	44321737	255,102,0	1	1611	0	.	Interdomain linker.
chr21	44321737	44326859	P17858	0	+	44321737	44326859	255,102,0	1	5122	0	.	C-terminal regulatory PFK domain 2.
chr21	44323846	44323861	P17858	0	+	44323846	44323861	255,102,0	1	15	0	.	Allosteric activator fructose 2,6-bisphosphate binding.
chr21	44324553	44324562	P17858	0	+	44324553	44324562	255,102,0	1	9	0	.	Allosteric activator fructose 2,6-bisphosphate binding.
chr21	44325252	44325264	P17858	0	+	44325252	44325264	255,102,0	1	12	0	.	Allosteric activator fructose 2,6-bisphosphate binding.
chr21	44539352	44540075	P60331	0	-	44539352	44540075	255,102,0	1	723	0	.	24 X 5 AA repeats of C-C-X(3).
chr21	44550774	44551383	P60368	0	-	44550774	44551383	255,102,0	1	609	0	.	22 X 5 AA repeats of C-C-X(3).
chr21	44558073	44558640	P60369	0	-	44558073	44558640	255,102,0	1	567	0	.	18 X 5 AA repeats of C-C-X(3).
chr21	44612175	44612829	P60410	0	+	44612175	44612829	255,102,0	1	654	0	.	19 X 5 AA repeats of C-C-X(3).
chr21	44627246	44627933	P60411	0	+	44627246	44627933	255,102,0	1	687	0	.	25 X 5 AA repeats of C-C-X(3).
chr21	44637492	44638089	P60014	0	+	44637492	44638089	255,102,0	1	597	0	.	15 X 5 AA repeats of C-C-X(3).
chr21	44646533	44647271	P60412	0	+	44646533	44647271	255,102,0	1	738	0	.	25 X 5 AA repeats of C-C-X(3).
chr21	44654314	44654587	P60329	0	-	44654314	44654587	255,102,0	1	273	0	.	15 X 5 AA approximate repeats.
chr21	44658006	44658261	P60328	0	+	44658006	44658261	255,102,0	1	255	0	.	14 X 5 AA approximate repeats.
chr21	44666469	44666859	P59991	0	-	44666469	44666859	255,102,0	1	390	0	.	23 X 5 AA approximate repeats.
chr21	44681841	44682096	P59990	0	-	44681841	44682096	255,102,0	1	255	0	.	14 X 5 AA approximate repeats.
chr21	44697306	44697855	P60413	0	+	44697306	44697855	255,102,0	1	549	0	.	19 X 5 AA repeats of C-C-X(3).
chr21	45175947	45175965	P78563	0	+	45175947	45175965	255,102,0	1	18	0	.	Interaction with substrate RNA.
chr21	45176010	45176016	P78563	0	+	45176010	45176016	255,102,0	1	6	0	.	Interaction with substrate RNA.
chr21	45176409	45176427	P78563	0	+	45176409	45176427	255,102,0	1	18	0	.	Interaction with substrate RNA.
chr21	45176475	45176478	P78563	0	+	45176475	45176478	255,102,0	1	3	0	.	Interaction with substrate RNA.
chr21	45265604	45265610	Q9Y2G5	0	-	45265604	45265610	255,102,0	1	6	0	.	Substrate binding.
chr21	45285891	45285903	Q9Y2G5	0	-	45285891	45285903	255,102,0	1	12	0	.	Substrate binding.
chr21	45473930	45477752	P39060	0	+	45473930	45477752	255,102,0	1	3822	0	.	Nonhelical region 1 (NC1).
chr21	45477752	45477854	P39060	0	+	45477752	45477854	255,102,0	1	102	0	.	Triple-helical region 1 (COL1).
chr21	45477854	45477884	P39060	0	+	45477854	45477884	255,102,0	1	30	0	.	Nonhelical region 2 (NC2).
chr21	45477884	45480138	P39060	0	+	45477884	45480138	255,102,0	1	2254	0	.	Triple-helical region 2 (COL2).
chr21	45480138	45480520	P39060	0	+	45480138	45480520	255,102,0	1	382	0	.	Nonhelical region 3 (NC3).
chr21	45480699	45486977	P39060	0	+	45480699	45486977	255,102,0	1	6278	0	.	Triple-helical region 3 (COL3).
chr21	45486977	45487500	P39060	0	+	45486977	45487500	255,102,0	1	523	0	.	Nonhelical region 4 (NC4).
chr21	45487500	45491293	P39060	0	+	45487500	45491293	255,102,0	1	3793	0	.	Triple-helical region 4 (COL4).
chr21	45491293	45492555	P39060	0	+	45491293	45492555	255,102,0	1	1262	0	.	Nonhelical region 5 (NC5).
chr21	45492555	45493527	P39060	0	+	45492555	45493527	255,102,0	1	972	0	.	Triple-helical region 5 (COL5).
chr21	45493527	45493566	P39060	0	+	45493527	45493566	255,102,0	1	39	0	.	Nonhelical region 6 (NC6).
chr21	45493566	45496553	P39060	0	+	45493566	45496553	255,102,0	1	2987	0	.	Triple-helical region 6 (COL6).
chr21	45496553	45497064	P39060	0	+	45496553	45497064	255,102,0	1	511	0	.	Nonhelical region 7 (NC7).
chr21	45497064	45504018	P39060	0	+	45497064	45504018	255,102,0	1	6954	0	.	Triple-helical region 7 (COL7).
chr21	45504018	45504054	P39060	0	+	45504018	45504054	255,102,0	1	36	0	.	Nonhelical region 8 (NC8).
chr21	45504415	45504481	P39060	0	+	45504415	45504481	255,102,0	1	66	0	.	Triple-helical region 8 (COL8).
chr21	45504481	45504502	P39060	0	+	45504481	45504502	255,102,0	1	21	0	.	Nonhelical region 9 (NC9).
chr21	45504502	45505253	P39060	0	+	45504502	45505253	255,102,0	1	751	0	.	Triple-helical region 9 (COL9).
chr21	45505253	45505371	P39060	0	+	45505253	45505371	255,102,0	1	118	0	.	Nonhelical region 10 (NC10).
chr21	45505371	45505425	P39060	0	+	45505371	45505425	255,102,0	1	54	0	.	Triple-helical region 10 (COL10).
chr21	45505425	45512395	P39060	0	+	45505425	45512395	255,102,0	1	6970	0	.	Nonhelical region 11 (NC11).
chr21	45981907	45987618	P12109	0	+	45981907	45987618	255,102,0	1	5711	0	.	N-terminal globular domain.
chr21	45987618	45999692	P12109	0	+	45987618	45999692	255,102,0	1	12074	0	.	Triple-helical region.
chr21	46000330	46004010	P12109	0	+	46000330	46004010	255,102,0	1	3680	0	.	C-terminal globular domain.
chr21	46111536	46114040	P12110	0	+	46111536	46114040	255,102,0	1	2504	0	.	Nonhelical region.
chr21	46114040	46124920	P12110	0	+	46114040	46124920	255,102,0	1	10880	0	.	Triple-helical region.
chr21	46125265	46132549	P12110	0	+	46125265	46132549	255,102,0	1	7284	0	.	Nonhelical region.
chr21	46136989	46145913	O95954	0	-	46136989	46145913	255,102,0	1	8924	0	.	Cyclodeaminase/cyclohydrolase.
chr21	46145913	46145937	O95954	0	-	46145913	46145937	255,102,0	1	24	0	.	Linker.
chr21	46145937	46151650	O95954	0	-	46145937	46151650	255,102,0	1	5713	0	.	Formiminotransferase C-subdomain.
chr21	46151650	46155523	O95954	0	-	46151650	46155523	255,102,0	1	3873	0	.	Formiminotransferase N-subdomain.
chr21	46242857	46244873	O60318	0	-	46242857	46244873	255,102,0	1	2016	0	.	Acetyltransferase.
chr21	46256952	46260890	O60318	0	-	46256952	46260890	255,102,0	1	3938	0	.	CID.
chr21	46265985	46275278	O60318	0	-	46265985	46275278	255,102,0	1	9293	0	.	SAC3 homology.
chr21	46277713	46283797	O60318	0	-	46277713	46283797	255,102,0	1	6084	0	.	DNA primase.
chr21	46284266	46285190	O60318	0	-	46284266	46285190	255,102,0	1	924	0	.	FG-repeats.
chr21	46436098	46443847	O95613	0	+	46436098	46443847	255,102,0	1	7749	0	.	Interaction with NEK2. Pubmed:20599736
chr21	46441043	46441085	O95613	0	+	46441043	46441085	255,102,0	1	42	0	.	Calmodulin-binding.
chr21	46636951	46658921	P55345	0	+	46636951	46658921	255,102,0	1	21970	0	.	Interaction with ESR1.
chr21	46644407	46649706	P55345	0	+	46644407	46649706	255,102,0	1	5299	0	.	Interaction with RB1.
chr21	46648526	46658915	P55345	0	+	46648526	46658915	255,102,0	1	10389	0	.	Interaction with ESR1.
chr22	17203682	17203706	Q9NZK5	0	-	17203682	17203706	255,102,0	1	24	0	.	Substrate binding.
chr22	17203760	17207234	Q9NZK5	0	-	17203760	17207234	255,102,0	1	3474	0	.	PRB domain.
chr22	17209377	17209590	Q9NZK5	0	-	17209377	17209590	255,102,0	1	213	0	.	Dimerization.
chr22	17790764	17810738	Q7RTP6	0	-	17790764	17810738	255,102,0	1	19974	0	.	RAB-binding domain (RBD). Pubmed:27552051
chr22	17893871	17906809	Q7RTP6	0	-	17893871	17906809	255,102,0	1	12938	0	.	Monooxygenase domain.
chr22	18517173	18517179	B5MD39	0	-	18517173	18517179	255,102,0	1	6	0	.	Glutamate binding.
chr22	18517239	18517245	B5MD39	0	-	18517239	18517245	255,102,0	1	6	0	.	Glutamate binding.
chr22	19180221	19183566	P53675	0	-	19180221	19183566	255,102,0	1	3345	0	.	Trimerization.
chr22	19180221	19226251	P53675	0	-	19180221	19226251	255,102,0	1	46030	0	.	Proximal segment.
chr22	19180221	19232550	P53675	0	-	19180221	19232550	255,102,0	1	52329	0	.	Heavy chain arm.
chr22	19187596	19201457	P53675	0	-	19187596	19201457	255,102,0	1	13861	0	.	Involved in binding clathrin light chain.
chr22	19226263	19232550	P53675	0	-	19226263	19232550	255,102,0	1	6287	0	.	Distal segment.
chr22	19232550	19233249	P53675	0	-	19232550	19233249	255,102,0	1	699	0	.	Flexible linker.
chr22	19233249	19291638	P53675	0	-	19233249	19291638	255,102,0	1	58389	0	.	Globular terminal domain.
chr22	19233291	19233445	P53675	0	-	19233291	19233445	255,102,0	1	154	0	.	Binding site for the uncoating ATPase, involved in lattice disassembly.
chr22	19234685	19235761	P53675	0	-	19234685	19235761	255,102,0	1	1076	0	.	WD40-like repeat 7.
chr22	19235761	19239298	P53675	0	-	19235761	19239298	255,102,0	1	3537	0	.	WD40-like repeat 6.
chr22	19239298	19242870	P53675	0	-	19239298	19242870	255,102,0	1	3572	0	.	WD40-like repeat 5.
chr22	19242870	19254030	P53675	0	-	19242870	19254030	255,102,0	1	11160	0	.	WD40-like repeat 4.
chr22	19254030	19254156	P53675	0	-	19254030	19254156	255,102,0	1	126	0	.	WD40-like repeat 3.
chr22	19254156	19275671	P53675	0	-	19254156	19275671	255,102,0	1	21515	0	.	WD40-like repeat 2.
chr22	19275671	19275803	P53675	0	-	19275671	19275803	255,102,0	1	132	0	.	WD40-like repeat 1.
chr22	19331442	19359358	P54198	0	-	19331442	19359358	255,102,0	1	27916	0	.	Interaction with histone H4.
chr22	19355836	19359352	P54198	0	-	19355836	19359352	255,102,0	1	3516	0	.	Interaction with PAX3.
chr22	19355842	19361930	P54198	0	-	19355842	19361930	255,102,0	1	6088	0	.	Interaction with histone H2B.
chr22	19359352	19361927	P54198	0	-	19359352	19361927	255,102,0	1	2575	0	.	Interaction with PAX3.
chr22	19359382	19385589	P54198	0	-	19359382	19385589	255,102,0	1	26207	0	.	Interaction with CCNA1. Pubmed:11238922
chr22	19378044	19385589	P54198	0	-	19378044	19385589	255,102,0	1	7545	0	.	Interaction with ASF1A.
chr22	19378056	19385535	P54198	0	-	19378056	19385535	255,102,0	1	7479	0	.	Required for repression of histone gene transcription.
chr22	19523601	19523607	O00501	0	-	19523601	19523607	255,102,0	1	6	0	.	Interactions with TJP1, TJP2 and TJP3.
chr22	19964182	19964194	A0A140VJG8	0	+	19964182	19964194	255,102,0	1	12	0	.	S-adenosyl-L-methionine binding.
chr22	19964182	19964194	E7EMS6	0	+	19964182	19964194	255,102,0	1	12	0	.	S-adenosyl-L-methionine binding.
chr22	19964182	19964194	E7EUU8	0	+	19964182	19964194	255,102,0	1	12	0	.	S-adenosyl-L-methionine binding.
chr22	19964182	19964194	P21964	0	+	19964182	19964194	255,102,0	1	12	0	.	S-adenosyl-L-methionine binding.
chr22	20085963	20087266	Q8WYQ5	0	+	20085963	20087266	255,102,0	1	1303	0	.	Necessary for nuclear localization and retention.
chr22	20085963	20089978	Q8WYQ5	0	+	20085963	20089978	255,102,0	1	4015	0	.	Necessary for interaction with NCL. Pubmed:17765891
chr22	20087266	20110039	Q8WYQ5	0	+	20087266	20110039	255,102,0	1	22773	0	.	Necessary for heme-binding and pri-miRNA processing.
chr22	20107374	20110105	Q8WYQ5	0	+	20107374	20110105	255,102,0	1	2731	0	.	Interaction with DROSHA. Pubmed:26748718
chr22	20507702	20553155	Q96RN5	0	+	20507702	20553155	255,102,0	1	45453	0	.	Interaction with SREBF1. Pubmed:16799563
chr22	20779513	20779549	P05546	0	+	20779513	20779549	255,102,0	1	36	0	.	Chemotactic activity.
chr22	20779528	20779603	P05546	0	+	20779528	20779603	255,102,0	1	75	0	.	2 X 11 AA approximate repeats, Asp/Glu-rich (acidic) (hirudin-like).
chr22	20779885	20779948	P05546	0	+	20779885	20779948	255,102,0	1	63	0	.	Glycosaminoglycan-binding site.
chr22	21445630	21445645	Q96JB3	0	+	21445630	21445645	255,102,0	1	15	0	.	Binding to CtBP.
chr22	21805879	21805885	P28482	0	-	21805879	21805885	255,102,0	1	6	0	.	Inhibitor-binding.
chr22	21806017	21806029	P28482	0	-	21806017	21806029	255,102,0	1	12	0	.	Inhibitor-binding.
chr22	22244956	22245022	P12018	0	+	22244956	22245022	255,102,0	1	66	0	.	Framework-1.
chr22	22245022	22245067	P12018	0	+	22245022	22245067	255,102,0	1	45	0	.	Complementarity-determining-1.
chr22	22245067	22245109	P12018	0	+	22245067	22245109	255,102,0	1	42	0	.	Framework-2.
chr22	22245109	22245142	P12018	0	+	22245109	22245142	255,102,0	1	33	0	.	Complementarity-determining-2.
chr22	22245142	22245244	P12018	0	+	22245142	22245244	255,102,0	1	102	0	.	Framework-3.
chr22	22395195	22395261	P04211	0	+	22395195	22395261	255,102,0	1	66	0	.	Framework-1.
chr22	22395196	22395262	P04211	0	+	22395196	22395262	255,102,0	1	66	0	.	Framework-1.
chr22	22395261	22395300	P04211	0	+	22395261	22395300	255,102,0	1	39	0	.	Complementarity-determining-1. Pubmed:6091030
chr22	22395262	22395301	P04211	0	+	22395262	22395301	255,102,0	1	39	0	.	Complementarity-determining-1. Pubmed:6091030
chr22	22395300	22395348	P04211	0	+	22395300	22395348	255,102,0	1	48	0	.	Framework-2.
chr22	22395301	22395349	P04211	0	+	22395301	22395349	255,102,0	1	48	0	.	Framework-2.
chr22	22395348	22395369	P04211	0	+	22395348	22395369	255,102,0	1	21	0	.	Complementarity-determining-2. Pubmed:6091030
chr22	22395349	22395370	P04211	0	+	22395349	22395370	255,102,0	1	21	0	.	Complementarity-determining-2. Pubmed:6091030
chr22	22395369	22395465	P04211	0	+	22395369	22395465	255,102,0	1	96	0	.	Framework-3.
chr22	22395370	22395466	P04211	0	+	22395370	22395466	255,102,0	1	96	0	.	Framework-3.
chr22	22395465	22395489	P04211	0	+	22395465	22395489	255,102,0	1	24	0	.	Complementarity-determining-3. Pubmed:6091030
chr22	22395466	22395490	P04211	0	+	22395466	22395490	255,102,0	1	24	0	.	Complementarity-determining-3. Pubmed:6091030
chr22	22548069	22548351	P78395	0	-	22548069	22548351	255,102,0	1	282	0	.	Mediates interaction with RARA. Pubmed:16179254
chr22	22557174	22557456	P78395	0	-	22557174	22557456	255,102,0	1	282	0	.	Mediates interaction with RARA. Pubmed:16179254
chr22	22646996	22647002	Q14390	0	+	22646996	22647002	255,102,0	1	6	0	.	Glutamate binding.
chr22	22893784	22895376	B9A064	0	+	22893784	22895376	255,102,0	1	1592	0	.	J region (By similarity to lambda light-chain).
chr22	22895376	22895691	B9A064	0	+	22895376	22895691	255,102,0	1	315	0	.	C region (By similarity to lambda light-chain).
chr22	23180960	23182238	P11274	0	+	23180960	23182238	255,102,0	1	1278	0	.	Kinase.
chr22	23181548	23182115	P11274	0	+	23181548	23182115	255,102,0	1	567	0	.	Binding to ABL SH2-domain.
chr22	23573268	23573583	P15814	0	-	23573268	23573583	255,102,0	1	315	0	.	C region (By similarity to lambda light-chain).
chr22	23573583	23575000	P15814	0	-	23573583	23575000	255,102,0	1	1417	0	.	J region (By similarity to lambda light-chain).
chr22	23787169	23793665	Q12824	0	+	23787169	23793665	255,102,0	1	6496	0	.	DNA-binding. Pubmed:26073604
chr22	23803340	23816870	Q12824	0	+	23803340	23816870	255,102,0	1	13530	0	.	HIV-1 integrase-binding.
chr22	23803349	23816876	Q12824	0	+	23803349	23816876	255,102,0	1	13527	0	.	MYC-binding.
chr22	23803349	23825386	Q12824	0	+	23803349	23825386	255,102,0	1	22037	0	.	2 X approximate tandem repeats.
chr22	23825338	23825383	Q12824	0	+	23825338	23825383	255,102,0	1	45	0	.	Interaction with PPP1R15A.
chr22	23960292	23960298	P0CG30	0	-	23960292	23960298	255,102,0	1	6	0	.	Glutathione binding.
chr22	23960331	23960337	P0CG30	0	-	23960331	23960337	255,102,0	1	6	0	.	Glutathione binding.
chr22	23960370	23960376	P0CG30	0	-	23960370	23960376	255,102,0	1	6	0	.	Glutathione binding.
chr22	23980995	23981001	P0CG29	0	+	23980995	23981001	255,102,0	1	6	0	.	Glutathione binding.
chr22	23981034	23981040	P0CG29	0	+	23981034	23981040	255,102,0	1	6	0	.	Glutathione binding.
chr22	24039511	24039517	P30711	0	-	24039511	24039517	255,102,0	1	6	0	.	Glutathione binding. Pubmed:16298388
chr22	24039550	24039556	P30711	0	-	24039550	24039556	255,102,0	1	6	0	.	Glutathione binding. Pubmed:16298388
chr22	24177643	24177757	Q9Y6J0	0	+	24177643	24177757	255,102,0	1	114	0	.	Required for interaction with calcineurin.
chr22	24225337	24225343	P36269	0	-	24225337	24225343	255,102,0	1	6	0	.	Glutamate binding.
chr22	24440751	24440781	P29274	0	+	24440751	24440781	255,102,0	1	30	0	.	Agonist binding.
chr22	24440985	24441009	P29274	0	+	24440985	24441009	255,102,0	1	24	0	.	Agonist binding.
chr22	24441039	24441072	P29274	0	+	24441039	24441072	255,102,0	1	33	0	.	Agonist binding.
chr22	24571923	24571953	P62318	0	+	24571923	24571953	255,102,0	1	30	0	.	5 X 2 AA tandem repeats of [RM]-G.
chr22	24628094	24628100	P19440	0	+	24628094	24628100	255,102,0	1	6	0	.	Glutamate binding.
chr22	24855644	24859805	Q2NKQ1	0	+	24855644	24859805	255,102,0	1	4161	0	.	Important for interaction with RAB9A and RAB9B.
chr22	24859814	24868431	Q2NKQ1	0	+	24859814	24868431	255,102,0	1	8617	0	.	Required for interaction with RAP family members.
chr22	25201396	25201465	P26998	0	+	25201396	25201465	255,102,0	1	69	0	.	N-terminal arm.
chr22	25203892	25205231	P26998	0	+	25203892	25205231	255,102,0	1	1339	0	.	Connecting peptide.
chr22	25207173	25207209	P26998	0	+	25207173	25207209	255,102,0	1	36	0	.	C-terminal arm.
chr22	25221432	25221477	P43320	0	+	25221432	25221477	255,102,0	1	45	0	.	N-terminal arm.
chr22	25227982	25229447	P43320	0	+	25227982	25229447	255,102,0	1	1465	0	.	Connecting peptide.
chr22	25231730	25231769	P43320	0	+	25231730	25231769	255,102,0	1	39	0	.	C-terminal arm.
chr22	25565040	25674451	P35626	0	+	25565040	25674451	255,102,0	1	109411	0	.	N-terminal.
chr22	26292749	26292794	Q9BYH1	0	+	26292749	26292794	255,102,0	1	45	0	.	O-glycosylated at one site.
chr22	26292836	26292851	Q9BYH1	0	+	26292836	26292851	255,102,0	1	15	0	.	O-glycosylated at one site.
chr22	26434488	26434497	Q6ICH7	0	+	26434488	26434497	255,102,0	1	9	0	.	2-oxoglutarate binding.
chr22	26483977	26484040	Q9UH36	0	+	26483977	26484040	255,102,0	1	63	0	.	3 X 7 AA tandem repeats of R-E-A-A-P-R-G.
chr22	26492324	26494169	Q9UBB9	0	-	26492324	26494169	255,102,0	1	1845	0	.	Required for nuclear speckle localization.
chr22	26510122	26510272	Q9UBB9	0	-	26510122	26510272	255,102,0	1	150	0	.	Required for interaction with DHX15. Pubmed:19103666
chr22	26599492	26599546	P53674	0	-	26599492	26599546	255,102,0	1	54	0	.	C-terminal arm.
chr22	26602009	26607891	P53674	0	-	26602009	26607891	255,102,0	1	5882	0	.	Connecting peptide.
chr22	26616145	26616316	P53674	0	-	26616145	26616316	255,102,0	1	171	0	.	N-terminal arm.
chr22	26622599	26622629	P53673	0	+	26622599	26622629	255,102,0	1	30	0	.	N-terminal arm.
chr22	26625616	26628299	P53673	0	+	26625616	26628299	255,102,0	1	2683	0	.	Connecting peptide.
chr22	28695786	28695867	O96017	0	-	28695786	28695867	255,102,0	1	81	0	.	T-loop/activation segment.
chr22	28795548	28795629	P17861	0	-	28795548	28795629	255,102,0	1	81	0	.	Necessary for the translational pausing of its own mRNA. Pubmed:21233347
chr22	28797130	28799089	P17861	0	-	28797130	28799089	255,102,0	1	1959	0	.	Leucine-zipper.
chr22	28799098	28800311	P17861	0	-	28799098	28800311	255,102,0	1	1213	0	.	Basic motif.
chr22	28799104	28800302	P17861	0	-	28799104	28800302	255,102,0	1	1198	0	.	Nuclear localization signal (NLS); in isoforms 1 and isoform 2. Pubmed:16461360
chr22	29268336	29288667	Q01844	0	+	29268336	29288667	255,102,0	1	20331	0	.	EAD (Gln/Pro/Thr-rich).
chr22	29272223	29288667	Q01844	0	+	29272223	29288667	255,102,0	1	16444	0	.	31 X approximate tandem repeats.
chr22	29313303	29315246	Q92737	0	-	29313303	29315246	255,102,0	1	1943	0	.	Small GTPase-like.
chr22	29539331	29549144	Q13769	0	-	29539331	29549144	255,102,0	1	9813	0	.	Interaction with THOC7. Pubmed:19059247
chr22	29542878	29549144	Q13769	0	-	29542878	29549144	255,102,0	1	6266	0	.	Interaction with CSF1R.
chr22	30007998	30008010	Q13615	0	+	30007998	30008010	255,102,0	1	12	0	.	Substrate binding.
chr22	30009058	30009064	Q13615	0	+	30009058	30009064	255,102,0	1	6	0	.	Substrate binding.
chr22	30012482	30012503	Q13615	0	+	30012482	30012503	255,102,0	1	21	0	.	Substrate binding.
chr22	30285840	30285855	Q8WTX7	0	-	30285840	30285855	255,102,0	1	15	0	.	Arginine-binding. Pubmed:27487210
chr22	30285909	30285915	Q8WTX7	0	-	30285909	30285915	255,102,0	1	6	0	.	Arginine-binding. Pubmed:27487210
chr22	30287408	30287414	Q8WTX7	0	-	30287408	30287414	255,102,0	1	6	0	.	Arginine-binding. Pubmed:27487210
chr22	30292377	30292389	Q9BXI6	0	-	30292377	30292389	255,102,0	1	12	0	.	Binding to the PDZ domain of EBP50.
chr22	30577048	30578905	O00541	0	-	30577048	30578905	255,102,0	1	1857	0	.	Required for 28S ribosomal RNA processing.
chr22	30579859	30580698	O00541	0	-	30579859	30580698	255,102,0	1	839	0	.	Sufficient for interaction with MAP1B.
chr22	30581384	30591833	O00541	0	-	30581384	30591833	255,102,0	1	10449	0	.	Sufficient for nucleolar localization.
chr22	30588116	30591833	O00541	0	-	30588116	30591833	255,102,0	1	3717	0	.	Required for 28S ribosomal RNA processing.
chr22	30614374	30614389	P20062	0	+	30614374	30614389	255,102,0	1	15	0	.	Cobalamin binding.
chr22	30614488	30615302	P20062	0	+	30614488	30615302	255,102,0	1	814	0	.	Cobalamin binding.
chr22	30623043	30623052	P20062	0	+	30623043	30623052	255,102,0	1	9	0	.	Cobalamin binding.
chr22	31126376	31128645	Q15735	0	+	31126376	31128645	255,102,0	1	2269	0	.	Catalytic.
chr22	31128645	31133918	Q15735	0	+	31128645	31133918	255,102,0	1	5273	0	.	Required for ruffle localization.
chr22	31137902	31139907	Q9NZ20	0	-	31137902	31139907	255,102,0	1	2005	0	.	Phospholipase A2-like.
chr22	31399686	31400625	Q9Y295	0	+	31399686	31400625	255,102,0	1	939	0	.	Required for interaction with STK16.
chr22	31471905	31488631	Q9NRA8	0	-	31471905	31488631	255,102,0	1	16726	0	.	EIF4E-binding.
chr22	31531121	31546912	A8K8P3	0	+	31531121	31546912	255,102,0	1	15791	0	.	Interaction with CETN2.
chr22	31589455	31589515	A8K8P3	0	+	31589455	31589515	255,102,0	1	60	0	.	Interaction with CETN2.
chr22	31604347	31604871	A8K8P3	0	+	31604347	31604871	255,102,0	1	524	0	.	Interaction with CETN2.
chr22	32475002	32479122	Q9Y3I1	0	+	32475002	32479122	255,102,0	1	4120	0	.	Ubiquitin-like.
chr22	32479131	32479245	Q9Y3I1	0	+	32479131	32479245	255,102,0	1	114	0	.	Important for interaction with PINK1. Pubmed:23933751
chr22	32479242	32483986	Q9Y3I1	0	+	32479242	32483986	255,102,0	1	4744	0	.	Important for interaction with CDK6.
chr22	32484016	32493109	Q9Y3I1	0	+	32484016	32493109	255,102,0	1	9093	0	.	Important for dimerization and interaction with PSMF1. Pubmed:18495667
chr22	32493277	32498527	Q9Y3I1	0	+	32493277	32498527	255,102,0	1	5250	0	.	Important for interaction with CDK6.
chr22	32513694	32518059	O14994	0	-	32513694	32518059	255,102,0	1	4365	0	.	E.
chr22	32518059	32528906	O14994	0	-	32518059	32528906	255,102,0	1	10847	0	.	J; Pro-rich linker.
chr22	32528906	33006392	O14994	0	-	32528906	33006392	255,102,0	1	477486	0	.	C; actin-binding and synaptic-vesicle binding.
chr22	32802070	32802085	P35625	0	+	32802070	32802085	255,102,0	1	15	0	.	Involved in metalloproteinase-binding.
chr22	32857305	32857311	P35625	0	+	32857305	32857311	255,102,0	1	6	0	.	Involved in metalloproteinase-binding.
chr22	32857356	32859305	P35625	0	+	32857356	32859305	255,102,0	1	1949	0	.	Mediates interaction with EFEMP1. Pubmed:15123717
chr22	33006392	33006581	O14994	0	-	33006392	33006581	255,102,0	1	189	0	.	B; linker.
chr22	33006578	33006662	O14994	0	-	33006578	33006662	255,102,0	1	84	0	.	A.
chr22	33274429	33337693	O95461	0	-	33274429	33337693	255,102,0	1	63264	0	.	Glucuronyltransferase activity. Pubmed:22223806
chr22	33337693	33626323	O95461	0	-	33337693	33626323	255,102,0	1	288630	0	.	Xylosyltransferase activity. Pubmed:22223806
chr22	35551795	35551936	Q96D21	0	+	35551795	35551936	255,102,0	1	141	0	.	Interaction with GNB1, GNB2 and GNB3. Pubmed:19255495
chr22	36306422	36306491	P35579	0	-	36306422	36306491	255,102,0	1	69	0	.	Actin-binding.
chr22	36517393	36518769	O15371	0	-	36517393	36518769	255,102,0	1	1376	0	.	RNA gate.
chr22	36864972	36864981	Q15080	0	+	36864972	36864981	255,102,0	1	9	0	.	Phosphatidylinositol 3-phosphate binding.
chr22	36867393	36867402	Q15080	0	+	36867393	36867402	255,102,0	1	9	0	.	Phosphatidylinositol 3-phosphate binding.
chr22	37018255	37018303	Q16762	0	-	37018255	37018303	255,102,0	1	48	0	.	Hinge.
chr22	37024647	37024695	P25325	0	+	37024647	37024695	255,102,0	1	48	0	.	Hinge.
chr22	37309316	37311004	Q9UIA0	0	+	37309316	37311004	255,102,0	1	1688	0	.	Phosphatidylinositol 3,4,5-trisphosphate binding.
chr22	37313481	37313508	Q9UIA0	0	+	37313481	37313508	255,102,0	1	27	0	.	C-terminal autoinhibitory region.
chr22	37568301	37568469	Q00587	0	+	37568301	37568469	255,102,0	1	168	0	.	8 X 7 AA tandem repeats of [PT]-[AT]-A-[ENT]-[PT]-[PTS]-[AG].
chr22	37570611	37570632	P05162	0	-	37570611	37570632	255,102,0	1	21	0	.	Beta-galactoside binding.
chr22	37620273	37623623	Q9UJY5	0	+	37620273	37623623	255,102,0	1	3350	0	.	Interaction with ARF3.
chr22	37625033	37631098	Q9UJY5	0	+	37625033	37631098	255,102,0	1	6065	0	.	Unstructured hinge.
chr22	37658953	37658968	Q96GD0	0	+	37658953	37658968	255,102,0	1	15	0	.	Substrate binding.
chr22	37678525	37678540	P09382	0	+	37678525	37678540	255,102,0	1	15	0	.	Beta-galactoside binding.
chr22	37678597	37678609	P09382	0	+	37678597	37678609	255,102,0	1	12	0	.	Beta-galactoside binding.
chr22	37812958	37812964	O75600	0	+	37812958	37812964	255,102,0	1	6	0	.	Pyridoxal phosphate binding.
chr22	37815469	37815481	O75600	0	+	37815469	37815481	255,102,0	1	12	0	.	Pyridoxal phosphate binding.
chr22	37815730	37815736	O75600	0	+	37815730	37815736	255,102,0	1	6	0	.	Pyridoxal phosphate binding; shared with dimeric partner.
chr22	37832741	37838554	Q6NXT1	0	-	37832741	37838554	255,102,0	1	5813	0	.	LYN-binding.
chr22	37931870	37940827	Q8N3F8	0	+	37931870	37940827	255,102,0	1	8957	0	.	RAB-binding domain (RBD); mediates the interaction with RAB13 and RAB35 and intramolecular interaction with the CH domain. Pubmed:21795389, Pubmed:21951725
chr22	37932633	37940827	Q8N3F8	0	+	37932633	37940827	255,102,0	1	8194	0	.	Necessary and sufficient to associate with tubular recycling endosome membranes, mediate phosphatidic acid-binding and membrane tubulation.
chr22	38112502	38112538	O60733	0	-	38112502	38112538	255,102,0	1	36	0	.	Calmodulin-binding.
chr22	38113600	38115532	O60733	0	-	38113600	38115532	255,102,0	1	1932	0	.	Calmodulin-binding.
chr22	38214533	38214611	Q9ULX9	0	+	38214533	38214611	255,102,0	1	78	0	.	Basic motif.
chr22	38214617	38214662	Q9ULX9	0	+	38214617	38214662	255,102,0	1	45	0	.	Leucine-zipper.
chr22	38427799	38427862	P48050	0	-	38427799	38427862	255,102,0	1	63	0	.	Val/Gly/Ala/Pro stretch.
chr22	38670982	38673191	Q9Y3M2	0	+	38670982	38673191	255,102,0	1	2209	0	.	Minimal region for the interaction with PKD2. Pubmed:15194699
chr22	38682325	38682355	Q9NS69	0	+	38682325	38682355	255,102,0	1	30	0	.	Import sequence; necessary for mitochondrion outer membrane localization and integration in the TOM complex.
chr22	38682888	38682951	Q9NS69	0	+	38682888	38682951	255,102,0	1	63	0	.	TMD; necessary for mitochondrion outer membrane localization and integration in the TOM complex.
chr22	38683778	38683838	Q9NS69	0	+	38683778	38683838	255,102,0	1	60	0	.	C-tail signal; necessary for mitochondrion outer membrane localization and integration in the TOM complex.
chr22	38716664	38716688	O00178	0	+	38716664	38716688	255,102,0	1	24	0	.	G1.
chr22	38716781	38716796	O00178	0	+	38716781	38716796	255,102,0	1	15	0	.	G2.
chr22	38716919	38716931	O00178	0	+	38716919	38716931	255,102,0	1	12	0	.	G3.
chr22	38721828	38721840	O00178	0	+	38721828	38721840	255,102,0	1	12	0	.	G4.
chr22	38726027	38726036	O00178	0	+	38726027	38726036	255,102,0	1	9	0	.	G5.
chr22	38736269	38739781	Q9UH99	0	-	38736269	38739781	255,102,0	1	3512	0	.	Sufficient for interaction with SYNE1 and SYNE2. Pubmed:22632968
chr22	38750904	38752628	Q9UH99	0	-	38750904	38752628	255,102,0	1	1724	0	.	LMNA-binding.
chr22	39040960	39080941	Q9HC16	0	+	39040960	39080941	255,102,0	1	39981	0	.	Essential for cytoplasmic localization.
chr22	39077361	39080941	Q9HC16	0	+	39077361	39080941	255,102,0	1	3580	0	.	Essential for cytoplasmic localization.
chr22	39083773	39086551	Q9HC16	0	+	39083773	39086551	255,102,0	1	2778	0	.	Necessary for homooligomerization.
chr22	39083785	39083794	Q9HC16	0	+	39083785	39083794	255,102,0	1	9	0	.	Interaction with DNA.
chr22	39086479	39086503	Q9HC16	0	+	39086479	39086503	255,102,0	1	24	0	.	Interaction with DNA.
chr22	39133938	39133980	O95931	0	-	39133938	39133980	255,102,0	1	42	0	.	Required for cellular lifespan extension.
chr22	39511848	39512494	Q9NQG6	0	+	39511848	39512494	255,102,0	1	646	0	.	Dimerization.
chr22	39512386	39512416	Q9NQG6	0	+	39512386	39512416	255,102,0	1	30	0	.	Important for interaction with DNM1L.
chr22	39513630	39513657	Q9NQG6	0	+	39513630	39513657	255,102,0	1	27	0	.	Important for interaction with DNM1L.
chr22	39522383	39522446	P18848	0	+	39522383	39522446	255,102,0	1	63	0	.	Basic motif.
chr22	39522458	39522569	P18848	0	+	39522458	39522569	255,102,0	1	111	0	.	Interaction with GABBR1.
chr22	39522461	39522548	P18848	0	+	39522461	39522548	255,102,0	1	87	0	.	Leucine-zipper.
chr22	40178135	40273441	Q9UPQ9	0	+	40178135	40273441	255,102,0	1	95306	0	.	Interaction with argonaute proteins.
chr22	40285713	40322908	Q9UPQ9	0	+	40285713	40322908	255,102,0	1	37195	0	.	Silencing domain; interaction with CNOT1 and PAN3. Pubmed:21981923
chr22	40310971	40312539	Q9UPQ9	0	+	40310971	40312539	255,102,0	1	1568	0	.	PABPC1-interacting motif-2 (PAM2).
chr22	40346615	40346621	P30566	0	+	40346615	40346621	255,102,0	1	6	0	.	Substrate binding; shared with neighboring subunit.
chr22	40349930	40349939	P30566	0	+	40349930	40349939	255,102,0	1	9	0	.	Substrate binding.
chr22	40350008	40350014	P30566	0	+	40350008	40350014	255,102,0	1	6	0	.	Substrate binding.
chr22	40420959	40463227	Q969V6	0	-	40420959	40463227	255,102,0	1	42268	0	.	Mediates interaction with SCAI and ACTB.
chr22	40770836	40773983	O43808	0	-	40770836	40773983	255,102,0	1	3147	0	.	Necessary for targeting to peroxisomes and interaction with PEX19.
chr22	40779018	40819248	O43808	0	-	40779018	40819248	255,102,0	1	40230	0	.	Necessary for targeting to peroxisomes and interaction with PEX19.
chr22	41093007	41117509	Q09472	0	+	41093007	41117509	255,102,0	1	24502	0	.	Interaction with ALX1. Pubmed:12929931
chr22	41093007	41117539	Q09472	0	+	41093007	41117539	255,102,0	1	24532	0	.	Interaction with RORA. Pubmed:9862959
chr22	41152256	41152295	Q09472	0	+	41152256	41152295	255,102,0	1	39	0	.	CRD1; mediates transcriptional repression.
chr22	41169518	41169527	Q09472	0	+	41169518	41169527	255,102,0	1	9	0	.	Interaction with histone. Pubmed:18273021
chr22	41169521	41169530	Q09472	0	+	41169521	41169530	255,102,0	1	9	0	.	Acetyl-CoA binding. Pubmed:24819397
chr22	41169557	41169563	Q09472	0	+	41169557	41169563	255,102,0	1	6	0	.	Acetyl-CoA binding. Pubmed:24819397
chr22	41173718	41177165	Q09472	0	+	41173718	41177165	255,102,0	1	3447	0	.	Binding region for E1A adenovirus.
chr22	41177717	41178347	Q09472	0	+	41177717	41178347	255,102,0	1	630	0	.	Interaction with HTLV-1 Tax.
chr22	41177831	41178431	Q09472	0	+	41177831	41178431	255,102,0	1	600	0	.	Interaction with NCOA2. Pubmed:15731352
chr22	41395750	41395813	Q10587	0	+	41395750	41395813	255,102,0	1	63	0	.	Basic motif.
chr22	41395813	41395837	Q10587	0	+	41395813	41395837	255,102,0	1	24	0	.	Leucine-zipper.
chr22	41515424	41515433	Q99798	0	+	41515424	41515433	255,102,0	1	9	0	.	Substrate binding.
chr22	41527341	41527347	Q99798	0	+	41527341	41527347	255,102,0	1	6	0	.	Substrate binding.
chr22	41663632	41663812	P12956	0	+	41663632	41663812	255,102,0	1	180	0	.	Interaction with DEAF1. Pubmed:22442688
chr22	41833270	41866892	Q12772	0	+	41833270	41866892	255,102,0	1	33622	0	.	Transcriptional activation (acidic).
chr22	41868780	41877315	Q12772	0	+	41868780	41877315	255,102,0	1	8535	0	.	Interaction with LMNA.
chr22	41875384	41875450	Q12772	0	+	41875384	41875450	255,102,0	1	66	0	.	Leucine-zipper.
chr22	41926680	41926698	Q96RJ3	0	-	41926680	41926698	255,102,0	1	18	0	.	Essential for TNFSF13B/TALL1/BAFF/BLyS binding.
chr22	42026773	42027046	Q6ICG8	0	+	42026773	42027046	255,102,0	1	273	0	.	10 X 7 AA tandem repeat of Y-G-X-P-P-X-G.
chr22	42067851	42067857	P17050	0	-	42067851	42067857	255,102,0	1	6	0	.	Substrate binding.
chr22	42079768	42079924	Q9H4I9	0	+	42079768	42079924	255,102,0	1	156	0	.	Interaction with C2orf47/MAIP1. Pubmed:27642048
chr22	42199583	42199649	Q9UGU0	0	-	42199583	42199649	255,102,0	1	66	0	.	Leucine-zipper.
chr22	42199585	42199651	Q9UGU0	0	-	42199585	42199651	255,102,0	1	66	0	.	Leucine-zipper.
chr22	42209183	42209249	Q9UGU0	0	-	42209183	42209249	255,102,0	1	66	0	.	Leucine-zipper.
chr22	42211732	42211798	Q9UGU0	0	-	42211732	42211798	255,102,0	1	66	0	.	Leucine-zipper.
chr22	42225394	42225460	Q9UGU0	0	-	42225394	42225460	255,102,0	1	66	0	.	Leucine-zipper.
chr22	42225417	42225483	Q9UGU0	0	-	42225417	42225483	255,102,0	1	66	0	.	Leucine-zipper.
chr22	42239116	42239182	Q9UGU0	0	-	42239116	42239182	255,102,0	1	66	0	.	Leucine-zipper.
chr22	43129230	43129296	Q13323	0	+	43129230	43129296	255,102,0	1	66	0	.	Leucine-zipper.
chr22	43528855	43534702	Q5THR3	0	-	43528855	43534702	255,102,0	1	5847	0	.	Interaction with AR. Pubmed:12612053
chr22	43528855	43537518	Q5THR3	0	-	43528855	43537518	255,102,0	1	8663	0	.	Interaction with PARK7. Pubmed:12612053
chr22	44702501	44726597	P85299	0	+	44702501	44726597	255,102,0	1	24096	0	.	Interaction with RICTOR.
chr22	44735032	44735125	P85299	0	+	44735032	44735125	255,102,0	1	93	0	.	Interaction with RICTOR.
chr22	45175965	45178809	Q9UKX7	0	+	45175965	45178809	255,102,0	1	2844	0	.	5 X 2 AA repeats of F-G.
chr22	45178326	45178515	Q9UKX7	0	+	45178326	45178515	255,102,0	1	189	0	.	Binding to CDKN1B.
chr22	45542153	45543525	P23142	0	+	45542153	45543525	255,102,0	1	1372	0	.	Self-association and FN1-binding; calcium is necessary for homotypic binding, but not for heterotypic binding.
chr22	46231917	46235377	Q07869	0	+	46231917	46235377	255,102,0	1	3460	0	.	Ligand-binding.
chr22	46231989	46235272	Q07869	0	+	46231989	46235272	255,102,0	1	3283	0	.	Required for heterodimerization with RXRA.
chr22	46343298	46343307	O75648	0	+	46343298	46343307	255,102,0	1	9	0	.	Interaction with target base in tRNA.
chr22	46350322	46350331	O75648	0	+	46350322	46350331	255,102,0	1	9	0	.	Interaction with tRNA.
chr22	46355569	46355575	O75648	0	+	46355569	46355575	255,102,0	1	6	0	.	Interaction with tRNA.
chr22	46707963	46707975	Q8TCT0	0	-	46707963	46707975	255,102,0	1	12	0	.	Substrate binding.
chr22	46720089	46738148	Q8TCT0	0	-	46720089	46738148	255,102,0	1	18059	0	.	Required for binding to sulfatide and phosphoinositides.
chr22	50220551	50221280	Q96RT7	0	-	50220551	50221280	255,102,0	1	729	0	.	9 X 27 AA tandem repeats.
chr22	50248409	50251032	Q969S8	0	-	50248409	50251032	255,102,0	1	2623	0	.	Histone deacetylase.
chr22	50267036	50267042	Q15759	0	-	50267036	50267042	255,102,0	1	6	0	.	Inhibitor-binding.
chr22	50267457	50267472	Q15759	0	-	50267457	50267472	255,102,0	1	15	0	.	Inhibitor-binding.
chr22	50487960	50487969	Q9UGB7	0	+	50487960	50487969	255,102,0	1	9	0	.	Substrate binding.
chr22	50489051	50489057	Q9UGB7	0	+	50489051	50489057	255,102,0	1	6	0	.	Substrate binding.
chr22	50489552	50489558	Q9UGB7	0	+	50489552	50489558	255,102,0	1	6	0	.	Substrate binding.
chr22	50571413	50571452	Q92523	0	-	50571413	50571452	255,102,0	1	39	0	.	Coenzyme A binding.
chr22	50582344	50582353	Q9Y259	0	-	50582344	50582353	255,102,0	1	9	0	.	Substrate binding.
chr22	50603378	50604124	Q13387	0	+	50603378	50604124	255,102,0	1	746	0	.	JNK-binding domain (JBD).
chr22	50604013	50604793	Q13387	0	+	50604013	50604793	255,102,0	1	780	0	.	Necessary for interaction with FGF13. Pubmed:11378392
chr3	3151035	3152472	Q96SW2	0	-	3151035	3152472	255,102,0	1	1437	0	.	Thalidomide binding. Pubmed:25108355
chr3	4303370	4316226	Q53H47	0	+	4303370	4316226	255,102,0	1	12856	0	.	Histone-lysine N-methyltransferase.
chr3	4313185	4313194	Q53H47	0	+	4313185	4313194	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr3	4313407	4313413	Q53H47	0	+	4313407	4313413	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr3	4316226	4317243	Q53H47	0	+	4316226	4317243	255,102,0	1	1017	0	.	Mariner transposase Hsmar1.
chr3	4362188	4362248	Q8NBK3	0	-	4362188	4362248	255,102,0	1	60	0	.	Interaction with sulfatases.
chr3	4645665	4645680	Q14643	0	+	4645665	4645680	255,102,0	1	15	0	.	Inositol 1,4,5-trisphosphate binding.
chr3	4663173	4663185	Q14643	0	+	4663173	4663185	255,102,0	1	12	0	.	Inositol 1,4,5-trisphosphate binding.
chr3	4665281	4665290	Q14643	0	+	4665281	4665290	255,102,0	1	9	0	.	Inositol 1,4,5-trisphosphate binding.
chr3	4811405	4814472	Q14643	0	+	4811405	4814472	255,102,0	1	3067	0	.	Interaction with ERP44.
chr3	4979718	4982870	O14503	0	+	4979718	4982870	255,102,0	1	3152	0	.	Essential for interaction with ARNTL/BMAL1, E-box binding and repressor activity against the CLOCK-ARNTL/BMAL1 heterodimer.
chr3	4980372	4980387	O14503	0	+	4980372	4980387	255,102,0	1	15	0	.	Necessary for interaction with RXRA and repressor activity against RXRA. Pubmed:19786558
chr3	7146469	7146478	Q14831	0	+	7146469	7146478	255,102,0	1	9	0	.	Glutamate binding.
chr3	8745600	8745753	P56539	0	+	8745600	8745753	255,102,0	1	153	0	.	Required for interaction with DAG1. Pubmed:10988290
chr3	9734314	9739065	P55201	0	+	9734314	9739065	255,102,0	1	4751	0	.	Interaction with KAT6A and KAT6B. Pubmed:18794358
chr3	9739899	9743747	P55201	0	+	9739899	9743747	255,102,0	1	3848	0	.	Interaction with MEAF6 and ING5. Pubmed:18794358
chr3	9740845	9745861	P55201	0	+	9740845	9745861	255,102,0	1	5016	0	.	Required for RUNX1 and RUNX2 transcriptional activation.
chr3	9757807	9759514	Q14012	0	-	9757807	9759514	255,102,0	1	1707	0	.	Calmodulin-binding.
chr3	9757810	9759574	Q14012	0	-	9757810	9759574	255,102,0	1	1764	0	.	Autoinhibitory domain.
chr3	9949209	9949227	Q5FWE3	0	-	9949209	9949227	255,102,0	1	18	0	.	O-glycosylated at one site.
chr3	10028657	10042648	Q9BXW9	0	+	10028657	10042648	255,102,0	1	13991	0	.	Interaction with FANCE.
chr3	10041668	10043571	Q9BXW9	0	+	10041668	10043571	255,102,0	1	1903	0	.	Interaction with BRCA2.
chr3	10141886	10142006	P40337	0	+	10141886	10142006	255,102,0	1	120	0	.	8 X 5 AA tandem repeats of G-[PAVG]-E-E-[DAYSLE].
chr3	10142144	10149788	P40337	0	+	10142144	10149788	255,102,0	1	7644	0	.	Involved in binding to CCT complex.
chr3	10149791	10149821	P40337	0	+	10149791	10149821	255,102,0	1	30	0	.	Interaction with Elongin BC complex.
chr3	10329095	10329125	Q01814	0	-	10329095	10329125	255,102,0	1	30	0	.	Calmodulin-binding subdomain B.
chr3	10338175	10338229	Q01814	0	-	10338175	10338229	255,102,0	1	54	0	.	Calmodulin-binding subdomain A.
chr3	11259355	11259373	P35367	0	+	11259355	11259373	255,102,0	1	18	0	.	Important for agonist binding.
chr3	11260306	11260321	P35367	0	+	11260306	11260321	255,102,0	1	15	0	.	Important for agonist binding.
chr3	12156871	12156877	Q99727	0	-	12156871	12156877	255,102,0	1	6	0	.	Involved in metalloproteinase-binding.
chr3	12158738	12158753	Q99727	0	-	12158738	12158753	255,102,0	1	15	0	.	Involved in metalloproteinase-binding.
chr3	12392745	12416724	P37231	0	+	12392745	12416724	255,102,0	1	23979	0	.	Interaction with FAM120B.
chr3	12416832	12434142	P37231	0	+	12416832	12434142	255,102,0	1	17310	0	.	Ligand-binding.
chr3	12572307	12574815	Q9H000	0	+	12572307	12574815	255,102,0	1	2508	0	.	Makorin-type Cys-His.
chr3	12599751	12599808	P04049	0	-	12599751	12599808	255,102,0	1	57	0	.	Interaction with PEBP1/RKIP.
chr3	13481282	13504617	Q96DB2	0	+	13481282	13504617	255,102,0	1	23335	0	.	Histone deacetylase.
chr3	13570436	13570886	P98095	0	+	13570436	13570886	255,102,0	1	450	0	.	Subdomain NA (Cys-rich).
chr3	13570436	13608087	P98095	0	+	13570436	13608087	255,102,0	1	37651	0	.	N.
chr3	13570886	13608087	P98095	0	+	13570886	13608087	255,102,0	1	37201	0	.	Subdomain NB (Cys-free).
chr3	13637571	13637916	P98095	0	+	13637571	13637916	255,102,0	1	345	0	.	Domain III.
chr3	14145943	14147976	Q01831	0	-	14145943	14147976	255,102,0	1	2033	0	.	Interaction with ERCC2 and GTF2H1. Pubmed:12509233
chr3	14147295	14147355	Q01831	0	-	14147295	14147355	255,102,0	1	60	0	.	Interaction with CETN2.
chr3	14147928	14148683	Q01831	0	-	14147928	14148683	255,102,0	1	755	0	.	DNA-binding; preference for single stranded DNA; required for formation of stable nucleoprotein complex.
chr3	14148683	14158064	Q01831	0	-	14148683	14158064	255,102,0	1	9381	0	.	Minimal sensor domain involved in damage recognition.
chr3	14148840	14158064	Q01831	0	-	14148840	14158064	255,102,0	1	9224	0	.	DNA-binding; preference for heteroduplex DNA.
chr3	14148861	14158397	Q01831	0	-	14148861	14158397	255,102,0	1	9536	0	.	Interaction with RAD23B.
chr3	15032429	15042879	P49116	0	+	15032429	15042879	255,102,0	1	10450	0	.	Ligand-binding.
chr3	15073784	15074258	Q9H1K0	0	-	15073784	15074258	255,102,0	1	474	0	.	Necessary for interaction with RAB5A.
chr3	15073784	15082417	Q9H1K0	0	-	15073784	15082417	255,102,0	1	8633	0	.	Necessary for interaction with EHD1. Pubmed:15020713
chr3	15074636	15082417	Q9H1K0	0	-	15074636	15082417	255,102,0	1	7781	0	.	Necessary for interaction with RAB4A.
chr3	15082417	15085953	Q9H1K0	0	-	15082417	15085953	255,102,0	1	3536	0	.	Necessary for the correct targeting to endosomes.
chr3	15240821	15247356	Q9Y6W3	0	+	15240821	15247356	255,102,0	1	6535	0	.	Domain III.
chr3	15247356	15251257	Q9Y6W3	0	+	15247356	15251257	255,102,0	1	3901	0	.	Domain N.
chr3	15436358	15439134	Q96JC9	0	+	15436358	15439134	255,102,0	1	2776	0	.	Necessary for transactivation activity.
chr3	15470538	15470550	Q9Y215	0	-	15470538	15470550	255,102,0	1	12	0	.	Heparan sulfate proteoglycan binding.
chr3	15477191	15478982	Q9Y215	0	-	15477191	15478982	255,102,0	1	1791	0	.	Heparan sulfate proteoglycan binding.
chr3	15489542	15489593	Q9Y215	0	-	15489542	15489593	255,102,0	1	51	0	.	PRAD.
chr3	15564609	15568481	Q9UJ83	0	-	15564609	15568481	255,102,0	1	3872	0	.	Thiamine pyrophosphate binding.
chr3	16195787	16200809	Q8N3T1	0	+	16195787	16200809	255,102,0	1	5022	0	.	Catalytic subdomain A.
chr3	16208662	16212631	Q8N3T1	0	+	16208662	16212631	255,102,0	1	3969	0	.	Catalytic subdomain B.
chr3	16596851	16598091	Q92904	0	-	16596851	16598091	255,102,0	1	1240	0	.	Homodimerization.
chr3	17160977	17160995	Q92609	0	-	17160977	17160995	255,102,0	1	18	0	.	Required for interaction with ATG8 family proteins. Pubmed:22354992
chr3	17406501	17428451	Q92609	0	-	17406501	17428451	255,102,0	1	21950	0	.	Required for interaction with retromer; involved in interaction with ATG8 family proteins. Pubmed:22354992
chr3	18386587	18394470	Q01826	0	-	18386587	18394470	255,102,0	1	7883	0	.	Matrix attachment region (MAR) DNA-binding.
chr3	18394833	18397260	Q01826	0	-	18394833	18397260	255,102,0	1	2427	0	.	Nuclear matrix targeting sequence (NMTS).
chr3	18415137	18417022	Q01826	0	-	18415137	18417022	255,102,0	1	1885	0	.	PDZ-like dimerization domain.
chr3	20127519	20127528	Q92831	0	+	20127519	20127528	255,102,0	1	9	0	.	Acetyl-CoA binding. Pubmed:10393169
chr3	20127540	20136953	Q92831	0	+	20127540	20136953	255,102,0	1	9413	0	.	Acetyl-CoA binding. Pubmed:10393169
chr3	20137025	20137037	Q92831	0	+	20137025	20137037	255,102,0	1	12	0	.	Acetyl-CoA binding. Pubmed:10393169
chr3	20175002	20184027	Q5FBB7	0	-	20175002	20184027	255,102,0	1	9025	0	.	Necessary for interaction with PPP2CA and PPP2R1A. Pubmed:16580887
chr3	23900864	23900972	Q9NYS0	0	-	23900864	23900972	255,102,0	1	108	0	.	Interactions with NFKBIA and NFKBIB.
chr3	24122886	24143509	P10828	0	-	24122886	24143509	255,102,0	1	20623	0	.	Interaction with NR2F6. Pubmed:10713182
chr3	24122886	24143509	P10828	0	-	24122886	24143509	255,102,0	1	20623	0	.	Ligand-binding.
chr3	24152455	24228959	P10828	0	-	24152455	24228959	255,102,0	1	76504	0	.	Modulating.
chr3	25619864	25619894	Q02880	0	-	25619864	25619894	255,102,0	1	30	0	.	Interaction with DNA.
chr3	25632725	25632734	Q02880	0	-	25632725	25632734	255,102,0	1	9	0	.	Interaction with DNA.
chr3	27385948	27385957	Q9Y6M7	0	-	27385948	27385957	255,102,0	1	9	0	.	CA2-binding.
chr3	27717072	27717420	O95936	0	-	27717072	27717420	255,102,0	1	348	0	.	Required for transcription activation.
chr3	28324449	28332370	Q9H6S1	0	-	28324449	28332370	255,102,0	1	7921	0	.	Interaction with TBK1 and IKBKE.
chr3	28332424	28340617	Q9H6S1	0	-	28332424	28340617	255,102,0	1	8193	0	.	Homodimerization.
chr3	31683751	31683757	Q9BXB5	0	-	31683751	31683757	255,102,0	1	6	0	.	Phosphatidylinositol 4-phosphate binding.
chr3	31683919	31683931	Q9BXB5	0	-	31683919	31683931	255,102,0	1	12	0	.	Phosphatidylinositol 4-phosphate binding.
chr3	31684105	31702367	Q9BXB5	0	-	31684105	31702367	255,102,0	1	18262	0	.	Phosphatidylinositol 4-phosphate binding.
chr3	31684105	31702367	Q9BXB5	0	-	31684105	31702367	255,102,0	1	18262	0	.	Phosphatidylserine binding.
chr3	32159067	32159073	Q8N335	0	+	32159067	32159073	255,102,0	1	6	0	.	Substrate binding.
chr3	33364666	33364699	Q9UKC9	0	+	33364666	33364699	255,102,0	1	33	0	.	Interaction with Calmodulin.
chr3	33825249	33845456	Q8WUM4	0	+	33825249	33845456	255,102,0	1	20207	0	.	Interaction with CHMP4A, CHMP4B and CHMP4C.
chr3	33825249	33866522	Q8WUM4	0	+	33825249	33866522	255,102,0	1	41273	0	.	Interaction with EIAV p9.
chr3	33841966	33866522	Q8WUM4	0	+	33841966	33866522	255,102,0	1	24556	0	.	Interaction with SDCBP. Pubmed:22660413
chr3	33845453	33866522	Q8WUM4	0	+	33845453	33866522	255,102,0	1	21069	0	.	Self-association.
chr3	33864033	33864045	Q8WUM4	0	+	33864033	33864045	255,102,0	1	12	0	.	Interaction with TSG101.
chr3	33865386	33865416	Q8WUM4	0	+	33865386	33865416	255,102,0	1	30	0	.	Interaction with CEP55.
chr3	33866507	33866522	Q8WUM4	0	+	33866507	33866522	255,102,0	1	15	0	.	Essential to promote virus budding.
chr3	37025825	37048570	P40692	0	+	37025825	37048570	255,102,0	1	22745	0	.	Interaction with EXO1.
chr3	37083803	37148983	Q9Y608	0	-	37083803	37148983	255,102,0	1	65180	0	.	DVL3-binding.
chr3	37282191	37295005	Q13439	0	+	37282191	37295005	255,102,0	1	12814	0	.	Interaction with MACF1. Pubmed:15265687
chr3	38020215	38020299	P51178	0	-	38020215	38020299	255,102,0	1	84	0	.	Substrate binding.
chr3	38483263	38483329	Q13705	0	+	38483263	38483329	255,102,0	1	66	0	.	Interaction with DYNLT1.
chr3	38550440	38550452	Q14524	0	-	38550440	38550452	255,102,0	1	12	0	.	Interaction with NEDD4, NEDD4L and WWP2. Pubmed:15548568
chr3	38550668	38550857	Q14524	0	-	38550668	38550857	255,102,0	1	189	0	.	Interaction with FGF13. Pubmed:22705208
chr3	39100463	39100502	Q9BQQ3	0	-	39100463	39100502	255,102,0	1	39	0	.	Essential for interaction with GOLGA2/GM130.
chr3	39183916	39184393	Q702N8	0	-	39183916	39184393	255,102,0	1	477	0	.	Interaction with FLNC. Pubmed:16631741
chr3	39187549	39187855	Q702N8	0	-	39187549	39187855	255,102,0	1	306	0	.	Interaction with CTNNB1.
chr3	39189283	39189445	Q702N8	0	-	39189283	39189445	255,102,0	1	162	0	.	Interaction with VASP. Pubmed:16631741
chr3	39408631	39410840	A0A024R2P0	0	+	39408631	39410840	255,102,0	1	2209	0	.	Interaction with PPP1R16B.
chr3	39408631	39410840	P08865	0	+	39408631	39410840	255,102,0	1	2209	0	.	Interaction with PPP1R16B. Pubmed:16263087
chr3	39410981	39411690	A0A024R2P0	0	+	39410981	39411690	255,102,0	1	709	0	.	Laminin-binding.
chr3	39410981	39411690	A0A0C4DG17	0	+	39410981	39411690	255,102,0	1	709	0	.	Laminin-binding.
chr3	39410981	39411690	P08865	0	+	39410981	39411690	255,102,0	1	709	0	.	Laminin-binding.
chr3	39411762	39411955	A0A024R2P0	0	+	39411762	39411955	255,102,0	1	193	0	.	Laminin-binding.
chr3	39411762	39411955	A0A0C4DG17	0	+	39411762	39411955	255,102,0	1	193	0	.	Laminin-binding.
chr3	39411762	39411955	P08865	0	+	39411762	39411955	255,102,0	1	193	0	.	Laminin-binding.
chr3	39411991	39412365	A0A024R2P0	0	+	39411991	39412365	255,102,0	1	374	0	.	Laminin-binding.
chr3	39411991	39412365	A0A0C4DG17	0	+	39411991	39412365	255,102,0	1	374	0	.	Laminin-binding.
chr3	39411991	39412365	P08865	0	+	39411991	39412365	255,102,0	1	374	0	.	Laminin-binding.
chr3	39502616	39502736	Q13875	0	+	39502616	39502736	255,102,0	1	120	0	.	4 X 10 AA tandem repeats of P-R-S-P-P-R-S-E-R-Q.
chr3	40151141	40209868	Q8NFW9	0	+	40151141	40209868	255,102,0	1	58727	0	.	Myosin-binding.
chr3	40166871	40166922	Q8NFW9	0	+	40166871	40166922	255,102,0	1	51	0	.	PKA-binding.
chr3	40167203	40169964	Q8NFW9	0	+	40167203	40169964	255,102,0	1	2761	0	.	Negative regulation of PKA-binding.
chr3	40190280	40258154	Q8NFW9	0	+	40190280	40258154	255,102,0	1	67874	0	.	Actin-binding.
chr3	40462094	40462154	P50914	0	+	40462094	40462154	255,102,0	1	60	0	.	4 X 5 AA tandem repeats of Q-K-A-[PAS]-X.
chr3	40462160	40462178	P50914	0	+	40462160	40462178	255,102,0	1	18	0	.	2 X 3 AA tandem repeats of K-[GA]-Q.
chr3	41224071	41224581	P35222	0	+	41224071	41224581	255,102,0	1	510	0	.	Interaction with VCL.
chr3	41225177	41225372	P35222	0	+	41225177	41225372	255,102,0	1	195	0	.	Interaction with BCL9. Pubmed:17052462
chr3	41239309	41239339	P35222	0	+	41239309	41239339	255,102,0	1	30	0	.	Interaction with SCRIB.
chr3	42194902	42202535	Q9UPV9	0	+	42194902	42202535	255,102,0	1	7633	0	.	Interaction with HGS. Pubmed:18675823
chr3	42639634	42639748	P30414	0	+	42639634	42639748	255,102,0	1	114	0	.	Arg/Ser tandem repeat-rich.
chr3	42865480	42865654	O00590	0	+	42865480	42865654	255,102,0	1	174	0	.	C-terminal cytoplasmic tail.
chr3	43032419	43032437	Q9UFP1	0	+	43032419	43032437	255,102,0	1	18	0	.	O-glycosylated at one site.
chr3	44651091	44659026	P13682	0	+	44651091	44659026	255,102,0	1	7935	0	.	Globular domain.
chr3	45595038	45595281	Q9UGP4	0	+	45595038	45595281	255,102,0	1	243	0	.	Mediates nuclear export.
chr3	45595434	45595659	Q9UGP4	0	+	45595434	45595659	255,102,0	1	225	0	.	Interaction with EGLN1/PHD2.
chr3	45596088	45596205	Q9UGP4	0	+	45596088	45596205	255,102,0	1	117	0	.	Interaction with RB1. Pubmed:15542589
chr3	45636154	45677056	Q9UGP4	0	+	45636154	45677056	255,102,0	1	40902	0	.	Necessary for nuclear localization.
chr3	45826316	45833073	Q9NQ48	0	-	45826316	45833073	255,102,0	1	6757	0	.	Interaction with BSS9.
chr3	46459688	46459694	P02788	0	-	46459688	46459694	255,102,0	1	6	0	.	Interaction with pspA.
chr3	46459709	46459727	P02788	0	-	46459709	46459727	255,102,0	1	18	0	.	Involved in glycosaminoglycan binding.
chr3	46459715	46459748	P02788	0	-	46459715	46459748	255,102,0	1	33	0	.	Bactericidal and antifungal activity.
chr3	46459715	46459748	P02788	0	-	46459715	46459748	255,102,0	1	33	0	.	Interaction with lipopolysaccharide.
chr3	46459724	46459748	P02788	0	-	46459724	46459748	255,102,0	1	24	0	.	Interaction with pspA.
chr3	46459775	46459805	P02788	0	-	46459775	46459805	255,102,0	1	30	0	.	Bactericidal and antifungal activity.
chr3	46459790	46459805	P02788	0	-	46459790	46459805	255,102,0	1	15	0	.	Critical for glycosaminoglycan, lipid A, lysozyme and DNA binding.
chr3	46459796	46459802	P02788	0	-	46459796	46459802	255,102,0	1	6	0	.	Important for full bactericidal and antifungal activities.
chr3	47017095	47019822	Q9BYW2	0	-	47017095	47019822	255,102,0	1	2727	0	.	Interaction with POLR2A.
chr3	47046486	47057375	Q9BYW2	0	-	47046486	47057375	255,102,0	1	10889	0	.	Low charge region.
chr3	47097954	47120384	Q9BYW2	0	-	47097954	47120384	255,102,0	1	22430	0	.	Interaction with TUBA1A. Pubmed:27518565
chr3	47103375	47103381	Q9BYW2	0	-	47103375	47103381	255,102,0	1	6	0	.	Inhibitor binding.
chr3	47103375	47103381	Q9BYW2	0	-	47103375	47103381	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr3	47106020	47106029	Q9BYW2	0	-	47106020	47106029	255,102,0	1	9	0	.	Inhibitor binding.
chr3	47106020	47106029	Q9BYW2	0	-	47106020	47106029	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr3	47113904	47113913	Q9BYW2	0	-	47113904	47113913	255,102,0	1	9	0	.	Inhibitor binding.
chr3	47113904	47113913	Q9BYW2	0	-	47113904	47113913	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr3	47410105	47411188	Q9H3S7	0	+	47410105	47411188	255,102,0	1	1083	0	.	His.
chr3	47410654	47410690	Q9H3S7	0	+	47410654	47410690	255,102,0	1	36	0	.	6 X 2 AA approximate tandem repeats of P-Q.
chr3	47413856	47418461	Q12770	0	-	47413856	47418461	255,102,0	1	4605	0	.	Interaction with SREBF2.
chr3	47420760	47420936	Q12770	0	-	47420760	47420936	255,102,0	1	176	0	.	ER export signal.
chr3	47572687	47572744	O95196	0	-	47572687	47572744	255,102,0	1	57	0	.	Interaction with GOPC. Pubmed:12885772
chr3	47577122	47577236	O95196	0	-	47577122	47577236	255,102,0	1	114	0	.	Interaction with TNC and TNR.
chr3	47916191	47917085	P27816	0	-	47916191	47917085	255,102,0	1	894	0	.	17 X 14 AA tandem repeats.
chr3	48450140	48451815	Q8WXE1	0	+	48450140	48451815	255,102,0	1	1675	0	.	Interaction with CINP. Pubmed:19889979
chr3	48466712	48466718	Q9NSU2	0	+	48466712	48466718	255,102,0	1	6	0	.	Substrate binding.
chr3	48466814	48466844	Q9NSU2	0	+	48466814	48466844	255,102,0	1	30	0	.	Proline-rich region.
chr3	48467360	48467597	Q9NSU2	0	+	48467360	48467597	255,102,0	1	237	0	.	Necessary for endoplasmic reticulum localization.
chr3	48467381	48467597	Q9NSU2	0	+	48467381	48467597	255,102,0	1	216	0	.	Interaction with UBQLN1. Pubmed:23979357
chr3	48467495	48467597	Q9NSU2	0	+	48467495	48467597	255,102,0	1	102	0	.	Necessary for cytoplasmic retention.
chr3	48519749	48536348	Q16877	0	-	48519749	48536348	255,102,0	1	16599	0	.	Fructose-2,6-bisphosphatase.
chr3	48536348	48556777	Q16877	0	-	48536348	48556777	255,102,0	1	20429	0	.	6-phosphofructo-2-kinase.
chr3	48564408	48566515	Q02388	0	-	48564408	48566515	255,102,0	1	2107	0	.	Nonhelical region (NC2).
chr3	48566515	48585856	Q02388	0	-	48566515	48585856	255,102,0	1	19341	0	.	Triple-helical region.
chr3	48583398	48585856	Q02388	0	-	48583398	48585856	255,102,0	1	2458	0	.	Interrupted collagenous region.
chr3	48585939	48595111	Q02388	0	-	48585939	48595111	255,102,0	1	9172	0	.	Nonhelical region (NC1).
chr3	48689645	48689672	Q9UHH9	0	-	48689645	48689672	255,102,0	1	27	0	.	Substrate binding.
chr3	48790564	48847593	P13861	0	-	48790564	48847593	255,102,0	1	57029	0	.	Dimerization and phosphorylation.
chr3	48927750	48964931	O95376	0	+	48927750	48964931	255,102,0	1	37181	0	.	UBA-like.
chr3	48979594	48983267	O95376	0	+	48979594	48983267	255,102,0	1	3673	0	.	Ariadne domain.
chr3	49024945	49024960	P12268	0	-	49024945	49024960	255,102,0	1	15	0	.	IMP binding.
chr3	49025026	49025032	P12268	0	-	49025026	49025032	255,102,0	1	6	0	.	IMP binding.
chr3	49025177	49025186	P12268	0	-	49025177	49025186	255,102,0	1	9	0	.	IMP binding.
chr3	49121228	49122950	P55268	0	-	49121228	49122950	255,102,0	1	1722	0	.	Domain I.
chr3	49122950	49123049	P55268	0	-	49122950	49123049	255,102,0	1	99	0	.	Domain alpha.
chr3	49123049	49123957	P55268	0	-	49123049	49123957	255,102,0	1	908	0	.	Domain II.
chr3	49300589	49300604	Q13107	0	-	49300589	49300604	255,102,0	1	15	0	.	Necessary for interaction with RB1 and RBL2.
chr3	49302449	49302458	Q13107	0	-	49302449	49302458	255,102,0	1	9	0	.	Necessary for interaction with RBL2.
chr3	49324748	49339946	Q13107	0	-	49324748	49339946	255,102,0	1	15198	0	.	Necessary for interaction with SART3. Pubmed:20595234
chr3	49510621	49531735	Q14118	0	+	49510621	49531735	255,102,0	1	21114	0	.	Required for laminin recognition.
chr3	49531015	49531111	Q14118	0	+	49531015	49531111	255,102,0	1	96	0	.	O-glycosylated at one site.
chr3	49531456	49531966	Q14118	0	+	49531456	49531966	255,102,0	1	510	0	.	Mucin-like domain.
chr3	49531897	49531966	Q14118	0	+	49531897	49531966	255,102,0	1	69	0	.	O-glycosylated at seven sites with GalNAc.
chr3	49532965	49533196	Q14118	0	+	49532965	49533196	255,102,0	1	231	0	.	Required for interaction with CAV3. Pubmed:10988290
chr3	49533148	49533196	Q14118	0	+	49533148	49533196	255,102,0	1	48	0	.	Required for binding DMD and UTRN.
chr3	49554668	49554698	Q9UPA5	0	+	49554668	49554698	255,102,0	1	30	0	.	5 X 2 AA tandem repeats of P-G.
chr3	49554782	49554824	Q9UPA5	0	+	49554782	49554824	255,102,0	1	42	0	.	7 X 2 AA tandem repeats of P-G.
chr3	49650803	49650866	Q9UPA5	0	+	49650803	49650866	255,102,0	1	63	0	.	3 X 7 AA tandem repeats of K-A-S-P-[LQ]-[APS]-[KST].
chr3	49728210	49728237	Q92551	0	-	49728210	49728237	255,102,0	1	27	0	.	Substrate binding.
chr3	49810091	49813637	P41226	0	-	49810091	49813637	255,102,0	1	3546	0	.	2 approximate repeats.
chr3	49829105	49841059	Q9BWF2	0	-	49829105	49841059	255,102,0	1	11954	0	.	Interaction with CYLD. Pubmed:14676304
chr3	50107488	50118435	P52756	0	+	50107488	50118435	255,102,0	1	10947	0	.	Required for interaction with U2AF2. Pubmed:18851835
chr3	50110453	50113532	P52756	0	+	50110453	50113532	255,102,0	1	3079	0	.	Sufficient for interaction with ACIN1, PRPF8, SFRS3, SNRPB, SNRPN, SNRNP70 and SNRNP200. Pubmed:18851835
chr3	50330661	50330673	Q9NS23	0	-	50330661	50330673	255,102,0	1	12	0	.	MOAP1-binding.
chr3	50337916	50340802	Q9NS23	0	-	50337916	50340802	255,102,0	1	2886	0	.	Mediates interaction with E4F1. Pubmed:14729613
chr3	50341412	50341835	O75800	0	-	50341412	50341835	255,102,0	1	423	0	.	Interaction with LRRC6.
chr3	50349434	50350652	Q8WTW4	0	-	50349434	50350652	255,102,0	1	1218	0	.	Interaction with PDPK1. Pubmed:18616680
chr3	50358376	50358448	Q12893	0	-	50358376	50358448	255,102,0	1	72	0	.	Mediates localization to the Golgi. Pubmed:24806965
chr3	50358448	50359063	Q12893	0	-	50358448	50359063	255,102,0	1	615	0	.	Mediates homooligomerization. Pubmed:24806965
chr3	50577135	50577150	Q9Y5R4	0	+	50577135	50577150	255,102,0	1	15	0	.	S-adenosyl-L-methionine binding.
chr3	50578870	50578882	Q9Y5R4	0	+	50578870	50578882	255,102,0	1	12	0	.	Substrate binding.
chr3	50647125	50647926	Q16644	0	+	50647125	50647926	255,102,0	1	801	0	.	Autoinhibitory helix.
chr3	50647929	50648004	Q16644	0	+	50647929	50648004	255,102,0	1	75	0	.	p38 MAPK-binding site.
chr3	51393562	51394069	Q8NDT2	0	+	51393562	51394069	255,102,0	1	507	0	.	Interaction with Epstein-Barr virus BMLF1.
chr3	51398771	51403356	Q9Y4B6	0	-	51398771	51403356	255,102,0	1	4585	0	.	Interaction with NF2.
chr3	51414010	51418842	Q9Y4B6	0	-	51414010	51418842	255,102,0	1	4832	0	.	WD repeat-like region.
chr3	51429437	51443858	Q9Y4B6	0	-	51429437	51443858	255,102,0	1	14421	0	.	Protein kinase-like.
chr3	51712517	51712526	Q14416	0	+	51712517	51712526	255,102,0	1	9	0	.	Glutamate binding.
chr3	51715801	51715828	Q14416	0	+	51715801	51715828	255,102,0	1	27	0	.	Important for interaction with HTR2A.
chr3	52402314	52403242	Q92560	0	-	52402314	52403242	255,102,0	1	928	0	.	Interaction with BRCA1.
chr3	52455644	52470897	Q9Y2I1	0	+	52455644	52470897	255,102,0	1	15253	0	.	Necessary for binding to phosphoinositide-3-P; not sufficient for targeting to endosomes.
chr3	52458841	52487577	Q9Y2I1	0	+	52458841	52487577	255,102,0	1	28736	0	.	Necessary for homooligomerization and targeting to endosomes.
chr3	52473796	52488099	Q9Y2I1	0	+	52473796	52488099	255,102,0	1	14303	0	.	Interaction with PAK1.
chr3	52487469	52488099	Q9Y2I1	0	+	52487469	52488099	255,102,0	1	630	0	.	Interaction with LIMK.
chr3	52487616	52487913	Q9Y2I1	0	+	52487616	52487913	255,102,0	1	297	0	.	Interaction with ITGA5.
chr3	52686095	52687311	Q9BVP2	0	+	52686095	52687311	255,102,0	1	1216	0	.	Basic.
chr3	52691603	52693675	Q9BVP2	0	+	52691603	52693675	255,102,0	1	2072	0	.	Intermediate.
chr3	52693699	52694254	Q9BVP2	0	+	52693699	52694254	255,102,0	1	555	0	.	Acidic.
chr3	52783272	52791908	P19827	0	+	52783272	52791908	255,102,0	1	8636	0	.	Hyaluronan-binding.
chr3	52818260	52818281	Q14624	0	-	52818260	52818281	255,102,0	1	21	0	.	O-glycosylated at three sites.
chr3	52819405	52819498	Q14624	0	-	52819405	52819498	255,102,0	1	93	0	.	Proline-rich (PRR) potential bioactive peptide.
chr3	52842840	52842858	Q86TL2	0	-	52842840	52842858	255,102,0	1	18	0	.	Required for localization in the endoplasmic reticulum. Pubmed:26322679
chr3	52943590	52954340	Q9UHJ3	0	-	52943590	52954340	255,102,0	1	10750	0	.	Antigenic epitope.
chr3	53702704	53702758	Q01668	0	+	53702704	53702758	255,102,0	1	54	0	.	Binding to the beta subunit.
chr3	53747356	53749448	Q01668	0	+	53747356	53749448	255,102,0	1	2092	0	.	Dihydropyridine binding.
chr3	53775940	53776698	Q01668	0	+	53775940	53776698	255,102,0	1	758	0	.	Dihydropyridine binding.
chr3	53775976	53776665	Q01668	0	+	53775976	53776665	255,102,0	1	689	0	.	Phenylalkylamine binding.
chr3	57227883	57257282	Q9UKG1	0	+	57227883	57257282	255,102,0	1	29399	0	.	Required for RAB5A binding.
chr3	57293906	57301905	Q6ZR08	0	-	57293906	57301905	255,102,0	1	7999	0	.	AAA 5.
chr3	57309761	57314571	Q6ZR08	0	-	57309761	57314571	255,102,0	1	4810	0	.	Stalk.
chr3	57314571	57405015	Q6ZR08	0	-	57314571	57405015	255,102,0	1	90444	0	.	AAA 4.
chr3	57405859	57419467	Q6ZR08	0	-	57405859	57419467	255,102,0	1	13608	0	.	AAA 3.
chr3	57433369	57437051	Q6ZR08	0	-	57433369	57437051	255,102,0	1	3682	0	.	AAA 2.
chr3	57445221	57452917	Q6ZR08	0	-	57445221	57452917	255,102,0	1	7696	0	.	AAA 1.
chr3	57452917	57542870	Q6ZR08	0	-	57452917	57542870	255,102,0	1	89953	0	.	Stem.
chr3	57757651	57849786	Q14BN4	0	+	57757651	57849786	255,102,0	1	92135	0	.	Necessary for targeting to centrosomes.
chr3	58123347	58134634	O75369	0	+	58123347	58134634	255,102,0	1	11287	0	.	Interaction with FBLP1. Pubmed:12496242
chr3	58141860	58142652	O75369	0	+	58141860	58142652	255,102,0	1	792	0	.	Hinge 1.
chr3	58146848	58153451	O75369	0	+	58146848	58153451	255,102,0	1	6603	0	.	Interaction with the cytoplasmic tail of GP1BA.
chr3	58149935	58154831	O75369	0	+	58149935	58154831	255,102,0	1	4896	0	.	Interaction with FLNA 1.
chr3	58153394	58170759	O75369	0	+	58153394	58170759	255,102,0	1	17365	0	.	Interaction with INPPL1. Pubmed:11739414
chr3	58168654	58169690	O75369	0	+	58168654	58169690	255,102,0	1	1036	0	.	Hinge 2.
chr3	58168654	58170759	O75369	0	+	58168654	58170759	255,102,0	1	2105	0	.	Self-association site, tail.
chr3	58169690	58170759	O75369	0	+	58169690	58170759	255,102,0	1	1069	0	.	Interaction with FLNA 2.
chr3	58192689	58192755	Q13609	0	-	58192689	58192755	255,102,0	1	66	0	.	Not required for free DNA-nuclease activity but required for activity towards liposome-coated DNA.
chr3	62271550	62272961	P23470	0	+	62271550	62272961	255,102,0	1	1411	0	.	Substrate binding.
chr3	62399408	62466362	Q9ULU8	0	-	62399408	62466362	255,102,0	1	66954	0	.	Mediates targeting and association with DCVs.
chr3	62474262	62518174	Q9ULU8	0	-	62474262	62518174	255,102,0	1	43912	0	.	Interaction with DRD2. Pubmed:15857609
chr3	63615310	63615409	Q8TBG9	0	+	63615310	63615409	255,102,0	1	99	0	.	5 X approximate repeats.
chr3	63834134	63838015	Q6I9Y2	0	-	63834134	63838015	255,102,0	1	3881	0	.	Interaction with NIF3L1. Pubmed:12951069
chr3	63836299	63838489	Q6I9Y2	0	-	63836299	63838489	255,102,0	1	2190	0	.	Interaction with THOC5. Pubmed:19059247
chr3	64622252	64631844	Q9P2N4	0	-	64622252	64631844	255,102,0	1	9592	0	.	Spacer.
chr3	67400812	67400821	Q96I99	0	-	67400812	67400821	255,102,0	1	9	0	.	Substrate binding; shared with subunit alpha.
chr3	69047678	69047708	P82094	0	-	69047678	69047708	255,102,0	1	30	0	.	Interaction with Elongin BC complex.
chr3	69055439	69056265	Q8TBC4	0	-	69055439	69056265	255,102,0	1	826	0	.	Interaction with UBE2M core domain.
chr3	69056623	69056641	Q8TBC4	0	-	69056623	69056641	255,102,0	1	18	0	.	Interaction with NEDD8.
chr3	69056680	69056789	Q8TBC4	0	-	69056680	69056789	255,102,0	1	109	0	.	Interaction with UBE2M N-terminus.
chr3	69061838	69061850	Q8TBC4	0	-	69061838	69061850	255,102,0	1	12	0	.	Interaction with NAE1. Pubmed:12740388
chr3	69062128	69062149	Q8TBC4	0	-	69062128	69062149	255,102,0	1	21	0	.	Interaction with NAE1. Pubmed:12740388
chr3	69062987	69062996	Q8TBC4	0	-	69062987	69062996	255,102,0	1	9	0	.	Interaction with NEDD8.
chr3	69063023	69063101	Q8TBC4	0	-	69063023	69063101	255,102,0	1	78	0	.	Interaction with UBE2M N-terminus.
chr3	69063492	69064071	Q8TBC4	0	-	69063492	69064071	255,102,0	1	579	0	.	Interaction with UBE2M N-terminus.
chr3	69075483	69077824	Q8TBC4	0	-	69075483	69077824	255,102,0	1	2341	0	.	Interaction with UBE2M N-terminus.
chr3	69101968	69102013	O75915	0	+	69101968	69102013	255,102,0	1	45	0	.	Required for homodimer formation and heterodimer formation with ARL6IP1.
chr3	69104474	69104633	O75915	0	+	69104474	69104633	255,102,0	1	159	0	.	Targeting to endoplasmic reticulum membrane.
chr3	69122239	69122386	Q0VAK6	0	-	69122239	69122386	255,102,0	1	147	0	.	Interaction with tropomyosin alpha. Pubmed:25250574
chr3	69941238	69951816	O75030	0	+	69941238	69951816	255,102,0	1	10578	0	.	Transactivation.
chr3	69959360	69964852	O75030	0	+	69959360	69964852	255,102,0	1	5492	0	.	Leucine-zipper.
chr3	69964867	69964960	O75030	0	+	69964867	69964960	255,102,0	1	93	0	.	DNA binding regulation.
chr3	70978017	70987996	Q9H334	0	-	70978017	70987996	255,102,0	1	9979	0	.	CTBP1-binding.
chr3	70988032	71000992	Q9H334	0	-	70988032	71000992	255,102,0	1	12960	0	.	Leucine-zipper.
chr3	71690115	71690133	Q8N5X7	0	-	71690115	71690133	255,102,0	1	18	0	.	7-methylguanosine-containing mRNA cap binding.
chr3	71696516	71699615	Q8N5X7	0	-	71696516	71699615	255,102,0	1	3099	0	.	7-methylguanosine-containing mRNA cap binding.
chr3	81594007	81594019	Q04446	0	-	81594007	81594019	255,102,0	1	12	0	.	Substrate binding. Pubmed:26199317
chr3	81670903	81670915	Q04446	0	-	81670903	81670915	255,102,0	1	12	0	.	Substrate binding. Pubmed:26199317
chr3	81705477	81705486	Q04446	0	-	81705477	81705486	255,102,0	1	9	0	.	Substrate binding. Pubmed:26199317
chr3	81705567	81705573	Q04446	0	-	81705567	81705573	255,102,0	1	6	0	.	Substrate binding. Pubmed:26199317
chr3	87991043	87991073	P30939	0	+	87991043	87991073	255,102,0	1	30	0	.	Agonist binding.
chr3	87991664	87991679	P30939	0	+	87991664	87991679	255,102,0	1	15	0	.	Agonist binding.
chr3	93906141	93910703	P07225	0	-	93906141	93910703	255,102,0	1	4562	0	.	Thrombin-sensitive.
chr3	94058693	94058711	Q86XF0	0	-	94058693	94058711	255,102,0	1	18	0	.	Substrate binding.
chr3	94061403	94061421	Q86XF0	0	-	94061403	94061421	255,102,0	1	18	0	.	Substrate binding.
chr3	94084398	94084419	Q9H649	0	+	94084398	94084419	255,102,0	1	21	0	.	S-adenosyl-L-methionine binding.
chr3	97875088	97875160	Q68DQ2	0	+	97875088	97875160	255,102,0	1	72	0	.	RII-binding helix. Pubmed:25097019
chr3	97986742	97992917	A8MPY1	0	-	97986742	97992917	255,102,0	1	6175	0	.	Interaction with SQSTM1.
chr3	98580763	98581510	P36551	0	-	98580763	98581510	255,102,0	1	747	0	.	Important for dimerization.
chr3	98581444	98581453	P36551	0	-	98581444	98581453	255,102,0	1	9	0	.	Substrate binding.
chr3	98590656	98590665	P36551	0	-	98590656	98590665	255,102,0	1	9	0	.	Substrate binding.
chr3	98591105	98591135	P36551	0	-	98591105	98591135	255,102,0	1	30	0	.	Important for dimerization.
chr3	99790766	99794252	P27658	0	+	99790766	99794252	255,102,0	1	3486	0	.	Nonhelical region (NC2).
chr3	99794252	99795614	P27658	0	+	99794252	99795614	255,102,0	1	1362	0	.	Triple-helical region (COL1).
chr3	99795614	99796133	P27658	0	+	99795614	99796133	255,102,0	1	519	0	.	Nonhelical region (NC1).
chr3	101228855	101229385	Q9BZV3	0	-	101228855	101229385	255,102,0	1	530	0	.	Hyaluronan-binding motif involved in chondroitin sulfate A- and C-binding motif.
chr3	101229577	101230973	Q9BZV3	0	-	101229577	101230973	255,102,0	1	1396	0	.	Hyaluronan-binding motif involved in chondroitin sulfate C-binding.
chr3	101230979	101231006	Q9BZV3	0	-	101230979	101231006	255,102,0	1	27	0	.	Hyaluronan-binding motif involved in chondroitin sulfate A- and C-binding.
chr3	101231114	101231141	Q9BZV3	0	-	101231114	101231141	255,102,0	1	27	0	.	Hyaluronan-binding motif involved in chondroitin sulfate C-binding.
chr3	101273607	101273634	Q9BZV3	0	-	101273607	101273634	255,102,0	1	27	0	.	Hyaluronan-binding motif involved in chondroitin sulfate A-binding.
chr3	101325945	101340174	Q9BQF6	0	-	101325945	101340174	255,102,0	1	14229	0	.	Protease.
chr3	101757066	101765203	Q8IW35	0	+	101757066	101765203	255,102,0	1	8137	0	.	CCP110-binding.
chr3	101853486	101853708	Q9BYH8	0	+	101853486	101853708	255,102,0	1	222	0	.	Required for transcriptional activity.
chr3	101853735	101859368	Q9BYH8	0	+	101853735	101859368	255,102,0	1	5633	0	.	Interaction with NFKB1/p50.
chr3	105659137	105670251	Q13191	0	-	105659137	105670251	255,102,0	1	11114	0	.	Interaction with SH3KBP1. Pubmed:12177062
chr3	105702348	105702426	Q13191	0	-	105702348	105702426	255,102,0	1	78	0	.	Interaction with VAV1. Pubmed:9399639
chr3	105734095	105737212	Q13191	0	-	105734095	105737212	255,102,0	1	3117	0	.	Linker.
chr3	105737212	105751464	Q13191	0	-	105737212	105751464	255,102,0	1	14252	0	.	SH2-like.
chr3	105751464	105776460	Q13191	0	-	105751464	105776460	255,102,0	1	24996	0	.	EF-hand-like.
chr3	105776460	105867475	Q13191	0	-	105776460	105867475	255,102,0	1	91015	0	.	4H.
chr3	108162488	108165472	Q9NWB7	0	-	108162488	108165472	255,102,0	1	2984	0	.	pDED.
chr3	108454115	108455753	Q9Y2K3	0	-	108454115	108455753	255,102,0	1	1638	0	.	Actin-binding.
chr3	108459374	108459443	Q9Y2K3	0	-	108459374	108459443	255,102,0	1	69	0	.	Actin-binding.
chr3	108849185	108849197	Q6PIZ9	0	+	108849185	108849197	255,102,0	1	12	0	.	Interaction with PIK3R1. Pubmed:9687533
chr3	112204355	112208372	Q4G0N8	0	-	112204355	112208372	255,102,0	1	4017	0	.	Ion transport-like.
chr3	113005859	113005916	Q6NW34	0	-	113005859	113005916	255,102,0	1	57	0	.	Nuclear localization signal.
chr3	113722967	113723452	Q9GZZ1	0	-	113722967	113723452	255,102,0	1	485	0	.	Coenzyme A binding.
chr3	114295576	114295609	Q495A1	0	+	114295576	114295609	255,102,0	1	33	0	.	Homodimerization.
chr3	115623689	115623701	P17677	0	+	115623689	115623701	255,102,0	1	12	0	.	Important for membrane binding.
chr3	119216268	119216277	O60513	0	-	119216268	119216277	255,102,0	1	9	0	.	UDP-alpha-D-galactose binding.
chr3	119218663	119218675	O60513	0	-	119218663	119218675	255,102,0	1	12	0	.	N-acetyl-D-glucosamine binding.
chr3	119224143	119224149	O60513	0	-	119224143	119224149	255,102,0	1	6	0	.	UDP-alpha-D-galactose binding.
chr3	119224221	119224230	O60513	0	-	119224221	119224230	255,102,0	1	9	0	.	UDP-alpha-D-galactose binding.
chr3	119226895	119226910	O60513	0	-	119226895	119226910	255,102,0	1	15	0	.	UDP-alpha-D-galactose binding.
chr3	119625230	119629465	Q53H76	0	+	119625230	119629465	255,102,0	1	4235	0	.	Involved in the recognition of diacyl-phospholipids.
chr3	120689825	120742507	Q5HYI8	0	-	120689825	120742507	255,102,0	1	52682	0	.	Small GTPase-like.
chr3	121432971	121436194	O75417	0	-	121432971	121436194	255,102,0	1	3223	0	.	Loop 3. Pubmed:21050863
chr3	121467519	121468381	O75417	0	-	121467519	121468381	255,102,0	1	862	0	.	Loop 2. Pubmed:25643323, Pubmed:21050863
chr3	121473361	121473469	O75417	0	-	121473361	121473469	255,102,0	1	108	0	.	Loop 1. Pubmed:21050863
chr3	121490248	121490392	O75417	0	-	121490248	121490392	255,102,0	1	144	0	.	Interaction with RAD51. Pubmed:25642963
chr3	121647408	121658269	P14317	0	-	121647408	121658269	255,102,0	1	10861	0	.	Involved in HAX-1 binding.
chr3	121770347	121770554	Q15051	0	-	121770347	121770554	255,102,0	1	207	0	.	Interaction with BBS1, BBS2, BBS4, BBS7, BBS8 and BBS9. Pubmed:25552655
chr3	121770347	121797135	Q15051	0	-	121770347	121797135	255,102,0	1	26788	0	.	Interaction with CEP290, BBS1, BBS2, BBS4, BBS5, BBS7, BBS8 and BBS9. Pubmed:25552655
chr3	121808931	121828960	Q15051	0	-	121808931	121828960	255,102,0	1	20029	0	.	Interaction with BBS1, BBS8 and BBS9. Pubmed:25552655
chr3	121835333	121854797	Q96CJ1	0	+	121835333	121854797	255,102,0	1	19464	0	.	Necessary for interaction with ELL. Pubmed:12446457
chr3	121872580	121886385	Q96CJ1	0	+	121872580	121886385	255,102,0	1	13805	0	.	Necessary for transactivation activity.
chr3	121886340	121886385	Q96CJ1	0	+	121886340	121886385	255,102,0	1	45	0	.	Necessary for interaction with TCEA1 and transactivation activity.
chr3	122404325	122407323	Q96A26	0	+	122404325	122407323	255,102,0	1	2998	0	.	Required for proapoptotic activity.
chr3	122427655	122451554	P52294	0	-	122427655	122451554	255,102,0	1	23899	0	.	Binding to RAG1.
chr3	122433692	122442082	P52294	0	-	122433692	122442082	255,102,0	1	8390	0	.	NLS binding site (minor).
chr3	122451563	122453989	P52294	0	-	122451563	122453989	255,102,0	1	2426	0	.	NLS binding site (major).
chr3	122617097	122617103	Q460N3	0	+	122617097	122617103	255,102,0	1	6	0	.	Substrate binding. Pubmed:23473667
chr3	122617133	122617139	Q460N3	0	+	122617133	122617139	255,102,0	1	6	0	.	Substrate binding. Pubmed:23473667
chr3	122621604	122626834	Q460N3	0	+	122621604	122626834	255,102,0	1	5230	0	.	Substrate binding. Pubmed:23473667
chr3	122701317	122701332	Q460N5	0	+	122701317	122701332	255,102,0	1	15	0	.	Substrate 1 binding. Pubmed:23473667
chr3	122701620	122701626	Q460N5	0	+	122701620	122701626	255,102,0	1	6	0	.	Substrate 2 binding. Pubmed:23473667
chr3	122703795	122703807	Q460N5	0	+	122703795	122703807	255,102,0	1	12	0	.	Substrate 2 binding. Pubmed:23473667
chr3	122704604	122704619	Q460N5	0	+	122704604	122704619	255,102,0	1	15	0	.	Substrate 2 binding. Pubmed:23473667
chr3	122704730	122704742	Q460N5	0	+	122704730	122704742	255,102,0	1	12	0	.	Substrate 2 binding. Pubmed:23473667
chr3	122713506	122713512	Q460N5	0	+	122713506	122713512	255,102,0	1	6	0	.	Substrate 3 binding. Pubmed:23473667
chr3	122714422	122718078	Q460N5	0	+	122714422	122718078	255,102,0	1	3656	0	.	Substrate 3 binding. Pubmed:23473667
chr3	122755376	122768871	Q96EW2	0	-	122755376	122768871	255,102,0	1	13495	0	.	Interaction with HSPB1.
chr3	123620252	123626925	Q15746	0	-	123620252	123626925	255,102,0	1	6673	0	.	Calmodulin-binding.
chr3	123649005	123700287	Q15746	0	-	123649005	123700287	255,102,0	1	51282	0	.	Actin-binding (calcium/calmodulin-insensitive).
chr3	123700278	123700473	Q15746	0	-	123700278	123700473	255,102,0	1	195	0	.	6 X 12 AA approximate tandem repeats.
chr3	123700473	123700866	Q15746	0	-	123700473	123700866	255,102,0	1	393	0	.	5 X 28 AA approximate tandem repeats.
chr3	123700578	123700626	Q15746	0	-	123700578	123700626	255,102,0	1	48	0	.	Calmodulin-binding.
chr3	123700578	123700701	Q15746	0	-	123700578	123700701	255,102,0	1	123	0	.	Actin-binding (calcium/calmodulin-sensitive).
chr3	123969157	123969169	Q9HAT0	0	-	123969157	123969169	255,102,0	1	12	0	.	Interaction with RHPN1.
chr3	124730474	124737899	P11172	0	+	124730474	124737899	255,102,0	1	7425	0	.	OPRTase.
chr3	124737899	124737917	P11172	0	+	124737899	124737917	255,102,0	1	18	0	.	Domain linker.
chr3	124737917	124744081	P11172	0	+	124737917	124744081	255,102,0	1	6164	0	.	OMPdecase.
chr3	124773715	124796688	P18084	0	-	124773715	124796688	255,102,0	1	22973	0	.	Cysteine-rich tandem repeats.
chr3	125983305	125983317	Q9BZX4	0	+	125983305	125983317	255,102,0	1	12	0	.	Interaction with RHPN1.
chr3	126103793	126136859	O75891	0	-	126103793	126136859	255,102,0	1	33066	0	.	Aldehyde dehydrogenase.
chr3	126155422	126160979	O75891	0	-	126155422	126160979	255,102,0	1	5557	0	.	GART.
chr3	126158496	126158505	O75891	0	-	126158496	126158505	255,102,0	1	9	0	.	Substrate binding.
chr3	126438377	126441818	Q2QGD7	0	-	126438377	126441818	255,102,0	1	3441	0	.	Interaction with CIITA.
chr3	126461597	126461927	Q2QGD7	0	-	126461597	126461927	255,102,0	1	330	0	.	Required for transcriptional activation.
chr3	127598469	127606215	P49736	0	+	127598469	127606215	255,102,0	1	7746	0	.	Interaction with KAT7.
chr3	127660412	127660430	Q9NZ53	0	+	127660412	127660430	255,102,0	1	18	0	.	O-glycosylated at one site.
chr3	128153546	128153570	P57772	0	+	128153546	128153570	255,102,0	1	24	0	.	G1.
chr3	128153642	128153657	P57772	0	+	128153642	128153657	255,102,0	1	15	0	.	G2.
chr3	128153780	128153792	P57772	0	+	128153780	128153792	255,102,0	1	12	0	.	G3.
chr3	128246954	128246966	P57772	0	+	128246954	128246966	255,102,0	1	12	0	.	G4.
chr3	128262155	128262164	P57772	0	+	128262155	128262164	255,102,0	1	9	0	.	G5.
chr3	129268981	129277421	Q9Y678	0	+	129268981	129277421	255,102,0	1	8440	0	.	Interaction with ZNF289/ARFGAP2. Pubmed:14690497
chr3	129529069	129530889	P08100	0	+	129529069	129530889	255,102,0	1	1820	0	.	Retinal chromophore binding.
chr3	129532338	129532356	P08100	0	+	129532338	129532356	255,102,0	1	18	0	.	Retinal chromophore binding.
chr3	130373692	130401809	A8TX70	0	+	130373692	130401809	255,102,0	1	28117	0	.	Nonhelical region.
chr3	130401809	130426234	A8TX70	0	+	130401809	130426234	255,102,0	1	24425	0	.	Triple-helical region.
chr3	130426234	130477062	A8TX70	0	+	130426234	130477062	255,102,0	1	50828	0	.	Nonhelical region.
chr3	130560421	130589137	A6NMZ7	0	+	130560421	130589137	255,102,0	1	28716	0	.	Nonhelical region.
chr3	130589137	130642852	A6NMZ7	0	+	130589137	130642852	255,102,0	1	53715	0	.	Triple-helical region.
chr3	130642852	130675394	A6NMZ7	0	+	130642852	130675394	255,102,0	1	32542	0	.	Nonhelical region.
chr3	132434550	132457278	O75165	0	+	132434550	132457278	255,102,0	1	22728	0	.	Involved in membrane association. Pubmed:18256511
chr3	133400083	133400425	Q13515	0	+	133400083	133400425	255,102,0	1	342	0	.	Head.
chr3	133400425	133472506	Q13515	0	+	133400425	133472506	255,102,0	1	72081	0	.	Rod.
chr3	133472506	133472566	Q13515	0	+	133472506	133472566	255,102,0	1	60	0	.	Tail.
chr3	136152532	136195113	Q9HCI7	0	-	136152532	136195113	255,102,0	1	42581	0	.	Sufficient for interaction with MSL1. Pubmed:23084835
chr3	136250468	136330005	P05166	0	+	136250468	136330005	255,102,0	1	79537	0	.	Carboxyltransferase.
chr3	136316946	136317048	P05166	0	+	136316946	136317048	255,102,0	1	102	0	.	Acyl-CoA binding.
chr3	138303525	138306472	Q86XW9	0	-	138303525	138306472	255,102,0	1	2947	0	.	NDK.
chr3	138452071	138462164	A0FGR9	0	+	138452071	138462164	255,102,0	1	10093	0	.	Glycerophospholipid-binding barrel-like domain.
chr3	138474284	138474308	A0FGR9	0	+	138474284	138474308	255,102,0	1	24	0	.	Required for phosphatidylinositol 4,5-bisphosphate-dependent location at the cell membrane.
chr3	139561324	139561330	Q96T66	0	-	139561324	139561330	255,102,0	1	6	0	.	Substrate binding. Pubmed:12574164
chr3	139578885	139578897	Q96T66	0	-	139578885	139578897	255,102,0	1	12	0	.	Substrate binding. Pubmed:12574164
chr3	139578999	139579008	Q96T66	0	-	139578999	139579008	255,102,0	1	9	0	.	Substrate binding. Pubmed:12574164
chr3	141443285	141443957	Q8NAP3	0	+	141443285	141443957	255,102,0	1	672	0	.	Interaction with CBFA2T3. Pubmed:23251453
chr3	141915993	141925698	P54709	0	+	141915993	141925698	255,102,0	1	9705	0	.	immunoglobulin-like.
chr3	141959734	141963876	Q14188	0	-	141959734	141963876	255,102,0	1	4142	0	.	DCB2.
chr3	141963819	141974056	Q14188	0	-	141963819	141974056	255,102,0	1	10237	0	.	Dimerization.
chr3	141963912	141970120	Q14188	0	-	141963912	141970120	255,102,0	1	6208	0	.	DCB1.
chr3	141995081	142005449	Q14188	0	-	141995081	142005449	255,102,0	1	10368	0	.	Interaction with CEBPA. Pubmed:20176812
chr3	146206585	146222071	Q9NRQ2	0	-	146206585	146222071	255,102,0	1	15486	0	.	Proline-rich domain (PRD).
chr3	146459907	146461873	Q9NRY7	0	-	146459907	146461873	255,102,0	1	1966	0	.	Proline-rich domain (PRD).
chr3	146528673	146536552	O15162	0	-	146528673	146536552	255,102,0	1	7879	0	.	Proline-rich domain (PRD).
chr3	146600341	146605212	A0PG75	0	-	146600341	146605212	255,102,0	1	4871	0	.	Proline-rich domain (PRD).
chr3	148841873	148841885	P15086	0	+	148841873	148841885	255,102,0	1	12	0	.	Substrate binding.
chr3	148844739	148844745	P15086	0	+	148844739	148844745	255,102,0	1	6	0	.	Substrate binding.
chr3	148845557	148845563	P15086	0	+	148845557	148845563	255,102,0	1	6	0	.	Substrate binding.
chr3	149026780	149026879	P46976	0	+	149026780	149026879	255,102,0	1	99	0	.	Interaction with GYS1. Pubmed:17055998
chr3	149032222	149039072	Q14527	0	-	149032222	149039072	255,102,0	1	6850	0	.	Interaction with SP1 and SP3. Pubmed:10391891
chr3	150742149	150762462	O43255	0	-	150742149	150762462	255,102,0	1	20313	0	.	SBD.
chr3	154316091	154324260	Q9H2U1	0	-	154316091	154324260	255,102,0	1	8169	0	.	Sufficient and required for interaction with TERC 5'-end.
chr3	154316091	154324416	Q9H2U1	0	-	154316091	154324416	255,102,0	1	8325	0	.	RNA-binding; sufficient and required for recruitment to cytoplasmic stress granules.
chr3	154324218	154324257	Q9H2U1	0	-	154324218	154324257	255,102,0	1	39	0	.	RSM.
chr3	157148525	157149351	Q9UK58	0	-	157148525	157149351	255,102,0	1	826	0	.	RS.
chr3	157150082	157153038	Q9UK58	0	-	157150082	157153038	255,102,0	1	2956	0	.	Cyclin-like 2.
chr3	157153074	157159833	Q9UK58	0	-	157153074	157159833	255,102,0	1	6759	0	.	Cyclin-like 1.
chr3	158592533	158598175	P58340	0	+	158592533	158598175	255,102,0	1	5642	0	.	Interaction with COPS3. Pubmed:15861129
chr3	158666648	158669451	Q9BS40	0	-	158666648	158669451	255,102,0	1	2803	0	.	Cystatin-like fold 2.
chr3	158669451	158669511	Q9BS40	0	-	158669451	158669511	255,102,0	1	60	0	.	Alpha-helical linker.
chr3	158669511	158672478	Q9BS40	0	-	158669511	158672478	255,102,0	1	2967	0	.	Cystatin-like fold 1.
chr3	160419450	160423813	Q9NTJ3	0	+	160419450	160423813	255,102,0	1	4363	0	.	Flexible hinge.
chr3	160509826	160515568	O00629	0	-	160509826	160515568	255,102,0	1	5742	0	.	NLS binding site (minor).
chr3	160525976	160530915	O00629	0	-	160525976	160530915	255,102,0	1	4939	0	.	NLS binding site (major).
chr3	161249522	161250907	Q96D46	0	+	161249522	161250907	255,102,0	1	1385	0	.	Necessary for the nuclear export of the 60S ribosomal subunit.
chr3	164979364	165023647	P14410	0	-	164979364	165023647	255,102,0	1	44283	0	.	Sucrase.
chr3	165023647	165069123	P14410	0	-	165023647	165069123	255,102,0	1	45476	0	.	Isomaltase.
chr3	165830598	165830604	P06276	0	-	165830598	165830604	255,102,0	1	6	0	.	Substrate binding.
chr3	168036934	168041466	O00461	0	-	168036934	168041466	255,102,0	1	4532	0	.	Golgi targeting.
chr3	168041466	168048315	O00461	0	-	168041466	168048315	255,102,0	1	6849	0	.	Endosome targeting.
chr3	168044872	168095174	O00461	0	-	168044872	168095174	255,102,0	1	50302	0	.	Golgi targeting.
chr3	169116551	169131477	Q03112	0	-	169116551	169131477	255,102,0	1	14926	0	.	Interaction with MAPK9, SMAD3 and probably SUV39H1. Pubmed:10856240
chr3	170222672	170222753	P41743	0	+	170222672	170222753	255,102,0	1	81	0	.	Required for interaction with RAB2.
chr3	170222672	170280280	P41743	0	+	170222672	170280280	255,102,0	1	57608	0	.	Regulatory domain.
chr3	170235341	170260018	P41743	0	+	170235341	170260018	255,102,0	1	24677	0	.	Interaction with PARD6A.
chr3	171005287	171005308	P11168	0	-	171005287	171005308	255,102,0	1	21	0	.	Monosaccharide binding.
chr3	171084182	171167176	Q9UKE5	0	-	171084182	171167176	255,102,0	1	82994	0	.	Mediates interaction with NEDD4. Pubmed:20159449
chr3	171612376	171688828	Q13393	0	-	171612376	171688828	255,102,0	1	76452	0	.	Catalytic.
chr3	178807409	178825666	Q9Y691	0	+	178807409	178825666	255,102,0	1	18257	0	.	Ball and chain.
chr3	179334074	179334329	Q9UID6	0	+	179334074	179334329	255,102,0	1	255	0	.	Interaction with CTNNA2. Pubmed:16182284
chr3	180968175	180968223	P51114	0	+	180968175	180968223	255,102,0	1	48	0	.	RNA-binding RGG-box.
chr3	184249694	184257756	O60344	0	+	184249694	184257756	255,102,0	1	8062	0	.	Methyltransferase-like region.
chr3	184257537	184257543	O60344	0	+	184257537	184257543	255,102,0	1	6	0	.	S-adenosyl-L-homocysteine binding.
chr3	184257612	184257618	O60344	0	+	184257612	184257618	255,102,0	1	6	0	.	S-adenosyl-L-homocysteine binding.
chr3	184260189	184261159	Q96S95	0	-	184260189	184261159	255,102,0	1	970	0	.	Inhibitory domain.
chr3	184277008	184292235	O60344	0	+	184277008	184292235	255,102,0	1	15227	0	.	Endothelin-converting enzyme 2 region.
chr3	184319777	184320692	Q04637	0	+	184319777	184320692	255,102,0	1	915	0	.	PABPC1-binding.
chr3	184322843	184322879	Q04637	0	+	184322843	184322879	255,102,0	1	36	0	.	EIF4E-binding.
chr3	184323196	184326559	Q04637	0	+	184323196	184326559	255,102,0	1	3363	0	.	eIF3/EIF4A-binding.
chr3	184331558	184334905	Q04637	0	+	184331558	184334905	255,102,0	1	3347	0	.	EIF4A-binding.
chr3	184334860	184334905	Q04637	0	+	184334860	184334905	255,102,0	1	45	0	.	Necessary but not sufficient for MKNK1-binding.
chr3	184363537	184365012	P52434	0	+	184363537	184365012	255,102,0	1	1475	0	.	Non-specific ssDNA binding.
chr3	185192681	185204479	Q08426	0	-	185192681	185204479	255,102,0	1	11798	0	.	3-hydroxyacyl-CoA dehydrogenase.
chr3	185204479	185254022	Q08426	0	-	185204479	185254022	255,102,0	1	49543	0	.	Enoyl-CoA hydratase / isomerase.
chr3	185463567	185463633	O43283	0	+	185463567	185463633	255,102,0	1	66	0	.	Leucine-zipper 1.
chr3	185465813	185466841	O43283	0	+	185465813	185466841	255,102,0	1	1028	0	.	Leucine-zipper 2.
chr3	185477337	185477379	O43283	0	+	185477337	185477379	255,102,0	1	42	0	.	Acidic.
chr3	185617554	185626366	Q9HC62	0	+	185617554	185626366	255,102,0	1	8812	0	.	Protease.
chr3	185921135	185922072	P62995	0	-	185921135	185922072	255,102,0	1	937	0	.	Linker.
chr3	186538953	186539357	P22914	0	-	186538953	186539357	255,102,0	1	404	0	.	Connecting peptide.
chr3	186544311	186544323	P22914	0	-	186544311	186544323	255,102,0	1	12	0	.	N-terminal arm.
chr3	186666151	186669003	P04196	0	+	186666151	186669003	255,102,0	1	2852	0	.	Interaction with ATP5A1. Pubmed:19285951
chr3	186677346	186677451	P04196	0	+	186677346	186677451	255,102,0	1	105	0	.	Necessary for endothelial cell focal adhesions and anti-angiogenic activities.
chr3	186722487	186725155	P01042	0	+	186722487	186725155	255,102,0	1	2668	0	.	O-glycosylated at one site only.
chr3	187074317	187074326	P15907	0	+	187074317	187074326	255,102,0	1	9	0	.	Substrate binding.
chr3	187253225	187286004	P48740	0	-	187253225	187286004	255,102,0	1	32779	0	.	Interaction with FCN2.
chr3	187256855	187286004	P48740	0	-	187256855	187286004	255,102,0	1	29149	0	.	Homodimerization.
chr3	187256855	187286004	P48740	0	-	187256855	187286004	255,102,0	1	29149	0	.	Interaction with MBL2.
chr3	187729267	187729279	P41182	0	-	187729267	187729279	255,102,0	1	12	0	.	Required for interaction with NuRD complex and for transcriptional repressor activity.
chr3	189631515	189738771	Q9H3D4	0	+	189631515	189738771	255,102,0	1	107256	0	.	Transcription activation.
chr3	189868640	189869358	Q9H3D4	0	+	189868640	189869358	255,102,0	1	718	0	.	Interaction with HIPK2. Pubmed:11925430
chr3	189869373	189872975	Q9H3D4	0	+	189869373	189872975	255,102,0	1	3602	0	.	Oligomerization.
chr3	189894286	189894499	Q9H3D4	0	+	189894286	189894499	255,102,0	1	213	0	.	Transactivation inhibition.
chr3	190308279	190308285	O95832	0	-	190308279	190308285	255,102,0	1	6	0	.	Interactions with TJP1, TJP2, TJP3 and PATJ.
chr3	195070098	195070110	Q8NBI6	0	-	195070098	195070110	255,102,0	1	12	0	.	Interaction with target proteins.
chr3	195270740	195270749	Q8NBI6	0	-	195270740	195270749	255,102,0	1	9	0	.	UDP-alpha-D-xylose binding.
chr3	195519138	195519150	P41236	0	-	195519138	195519150	255,102,0	1	12	0	.	Required for binding PPP1CC catalytic center, displacing metal ions and inhibition of PPP1CC catyltic activity.
chr3	195529858	195529897	P41236	0	-	195529858	195529897	255,102,0	1	39	0	.	Required for binding PPP1CC.
chr3	195542974	195542992	P41236	0	-	195542974	195542992	255,102,0	1	18	0	.	Required for binding PPP1CC.
chr3	195725119	195725803	Q8N307	0	+	195725119	195725803	255,102,0	1	684	0	.	12 X 20 AA approximate tandem repeats of S-S-E-S-S-A-S-S-D-S-P-H-P-V-I-T-P-S-R-A.
chr3	195725950	195726571	Q8N307	0	+	195725950	195726571	255,102,0	1	621	0	.	Involved in oligomerization.
chr3	195729646	195733215	Q8N307	0	+	195729646	195733215	255,102,0	1	3569	0	.	Interaction with MET. Pubmed:15314156
chr3	195867624	195868056	Q07912	0	-	195867624	195868056	255,102,0	1	432	0	.	EBD domain.
chr3	195868296	195868386	Q07912	0	-	195868296	195868386	255,102,0	1	90	0	.	Required for interaction with SRC. Pubmed:21309750
chr3	195868347	195868359	Q07912	0	-	195868347	195868359	255,102,0	1	12	0	.	Required for interaction with NEDD4.
chr3	195884937	195888588	Q07912	0	-	195884937	195888588	255,102,0	1	3651	0	.	SAM-like domain.
chr3	196051944	196055274	P02786	0	-	196051944	196055274	255,102,0	1	3330	0	.	Ligand-binding.
chr3	196075195	196077099	P02786	0	-	196075195	196077099	255,102,0	1	1904	0	.	Mediates interaction with SH3BP4. Pubmed:16325581
chr3	196238747	196238837	P49585	0	-	196238747	196238837	255,102,0	1	90	0	.	3 X repeats.
chr3	196239579	196239678	P49585	0	-	196239579	196239678	255,102,0	1	99	0	.	3 X 11 AA approximate tandem repeats.
chr3	196239582	196241974	P49585	0	-	196239582	196241974	255,102,0	1	2392	0	.	Amphipathic.
chr3	196801943	196803064	Q13177	0	+	196801943	196803064	255,102,0	1	1121	0	.	GTPase-binding.
chr3	196801943	196803139	Q13177	0	+	196801943	196803139	255,102,0	1	1196	0	.	Autoregulatory region.
chr3	196900002	196930827	Q96HI0	0	+	196900002	196930827	255,102,0	1	30825	0	.	Protease.
chr3	196937079	196937512	P52298	0	-	196937079	196937512	255,102,0	1	433	0	.	mRNA cap-binding.
chr3	196937527	196937542	P52298	0	-	196937527	196937542	255,102,0	1	15	0	.	mRNA cap-binding.
chr3	196937560	196937575	P52298	0	-	196937560	196937575	255,102,0	1	15	0	.	mRNA cap-binding.
chr3	197027869	197027902	P08582	0	-	197027869	197027902	255,102,0	1	33	0	.	Antigenic epitope.
chr3	197149742	197161738	Q12959	0	-	197149742	197161738	255,102,0	1	11996	0	.	Interaction with SH3 domains.
chr3	197675020	197681865	Q92622	0	-	197675020	197681865	255,102,0	1	6845	0	.	Interaction with Rab7. Pubmed:20943950
chr3	197681278	197682582	Q92622	0	-	197681278	197682582	255,102,0	1	1304	0	.	Interaction with CARD9. Pubmed:22423967
chr3	197683411	197693802	Q92622	0	-	197683411	197693802	255,102,0	1	10391	0	.	Interaction with CYBA. Pubmed:22423966
chr3	197684203	197700976	Q92622	0	-	197684203	197700976	255,102,0	1	16773	0	.	Interaction with UVRAG. Pubmed:21062745
chr3	197694387	197694546	Q92622	0	-	197694387	197694546	255,102,0	1	159	0	.	Interaction with BECN1. Pubmed:22423966
chr3	197696969	197701825	Q92622	0	-	197696969	197701825	255,102,0	1	4856	0	.	Interaction with YWHAB. Pubmed:22423967
chr3	197703577	197718051	Q92622	0	-	197703577	197718051	255,102,0	1	14474	0	.	Interaction with PIK3C3. Pubmed:19270696, Pubmed:21062745
chr4	786695	792498	O14810	0	-	786695	792498	255,102,0	1	5803	0	.	Interaction with the SNARE complex.
chr4	1002101	1002107	P35475	0	+	1002101	1002107	255,102,0	1	6	0	.	Substrate binding.
chr4	1212971	1214374	Q13363	0	-	1212971	1214374	255,102,0	1	1403	0	.	Interaction with GLIS2 2.
chr4	1228328	1248955	Q13363	0	-	1228328	1248955	255,102,0	1	20627	0	.	Interaction with GLIS2 1.
chr4	1289913	1315516	Q7L5Y9	0	+	1289913	1315516	255,102,0	1	25603	0	.	Extracellular and involved in cell to cell contact.
chr4	1348094	1351720	Q2YD98	0	+	1348094	1351720	255,102,0	1	3626	0	.	VHS-like.
chr4	1395609	1395849	Q8N1N5	0	+	1395609	1395849	255,102,0	1	240	0	.	Interaction with PAK1. Pubmed:16278681
chr4	1696236	1699658	Q14493	0	-	1696236	1699658	255,102,0	1	3422	0	.	RNA-binding.
chr4	1731273	1735817	Q9Y6A5	0	+	1731273	1735817	255,102,0	1	4544	0	.	Necessary but not sufficient for spindle localization. Pubmed:23918938
chr4	1737271	1745010	Q9Y6A5	0	+	1737271	1745010	255,102,0	1	7739	0	.	Necessary but not sufficient for spindle localization. Pubmed:23918938
chr4	2261819	2261965	Q14582	0	-	2261819	2261965	255,102,0	1	146	0	.	Interaction with SIN3A and SIN3B.
chr4	2490493	2497045	P78317	0	+	2490493	2497045	255,102,0	1	6552	0	.	Required for ubiquitination activity.
chr4	2497006	2500717	P78317	0	+	2497006	2500717	255,102,0	1	3711	0	.	Mediates interaction with TRPS1.
chr4	2742505	2744738	Q8NFZ5	0	-	2742505	2744738	255,102,0	1	2233	0	.	Ubiquitin-binding domain (UBD).
chr4	2928457	2928511	P35611	0	+	2928457	2928511	255,102,0	1	54	0	.	Interaction with calmodulin.
chr4	2964070	3007754	P32298	0	+	2964070	3007754	255,102,0	1	43684	0	.	N-terminal.
chr4	3074831	3074864	P42858	0	+	3074831	3074864	255,102,0	1	33	0	.	Sufficient for interaction with TPR. Pubmed:15654337
chr4	3512988	3518076	P30533	0	-	3512988	3518076	255,102,0	1	5088	0	.	LDL receptor binding.
chr4	6053977	6081617	Q96N16	0	-	6053977	6081617	255,102,0	1	27640	0	.	Mediates interaction with TYK2 and GABBR1. Pubmed:14718537, Pubmed:15277531
chr4	6081614	6112850	Q96N16	0	-	6081614	6112850	255,102,0	1	31236	0	.	Mediates association with microtubules.
chr4	7772909	7774769	Q8N556	0	-	7772909	7774769	255,102,0	1	1860	0	.	Interaction with F-actin.
chr4	8286597	8294170	P83110	0	+	8286597	8294170	255,102,0	1	7573	0	.	Serine protease.
chr4	9920387	9920408	Q9NRM0	0	-	9920387	9920408	255,102,0	1	21	0	.	Monosaccharide binding.
chr4	10540555	10540564	Q7Z7G1	0	-	10540555	10540564	255,102,0	1	9	0	.	Mediates interaction with LAT and GRB2.
chr4	10542020	10542038	Q7Z7G1	0	-	10542020	10542038	255,102,0	1	18	0	.	Mediates interaction with PLCG1.
chr4	15638613	15655287	Q9UKA1	0	-	15638613	15655287	255,102,0	1	16674	0	.	Hemerythrin-like.
chr4	15935930	15936056	Q14512	0	-	15935930	15936056	255,102,0	1	126	0	.	Sufficient for interaction with FGF2 and FGF2-induced effects.
chr4	16502756	16502873	O43679	0	-	16502756	16502873	255,102,0	1	117	0	.	LIM-binding domain (LID).
chr4	20730084	20730126	Q6PIL6	0	-	20730084	20730126	255,102,0	1	42	0	.	Interaction with KCND2.
chr4	20882638	21948628	Q6PIL6	0	-	20882638	21948628	255,102,0	1	1065990	0	.	KIS.
chr4	23795824	23814435	Q9UBK2	0	-	23795824	23814435	255,102,0	1	18611	0	.	Mediates interaction with RNF34. Pubmed:22064484
chr4	23814465	23814606	Q9UBK2	0	-	23814465	23814606	255,102,0	1	141	0	.	Interaction with PPARG.
chr4	25123957	25124017	Q9HD40	0	-	25123957	25124017	255,102,0	1	60	0	.	SLA/LP epitope. Pubmed:11826415
chr4	25156925	25156958	Q9HD40	0	-	25156925	25156958	255,102,0	1	33	0	.	Phosphate loop (P-loop). Pubmed:19608919
chr4	25159089	25160369	Q9HD40	0	-	25159089	25160369	255,102,0	1	1280	0	.	Tetramerization. Pubmed:19608919
chr4	25255097	25255106	Q8TCG2	0	+	25255097	25255106	255,102,0	1	9	0	.	Important for substrate binding.
chr4	25255121	25255163	Q8TCG2	0	+	25255121	25255163	255,102,0	1	42	0	.	Important for interaction with membranes.
chr4	25259069	25259096	Q8TCG2	0	+	25259069	25259096	255,102,0	1	27	0	.	Important for interaction with membranes.
chr4	25263839	25268462	Q8TCG2	0	+	25263839	25268462	255,102,0	1	4623	0	.	Important for interaction with membranes.
chr4	37839898	37839904	Q96G03	0	+	37839898	37839904	255,102,0	1	6	0	.	Substrate binding.
chr4	37845698	37845704	Q96G03	0	+	37845698	37845704	255,102,0	1	6	0	.	Substrate binding.
chr4	37847282	37847291	Q96G03	0	+	37847282	37847291	255,102,0	1	9	0	.	Substrate binding.
chr4	38680625	38688749	P57682	0	+	38680625	38688749	255,102,0	1	8124	0	.	Repressor domain.
chr4	38797883	38797895	Q15399	0	-	38797883	38797895	255,102,0	1	12	0	.	Interaction with bacterial lipopeptide.
chr4	39407177	39437914	Q86Z14	0	+	39407177	39437914	255,102,0	1	30737	0	.	Glycosyl hydrolase-1 1.
chr4	39437938	39448452	Q86Z14	0	+	39437938	39448452	255,102,0	1	10514	0	.	Glycosyl hydrolase-1 2.
chr4	39505637	39505643	O60701	0	-	39505637	39505643	255,102,0	1	6	0	.	Substrate binding. Pubmed:21502315
chr4	39508652	39509772	O60701	0	-	39508652	39509772	255,102,0	1	1120	0	.	Substrate binding. Pubmed:21502315
chr4	39509898	39510358	O60701	0	-	39509898	39510358	255,102,0	1	460	0	.	Substrate binding. Pubmed:21502315
chr4	39510520	39510535	O60701	0	-	39510520	39510535	255,102,0	1	15	0	.	Substrate binding. Pubmed:21502315
chr4	40243602	40243644	Q15669	0	+	40243602	40243644	255,102,0	1	42	0	.	Interaction with ZAP70.
chr4	41256988	41257006	P09936	0	+	41256988	41257006	255,102,0	1	18	0	.	Interaction with ubiquitin. Pubmed:20439756
chr4	41268031	41268049	P09936	0	+	41268031	41268049	255,102,0	1	18	0	.	Interaction with ubiquitin. Pubmed:20439756
chr4	47161365	47161374	P18505	0	+	47161365	47161374	255,102,0	1	9	0	.	Agonist binding.
chr4	47320202	47403319	P18505	0	+	47320202	47403319	255,102,0	1	83117	0	.	Agonist binding.
chr4	47406713	47406779	P18505	0	+	47406713	47406779	255,102,0	1	66	0	.	Allosteric effector binding.
chr4	49044800	49050709	Q9H720	0	+	49044800	49050709	255,102,0	1	5909	0	.	Required for function in lipid remodeling.
chr4	52862591	52865796	Q9BPW5	0	+	52862591	52865796	255,102,0	1	3205	0	.	Small GTPase-like.
chr4	53377838	53383877	Q6UN15	0	+	53377838	53383877	255,102,0	1	6039	0	.	Sufficient for interaction with PAPOLA.
chr4	53377838	53428077	Q6UN15	0	+	53377838	53428077	255,102,0	1	50239	0	.	Necessary for stimulating PAPOLA activity.
chr4	53390531	53399753	Q6UN15	0	+	53390531	53399753	255,102,0	1	9222	0	.	Sufficient for interaction with CPSF4. Pubmed:14749727
chr4	53452960	53459446	Q6UN15	0	+	53452960	53459446	255,102,0	1	6486	0	.	Sufficient for interaction with CPSF1 and CSTF3. Pubmed:14749727
chr4	53507359	53508052	Q8TBB1	0	-	53507359	53508052	255,102,0	1	693	0	.	Interaction with MAGEB18. Pubmed:20864041
chr4	54727469	54727478	P10721	0	+	54727469	54727478	255,102,0	1	9	0	.	Important for interaction with phosphotyrosine-binding proteins.
chr4	55435420	55453696	O15516	0	-	55435420	55453696	255,102,0	1	18276	0	.	Interaction with NR3C1.
chr4	55443878	55449497	O15516	0	-	55443878	55449497	255,102,0	1	5619	0	.	Interaction with SIRT1.
chr4	55444632	55444785	O15516	0	-	55444632	55444785	255,102,0	1	153	0	.	Implicated in the circadian rhythmicity.
chr4	55556559	55569815	Q8N4E4	0	-	55556559	55569815	255,102,0	1	13256	0	.	Thioredoxin fold.
chr4	56436315	56451880	P22234	0	+	56436315	56451880	255,102,0	1	15565	0	.	SAICAR synthetase.
chr4	56451880	56451898	P22234	0	+	56451880	56451898	255,102,0	1	18	0	.	Linker.
chr4	56451898	56459535	P22234	0	+	56451898	56459535	255,102,0	1	7637	0	.	AIR carboxylase.
chr4	56910731	56911004	Q13127	0	+	56910731	56911004	255,102,0	1	273	0	.	Interaction with SIN3A. Pubmed:10734093
chr4	56910764	56910809	Q13127	0	+	56910764	56910809	255,102,0	1	45	0	.	Interaction with SIN3B. Pubmed:16288918
chr4	56911070	56930112	Q13127	0	+	56911070	56930112	255,102,0	1	19042	0	.	Interaction with ZFP90. Pubmed:21284946
chr4	56931882	56932119	Q13127	0	+	56931882	56932119	255,102,0	1	237	0	.	Interaction with RCOR1.
chr4	67472607	67489969	Q03188	0	-	67472607	67489969	255,102,0	1	17362	0	.	MIF2 homology domain III.
chr4	67493896	67493965	Q03188	0	-	67493896	67493965	255,102,0	1	69	0	.	MIF2 homology domain II.
chr4	68332135	68332144	Q96MU7	0	-	68332135	68332144	255,102,0	1	9	0	.	N6-methyladenosine binding.
chr4	69749768	69749777	O43704	0	-	69749768	69749777	255,102,0	1	9	0	.	Substrate binding.
chr4	69854264	69854273	P49888	0	-	69854264	69854273	255,102,0	1	9	0	.	Substrate binding.
chr4	69999672	69999782	P02808	0	+	69999672	69999782	255,102,0	1	110	0	.	Hydroxyapatite-binding; inhibits crystal growth.
chr4	70000871	70000946	P02808	0	+	70000871	70000946	255,102,0	1	75	0	.	Hydrophobic; inhibits precipitation of calcium phosphate salts.
chr4	70198581	70198590	A1E959	0	+	70198581	70198590	255,102,0	1	9	0	.	Interaction with ARHGEF5. Pubmed:25911094
chr4	70234151	70234178	Q8NFU4	0	+	70234151	70234178	255,102,0	1	27	0	.	O-glycosylated at one site.
chr4	71236576	71255332	Q9Y6R1	0	+	71236576	71255332	255,102,0	1	18756	0	.	Required for interaction with AHCYL1. Pubmed:16769890
chr4	71532136	71534283	Q9Y6R1	0	+	71532136	71534283	255,102,0	1	2147	0	.	Interaction with CA4.
chr4	71560158	71560167	Q9Y6R1	0	+	71560158	71560167	255,102,0	1	9	0	.	CA2-binding.
chr4	71560242	71560254	Q9Y6R1	0	+	71560242	71560254	255,102,0	1	12	0	.	CA2-binding.
chr4	71563861	71563870	Q9Y6R1	0	+	71563861	71563870	255,102,0	1	9	0	.	Required for basolateral targeting.
chr4	72298334	72309439	O15072	0	-	72298334	72309439	255,102,0	1	11105	0	.	Spacer.
chr4	73854089	73854110	P10720	0	+	73854089	73854110	255,102,0	1	21	0	.	Heparin-binding.
chr4	73981215	73981236	P02776	0	-	73981215	73981236	255,102,0	1	21	0	.	Heparin-binding.
chr4	75724819	75801125	O60763	0	+	75724819	75801125	255,102,0	1	76306	0	.	Globular head.
chr4	75872053	75889992	O14830	0	-	75872053	75889992	255,102,0	1	17939	0	.	Catalytic.
chr4	76100289	76101018	Q13508	0	+	76100289	76101018	255,102,0	1	729	0	.	3 X 10 AA tandem repeats of [GS]-E-K-N-[QW]-K-L-E-D-H.
chr4	76117723	76148362	Q7Z3B4	0	-	76117723	76148362	255,102,0	1	30639	0	.	9 X 2 AA repeats of F-G.
chr4	76179555	76179666	Q14108	0	-	76179555	76179666	255,102,0	1	111	0	.	Important for interaction with GBA.
chr4	77720433	77756880	Q96LI5	0	-	77720433	77756880	255,102,0	1	36447	0	.	Nuclease domain.
chr4	77756895	77819237	Q96LI5	0	-	77756895	77819237	255,102,0	1	62342	0	.	Required for interaction with CNOT1, CNOT3 and CNOT7. Pubmed:17452450
chr4	78920565	78920580	Q6TCH7	0	-	78920565	78920580	255,102,0	1	15	0	.	Golgi targeting.
chr4	78935255	78939044	Q6TCH7	0	-	78935255	78939044	255,102,0	1	3789	0	.	Golgi targeting.
chr4	79317444	79317618	Q9BSU3	0	-	79317444	79317618	255,102,0	1	174	0	.	Interaction with NAA15.
chr4	81144236	81167217	Q13237	0	-	81144236	81167217	255,102,0	1	22981	0	.	cGMP-binding, high affinity; cAMP-binding, low affinity. Pubmed:26769964
chr4	81169661	81174919	Q13237	0	-	81169661	81174919	255,102,0	1	5258	0	.	cGMP-binding, high affinity; cAMP-binding, moderate affinity. Pubmed:26769964
chr4	82426061	82426469	O14979	0	-	82426061	82426469	255,102,0	1	408	0	.	Necessary for its nuclear import and export.
chr4	82426061	82426631	O14979	0	-	82426061	82426631	255,102,0	1	570	0	.	Necessary for interaction with TNPO1. Pubmed:9524220
chr4	82454788	82454794	Q9UHY7	0	+	82454788	82454794	255,102,0	1	6	0	.	Substrate binding.
chr4	82824626	82848908	O94979	0	-	82824626	82848908	255,102,0	1	24282	0	.	Interaction with PDCD6.
chr4	82864382	82875744	O94979	0	-	82864382	82875744	255,102,0	1	11362	0	.	Interaction with SEC13. Pubmed:16957052
chr4	83273605	83279004	E2QRG7	0	-	83273605	83279004	255,102,0	1	5399	0	.	Allylic polyprenyl diphosphate-binding site.
chr4	83295346	83295397	Q9Y251	0	-	83295346	83295397	255,102,0	1	51	0	.	Required for transferring proheparanase to the Golgi apparatus, secretion and subsequent enzyme activity and for enhancement of PKB/AKT1 phosphorylation.
chr4	83310723	83310756	Q9Y251	0	-	83310723	83310756	255,102,0	1	33	0	.	Heparin/HS-binding.
chr4	83319356	83319371	Q9Y251	0	-	83319356	83319371	255,102,0	1	15	0	.	Heparin/HS-binding.
chr4	83470315	83485042	Q6UWZ7	0	-	83470315	83485042	255,102,0	1	14727	0	.	MPN-like.
chr4	84493291	84493477	P78426	0	-	84493291	84493477	255,102,0	1	186	0	.	Involved in DNA-binding.
chr4	84495710	84497925	P78426	0	-	84495710	84497925	255,102,0	1	2215	0	.	Repressor domain.
chr4	84672870	84692993	Q8IZQ1	0	-	84672870	84692993	255,102,0	1	20123	0	.	Interaction with ATG5. Pubmed:20417604
chr4	84672870	84717015	Q8IZQ1	0	-	84672870	84717015	255,102,0	1	44145	0	.	Interaction with SQSTM1.
chr4	84692990	84736232	Q8IZQ1	0	-	84692990	84736232	255,102,0	1	43242	0	.	Sufficient for translocalization to p62 bodies/ALIS.
chr4	86809906	86809927	Q12923	0	+	86809906	86809927	255,102,0	1	21	0	.	Substrate.
chr4	86809906	86809927	Q12923	0	+	86809906	86809927	255,102,0	1	21	0	.	Substrate binding.
chr4	87495079	87495109	Q14515	0	-	87495079	87495109	255,102,0	1	30	0	.	O-glycosylated at one additional site.
chr4	88061995	88067921	Q13563	0	+	88061995	88067921	255,102,0	1	5926	0	.	EF-hand domain.
chr4	88067945	88068005	Q13563	0	+	88067945	88068005	255,102,0	1	60	0	.	Linker.
chr4	88068020	88075691	Q13563	0	+	88068020	88075691	255,102,0	1	7671	0	.	C-terminal coiled coil domain.
chr4	89822350	89835610	P37840	0	-	89822350	89835610	255,102,0	1	13260	0	.	4 X 11 AA tandem repeats of [EGS]-K-T-K-[EQ]-[GQ]-V-X(4).
chr4	93772234	93772447	O43424	0	+	93772234	93772447	255,102,0	1	213	0	.	Interaction with AP4M1.
chr4	94317906	94317912	O60760	0	-	94317906	94317912	255,102,0	1	6	0	.	Glutathione binding. Pubmed:16547010, Pubmed:18341273
chr4	94317945	94317954	O60760	0	-	94317945	94317954	255,102,0	1	9	0	.	Glutathione binding. Pubmed:16547010, Pubmed:18341273
chr4	95202730	95202787	O95185	0	-	95202730	95202787	255,102,0	1	57	0	.	Interaction with DCC.
chr4	98881060	98881069	P06730	0	-	98881060	98881069	255,102,0	1	9	0	.	7-methylguanosine-containing mRNA cap binding.
chr4	98884974	98884992	P06730	0	-	98884974	98884992	255,102,0	1	18	0	.	7-methylguanosine-containing mRNA cap binding.
chr4	98885043	98887084	P06730	0	-	98885043	98887084	255,102,0	1	2041	0	.	EIF4EBP1/2/3 binding.
chr4	98887168	98887174	P06730	0	-	98887168	98887174	255,102,0	1	6	0	.	7-methylguanosine-containing mRNA cap binding.
chr4	98887942	98891241	P06730	0	-	98887942	98891241	255,102,0	1	3299	0	.	EIF4EBP1/2/3 binding.
chr4	98891286	98891292	P06730	0	-	98891286	98891292	255,102,0	1	6	0	.	7-methylguanosine-containing mRNA cap binding.
chr4	98901880	98901892	P06730	0	-	98901880	98901892	255,102,0	1	12	0	.	EIF4EBP1/2/3 binding.
chr4	98995777	99028908	P53582	0	+	98995777	99028908	255,102,0	1	33131	0	.	Zinc finger-like; important for proper ribosome association.
chr4	99885568	99885610	Q9UHA4	0	-	99885568	99885610	255,102,0	1	42	0	.	Required for interaction with LAMTOR2.
chr4	99948826	99948859	P0C0S5	0	-	99948826	99948859	255,102,0	1	33	0	.	Required for interaction with INCENP.
chr4	99948835	99948871	P0C0S5	0	-	99948835	99948871	255,102,0	1	36	0	.	M6 cassette.
chr4	99949692	99949740	P0C0S5	0	-	99949692	99949740	255,102,0	1	48	0	.	Required for interaction with INCENP.
chr4	101025969	101026038	Q08209	0	-	101025969	101026038	255,102,0	1	69	0	.	Inhibitory domain.
chr4	101040480	101040549	Q08209	0	-	101040480	101040549	255,102,0	1	69	0	.	Calmodulin-binding.
chr4	101080583	101080601	Q08209	0	-	101080583	101080601	255,102,0	1	18	0	.	Calcineurin B binding-site 2.
chr4	101080583	101346793	Q08209	0	-	101080583	101346793	255,102,0	1	266210	0	.	Catalytic.
chr4	101093798	101093819	Q08209	0	-	101093798	101093819	255,102,0	1	21	0	.	Calcineurin B binding-site 1.
chr4	101790880	101830199	Q8NDB2	0	+	101790880	101830199	255,102,0	1	39319	0	.	Interaction with ITPR2. Pubmed:11782428
chr4	102593474	102593543	P19838	0	+	102593474	102593543	255,102,0	1	69	0	.	GRR.
chr4	102596142	102616591	P19838	0	+	102596142	102616591	255,102,0	1	20449	0	.	Interaction with CFLAR. Pubmed:13679070
chr4	102606693	102607250	P19838	0	+	102606693	102607250	255,102,0	1	557	0	.	Essential for interaction with HIF1AN. Pubmed:17003112
chr4	103106233	103114467	Q02224	0	-	103106233	103114467	255,102,0	1	8234	0	.	Globular autoinhibitory domain.
chr4	103116590	103136287	Q02224	0	-	103116590	103136287	255,102,0	1	19697	0	.	Kinetochore-binding domain.
chr4	105259682	105259724	Q6N021	0	+	105259682	105259724	255,102,0	1	42	0	.	Interaction with DNA.
chr4	105276195	105276204	Q6N021	0	+	105276195	105276204	255,102,0	1	9	0	.	2-oxoglutarate binding.
chr4	105276213	105276222	Q6N021	0	+	105276213	105276222	255,102,0	1	9	0	.	Substrate binding.
chr4	106325024	106327479	Q12904	0	+	106325024	106327479	255,102,0	1	2455	0	.	Required for fibroblast proliferation.
chr4	106327500	106331862	Q12904	0	+	106327500	106331862	255,102,0	1	4362	0	.	Interaction with HSP90B1.
chr4	106328152	106328194	Q12904	0	+	106328152	106328194	255,102,0	1	42	0	.	Required for endothelial cell death.
chr4	106328191	106331856	Q12904	0	+	106328191	106331856	255,102,0	1	3665	0	.	Required for endothelial cell migration.
chr4	106923965	106924187	Q9UBU2	0	-	106923965	106924187	255,102,0	1	222	0	.	DKK-type Cys-2.
chr4	106924692	106925940	Q9UBU2	0	-	106924692	106925940	255,102,0	1	1248	0	.	DKK-type Cys-1.
chr4	107614251	107660042	O43252	0	-	107614251	107660042	255,102,0	1	45791	0	.	Sulfate adenylyltransferase. Pubmed:15755455
chr4	107660066	107720179	O43252	0	-	107660066	107720179	255,102,0	1	60113	0	.	Adenylyl-sulfate kinase. Pubmed:17276460, Pubmed:15755455, Pubmed:17540769
chr4	107682128	107682134	O43252	0	-	107682128	107682134	255,102,0	1	6	0	.	Adenylyl sulfate binding. Pubmed:17276460, Pubmed:17540769
chr4	107693782	107693788	O43252	0	-	107693782	107693788	255,102,0	1	6	0	.	Adenylyl sulfate binding. Pubmed:17276460, Pubmed:17540769
chr4	107693854	107693866	O43252	0	-	107693854	107693866	255,102,0	1	12	0	.	Adenylyl sulfate binding. Pubmed:17276460, Pubmed:17540769
chr4	107693905	107693917	O43252	0	-	107693905	107693917	255,102,0	1	12	0	.	Adenylyl sulfate binding. Pubmed:17276460
chr4	108167581	108167767	Q9UJU2	0	-	108167581	108167767	255,102,0	1	186	0	.	CTNNB1-binding.
chr4	108941365	108941389	Q9BXS0	0	-	108941365	108941389	255,102,0	1	24	0	.	Interaction with beta amyloid peptide. Pubmed:15522881
chr4	109511992	109512067	O95487	0	+	109511992	109512067	255,102,0	1	75	0	.	Zinc finger-like.
chr4	109816173	109816335	Q9NY12	0	+	109816173	109816335	255,102,0	1	162	0	.	RGG-box 1.
chr4	109822421	109824428	Q9NY12	0	+	109822421	109824428	255,102,0	1	2007	0	.	RGG-box 2.
chr4	109983450	109983471	P01133	0	+	109983450	109983471	255,102,0	1	21	0	.	O-glycosylated at one site.
chr4	110509681	110509696	Q07075	0	+	110509681	110509696	255,102,0	1	15	0	.	Substrate binding.
chr4	112260811	112265041	Q63HQ0	0	+	112260811	112265041	255,102,0	1	4230	0	.	Interaction with AP1G1.
chr4	112266667	112268145	Q63HQ0	0	+	112266667	112268145	255,102,0	1	1478	0	.	Sufficient for association with the Arp2/3 complex.
chr4	113318615	113333204	Q01484	0	+	113318615	113333204	255,102,0	1	14589	0	.	Interaction with SPTBN1. Pubmed:15262991
chr4	113339293	113345920	Q01484	0	+	113339293	113345920	255,102,0	1	6627	0	.	UPA domain.
chr4	113354033	113354567	Q01484	0	+	113354033	113354567	255,102,0	1	534	0	.	Repeat-rich region.
chr4	113513829	113513862	Q13557	0	-	113513829	113513862	255,102,0	1	33	0	.	Calmodulin-binding.
chr4	113513856	113513886	Q13557	0	-	113513856	113513886	255,102,0	1	30	0	.	Autoinhibitory domain.
chr4	114827818	114852776	Q9H3R1	0	-	114827818	114852776	255,102,0	1	24958	0	.	Heparan sulfate N-sulfotransferase 4.
chr4	114852776	115076931	Q9H3R1	0	-	114852776	115076931	255,102,0	1	224155	0	.	Heparan sulfate N-deacetylase 4.
chr4	118054015	118226930	O95803	0	+	118054015	118226930	255,102,0	1	172915	0	.	Heparan sulfate N-deacetylase 3.
chr4	118226930	118255709	O95803	0	+	118226930	118255709	255,102,0	1	28779	0	.	Heparan sulfate N-sulfotransferase 3.
chr4	118295803	118295839	P56730	0	-	118295803	118295839	255,102,0	1	36	0	.	Zymogen activation region.
chr4	118692058	118692064	Q9HCE5	0	+	118692058	118692064	255,102,0	1	6	0	.	Interaction with METTL3. Pubmed:27281194, Pubmed:24275569
chr4	118700612	118700618	Q9HCE5	0	+	118700612	118700618	255,102,0	1	6	0	.	Interaction with METTL3. Pubmed:27281194, Pubmed:24275569
chr4	118700636	118703958	Q9HCE5	0	+	118700636	118703958	255,102,0	1	3322	0	.	Positively charged region required for RNA-binding. Pubmed:27281194
chr4	118703958	118703970	Q9HCE5	0	+	118703958	118703970	255,102,0	1	12	0	.	Interaction with METTL3. Pubmed:27281194, Pubmed:24275569
chr4	118704027	118705616	Q9HCE5	0	+	118704027	118705616	255,102,0	1	1589	0	.	Interaction with METTL3. Pubmed:27281194, Pubmed:24275569
chr4	118705643	118705649	Q9HCE5	0	+	118705643	118705649	255,102,0	1	6	0	.	Positively charged region required for RNA-binding. Pubmed:27281194
chr4	118705676	118705691	Q9HCE5	0	+	118705676	118705691	255,102,0	1	15	0	.	Interaction with METTL3. Pubmed:27281194, Pubmed:24275569
chr4	118768188	118768266	O94855	0	-	118768188	118768266	255,102,0	1	78	0	.	Zinc finger-like.
chr4	119498669	119525566	O76074	0	-	119498669	119525566	255,102,0	1	26897	0	.	Catalytic.
chr4	120060120	120060153	Q13257	0	-	120060120	120060153	255,102,0	1	33	0	.	Required for assuming the closed conformation and for interaction with CDC20.
chr4	121142767	121150144	Q96KP6	0	-	121142767	121150144	255,102,0	1	7377	0	.	Ubiquitin-binding domain (UBD).
chr4	121801424	121811648	Q06265	0	+	121801424	121811648	255,102,0	1	10224	0	.	ARE binding.
chr4	125490937	125491207	Q6V0I7	0	+	125490937	125491207	255,102,0	1	270	0	.	Necessary and sufficient for interaction with MPDZ.
chr4	137521031	137528541	Q9HCL0	0	-	137521031	137528541	255,102,0	1	7510	0	.	Interaction with DAB1.
chr4	139045204	139045237	Q9UK39	0	+	139045204	139045237	255,102,0	1	33	0	.	Interaction with PPARG.
chr4	139360586	139388081	Q9BXJ9	0	+	139360586	139388081	255,102,0	1	27495	0	.	Interaction with HYPK. Pubmed:20154145
chr4	139517913	139517919	Q8WTS6	0	-	139517913	139517919	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr4	139518000	139518009	Q8WTS6	0	-	139518000	139518009	255,102,0	1	9	0	.	Substrate binding.
chr4	139518030	139518039	Q8WTS6	0	-	139518030	139518039	255,102,0	1	9	0	.	Substrate binding.
chr4	139520354	139520363	D6RJA0	0	-	139520354	139520363	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr4	139520354	139520363	Q8WTS6	0	-	139520354	139520363	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr4	140395917	140396141	O14967	0	-	140395917	140396141	255,102,0	1	224	0	.	Interaction with PPIB.
chr4	144707228	144708174	Q96QV1	0	+	144707228	144708174	255,102,0	1	946	0	.	Interaction with SHH zinc binding site.
chr4	145162691	145162709	Q01804	0	-	145162691	145162709	255,102,0	1	18	0	.	His-loop.
chr4	145165179	145171684	Q01804	0	-	145165179	145171684	255,102,0	1	6505	0	.	Variable-loop.
chr4	145179838	145179859	Q01804	0	-	145179838	145179859	255,102,0	1	21	0	.	Cys-loop.
chr4	145554037	145557820	Q15797	0	+	145554037	145557820	255,102,0	1	3783	0	.	L3 loop. Pubmed:11779505
chr4	151148089	151148140	Q5HYK7	0	-	151148089	151148140	255,102,0	1	51	0	.	Interaction with SH3GL1. Pubmed:14551139
chr4	153596350	153603414	A2VDJ0	0	+	153596350	153603414	255,102,0	1	7064	0	.	Required for Wnt-signaling inhibition and LRP6 degradation. Pubmed:23690469
chr4	154565825	154565834	P02675	0	+	154565825	154565834	255,102,0	1	9	0	.	Beta-chain polymerization, binding distal domain of another fibrin.
chr4	154589502	154589511	P02671	0	-	154589502	154589511	255,102,0	1	9	0	.	Alpha-chain polymerization, binding distal domain of another fibrin gamma chain.
chr4	154604884	154604929	P02679	0	-	154604884	154604929	255,102,0	1	45	0	.	Platelet aggregation and Staphylococcus clumping.
chr4	154604929	154604998	P02679	0	-	154604929	154604998	255,102,0	1	69	0	.	Gamma-chain polymerization, binding amino end of another fibrin alpha chain.
chr4	155905138	155905153	P48775	0	+	155905138	155905153	255,102,0	1	15	0	.	Substrate binding. Pubmed:27762317
chr4	157138936	157143814	P48167	0	+	157138936	157143814	255,102,0	1	4878	0	.	Strychnine-binding.
chr4	157336397	157336406	P42262	0	+	157336397	157336406	255,102,0	1	9	0	.	Glutamate binding.
chr4	157341441	157341447	P42262	0	+	157341441	157341447	255,102,0	1	6	0	.	Glutamate binding.
chr4	158709738	158715567	Q08752	0	-	158709738	158715567	255,102,0	1	5829	0	.	Interaction with HSP90AB1.
chr4	158715561	158715654	Q08752	0	-	158715561	158715654	255,102,0	1	93	0	.	Chaperone activity.
chr4	158868265	158869369	Q9P278	0	+	158868265	158869369	255,102,0	1	1104	0	.	Interaction with PRKAA1. Pubmed:18663353
chr4	163528780	163528954	Q8TCQ1	0	-	163528780	163528954	255,102,0	1	174	0	.	Responsible for down-regulation of CD86 and MHC class II cell surface expression.
chr4	163613357	163854131	Q8TCQ1	0	-	163613357	163854131	255,102,0	1	240774	0	.	Responsible for low stability.
chr4	165994460	166025317	O43897	0	+	165994460	166025317	255,102,0	1	30857	0	.	Metalloprotease.
chr4	169117670	169122128	Q7Z6J0	0	-	169117670	169122128	255,102,0	1	4458	0	.	Interaction with AKT2.
chr4	169729580	169737672	Q9NWY4	0	-	169729580	169737672	255,102,0	1	8092	0	.	Interaction with PARP1. Pubmed:27067600
chr4	172348550	172813544	Q49A17	0	+	172348550	172813544	255,102,0	1	464994	0	.	Catalytic subdomain A.
chr4	172813715	172931223	Q49A17	0	+	172813715	172931223	255,102,0	1	117508	0	.	Catalytic subdomain B.
chr4	173292135	173295829	Q86SF2	0	+	173292135	173295829	255,102,0	1	3694	0	.	Catalytic subdomain A.
chr4	173298289	173304058	Q86SF2	0	+	173298289	173304058	255,102,0	1	5769	0	.	Catalytic subdomain B.
chr4	173332169	173332217	P26583	0	-	173332169	173332217	255,102,0	1	48	0	.	Required for chemotactic activity. Pubmed:19811285
chr4	173371182	173373461	O75446	0	+	173371182	173373461	255,102,0	1	2279	0	.	Interaction with NCOR1.
chr4	173373461	173377324	O75446	0	+	173373461	173377324	255,102,0	1	3863	0	.	Interaction with SIN3A.
chr4	174677284	174682811	O75311	0	-	174677284	174682811	255,102,0	1	5527	0	.	Strychnine-binding. Pubmed:26416729
chr4	174977739	174977982	Q9UKF5	0	+	174977739	174977982	255,102,0	1	243	0	.	9 X 9 AA approximate repeats.
chr4	176687245	176687494	P49767	0	-	176687245	176687494	255,102,0	1	249	0	.	4 X 16 AA repeats of C-X(10)-C-X-C-X(1,3)-C.
chr4	177434407	177434419	P20933	0	-	177434407	177434419	255,102,0	1	12	0	.	Substrate binding.
chr4	177434476	177434488	P20933	0	-	177434476	177434488	255,102,0	1	12	0	.	Substrate binding.
chr4	183510898	183510949	Q9H160	0	+	183510898	183510949	255,102,0	1	51	0	.	PBR. Pubmed:16728974
chr4	186287745	186287757	P03951	0	+	186287745	186287757	255,102,0	1	12	0	.	Heparin-binding.
chr5	434378	434831	A9YTQ3	0	+	434378	434831	255,102,0	1	453	0	.	Needed for transcriptional repression.
chr5	476267	476665	P48764	0	-	476267	476665	255,102,0	1	398	0	.	Interaction with PDZD3.
chr5	666086	678060	O94811	0	-	666086	678060	255,102,0	1	11974	0	.	Mediates interaction with LIMK1. Pubmed:18028908
chr5	1009060	1034848	Q969F2	0	+	1009060	1034848	255,102,0	1	25788	0	.	Targeting to the basolateral cell membrane.
chr5	1034240	1034863	Q969F2	0	+	1034240	1034863	255,102,0	1	623	0	.	Interaction with DVL1, DVL2 and DVL3.
chr5	1037914	1038172	Q969F2	0	+	1037914	1038172	255,102,0	1	258	0	.	Interaction with TGFA.
chr5	1253730	1264441	O14746	0	-	1253730	1264441	255,102,0	1	10711	0	.	CTE.
chr5	1264444	1264459	O14746	0	-	1264444	1264459	255,102,0	1	15	0	.	Primer grip sequence.
chr5	1264462	1264507	O14746	0	-	1264462	1264507	255,102,0	1	45	0	.	Required for oligomerization.
chr5	1282547	1293913	O14746	0	-	1282547	1293913	255,102,0	1	11366	0	.	RNA-interacting domain 2.
chr5	1282583	1293985	O14746	0	-	1282583	1293985	255,102,0	1	11402	0	.	Required for oligomerization.
chr5	1293322	1293760	O14746	0	-	1293322	1293760	255,102,0	1	438	0	.	QFP motif.
chr5	1293634	1293697	O14746	0	-	1293634	1293697	255,102,0	1	63	0	.	CP motif.
chr5	1293913	1294195	O14746	0	-	1293913	1294195	255,102,0	1	282	0	.	Linker.
chr5	1294195	1294989	O14746	0	-	1294195	1294989	255,102,0	1	794	0	.	RNA-interacting domain 1.
chr5	1294294	1294818	O14746	0	-	1294294	1294818	255,102,0	1	524	0	.	GQ motif.
chr5	1294462	1294477	O14746	0	-	1294462	1294477	255,102,0	1	15	0	.	Required for regulating specificity for telomeric DNA and for processivity for primer elongation.
chr5	1400983	1403008	Q01959	0	-	1400983	1403008	255,102,0	1	2025	0	.	Interaction with TGFB1I1. Pubmed:12177201
chr5	5239234	5242148	Q8TE57	0	+	5239234	5242148	255,102,0	1	2914	0	.	Spacer.
chr5	6622067	6622088	Q08J23	0	-	6622067	6622088	255,102,0	1	21	0	.	S-adenosyl-L-methionine binding.
chr5	7802301	7802355	Q08462	0	+	7802301	7802355	255,102,0	1	54	0	.	Interaction with GNAS.
chr5	7816949	7816961	Q08462	0	+	7816949	7816961	255,102,0	1	12	0	.	Interaction with GNAS.
chr5	7878037	7878283	Q9UBK8	0	+	7878037	7878283	255,102,0	1	246	0	.	Hinge.
chr5	13717341	13721245	Q8TE73	0	-	13717341	13721245	255,102,0	1	3904	0	.	AAA 6.
chr5	13737315	13753406	Q8TE73	0	-	13737315	13753406	255,102,0	1	16091	0	.	AAA 5.
chr5	13754311	13770801	Q8TE73	0	-	13754311	13770801	255,102,0	1	16490	0	.	Stalk.
chr5	13770843	13786253	Q8TE73	0	-	13770843	13786253	255,102,0	1	15410	0	.	AAA 4.
chr5	13792032	13809148	Q8TE73	0	-	13792032	13809148	255,102,0	1	17116	0	.	AAA 3.
chr5	13811724	13823280	Q8TE73	0	-	13811724	13823280	255,102,0	1	11556	0	.	AAA 2.
chr5	13824285	13839414	Q8TE73	0	-	13824285	13839414	255,102,0	1	15129	0	.	AAA 1.
chr5	13839414	13944438	Q8TE73	0	-	13839414	13944438	255,102,0	1	105024	0	.	Stem.
chr5	14678733	14678739	Q96BN8	0	+	14678733	14678739	255,102,0	1	6	0	.	Linear diubiquitin binding. Pubmed:23746843, Pubmed:23708998
chr5	14681508	14681517	Q96BN8	0	+	14681508	14681517	255,102,0	1	9	0	.	Linear diubiquitin binding. Pubmed:23746843, Pubmed:23708998
chr5	14690206	14690221	Q96BN8	0	+	14690206	14690221	255,102,0	1	15	0	.	Linear diubiquitin binding. Pubmed:23746843, Pubmed:23708998
chr5	14690290	14692856	Q96BN8	0	+	14690290	14692856	255,102,0	1	2566	0	.	Linear diubiquitin binding. Pubmed:23746843, Pubmed:23708998
chr5	14692994	14693003	Q96BN8	0	+	14692994	14693003	255,102,0	1	9	0	.	Linear diubiquitin binding. Pubmed:23746843, Pubmed:23708998
chr5	16478958	16616722	Q9H6L5	0	-	16478958	16616722	255,102,0	1	137764	0	.	Reticulon homology domain. Pubmed:26040720
chr5	16701595	16701748	Q9HD67	0	-	16701595	16701748	255,102,0	1	153	0	.	Mediates antiparallel dimerization. Pubmed:23012428
chr5	16701670	16702992	Q9HD67	0	-	16701670	16702992	255,102,0	1	1322	0	.	SAH.
chr5	31401461	31515110	Q9NRR4	0	-	31401461	31515110	255,102,0	1	113649	0	.	Necessary for interaction with DGCR8 and pri-miRNA processing activity. Pubmed:26748718, Pubmed:26027739
chr5	32126505	32126541	Q9H4A6	0	-	32126505	32126541	255,102,0	1	36	0	.	Beta-hairpin required for oligomerization.
chr5	32233772	32235129	Q9C0I1	0	-	32233772	32235129	255,102,0	1	1357	0	.	Interaction with MTM1. Pubmed:12847286
chr5	32588515	32591640	P53999	0	+	32588515	32591640	255,102,0	1	3125	0	.	Regulatory.
chr5	32598993	32599068	P53999	0	+	32598993	32599068	255,102,0	1	75	0	.	Interaction with ssDNA.
chr5	33576077	33577037	P58397	0	-	33576077	33577037	255,102,0	1	960	0	.	Spacer 2.
chr5	33614283	33624273	P58397	0	-	33614283	33624273	255,102,0	1	9990	0	.	Spacer 1.
chr5	38958495	39074377	Q6R327	0	-	38958495	39074377	255,102,0	1	115882	0	.	Interaction with NBN. Pubmed:23762398
chr5	39139247	39201919	O15117	0	-	39139247	39201919	255,102,0	1	62672	0	.	Interaction with SKAP1.
chr5	39375021	39376842	P98082	0	-	39375021	39376842	255,102,0	1	1821	0	.	Required for interaction with MYO6.
chr5	39376047	39376977	P98082	0	-	39376047	39376977	255,102,0	1	930	0	.	Sufficient for interaction with GRB2.
chr5	39376068	39376662	P98082	0	-	39376068	39376662	255,102,0	1	594	0	.	Sufficient for interaction with SH3KBP1 SH3 domain.
chr5	39376773	39376800	P98082	0	-	39376773	39376800	255,102,0	1	27	0	.	Required for interaction with GRB2 and CSK.
chr5	39376905	39376932	P98082	0	-	39376905	39376932	255,102,0	1	27	0	.	Required for interaction with CSK.
chr5	39382617	39383271	P98082	0	-	39382617	39383271	255,102,0	1	654	0	.	Required for localization to clathrin-coated pits.
chr5	40764916	40765156	Q13131	0	-	40764916	40765156	255,102,0	1	240	0	.	AIS.
chr5	40959591	40964836	P10643	0	+	40959591	40964836	255,102,0	1	5245	0	.	CCP 1.
chr5	40964836	40976754	P10643	0	+	40964836	40976754	255,102,0	1	11918	0	.	CCP 2.
chr5	40976757	40979869	P10643	0	+	40976757	40979869	255,102,0	1	3112	0	.	Factor I module (FIM) 1.
chr5	40979869	40981570	P10643	0	+	40979869	40981570	255,102,0	1	1701	0	.	Factor I module (FIM) 2.
chr5	41142827	41149292	P13671	0	-	41142827	41149292	255,102,0	1	6465	0	.	Factor I module (FIM) 2.
chr5	41142827	41158718	P13671	0	-	41142827	41158718	255,102,0	1	15891	0	.	C5b-binding domain.
chr5	41149343	41150020	P13671	0	-	41149343	41150020	255,102,0	1	677	0	.	Factor I module (FIM) 1.
chr5	41150020	41155008	P13671	0	-	41150020	41155008	255,102,0	1	4988	0	.	CCP 2.
chr5	41155008	41159107	P13671	0	-	41155008	41159107	255,102,0	1	4099	0	.	CCP 1.
chr5	42711365	42713430	P10912	0	+	42711365	42713430	255,102,0	1	2065	0	.	Required for ADAM17-mediated proteolysis.
chr5	43527378	43529814	Q9H074	0	-	43527378	43529814	255,102,0	1	2436	0	.	PABPC1-interacting motif-1 (PAM1).
chr5	43555835	43555919	Q9H074	0	-	43555835	43555919	255,102,0	1	84	0	.	PABPC1-interacting motif-2 (PAM2).
chr5	45695673	45695829	O60741	0	-	45695673	45695829	255,102,0	1	156	0	.	Involved in subunit assembly.
chr5	51391291	51391381	P61371	0	+	51391291	51391381	255,102,0	1	90	0	.	LIM-binding domain (LID).
chr5	53098664	53100416	A0A024QZS1	0	-	53098664	53100416	255,102,0	1	1752	0	.	Substrate binding.
chr5	53098664	53100416	O96007	0	-	53098664	53100416	255,102,0	1	1752	0	.	Substrate binding.
chr5	53100479	53100485	A0A024QZS1	0	-	53100479	53100485	255,102,0	1	6	0	.	Substrate binding.
chr5	53100479	53100485	O96007	0	-	53100479	53100485	255,102,0	1	6	0	.	Substrate binding.
chr5	55220368	55222391	D6RGH6	0	-	55220368	55222391	255,102,0	1	2023	0	.	Necessary and sufficient for proper nuclear localization.
chr5	55220788	55222265	D6RGH6	0	-	55220788	55222265	255,102,0	1	1477	0	.	Necessary and sufficient for interaction with GMNN and sufficient for homodimerization. Pubmed:21543332
chr5	55222391	55227138	D6RGH6	0	-	55222391	55227138	255,102,0	1	4747	0	.	Necessary and sufficient for its degradation during the cell cycle.
chr5	62306472	62355251	O00139	0	+	62306472	62355251	255,102,0	1	48779	0	.	Globular.
chr5	63960633	63960648	P08908	0	-	63960633	63960648	255,102,0	1	15	0	.	Agonist binding.
chr5	63961356	63961386	P08908	0	-	63961356	63961386	255,102,0	1	30	0	.	Agonist binding.
chr5	64214166	64330294	Q86T96	0	+	64214166	64330294	255,102,0	1	116128	0	.	Interaction with ZIC2.
chr5	65214839	65224966	Q9UKP5	0	-	65214839	65224966	255,102,0	1	10127	0	.	Spacer.
chr5	65591771	65604922	P36406	0	-	65591771	65604922	255,102,0	1	13151	0	.	ARF-like.
chr5	69121747	69121858	Q8TAD4	0	+	69121747	69121858	255,102,0	1	111	0	.	His-rich loop.
chr5	69171410	69171437	P14635	0	+	69171410	69171437	255,102,0	1	27	0	.	Interaction with CDK2.
chr5	69174942	69174954	P14635	0	+	69174942	69174954	255,102,0	1	12	0	.	Interaction with CDK2.
chr5	69352225	69355653	Q9Y3D8	0	-	69352225	69355653	255,102,0	1	3428	0	.	LID.
chr5	69352236	69355665	Q9Y3D8	0	-	69352236	69355665	255,102,0	1	3429	0	.	LID.
chr5	69355906	69366527	Q9Y3D8	0	-	69355906	69366527	255,102,0	1	10621	0	.	NMPbind.
chr5	69355918	69366540	Q9Y3D8	0	-	69355918	69366540	255,102,0	1	10622	0	.	NMPbind.
chr5	69393225	69414289	O75943	0	+	69393225	69414289	255,102,0	1	21064	0	.	Interaction with MCM7. Pubmed:15538388
chr5	69675620	69675668	Q16637	0	-	69675620	69675668	255,102,0	1	48	0	.	Required for interaction with SYNCRIP. Pubmed:11574476
chr5	69681464	69682858	Q16637	0	-	69681464	69682858	255,102,0	1	1394	0	.	P2 (binding site for SNRPB).
chr5	69684735	69685233	Q16637	0	-	69684735	69685233	255,102,0	1	498	0	.	Required for interaction with RPP20/POP7.
chr5	69688716	69702465	Q16637	0	-	69688716	69702465	255,102,0	1	13749	0	.	P1 (binding site for GEMIN2).
chr5	70049721	70063465	Q16637	0	+	70049721	70063465	255,102,0	1	13744	0	.	P1 (binding site for GEMIN2).
chr5	70066948	70067446	Q16637	0	+	70066948	70067446	255,102,0	1	498	0	.	Required for interaction with RPP20/POP7.
chr5	70069324	70070718	Q16637	0	+	70069324	70070718	255,102,0	1	1394	0	.	P2 (binding site for SNRPB).
chr5	70070396	70084144	Q16637	0	+	70070396	70084144	255,102,0	1	13748	0	.	P1 (binding site for GEMIN2).
chr5	70076520	70076568	Q16637	0	+	70076520	70076568	255,102,0	1	48	0	.	Required for interaction with SYNCRIP. Pubmed:11574476
chr5	70087627	70088125	Q16637	0	+	70087627	70088125	255,102,0	1	498	0	.	Required for interaction with RPP20/POP7.
chr5	70090002	70091396	Q16637	0	+	70090002	70091396	255,102,0	1	1394	0	.	P2 (binding site for SNRPB).
chr5	70097197	70097245	Q16637	0	+	70097197	70097245	255,102,0	1	48	0	.	Required for interaction with SYNCRIP. Pubmed:11574476
chr5	70268910	70282658	Q16637	0	+	70268910	70282658	255,102,0	1	13748	0	.	P1 (binding site for GEMIN2).
chr5	70286141	70286639	Q16637	0	+	70286141	70286639	255,102,0	1	498	0	.	Required for interaction with RPP20/POP7.
chr5	70288516	70289912	Q16637	0	+	70288516	70289912	255,102,0	1	1396	0	.	P2 (binding site for SNRPB).
chr5	70295708	70295756	Q16637	0	+	70295708	70295756	255,102,0	1	48	0	.	Required for interaction with SYNCRIP. Pubmed:11574476
chr5	70671180	70682768	A6H8Y1	0	+	70671180	70682768	255,102,0	1	11588	0	.	Interaction with ZBTB43. Pubmed:16542149
chr5	70699192	70704903	A6H8Y1	0	+	70699192	70704903	255,102,0	1	5711	0	.	Required for phosphorylation by CSNK2A1.
chr5	70724861	70726376	A6H8Y1	0	+	70724861	70726376	255,102,0	1	1515	0	.	9 X 55 AA repeats of G-R-R-X-I-S-P-X-E-N-G-X-E-E-V-K-P-X-X-E-M-E-T-D-L-K-X-T-G-R-E-X-X-X-R-E-K-T-X-E-X-X-D-A-X-E-E-I-D-X-D-L-E-E-T.
chr5	70925139	70938889	Q16637	0	+	70925139	70938889	255,102,0	1	13750	0	.	P1 (binding site for GEMIN2).
chr5	70942372	70942870	Q16637	0	+	70942372	70942870	255,102,0	1	498	0	.	Required for interaction with RPP20/POP7.
chr5	70944747	70946143	Q16637	0	+	70944747	70946143	255,102,0	1	1396	0	.	P2 (binding site for SNRPB).
chr5	70951940	70951988	Q16637	0	+	70951940	70951988	255,102,0	1	48	0	.	Required for interaction with SYNCRIP. Pubmed:11574476
chr5	71455877	71467465	A6H8Y1	0	+	71455877	71467465	255,102,0	1	11588	0	.	Interaction with ZBTB43. Pubmed:16542149
chr5	71483889	71489600	A6H8Y1	0	+	71483889	71489600	255,102,0	1	5711	0	.	Required for phosphorylation by CSNK2A1.
chr5	71509558	71511073	A6H8Y1	0	+	71509558	71511073	255,102,0	1	1515	0	.	9 X 55 AA repeats of G-R-R-X-I-S-P-X-E-N-G-X-E-E-V-K-P-X-X-E-M-E-T-D-L-K-X-T-G-R-E-X-X-X-R-E-K-T-X-E-X-X-D-A-X-E-E-I-D-X-D-L-E-E-T.
chr5	71592940	71656833	Q9HCC0	0	+	71592940	71656833	255,102,0	1	63893	0	.	Carboxyltransferase.
chr5	71641029	71643862	Q9HCC0	0	+	71641029	71643862	255,102,0	1	2833	0	.	Acyl-CoA binding.
chr5	72200234	72205236	P46821	0	+	72200234	72205236	255,102,0	1	5002	0	.	Mediates interaction with TMEM185A. Pubmed:15525354
chr5	72443758	72447270	Q8N895	0	-	72443758	72447270	255,102,0	1	3512	0	.	Interaction with CTBP1. Pubmed:17085477
chr5	72443758	72456565	Q8N895	0	-	72443758	72456565	255,102,0	1	12807	0	.	Interaction with NRIP1. Pubmed:17085477
chr5	72956102	73034682	Q0JRZ9	0	+	72956102	73034682	255,102,0	1	78580	0	.	Mediates dimerization and binding to membranes enriched in Pi(4,5)-P2 and induces their tubulation.
chr5	73068760	73088087	Q0JRZ9	0	+	73068760	73088087	255,102,0	1	19327	0	.	Mediates interaction with DAB2, EPS15, EPS15R and ITSN1.
chr5	73898002	73898032	Q8N1W1	0	+	73898002	73898032	255,102,0	1	30	0	.	Interaction with PTK2/FAK1; required for regulation of axonal branching and synapse formation.
chr5	73904357	73904393	Q8N1W1	0	+	73904357	73904393	255,102,0	1	36	0	.	Mediates cytoplasmic retention and interaction with YWHAH.
chr5	73909522	73941010	Q8N1W1	0	+	73909522	73941010	255,102,0	1	31488	0	.	Interaction with microtubules.
chr5	73909735	73909831	Q8N1W1	0	+	73909735	73909831	255,102,0	1	96	0	.	RNA-binding.
chr5	73911322	73911364	Q8N1W1	0	+	73911322	73911364	255,102,0	1	42	0	.	Mediates cytoplasmic retention and interaction with MAPK8IP1.
chr5	75351143	75351581	P04035	0	+	75351143	75351581	255,102,0	1	438	0	.	Linker.
chr5	75351581	75360339	P04035	0	+	75351581	75360339	255,102,0	1	8758	0	.	Catalytic.
chr5	76131750	76131921	Q496J9	0	+	76131750	76131921	255,102,0	1	171	0	.	Interaction with SYT1.
chr5	77413165	77426500	O95263	0	+	77413165	77426500	255,102,0	1	13335	0	.	Catalytic.
chr5	79026558	79026567	Q9UI17	0	-	79026558	79026567	255,102,0	1	9	0	.	Tetrahydrofolate binding.
chr5	79029971	79029980	Q9UI17	0	-	79029971	79029980	255,102,0	1	9	0	.	Tetrahydrofolate binding.
chr5	79236650	79237028	Q8N9B5	0	+	79236650	79237028	255,102,0	1	378	0	.	Interaction with p300/EP300.
chr5	79291203	79300683	Q8N9B5	0	+	79291203	79300683	255,102,0	1	9480	0	.	Interaction with p300/EP300.
chr5	79739313	79739397	Q8N3K9	0	+	79739313	79739397	255,102,0	1	84	0	.	Amphipathic helix H1.
chr5	79739397	79752700	Q8N3K9	0	+	79739397	79752700	255,102,0	1	13303	0	.	B-box coiled-coil; BBC.
chr5	79745377	79745431	Q8N3K9	0	+	79745377	79745431	255,102,0	1	54	0	.	Amphipathic helix H2.
chr5	79758892	79761851	Q8N3K9	0	+	79758892	79761851	255,102,0	1	2959	0	.	Amphipathic helix H3.
chr5	80320710	80320746	Q9BXG8	0	+	80320710	80320746	255,102,0	1	36	0	.	Helix-loop-helix motif.
chr5	80320746	80320947	Q9BXG8	0	+	80320746	80320947	255,102,0	1	201	0	.	Basic motif.
chr5	80321121	80321187	Q9BXG8	0	+	80321121	80321187	255,102,0	1	66	0	.	Leucine-zipper.
chr5	80654035	80654053	P00374	0	-	80654035	80654053	255,102,0	1	18	0	.	Substrate binding. Pubmed:2248959
chr5	80654949	80672342	P20585	0	+	80654949	80672342	255,102,0	1	17393	0	.	Interaction with EXO1. Pubmed:11427529
chr5	81113679	81113706	O14827	0	+	81113679	81113706	255,102,0	1	27	0	.	Regulates proteasomal degradation.
chr5	81212503	81215905	O14827	0	+	81212503	81215905	255,102,0	1	3402	0	.	Responsible of the affinity for farnesylated versus geranylgeranylated Ras.
chr5	81251249	81252734	P17540	0	+	81251249	81252734	255,102,0	1	1485	0	.	Cardiolipin-binding.
chr5	81345949	81345958	Q8WYK0	0	-	81345949	81345958	255,102,0	1	9	0	.	Coenzyme A binding.
chr5	81371755	81371764	Q8WYK0	0	-	81371755	81371764	255,102,0	1	9	0	.	Coenzyme A binding.
chr5	81385788	81385797	Q8WYK0	0	-	81385788	81385797	255,102,0	1	9	0	.	Coenzyme A binding.
chr5	83203606	83203708	Q13426	0	+	83203606	83203708	255,102,0	1	102	0	.	Interaction with LIG4.
chr5	83519347	83537008	P13611	0	+	83519347	83537008	255,102,0	1	17661	0	.	GAG-alpha (glucosaminoglycan attachment domain).
chr5	83537008	83545538	P13611	0	+	83537008	83545538	255,102,0	1	8530	0	.	GAG-beta.
chr5	88722828	88722924	Q06413	0	-	88722828	88722924	255,102,0	1	96	0	.	Transcription repressor.
chr5	88730210	88730234	Q06413	0	-	88730210	88730234	255,102,0	1	24	0	.	Beta domain.
chr5	95731682	95748442	O94955	0	+	95731682	95748442	255,102,0	1	16760	0	.	Rho-like.
chr5	95768141	95793171	O94955	0	+	95768141	95793171	255,102,0	1	25030	0	.	Interaction with Rab9.
chr5	96793913	96793928	Q9NZ08	0	-	96793913	96793928	255,102,0	1	15	0	.	Substrate binding.
chr5	96892327	96892342	Q6P179	0	+	96892327	96892342	255,102,0	1	15	0	.	Substrate binding.
chr5	96979403	96979421	Q9UIQ6	0	+	96979403	96979421	255,102,0	1	18	0	.	Tankyrase binding.
chr5	96993845	96993860	Q9UIQ6	0	+	96993845	96993860	255,102,0	1	15	0	.	Substrate binding.
chr5	98856580	98856631	O14646	0	-	98856580	98856631	255,102,0	1	51	0	.	3 X 5 AA repeats of H-S-D-H-R.
chr5	100811981	100811987	Q92187	0	-	100811981	100811987	255,102,0	1	6	0	.	Substrate binding.
chr5	100812083	100812092	Q92187	0	-	100812083	100812092	255,102,0	1	9	0	.	Substrate binding.
chr5	100856320	100856329	Q92187	0	-	100856320	100856329	255,102,0	1	9	0	.	Substrate binding.
chr5	102866195	102974435	P19021	0	+	102866195	102974435	255,102,0	1	108240	0	.	Peptidylglycine alpha-hydroxylating monooxygenase.
chr5	102990270	103019809	P19021	0	+	102990270	103019809	255,102,0	1	29539	0	.	Peptidyl-alpha-hydroxyglycine alpha-amidating lyase.
chr5	103028915	103028969	P19021	0	+	103028915	103028969	255,102,0	1	54	0	.	Interaction with RASSF9.
chr5	103133494	103133500	O43314	0	+	103133494	103133500	255,102,0	1	6	0	.	Substrate binding. Pubmed:22119861
chr5	103146675	103146681	O43314	0	+	103146675	103146681	255,102,0	1	6	0	.	Substrate binding. Pubmed:22119861
chr5	103151321	103151333	O43314	0	+	103151321	103151333	255,102,0	1	12	0	.	Substrate binding. Pubmed:22119861
chr5	103152729	103154866	O43314	0	+	103152729	103154866	255,102,0	1	2137	0	.	Polyphosphoinositide-binding domain. Pubmed:21222653
chr5	108798182	108872189	P16591	0	+	108798182	108872189	255,102,0	1	74007	0	.	Important for interaction with membranes containing phosphoinositides.
chr5	109337233	109362901	O43164	0	-	109337233	109362901	255,102,0	1	25668	0	.	Interaction with PRKAR1A, PRKAR2A and PRKAR2B. Pubmed:21423175
chr5	111482868	111482919	Q16566	0	+	111482868	111482919	255,102,0	1	51	0	.	Autoinhibitory domain.
chr5	111482871	111482925	Q16566	0	+	111482871	111482925	255,102,0	1	54	0	.	PP2A-binding.
chr5	111482919	111484067	Q16566	0	+	111482919	111484067	255,102,0	1	1148	0	.	Calmodulin-binding.
chr5	112838471	112839605	P25054	0	+	112838471	112839605	255,102,0	1	1134	0	.	Responsible for down-regulation through a process mediated by direct ubiquitination.
chr5	112841189	112841273	P25054	0	+	112841189	112841273	255,102,0	1	84	0	.	Highly charged.
chr5	112867507	112867534	P09132	0	+	112867507	112867534	255,102,0	1	27	0	.	Basic region, potentially involved in RNA-binding.
chr5	113591094	113591103	Q9H6S0	0	+	113591094	113591103	255,102,0	1	9	0	.	N6-methyladenosine binding.
chr5	114473143	114495906	Q9H2S1	0	+	114473143	114495906	255,102,0	1	22763	0	.	Calmodulin-binding.
chr5	115221841	115221853	P53609	0	-	115221841	115221853	255,102,0	1	12	0	.	Geranylgeranyl diphosphate binding.
chr5	115221868	115221880	P53609	0	-	115221868	115221880	255,102,0	1	12	0	.	Geranylgeranyl diphosphate binding.
chr5	115222003	115230979	P53609	0	-	115222003	115230979	255,102,0	1	8976	0	.	Geranylgeranyl diphosphate binding.
chr5	115992151	115992166	Q6Q4G3	0	+	115992151	115992166	255,102,0	1	15	0	.	Substrate binding.
chr5	119452575	119496589	P51659	0	+	119452575	119496589	255,102,0	1	44014	0	.	3R)-hydroxyacyl-CoA dehydrogenase.
chr5	119496637	119531277	P51659	0	+	119496637	119531277	255,102,0	1	34640	0	.	Enoyl-CoA hydratase 2.
chr5	119502046	119502052	P51659	0	+	119502046	119502052	255,102,0	1	6	0	.	3R)-3-hydroxydecanoyl-CoA binding.
chr5	119525239	119525257	P51659	0	+	119525239	119525257	255,102,0	1	18	0	.	3R)-3-hydroxydecanoyl-CoA binding.
chr5	122066745	122076996	P28300	0	-	122066745	122076996	255,102,0	1	10251	0	.	Lysyl-oxidase like.
chr5	122815950	122829645	O60749	0	+	122815950	122829645	255,102,0	1	13695	0	.	Interaction with RhoG. Pubmed:20604901
chr5	122816947	122817001	O60749	0	+	122816947	122817001	255,102,0	1	54	0	.	Membrane-binding amphipathic helix. Pubmed:19816406
chr5	123573451	123573478	Q9Y6M4	0	+	123573451	123573478	255,102,0	1	27	0	.	Inhibitors binding.
chr5	126600965	126624646	Q9H814	0	+	126600965	126624646	255,102,0	1	23681	0	.	Necessary for interaction with CBP80.
chr5	126604154	126624643	Q9H814	0	+	126604154	126624643	255,102,0	1	20489	0	.	Sufficient for poly U RNA-binding.
chr5	126617252	126617279	Q9H814	0	+	126617252	126617279	255,102,0	1	27	0	.	Necessary for poly U RNA-binding and snRNA export.
chr5	126777511	126777610	P20700	0	+	126777511	126777610	255,102,0	1	99	0	.	Head.
chr5	126777610	126777715	P20700	0	+	126777610	126777715	255,102,0	1	105	0	.	Coil 1A.
chr5	126777610	126819140	P20700	0	+	126777610	126819140	255,102,0	1	41530	0	.	Rod.
chr5	126777715	126777751	P20700	0	+	126777715	126777751	255,102,0	1	36	0	.	Linker 1.
chr5	126777751	126810182	P20700	0	+	126777751	126810182	255,102,0	1	32431	0	.	Coil 1B.
chr5	126810182	126810266	P20700	0	+	126810182	126810266	255,102,0	1	84	0	.	Linker 2.
chr5	126810266	126819140	P20700	0	+	126810266	126819140	255,102,0	1	8874	0	.	Coil 2.
chr5	126819140	126836261	P20700	0	+	126819140	126836261	255,102,0	1	17121	0	.	Tail.
chr5	127331308	127445536	Q96KG7	0	+	127331308	127445536	255,102,0	1	114228	0	.	Necessary for interaction with AP2M1, self-assembly and formation of the irregular, mosaic-like adhesion pattern. Pubmed:17643423
chr5	127447660	127457315	Q96KG7	0	+	127447660	127457315	255,102,0	1	9655	0	.	Necessary for formation of large intracellular vacuoles.
chr5	128289250	128309397	P35556	0	-	128289250	128309397	255,102,0	1	20147	0	.	Interaction with MFAP4. Pubmed:26601954
chr5	128408674	128527959	P35556	0	-	128408674	128527959	255,102,0	1	119285	0	.	Interaction with MFAP4. Pubmed:26601954
chr5	129658700	129684215	Q8TE59	0	+	129658700	129684215	255,102,0	1	25515	0	.	Spacer.
chr5	131644687	131671659	Q8TF40	0	-	131644687	131671659	255,102,0	1	26972	0	.	Interaction with HSP90AA1. Pubmed:27353360
chr5	131818833	131818845	A0A087WXM9	0	-	131818833	131818845	255,102,0	1	12	0	.	Required for localization to kinetochores.
chr5	132696636	132696645	Q9Y496	0	-	132696636	132696645	255,102,0	1	9	0	.	Globular.
chr5	134157735	134160992	P63208	0	-	134157735	134160992	255,102,0	1	3257	0	.	Interaction with the F-box domain of F-box proteins.
chr5	134679637	134679712	O95486	0	+	134679637	134679712	255,102,0	1	75	0	.	Zinc finger-like.
chr5	135028886	135029285	P78337	0	-	135028886	135029285	255,102,0	1	399	0	.	Interaction with PIT-1.
chr5	138186362	138187410	O95235	0	+	138186362	138187410	255,102,0	1	1048	0	.	Globular.
chr5	138286519	138287195	P30307	0	-	138286519	138287195	255,102,0	1	676	0	.	HIV-1 Vpr binding site.
chr5	138781927	138824625	P35221	0	+	138781927	138824625	255,102,0	1	42698	0	.	Involved in homodimerization.
chr5	138783359	138810180	P35221	0	+	138783359	138810180	255,102,0	1	26821	0	.	Interaction with JUP and CTNNB1. Pubmed:9152027
chr5	138827628	138887528	P35221	0	+	138827628	138887528	255,102,0	1	59900	0	.	Interaction with alpha-actinin.
chr5	139021169	139127843	Q9H173	0	-	139021169	139127843	255,102,0	1	106674	0	.	Interaction with HSPA5 and localization to the endoplasmic reticulum.
chr5	139363847	139364650	Q9BPZ3	0	+	139363847	139364650	255,102,0	1	803	0	.	PABPC1-interacting motif-1 (PAM1).
chr5	139364737	139368774	Q9BPZ3	0	+	139364737	139368774	255,102,0	1	4037	0	.	PABPC1-interacting motif-2 (PAM2).
chr5	139396862	139397117	Q86W54	0	-	139396862	139397117	255,102,0	1	255	0	.	Required for interaction with CBX5 and TBPL1.
chr5	139476263	139476383	Q86WV6	0	-	139476263	139476383	255,102,0	1	120	0	.	C-terminal tail (CTT).
chr5	139476380	139480853	Q86WV6	0	-	139476380	139480853	255,102,0	1	4473	0	.	c-di-GMP-binding domain (CBD).
chr5	139478305	139478317	Q86WV6	0	-	139478305	139478317	255,102,0	1	12	0	.	c-di-GMP binding.
chr5	139480808	139480826	Q86WV6	0	-	139480808	139480826	255,102,0	1	18	0	.	c-di-GMP binding.
chr5	140363818	140372795	Q96Q91	0	+	140363818	140372795	255,102,0	1	8977	0	.	Membrane (anion exchange).
chr5	140631858	140632116	P08571	0	-	140631858	140632116	255,102,0	1	258	0	.	Required for response to bacterial lipopolysaccharide (LPS).
chr5	140659011	140659113	Q13123	0	+	140659011	140659113	255,102,0	1	102	0	.	17 X 2 AA tandem repeats of R-[ED].
chr5	140788489	141009766	Q9Y5I3	0	+	140788489	141009766	255,102,0	1	221277	0	.	5 X 4 AA repeats of P-X-X-P.
chr5	140797163	141009766	Q9Y5H9	0	+	140797163	141009766	255,102,0	1	212603	0	.	5 X 4 AA repeats of P-X-X-P.
chr5	140803396	141009766	Q9Y5H8	0	+	140803396	141009766	255,102,0	1	206370	0	.	6 X 4 AA repeats of P-X-X-P.
chr5	140809386	141009766	Q9UN74	0	+	140809386	141009766	255,102,0	1	200380	0	.	6 X 4 AA repeats of P-X-X-P.
chr5	140809398	141009934	Q9UN74	0	+	140809398	141009934	255,102,0	1	200536	0	.	Required for interaction with FYN.
chr5	140824091	141009796	Q9Y5H7	0	+	140824091	141009796	255,102,0	1	185705	0	.	5 X 4 AA repeats of P-X-X-P.
chr5	140836702	141009766	Q9UN72	0	+	140836702	141009766	255,102,0	1	173064	0	.	5 X 4 AA repeats of P-X-X-P.
chr5	140843640	141009766	Q9Y5H6	0	+	140843640	141009766	255,102,0	1	166126	0	.	5 X 4 AA repeats of P-X-X-P.
chr5	140850694	141009766	Q9Y5H5	0	+	140850694	141009766	255,102,0	1	159072	0	.	5 X 4 AA repeats of P-X-X-P.
chr5	140858241	141009766	Q9Y5I2	0	+	140858241	141009766	255,102,0	1	151525	0	.	6 X 4 AA repeats of P-X-X-P.
chr5	140871299	141009766	Q9Y5I1	0	+	140871299	141009766	255,102,0	1	138467	0	.	6 X 4 AA repeats of P-X-X-P.
chr5	140877671	141009766	Q9UN75	0	+	140877671	141009766	255,102,0	1	132095	0	.	5 X 4 AA repeats of P-X-X-P.
chr5	140884467	141009766	Q9Y5I0	0	+	140884467	141009766	255,102,0	1	125299	0	.	6 X 4 AA repeats of P-X-X-P.
chr5	140978948	141009766	Q9H158	0	+	140978948	141009766	255,102,0	1	30818	0	.	4 X 4 AA repeats of P-X-X-P.
chr5	140978948	141009766	Q9UN73	0	+	140978948	141009766	255,102,0	1	30818	0	.	4 X 4 AA repeats of P-X-X-P.
chr5	140978948	141009766	Q9Y5I4	0	+	140978948	141009766	255,102,0	1	30818	0	.	4 X 4 AA repeats of P-X-X-P.
chr5	141626043	141636784	O15379	0	-	141626043	141636784	255,102,0	1	10741	0	.	Histone deacetylase.
chr5	141983396	141987787	Q9UBS8	0	+	141983396	141987787	255,102,0	1	4391	0	.	Interaction with androgen receptor.
chr5	142108977	142131867	Q9BT67	0	+	142108977	142131867	255,102,0	1	22890	0	.	Interaction with UBE2L3.
chr5	142131867	142132288	Q9BT67	0	+	142131867	142132288	255,102,0	1	421	0	.	Interaction with ITCH.
chr5	142595328	142595379	P05230	0	-	142595328	142595379	255,102,0	1	51	0	.	Heparin-binding.
chr5	143281891	143300650	P04150	0	-	143281891	143300650	255,102,0	1	18759	0	.	Steroid-binding.
chr5	143281891	143310112	P04150	0	-	143281891	143310112	255,102,0	1	28221	0	.	Interaction with CLOCK.
chr5	143282657	143300638	P04150	0	-	143282657	143300638	255,102,0	1	17981	0	.	Interaction with CRY1. Pubmed:22170608
chr5	143300650	143310106	P04150	0	-	143300650	143310106	255,102,0	1	9456	0	.	Hinge.
chr5	143314092	143400839	P04150	0	-	143314092	143400839	255,102,0	1	86747	0	.	Modulating.
chr5	143400494	143400548	P04150	0	-	143400494	143400548	255,102,0	1	54	0	.	Required for high transcriptional activity of isoform Alpha-C3. Pubmed:23820903
chr5	144164221	144165492	Q969M3	0	-	144164221	144165492	255,102,0	1	1271	0	.	Interaction with Sec23.
chr5	146062431	146062449	Q8TEC5	0	+	146062431	146062449	255,102,0	1	18	0	.	Interaction with PPP1CA.
chr5	146144685	146157789	Q9P2J5	0	-	146144685	146157789	255,102,0	1	13104	0	.	Editing domain.
chr5	148399044	148402076	Q6PIJ6	0	+	148399044	148402076	255,102,0	1	3032	0	.	Interaction with KLF7.
chr5	148827407	148827452	P07550	0	+	148827407	148827452	255,102,0	1	45	0	.	Agonist and antagonist binding.
chr5	148827686	148827710	P07550	0	+	148827686	148827710	255,102,0	1	24	0	.	Agonist and antagonist binding.
chr5	148827764	148827779	P07550	0	+	148827764	148827779	255,102,0	1	15	0	.	Agonist and antagonist binding.
chr5	149730342	149826693	Q86YN6	0	+	149730342	149826693	255,102,0	1	96351	0	.	Abolishes DNA transcriptional activity when missing.
chr5	150056125	150056275	P07333	0	-	150056125	150056275	255,102,0	1	150	0	.	Activation loop.
chr5	150061753	150068217	P07333	0	-	150061753	150068217	255,102,0	1	6464	0	.	Regulatory juxtamembrane domain.
chr5	150245184	150247787	Q9UQM7	0	-	150245184	150247787	255,102,0	1	2603	0	.	Interaction with BAALC.
chr5	150250225	150250258	Q9UQM7	0	-	150250225	150250258	255,102,0	1	33	0	.	Calmodulin-binding.
chr5	150406907	150406952	P04233	0	-	150406907	150406952	255,102,0	1	45	0	.	CLIP.
chr5	150521371	150541614	P52848	0	+	150521371	150541614	255,102,0	1	20243	0	.	Heparan sulfate N-deacetylase 1.
chr5	150541614	150553329	P52848	0	+	150541614	150553329	255,102,0	1	11715	0	.	Heparan sulfate N-sulfotransferase 1.
chr5	150670569	150670623	Q8TDC0	0	+	150670569	150670623	255,102,0	1	54	0	.	Binding to ACTN2, PPP3CA and TCAP. Pubmed:11842093
chr5	150670620	150671814	Q8TDC0	0	+	150670620	150671814	255,102,0	1	1194	0	.	Binding to FLNC. Pubmed:11842093
chr5	150672470	150676740	Q8TDC0	0	+	150672470	150676740	255,102,0	1	4270	0	.	Binding to ACTN2. Pubmed:11842093
chr5	151033622	151036894	Q15025	0	-	151033622	151036894	255,102,0	1	3272	0	.	Required for inhibitory activity of TNF-induced NF-kappa-B activation.
chr5	151035058	151036831	Q15025	0	-	151035058	151036831	255,102,0	1	1773	0	.	Ubiquitin-binding domain (UBD).
chr5	151039123	151062204	Q15025	0	-	151039123	151062204	255,102,0	1	23081	0	.	Interaction with Nef.
chr5	151042572	151042623	Q15025	0	-	151042572	151042623	255,102,0	1	51	0	.	Interaction with Shigella flexneri ipah9.8.
chr5	151851596	151855049	P23415	0	-	151851596	151855049	255,102,0	1	3453	0	.	Strychnine-binding.
chr5	153705717	153705726	P42261	0	+	153705717	153705726	255,102,0	1	9	0	.	Glutamate binding.
chr5	153764611	153764617	P42261	0	+	153764611	153764617	255,102,0	1	6	0	.	Glutamate binding.
chr5	154329599	154380452	Q86SR1	0	+	154329599	154380452	255,102,0	1	50853	0	.	Catalytic subdomain A.
chr5	154380623	154404166	Q86SR1	0	+	154380623	154404166	255,102,0	1	23543	0	.	Catalytic subdomain B.
chr5	154404163	154404199	Q86SR1	0	+	154404163	154404199	255,102,0	1	36	0	.	Flexible loop.
chr5	154451150	154451159	Q9HAJ7	0	+	154451150	154451159	255,102,0	1	9	0	.	Important for DNA and phosphoinositide binding. Pubmed:19015240
chr5	154935977	154938133	Q8TEQ6	0	-	154935977	154938133	255,102,0	1	2156	0	.	Important for interaction with U1 snRNA. Pubmed:19377484
chr5	154938088	154938097	Q8TEQ6	0	-	154938088	154938097	255,102,0	1	9	0	.	Interaction with U4 snRNA. Pubmed:27834343, Pubmed:27881600, Pubmed:27881601
chr5	155015845	155017561	Q2VIQ3	0	+	155015845	155017561	255,102,0	1	1716	0	.	Interaction with PRC1.
chr5	155016856	155017561	Q2VIQ3	0	+	155016856	155017561	255,102,0	1	705	0	.	Globular.
chr5	157751451	157754027	P83369	0	+	157751451	157754027	255,102,0	1	2576	0	.	SM 1.
chr5	157755207	157755249	P83369	0	+	157755207	157755249	255,102,0	1	42	0	.	SM 2.
chr5	157813120	157813156	Q14677	0	-	157813120	157813156	255,102,0	1	36	0	.	Interaction with VTI1B. Pubmed:18033301
chr5	157814248	157814257	Q14677	0	-	157814248	157814257	255,102,0	1	9	0	.	Interaction with VTI1B. Pubmed:18033301
chr5	157816814	157816823	Q14677	0	-	157816814	157816823	255,102,0	1	9	0	.	Interaction with VTI1B. Pubmed:18033301
chr5	158823236	158823248	Q9UH73	0	-	158823236	158823248	255,102,0	1	12	0	.	Interaction with DNA.
chr5	158840052	158840076	Q9UH73	0	-	158840052	158840076	255,102,0	1	24	0	.	Interaction with DNA.
chr5	159097066	159097078	Q9UH73	0	-	159097066	159097078	255,102,0	1	12	0	.	Interaction with DNA.
chr5	159270591	159283292	Q8WVY7	0	+	159270591	159283292	255,102,0	1	12701	0	.	Phosphatase.
chr5	161331029	161331095	P47870	0	-	161331029	161331095	255,102,0	1	66	0	.	Allosteric effector binding.
chr5	161336767	161410981	P47870	0	-	161336767	161410981	255,102,0	1	74214	0	.	Agonist binding.
chr5	161459718	161459727	P47870	0	-	161459718	161459727	255,102,0	1	9	0	.	Agonist binding.
chr5	162153236	162153290	P18507	0	+	162153236	162153290	255,102,0	1	54	0	.	Interaction with GABARAP.
chr5	163484188	163484221	O75330	0	+	163484188	163484221	255,102,0	1	33	0	.	Hyaluronic acid-binding.
chr5	163490398	163490428	O75330	0	+	163490398	163490428	255,102,0	1	30	0	.	Hyaluronic acid-binding.
chr5	163518312	163518360	Q9NZL9	0	+	163518312	163518360	255,102,0	1	48	0	.	Required for interaction with MAT2A. Pubmed:25075345
chr5	168444574	168469014	Q8IX03	0	+	168444574	168469014	255,102,0	1	24440	0	.	Interaction with histone H3.
chr5	168460682	168464800	Q8IX03	0	+	168460682	168464800	255,102,0	1	4118	0	.	Interaction with PRKCZ.
chr5	168486498	168492694	P54136	0	+	168486498	168492694	255,102,0	1	6196	0	.	Could be involved in the assembly of the multisynthetase complex.
chr5	168530053	168530059	A6NHQ2	0	+	168530053	168530059	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr5	168530110	168530116	A6NHQ2	0	+	168530110	168530116	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr5	168530185	168530191	A6NHQ2	0	+	168530185	168530191	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr5	168530245	168530257	A6NHQ2	0	+	168530245	168530257	255,102,0	1	12	0	.	S-adenosyl-L-methionine binding.
chr5	169983082	170057627	Q92608	0	+	169983082	170057627	255,102,0	1	74545	0	.	Interaction with CRKL. Pubmed:12393632
chr5	170735761	170735803	Q9NZI2	0	+	170735761	170735803	255,102,0	1	42	0	.	Interaction with KCND2.
chr5	171387948	171391798	P06748	0	+	171387948	171391798	255,102,0	1	3850	0	.	Necessary for interaction with APEX1. Pubmed:19188445
chr5	171387948	171400186	P06748	0	+	171387948	171400186	255,102,0	1	12238	0	.	Required for interaction with SENP3.
chr5	171405358	171410562	P06748	0	+	171405358	171410562	255,102,0	1	5204	0	.	Required for nucleolar localization.
chr5	171910596	171910746	Q9UKB1	0	-	171910596	171910746	255,102,0	1	150	0	.	Homodimerization domain D.
chr5	172106735	172107850	O94804	0	-	172106735	172107850	255,102,0	1	1115	0	.	Activation segment.
chr5	173110670	173110700	Q8IUR6	0	+	173110670	173110700	255,102,0	1	30	0	.	Basic motif.
chr5	173110700	173112318	Q8IUR6	0	+	173110700	173112318	255,102,0	1	1618	0	.	Leucine-zipper.
chr5	173950033	173950042	Q17RY0	0	+	173950033	173950042	255,102,0	1	9	0	.	RNA-binding.
chr5	175878996	175879931	Q6PUV4	0	+	175878996	175879931	255,102,0	1	935	0	.	Interaction with the SNARE complex.
chr5	176397605	176398005	P09497	0	-	176397605	176398005	255,102,0	1	400	0	.	Involved in binding clathrin heavy chain.
chr5	176590685	176595669	Q9BYE9	0	+	176590685	176595669	255,102,0	1	4984	0	.	Mediates interaction with USH1C and MYO7B and is required for proper localization to microvilli tips and function in microvilli organization. Pubmed:24725409
chr5	176596810	176597140	Q7Z2K8	0	-	176596810	176597140	255,102,0	1	330	0	.	Interaction with GNAO1.
chr5	176626478	176629597	Q16143	0	-	176626478	176629597	255,102,0	1	3119	0	.	4 X 11 AA tandem repeats of [EGS]-K-T-K-[EQ]-[GQ]-V-X(4).
chr5	176643249	176643261	A6NMX2	0	+	176643249	176643261	255,102,0	1	12	0	.	EIF4EBP1/2/3 binding.
chr5	176643678	176643684	A6NMX2	0	+	176643678	176643684	255,102,0	1	6	0	.	7-methylguanosine-containing mRNA cap binding.
chr5	176643729	176644385	A6NMX2	0	+	176643729	176644385	255,102,0	1	656	0	.	EIF4EBP1/2/3 binding.
chr5	176645147	176645153	A6NMX2	0	+	176645147	176645153	255,102,0	1	6	0	.	7-methylguanosine-containing mRNA cap binding.
chr5	176645237	176645394	A6NMX2	0	+	176645237	176645394	255,102,0	1	157	0	.	EIF4EBP1/2/3 binding.
chr5	176645445	176645463	A6NMX2	0	+	176645445	176645463	255,102,0	1	18	0	.	7-methylguanosine-containing mRNA cap binding.
chr5	176645938	176645947	A6NMX2	0	+	176645938	176645947	255,102,0	1	9	0	.	7-methylguanosine-containing mRNA cap binding.
chr5	176878070	176878127	Q6ZN44	0	+	176878070	176878127	255,102,0	1	57	0	.	Interaction with DCC.
chr5	176881075	176887586	P52790	0	-	176881075	176887586	255,102,0	1	6511	0	.	Catalytic.
chr5	176881141	176883839	P52790	0	-	176881141	176883839	255,102,0	1	2698	0	.	Hexokinase large subdomain 2.
chr5	176883839	176887460	P52790	0	-	176883839	176887460	255,102,0	1	3621	0	.	Hexokinase small subdomain 2.
chr5	176884104	176887052	P52790	0	-	176884104	176887052	255,102,0	1	2948	0	.	Glucose-binding.
chr5	176887586	176896159	P52790	0	-	176887586	176896159	255,102,0	1	8573	0	.	Regulatory.
chr5	176887670	176889714	P52790	0	-	176887670	176889714	255,102,0	1	2044	0	.	Hexokinase large subdomain 1.
chr5	176889714	176891397	P52790	0	-	176889714	176891397	255,102,0	1	1683	0	.	Hexokinase small subdomain 1.
chr5	176890700	176890872	P52790	0	-	176890700	176890872	255,102,0	1	172	0	.	Glucose-binding.
chr5	176908624	176943419	Q96RL1	0	-	176908624	176943419	255,102,0	1	34795	0	.	Zinc-finger-like region.
chr5	176943431	176968557	Q96RL1	0	-	176943431	176968557	255,102,0	1	25126	0	.	Necessary for interaction with NR6A1 C-terminus.
chr5	176968554	176968947	Q96RL1	0	-	176968554	176968947	255,102,0	1	393	0	.	AIR.
chr5	176969154	176970801	Q96RL1	0	-	176969154	176970801	255,102,0	1	1647	0	.	Necessary for interaction with NR6A1 N-terminus.
chr5	176970789	176970810	Q96RL1	0	-	176970789	176970810	255,102,0	1	21	0	.	UIM-linker.
chr5	176970795	176982615	Q96RL1	0	-	176970795	176982615	255,102,0	1	11820	0	.	Necessary for transcriptional repression.
chr5	177280795	177280804	Q96L73	0	+	177280795	177280804	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr5	177282551	177282563	Q96L73	0	+	177282551	177282563	255,102,0	1	12	0	.	S-adenosyl-L-methionine binding.
chr5	177283834	177283840	Q96L73	0	+	177283834	177283840	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr5	177288844	177288865	Q96L73	0	+	177288844	177288865	255,102,0	1	21	0	.	Inhibits enzyme activity in the absence of bound histone.
chr5	177311479	177311809	Q9BW11	0	-	177311479	177311809	255,102,0	1	330	0	.	Interaction with SIN3A and SIN3B.
chr5	177337139	177337148	Q12907	0	-	177337139	177337148	255,102,0	1	9	0	.	Carbohydrate binding.
chr5	177337720	177337729	Q12907	0	-	177337720	177337729	255,102,0	1	9	0	.	Carbohydrate binding.
chr5	177368761	177371185	O43566	0	+	177368761	177371185	255,102,0	1	2424	0	.	Necessary for interaction with RABGEF1.
chr5	177426845	177433368	P43250	0	+	177426845	177433368	255,102,0	1	6523	0	.	N-terminal.
chr5	177593724	177594207	Q9BVK6	0	+	177593724	177594207	255,102,0	1	483	0	.	Required for interaction with STX17. Pubmed:21545355
chr5	177604425	177604440	Q9UBV7	0	+	177604425	177604440	255,102,0	1	15	0	.	UDP-alpha-D-galactose binding. Pubmed:24052259
chr5	177607302	177607311	Q9UBV7	0	+	177607302	177607311	255,102,0	1	9	0	.	UDP-alpha-D-galactose binding. Pubmed:24052259
chr5	177607377	177607383	Q9UBV7	0	+	177607377	177607383	255,102,0	1	6	0	.	UDP-alpha-D-galactose binding. Pubmed:24052259
chr5	177608574	177608586	Q9UBV7	0	+	177608574	177608586	255,102,0	1	12	0	.	N-acetyl-D-glucosamine binding.
chr5	177608954	177608963	Q9UBV7	0	+	177608954	177608963	255,102,0	1	9	0	.	UDP-alpha-D-galactose binding. Pubmed:24052259
chr5	178992056	178992065	O15303	0	-	178992056	178992065	255,102,0	1	9	0	.	Glutamate binding.
chr5	179128022	179132819	O95450	0	-	179128022	179132819	255,102,0	1	4797	0	.	Spacer.
chr5	179601972	179605894	Q96T51	0	+	179601972	179605894	255,102,0	1	3922	0	.	Interaction with RAB4.
chr5	179616126	179618160	P31943	0	-	179616126	179618160	255,102,0	1	2034	0	.	2 X 16 AA Gly-rich approximate repeats.
chr5	179616899	179617108	P31943	0	-	179616899	179617108	255,102,0	1	209	0	.	2 X 19 AA perfect repeats.
chr5	179716208	179722848	P27824	0	+	179716208	179722848	255,102,0	1	6640	0	.	P domain (Extended arm).
chr5	179716214	179720413	P27824	0	+	179716214	179720413	255,102,0	1	4199	0	.	4 X approximate repeats.
chr5	179719731	179720455	P27824	0	+	179719731	179720455	255,102,0	1	724	0	.	Interaction with PPIB.
chr5	179720419	179722836	P27824	0	+	179720419	179722836	255,102,0	1	2417	0	.	4 X approximate repeats.
chr5	179723767	179728641	P27824	0	+	179723767	179728641	255,102,0	1	4874	0	.	Sufficient to mediate interaction with SGIP1.
chr5	179733112	179765379	Q92585	0	+	179733112	179765379	255,102,0	1	32267	0	.	Required for interaction with NOTCH proteins. Pubmed:11101851
chr5	179795675	179795792	Q16873	0	+	179795675	179795792	255,102,0	1	117	0	.	Glutathione binding.
chr5	179795798	179795804	Q16873	0	+	179795798	179795804	255,102,0	1	6	0	.	Glutathione binding.
chr5	179795987	179796002	Q16873	0	+	179795987	179796002	255,102,0	1	15	0	.	Glutathione binding.
chr5	179820939	179821086	Q13501	0	+	179820939	179821086	255,102,0	1	147	0	.	Interaction with LCK.
chr5	179821062	179823877	Q13501	0	+	179821062	179823877	255,102,0	1	2815	0	.	Interaction with PRKCZ and dimerization.
chr5	179821083	179822992	Q13501	0	+	179821083	179822992	255,102,0	1	1909	0	.	Interaction with PAWR. Pubmed:11755531
chr5	179823919	179824322	Q13501	0	+	179823919	179824322	255,102,0	1	403	0	.	Interaction with GABRR3.
chr5	179824063	179824310	Q13501	0	+	179824063	179824310	255,102,0	1	247	0	.	LIM protein-binding (LB).
chr5	179833081	179836590	Q13501	0	+	179833081	179836590	255,102,0	1	3509	0	.	Interaction with NTRK1.
chr5	179833237	179833643	Q13501	0	+	179833237	179833643	255,102,0	1	406	0	.	MAP1LC3B-binding.
chr5	179837711	179837786	Q6NTE8	0	-	179837711	179837786	255,102,0	1	75	0	.	Necessary for the association with the MRN complex. Pubmed:27568553
chr5	180316341	180316350	O94808	0	-	180316341	180316350	255,102,0	1	9	0	.	Substrate-binding.
chr5	180316781	180316787	O94808	0	-	180316781	180316787	255,102,0	1	6	0	.	Substrate-binding.
chr5	180564559	180574197	Q9ULM6	0	+	180564559	180574197	255,102,0	1	9638	0	.	Nuclease domain.
chr6	3015604	3015613	P16083	0	+	3015604	3015613	255,102,0	1	9	0	.	Substrate binding.
chr6	3089609	3113069	Q13546	0	+	3089609	3113069	255,102,0	1	23460	0	.	Interaction with SQSTM1. Pubmed:10356400
chr6	4117370	4130422	O75521	0	-	4117370	4130422	255,102,0	1	13052	0	.	ECH-like.
chr6	4126202	4126217	O75521	0	-	4126202	4126217	255,102,0	1	15	0	.	Substrate binding.
chr6	4133551	4133566	O75521	0	-	4133551	4133566	255,102,0	1	15	0	.	Acyl-CoA binding.
chr6	4734838	4935588	Q9Y232	0	+	4734838	4935588	255,102,0	1	200750	0	.	Interaction with EZH2. Pubmed:22009739
chr6	5369038	5369050	O95363	0	+	5369038	5369050	255,102,0	1	12	0	.	Substrate binding.
chr6	5369125	5369134	O95363	0	+	5369125	5369134	255,102,0	1	9	0	.	Substrate binding.
chr6	5369146	5369155	O95363	0	+	5369146	5369155	255,102,0	1	9	0	.	Substrate binding.
chr6	7541915	7571433	P15924	0	+	7541915	7571433	255,102,0	1	29518	0	.	Interaction with plakophilin 1 and junction plakoglobin.
chr6	7541915	7579358	P15924	0	+	7541915	7579358	255,102,0	1	37443	0	.	Globular 1.
chr6	7579358	7583097	P15924	0	+	7579358	7583097	255,102,0	1	3739	0	.	Central fibrous rod domain.
chr6	7583097	7585875	P15924	0	+	7583097	7585875	255,102,0	1	2778	0	.	Globular 2.
chr6	7583139	7583886	P15924	0	+	7583139	7583886	255,102,0	1	747	0	.	4.5 X 38 AA tandem repeats (Domain A).
chr6	7583991	7584600	P15924	0	+	7583991	7584600	255,102,0	1	609	0	.	4.5 X 38 AA tandem repeats (Domain B).
chr6	7585086	7585728	P15924	0	+	7585086	7585728	255,102,0	1	642	0	.	4.5 X 38 AA tandem repeats (Domain C).
chr6	7585731	7585803	P15924	0	+	7585731	7585803	255,102,0	1	72	0	.	6 X 4 AA tandem repeats of G-S-R-[SR].
chr6	8079958	8097365	O43324	0	-	8079958	8097365	255,102,0	1	17407	0	.	C-terminal.
chr6	8097365	8097386	O43324	0	-	8097365	8097386	255,102,0	1	21	0	.	Linker.
chr6	8097386	8102518	O43324	0	-	8097386	8102518	255,102,0	1	5132	0	.	N-terminal.
chr6	10398500	10402537	P05549	0	-	10398500	10402537	255,102,0	1	4037	0	.	H-S-H (helix-span-helix), dimerization.
chr6	11104188	11104251	P60508	0	-	11104188	11104251	255,102,0	1	63	0	.	Fusion peptide.
chr6	11185386	11185539	Q14511	0	-	11185386	11185539	255,102,0	1	153	0	.	Divergent helix-loop-helix motif.
chr6	11191181	11213436	Q14511	0	-	11191181	11213436	255,102,0	1	22255	0	.	Interacts strongly with spindle-regulatory protein D1M1.
chr6	12294031	12294076	P05305	0	+	12294031	12294076	255,102,0	1	45	0	.	Endothelin-like.
chr6	13622364	13632474	Q96S59	0	-	13622364	13632474	255,102,0	1	10110	0	.	Interaction with FMR1. Pubmed:15381419
chr6	13642482	13642503	Q96S59	0	-	13642482	13642503	255,102,0	1	21	0	.	Interaction with CALB1.
chr6	15523037	15533390	Q96EV8	0	-	15523037	15533390	255,102,0	1	10353	0	.	Dysbindin.
chr6	16146703	16146712	Q8WY64	0	+	16146703	16146712	255,102,0	1	9	0	.	Critical for homodimerization.
chr6	16285792	16285801	P36959	0	+	16285792	16285801	255,102,0	1	9	0	.	GMP binding.
chr6	16290487	16290493	P36959	0	+	16290487	16290493	255,102,0	1	6	0	.	GMP binding.
chr6	16290565	16290574	P36959	0	+	16290565	16290574	255,102,0	1	9	0	.	GMP binding.
chr6	16290619	16295018	P36959	0	+	16290619	16295018	255,102,0	1	4399	0	.	GMP binding.
chr6	16306331	16326699	P54253	0	-	16306331	16326699	255,102,0	1	20368	0	.	Interaction with USP7. Pubmed:12093161
chr6	16306478	16326693	P54253	0	-	16306478	16326693	255,102,0	1	20215	0	.	RNA-binding. Pubmed:11136710
chr6	16326498	16326831	P54253	0	-	16326498	16326831	255,102,0	1	333	0	.	Self-association. Pubmed:9097953
chr6	18139678	18139684	A0A024QZW0	0	-	18139678	18139684	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr6	18139678	18139684	P51580	0	-	18139678	18139684	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr6	18149007	18149043	A0A024QZW0	0	-	18149007	18149043	255,102,0	1	36	0	.	S-adenosyl-L-methionine binding.
chr6	18149007	18149043	P51580	0	-	18149007	18149043	255,102,0	1	36	0	.	S-adenosyl-L-methionine binding.
chr6	20402532	20479911	O00716	0	+	20402532	20479911	255,102,0	1	77379	0	.	Cyclin A/CDK2 binding.
chr6	20481309	20481375	O00716	0	+	20481309	20481375	255,102,0	1	66	0	.	Leucine-zipper.
chr6	20482771	20488124	O00716	0	+	20482771	20488124	255,102,0	1	5353	0	.	Dimerization.
chr6	20490202	20490427	O00716	0	+	20490202	20490427	255,102,0	1	225	0	.	Transactivation.
chr6	20490325	20490379	O00716	0	+	20490325	20490379	255,102,0	1	54	0	.	Retinoblastoma protein binding.
chr6	24781590	24785652	O75496	0	+	24781590	24785652	255,102,0	1	4062	0	.	Necessary and sufficient for interaction with IDAS and CDT1. Pubmed:21543332
chr6	24785676	24785739	O75496	0	+	24785676	24785739	255,102,0	1	63	0	.	Homeodomain binding.
chr6	24870886	24873738	Q9Y4F9	0	-	24870886	24873738	255,102,0	1	2852	0	.	Involved in cell filopodia formation.
chr6	25581304	25600440	Q5VZK9	0	+	25581304	25600440	255,102,0	1	19136	0	.	Inhibits capping activity of CAPZA2.
chr6	25600356	25600461	Q5VZK9	0	+	25600356	25600461	255,102,0	1	105	0	.	Necessary for localization at the cell membrane. Pubmed:26578515
chr6	26087506	26091315	Q30201	0	+	26087506	26091315	255,102,0	1	3809	0	.	Alpha-1.
chr6	26091315	26091588	Q30201	0	+	26091315	26091588	255,102,0	1	273	0	.	Alpha-2.
chr6	26092683	26092959	Q30201	0	+	26092683	26092959	255,102,0	1	276	0	.	Alpha-3.
chr6	26093117	26093144	Q30201	0	+	26093117	26093144	255,102,0	1	27	0	.	Connecting peptide.
chr6	29600279	29601143	Q9UBS5	0	-	29600279	29601143	255,102,0	1	864	0	.	Interaction with ATF4.
chr6	29603482	29604346	Q9UBS5	0	-	29603482	29604346	255,102,0	1	864	0	.	Interaction with ATF4.
chr6	29603599	29604463	Q9UBS5	0	-	29603599	29604463	255,102,0	1	864	0	.	Interaction with ATF4.
chr6	29603636	29604500	Q9UBS5	0	-	29603636	29604500	255,102,0	1	864	0	.	Interaction with ATF4.
chr6	29603680	29604544	Q9UBS5	0	-	29603680	29604544	255,102,0	1	864	0	.	Interaction with ATF4.
chr6	29603812	29604676	Q9UBS5	0	-	29603812	29604676	255,102,0	1	864	0	.	Interaction with ATF4.
chr6	29723656	29723926	P30511	0	+	29723656	29723926	255,102,0	1	270	0	.	Alpha-1.
chr6	29724171	29724447	P30511	0	+	29724171	29724447	255,102,0	1	276	0	.	Alpha-2.
chr6	29725029	29725305	P30511	0	+	29725029	29725305	255,102,0	1	276	0	.	Alpha-3.
chr6	29725445	29725475	P30511	0	+	29725445	29725475	255,102,0	1	30	0	.	Connecting peptide.
chr6	29821726	29821996	P17693	0	+	29821726	29821996	255,102,0	1	270	0	.	Alpha-1.
chr6	29822222	29822498	P17693	0	+	29822222	29822498	255,102,0	1	276	0	.	Alpha-2.
chr6	29823097	29823373	P17693	0	+	29823097	29823373	255,102,0	1	276	0	.	Alpha-3.
chr6	29823495	29823525	P17693	0	+	29823495	29823525	255,102,0	1	30	0	.	Connecting peptide.
chr6	29824923	29825193	P17693	0	+	29824923	29825193	255,102,0	1	270	0	.	Alpha-1.
chr6	29824938	29825208	P17693	0	+	29824938	29825208	255,102,0	1	270	0	.	Alpha-1.
chr6	29825218	29825488	P17693	0	+	29825218	29825488	255,102,0	1	270	0	.	Alpha-1.
chr6	29825265	29825535	P17693	0	+	29825265	29825535	255,102,0	1	270	0	.	Alpha-1.
chr6	29825419	29825695	P17693	0	+	29825419	29825695	255,102,0	1	276	0	.	Alpha-2.
chr6	29825434	29825710	P17693	0	+	29825434	29825710	255,102,0	1	276	0	.	Alpha-2.
chr6	29825541	29825811	P17693	0	+	29825541	29825811	255,102,0	1	270	0	.	Alpha-1.
chr6	29825714	29825990	P17693	0	+	29825714	29825990	255,102,0	1	276	0	.	Alpha-2.
chr6	29825761	29826037	P17693	0	+	29825761	29826037	255,102,0	1	276	0	.	Alpha-2.
chr6	29826037	29826313	P17693	0	+	29826037	29826313	255,102,0	1	276	0	.	Alpha-2.
chr6	29826294	29826570	P17693	0	+	29826294	29826570	255,102,0	1	276	0	.	Alpha-3.
chr6	29826309	29826585	P17693	0	+	29826309	29826585	255,102,0	1	276	0	.	Alpha-3.
chr6	29826589	29826865	P17693	0	+	29826589	29826865	255,102,0	1	276	0	.	Alpha-3.
chr6	29826636	29826912	P17693	0	+	29826636	29826912	255,102,0	1	276	0	.	Alpha-3.
chr6	29826692	29826722	P17693	0	+	29826692	29826722	255,102,0	1	30	0	.	Connecting peptide.
chr6	29826707	29826737	P17693	0	+	29826707	29826737	255,102,0	1	30	0	.	Connecting peptide.
chr6	29826912	29827188	P17693	0	+	29826912	29827188	255,102,0	1	276	0	.	Alpha-3.
chr6	29826987	29827017	P17693	0	+	29826987	29827017	255,102,0	1	30	0	.	Connecting peptide.
chr6	29827034	29827064	P17693	0	+	29827034	29827064	255,102,0	1	30	0	.	Connecting peptide.
chr6	29827310	29827340	P17693	0	+	29827310	29827340	255,102,0	1	30	0	.	Connecting peptide.
chr6	29828045	29828315	P17693	0	+	29828045	29828315	255,102,0	1	270	0	.	Alpha-1.
chr6	29828541	29828817	P17693	0	+	29828541	29828817	255,102,0	1	276	0	.	Alpha-2.
chr6	29829416	29829692	P17693	0	+	29829416	29829692	255,102,0	1	276	0	.	Alpha-3.
chr6	29829814	29829844	P17693	0	+	29829814	29829844	255,102,0	1	30	0	.	Connecting peptide.
chr6	29932033	29932303	P10314	0	+	29932033	29932303	255,102,0	1	270	0	.	Alpha-1.
chr6	29932121	29932391	P30450	0	+	29932121	29932391	255,102,0	1	270	0	.	Alpha-1.
chr6	29932296	29932566	P30443	0	+	29932296	29932566	255,102,0	1	270	0	.	Alpha-1.
chr6	29932544	29932820	P10314	0	+	29932544	29932820	255,102,0	1	276	0	.	Alpha-2.
chr6	29932632	29932908	P30450	0	+	29932632	29932908	255,102,0	1	276	0	.	Alpha-2.
chr6	29932715	29932985	P01892	0	+	29932715	29932985	255,102,0	1	270	0	.	Alpha-1.
chr6	29932807	29933083	P30443	0	+	29932807	29933083	255,102,0	1	276	0	.	Alpha-2.
chr6	29933226	29933502	P01892	0	+	29933226	29933502	255,102,0	1	276	0	.	Alpha-2.
chr6	29933420	29933696	P10314	0	+	29933420	29933696	255,102,0	1	276	0	.	Alpha-3.
chr6	29933508	29933784	P30450	0	+	29933508	29933784	255,102,0	1	276	0	.	Alpha-3.
chr6	29933662	29933938	P30443	0	+	29933662	29933938	255,102,0	1	276	0	.	Alpha-3.
chr6	29933795	29933825	P10314	0	+	29933795	29933825	255,102,0	1	30	0	.	Connecting peptide.
chr6	29933883	29933913	P30450	0	+	29933883	29933913	255,102,0	1	30	0	.	Connecting peptide.
chr6	29934040	29934070	P30443	0	+	29934040	29934070	255,102,0	1	30	0	.	Connecting peptide.
chr6	29934102	29934378	P01892	0	+	29934102	29934378	255,102,0	1	276	0	.	Alpha-3.
chr6	29934477	29934507	P01892	0	+	29934477	29934507	255,102,0	1	30	0	.	Connecting peptide.
chr6	29934909	29935179	P30443	0	+	29934909	29935179	255,102,0	1	270	0	.	Alpha-1.
chr6	29935420	29935696	P30443	0	+	29935420	29935696	255,102,0	1	276	0	.	Alpha-2.
chr6	29936275	29936551	P30443	0	+	29936275	29936551	255,102,0	1	276	0	.	Alpha-3.
chr6	29936653	29936683	P30443	0	+	29936653	29936683	255,102,0	1	30	0	.	Connecting peptide.
chr6	29942755	29943025	P04439	0	+	29942755	29943025	255,102,0	1	270	0	.	Alpha-1.
chr6	29943266	29943542	P04439	0	+	29943266	29943542	255,102,0	1	276	0	.	Alpha-2.
chr6	29944120	29944396	P04439	0	+	29944120	29944396	255,102,0	1	276	0	.	Alpha-3.
chr6	29944498	29944528	P04439	0	+	29944498	29944528	255,102,0	1	30	0	.	Connecting peptide.
chr6	30479227	30479497	P13747	0	+	30479227	30479497	255,102,0	1	270	0	.	Alpha-1.
chr6	30479578	30479848	P13747	0	+	30479578	30479848	255,102,0	1	270	0	.	Alpha-1.
chr6	30479741	30480017	P13747	0	+	30479741	30480017	255,102,0	1	276	0	.	Alpha-2.
chr6	30479963	30480233	P13747	0	+	30479963	30480233	255,102,0	1	270	0	.	Alpha-1.
chr6	30480092	30480368	P13747	0	+	30480092	30480368	255,102,0	1	276	0	.	Alpha-2.
chr6	30480477	30480753	P13747	0	+	30480477	30480753	255,102,0	1	276	0	.	Alpha-2.
chr6	30480638	30480914	P13747	0	+	30480638	30480914	255,102,0	1	276	0	.	Alpha-3.
chr6	30480989	30481265	P13747	0	+	30480989	30481265	255,102,0	1	276	0	.	Alpha-3.
chr6	30481038	30481068	P13747	0	+	30481038	30481068	255,102,0	1	30	0	.	Connecting peptide.
chr6	30481374	30481650	P13747	0	+	30481374	30481650	255,102,0	1	276	0	.	Alpha-3.
chr6	30481389	30481419	P13747	0	+	30481389	30481419	255,102,0	1	30	0	.	Connecting peptide.
chr6	30481774	30481804	P13747	0	+	30481774	30481804	255,102,0	1	30	0	.	Connecting peptide.
chr6	30481958	30482228	P13747	0	+	30481958	30482228	255,102,0	1	270	0	.	Alpha-1.
chr6	30482472	30482748	P13747	0	+	30482472	30482748	255,102,0	1	276	0	.	Alpha-2.
chr6	30483369	30483645	P13747	0	+	30483369	30483645	255,102,0	1	276	0	.	Alpha-3.
chr6	30483769	30483799	P13747	0	+	30483769	30483799	255,102,0	1	30	0	.	Connecting peptide.
chr6	30592441	30593858	Q96QC0	0	-	30592441	30593858	255,102,0	1	1417	0	.	Interaction with WDR82.
chr6	30592788	30594205	Q96QC0	0	-	30592788	30594205	255,102,0	1	1417	0	.	Interaction with WDR82.
chr6	30593182	30594599	Q96QC0	0	-	30593182	30594599	255,102,0	1	1417	0	.	Interaction with WDR82.
chr6	30593661	30593966	Q96QC0	0	-	30593661	30593966	255,102,0	1	305	0	.	Essential for PPP1CA inhibition.
chr6	30593858	30593948	Q96QC0	0	-	30593858	30593948	255,102,0	1	90	0	.	Necessary for interaction with PPP1CA.
chr6	30593885	30593933	Q96QC0	0	-	30593885	30593933	255,102,0	1	48	0	.	Necessary for interaction with PPP1CC. Pubmed:9450550
chr6	30594008	30594313	Q96QC0	0	-	30594008	30594313	255,102,0	1	305	0	.	Essential for PPP1CA inhibition.
chr6	30594141	30599439	Q96QC0	0	-	30594141	30599439	255,102,0	1	5298	0	.	Interaction with TOX4.
chr6	30594205	30594295	Q96QC0	0	-	30594205	30594295	255,102,0	1	90	0	.	Necessary for interaction with PPP1CA.
chr6	30594232	30594280	Q96QC0	0	-	30594232	30594280	255,102,0	1	48	0	.	Necessary for interaction with PPP1CC. Pubmed:9450550
chr6	30594402	30594707	Q96QC0	0	-	30594402	30594707	255,102,0	1	305	0	.	Essential for PPP1CA inhibition.
chr6	30594488	30599787	Q96QC0	0	-	30594488	30599787	255,102,0	1	5299	0	.	Interaction with TOX4.
chr6	30594599	30594689	Q96QC0	0	-	30594599	30594689	255,102,0	1	90	0	.	Necessary for interaction with PPP1CA.
chr6	30594626	30594674	Q96QC0	0	-	30594626	30594674	255,102,0	1	48	0	.	Necessary for interaction with PPP1CC. Pubmed:9450550
chr6	30594882	30600181	Q96QC0	0	-	30594882	30600181	255,102,0	1	5299	0	.	Interaction with TOX4.
chr6	30595168	30596585	Q96QC0	0	-	30595168	30596585	255,102,0	1	1417	0	.	Interaction with WDR82.
chr6	30596388	30596693	Q96QC0	0	-	30596388	30596693	255,102,0	1	305	0	.	Essential for PPP1CA inhibition.
chr6	30596585	30596675	Q96QC0	0	-	30596585	30596675	255,102,0	1	90	0	.	Necessary for interaction with PPP1CA.
chr6	30596612	30596660	Q96QC0	0	-	30596612	30596660	255,102,0	1	48	0	.	Necessary for interaction with PPP1CC. Pubmed:9450550
chr6	30596868	30602167	Q96QC0	0	-	30596868	30602167	255,102,0	1	5299	0	.	Interaction with TOX4.
chr6	30602945	30604362	Q96QC0	0	-	30602945	30604362	255,102,0	1	1417	0	.	Interaction with WDR82.
chr6	30604165	30604470	Q96QC0	0	-	30604165	30604470	255,102,0	1	305	0	.	Essential for PPP1CA inhibition.
chr6	30604362	30604452	Q96QC0	0	-	30604362	30604452	255,102,0	1	90	0	.	Necessary for interaction with PPP1CA.
chr6	30604389	30604437	Q96QC0	0	-	30604389	30604437	255,102,0	1	48	0	.	Necessary for interaction with PPP1CC. Pubmed:9450550
chr6	30604645	30609944	Q96QC0	0	-	30604645	30609944	255,102,0	1	5299	0	.	Interaction with TOX4.
chr6	30617574	30617616	Q5SQI0	0	+	30617574	30617616	255,102,0	1	42	0	.	Acetyl-CoA binding. Pubmed:24906155, Pubmed:23071314, Pubmed:23071318
chr6	30617865	30617895	Q5SQI0	0	+	30617865	30617895	255,102,0	1	30	0	.	Acetyl-CoA binding. Pubmed:24906155, Pubmed:23071314, Pubmed:23071318
chr6	30617922	30617964	Q5SQI0	0	+	30617922	30617964	255,102,0	1	42	0	.	Acetyl-CoA binding. Pubmed:24906155, Pubmed:23071314, Pubmed:23071318
chr6	30618213	30618243	Q5SQI0	0	+	30618213	30618243	255,102,0	1	30	0	.	Acetyl-CoA binding. Pubmed:24906155, Pubmed:23071314, Pubmed:23071318
chr6	30618316	30618358	Q5SQI0	0	+	30618316	30618358	255,102,0	1	42	0	.	Acetyl-CoA binding. Pubmed:24906155, Pubmed:23071314, Pubmed:23071318
chr6	30618607	30618637	Q5SQI0	0	+	30618607	30618637	255,102,0	1	30	0	.	Acetyl-CoA binding. Pubmed:24906155, Pubmed:23071314, Pubmed:23071318
chr6	30620302	30620344	Q5SQI0	0	+	30620302	30620344	255,102,0	1	42	0	.	Acetyl-CoA binding. Pubmed:24906155, Pubmed:23071314, Pubmed:23071318
chr6	30620593	30620623	Q5SQI0	0	+	30620593	30620623	255,102,0	1	30	0	.	Acetyl-CoA binding. Pubmed:24906155, Pubmed:23071314, Pubmed:23071318
chr6	30628079	30628121	Q5SQI0	0	+	30628079	30628121	255,102,0	1	42	0	.	Acetyl-CoA binding. Pubmed:24906155, Pubmed:23071314, Pubmed:23071318
chr6	30628370	30628400	Q5SQI0	0	+	30628370	30628400	255,102,0	1	30	0	.	Acetyl-CoA binding. Pubmed:24906155, Pubmed:23071314, Pubmed:23071318
chr6	30647581	30648998	Q96QC0	0	-	30647581	30648998	255,102,0	1	1417	0	.	Interaction with WDR82.
chr6	30648801	30649106	Q96QC0	0	-	30648801	30649106	255,102,0	1	305	0	.	Essential for PPP1CA inhibition.
chr6	30648998	30649088	Q96QC0	0	-	30648998	30649088	255,102,0	1	90	0	.	Necessary for interaction with PPP1CA.
chr6	30649025	30649073	Q96QC0	0	-	30649025	30649073	255,102,0	1	48	0	.	Necessary for interaction with PPP1CC. Pubmed:9450550
chr6	30649281	30654580	Q96QC0	0	-	30649281	30654580	255,102,0	1	5299	0	.	Interaction with TOX4.
chr6	30672715	30672757	Q5SQI0	0	+	30672715	30672757	255,102,0	1	42	0	.	Acetyl-CoA binding. Pubmed:24906155, Pubmed:23071314, Pubmed:23071318
chr6	30673006	30673036	Q5SQI0	0	+	30673006	30673036	255,102,0	1	30	0	.	Acetyl-CoA binding. Pubmed:24906155, Pubmed:23071314, Pubmed:23071318
chr6	30681399	30682816	Q96QC0	0	-	30681399	30682816	255,102,0	1	1417	0	.	Interaction with WDR82.
chr6	30682619	30682924	Q96QC0	0	-	30682619	30682924	255,102,0	1	305	0	.	Essential for PPP1CA inhibition.
chr6	30682816	30682906	Q96QC0	0	-	30682816	30682906	255,102,0	1	90	0	.	Necessary for interaction with PPP1CA.
chr6	30682843	30682891	Q96QC0	0	-	30682843	30682891	255,102,0	1	48	0	.	Necessary for interaction with PPP1CC. Pubmed:9450550
chr6	30683099	30688398	Q96QC0	0	-	30683099	30688398	255,102,0	1	5299	0	.	Interaction with TOX4.
chr6	30690326	30693951	Q14676	0	-	30690326	30693951	255,102,0	1	3625	0	.	Required for nuclear localization (NLS2).
chr6	30690726	30694350	Q14676	0	-	30690726	30694350	255,102,0	1	3624	0	.	Required for nuclear localization (NLS2).
chr6	30694212	30695601	Q14676	0	-	30694212	30695601	255,102,0	1	1389	0	.	Interaction with the PRKDC complex.
chr6	30694611	30696000	Q14676	0	-	30694611	30696000	255,102,0	1	1389	0	.	Interaction with the PRKDC complex.
chr6	30700467	30704091	Q14676	0	-	30700467	30704091	255,102,0	1	3624	0	.	Required for nuclear localization (NLS2).
chr6	30702096	30703746	Q14676	0	-	30702096	30703746	255,102,0	1	1650	0	.	Required for nuclear localization (NLS1).
chr6	30702495	30704145	Q14676	0	-	30702495	30704145	255,102,0	1	1650	0	.	Required for nuclear localization (NLS1).
chr6	30703140	30705031	Q14676	0	-	30703140	30705031	255,102,0	1	1891	0	.	Interaction with the MRN complex.
chr6	30703539	30705430	Q14676	0	-	30703539	30705430	255,102,0	1	1891	0	.	Interaction with the MRN complex.
chr6	30703728	30705034	Q14676	0	-	30703728	30705034	255,102,0	1	1306	0	.	Interaction with CHEK2.
chr6	30704127	30705433	Q14676	0	-	30704127	30705433	255,102,0	1	1306	0	.	Interaction with CHEK2.
chr6	30704352	30705741	Q14676	0	-	30704352	30705741	255,102,0	1	1389	0	.	Interaction with the PRKDC complex.
chr6	30706534	30706576	Q5SQI0	0	+	30706534	30706576	255,102,0	1	42	0	.	Acetyl-CoA binding. Pubmed:24906155, Pubmed:23071314, Pubmed:23071318
chr6	30706825	30706855	Q5SQI0	0	+	30706825	30706855	255,102,0	1	30	0	.	Acetyl-CoA binding. Pubmed:24906155, Pubmed:23071314, Pubmed:23071318
chr6	30712237	30713887	Q14676	0	-	30712237	30713887	255,102,0	1	1650	0	.	Required for nuclear localization (NLS1).
chr6	30713281	30715172	Q14676	0	-	30713281	30715172	255,102,0	1	1891	0	.	Interaction with the MRN complex.
chr6	30713869	30715175	Q14676	0	-	30713869	30715175	255,102,0	1	1306	0	.	Interaction with CHEK2.
chr6	30745126	30748750	Q14676	0	-	30745126	30748750	255,102,0	1	3624	0	.	Required for nuclear localization (NLS2).
chr6	30749011	30750400	Q14676	0	-	30749011	30750400	255,102,0	1	1389	0	.	Interaction with the PRKDC complex.
chr6	30756895	30758545	Q14676	0	-	30756895	30758545	255,102,0	1	1650	0	.	Required for nuclear localization (NLS1).
chr6	30757939	30759830	Q14676	0	-	30757939	30759830	255,102,0	1	1891	0	.	Interaction with the MRN complex.
chr6	30758527	30759833	Q14676	0	-	30758527	30759833	255,102,0	1	1306	0	.	Interaction with CHEK2.
chr6	30764379	30768003	Q14676	0	-	30764379	30768003	255,102,0	1	3624	0	.	Required for nuclear localization (NLS2).
chr6	30768264	30769653	Q14676	0	-	30768264	30769653	255,102,0	1	1389	0	.	Interaction with the PRKDC complex.
chr6	30776148	30777798	Q14676	0	-	30776148	30777798	255,102,0	1	1650	0	.	Required for nuclear localization (NLS1).
chr6	30777192	30779083	Q14676	0	-	30777192	30779083	255,102,0	1	1891	0	.	Interaction with the MRN complex.
chr6	30777780	30779086	Q14676	0	-	30777780	30779086	255,102,0	1	1306	0	.	Interaction with CHEK2.
chr6	30778950	30782574	Q14676	0	-	30778950	30782574	255,102,0	1	3624	0	.	Required for nuclear localization (NLS2).
chr6	30782835	30784224	Q14676	0	-	30782835	30784224	255,102,0	1	1389	0	.	Interaction with the PRKDC complex.
chr6	30790719	30792369	Q14676	0	-	30790719	30792369	255,102,0	1	1650	0	.	Required for nuclear localization (NLS1).
chr6	30791763	30793654	Q14676	0	-	30791763	30793654	255,102,0	1	1891	0	.	Interaction with the MRN complex.
chr6	30792351	30793657	Q14676	0	-	30792351	30793657	255,102,0	1	1306	0	.	Interaction with CHEK2.
chr6	30880962	30882646	Q08345	0	+	30880962	30882646	255,102,0	1	1684	0	.	DS-like domain.
chr6	30881275	30882959	Q08345	0	+	30881275	30882959	255,102,0	1	1684	0	.	DS-like domain.
chr6	30882088	30883786	Q08345	0	+	30882088	30883786	255,102,0	1	1698	0	.	DS-like domain.
chr6	30891387	30893069	Q08345	0	+	30891387	30893069	255,102,0	1	1682	0	.	DS-like domain.
chr6	30936036	30937714	Q08345	0	+	30936036	30937714	255,102,0	1	1678	0	.	DS-like domain.
chr6	30986265	30987480	Q5SSG8	0	+	30986265	30987480	255,102,0	1	1215	0	.	28 X 15 AA approximate tandem repeats.
chr6	30988053	30988191	Q5SSG8	0	+	30988053	30988191	255,102,0	1	138	0	.	Cytoplasmic tail.
chr6	31025887	31029973	E2RYF6	0	+	31025887	31029973	255,102,0	1	4086	0	.	124 X 10 AA approximate repeats.
chr6	31259892	31259922	Q9TNN7	0	-	31259892	31259922	255,102,0	1	30	0	.	Connecting peptide.
chr6	31260043	31260319	Q9TNN7	0	-	31260043	31260319	255,102,0	1	276	0	.	Alpha-3.
chr6	31260906	31261182	Q9TNN7	0	-	31260906	31261182	255,102,0	1	276	0	.	Alpha-2.
chr6	31261428	31261698	Q9TNN7	0	-	31261428	31261698	255,102,0	1	270	0	.	Alpha-1.
chr6	31262260	31262290	Q29963	0	-	31262260	31262290	255,102,0	1	30	0	.	Connecting peptide.
chr6	31262411	31262687	Q29963	0	-	31262411	31262687	255,102,0	1	276	0	.	Alpha-3.
chr6	31263274	31263550	Q29963	0	-	31263274	31263550	255,102,0	1	276	0	.	Alpha-2.
chr6	31263476	31263506	Q9TNN7	0	-	31263476	31263506	255,102,0	1	30	0	.	Connecting peptide.
chr6	31263627	31263903	Q9TNN7	0	-	31263627	31263903	255,102,0	1	276	0	.	Alpha-3.
chr6	31263796	31264066	Q29963	0	-	31263796	31264066	255,102,0	1	270	0	.	Alpha-1.
chr6	31264490	31264766	Q9TNN7	0	-	31264490	31264766	255,102,0	1	276	0	.	Alpha-2.
chr6	31265012	31265282	Q9TNN7	0	-	31265012	31265282	255,102,0	1	270	0	.	Alpha-1.
chr6	31270056	31270086	P10321	0	-	31270056	31270086	255,102,0	1	30	0	.	Connecting peptide.
chr6	31270210	31270486	P10321	0	-	31270210	31270486	255,102,0	1	276	0	.	Alpha-3.
chr6	31271073	31271349	P10321	0	-	31271073	31271349	255,102,0	1	276	0	.	Alpha-2.
chr6	31271599	31271869	P10321	0	-	31271599	31271869	255,102,0	1	270	0	.	Alpha-1.
chr6	31345285	31345318	P30466	0	-	31345285	31345318	255,102,0	1	33	0	.	Connecting peptide.
chr6	31345422	31345698	P30466	0	-	31345422	31345698	255,102,0	1	276	0	.	Alpha-3.
chr6	31345670	31345703	P30460	0	-	31345670	31345703	255,102,0	1	33	0	.	Connecting peptide.
chr6	31345796	31346072	P30460	0	-	31345796	31346072	255,102,0	1	276	0	.	Alpha-3.
chr6	31346270	31346546	P30466	0	-	31346270	31346546	255,102,0	1	276	0	.	Alpha-2.
chr6	31346644	31346920	P30460	0	-	31346644	31346920	255,102,0	1	276	0	.	Alpha-2.
chr6	31346792	31347062	P30466	0	-	31346792	31347062	255,102,0	1	270	0	.	Alpha-1.
chr6	31347166	31347436	P30460	0	-	31347166	31347436	255,102,0	1	270	0	.	Alpha-1.
chr6	31347190	31347220	P04222	0	-	31347190	31347220	255,102,0	1	30	0	.	Connecting peptide.
chr6	31347341	31347617	P04222	0	-	31347341	31347617	255,102,0	1	276	0	.	Alpha-3.
chr6	31348204	31348480	P04222	0	-	31348204	31348480	255,102,0	1	276	0	.	Alpha-2.
chr6	31348725	31348995	P04222	0	-	31348725	31348995	255,102,0	1	270	0	.	Alpha-1.
chr6	31348894	31348927	P30481	0	-	31348894	31348927	255,102,0	1	33	0	.	Connecting peptide.
chr6	31349020	31349296	P30481	0	-	31349020	31349296	255,102,0	1	276	0	.	Alpha-3.
chr6	31349871	31350147	P30481	0	-	31349871	31350147	255,102,0	1	276	0	.	Alpha-2.
chr6	31350390	31350660	P30481	0	-	31350390	31350660	255,102,0	1	270	0	.	Alpha-1.
chr6	31355191	31355224	P01889	0	-	31355191	31355224	255,102,0	1	33	0	.	Connecting peptide.
chr6	31355317	31355593	P01889	0	-	31355317	31355593	255,102,0	1	276	0	.	Alpha-3.
chr6	31356167	31356443	P01889	0	-	31356167	31356443	255,102,0	1	276	0	.	Alpha-2.
chr6	31356688	31356958	P01889	0	-	31356688	31356958	255,102,0	1	270	0	.	Alpha-1.
chr6	31431570	31431603	P30464	0	-	31431570	31431603	255,102,0	1	33	0	.	Connecting peptide.
chr6	31431707	31431983	P30464	0	-	31431707	31431983	255,102,0	1	276	0	.	Alpha-3.
chr6	31432558	31432834	P30464	0	-	31432558	31432834	255,102,0	1	276	0	.	Alpha-2.
chr6	31433079	31433349	P30464	0	-	31433079	31433349	255,102,0	1	270	0	.	Alpha-1.
chr6	31623739	31635644	P48634	0	+	31623739	31635644	255,102,0	1	11905	0	.	4 X 57 AA type A repeats.
chr6	31626797	31628157	P48634	0	+	31626797	31628157	255,102,0	1	1360	0	.	2 X type B repeats.
chr6	31630279	31635081	P46379	0	-	31630279	31635081	255,102,0	1	4802	0	.	4 X 29 AA approximate repeats.
chr6	31633098	31637900	P46379	0	-	31633098	31637900	255,102,0	1	4802	0	.	4 X 29 AA approximate repeats.
chr6	31633619	31638421	P46379	0	-	31633619	31638421	255,102,0	1	4802	0	.	4 X 29 AA approximate repeats.
chr6	31636329	31637309	P48634	0	+	31636329	31637309	255,102,0	1	980	0	.	3 X 50 AA type C repeats.
chr6	31642873	31647673	P46379	0	-	31642873	31647673	255,102,0	1	4800	0	.	4 X 29 AA approximate repeats.
chr6	31652018	31652036	P67870	0	+	31652018	31652036	255,102,0	1	18	0	.	Interaction with alpha subunit.
chr6	31657249	31657267	P67870	0	+	31657249	31657267	255,102,0	1	18	0	.	Interaction with alpha subunit.
chr6	31660070	31660088	P67870	0	+	31660070	31660088	255,102,0	1	18	0	.	Interaction with alpha subunit.
chr6	31660588	31660606	P67870	0	+	31660588	31660606	255,102,0	1	18	0	.	Interaction with alpha subunit.
chr6	31669839	31669857	P67870	0	+	31669839	31669857	255,102,0	1	18	0	.	Interaction with alpha subunit.
chr6	31709293	31709311	P67870	0	+	31709293	31709311	255,102,0	1	18	0	.	Interaction with alpha subunit.
chr6	31716008	31718467	O00299	0	-	31716008	31718467	255,102,0	1	2459	0	.	Required for insertion into the membrane.
chr6	31721247	31723708	O00299	0	-	31721247	31723708	255,102,0	1	2461	0	.	Required for insertion into the membrane.
chr6	31724058	31726523	O00299	0	-	31724058	31726523	255,102,0	1	2465	0	.	Required for insertion into the membrane.
chr6	31724601	31727064	O00299	0	-	31724601	31727064	255,102,0	1	2463	0	.	Required for insertion into the membrane.
chr6	31733840	31736297	O00299	0	-	31733840	31736297	255,102,0	1	2457	0	.	Required for insertion into the membrane.
chr6	31746118	31746136	P67870	0	+	31746118	31746136	255,102,0	1	18	0	.	Interaction with alpha subunit.
chr6	31773294	31775755	O00299	0	-	31773294	31775755	255,102,0	1	2461	0	.	Required for insertion into the membrane.
chr6	31792625	31792973	P34931	0	-	31792625	31792973	255,102,0	1	348	0	.	Substrate-binding domain (SBD).
chr6	31792994	31794152	P34931	0	-	31792994	31794152	255,102,0	1	1158	0	.	Nucleotide-binding domain (NBD).
chr6	31797945	31799100	P0DMV8	0	+	31797945	31799100	255,102,0	1	1155	0	.	Nucleotide-binding domain (NBD).
chr6	31797945	31799100	P0DMV9	0	+	31797945	31799100	255,102,0	1	1155	0	.	Nucleotide-binding domain (NBD).
chr6	31799121	31799469	P0DMV8	0	+	31799121	31799469	255,102,0	1	348	0	.	Substrate-binding domain (SBD).
chr6	31799121	31799469	P0DMV9	0	+	31799121	31799469	255,102,0	1	348	0	.	Substrate-binding domain (SBD).
chr6	31803129	31804284	P0DMV8	0	+	31803129	31804284	255,102,0	1	1155	0	.	Nucleotide-binding domain (NBD).
chr6	31803129	31804284	P0DMV9	0	+	31803129	31804284	255,102,0	1	1155	0	.	Nucleotide-binding domain (NBD).
chr6	31804305	31804653	P0DMV8	0	+	31804305	31804653	255,102,0	1	348	0	.	Substrate-binding domain (SBD).
chr6	31804305	31804653	P0DMV9	0	+	31804305	31804653	255,102,0	1	348	0	.	Substrate-binding domain (SBD).
chr6	31810122	31812583	O00299	0	-	31810122	31812583	255,102,0	1	2461	0	.	Required for insertion into the membrane.
chr6	31810139	31811294	P0DMV8	0	+	31810139	31811294	255,102,0	1	1155	0	.	Nucleotide-binding domain (NBD).
chr6	31810139	31811294	P0DMV9	0	+	31810139	31811294	255,102,0	1	1155	0	.	Nucleotide-binding domain (NBD).
chr6	31810439	31810787	P34931	0	-	31810439	31810787	255,102,0	1	348	0	.	Substrate-binding domain (SBD).
chr6	31810808	31811966	P34931	0	-	31810808	31811966	255,102,0	1	1158	0	.	Nucleotide-binding domain (NBD).
chr6	31811315	31811663	P0DMV8	0	+	31811315	31811663	255,102,0	1	348	0	.	Substrate-binding domain (SBD).
chr6	31811315	31811663	P0DMV9	0	+	31811315	31811663	255,102,0	1	348	0	.	Substrate-binding domain (SBD).
chr6	31815325	31816480	P0DMV8	0	+	31815325	31816480	255,102,0	1	1155	0	.	Nucleotide-binding domain (NBD).
chr6	31815325	31816480	P0DMV9	0	+	31815325	31816480	255,102,0	1	1155	0	.	Nucleotide-binding domain (NBD).
chr6	31815759	31816914	P0DMV8	0	+	31815759	31816914	255,102,0	1	1155	0	.	Nucleotide-binding domain (NBD).
chr6	31815759	31816914	P0DMV9	0	+	31815759	31816914	255,102,0	1	1155	0	.	Nucleotide-binding domain (NBD).
chr6	31816501	31816849	P0DMV8	0	+	31816501	31816849	255,102,0	1	348	0	.	Substrate-binding domain (SBD).
chr6	31816501	31816849	P0DMV9	0	+	31816501	31816849	255,102,0	1	348	0	.	Substrate-binding domain (SBD).
chr6	31816935	31817283	P0DMV8	0	+	31816935	31817283	255,102,0	1	348	0	.	Substrate-binding domain (SBD).
chr6	31816935	31817283	P0DMV9	0	+	31816935	31817283	255,102,0	1	348	0	.	Substrate-binding domain (SBD).
chr6	31818192	31819347	P0DMV8	0	+	31818192	31819347	255,102,0	1	1155	0	.	Nucleotide-binding domain (NBD).
chr6	31818192	31819347	P0DMV9	0	+	31818192	31819347	255,102,0	1	1155	0	.	Nucleotide-binding domain (NBD).
chr6	31819368	31819716	P0DMV8	0	+	31819368	31819716	255,102,0	1	348	0	.	Substrate-binding domain (SBD).
chr6	31819368	31819716	P0DMV9	0	+	31819368	31819716	255,102,0	1	348	0	.	Substrate-binding domain (SBD).
chr6	31827953	31829108	P0DMV8	0	+	31827953	31829108	255,102,0	1	1155	0	.	Nucleotide-binding domain (NBD).
chr6	31827953	31829108	P0DMV9	0	+	31827953	31829108	255,102,0	1	1155	0	.	Nucleotide-binding domain (NBD).
chr6	31829129	31829477	P0DMV8	0	+	31829129	31829477	255,102,0	1	348	0	.	Substrate-binding domain (SBD).
chr6	31829129	31829477	P0DMV9	0	+	31829129	31829477	255,102,0	1	348	0	.	Substrate-binding domain (SBD).
chr6	31862426	31862438	Q96KQ7	0	-	31862426	31862438	255,102,0	1	12	0	.	Interaction with histone H3.
chr6	31862966	31862972	Q96KQ7	0	-	31862966	31862972	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr6	31863026	31863251	Q96KQ7	0	-	31863026	31863251	255,102,0	1	225	0	.	Interaction with histone H3.
chr6	31864926	31864935	Q96KQ7	0	-	31864926	31864935	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr6	31866971	31866980	Q96KQ7	0	-	31866971	31866980	255,102,0	1	9	0	.	Histone H3K9me binding.
chr6	31867789	31867801	Q96KQ7	0	-	31867789	31867801	255,102,0	1	12	0	.	Interaction with histone H3.
chr6	31868329	31868335	Q96KQ7	0	-	31868329	31868335	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr6	31868389	31868614	Q96KQ7	0	-	31868389	31868614	255,102,0	1	225	0	.	Interaction with histone H3.
chr6	31870289	31870298	Q96KQ7	0	-	31870289	31870298	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr6	31870625	31870637	Q96KQ7	0	-	31870625	31870637	255,102,0	1	12	0	.	Interaction with histone H3.
chr6	31871165	31871171	Q96KQ7	0	-	31871165	31871171	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr6	31871225	31871450	Q96KQ7	0	-	31871225	31871450	255,102,0	1	225	0	.	Interaction with histone H3.
chr6	31872334	31872343	Q96KQ7	0	-	31872334	31872343	255,102,0	1	9	0	.	Histone H3K9me binding.
chr6	31873124	31873133	Q96KQ7	0	-	31873124	31873133	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr6	31875169	31875178	Q96KQ7	0	-	31875169	31875178	255,102,0	1	9	0	.	Histone H3K9me binding.
chr6	31880245	31880257	Q96KQ7	0	-	31880245	31880257	255,102,0	1	12	0	.	Interaction with histone H3.
chr6	31880785	31880791	Q96KQ7	0	-	31880785	31880791	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr6	31880845	31881070	Q96KQ7	0	-	31880845	31881070	255,102,0	1	225	0	.	Interaction with histone H3.
chr6	31882745	31882754	Q96KQ7	0	-	31882745	31882754	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr6	31882788	31883943	P0DMV8	0	+	31882788	31883943	255,102,0	1	1155	0	.	Nucleotide-binding domain (NBD).
chr6	31882788	31883943	P0DMV9	0	+	31882788	31883943	255,102,0	1	1155	0	.	Nucleotide-binding domain (NBD).
chr6	31883964	31884312	P0DMV8	0	+	31883964	31884312	255,102,0	1	348	0	.	Substrate-binding domain (SBD).
chr6	31883964	31884312	P0DMV9	0	+	31883964	31884312	255,102,0	1	348	0	.	Substrate-binding domain (SBD).
chr6	31884790	31884799	Q96KQ7	0	-	31884790	31884799	255,102,0	1	9	0	.	Histone H3K9me binding.
chr6	31894985	31896140	P0DMV8	0	+	31894985	31896140	255,102,0	1	1155	0	.	Nucleotide-binding domain (NBD).
chr6	31894985	31896140	P0DMV9	0	+	31894985	31896140	255,102,0	1	1155	0	.	Nucleotide-binding domain (NBD).
chr6	31896161	31896509	P0DMV8	0	+	31896161	31896509	255,102,0	1	348	0	.	Substrate-binding domain (SBD).
chr6	31896161	31896509	P0DMV9	0	+	31896161	31896509	255,102,0	1	348	0	.	Substrate-binding domain (SBD).
chr6	31936754	31936934	P18615	0	-	31936754	31936934	255,102,0	1	180	0	.	30 X 2 AA approximate tandem repeats of R-[DSNE].
chr6	31942113	31942293	P18615	0	-	31942113	31942293	255,102,0	1	180	0	.	30 X 2 AA approximate tandem repeats of R-[DSNE].
chr6	31944949	31945129	P18615	0	-	31944949	31945129	255,102,0	1	180	0	.	30 X 2 AA approximate tandem repeats of R-[DSNE].
chr6	31947221	31947401	P18615	0	-	31947221	31947401	255,102,0	1	180	0	.	30 X 2 AA approximate tandem repeats of R-[DSNE].
chr6	31954567	31954747	P18615	0	-	31954567	31954747	255,102,0	1	180	0	.	30 X 2 AA approximate tandem repeats of R-[DSNE].
chr6	32031010	32031190	P18615	0	-	32031010	32031190	255,102,0	1	180	0	.	30 X 2 AA approximate tandem repeats of R-[DSNE].
chr6	32033144	32033195	P08686	0	+	32033144	32033195	255,102,0	1	51	0	.	Steroid-binding.
chr6	32067488	32067512	Q99941	0	-	32067488	32067512	255,102,0	1	24	0	.	Leucine-zipper.
chr6	32067518	32067581	Q99941	0	-	32067518	32067581	255,102,0	1	63	0	.	Basic motif.
chr6	32075636	32076654	Q99941	0	-	32075636	32076654	255,102,0	1	1018	0	.	Transcription activation.
chr6	32094809	32094833	Q99941	0	-	32094809	32094833	255,102,0	1	24	0	.	Leucine-zipper.
chr6	32094839	32094902	Q99941	0	-	32094839	32094902	255,102,0	1	63	0	.	Basic motif.
chr6	32102957	32103975	Q99941	0	-	32102957	32103975	255,102,0	1	1018	0	.	Transcription activation.
chr6	32116932	32116983	P08686	0	+	32116932	32116983	255,102,0	1	51	0	.	Steroid-binding.
chr6	32119036	32119060	Q99941	0	-	32119036	32119060	255,102,0	1	24	0	.	Leucine-zipper.
chr6	32119066	32119129	Q99941	0	-	32119066	32119129	255,102,0	1	63	0	.	Basic motif.
chr6	32127186	32128204	Q99941	0	-	32127186	32128204	255,102,0	1	1018	0	.	Transcription activation.
chr6	32195463	32195487	Q99941	0	-	32195463	32195487	255,102,0	1	24	0	.	Leucine-zipper.
chr6	32195493	32195556	Q99941	0	-	32195493	32195556	255,102,0	1	63	0	.	Basic motif.
chr6	32203613	32204631	Q99941	0	-	32203613	32204631	255,102,0	1	1018	0	.	Transcription activation.
chr6	32397481	32400146	P01903	0	+	32397481	32400146	255,102,0	1	2665	0	.	Alpha-1.
chr6	32400637	32400919	P01903	0	+	32400637	32400919	255,102,0	1	282	0	.	Alpha-2.
chr6	32401208	32401247	P01903	0	+	32401208	32401247	255,102,0	1	39	0	.	Connecting peptide.
chr6	32414737	32417402	P01903	0	+	32414737	32417402	255,102,0	1	2665	0	.	Alpha-1.
chr6	32417893	32418175	P01903	0	+	32417893	32418175	255,102,0	1	282	0	.	Alpha-2.
chr6	32418464	32418503	P01903	0	+	32418464	32418503	255,102,0	1	39	0	.	Connecting peptide.
chr6	32445848	32446841	P79483	0	-	32445848	32446841	255,102,0	1	993	0	.	Beta-2.
chr6	32446633	32449298	P01903	0	+	32446633	32449298	255,102,0	1	2665	0	.	Alpha-1.
chr6	32446841	32457081	P79483	0	-	32446841	32457081	255,102,0	1	10240	0	.	Beta-1.
chr6	32449789	32450071	P01903	0	+	32449789	32450071	255,102,0	1	282	0	.	Alpha-2.
chr6	32450360	32450399	P01903	0	+	32450360	32450399	255,102,0	1	39	0	.	Connecting peptide.
chr6	32478649	32481315	P01903	0	+	32478649	32481315	255,102,0	1	2666	0	.	Alpha-1.
chr6	32481806	32482088	P01903	0	+	32481806	32482088	255,102,0	1	282	0	.	Alpha-2.
chr6	32482377	32482416	P01903	0	+	32482377	32482416	255,102,0	1	39	0	.	Connecting peptide.
chr6	32509869	32509899	P01912	0	-	32509869	32509899	255,102,0	1	30	0	.	Connecting peptide.
chr6	32510597	32510879	P01912	0	-	32510597	32510879	255,102,0	1	282	0	.	Beta-2.
chr6	32513109	32521385	P01912	0	-	32513109	32521385	255,102,0	1	8276	0	.	Beta-1.
chr6	32515116	32515146	P01912	0	-	32515116	32515146	255,102,0	1	30	0	.	Connecting peptide.
chr6	32515398	32518063	P01903	0	+	32515398	32518063	255,102,0	1	2665	0	.	Alpha-1.
chr6	32515844	32516126	P01912	0	-	32515844	32516126	255,102,0	1	282	0	.	Beta-2.
chr6	32518366	32526642	P01912	0	-	32518366	32526642	255,102,0	1	8276	0	.	Beta-1.
chr6	32518554	32518836	P01903	0	+	32518554	32518836	255,102,0	1	282	0	.	Alpha-2.
chr6	32518637	32519649	Q30154	0	-	32518637	32519649	255,102,0	1	1012	0	.	Beta-2.
chr6	32519125	32519164	P01903	0	+	32519125	32519164	255,102,0	1	39	0	.	Connecting peptide.
chr6	32519649	32530137	Q30154	0	-	32519649	32530137	255,102,0	1	10488	0	.	Beta-1.
chr6	32543813	32544826	P13762	0	-	32543813	32544826	255,102,0	1	1013	0	.	Beta-2.
chr6	32544826	32557411	P13762	0	-	32544826	32557411	255,102,0	1	12585	0	.	Beta-1.
chr6	32550585	32551590	P13761	0	-	32550585	32551590	255,102,0	1	1005	0	.	Beta-2.
chr6	32551590	32564372	P13761	0	-	32551590	32564372	255,102,0	1	12782	0	.	Beta-1.
chr6	32565705	32570224	P01909	0	+	32565705	32570224	255,102,0	1	4519	0	.	Alpha-1.
chr6	32570224	32570476	P01909	0	+	32570224	32570476	255,102,0	1	252	0	.	Alpha-2.
chr6	32570839	32570878	P01909	0	+	32570839	32570878	255,102,0	1	39	0	.	Connecting peptide.
chr6	32570962	32575481	P01909	0	+	32570962	32575481	255,102,0	1	4519	0	.	Alpha-1.
chr6	32575481	32575733	P01909	0	+	32575481	32575733	255,102,0	1	252	0	.	Alpha-2.
chr6	32576096	32576135	P01909	0	+	32576096	32576135	255,102,0	1	39	0	.	Connecting peptide.
chr6	32580827	32581836	P01911	0	-	32580827	32581836	255,102,0	1	1009	0	.	Beta-2.
chr6	32581836	32589655	P01911	0	-	32581836	32589655	255,102,0	1	7819	0	.	Beta-1.
chr6	32612358	32613371	P13762	0	-	32612358	32613371	255,102,0	1	1013	0	.	Beta-2.
chr6	32613371	32625956	P13762	0	-	32613371	32625956	255,102,0	1	12585	0	.	Beta-1.
chr6	32665203	32669098	P01906	0	+	32665203	32669098	255,102,0	1	3895	0	.	Alpha-1.
chr6	32669481	32669763	P01906	0	+	32669481	32669763	255,102,0	1	282	0	.	Alpha-2.
chr6	32669930	32669969	P01906	0	+	32669930	32669969	255,102,0	1	39	0	.	Connecting peptide.
chr6	32692225	32692255	P01920	0	-	32692225	32692255	255,102,0	1	30	0	.	Connecting peptide.
chr6	32692772	32693054	P01920	0	-	32692772	32693054	255,102,0	1	282	0	.	Beta-2.
chr6	32695683	32697413	P01920	0	-	32695683	32697413	255,102,0	1	1730	0	.	Beta-1.
chr6	32720674	32724571	P01906	0	+	32720674	32724571	255,102,0	1	3897	0	.	Alpha-1.
chr6	32724954	32725236	P01906	0	+	32724954	32725236	255,102,0	1	282	0	.	Alpha-2.
chr6	32724985	32725990	P13761	0	-	32724985	32725990	255,102,0	1	1005	0	.	Beta-2.
chr6	32725403	32725442	P01906	0	+	32725403	32725442	255,102,0	1	39	0	.	Connecting peptide.
chr6	32725990	32738770	P13761	0	-	32725990	32738770	255,102,0	1	12780	0	.	Beta-1.
chr6	32736124	32736154	P13765	0	-	32736124	32736154	255,102,0	1	30	0	.	Connecting peptide.
chr6	32736640	32736922	P13765	0	-	32736640	32736922	255,102,0	1	282	0	.	Beta-2.
chr6	32737364	32739193	P13765	0	-	32737364	32739193	255,102,0	1	1829	0	.	Beta-1.
chr6	32741512	32745406	P01906	0	+	32741512	32745406	255,102,0	1	3894	0	.	Alpha-1.
chr6	32745789	32746071	P01906	0	+	32745789	32746071	255,102,0	1	282	0	.	Alpha-2.
chr6	32746238	32746277	P01906	0	+	32746238	32746277	255,102,0	1	39	0	.	Connecting peptide.
chr6	32753098	32754684	Q03519	0	-	32753098	32754684	255,102,0	1	1586	0	.	Involved in peptide-binding site.
chr6	32754756	32757517	Q03519	0	-	32754756	32757517	255,102,0	1	2761	0	.	Involved in peptide-binding site.
chr6	32759473	32761059	Q03519	0	-	32759473	32761059	255,102,0	1	1586	0	.	Involved in peptide-binding site.
chr6	32761131	32763892	Q03519	0	-	32761131	32763892	255,102,0	1	2761	0	.	Involved in peptide-binding site.
chr6	32771074	32771328	Q03518	0	-	32771074	32771328	255,102,0	1	254	0	.	Involved in peptide-binding site.
chr6	32771424	32772763	Q03518	0	-	32771424	32772763	255,102,0	1	1339	0	.	Involved in peptide-binding site.
chr6	32777451	32777705	Q03518	0	-	32777451	32777705	255,102,0	1	254	0	.	Involved in peptide-binding site.
chr6	32777801	32779140	Q03518	0	-	32777801	32779140	255,102,0	1	1339	0	.	Involved in peptide-binding site.
chr6	32782057	32785952	P01906	0	+	32782057	32785952	255,102,0	1	3895	0	.	Alpha-1.
chr6	32786335	32786617	P01906	0	+	32786335	32786617	255,102,0	1	282	0	.	Alpha-2.
chr6	32786784	32786823	P01906	0	+	32786784	32786823	255,102,0	1	39	0	.	Connecting peptide.
chr6	32813804	32813834	P13765	0	-	32813804	32813834	255,102,0	1	30	0	.	Connecting peptide.
chr6	32814320	32814602	P13765	0	-	32814320	32814602	255,102,0	1	282	0	.	Beta-2.
chr6	32815044	32816873	P13765	0	-	32815044	32816873	255,102,0	1	1829	0	.	Beta-1.
chr6	32826733	32826987	Q03518	0	-	32826733	32826987	255,102,0	1	254	0	.	Involved in peptide-binding site.
chr6	32827083	32828420	Q03518	0	-	32827083	32828420	255,102,0	1	1337	0	.	Involved in peptide-binding site.
chr6	32830779	32832365	Q03519	0	-	32830779	32832365	255,102,0	1	1586	0	.	Involved in peptide-binding site.
chr6	32832437	32835198	Q03519	0	-	32832437	32835198	255,102,0	1	2761	0	.	Involved in peptide-binding site.
chr6	32847304	32847334	P13765	0	-	32847304	32847334	255,102,0	1	30	0	.	Connecting peptide.
chr6	32847820	32848102	P13765	0	-	32847820	32848102	255,102,0	1	282	0	.	Beta-2.
chr6	32848544	32850373	P13765	0	-	32848544	32850373	255,102,0	1	1829	0	.	Beta-1.
chr6	32848756	32849010	Q03518	0	-	32848756	32849010	255,102,0	1	254	0	.	Involved in peptide-binding site.
chr6	32849106	32850445	Q03518	0	-	32849106	32850445	255,102,0	1	1339	0	.	Involved in peptide-binding site.
chr6	32853235	32853265	P13765	0	-	32853235	32853265	255,102,0	1	30	0	.	Connecting peptide.
chr6	32853751	32854033	P13765	0	-	32853751	32854033	255,102,0	1	282	0	.	Beta-2.
chr6	32854475	32856304	P13765	0	-	32854475	32856304	255,102,0	1	1829	0	.	Beta-1.
chr6	32864335	32864368	P28068	0	-	32864335	32864368	255,102,0	1	33	0	.	Connecting peptide.
chr6	32865887	32866172	P28068	0	-	32865887	32866172	255,102,0	1	285	0	.	Beta-2.
chr6	32867399	32867681	P28068	0	-	32867399	32867681	255,102,0	1	282	0	.	Beta-1.
chr6	32882232	32882486	Q03518	0	-	32882232	32882486	255,102,0	1	254	0	.	Involved in peptide-binding site.
chr6	32882582	32883919	Q03518	0	-	32882582	32883919	255,102,0	1	1337	0	.	Involved in peptide-binding site.
chr6	32888028	32888282	Q03518	0	-	32888028	32888282	255,102,0	1	254	0	.	Involved in peptide-binding site.
chr6	32888378	32889715	Q03518	0	-	32888378	32889715	255,102,0	1	1337	0	.	Involved in peptide-binding site.
chr6	32904681	32904711	P13765	0	-	32904681	32904711	255,102,0	1	30	0	.	Connecting peptide.
chr6	32905197	32905479	P13765	0	-	32905197	32905479	255,102,0	1	282	0	.	Beta-2.
chr6	32905921	32907750	P13765	0	-	32905921	32907750	255,102,0	1	1829	0	.	Beta-1.
chr6	32913556	32913589	P28068	0	-	32913556	32913589	255,102,0	1	33	0	.	Connecting peptide.
chr6	32915108	32915393	P28068	0	-	32915108	32915393	255,102,0	1	285	0	.	Beta-2.
chr6	32916620	32916902	P28068	0	-	32916620	32916902	255,102,0	1	282	0	.	Beta-1.
chr6	32929464	32929503	P06340	0	-	32929464	32929503	255,102,0	1	39	0	.	Connecting peptide.
chr6	32929598	32929880	P06340	0	-	32929598	32929880	255,102,0	1	282	0	.	Alpha-2.
chr6	32930300	32931748	P06340	0	-	32930300	32931748	255,102,0	1	1448	0	.	Alpha-1.
chr6	32935858	32935897	P06340	0	-	32935858	32935897	255,102,0	1	39	0	.	Connecting peptide.
chr6	32935992	32936274	P06340	0	-	32935992	32936274	255,102,0	1	282	0	.	Alpha-2.
chr6	32936694	32938142	P06340	0	-	32936694	32938142	255,102,0	1	1448	0	.	Alpha-1.
chr6	32974872	32974905	P28068	0	-	32974872	32974905	255,102,0	1	33	0	.	Connecting peptide.
chr6	32976424	32976709	P28068	0	-	32976424	32976709	255,102,0	1	285	0	.	Beta-2.
chr6	32977936	32978218	P28068	0	-	32977936	32978218	255,102,0	1	282	0	.	Beta-1.
chr6	32984538	32986124	Q03519	0	-	32984538	32986124	255,102,0	1	1586	0	.	Involved in peptide-binding site.
chr6	32985124	32985163	P06340	0	-	32985124	32985163	255,102,0	1	39	0	.	Connecting peptide.
chr6	32985258	32985540	P06340	0	-	32985258	32985540	255,102,0	1	282	0	.	Alpha-2.
chr6	32985960	32987408	P06340	0	-	32985960	32987408	255,102,0	1	1448	0	.	Alpha-1.
chr6	32986196	32988957	Q03519	0	-	32986196	32988957	255,102,0	1	2761	0	.	Involved in peptide-binding site.
chr6	32990736	32990775	P20036	0	-	32990736	32990775	255,102,0	1	39	0	.	Connecting peptide.
chr6	32990989	32991271	P20036	0	-	32990989	32991271	255,102,0	1	282	0	.	Alpha-2.
chr6	32991611	32995456	P20036	0	-	32991611	32995456	255,102,0	1	3845	0	.	Alpha-1.
chr6	32997805	32997844	P20036	0	-	32997805	32997844	255,102,0	1	39	0	.	Connecting peptide.
chr6	32998058	32998340	P20036	0	-	32998058	32998340	255,102,0	1	282	0	.	Alpha-2.
chr6	32998680	33002525	P20036	0	-	32998680	33002525	255,102,0	1	3845	0	.	Alpha-1.
chr6	33002516	33002770	Q03518	0	-	33002516	33002770	255,102,0	1	254	0	.	Involved in peptide-binding site.
chr6	33002866	33004205	Q03518	0	-	33002866	33004205	255,102,0	1	1339	0	.	Involved in peptide-binding site.
chr6	33007177	33007216	P06340	0	-	33007177	33007216	255,102,0	1	39	0	.	Connecting peptide.
chr6	33007311	33007593	P06340	0	-	33007311	33007593	255,102,0	1	282	0	.	Alpha-2.
chr6	33008013	33009461	P06340	0	-	33008013	33009461	255,102,0	1	1448	0	.	Alpha-1.
chr6	33040639	33040678	P06340	0	-	33040639	33040678	255,102,0	1	39	0	.	Connecting peptide.
chr6	33040773	33041055	P06340	0	-	33040773	33041055	255,102,0	1	282	0	.	Alpha-2.
chr6	33041475	33042923	P06340	0	-	33041475	33042923	255,102,0	1	1448	0	.	Alpha-1.
chr6	33046704	33046743	P20036	0	-	33046704	33046743	255,102,0	1	39	0	.	Connecting peptide.
chr6	33046957	33047239	P20036	0	-	33046957	33047239	255,102,0	1	282	0	.	Alpha-2.
chr6	33047579	33051424	P20036	0	-	33047579	33051424	255,102,0	1	3845	0	.	Alpha-1.
chr6	33054066	33058872	P04440	0	+	33054066	33058872	255,102,0	1	4806	0	.	Beta-1.
chr6	33062878	33063160	P04440	0	+	33062878	33063160	255,102,0	1	282	0	.	Beta-2.
chr6	33063707	33063737	P04440	0	+	33063707	33063737	255,102,0	1	30	0	.	Connecting peptide.
chr6	33068766	33068805	P20036	0	-	33068766	33068805	255,102,0	1	39	0	.	Connecting peptide.
chr6	33069019	33069301	P20036	0	-	33069019	33069301	255,102,0	1	282	0	.	Alpha-2.
chr6	33069641	33073486	P20036	0	-	33069641	33073486	255,102,0	1	3845	0	.	Alpha-1.
chr6	33076128	33080934	P04440	0	+	33076128	33080934	255,102,0	1	4806	0	.	Beta-1.
chr6	33084948	33085230	P04440	0	+	33084948	33085230	255,102,0	1	282	0	.	Beta-2.
chr6	33085777	33085807	P04440	0	+	33085777	33085807	255,102,0	1	30	0	.	Connecting peptide.
chr6	33087425	33101101	P13942	0	-	33087425	33101101	255,102,0	1	13676	0	.	Triple-helical region.
chr6	33089395	33089428	P28068	0	-	33089395	33089428	255,102,0	1	33	0	.	Connecting peptide.
chr6	33090947	33091232	P28068	0	-	33090947	33091232	255,102,0	1	285	0	.	Beta-2.
chr6	33092459	33092741	P28068	0	-	33092459	33092741	255,102,0	1	282	0	.	Beta-1.
chr6	33101101	33108408	P13942	0	-	33101101	33108408	255,102,0	1	7307	0	.	Nonhelical region.
chr6	33102238	33102277	P20036	0	-	33102238	33102277	255,102,0	1	39	0	.	Connecting peptide.
chr6	33102491	33102773	P20036	0	-	33102491	33102773	255,102,0	1	282	0	.	Alpha-2.
chr6	33103113	33106940	P20036	0	-	33103113	33106940	255,102,0	1	3827	0	.	Alpha-1.
chr6	33107853	33107892	P20036	0	-	33107853	33107892	255,102,0	1	39	0	.	Connecting peptide.
chr6	33108106	33108388	P20036	0	-	33108106	33108388	255,102,0	1	282	0	.	Alpha-2.
chr6	33108728	33112555	P20036	0	-	33108728	33112555	255,102,0	1	3827	0	.	Alpha-1.
chr6	33116310	33118062	P28702	0	-	33116310	33118062	255,102,0	1	1752	0	.	Ligand-binding. Pubmed:11782480
chr6	33118062	33119397	P28702	0	-	33118062	33119397	255,102,0	1	1335	0	.	Hinge.
chr6	33119961	33122100	P28702	0	-	33119961	33122100	255,102,0	1	2139	0	.	Modulating.
chr6	33123495	33125247	P28702	0	-	33123495	33125247	255,102,0	1	1752	0	.	Ligand-binding. Pubmed:11782480
chr6	33125247	33126582	P28702	0	-	33125247	33126582	255,102,0	1	1335	0	.	Hinge.
chr6	33127146	33129287	P28702	0	-	33127146	33129287	255,102,0	1	2141	0	.	Modulating.
chr6	33131254	33133024	Q06587	0	+	33131254	33133024	255,102,0	1	1770	0	.	Necessary for transcriptional repression.
chr6	33133009	33134016	Q06587	0	+	33133009	33134016	255,102,0	1	1007	0	.	Necessary for interaction with CBX2.
chr6	33138449	33140219	Q06587	0	+	33138449	33140219	255,102,0	1	1770	0	.	Necessary for transcriptional repression.
chr6	33140204	33141211	Q06587	0	+	33140204	33141211	255,102,0	1	1007	0	.	Necessary for interaction with CBX2.
chr6	33147836	33147875	P06340	0	-	33147836	33147875	255,102,0	1	39	0	.	Connecting peptide.
chr6	33147970	33148252	P06340	0	-	33147970	33148252	255,102,0	1	282	0	.	Alpha-2.
chr6	33148672	33150120	P06340	0	-	33148672	33150120	255,102,0	1	1448	0	.	Alpha-1.
chr6	33160932	33160971	P06340	0	-	33160932	33160971	255,102,0	1	39	0	.	Connecting peptide.
chr6	33161066	33161348	P06340	0	-	33161066	33161348	255,102,0	1	282	0	.	Alpha-2.
chr6	33161768	33163216	P06340	0	-	33161768	33163216	255,102,0	1	1448	0	.	Alpha-1.
chr6	33172590	33174342	P28702	0	-	33172590	33174342	255,102,0	1	1752	0	.	Ligand-binding. Pubmed:11782480
chr6	33174342	33175677	P28702	0	-	33174342	33175677	255,102,0	1	1335	0	.	Hinge.
chr6	33176241	33178382	P28702	0	-	33176241	33178382	255,102,0	1	2141	0	.	Modulating.
chr6	33187540	33189310	Q06587	0	+	33187540	33189310	255,102,0	1	1770	0	.	Necessary for transcriptional repression.
chr6	33189295	33190302	Q06587	0	+	33189295	33190302	255,102,0	1	1007	0	.	Necessary for interaction with CBX2.
chr6	33194684	33196436	P28702	0	-	33194684	33196436	255,102,0	1	1752	0	.	Ligand-binding. Pubmed:11782480
chr6	33196436	33197771	P28702	0	-	33196436	33197771	255,102,0	1	1335	0	.	Hinge.
chr6	33198335	33200476	P28702	0	-	33198335	33200476	255,102,0	1	2141	0	.	Modulating.
chr6	33209214	33209253	P20036	0	-	33209214	33209253	255,102,0	1	39	0	.	Connecting peptide.
chr6	33209467	33209749	P20036	0	-	33209467	33209749	255,102,0	1	282	0	.	Alpha-2.
chr6	33209634	33211404	Q06587	0	+	33209634	33211404	255,102,0	1	1770	0	.	Necessary for transcriptional repression.
chr6	33210089	33213934	P20036	0	-	33210089	33213934	255,102,0	1	3845	0	.	Alpha-1.
chr6	33211389	33212396	Q06587	0	+	33211389	33212396	255,102,0	1	1007	0	.	Necessary for interaction with CBX2.
chr6	33216576	33221382	P04440	0	+	33216576	33221382	255,102,0	1	4806	0	.	Beta-1.
chr6	33222870	33222909	P20036	0	-	33222870	33222909	255,102,0	1	39	0	.	Connecting peptide.
chr6	33223123	33223405	P20036	0	-	33223123	33223405	255,102,0	1	282	0	.	Alpha-2.
chr6	33223745	33227590	P20036	0	-	33223745	33227590	255,102,0	1	3845	0	.	Alpha-1.
chr6	33225396	33225678	P04440	0	+	33225396	33225678	255,102,0	1	282	0	.	Beta-2.
chr6	33226225	33226255	P04440	0	+	33226225	33226255	255,102,0	1	30	0	.	Connecting peptide.
chr6	33240351	33240375	Q9UER7	0	-	33240351	33240375	255,102,0	1	24	0	.	Sumo interaction motif (SIM).
chr6	33240351	33241050	Q9UER7	0	-	33240351	33241050	255,102,0	1	699	0	.	Interaction with SPOP. Pubmed:15240113
chr6	33241050	33241425	Q9UER7	0	-	33241050	33241425	255,102,0	1	375	0	.	Interaction with MAP3K5.
chr6	33241215	33242198	Q9UER7	0	-	33241215	33242198	255,102,0	1	983	0	.	Necessary for interaction with USP7.
chr6	33241985	33242834	Q9UER7	0	-	33241985	33242834	255,102,0	1	849	0	.	Interaction with histone H3.3.
chr6	33242900	33243531	Q9UER7	0	-	33242900	33243531	255,102,0	1	631	0	.	Necessary for interaction with USP7 and ATRX.
chr6	33247582	33247606	Q9UER7	0	-	33247582	33247606	255,102,0	1	24	0	.	Sumo interaction motif (SIM).
chr6	33247582	33248281	Q9UER7	0	-	33247582	33248281	255,102,0	1	699	0	.	Interaction with SPOP. Pubmed:15240113
chr6	33248281	33248656	Q9UER7	0	-	33248281	33248656	255,102,0	1	375	0	.	Interaction with MAP3K5.
chr6	33248446	33249429	Q9UER7	0	-	33248446	33249429	255,102,0	1	983	0	.	Necessary for interaction with USP7.
chr6	33249216	33250065	Q9UER7	0	-	33249216	33250065	255,102,0	1	849	0	.	Interaction with histone H3.3.
chr6	33250131	33250762	Q9UER7	0	-	33250131	33250762	255,102,0	1	631	0	.	Necessary for interaction with USP7 and ATRX.
chr6	33296669	33296693	Q9UER7	0	-	33296669	33296693	255,102,0	1	24	0	.	Sumo interaction motif (SIM).
chr6	33296669	33297368	Q9UER7	0	-	33296669	33297368	255,102,0	1	699	0	.	Interaction with SPOP. Pubmed:15240113
chr6	33297368	33297743	Q9UER7	0	-	33297368	33297743	255,102,0	1	375	0	.	Interaction with MAP3K5.
chr6	33297533	33298516	Q9UER7	0	-	33297533	33298516	255,102,0	1	983	0	.	Necessary for interaction with USP7.
chr6	33298303	33299152	Q9UER7	0	-	33298303	33299152	255,102,0	1	849	0	.	Interaction with histone H3.3.
chr6	33299218	33299849	Q9UER7	0	-	33299218	33299849	255,102,0	1	631	0	.	Necessary for interaction with USP7 and ATRX.
chr6	33318745	33318769	Q9UER7	0	-	33318745	33318769	255,102,0	1	24	0	.	Sumo interaction motif (SIM).
chr6	33318745	33319444	Q9UER7	0	-	33318745	33319444	255,102,0	1	699	0	.	Interaction with SPOP. Pubmed:15240113
chr6	33319444	33319819	Q9UER7	0	-	33319444	33319819	255,102,0	1	375	0	.	Interaction with MAP3K5.
chr6	33319609	33320592	Q9UER7	0	-	33319609	33320592	255,102,0	1	983	0	.	Necessary for interaction with USP7.
chr6	33320379	33321228	Q9UER7	0	-	33320379	33321228	255,102,0	1	849	0	.	Interaction with histone H3.3.
chr6	33321294	33321925	Q9UER7	0	-	33321294	33321925	255,102,0	1	631	0	.	Necessary for interaction with USP7 and ATRX.
chr6	33348564	33350316	P28702	0	-	33348564	33350316	255,102,0	1	1752	0	.	Ligand-binding. Pubmed:11782480
chr6	33350316	33351651	P28702	0	-	33350316	33351651	255,102,0	1	1335	0	.	Hinge.
chr6	33352215	33354356	P28702	0	-	33352215	33354356	255,102,0	1	2141	0	.	Modulating.
chr6	33363518	33365288	Q06587	0	+	33363518	33365288	255,102,0	1	1770	0	.	Necessary for transcriptional repression.
chr6	33365047	33366797	P28702	0	-	33365047	33366797	255,102,0	1	1750	0	.	Ligand-binding. Pubmed:11782480
chr6	33365273	33366280	Q06587	0	+	33365273	33366280	255,102,0	1	1007	0	.	Necessary for interaction with CBX2.
chr6	33366797	33368132	P28702	0	-	33366797	33368132	255,102,0	1	1335	0	.	Hinge.
chr6	33368696	33370836	P28702	0	-	33368696	33370836	255,102,0	1	2140	0	.	Modulating.
chr6	33379994	33381764	Q06587	0	+	33379994	33381764	255,102,0	1	1770	0	.	Necessary for transcriptional repression.
chr6	33381749	33382756	Q06587	0	+	33381749	33382756	255,102,0	1	1007	0	.	Necessary for interaction with CBX2.
chr6	33416661	33416688	O60888	0	-	33416661	33416688	255,102,0	1	27	0	.	O-glycosylated at one site.
chr6	33489086	33489110	Q9UER7	0	-	33489086	33489110	255,102,0	1	24	0	.	Sumo interaction motif (SIM).
chr6	33489086	33489785	Q9UER7	0	-	33489086	33489785	255,102,0	1	699	0	.	Interaction with SPOP. Pubmed:15240113
chr6	33489785	33490160	Q9UER7	0	-	33489785	33490160	255,102,0	1	375	0	.	Interaction with MAP3K5.
chr6	33489950	33490933	Q9UER7	0	-	33489950	33490933	255,102,0	1	983	0	.	Necessary for interaction with USP7.
chr6	33490720	33491569	Q9UER7	0	-	33490720	33491569	255,102,0	1	849	0	.	Interaction with histone H3.3.
chr6	33491635	33492266	Q9UER7	0	-	33491635	33492266	255,102,0	1	631	0	.	Necessary for interaction with USP7 and ATRX.
chr6	33556851	33556878	O60888	0	-	33556851	33556878	255,102,0	1	27	0	.	O-glycosylated at one site.
chr6	33662611	33662626	Q14573	0	+	33662611	33662626	255,102,0	1	15	0	.	Inositol 1,4,5-trisphosphate binding.
chr6	33665943	33665955	Q14573	0	+	33665943	33665955	255,102,0	1	12	0	.	Inositol 1,4,5-trisphosphate binding.
chr6	33667275	33667284	Q14573	0	+	33667275	33667284	255,102,0	1	9	0	.	Inositol 1,4,5-trisphosphate binding.
chr6	33725548	33725575	Q96PC2	0	-	33725548	33725575	255,102,0	1	27	0	.	Substrate binding.
chr6	33788807	33788897	Q8NC56	0	-	33788807	33788897	255,102,0	1	90	0	.	Interaction with lamin A/C complexes.
chr6	34092072	34092081	Q14833	0	-	34092072	34092081	255,102,0	1	9	0	.	Glutamate binding.
chr6	34242732	34243479	P17096	0	+	34242732	34243479	255,102,0	1	747	0	.	Interaction with HIPK2.
chr6	34293517	34293526	O95989	0	-	34293517	34293526	255,102,0	1	9	0	.	Substrate binding.
chr6	34392302	34392311	O95989	0	-	34392302	34392311	255,102,0	1	9	0	.	Substrate binding.
chr6	35286153	35287710	P36508	0	+	35286153	35287710	255,102,0	1	1557	0	.	3 X 12 AA approximate repeats.
chr6	35424460	35426076	Q03181	0	+	35424460	35426076	255,102,0	1	1616	0	.	Ligand-binding.
chr6	35455945	35458440	Q9HB96	0	+	35455945	35458440	255,102,0	1	2495	0	.	Interaction with FANCC. Pubmed:12649160
chr6	35943902	35955394	Q96RN1	0	-	35943902	35955394	255,102,0	1	11492	0	.	Interaction with RACGAP1. Pubmed:11278976
chr6	36052789	36052795	Q16539	0	+	36052789	36052795	255,102,0	1	6	0	.	Inhibitor-binding.
chr6	36072882	36072897	Q16539	0	+	36072882	36072897	255,102,0	1	15	0	.	Inhibitor-binding.
chr6	36075853	36075859	Q16539	0	+	36075853	36075859	255,102,0	1	6	0	.	Inhibitor-binding.
chr6	36524385	36524463	Q15208	0	-	36524385	36524463	255,102,0	1	78	0	.	Interaction with S100B. Pubmed:14661952
chr6	36596762	36598912	P84103	0	+	36596762	36598912	255,102,0	1	2150	0	.	Sufficient for interaction with NXF1.
chr6	36601164	36601986	P84103	0	+	36601164	36601986	255,102,0	1	822	0	.	2 X approximate repeats, basic.
chr6	36684149	36684173	P38936	0	+	36684149	36684173	255,102,0	1	24	0	.	Required for binding cyclins.
chr6	36684257	36684275	P38936	0	+	36684257	36684275	255,102,0	1	18	0	.	Required for binding CDKs.
chr6	36855974	36855989	Q9Y3C6	0	-	36855974	36855989	255,102,0	1	15	0	.	Cyclosporin A binding.
chr6	36856001	36856019	Q9Y3C6	0	-	36856001	36856019	255,102,0	1	18	0	.	Cyclosporin A binding.
chr6	36856652	36871721	Q9Y3C6	0	-	36856652	36871721	255,102,0	1	15069	0	.	Cyclosporin A binding.
chr6	36871733	36871769	Q9Y3C6	0	-	36871733	36871769	255,102,0	1	36	0	.	Cyclosporin A binding.
chr6	36963497	36963527	Q6UXB8	0	+	36963497	36963527	255,102,0	1	30	0	.	O-glycosylated at one site.
chr6	37451874	37453058	Q8N1G2	0	+	37451874	37453058	255,102,0	1	1184	0	.	Substrate binding. Pubmed:24402442
chr6	37458662	37458683	Q8N1G2	0	+	37458662	37458683	255,102,0	1	21	0	.	S-adenosyl-L-methionine binding. Pubmed:24402442
chr6	37459591	37459597	Q8N1G2	0	+	37459591	37459597	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding. Pubmed:24402442
chr6	37461572	37461581	Q8N1G2	0	+	37461572	37461581	255,102,0	1	9	0	.	Substrate binding. Pubmed:24402442
chr6	37478433	37480142	Q8N1G2	0	+	37478433	37480142	255,102,0	1	1709	0	.	Interaction with POLR2A. Pubmed:18533109
chr6	38677375	38677381	Q04760	0	-	38677375	38677381	255,102,0	1	6	0	.	Substrate binding.
chr6	38860570	38868109	Q96JB1	0	+	38860570	38868109	255,102,0	1	7539	0	.	AAA 1.
chr6	38870490	38873334	Q96JB1	0	+	38870490	38873334	255,102,0	1	2844	0	.	AAA 2.
chr6	38882947	38894775	Q96JB1	0	+	38882947	38894775	255,102,0	1	11828	0	.	AAA 3.
chr6	38898305	38911480	Q96JB1	0	+	38898305	38911480	255,102,0	1	13175	0	.	AAA 4.
chr6	38911522	38923084	Q96JB1	0	+	38911522	38923084	255,102,0	1	11562	0	.	Stalk.
chr6	38924144	38938047	Q96JB1	0	+	38924144	38938047	255,102,0	1	13903	0	.	AAA 5.
chr6	38951348	38982435	Q96JB1	0	+	38951348	38982435	255,102,0	1	31087	0	.	AAA 6.
chr6	39906359	39907028	Q9NZB8	0	-	39906359	39907028	255,102,0	1	669	0	.	Molybdenum cofactor biosynthesis protein C.
chr6	39909055	39934417	Q9NZB8	0	-	39909055	39934417	255,102,0	1	25362	0	.	Molybdenum cofactor biosynthesis protein A.
chr6	39912287	39912296	Q9NZB8	0	-	39912287	39912296	255,102,0	1	9	0	.	GTP binding.
chr6	41030674	41034011	Q8IV45	0	-	41030674	41034011	255,102,0	1	3337	0	.	Interaction with RELA and NFKB1. Pubmed:14769797
chr6	41067418	41068842	Q9Y530	0	-	41067418	41068842	255,102,0	1	1424	0	.	Substrate binding.
chr6	41588710	41589815	Q8IVH2	0	+	41588710	41589815	255,102,0	1	1105	0	.	Leucine-zipper.
chr6	41685072	41686149	P19484	0	-	41685072	41686149	255,102,0	1	1077	0	.	Leucine-zipper.
chr6	41689784	41690665	P19484	0	-	41689784	41690665	255,102,0	1	881	0	.	Strong transcription activation domain.
chr6	42228347	42268276	Q96PN7	0	-	42228347	42268276	255,102,0	1	39929	0	.	Interaction with CREBBP. Pubmed:11349124
chr6	42962775	42962781	Q14749	0	+	42962775	42962781	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr6	42962775	42962781	V9HW60	0	+	42962775	42962781	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr6	43006465	43006513	Q14738	0	+	43006465	43006513	255,102,0	1	48	0	.	8 X 2 AA approximate tandem repeats of Q-P.
chr6	43050151	43051123	Q14999	0	-	43050151	43051123	255,102,0	1	972	0	.	Interaction with TP53.
chr6	43144578	43160878	Q13308	0	+	43144578	43160878	255,102,0	1	16300	0	.	Interaction with CTNNB1. Pubmed:21132015
chr6	43172157	43173999	P11831	0	+	43172157	43173999	255,102,0	1	1842	0	.	Involved in dimerization.
chr6	43225867	43225876	O43598	0	-	43225867	43225876	255,102,0	1	9	0	.	Substrate binding; shared with homodimeric partner.
chr6	43229366	43229387	O43598	0	-	43229366	43229387	255,102,0	1	21	0	.	Substrate binding. Pubmed:25108359
chr6	43548400	43551429	Q9HAV4	0	-	43548400	43551429	255,102,0	1	3029	0	.	Necessary for interaction with ILF3.
chr6	43570970	43575861	Q9HAV4	0	-	43570970	43575861	255,102,0	1	4891	0	.	Necessary for interaction with Ran.
chr6	43636466	43636568	Q15013	0	+	43636466	43636568	255,102,0	1	102	0	.	Interaction with MAD2L1.
chr6	44176895	44180472	Q9UMQ6	0	+	44176895	44180472	255,102,0	1	3577	0	.	Domain III.
chr6	44180472	44180617	Q9UMQ6	0	+	44180472	44180617	255,102,0	1	145	0	.	Linker.
chr6	44180617	44183926	Q9UMQ6	0	+	44180617	44183926	255,102,0	1	3309	0	.	Domain IV.
chr6	44403866	44403887	Q99459	0	+	44403866	44403887	255,102,0	1	21	0	.	Required for interaction with CTNNBL1. Pubmed:21385873
chr6	44406341	44426649	Q99459	0	+	44406341	44426649	255,102,0	1	20308	0	.	Interaction with PPP1R8. Pubmed:10827081
chr6	44424514	44429796	Q99459	0	+	44424514	44429796	255,102,0	1	5282	0	.	Interaction with DAPK3.
chr6	44445678	44446702	Q99459	0	+	44445678	44446702	255,102,0	1	1024	0	.	Interaction with PLRG1. Pubmed:11544257
chr6	45491978	45492029	Q13950	0	+	45491978	45492029	255,102,0	1	51	0	.	Required for interaction with FOXO1.
chr6	45512391	45547056	Q13950	0	+	45512391	45547056	255,102,0	1	34665	0	.	Interaction with KAT6A.
chr6	45546858	45547143	Q13950	0	+	45546858	45547143	255,102,0	1	285	0	.	Interaction with KAT6B. Pubmed:11965546
chr6	46799114	46826364	Q16819	0	+	46799114	46826364	255,102,0	1	27250	0	.	Metalloprotease.
chr6	47478244	47554750	Q9Y5K6	0	+	47478244	47554750	255,102,0	1	76506	0	.	Interaction with ANLN and localization to the midbody. Pubmed:15800069
chr6	49786989	49787001	A0A140VJR3	0	-	49786989	49787001	255,102,0	1	12	0	.	Substrate binding.
chr6	49786989	49787001	P07205	0	-	49786989	49787001	255,102,0	1	12	0	.	Substrate binding.
chr6	49787109	49787118	A0A140VJR3	0	-	49787109	49787118	255,102,0	1	9	0	.	Substrate binding.
chr6	49787109	49787118	P07205	0	-	49787109	49787118	255,102,0	1	9	0	.	Substrate binding.
chr6	50729266	50772735	Q7Z6R9	0	+	50729266	50772735	255,102,0	1	43469	0	.	H-S-H (helix-span-helix), dimerization.
chr6	52755010	52755016	P09210	0	-	52755010	52755016	255,102,0	1	6	0	.	Glutathione binding. Pubmed:20083122
chr6	52755049	52755055	P09210	0	-	52755049	52755055	255,102,0	1	6	0	.	Glutathione binding. Pubmed:20083122
chr6	52796249	52796255	P08263	0	-	52796249	52796255	255,102,0	1	6	0	.	Glutathione binding. Pubmed:19618965, Pubmed:16421451
chr6	52796288	52796294	P08263	0	-	52796288	52796294	255,102,0	1	6	0	.	Glutathione binding. Pubmed:19618965, Pubmed:16421451
chr6	52836303	52836309	Q7RTV2	0	-	52836303	52836309	255,102,0	1	6	0	.	Glutathione binding.
chr6	52836342	52836348	Q7RTV2	0	-	52836342	52836348	255,102,0	1	6	0	.	Glutathione binding.
chr6	52902413	52902419	Q16772	0	-	52902413	52902419	255,102,0	1	6	0	.	Glutathione binding. Pubmed:20083122, Pubmed:15595823
chr6	52902452	52902458	Q16772	0	-	52902452	52902458	255,102,0	1	6	0	.	Glutathione binding. Pubmed:20083122, Pubmed:15595823
chr6	52985518	52985524	O15217	0	-	52985518	52985524	255,102,0	1	6	0	.	Glutathione binding.
chr6	52985557	52985563	O15217	0	-	52985557	52985563	255,102,0	1	6	0	.	Glutathione binding.
chr6	54019028	54121503	Q5VWP3	0	+	54019028	54121503	255,102,0	1	102475	0	.	Interaction with LMNA. Pubmed:21498514
chr6	54870246	54939823	Q5T0W9	0	+	54870246	54939823	255,102,0	1	69577	0	.	Required for interaction with RAF1 and for the function. Pubmed:22886302
chr6	55174683	55174734	O43614	0	+	55174683	55174734	255,102,0	1	51	0	.	Required for response to orexin-A. Pubmed:26950369
chr6	57046755	57053168	Q9HCI6	0	+	57046755	57053168	255,102,0	1	6413	0	.	Sufficient for E3 SUMO-protein ligase activity.
chr6	57047378	57050779	Q9HCI6	0	+	57047378	57050779	255,102,0	1	3401	0	.	Interaction with SUMO2 1.
chr6	57050791	57050818	Q9HCI6	0	+	57050791	57050818	255,102,0	1	27	0	.	Interaction with SUMO2 2.
chr6	57090253	57141337	Q9Y4E5	0	+	57090253	57141337	255,102,0	1	51084	0	.	Sufficient for E3 SUMO-protein ligase activity. Pubmed:26524493
chr6	57090253	57147117	Q9Y4E5	0	+	57090253	57147117	255,102,0	1	56864	0	.	Important for interaction with SUMO1 and SUMO2. Pubmed:18656483
chr6	57090876	57099066	Q9Y4E5	0	+	57090876	57099066	255,102,0	1	8190	0	.	Interaction with SUMO2 1. Pubmed:26524494
chr6	57099078	57099105	Q9Y4E5	0	+	57099078	57099105	255,102,0	1	27	0	.	Interaction with SUMO2 2. Pubmed:26524494
chr6	57133118	57147660	Q9Y4E5	0	+	57133118	57147660	255,102,0	1	14542	0	.	Important for interaction with SMAD4. Pubmed:24324267
chr6	57168430	57168466	Q9Y4E5	0	+	57168430	57168466	255,102,0	1	36	0	.	Important for ubiquitin binding. Pubmed:18656483
chr6	63578987	63579323	Q93096	0	+	63578987	63579323	255,102,0	1	336	0	.	Interaction with ATF5.
chr6	63579011	63579029	Q93096	0	+	63579011	63579029	255,102,0	1	18	0	.	Phosphate binding.
chr6	69938037	70023653	Q14993	0	+	69938037	70023653	255,102,0	1	85616	0	.	Triple-helical region 1 (COL1).
chr6	70034271	70121888	Q14993	0	+	70034271	70121888	255,102,0	1	87617	0	.	Triple-helical region 2 (COL2).
chr6	70130181	70151423	Q14993	0	+	70130181	70151423	255,102,0	1	21242	0	.	Triple-helical region 3 (COL3).
chr6	70156144	70168033	Q14993	0	+	70156144	70168033	255,102,0	1	11889	0	.	Triple-helical region 4 (COL4).
chr6	70168170	70190323	Q14993	0	+	70168170	70190323	255,102,0	1	22153	0	.	Triple-helical region 5 (COL5).
chr6	70199672	70207178	Q14993	0	+	70199672	70207178	255,102,0	1	7506	0	.	Triple-helical region 6 (COL6).
chr6	70216899	70216959	P20849	0	-	70216899	70216959	255,102,0	1	60	0	.	Nonhelical region (NC1).
chr6	70216959	70232727	P20849	0	-	70216959	70232727	255,102,0	1	15768	0	.	Triple-helical region (COL1).
chr6	70232727	70234584	P20849	0	-	70232727	70234584	255,102,0	1	1857	0	.	Nonhelical region (NC2).
chr6	70234584	70268839	P20849	0	-	70234584	70268839	255,102,0	1	34255	0	.	Triple-helical region (COL2).
chr6	70268839	70269647	P20849	0	-	70268839	70269647	255,102,0	1	808	0	.	Nonhelical region (NC3).
chr6	70269647	70281461	P20849	0	-	70269647	70281461	255,102,0	1	11814	0	.	Triple-helical region (COL3).
chr6	70281461	70302019	P20849	0	-	70281461	70302019	255,102,0	1	20558	0	.	Nonhelical region (NC4).
chr6	70894134	70894164	Q9NPZ5	0	-	70894134	70894164	255,102,0	1	30	0	.	Interaction with galactose moiety of substrate glycoprotein.
chr6	73425574	73428776	Q8N884	0	-	73425574	73428776	255,102,0	1	3202	0	.	DNA-binding. Pubmed:23707061
chr6	73451536	73451665	Q8N884	0	-	73451536	73451665	255,102,0	1	129	0	.	DNA-binding. Pubmed:23707061
chr6	73518964	73518973	P68104	0	-	73518964	73518973	255,102,0	1	9	0	.	G5.
chr6	73519084	73519096	P68104	0	-	73519084	73519096	255,102,0	1	12	0	.	G4.
chr6	73519378	73519390	P68104	0	-	73519378	73519390	255,102,0	1	12	0	.	G3.
chr6	73519438	73519453	P68104	0	-	73519438	73519453	255,102,0	1	15	0	.	G2.
chr6	73519963	73519987	P68104	0	-	73519963	73519987	255,102,0	1	24	0	.	G1.
chr6	73771530	73782756	Q6YHK3	0	+	73771530	73782756	255,102,0	1	11226	0	.	Bait region (approximate).
chr6	75086549	75087625	Q99715	0	-	75086549	75087625	255,102,0	1	1076	0	.	Nonhelical region (NC1).
chr6	75087625	75090227	Q99715	0	-	75087625	75090227	255,102,0	1	2602	0	.	Triple-helical region (COL1) with 2 imperfections.
chr6	75090227	75091380	Q99715	0	-	75090227	75091380	255,102,0	1	1153	0	.	Nonhelical region (NC2).
chr6	75091380	75105232	Q99715	0	-	75091380	75105232	255,102,0	1	13852	0	.	Triple-helical region (COL2) with 1 imperfection.
chr6	75105232	75119046	Q99715	0	-	75105232	75119046	255,102,0	1	13814	0	.	Nonhelical region (NC3).
chr6	75678847	75715591	Q9GZR1	0	+	75678847	75715591	255,102,0	1	36744	0	.	Protease.
chr6	77462410	77462425	P28222	0	-	77462410	77462425	255,102,0	1	15	0	.	Agonist binding.
chr6	77463001	77463031	P28222	0	-	77463001	77463031	255,102,0	1	30	0	.	Agonist binding.
chr6	78867576	78867849	Q5VVH5	0	+	78867576	78867849	255,102,0	1	273	0	.	Intrinsically disordered.
chr6	78898268	78898331	Q5VVH5	0	+	78898268	78898331	255,102,0	1	63	0	.	Required for nuclear localization (NLS).
chr6	78963244	78978711	Q8WWQ0	0	-	78963244	78978711	255,102,0	1	15467	0	.	Mediates interaction with IRS1.
chr6	82893024	82957404	Q7Z6J8	0	-	82893024	82957404	255,102,0	1	64380	0	.	HECT-like.
chr6	83022527	83024003	Q7Z6J8	0	-	83022527	83024003	255,102,0	1	1476	0	.	Interaction with UBE2C. Pubmed:15749827
chr6	83170343	83170358	A0A087WT27	0	-	83170343	83170358	255,102,0	1	15	0	.	Substrate binding.
chr6	83170343	83170358	J3KN95	0	-	83170343	83170358	255,102,0	1	15	0	.	Substrate binding.
chr6	83170343	83170358	O95394	0	-	83170343	83170358	255,102,0	1	15	0	.	Substrate binding.
chr6	83175973	83175982	A0A087WT27	0	-	83175973	83175982	255,102,0	1	9	0	.	Substrate binding.
chr6	83175973	83175982	J3KN95	0	-	83175973	83175982	255,102,0	1	9	0	.	Substrate binding.
chr6	83175973	83175982	O95394	0	-	83175973	83175982	255,102,0	1	9	0	.	Substrate binding.
chr6	83854150	83857338	Q5TAB7	0	+	83854150	83857338	255,102,0	1	3188	0	.	Ripply homology domain.
chr6	85492113	85492134	P21589	0	+	85492113	85492134	255,102,0	1	21	0	.	Substrate binding.
chr6	85614944	85618900	O60506	0	-	85614944	85618900	255,102,0	1	3956	0	.	Interaction with APOBEC1.
chr6	85614950	85615286	O60506	0	-	85614950	85615286	255,102,0	1	336	0	.	8 X 3 AA repeats of R-G-G.
chr6	85614980	85615076	O60506	0	-	85614980	85615076	255,102,0	1	96	0	.	Interaction with SMN. Pubmed:11574476
chr6	85615163	85615250	O60506	0	-	85615163	85615250	255,102,0	1	87	0	.	3 X 4 AA repeats of Y-Y-G-Y.
chr6	87015625	87015655	P28566	0	+	87015625	87015655	255,102,0	1	30	0	.	Agonist binding.
chr6	87016243	87016258	P28566	0	+	87016243	87016258	255,102,0	1	15	0	.	Agonist binding.
chr6	88612721	88891915	O60942	0	-	88612721	88891915	255,102,0	1	279194	0	.	GTase.
chr6	88844467	88853673	O60942	0	-	88844467	88853673	255,102,0	1	9206	0	.	Interaction with POLR2A.
chr6	88904762	88963409	O60942	0	-	88904762	88963409	255,102,0	1	58647	0	.	TPase.
chr6	89938152	89938176	Q9BYV9	0	-	89938152	89938176	255,102,0	1	24	0	.	Leucine-zipper.
chr6	89938185	89938236	Q9BYV9	0	-	89938185	89938236	255,102,0	1	51	0	.	Basic motif.
chr6	90550516	90586883	O43318	0	-	90550516	90586883	255,102,0	1	36367	0	.	Interaction with MAPK8IP1.
chr6	95586616	95606402	Q5SRI9	0	+	95586616	95606402	255,102,0	1	19786	0	.	Catalytic.
chr6	96521876	96534266	O94874	0	+	96521876	96534266	255,102,0	1	12390	0	.	Mediates interaction with DDRGK1. Pubmed:25219498
chr6	96521876	96534302	O94874	0	+	96521876	96534302	255,102,0	1	12426	0	.	Required for E3 UFM1-protein ligase activity. Pubmed:20018847
chr6	96526330	96536338	O94874	0	+	96526330	96536338	255,102,0	1	10008	0	.	Involved in CDK5RAP3-binding. Pubmed:20164180
chr6	96534263	96540576	O94874	0	+	96534263	96540576	255,102,0	1	6313	0	.	Mediates interaction with TRIP4. Pubmed:25219498
chr6	101889660	101889669	Q13002	0	+	101889660	101889669	255,102,0	1	9	0	.	Glutamate binding.
chr6	101928611	101928617	Q13002	0	+	101928611	101928617	255,102,0	1	6	0	.	Glutamate binding.
chr6	105124636	105125524	Q8NE79	0	-	105124636	105125524	255,102,0	1	888	0	.	Required for interaction with KCNK2. Pubmed:26642364
chr6	105129384	105129453	Q8NE79	0	-	105129384	105129453	255,102,0	1	69	0	.	Required for interaction with CAV3.
chr6	106105738	106105882	O75626	0	+	106105738	106105882	255,102,0	1	144	0	.	Interaction with PIAS1.
chr6	108178157	108187367	Q9Y466	0	+	108178157	108187367	255,102,0	1	9210	0	.	Ligand-binding.
chr6	108187325	108187460	Q9Y466	0	+	108187325	108187460	255,102,0	1	135	0	.	Required for transcriptional repression.
chr6	108212151	108212199	O60493	0	-	108212151	108212199	255,102,0	1	48	0	.	Binds predominantly to PtdIns(P5) and weaker to PtdIns(P3) abd PtdIns(P4); involved in neurite outgrowth regulation.
chr6	108663730	108664852	O43524	0	+	108663730	108664852	255,102,0	1	1122	0	.	Mediates interaction with CHUK/IKKA and IKBKB/IKKB. Pubmed:15084260
chr6	108987546	108992882	Q9Y6P5	0	-	108987546	108992882	255,102,0	1	5336	0	.	C-terminal domain; mediates TORC1 regulation.
chr6	108990724	108990736	Q9Y6P5	0	-	108990724	108990736	255,102,0	1	12	0	.	Leucine-binding.
chr6	108998551	109001446	Q9Y6P5	0	-	108998551	109001446	255,102,0	1	2895	0	.	N-terminal domain; mediates the alkylhydroperoxide reductase activity.
chr6	109368853	109368874	Q04900	0	-	109368853	109368874	255,102,0	1	21	0	.	Required for endosomal and lysosomal localization.
chr6	109444211	109445448	Q8TDZ2	0	-	109444211	109445448	255,102,0	1	1237	0	.	RAB-binding domain (RBD). Pubmed:27552051
chr6	109449448	109454196	Q8TDZ2	0	-	109449448	109454196	255,102,0	1	4748	0	.	Monooxygenase domain.
chr6	109506372	109514269	Q5TCS8	0	-	109506372	109514269	255,102,0	1	7897	0	.	Adenylate kinase 3.
chr6	109506525	109506676	Q5TCS8	0	-	109506525	109506676	255,102,0	1	151	0	.	LID 3.
chr6	109509243	109509339	Q5TCS8	0	-	109509243	109509339	255,102,0	1	96	0	.	NMPbind 3.
chr6	109529034	109546118	Q5TCS8	0	-	109529034	109546118	255,102,0	1	17084	0	.	Adenylate kinase 2.
chr6	109533388	109533451	Q5TCS8	0	-	109533388	109533451	255,102,0	1	63	0	.	LID 2.
chr6	109545935	109546031	Q5TCS8	0	-	109545935	109546031	255,102,0	1	96	0	.	NMPbind 2.
chr6	109641595	109675655	Q5TCS8	0	-	109641595	109675655	255,102,0	1	34060	0	.	Adenylate kinase 1.
chr6	109659242	109659380	Q5TCS8	0	-	109659242	109659380	255,102,0	1	138	0	.	LID 1.
chr6	109671982	109674201	Q5TCS8	0	-	109671982	109674201	255,102,0	1	2219	0	.	NMPbind 1.
chr6	111372660	111372816	O60673	0	-	111372660	111372816	255,102,0	1	156	0	.	Mediates interaction with MAD2L2. Pubmed:10660610
chr6	111591345	111601214	O43734	0	-	111591345	111601214	255,102,0	1	9869	0	.	Mediates interaction with TRAF6. Pubmed:12459498
chr6	113860033	113860108	P29966	0	+	113860033	113860108	255,102,0	1	75	0	.	Calmodulin-binding (PSD).
chr6	113946023	113970884	Q92769	0	-	113946023	113970884	255,102,0	1	24861	0	.	Histone deacetylase.
chr6	114057616	114057622	Q8IZT8	0	-	114057616	114057622	255,102,0	1	6	0	.	Substrate binding.
chr6	114057823	114057835	Q8IZT8	0	-	114057823	114057835	255,102,0	1	12	0	.	Substrate binding.
chr6	114057913	114057934	Q8IZT8	0	-	114057913	114057934	255,102,0	1	21	0	.	Substrate binding.
chr6	116120075	116120558	Q03692	0	-	116120075	116120558	255,102,0	1	483	0	.	Nonhelical region (NC1).
chr6	116120558	116121947	Q03692	0	-	116120558	116121947	255,102,0	1	1389	0	.	Triple-helical region.
chr6	116121947	116125438	Q03692	0	-	116121947	116125438	255,102,0	1	3491	0	.	Nonhelical region (NC2).
chr6	116590280	116590931	Q9H446	0	+	116590280	116590931	255,102,0	1	651	0	.	Interaction with DRG2.
chr6	118558966	118558987	P26678	0	+	118558966	118558987	255,102,0	1	21	0	.	Involved in HAX1 binding.
chr6	118894413	118907467	Q9Y294	0	+	118894413	118907467	255,102,0	1	13054	0	.	Interaction with histone H3, CHAF1B, and HIRA.
chr6	118907461	118907611	Q9Y294	0	+	118907461	118907611	255,102,0	1	150	0	.	Required for interaction with HIRA.
chr6	121447576	121447993	P17302	0	+	121447576	121447993	255,102,0	1	417	0	.	Interaction with NOV.
chr6	121447636	121447993	P17302	0	+	121447636	121447993	255,102,0	1	357	0	.	Interaction with UBQLN4.
chr6	122413548	122419212	Q03933	0	+	122413548	122419212	255,102,0	1	5664	0	.	Hydrophobic repeat HR-A/B.
chr6	122423587	122423665	Q03933	0	+	122423587	122423665	255,102,0	1	78	0	.	Hydrophobic repeat HR-C.
chr6	122783746	122783755	O15540	0	+	122783746	122783755	255,102,0	1	9	0	.	Fatty acid binding.
chr6	125751855	125759136	Q9UBP5	0	+	125751855	125759136	255,102,0	1	7281	0	.	Transcriptional repression and interaction with NCOR1 and SIN3A.
chr6	127813086	127813863	Q8N1K5	0	-	127813086	127813863	255,102,0	1	777	0	.	CABIT 2.
chr6	127813863	127900932	Q8N1K5	0	-	127813863	127900932	255,102,0	1	87069	0	.	CABIT 1.
chr6	127983361	127985725	Q15262	0	-	127983361	127985725	255,102,0	1	2364	0	.	Substrate binding.
chr6	129366220	129452990	P24043	0	+	129366220	129452990	255,102,0	1	86770	0	.	Domain II and I.
chr6	130858138	130869607	O43491	0	-	130858138	130869607	255,102,0	1	11469	0	.	C-terminal (CTD).
chr6	130878118	130885098	O43491	0	-	130878118	130885098	255,102,0	1	6980	0	.	Spectrin--actin-binding.
chr6	130885098	130890450	O43491	0	-	130885098	130890450	255,102,0	1	5352	0	.	Hydrophilic.
chr6	131250570	131250600	O43687	0	+	131250570	131250600	255,102,0	1	30	0	.	Required for membrane localization.
chr6	131253038	131281531	O43687	0	+	131253038	131281531	255,102,0	1	28493	0	.	Required for apical membrane localization.
chr6	131281558	131281723	Q9P0M2	0	+	131281558	131281723	255,102,0	1	165	0	.	PKA-RII-alpha subunit binding domain.
chr6	131281561	131281636	Q9P0M2	0	+	131281561	131281636	255,102,0	1	75	0	.	RI-alpha-binding.
chr6	131281564	131281606	O43687	0	+	131281564	131281606	255,102,0	1	42	0	.	RII-binding.
chr6	131281564	131281606	Q9P0M2	0	+	131281564	131281606	255,102,0	1	42	0	.	RII-binding.
chr6	131581288	131581303	P05089	0	+	131581288	131581303	255,102,0	1	15	0	.	Substrate binding.
chr6	131581321	131581330	P05089	0	+	131581321	131581330	255,102,0	1	9	0	.	Substrate binding.
chr6	131652844	131720342	O14638	0	+	131652844	131720342	255,102,0	1	67498	0	.	Phosphodiesterase.
chr6	131726059	131746953	O14638	0	+	131726059	131746953	255,102,0	1	20894	0	.	Nuclease.
chr6	131852188	131877041	P22413	0	+	131852188	131877041	255,102,0	1	24853	0	.	Phosphodiesterase.
chr6	131877056	131878589	P22413	0	+	131877056	131878589	255,102,0	1	1533	0	.	Linker.
chr6	131879893	131890508	P22413	0	+	131879893	131890508	255,102,0	1	10615	0	.	Nuclease.
chr6	131949266	131949963	P29279	0	-	131949266	131949963	255,102,0	1	697	0	.	Heparin-binding.
chr6	134174052	134174807	O00141	0	-	134174052	134174807	255,102,0	1	755	0	.	Necessary for localization to the mitochondria.
chr6	134986147	134986156	Q9Y450	0	-	134986147	134986156	255,102,0	1	9	0	.	G5.
chr6	134987647	134987659	Q9Y450	0	-	134987647	134987659	255,102,0	1	12	0	.	G4.
chr6	134993799	134993811	Q9Y450	0	-	134993799	134993811	255,102,0	1	12	0	.	G3.
chr6	134993859	134993874	Q9Y450	0	-	134993859	134993874	255,102,0	1	15	0	.	G2.
chr6	134996919	134996943	Q9Y450	0	-	134996919	134996943	255,102,0	1	24	0	.	G1.
chr6	135189844	135192375	P10242	0	+	135189844	135192375	255,102,0	1	2531	0	.	Interaction with HIPK2 and NLK.
chr6	135193897	135195780	P10242	0	+	135193897	135195780	255,102,0	1	1883	0	.	Transcription activation domain (PubMed:2189102). Pubmed:2189102
chr6	135195780	135200133	P10242	0	+	135195780	135200133	255,102,0	1	4353	0	.	Negative regulatory domain.
chr6	135195924	135195990	P10242	0	+	135195924	135195990	255,102,0	1	66	0	.	Leucine-zipper.
chr6	135455775	135466142	Q8N157	0	-	135455775	135466142	255,102,0	1	10367	0	.	Interaction with HAP1. Pubmed:23532844
chr6	136154109	136191717	Q9NP56	0	+	136154109	136191717	255,102,0	1	37608	0	.	Catalytic.
chr6	137871398	137877170	P21580	0	+	137871398	137877170	255,102,0	1	5772	0	.	TRAF-binding.
chr6	137875017	137875026	P21580	0	+	137875017	137875026	255,102,0	1	9	0	.	Interaction with ubiquitin.
chr6	137875768	137875777	P21580	0	+	137875768	137875777	255,102,0	1	9	0	.	Interaction with ubiquitin.
chr6	137876030	137876042	P21580	0	+	137876030	137876042	255,102,0	1	12	0	.	Interaction with ubiquitin.
chr6	137877125	137878513	P21580	0	+	137877125	137878513	255,102,0	1	1388	0	.	2 X approximate repeats.
chr6	137878549	137881271	P21580	0	+	137878549	137881271	255,102,0	1	2722	0	.	Interaction with TNIP1.
chr6	137878600	137878804	P21580	0	+	137878600	137878804	255,102,0	1	204	0	.	Interaction with RIPK1. Pubmed:19131965
chr6	137879257	137880129	P21580	0	+	137879257	137880129	255,102,0	1	872	0	.	Required for proteosomal degradation of UBE2N and UBE2D3, TRAF6 deubiquitination, and TAX1BP1 interaction with UBE2N.
chr6	137879260	137881316	P21580	0	+	137879260	137881316	255,102,0	1	2056	0	.	Sufficient for inhibitory activity of TNF-induced NF-kappa-B activity.
chr6	137881034	137881316	P21580	0	+	137881034	137881316	255,102,0	1	282	0	.	Required for lysosomal localization and for TRAF2 lysosomal degradation.
chr6	138905066	138912782	Q96D71	0	-	138905066	138912782	255,102,0	1	7716	0	.	Interaction with RALBP1.
chr6	142147290	142169567	Q9NP79	0	+	142147290	142169567	255,102,0	1	22277	0	.	Interaction with CHMP5.
chr6	142147290	142198476	Q9NP79	0	+	142147290	142198476	255,102,0	1	51186	0	.	Interaction with IST1.
chr6	142198509	142218640	Q9NP79	0	+	142198509	142218640	255,102,0	1	20131	0	.	Interaction with VPS4B.
chr6	142367585	142370789	Q86SQ4	0	+	142367585	142370789	255,102,0	1	3204	0	.	Mediates interaction with type IV collagen.
chr6	142367585	142414983	Q86SQ4	0	+	142367585	142414983	255,102,0	1	47398	0	.	Inhibits receptor signaling in absence of type IV collagen.
chr6	142393950	142411381	Q86SQ4	0	+	142393950	142411381	255,102,0	1	17431	0	.	Mediates interaction with laminin-2.
chr6	142759843	142760131	P31629	0	-	142759843	142760131	255,102,0	1	288	0	.	10 X 4 AA tandem repeats of S-P-[RGMKC]-[RK].
chr6	143451042	143459146	P56589	0	+	143451042	143459146	255,102,0	1	8104	0	.	Targeting to peroxisomes.
chr6	143470986	143471037	P56589	0	+	143470986	143471037	255,102,0	1	51	0	.	Interaction with PEX19.
chr6	144429687	144461204	P46939	0	+	144429687	144461204	255,102,0	1	31517	0	.	Interaction with SYNM. Pubmed:16777071
chr6	144488705	144516288	P46939	0	+	144488705	144516288	255,102,0	1	27583	0	.	Interaction with SYNM. Pubmed:16777071
chr6	144754755	144821019	P46939	0	+	144754755	144821019	255,102,0	1	66264	0	.	Interaction with SYNM. Pubmed:16777071
chr6	146030072	146030081	Q13255	0	+	146030072	146030081	255,102,0	1	9	0	.	Glutamate binding.
chr6	146554458	146554518	Q13637	0	+	146554458	146554518	255,102,0	1	60	0	.	PKA-RII subunit binding domain.
chr6	149409659	149409692	Q9NYJ8	0	+	149409659	149409692	255,102,0	1	33	0	.	Interaction with polyubiquitin.
chr6	149451198	149452628	A2A288	0	-	149451198	149452628	255,102,0	1	1430	0	.	Necessary for interaction with ZC3H12A. Pubmed:26134560
chr6	149604728	149638547	O75449	0	-	149604728	149638547	255,102,0	1	33819	0	.	Interaction with microtubules.
chr6	149632853	149638547	O75449	0	-	149632853	149638547	255,102,0	1	5694	0	.	Interaction with dynein and NDEL1.
chr6	149638460	149638547	O75449	0	-	149638460	149638547	255,102,0	1	87	0	.	Interaction with KATNB1. Pubmed:10751153
chr6	149683123	149683513	O95835	0	-	149683123	149683513	255,102,0	1	390	0	.	Interaction with YAP1. Pubmed:18158288
chr6	149889348	149889621	Q8TD07	0	-	149889348	149889621	255,102,0	1	273	0	.	MHC class I alpha-2 like.
chr6	149889621	149890140	Q8TD07	0	-	149889621	149890140	255,102,0	1	519	0	.	MHC class I alpha-1 like.
chr6	149919043	149919322	Q6H3X3	0	-	149919043	149919322	255,102,0	1	279	0	.	MHC class I alpha-2 like.
chr6	149919322	149919817	Q6H3X3	0	-	149919322	149919817	255,102,0	1	495	0	.	MHC class I alpha-1 like.
chr6	149945307	149946373	Q9BZM5	0	+	149945307	149946373	255,102,0	1	1066	0	.	MHC class I alpha-1 like.
chr6	149946373	149946652	Q9BZM5	0	+	149946373	149946652	255,102,0	1	279	0	.	MHC class I alpha-2 like.
chr6	149964124	149969086	Q9BZM6	0	+	149964124	149969086	255,102,0	1	4962	0	.	MHC class I alpha-1 like.
chr6	149969086	149969359	Q9BZM6	0	+	149969086	149969359	255,102,0	1	273	0	.	MHC class I alpha-2 like.
chr6	150020905	150021184	Q5VY80	0	-	150020905	150021184	255,102,0	1	279	0	.	MHC class I alpha-2 like.
chr6	150021184	150022244	Q5VY80	0	-	150021184	150022244	255,102,0	1	1060	0	.	MHC class I alpha-1 like.
chr6	150065398	150065671	Q9BZM4	0	-	150065398	150065671	255,102,0	1	273	0	.	MHC class I alpha-2 like.
chr6	150065671	150066163	Q9BZM4	0	-	150065671	150066163	255,102,0	1	492	0	.	MHC class I alpha-1 like.
chr6	150865912	150922264	Q6UB35	0	+	150865912	150922264	255,102,0	1	56352	0	.	Methylenetetrahydrofolate dehydrogenase and cyclohydrolase.
chr6	150922264	151092553	Q6UB35	0	+	150922264	151092553	255,102,0	1	170289	0	.	Formyltetrahydrofolate synthetase.
chr6	151349186	151350062	Q02952	0	+	151349186	151350062	255,102,0	1	876	0	.	Involved in PKC-binding.
chr6	151353011	151353053	Q02952	0	+	151353011	151353053	255,102,0	1	42	0	.	RII-binding.
chr6	151807912	151842696	P03372	0	+	151807912	151842696	255,102,0	1	34784	0	.	Modulating (transactivation AF-1); mediates interaction with MACROD1. Pubmed:17914104
chr6	151808014	151808053	P03372	0	+	151808014	151808053	255,102,0	1	39	0	.	Required for interaction with NCOA1.
chr6	151808014	151842666	P03372	0	+	151808014	151842666	255,102,0	1	34652	0	.	Interaction with DDX5; self-association.
chr6	151842696	151944342	P03372	0	+	151842696	151944342	255,102,0	1	101646	0	.	Mediates interaction with DNTTIP2. Pubmed:15047147
chr6	151880761	151944342	P03372	0	+	151880761	151944342	255,102,0	1	63581	0	.	Hinge.
chr6	151944195	152098963	P03372	0	+	151944195	152098963	255,102,0	1	154768	0	.	Interaction with AKAP13. Pubmed:9627117
chr6	151944201	152098963	P03372	0	+	151944201	152098963	255,102,0	1	154762	0	.	Self-association.
chr6	151944342	152098831	P03372	0	+	151944342	152098831	255,102,0	1	154489	0	.	Steroid-binding.
chr6	151944342	152098963	P03372	0	+	151944342	152098963	255,102,0	1	154621	0	.	Transactivation AF-2.
chr6	152974992	152975322	Q9UKT4	0	-	152974992	152975322	255,102,0	1	330	0	.	Interaction with EVI5. Pubmed:16439210
chr6	155314314	155314326	Q8WVM0	0	-	155314314	155314326	255,102,0	1	12	0	.	S-adenosyl-L-methionine binding.
chr6	157902025	157906146	Q9Y5X1	0	+	157902025	157906146	255,102,0	1	4121	0	.	Critical for tubulation activity.
chr6	158504058	158506691	Q9NRJ4	0	+	158504058	158506691	255,102,0	1	2633	0	.	TUB.
chr6	158636829	158637843	P63172	0	-	158636829	158637843	255,102,0	1	1014	0	.	Interaction with GNB1.
chr6	158766916	158776473	P15311	0	-	158766916	158776473	255,102,0	1	9557	0	.	Interaction with SCYL3. Pubmed:12651155
chr6	161360142	161386829	O60260	0	-	161360142	161386829	255,102,0	1	26687	0	.	REP.
chr6	161569408	161785874	O60260	0	-	161569408	161785874	255,102,0	1	216466	0	.	SYT11 binding 2. Pubmed:12925569
chr6	161973321	162054099	O60260	0	-	161973321	162054099	255,102,0	1	80778	0	.	SYT11 binding 1. Pubmed:12925569
chr6	163415223	163455382	Q96PU8	0	+	163415223	163455382	255,102,0	1	40159	0	.	Qua1 domain; involved in homodimerization.
chr6	163535122	163563424	Q96PU8	0	+	163535122	163563424	255,102,0	1	28302	0	.	Qua2 domain; involved in RNA binding. Pubmed:23630077
chr6	165416256	165416262	Q9Y233	0	-	165416256	165416262	255,102,0	1	6	0	.	Allosteric effector binding.
chr6	165418741	165418747	Q9Y233	0	-	165418741	165418747	255,102,0	1	6	0	.	Allosteric effector binding.
chr6	169241956	169248971	P35442	0	-	169241956	169248971	255,102,0	1	7015	0	.	Heparin-binding.
chr6	169710346	169712469	Q8WUB8	0	-	169710346	169712469	255,102,0	1	2123	0	.	Essential to induce neural progenitor proliferation.
chr6	169712457	169718848	Q8WUB8	0	-	169712457	169718848	255,102,0	1	6391	0	.	SAY.
chr6	169715845	169718848	Q8WUB8	0	-	169715845	169718848	255,102,0	1	3003	0	.	Essential to induce neural progenitor proliferation.
chr6	170282876	170282996	O00548	0	-	170282876	170282996	255,102,0	1	120	0	.	Interaction with MAGI1.
chr7	248417	259920	Q8IXL6	0	+	248417	259920	255,102,0	1	11503	0	.	Kinase domain. Pubmed:22582013
chr7	501209	501224	P04085	0	-	501209	501224	255,102,0	1	15	0	.	Receptor binding site.
chr7	677260	711502	P31321	0	-	677260	711502	255,102,0	1	34242	0	.	Dimerization and phosphorylation.
chr7	1434601	1437592	Q8IY33	0	-	1434601	1437592	255,102,0	1	2991	0	.	Mediates interaction with RAB13 and is required for transition from the closed to the opened conformation.
chr7	1437589	1438870	Q8IY33	0	-	1437589	1438870	255,102,0	1	1281	0	.	Forms an intramolecular interaction with the N-terminal CH and LIM zinc-binding domains-containing region keeping the protein in a closed conformation.
chr7	1438870	1445289	Q8IY33	0	-	1438870	1445289	255,102,0	1	6419	0	.	Mediates targeting to the cell plasma membrane.
chr7	1444905	1445289	Q8IY33	0	-	1444905	1445289	255,102,0	1	384	0	.	Necessary and sufficient for interaction with actinins.
chr7	1445289	1459326	Q8IY33	0	-	1445289	1459326	255,102,0	1	14037	0	.	Forms an intramolecular interaction with the C-terminal coiled coil domain keeping the protein in a closed conformation.
chr7	1540054	1540132	O60675	0	+	1540054	1540132	255,102,0	1	78	0	.	Basic motif.
chr7	1540138	1540183	O60675	0	+	1540138	1540183	255,102,0	1	45	0	.	Leucine-zipper.
chr7	1957628	2069274	Q9Y6D9	0	-	1957628	2069274	255,102,0	1	111646	0	.	Necessary for interaction with NEK2. Pubmed:14978040
chr7	2235472	2235478	Q9UI43	0	-	2235472	2235478	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr7	2239457	2239469	Q9UI43	0	-	2239457	2239469	255,102,0	1	12	0	.	S-adenosyl-L-methionine binding.
chr7	2355290	2366398	P55884	0	+	2355290	2366398	255,102,0	1	11108	0	.	Sufficient for interaction with EIF3E.
chr7	2360717	2363079	P55884	0	+	2360717	2363079	255,102,0	1	2362	0	.	Sufficient for interaction with EIF3J.
chr7	2543792	2545041	Q6PJG6	0	-	2543792	2545041	255,102,0	1	1249	0	.	Required for interaction with NDFIP1. Pubmed:25631046
chr7	4682308	4682428	P85037	0	+	4682308	4682428	255,102,0	1	120	0	.	Interaction with SIN3A and SIN3B.
chr7	4682590	4759066	P85037	0	+	4682590	4759066	255,102,0	1	76476	0	.	Required for interaction with FOXO4 and MEF2C.
chr7	5063966	5064236	Q9NYW8	0	+	5063966	5064236	255,102,0	1	270	0	.	Required for interaction with RB1. Pubmed:10702291
chr7	5064704	5065598	Q9NYW8	0	+	5064704	5065598	255,102,0	1	894	0	.	Interaction with AR. Pubmed:14664718
chr7	6015253	6017957	Q13155	0	+	6015253	6017957	255,102,0	1	2704	0	.	Interaction with PARK2. Pubmed:16135753
chr7	6017954	6023403	Q13155	0	+	6017954	6023403	255,102,0	1	5449	0	.	Interaction with TP53. Pubmed:18695251
chr7	6164946	6164973	O43739	0	-	6164946	6164973	255,102,0	1	27	0	.	C-terminal autoinhibitory region.
chr7	6165793	6170541	O43739	0	-	6165793	6170541	255,102,0	1	4748	0	.	Phosphatidylinositol 3,4,5-trisphosphate binding.
chr7	8751016	8751244	P58417	0	+	8751016	8751244	255,102,0	1	228	0	.	II.
chr7	8751244	8751481	P58417	0	+	8751244	8751481	255,102,0	1	237	0	.	III.
chr7	8751481	8751508	P58417	0	+	8751481	8751508	255,102,0	1	27	0	.	IV (linker domain).
chr7	8751508	8751766	P58417	0	+	8751508	8751766	255,102,0	1	258	0	.	V (Cys-rich).
chr7	12570786	12626691	Q9Y6U3	0	+	12570786	12626691	255,102,0	1	55905	0	.	Actin-severing.
chr7	12578197	12581062	Q9Y6U3	0	+	12578197	12581062	255,102,0	1	2865	0	.	Polyphosphoinositide binding.
chr7	12581116	12581143	Q9Y6U3	0	+	12581116	12581143	255,102,0	1	27	0	.	Polyphosphoinositide binding.
chr7	12626691	12652712	Q9Y6U3	0	+	12626691	12652712	255,102,0	1	26021	0	.	Ca(2+)-dependent actin binding.
chr7	16801676	16801736	O95994	0	-	16801676	16801736	255,102,0	1	60	0	.	Required to promote cell adhesion. Pubmed:23274113
chr7	18585324	18585339	Q9UKV0	0	+	18585324	18585339	255,102,0	1	15	0	.	Interaction with CTBP1.
chr7	18591514	18591571	Q9UKV0	0	+	18591514	18591571	255,102,0	1	57	0	.	Interaction with MEF2.
chr7	18591631	18647787	Q9UKV0	0	+	18591631	18647787	255,102,0	1	56156	0	.	Interaction with MAPK10.
chr7	18594025	18629477	Q9UKV0	0	+	18594025	18629477	255,102,0	1	35452	0	.	Interaction with ETV6. Pubmed:12590135
chr7	18727747	18954151	Q9UKV0	0	+	18727747	18954151	255,102,0	1	226404	0	.	Histone deacetylase.
chr7	19115207	19115300	Q15672	0	-	19115207	19115300	255,102,0	1	93	0	.	Sufficient for transactivation activity.
chr7	20401849	20404827	P26012	0	+	20401849	20404827	255,102,0	1	2978	0	.	Cysteine-rich tandem repeats.
chr7	21543245	21683885	Q96DT5	0	+	21543245	21683885	255,102,0	1	140640	0	.	Stem.
chr7	21683885	21702757	Q96DT5	0	+	21683885	21702757	255,102,0	1	18872	0	.	AAA 1.
chr7	21704565	21717889	Q96DT5	0	+	21704565	21717889	255,102,0	1	13324	0	.	AAA 2.
chr7	21725957	21744440	Q96DT5	0	+	21725957	21744440	255,102,0	1	18483	0	.	AAA 3.
chr7	21745001	21773861	Q96DT5	0	+	21745001	21773861	255,102,0	1	28860	0	.	AAA 4.
chr7	21773876	21807926	Q96DT5	0	+	21773876	21807926	255,102,0	1	34050	0	.	Stalk.
chr7	21816508	21852628	Q96DT5	0	+	21816508	21852628	255,102,0	1	36120	0	.	AAA 5.
chr7	21866658	21880872	Q96DT5	0	+	21866658	21880872	255,102,0	1	14214	0	.	AAA 6.
chr7	21906615	21908174	Q96GN5	0	-	21906615	21908174	255,102,0	1	1559	0	.	MYC-binding.
chr7	21908453	21911748	Q96GN5	0	-	21908453	21911748	255,102,0	1	3295	0	.	PSIP1-binding.
chr7	23185227	23195903	O15504	0	+	23185227	23195903	255,102,0	1	10676	0	.	Interaction with HIV-1 Vpr.
chr7	23200565	23200742	O15504	0	+	23200565	23200742	255,102,0	1	177	0	.	Interaction with GLE1. Pubmed:16000379
chr7	23506232	23507469	Q13595	0	-	23506232	23507469	255,102,0	1	1237	0	.	Linker.
chr7	24710284	24749774	O60443	0	-	24710284	24749774	255,102,0	1	39490	0	.	Triggers pyroptosis. Pubmed:27281216
chr7	26185435	26185495	Q9Y4A8	0	+	26185435	26185495	255,102,0	1	60	0	.	Basic motif.
chr7	26185513	26185558	Q9Y4A8	0	+	26185513	26185558	255,102,0	1	45	0	.	Leucine-zipper.
chr7	26192518	26196593	P22626	0	-	26192518	26196593	255,102,0	1	4075	0	.	Low complexity (LC) region. Pubmed:26544936
chr7	26192536	26193329	P22626	0	-	26192536	26193329	255,102,0	1	793	0	.	Nuclear targeting sequence.
chr7	26346463	26371884	Q9Y5X0	0	+	26346463	26371884	255,102,0	1	25421	0	.	Required for interaction with ATP6V1D. Pubmed:21844891
chr7	26854143	26864390	O75563	0	-	26854143	26864390	255,102,0	1	10247	0	.	Homodimerization.
chr7	27787522	27792227	Q86VP1	0	+	27787522	27792227	255,102,0	1	4705	0	.	Oligomerization.
chr7	27895367	27991982	Q86VZ6	0	-	27895367	27991982	255,102,0	1	96615	0	.	Required for interaction with NR2C2. Pubmed:15302918
chr7	28809288	28809351	Q02930	0	+	28809288	28809351	255,102,0	1	63	0	.	Basic motif.
chr7	28809366	28818109	Q02930	0	+	28809366	28818109	255,102,0	1	8743	0	.	Leucine-zipper.
chr7	30054839	30078784	Q96JA3	0	+	30054839	30078784	255,102,0	1	23945	0	.	Glycolipid transfer protein homology domain.
chr7	30504637	30504655	O75223	0	-	30504637	30504655	255,102,0	1	18	0	.	Substrate binding. Pubmed:18515354
chr7	30615899	30615914	P41250	0	+	30615899	30615914	255,102,0	1	15	0	.	Substrate binding.
chr7	30628585	30628600	P41250	0	+	30628585	30628600	255,102,0	1	15	0	.	Substrate binding.
chr7	30753828	30753837	O95050	0	+	30753828	30753837	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr7	30755482	30755488	O95050	0	+	30755482	30755488	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr7	31084184	31084229	P41586	0	+	31084184	31084229	255,102,0	1	45	0	.	Important for ligand binding and specificity.
chr7	31823091	31873297	Q14123	0	-	31823091	31873297	255,102,0	1	50206	0	.	Catalytic.
chr7	33017534	33017540	Q9H0P0	0	-	33017534	33017540	255,102,0	1	6	0	.	Substrate binding. Pubmed:17405878
chr7	33096494	33109372	Q8TA86	0	-	33096494	33109372	255,102,0	1	12878	0	.	PIM1-binding.
chr7	33388081	33505642	Q3SYG4	0	+	33388081	33505642	255,102,0	1	117561	0	.	Interaction with LZTL1. Pubmed:22072986
chr7	36390026	36396382	Q9NQW6	0	+	36390026	36396382	255,102,0	1	6356	0	.	Required for ubiquitination.
chr7	36390026	36399371	Q9NQW6	0	+	36390026	36399371	255,102,0	1	9345	0	.	Interaction with CD2AP. Pubmed:15800069
chr7	36390026	36406383	Q9NQW6	0	+	36390026	36406383	255,102,0	1	16357	0	.	Nuclear localization.
chr7	36406383	36420609	Q9NQW6	0	+	36406383	36420609	255,102,0	1	14226	0	.	Interaction with F-actin.
chr7	36421880	36452597	Q9NQW6	0	+	36421880	36452597	255,102,0	1	30717	0	.	Localization to the cleavage furrow.
chr7	37864361	37867851	Q8N427	0	+	37864361	37867851	255,102,0	1	3490	0	.	NDK 1.
chr7	37876955	37888394	Q8N427	0	+	37876955	37888394	255,102,0	1	11439	0	.	NDK 2.
chr7	37888394	37897089	Q8N427	0	+	37888394	37897089	255,102,0	1	8695	0	.	NDK 3.
chr7	38756912	38909174	P49754	0	-	38756912	38909174	255,102,0	1	152262	0	.	Interaction with ARL8B. Pubmed:25908847
chr7	44064862	44064868	P15259	0	-	44064862	44064868	255,102,0	1	6	0	.	Substrate binding.
chr7	44065178	44065184	P15259	0	-	44065178	44065184	255,102,0	1	6	0	.	Substrate binding.
chr7	44065253	44065265	P15259	0	-	44065253	44065265	255,102,0	1	12	0	.	Substrate binding.
chr7	44065457	44065463	P15259	0	-	44065457	44065463	255,102,0	1	6	0	.	Substrate binding.
chr7	44065478	44065502	P15259	0	-	44065478	44065502	255,102,0	1	24	0	.	Substrate binding.
chr7	44074205	44074399	Q9NP87	0	-	44074205	44074399	255,102,0	1	194	0	.	Involved in ssDNA binding.
chr7	44110031	44111188	Q8IUX7	0	+	44110031	44111188	255,102,0	1	1157	0	.	Required for DNA-binding and interaction with NFKBIA.
chr7	44110206	44111885	Q8IUX7	0	+	44110206	44111885	255,102,0	1	1679	0	.	Interaction with MAPK1 and MAPK3.
chr7	44111185	44113739	Q8IUX7	0	+	44111185	44113739	255,102,0	1	2554	0	.	Interaction with PTEN.
chr7	44113604	44114258	Q8IUX7	0	+	44113604	44114258	255,102,0	1	654	0	.	Required for transcriptional repression.
chr7	44113799	44114258	Q8IUX7	0	+	44113799	44114258	255,102,0	1	459	0	.	Interaction with MAPK1 and MAPK3.
chr7	44145204	44149829	P35557	0	-	44145204	44149829	255,102,0	1	4625	0	.	Hexokinase large subdomain.
chr7	44149823	44149829	P35557	0	-	44149823	44149829	255,102,0	1	6	0	.	Substrate binding.
chr7	44149829	44153310	P35557	0	-	44149829	44153310	255,102,0	1	3481	0	.	Hexokinase small subdomain.
chr7	44150040	44150046	P35557	0	-	44150040	44150046	255,102,0	1	6	0	.	Substrate binding.
chr7	44150982	44150988	P35557	0	-	44150982	44150988	255,102,0	1	6	0	.	Substrate binding.
chr7	44241699	44241732	Q13554	0	-	44241699	44241732	255,102,0	1	33	0	.	Calmodulin-binding.
chr7	44241726	44241756	Q13554	0	-	44241726	44241756	255,102,0	1	30	0	.	Autoinhibitory domain.
chr7	44761510	44761827	Q8NF64	0	+	44761510	44761827	255,102,0	1	317	0	.	Interaction with AR. Pubmed:16051670
chr7	45073502	45075850	Q9BSQ5	0	+	45073502	45075850	255,102,0	1	2348	0	.	Harmonin homology domain.
chr7	45662085	45662169	Q08828	0	+	45662085	45662169	255,102,0	1	84	0	.	Interaction with calmodulin.
chr7	45713704	45713776	Q08828	0	+	45713704	45713776	255,102,0	1	72	0	.	Interaction with calmodulin.
chr7	45920738	45921059	P17936	0	-	45920738	45921059	255,102,0	1	321	0	.	IGF-binding.
chr7	48103386	48103398	Q16831	0	+	48103386	48103398	255,102,0	1	12	0	.	Phosphate binding. Pubmed:19291308
chr7	50382577	50382607	Q13422	0	+	50382577	50382607	255,102,0	1	30	0	.	Required for both high-affinity DNA binding and pericentromeric heterochromatin localization.
chr7	50382655	50382703	Q13422	0	+	50382655	50382703	255,102,0	1	48	0	.	Required for both high-affinity DNA binding and pericentromeric heterochromatin localization.
chr7	50400468	50400480	Q13422	0	+	50400468	50400480	255,102,0	1	12	0	.	Required for binding PP1CC.
chr7	50446255	50446405	Q6PIW4	0	-	50446255	50446405	255,102,0	1	150	0	.	Necessary and sufficient for interaction with RAD51. Pubmed:23754376
chr7	50529243	50543914	P20711	0	-	50529243	50543914	255,102,0	1	14671	0	.	2 X approximate tandem repeats.
chr7	55173920	55173971	P00533	0	+	55173920	55173971	255,102,0	1	51	0	.	Important for dimerization, phosphorylation and activation.
chr7	55366028	55366070	Q9NS86	0	+	55366028	55366070	255,102,0	1	42	0	.	Interaction with inositol phospholipids.
chr7	56017324	56017330	P78330	0	-	56017324	56017330	255,102,0	1	6	0	.	Substrate binding.
chr7	56081116	56081191	Q16816	0	-	56081116	56081191	255,102,0	1	75	0	.	Calmodulin-binding (domain-C).
chr7	56081236	56081641	Q16816	0	-	56081236	56081641	255,102,0	1	405	0	.	Calmodulin-binding (domain-N).
chr7	71388262	71420929	Q6IS24	0	+	71388262	71420929	255,102,0	1	32667	0	.	Catalytic subdomain A.
chr7	71421097	71665473	Q6IS24	0	+	71421097	71665473	255,102,0	1	244376	0	.	Catalytic subdomain B.
chr7	72925121	72925223	Q96HA1	0	+	72925121	72925223	255,102,0	1	102	0	.	Cisternal side.
chr7	72925121	72926472	Q96HA1	0	+	72925121	72926472	255,102,0	1	1351	0	.	Required for targeting to the nucleus and nuclear pore complex.
chr7	72925286	72946231	Q96HA1	0	+	72925286	72946231	255,102,0	1	20945	0	.	Pore side.
chr7	73304781	73304802	Q96P11	0	-	73304781	73304802	255,102,0	1	21	0	.	S-adenosyl-L-methionine binding.
chr7	73434178	73434523	O00144	0	+	73434178	73434523	255,102,0	1	345	0	.	Required for Wnt-activated receptor activity.
chr7	73435666	73435780	O00144	0	+	73435666	73435780	255,102,0	1	114	0	.	Required for CTNNB1 accumulation and TCF transcription factor activity.
chr7	73478425	73521933	Q9UIG0	0	-	73478425	73521933	255,102,0	1	43508	0	.	Mediates the tyrosine-protein kinase activity.
chr7	73595855	73595921	Q9NP71	0	-	73595855	73595921	255,102,0	1	66	0	.	Leucine-zipper.
chr7	73769389	73769395	O15551	0	-	73769389	73769395	255,102,0	1	6	0	.	Interactions with TJP1, TJP2 and TJP3.
chr7	73831201	73831510	O14493	0	+	73831201	73831510	255,102,0	1	309	0	.	Interaction with EPHA2. Pubmed:16236711
chr7	73831822	73831828	O14493	0	+	73831822	73831828	255,102,0	1	6	0	.	Interactions with TJP1, TJP2 and TJP3.
chr7	74190245	74194742	Q15056	0	+	74190245	74194742	255,102,0	1	4497	0	.	HHV-1 Vhs binding site.
chr7	75542968	75545149	O00291	0	-	75542968	75545149	255,102,0	1	2181	0	.	Important for actin binding.
chr7	75557761	75559879	O00291	0	-	75557761	75559879	255,102,0	1	2118	0	.	pDED.
chr7	76302919	76304170	P04792	0	+	76302919	76304170	255,102,0	1	1251	0	.	Interaction with TGFB1I1.
chr7	77571164	77571179	Q05209	0	+	77571164	77571179	255,102,0	1	15	0	.	Substrate binding. Pubmed:27134172
chr7	77600801	77607250	Q05209	0	+	77600801	77607250	255,102,0	1	6449	0	.	Substrate binding.
chr7	77626711	77626993	Q05209	0	+	77626711	77626993	255,102,0	1	282	0	.	Interaction with TGFB1I1.
chr7	78346003	78501638	Q86UL8	0	-	78346003	78501638	255,102,0	1	155635	0	.	Interaction with DDN. Pubmed:16464232
chr7	80656695	80661141	P16671	0	+	80656695	80661141	255,102,0	1	4446	0	.	Required for interaction with thrombospondins, THBS1 and THBS2. Pubmed:1371676
chr7	80674105	80674144	P16671	0	+	80674105	80674144	255,102,0	1	39	0	.	Interaction with PTK2, PXN and LYN. Pubmed:20037584
chr7	86786305	86786314	Q14832	0	+	86786305	86786314	255,102,0	1	9	0	.	Glutamate binding.
chr7	87164941	87181342	Q9Y222	0	+	87164941	87181342	255,102,0	1	16401	0	.	Interaction with CCND2.
chr7	87171020	87174660	Q9Y222	0	+	87171020	87174660	255,102,0	1	3640	0	.	Required for transcriptional activation.
chr7	87171020	87188264	Q9Y222	0	+	87171020	87188264	255,102,0	1	17244	0	.	Required for DNA-binding.
chr7	87179550	87195137	Q9Y222	0	+	87179550	87195137	255,102,0	1	15587	0	.	Interaction with CCND1, CCND2 and CCND3.
chr7	87188264	87195137	Q9Y222	0	+	87188264	87195137	255,102,0	1	6873	0	.	Required for transcriptional activation.
chr7	87382469	87382493	Q9UKG9	0	+	87382469	87382493	255,102,0	1	24	0	.	Coenzyme A binding.
chr7	87426872	87431424	P21439	0	-	87426872	87431424	255,102,0	1	4552	0	.	Interaction with HAX1.
chr7	91873620	91873644	Q99551	0	-	91873620	91873644	255,102,0	1	24	0	.	Interaction with DNA.
chr7	91873719	91873731	Q99551	0	-	91873719	91873731	255,102,0	1	12	0	.	Interaction with DNA.
chr7	91873800	91873824	Q99551	0	-	91873800	91873824	255,102,0	1	24	0	.	Interaction with DNA.
chr7	91874040	91874055	Q99551	0	-	91874040	91874055	255,102,0	1	15	0	.	Interaction with DNA.
chr7	91874283	91874289	Q99551	0	-	91874283	91874289	255,102,0	1	6	0	.	Interaction with DNA.
chr7	92222876	92222945	O00522	0	-	92222876	92222945	255,102,0	1	69	0	.	Interaction with RAP1B. Pubmed:22577140
chr7	92235546	92235618	O00522	0	-	92235546	92235618	255,102,0	1	72	0	.	Interaction with ITGB1BP1.
chr7	92235621	92242135	O00522	0	-	92235621	92242135	255,102,0	1	6514	0	.	N-terminal domain similar to Nudix hydrolase domain.
chr7	92468929	92468989	Q9UQF0	0	-	92468929	92468989	255,102,0	1	60	0	.	Essential for the fusiogenic function.
chr7	92469193	92469244	Q9UQF0	0	-	92469193	92469244	255,102,0	1	51	0	.	Immunosuppression.
chr7	92469361	92469424	Q9UQF0	0	-	92469361	92469424	255,102,0	1	63	0	.	Fusion peptide.
chr7	94910113	94910545	Q9ULJ8	0	+	94910113	94910545	255,102,0	1	432	0	.	Actin-binding.
chr7	94911385	95111369	Q9ULJ8	0	+	94911385	95111369	255,102,0	1	199984	0	.	Interaction with protein phosphatase 1.
chr7	95198382	95290276	Q9ULJ8	0	+	95198382	95290276	255,102,0	1	91894	0	.	Interaction with TGN38.
chr7	95528036	95528042	Q9Y574	0	+	95528036	95528042	255,102,0	1	6	0	.	Essential for interaction with HIF1AN.
chr7	95528054	95528063	Q9Y574	0	+	95528054	95528063	255,102,0	1	9	0	.	Essential for interaction with HIF1AN.
chr7	95804729	95828060	O14576	0	+	95804729	95828060	255,102,0	1	23331	0	.	Interaction with DCTN1.
chr7	95869895	95869946	O14576	0	+	95869895	95869946	255,102,0	1	51	0	.	Interaction with DYNLT1. Pubmed:27502274
chr7	97868925	97868934	P08243	0	-	97868925	97868934	255,102,0	1	9	0	.	Glutamine binding.
chr7	97868997	97869012	P08243	0	-	97868997	97869012	255,102,0	1	15	0	.	Glutamine binding.
chr7	98293523	98294087	Q9UHR4	0	-	98293523	98294087	255,102,0	1	564	0	.	Binds F-actin.
chr7	98956256	98967049	Q9Y4A5	0	+	98956256	98967049	255,102,0	1	10793	0	.	Interaction with TP53. Pubmed:12138177
chr7	100091133	100091786	Q7L5N1	0	+	100091133	100091786	255,102,0	1	653	0	.	Interaction with Vpr.
chr7	100092934	100094292	P33993	0	-	100092934	100094292	255,102,0	1	1358	0	.	Interaction with ATRIP.
chr7	100094328	100095808	P33993	0	-	100094328	100095808	255,102,0	1	1480	0	.	Interaction with RAD17. Pubmed:15538388
chr7	100431368	100431377	Q7L2J0	0	+	100431368	100431377	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr7	100431437	100431443	Q7L2J0	0	+	100431437	100431443	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr7	100432921	100432927	Q7L2J0	0	+	100432921	100432927	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr7	100467051	100467117	Q9Y3Q8	0	-	100467051	100467117	255,102,0	1	66	0	.	Leucine-zipper.
chr7	100486977	100488279	Q6ZVC0	0	+	100486977	100488279	255,102,0	1	1302	0	.	Involved in CYFIP1- and NCKAP1-binding.
chr7	100655442	100655574	O94805	0	-	100655442	100655574	255,102,0	1	132	0	.	Essential for mediating its function in dendritic development; may contribute to neuronal-specific targeting.
chr7	100873276	100873300	Q15654	0	+	100873276	100873300	255,102,0	1	24	0	.	Interaction with MAGI1 and PTPN13. Pubmed:19017743
chr7	100893530	100893536	P22303	0	-	100893530	100893536	255,102,0	1	6	0	.	Galanthamine binding.
chr7	100957455	100959117	Q02505	0	+	100957455	100959117	255,102,0	1	1662	0	.	32 X approximate tandem repeats, Ser/Thr-rich.
chr7	100990797	101004417	Q9UKN1	0	+	100990797	101004417	255,102,0	1	13620	0	.	28 X 19 AA approximate tandem repeats of E-E-S-X-X-X-H-X-X-P-X-X-T-X-T-X-X-X-P.
chr7	101031968	101042597	Q685J3	0	+	101031968	101042597	255,102,0	1	10629	0	.	59 X approximate tandem repeats.
chr7	101223496	101223729	O43257	0	+	101223496	101223729	255,102,0	1	233	0	.	Interaction with NR1D2. Pubmed:17892483
chr7	101232855	101232861	P56746	0	-	101232855	101232861	255,102,0	1	6	0	.	Important for the formation of tight-junction strand-like structures.
chr7	102396411	102397643	Q9H875	0	+	102396411	102397643	255,102,0	1	1232	0	.	Interaction with EIF2AK2.
chr7	102397643	102407470	Q9H875	0	+	102397643	102407470	255,102,0	1	9827	0	.	Required for RNA-binding.
chr7	102404666	102407455	Q9H875	0	+	102404666	102407455	255,102,0	1	2789	0	.	Required for nuclear localization.
chr7	103322763	103326637	Q99543	0	-	103322763	103326637	255,102,0	1	3874	0	.	ZRF1-UBD.
chr7	103341925	103341952	Q99543	0	-	103341925	103341952	255,102,0	1	27	0	.	Epitope (recognized by CD8(+) cytotoxic T-lymphocytes).
chr7	106261614	106261620	A0A024R718	0	-	106261614	106261620	255,102,0	1	6	0	.	Nicotinamide ribonucleotide binding.
chr7	106261614	106261620	P43490	0	-	106261614	106261620	255,102,0	1	6	0	.	Nicotinamide ribonucleotide binding.
chr7	106263421	106263430	A0A024R718	0	-	106263421	106263430	255,102,0	1	9	0	.	Nicotinamide ribonucleotide binding.
chr7	106263421	106263430	P43490	0	-	106263421	106263430	255,102,0	1	9	0	.	Nicotinamide ribonucleotide binding.
chr7	107044910	107128274	P31323	0	+	107044910	107128274	255,102,0	1	83364	0	.	Dimerization and phosphorylation.
chr7	107758143	107758320	Q75N03	0	+	107758143	107758320	255,102,0	1	177	0	.	HYB domain.
chr7	107923953	107932275	P07942	0	-	107923953	107932275	255,102,0	1	8322	0	.	Domain I.
chr7	107932275	107932374	P07942	0	-	107932275	107932374	255,102,0	1	99	0	.	Domain alpha.
chr7	107932374	107940215	P07942	0	-	107932374	107940215	255,102,0	1	7841	0	.	Domain II.
chr7	108024041	108048009	A4D0S4	0	-	108024041	108048009	255,102,0	1	23968	0	.	Domain I.
chr7	108048009	108048108	A4D0S4	0	-	108048009	108048108	255,102,0	1	99	0	.	Domain alpha.
chr7	108048108	108055864	A4D0S4	0	-	108048108	108055864	255,102,0	1	7756	0	.	Domain II.
chr7	114652269	114653970	O15409	0	+	114652269	114653970	255,102,0	1	1701	0	.	Leucine-zipper.
chr7	114654006	114658077	O15409	0	+	114654006	114658077	255,102,0	1	4071	0	.	CTBP1-binding.
chr7	115940553	115940784	O14948	0	-	115940553	115940784	255,102,0	1	231	0	.	Necessary for transcriptional transactivation.
chr7	115956703	115984441	O14948	0	-	115956703	115984441	255,102,0	1	27738	0	.	Necessary for transcriptional transactivation.
chr7	116783304	116796121	P08581	0	+	116783304	116796121	255,102,0	1	12817	0	.	Interaction with RANBP9.
chr7	116795908	116796028	P08581	0	+	116795908	116796028	255,102,0	1	120	0	.	Interaction with MUC20. Pubmed:15314156
chr7	120274635	120274692	Q9NZV8	0	+	120274635	120274692	255,102,0	1	57	0	.	Interaction with KCNIP1, KCNIP2, and other family members.
chr7	120274842	120274902	Q9NZV8	0	+	120274842	120274902	255,102,0	1	60	0	.	Interaction with KCNIP1.
chr7	120275553	120275595	Q9NZV8	0	+	120275553	120275595	255,102,0	1	42	0	.	S4-S5 linker.
chr7	120742554	120742602	Q9NZV8	0	+	120742554	120742602	255,102,0	1	48	0	.	Required for dendritic targeting.
chr7	120742554	120747855	Q9NZV8	0	+	120742554	120747855	255,102,0	1	5301	0	.	Important for normal channel activation and inactivation, for interaction with KCNIP2, and probably other family members as well. Pubmed:16934482
chr7	122040974	122042623	P23471	0	+	122040974	122042623	255,102,0	1	1649	0	.	Substrate binding.
chr7	122076491	122098844	Q9UDR5	0	-	122076491	122098844	255,102,0	1	22353	0	.	Saccharopine dehydrogenase.
chr7	122101411	122133630	Q9UDR5	0	-	122101411	122133630	255,102,0	1	32219	0	.	Lysine-ketoglutarate reductase.
chr7	122387115	122451399	Q86UW7	0	-	122387115	122451399	255,102,0	1	64284	0	.	Interaction with DRD2. Pubmed:15857609
chr7	123655963	123656104	Q6P5Q4	0	+	123655963	123656104	255,102,0	1	141	0	.	Interaction with tropomyosin alpha. Pubmed:25250574
chr7	123655963	123662069	Q6P5Q4	0	+	123655963	123662069	255,102,0	1	6106	0	.	Interaction with actin 1. Pubmed:26417072
chr7	123662069	123663077	Q6P5Q4	0	+	123662069	123663077	255,102,0	1	1008	0	.	Interaction with actin 2. Pubmed:26417072
chr7	123663146	123663721	Q6P5Q4	0	+	123663146	123663721	255,102,0	1	575	0	.	Interaction with actin 3. Pubmed:26417072
chr7	124853021	124853033	Q9NUX5	0	-	124853021	124853033	255,102,0	1	12	0	.	DNA binding.
chr7	124871021	124892293	Q9NUX5	0	-	124871021	124892293	255,102,0	1	21272	0	.	DNA binding.
chr7	127106685	127106694	O00222	0	-	127106685	127106694	255,102,0	1	9	0	.	Glutamate binding.
chr7	128394938	128394953	C9J381	0	-	128394938	128394953	255,102,0	1	15	0	.	IMP binding.
chr7	128395019	128395025	C9J381	0	-	128395019	128395025	255,102,0	1	6	0	.	IMP binding.
chr7	128395182	128395191	C9J381	0	-	128395182	128395191	255,102,0	1	9	0	.	IMP binding.
chr7	128457268	128457379	Q9Y5L2	0	+	128457268	128457379	255,102,0	1	111	0	.	Required for targeting to lipid droplets.
chr7	128849978	128850050	Q14315	0	+	128849978	128850050	255,102,0	1	72	0	.	Hinge 1.
chr7	128853972	128854414	Q14315	0	+	128853972	128854414	255,102,0	1	442	0	.	Intradomain insert; mediate targeting to Z lines.
chr7	128855269	128858517	Q14315	0	+	128855269	128858517	255,102,0	1	3248	0	.	Interaction with INPPL1. Pubmed:11739414
chr7	128857332	128858114	Q14315	0	+	128857332	128858114	255,102,0	1	782	0	.	Hinge 2.
chr7	128857332	128858520	Q14315	0	+	128857332	128858520	255,102,0	1	1188	0	.	Self-association site, tail.
chr7	129210507	129211019	Q99835	0	+	129210507	129211019	255,102,0	1	512	0	.	Interaction with BBS5 and BBS7. Pubmed:22072986
chr7	129225079	129225403	Q96HN2	0	+	129225079	129225403	255,102,0	1	324	0	.	LISN domain, inhibits interaction with ITPR1. Pubmed:19220705
chr7	129657351	129671439	Q16656	0	+	129657351	129671439	255,102,0	1	14088	0	.	Dimerization.
chr7	129710508	129755097	Q16656	0	+	129710508	129755097	255,102,0	1	44589	0	.	Required for transcriptional activation.
chr7	130026303	130029015	Q86WB0	0	-	130026303	130029015	255,102,0	1	2712	0	.	F-box-like.
chr7	130130617	130130743	Q6PID8	0	+	130130617	130130743	255,102,0	1	126	0	.	Interaction with CUL2. Pubmed:23102700
chr7	130275196	130275208	P48052	0	+	130275196	130275208	255,102,0	1	12	0	.	Substrate binding.
chr7	130277888	130277894	P48052	0	+	130277888	130277894	255,102,0	1	6	0	.	Substrate binding.
chr7	130279593	130279599	P48052	0	+	130279593	130279599	255,102,0	1	6	0	.	Substrate binding.
chr7	130305869	130305881	Q9UI42	0	+	130305869	130305881	255,102,0	1	12	0	.	Substrate binding.
chr7	130308369	130308375	Q9UI42	0	+	130308369	130308375	255,102,0	1	6	0	.	Substrate binding.
chr7	130310815	130310821	Q9UI42	0	+	130310815	130310821	255,102,0	1	6	0	.	Substrate binding.
chr7	130310917	130310923	Q9UI42	0	+	130310917	130310923	255,102,0	1	6	0	.	Substrate binding.
chr7	130362488	130362500	Q8WXQ8	0	+	130362488	130362500	255,102,0	1	12	0	.	Substrate binding.
chr7	130363481	130363487	Q8WXQ8	0	+	130363481	130363487	255,102,0	1	6	0	.	Substrate binding.
chr7	130367502	130367508	Q8WXQ8	0	+	130367502	130367508	255,102,0	1	6	0	.	Substrate binding.
chr7	130383441	130383453	P15085	0	+	130383441	130383453	255,102,0	1	12	0	.	Substrate binding. Pubmed:18566513
chr7	130384598	130384604	P15085	0	+	130384598	130384604	255,102,0	1	6	0	.	Substrate binding. Pubmed:18566513
chr7	130385276	130385282	P15085	0	+	130385276	130385282	255,102,0	1	6	0	.	Substrate binding. Pubmed:18566513
chr7	134661534	134661558	P07738	0	+	134661534	134661558	255,102,0	1	24	0	.	Substrate binding. Pubmed:17052986
chr7	134661573	134661579	P07738	0	+	134661573	134661579	255,102,0	1	6	0	.	Substrate binding. Pubmed:17052986
chr7	134661771	134661783	P07738	0	+	134661771	134661783	255,102,0	1	12	0	.	Substrate binding. Pubmed:17052986
chr7	134661852	134661858	P07738	0	+	134661852	134661858	255,102,0	1	6	0	.	Substrate binding. Pubmed:17052986
chr7	134662071	134662077	P07738	0	+	134662071	134662077	255,102,0	1	6	0	.	Substrate binding. Pubmed:17052986
chr7	134928757	134933390	Q05682	0	+	134928757	134933390	255,102,0	1	4633	0	.	Myosin and calmodulin-binding.
chr7	134933723	134933894	Q05682	0	+	134933723	134933894	255,102,0	1	171	0	.	3 X 14 AA tandem repeats of E-E-E-K-R-A-A-E-E-R-Q-R-I-K.
chr7	134947664	134950442	Q05682	0	+	134947664	134950442	255,102,0	1	2778	0	.	Tropomyosin-binding.
chr7	134958089	134958287	Q05682	0	+	134958089	134958287	255,102,0	1	198	0	.	Strong actin-binding.
chr7	134958218	134958251	Q05682	0	+	134958218	134958251	255,102,0	1	33	0	.	Tropomyosin-binding.
chr7	134960057	134960078	Q05682	0	+	134960057	134960078	255,102,0	1	21	0	.	Calmodulin-binding.
chr7	134965311	134968342	Q05682	0	+	134965311	134968342	255,102,0	1	3031	0	.	Weak actin-binding.
chr7	137015171	137015186	P08172	0	+	137015171	137015186	255,102,0	1	15	0	.	Agonist binding.
chr7	137016071	137016077	P08172	0	+	137016071	137016077	255,102,0	1	6	0	.	Agonist binding.
chr7	137016140	137016155	P08172	0	+	137016140	137016155	255,102,0	1	15	0	.	Agonist binding.
chr7	137228022	137251242	P21246	0	-	137228022	137251242	255,102,0	1	23220	0	.	Chondroitin sulfate A binding. Pubmed:26896299
chr7	137251287	137251314	P21246	0	-	137251287	137251314	255,102,0	1	27	0	.	Chondroitin sulfate binding. Pubmed:26896299
chr7	137251383	137253479	P21246	0	-	137251383	137253479	255,102,0	1	2096	0	.	Chondroitin sulfate binding. Pubmed:26896299
chr7	137885474	137901391	Q70SY1	0	-	137885474	137901391	255,102,0	1	15917	0	.	Leucine-zipper.
chr7	137903957	137905731	Q70SY1	0	-	137903957	137905731	255,102,0	1	1774	0	.	Basic motif.
chr7	138579206	138579284	O15164	0	+	138579206	138579284	255,102,0	1	78	0	.	Nuclear receptor binding site (NRBS).
chr7	138579446	138579467	O15164	0	+	138579446	138579467	255,102,0	1	21	0	.	Interaction with histone H3 that is not methylated at 'Lys-4' (H3K4me0).
chr7	138583990	138583996	O15164	0	+	138583990	138583996	255,102,0	1	6	0	.	Interaction with histone H3 that is acetylated at 'Lys-23' (H3K23ac).
chr7	139080178	139083807	Q7Z2W4	0	-	139080178	139083807	255,102,0	1	3629	0	.	Binding to EXOSC5.
chr7	139080178	139109328	Q7Z2W4	0	-	139080178	139109328	255,102,0	1	29150	0	.	N-terminal domain.
chr7	139572929	139583832	Q9H2X6	0	-	139572929	139583832	255,102,0	1	10903	0	.	Autoinhibitory domain (AID).
chr7	139573376	139583979	Q9H2X6	0	-	139573376	139583979	255,102,0	1	10603	0	.	Interaction with AXIN1.
chr7	139583841	139596817	Q9H2X6	0	-	139583841	139596817	255,102,0	1	12976	0	.	Required for localization to nuclear speckles.
chr7	139583958	139596898	Q9H2X6	0	-	139583958	139596898	255,102,0	1	12940	0	.	Interaction with TP53 and TP73. Pubmed:11925430
chr7	139584057	139596784	Q9H2X6	0	-	139584057	139596784	255,102,0	1	12727	0	.	SUMO interaction motifs (SIM); required for nuclear localization and kinase activity.
chr7	139584060	139596817	Q9H2X6	0	-	139584060	139596817	255,102,0	1	12757	0	.	Interaction with UBE2I.
chr7	139596742	139600493	Q9H2X6	0	-	139596742	139600493	255,102,0	1	3751	0	.	Interaction with HMGA1.
chr7	139596742	139604082	Q9H2X6	0	-	139596742	139604082	255,102,0	1	7340	0	.	Interaction with POU4F1.
chr7	139596805	139600532	Q9H2X6	0	-	139596805	139600532	255,102,0	1	3727	0	.	Interaction with CTBP1.
chr7	139596901	139626605	Q9H2X6	0	-	139596901	139626605	255,102,0	1	29704	0	.	Interaction with SKI and SMAD1. Pubmed:12874272
chr7	139626659	139716470	Q9H2X6	0	-	139626659	139716470	255,102,0	1	89811	0	.	Interaction with DAXX. Pubmed:14678985
chr7	139716344	139716746	Q9H2X6	0	-	139716344	139716746	255,102,0	1	402	0	.	Transcriptional corepression.
chr7	140133594	140133648	Q6ZMT4	0	-	140133594	140133648	255,102,0	1	54	0	.	Linker.
chr7	140456848	140459072	Q9UHC7	0	-	140456848	140459072	255,102,0	1	2224	0	.	Makorin-type Cys-His.
chr7	142021618	142050804	O43451	0	+	142021618	142050804	255,102,0	1	29186	0	.	Maltase.
chr7	142054792	142103382	O43451	0	+	142054792	142103382	255,102,0	1	48590	0	.	Glucoamylase.
chr7	142131963	142164966	Q2M2H8	0	+	142131963	142164966	255,102,0	1	33003	0	.	Maltase.
chr7	142170113	142218471	Q2M2H8	0	+	142170113	142218471	255,102,0	1	48358	0	.	Glucoamylase.
chr7	143263558	143263567	Q9Y2Q3	0	+	143263558	143263567	255,102,0	1	9	0	.	Glutathione binding.
chr7	143268150	143268156	Q9Y2Q3	0	+	143268150	143268156	255,102,0	1	6	0	.	Glutathione binding.
chr7	148815004	148818117	Q15910	0	-	148815004	148818117	255,102,0	1	3113	0	.	Interaction with CDYL. Pubmed:22009739
chr7	148818081	148847298	Q15910	0	-	148818081	148847298	255,102,0	1	29217	0	.	Interaction with DNMT1, DNMT3A and DNMT3B.
chr7	148846511	148847184	Q15910	0	-	148846511	148847184	255,102,0	1	673	0	.	Interaction with EED.
chr7	150857580	150857613	P19801	0	+	150857580	150857613	255,102,0	1	33	0	.	Substrate binding. Pubmed:19764817
chr7	150857841	150857859	P19801	0	+	150857841	150857859	255,102,0	1	18	0	.	Substrate binding. Pubmed:19764817
chr7	150858893	150858917	P19801	0	+	150858893	150858917	255,102,0	1	24	0	.	Heparin-binding.
chr7	151071535	151076364	P04920	0	+	151071535	151076364	255,102,0	1	4829	0	.	Membrane (anion exchange).
chr7	151082473	151082560	Q9BVT8	0	-	151082473	151082560	255,102,0	1	87	0	.	Required to release iHOPS from membranes.
chr7	151116818	151128591	Q96P47	0	+	151116818	151128591	255,102,0	1	11773	0	.	Small GTPase-like.
chr7	151983013	152002784	Q7Z4T8	0	+	151983013	152002784	255,102,0	1	19771	0	.	Catalytic subdomain A.
chr7	152002955	152014706	Q7Z4T8	0	+	152002955	152014706	255,102,0	1	11751	0	.	Catalytic subdomain B.
chr7	152103139	152108108	Q8NCW6	0	+	152103139	152108108	255,102,0	1	4969	0	.	Catalytic subdomain A.
chr7	152108279	152113308	Q8NCW6	0	+	152108279	152113308	255,102,0	1	5029	0	.	Catalytic subdomain B.
chr7	152138891	152138897	Q8NEZ4	0	-	152138891	152138897	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr7	154944151	154968433	Q6ZW49	0	-	154944151	154968433	255,102,0	1	24282	0	.	Interaction with TP53BP1.
chr7	154976220	154991050	Q6ZW49	0	-	154976220	154991050	255,102,0	1	14830	0	.	Interaction with PAGR1.
chr7	156949737	156950544	Q5C9Z4	0	+	156949737	156950544	255,102,0	1	807	0	.	Necessary for nucleolar localization and for targeting PPP1CA to the nucleolus.
chr7	157139272	157169107	Q15386	0	+	157139272	157169107	255,102,0	1	29835	0	.	Cis-determinant of acceptor ubiquitin-binding.
chr7	157358575	157382337	O75190	0	+	157358575	157382337	255,102,0	1	23762	0	.	Interaction with HSP70. Pubmed:10954706
chr7	157382253	157409829	O75190	0	+	157382253	157409829	255,102,0	1	27576	0	.	Interaction with KRT18. Pubmed:10954706
chr7	157568950	157571444	Q92932	0	-	157568950	157571444	255,102,0	1	2494	0	.	Substrate binding.
chr7	158133969	158587669	Q92932	0	-	158133969	158587669	255,102,0	1	453700	0	.	Involved in localization to secretory granules; interaction with CPE.
chr8	413079	432896	Q8TCJ0	0	+	413079	432896	255,102,0	1	19817	0	.	Interaction with beta-actin.
chr8	10765403	10765628	Q96BK5	0	-	10765403	10765628	255,102,0	1	225	0	.	Telomerase inhibitory domain (TID).
chr8	12137170	12137566	Q6R6M4	0	-	12137170	12137566	255,102,0	1	396	0	.	Mediates interaction with SUDS3. Pubmed:21239494
chr8	12186592	12186601	Q8N7N1	0	-	12186592	12186601	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr8	12428873	12428882	P0C5J1	0	-	12428873	12428882	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr8	13095193	13098415	Q96QB1	0	-	13095193	13098415	255,102,0	1	3222	0	.	Polybasic cluster (PBR).
chr8	13099684	13100209	Q96QB1	0	-	13099684	13100209	255,102,0	1	525	0	.	Focal adhesion-targeting (FAT).
chr8	16168760	16168859	P21757	0	-	16168760	16168859	255,102,0	1	99	0	.	Spacer.
chr8	17311579	17311600	Q9Y216	0	-	17311579	17311600	255,102,0	1	21	0	.	Substrate binding.
chr8	17331186	17331192	Q9Y216	0	-	17331186	17331192	255,102,0	1	6	0	.	Substrate binding.
chr8	17331255	17331267	Q9Y216	0	-	17331255	17331267	255,102,0	1	12	0	.	Substrate binding.
chr8	18222362	18222368	P18440	0	+	18222362	18222368	255,102,0	1	6	0	.	Substrate binding.
chr8	19959276	19961084	P06858	0	+	19959276	19961084	255,102,0	1	1808	0	.	Heparin-binding.
chr8	22034128	22034200	Q86SE8	0	+	22034128	22034200	255,102,0	1	72	0	.	Acidic tract A2.
chr8	22072390	22080435	Q08495	0	+	22072390	22080435	255,102,0	1	8045	0	.	Interaction with RASGRF2. Pubmed:11856323
chr8	22176240	22180369	P13497	0	+	22176240	22180369	255,102,0	1	4129	0	.	Metalloprotease.
chr8	22566707	22571023	O60504	0	+	22566707	22571023	255,102,0	1	4316	0	.	Binds to vinculin.
chr8	22571807	22574725	O60504	0	+	22571807	22574725	255,102,0	1	2918	0	.	Binds to SOS.
chr8	22616230	22617715	Q8N163	0	+	22616230	22617715	255,102,0	1	1485	0	.	Interaction with MCC. Pubmed:24824780
chr8	22618384	22619679	Q8N163	0	+	22618384	22619679	255,102,0	1	1295	0	.	Interaction with NR1D1. Pubmed:23398316
chr8	23004434	23006875	Q9BYZ6	0	+	23004434	23006875	255,102,0	1	2441	0	.	Rho-like.
chr8	23298114	23309906	Q9Y4K0	0	-	23298114	23309906	255,102,0	1	11792	0	.	Lysyl-oxidase like.
chr8	24913796	24914105	P07197	0	+	24913796	24914105	255,102,0	1	309	0	.	Head.
chr8	24914105	24914201	P07197	0	+	24914105	24914201	255,102,0	1	96	0	.	Coil 1A.
chr8	24914105	24917091	P07197	0	+	24914105	24917091	255,102,0	1	2986	0	.	Rod.
chr8	24914201	24914240	P07197	0	+	24914201	24914240	255,102,0	1	39	0	.	Linker 1.
chr8	24914240	24914537	P07197	0	+	24914240	24914537	255,102,0	1	297	0	.	Coil 1B.
chr8	24914537	24914588	P07197	0	+	24914537	24914588	255,102,0	1	51	0	.	Linker 12.
chr8	24914588	24914654	P07197	0	+	24914588	24914654	255,102,0	1	66	0	.	Coil 2A.
chr8	24914654	24914666	P07197	0	+	24914654	24914666	255,102,0	1	12	0	.	Linker 2.
chr8	24914666	24917091	P07197	0	+	24914666	24917091	255,102,0	1	2425	0	.	Coil 2B.
chr8	24917091	24918603	P07197	0	+	24917091	24918603	255,102,0	1	1512	0	.	Tail.
chr8	24917694	24917928	P07197	0	+	24917694	24917928	255,102,0	1	234	0	.	6 X 13 AA approximate tandem repeats of K-S-P-V-[PS]-K-S-P-V-E-E-[KA]-[GAK].
chr8	24952812	24953635	P07196	0	-	24952812	24953635	255,102,0	1	823	0	.	Tail, subdomain B (acidic).
chr8	24952812	24953776	P07196	0	-	24952812	24953776	255,102,0	1	964	0	.	Tail.
chr8	24953635	24953776	P07196	0	-	24953635	24953776	255,102,0	1	141	0	.	Tail, subdomain A.
chr8	24953776	24955675	P07196	0	-	24953776	24955675	255,102,0	1	1899	0	.	Coil 2B.
chr8	24953776	24956239	P07196	0	-	24953776	24956239	255,102,0	1	2463	0	.	Rod.
chr8	24953791	24954209	P07196	0	-	24953791	24954209	255,102,0	1	418	0	.	Epitope; recognized by IF-specific monoclonal antibody.
chr8	24955675	24955702	P07196	0	-	24955675	24955702	255,102,0	1	27	0	.	Linker 2.
chr8	24955702	24955759	P07196	0	-	24955702	24955759	255,102,0	1	57	0	.	Coil 2A.
chr8	24955759	24955813	P07196	0	-	24955759	24955813	255,102,0	1	54	0	.	Linker 12.
chr8	24955813	24956104	P07196	0	-	24955813	24956104	255,102,0	1	291	0	.	Coil 1B.
chr8	24956104	24956143	P07196	0	-	24956104	24956143	255,102,0	1	39	0	.	Linker 1.
chr8	24956143	24956239	P07196	0	-	24956143	24956239	255,102,0	1	96	0	.	Coil 1A.
chr8	24956239	24956512	P07196	0	-	24956239	24956512	255,102,0	1	273	0	.	Head.
chr8	25889788	25889800	Q9HAK2	0	-	25889788	25889800	255,102,0	1	12	0	.	Interaction with DNA.
chr8	25908497	25908521	Q9HAK2	0	-	25908497	25908521	255,102,0	1	24	0	.	Interaction with DNA.
chr8	26042187	26042199	Q9HAK2	0	-	26042187	26042199	255,102,0	1	12	0	.	Interaction with DNA.
chr8	27450808	27458506	Q14289	0	+	27450808	27458506	255,102,0	1	7698	0	.	Interaction with TGFB1I1.
chr8	27454159	27458506	Q14289	0	+	27454159	27458506	255,102,0	1	4347	0	.	Focal adhesion targeting (FAT).
chr8	27491208	27511847	P34913	0	+	27491208	27511847	255,102,0	1	20639	0	.	Phosphatase.
chr8	27504975	27504981	P34913	0	+	27504975	27504981	255,102,0	1	6	0	.	Phosphate binding.
chr8	27511877	27544519	P34913	0	+	27511877	27544519	255,102,0	1	32642	0	.	Epoxide hydrolase.
chr8	27810307	27810316	Q96KB5	0	-	27810307	27810316	255,102,0	1	9	0	.	PDZ-interaction.
chr8	28731240	28731258	O43909	0	+	28731240	28731258	255,102,0	1	18	0	.	Substrate binding.
chr8	28731303	28731312	O43909	0	+	28731303	28731312	255,102,0	1	9	0	.	Substrate binding.
chr8	28743148	28743163	O43909	0	+	28743148	28743163	255,102,0	1	15	0	.	Substrate binding.
chr8	30504330	30504354	Q93062	0	+	30504330	30504354	255,102,0	1	24	0	.	Interaction with RNA. Pubmed:26347403
chr8	31058450	31076279	Q14191	0	+	31058450	31076279	255,102,0	1	17829	0	.	Interaction with WRNIP1.
chr8	31083698	31085246	Q14191	0	+	31083698	31085246	255,102,0	1	1548	0	.	2 X 27 AA tandem repeats of H-L-S-P-N-D-N-E-N-D-T-S-Y-V-I-E-S-D-E-D-L-E-M-E-M-L-K.
chr8	31132497	31141441	Q14191	0	+	31132497	31141441	255,102,0	1	8944	0	.	Interaction with DNA. Pubmed:20159463
chr8	35549458	35549467	Q6UXZ4	0	+	35549458	35549467	255,102,0	1	9	0	.	Important for interaction with FLRT2.
chr8	36836864	36836927	A8MYU2	0	+	36836864	36836927	255,102,0	1	63	0	.	Segment S7.
chr8	36840552	36840971	A8MYU2	0	+	36840552	36840971	255,102,0	1	419	0	.	Segment S8.
chr8	36909334	36909397	A8MYU2	0	+	36909334	36909397	255,102,0	1	63	0	.	Segment S9.
chr8	36922575	36930959	A8MYU2	0	+	36922575	36930959	255,102,0	1	8384	0	.	Segment S10.
chr8	37749823	37754022	O94905	0	+	37749823	37754022	255,102,0	1	4199	0	.	Interaction with ERLIN1. Pubmed:19240031
chr8	37844492	37844657	Q9HAW0	0	-	37844492	37844657	255,102,0	1	165	0	.	Required for interaction with TBP and formation of a ternary complex with DNA and TBP. Pubmed:26638071
chr8	37844660	37844681	Q9HAW0	0	-	37844660	37844681	255,102,0	1	21	0	.	Required for the formation of a ternary complex with DNA and TBP; not required for interaction with TBP in the absence of DNA. Pubmed:26638071
chr8	37847047	37847068	Q9HAW0	0	-	37847047	37847068	255,102,0	1	21	0	.	Interaction with target DNA. Pubmed:26638071
chr8	37862897	37863092	Q6WKZ4	0	-	37862897	37863092	255,102,0	1	195	0	.	Necessary for interaction with RAB4A and RAB11A, subcellular location and endosomal recycling.
chr8	37965461	37965476	P13945	0	-	37965461	37965476	255,102,0	1	15	0	.	Agonist and antagonist binding.
chr8	37965533	37965557	P13945	0	-	37965533	37965557	255,102,0	1	24	0	.	Agonist and antagonist binding.
chr8	37965833	37965878	P13945	0	-	37965833	37965878	255,102,0	1	45	0	.	Agonist and antagonist binding.
chr8	38106387	38110779	Q9UBL3	0	+	38106387	38110779	255,102,0	1	4392	0	.	DNA-binding.
chr8	38266141	38266174	Q8NEB5	0	-	38266141	38266174	255,102,0	1	33	0	.	Phosphatase sequence motif III.
chr8	38267273	38267285	Q8NEB5	0	-	38267273	38267285	255,102,0	1	12	0	.	Phosphatase sequence motif II.
chr8	38267381	38267913	Q8NEB5	0	-	38267381	38267913	255,102,0	1	532	0	.	Phosphatase sequence motif I.
chr8	38428010	38428064	P11362	0	-	38428010	38428064	255,102,0	1	54	0	.	Heparin-binding.
chr8	38787585	38788707	O75410	0	+	38787585	38788707	255,102,0	1	1122	0	.	Interaction with LSM7 and SNRPG. Pubmed:12165861
chr8	38819697	38820021	O75410	0	+	38819697	38820021	255,102,0	1	324	0	.	Interaction with TDRD7. Pubmed:14603251
chr8	38819859	38820525	O75410	0	+	38819859	38820525	255,102,0	1	666	0	.	Interaction with YEATS4. Pubmed:11903063
chr8	38842426	38848020	O75410	0	+	38842426	38848020	255,102,0	1	5594	0	.	Interaction with CH-TOG.
chr8	38976571	38981739	P83105	0	+	38976571	38981739	255,102,0	1	5168	0	.	Serine protease.
chr8	41541819	41542084	Q9BRT9	0	+	41541819	41542084	255,102,0	1	265	0	.	Important for GINS complex assembly.
chr8	41655729	41688547	P16157	0	-	41655729	41688547	255,102,0	1	32818	0	.	55 kDa regulatory domain.
chr8	41690244	41692806	P16157	0	-	41690244	41692806	255,102,0	1	2562	0	.	UPA domain.
chr8	41699528	41797538	P16157	0	-	41699528	41797538	255,102,0	1	98010	0	.	89 kDa domain.
chr8	41932375	41932483	Q92794	0	-	41932375	41932483	255,102,0	1	108	0	.	Required for activation of RUNX1-2.
chr8	41932996	41933671	Q92794	0	-	41932996	41933671	255,102,0	1	675	0	.	Interaction with PML. Pubmed:23431171
chr8	41933293	41933671	Q92794	0	-	41933293	41933671	255,102,0	1	378	0	.	Interaction with RUNX1-2.
chr8	41942798	41955375	Q92794	0	-	41942798	41955375	255,102,0	1	12577	0	.	Mediates interaction with BRPF1, required for histone H3 acetyltransferase activity. Pubmed:18794358
chr8	41942894	41974724	Q92794	0	-	41942894	41974724	255,102,0	1	31830	0	.	Catalytic.
chr8	41946594	41978751	Q92794	0	-	41946594	41978751	255,102,0	1	32157	0	.	Interaction with RUNX1-1.
chr8	41946594	42048548	Q92794	0	-	41946594	42048548	255,102,0	1	101954	0	.	Interaction with PML. Pubmed:23431171
chr8	41946606	41946627	Q92794	0	-	41946606	41946627	255,102,0	1	21	0	.	Acetyl-CoA binding.
chr8	41946639	41946654	Q92794	0	-	41946639	41946654	255,102,0	1	15	0	.	Acetyl-CoA binding.
chr8	42048479	42048824	Q92794	0	-	42048479	42048824	255,102,0	1	345	0	.	Required for nuclear localization.
chr8	42048545	42048977	Q92794	0	-	42048545	42048977	255,102,0	1	432	0	.	Required for activation of RUNX1-1.
chr8	42189030	42189063	P00750	0	-	42189030	42189063	255,102,0	1	33	0	.	Important for binding to annexin A2.
chr8	42319276	42319342	O14920	0	+	42319276	42319342	255,102,0	1	66	0	.	Leucine-zipper.
chr8	42330916	42330934	O14920	0	+	42330916	42330934	255,102,0	1	18	0	.	NEMO-binding.
chr8	42357388	42361320	P06746	0	+	42357388	42361320	255,102,0	1	3932	0	.	DNA binding.
chr8	42374120	42374342	Q9UBT3	0	-	42374120	42374342	255,102,0	1	222	0	.	DKK-type Cys-2.
chr8	42374905	42375821	Q9UBT3	0	-	42374905	42375821	255,102,0	1	916	0	.	DKK-type Cys-1.
chr8	42897131	42957117	Q86VS8	0	+	42897131	42957117	255,102,0	1	59986	0	.	Sufficient for interaction with microtubules.
chr8	43007847	43018495	Q86VS8	0	+	43007847	43018495	255,102,0	1	10648	0	.	Required for association with Golgi.
chr8	43007856	43018495	Q86VS8	0	+	43007856	43018495	255,102,0	1	10639	0	.	Required for interaction with MSR1. Pubmed:17237231
chr8	47293955	47599002	Q14159	0	+	47293955	47599002	255,102,0	1	305047	0	.	Necessary for interaction with RAD51. Pubmed:23509288
chr8	47737358	47737445	P49716	0	-	47737358	47737445	255,102,0	1	87	0	.	Leucine-zipper.
chr8	47737454	47737538	P49716	0	-	47737454	47737538	255,102,0	1	84	0	.	Basic motif.
chr8	47807247	47840164	P78527	0	-	47807247	47840164	255,102,0	1	32917	0	.	KIP-binding.
chr8	47886105	47887612	P78527	0	-	47886105	47887612	255,102,0	1	1507	0	.	Interaction with C1D. Pubmed:9679063
chr8	47886105	47887612	P78527	0	-	47886105	47887612	255,102,0	1	1507	0	.	Leucine-zipper.
chr8	48921205	48921265	O43623	0	-	48921205	48921265	255,102,0	1	60	0	.	SNAG domain.
chr8	55802497	55824679	Q96RS0	0	+	55802497	55824679	255,102,0	1	22182	0	.	Sufficient for catalytic activity.
chr8	56166245	56166593	Q6DJT9	0	-	56166245	56166593	255,102,0	1	348	0	.	Massively activates transcription.
chr8	56166245	56167019	Q6DJT9	0	-	56166245	56167019	255,102,0	1	774	0	.	Activates transcription; Inhibition of nuclear import due to lack of NLS and KPNA2 interaction.
chr8	56166593	56167019	Q6DJT9	0	-	56166593	56167019	255,102,0	1	426	0	.	Repression domain; contains 3 sumoylation motifs and massively decrease transcription activity.
chr8	56167019	56168149	Q6DJT9	0	-	56167019	56168149	255,102,0	1	1130	0	.	Decreased nuclear import with localization in the nucleus but also in the cytoplasm.
chr8	56167493	56168266	Q6DJT9	0	-	56167493	56168266	255,102,0	1	773	0	.	Interaction with KPNA2. Pubmed:11882654
chr8	56980047	56980059	Q9NX62	0	-	56980047	56980059	255,102,0	1	12	0	.	Substrate binding.
chr8	58565036	58572254	O00560	0	+	58565036	58572254	255,102,0	1	7218	0	.	Interaction with PDCD6IP. Pubmed:22660413
chr8	58579791	58580519	O00560	0	+	58579791	58580519	255,102,0	1	728	0	.	phosphatidylinositol-4,5-bisphosphate-binding. Pubmed:27386966
chr8	60517210	60558862	P61019	0	+	60517210	60558862	255,102,0	1	41652	0	.	Required for interaction with PRKCI. Pubmed:14570876
chr8	61517583	61517592	Q12797	0	-	61517583	61517592	255,102,0	1	9	0	.	2-oxoglutarate binding.
chr8	63187274	63187283	Q7Z739	0	+	63187274	63187283	255,102,0	1	9	0	.	N6-methyladenosine binding.
chr8	63187322	63187328	Q7Z739	0	+	63187322	63187328	255,102,0	1	6	0	.	N6-methyladenosine binding.
chr8	65707026	65707990	Q15390	0	+	65707026	65707990	255,102,0	1	964	0	.	Necessary and sufficient to promote mitochondrial fission.
chr8	65719385	65739538	Q13946	0	-	65719385	65739538	255,102,0	1	20153	0	.	Catalytic.
chr8	66572550	66580342	P10243	0	-	66572550	66580342	255,102,0	1	7792	0	.	Negative regulatory domain.
chr8	66580348	66593194	P10243	0	-	66580348	66593194	255,102,0	1	12846	0	.	Transcriptional activation domain.
chr8	67267171	67267346	Q9Y6D6	0	-	67267171	67267346	255,102,0	1	175	0	.	HUS; DCB:HUS domain interaction.
chr8	67292090	67343284	Q9Y6D6	0	-	67292090	67343284	255,102,0	1	51194	0	.	DCB; DCB:DCB domain and DCB:HUS domain interaction.
chr8	67434100	67434106	Q8N4T0	0	-	67434100	67434106	255,102,0	1	6	0	.	Substrate binding.
chr8	67483789	67483795	Q8N4T0	0	-	67483789	67483795	255,102,0	1	6	0	.	Substrate binding.
chr8	67506825	67506837	Q8N4T0	0	-	67506825	67506837	255,102,0	1	12	0	.	Substrate binding.
chr8	70066265	70069281	Q9GZV8	0	-	70066265	70069281	255,102,0	1	3016	0	.	Interaction with CBFA2T2.
chr8	70128941	70156177	Q15596	0	-	70128941	70156177	255,102,0	1	27236	0	.	Interaction with ARNTL.
chr8	70156135	70156294	Q15596	0	-	70156135	70156294	255,102,0	1	159	0	.	CASP8AP2-binding.
chr8	72023109	72023827	O75762	0	-	72023109	72023827	255,102,0	1	718	0	.	Inositolphosphate binding. Pubmed:25855297
chr8	73009057	73026969	P54274	0	+	73009057	73026969	255,102,0	1	17912	0	.	TRFH dimerization.
chr8	73026957	73039210	P54274	0	+	73026957	73039210	255,102,0	1	12253	0	.	Interaction with RLIM. Pubmed:19164295
chr8	73292366	73292793	P18124	0	-	73292366	73292793	255,102,0	1	427	0	.	4 X 12 AA tandem repeats.
chr8	74026811	74026826	Q9Y6Y9	0	+	74026811	74026826	255,102,0	1	15	0	.	Interaction with lipopolysaccharide. Pubmed:17569869, Pubmed:17803912
chr8	74364247	74364364	Q8TB36	0	+	74364247	74364364	255,102,0	1	117	0	.	Required for mitochondrial localization.
chr8	79611195	79636860	Q93045	0	+	79611195	79636860	255,102,0	1	25665	0	.	Membrane attachment.
chr8	79641376	79641550	Q93045	0	+	79641376	79641550	255,102,0	1	174	0	.	Regulatory/phosphorylation domain.
chr8	79765751	79767242	Q9Y5J3	0	-	79765751	79767242	255,102,0	1	1491	0	.	Transcriptional repression and interaction with NCOR1 and SIN3A.
chr8	80976546	80976555	Q9NWQ8	0	-	80976546	80976555	255,102,0	1	9	0	.	Interaction with SLC9A3R1. Pubmed:11684085
chr8	80976882	80976894	Q9NWQ8	0	-	80976882	80976894	255,102,0	1	12	0	.	Interaction with CSK. Pubmed:10790433
chr8	81284543	81284552	Q01469	0	+	81284543	81284552	255,102,0	1	9	0	.	Fatty acid binding.
chr8	81443409	81443418	P02689	0	-	81443409	81443418	255,102,0	1	9	0	.	Fatty acid binding.
chr8	81478876	81478885	P15090	0	-	81478876	81478885	255,102,0	1	9	0	.	Fatty acid binding.
chr8	81525081	81525090	A6NFH5	0	-	81525081	81525090	255,102,0	1	9	0	.	Fatty acid binding.
chr8	81660645	81660654	P29218	0	-	81660645	81660654	255,102,0	1	9	0	.	Substrate binding. Pubmed:8068620
chr8	81679142	81679154	P29218	0	-	81679142	81679154	255,102,0	1	12	0	.	Substrate binding. Pubmed:8068620, Pubmed:8068621
chr8	81732626	81755460	Q96CF2	0	+	81732626	81755460	255,102,0	1	22834	0	.	Intramolecular interaction with C-terminus.
chr8	81755460	81758541	Q96CF2	0	+	81755460	81758541	255,102,0	1	3081	0	.	Intramolecular interaction with N-terminus.
chr8	85177645	85202206	Q15329	0	+	85177645	85202206	255,102,0	1	24561	0	.	Leucine-zipper.
chr8	85203103	85209171	Q15329	0	+	85203103	85209171	255,102,0	1	6068	0	.	Dimerization.
chr8	85209384	85213859	Q15329	0	+	85209384	85213859	255,102,0	1	4475	0	.	Transactivation.
chr8	85213787	85213841	Q15329	0	+	85213787	85213841	255,102,0	1	54	0	.	RBL2 association.
chr8	85268555	85268561	Q8N1Q1	0	+	85268555	85268561	255,102,0	1	6	0	.	Substrate binding.
chr8	85329754	85329760	P00915	0	-	85329754	85329760	255,102,0	1	6	0	.	Substrate binding.
chr8	85439866	85439878	P07451	0	+	85439866	85439878	255,102,0	1	12	0	.	Involved in proton transfer.
chr8	85446225	85446231	P07451	0	+	85446225	85446231	255,102,0	1	6	0	.	Substrate binding.
chr8	85477203	85477209	P00918	0	+	85477203	85477209	255,102,0	1	6	0	.	Substrate binding. Pubmed:10550681, Pubmed:19520834
chr8	89955473	89971214	O60934	0	-	89955473	89971214	255,102,0	1	15741	0	.	Interaction with MTOR, MAPKAP1 and RICTOR. Pubmed:23762398
chr8	89964419	89980883	O60934	0	-	89964419	89980883	255,102,0	1	16464	0	.	Mediates interaction with SP100.
chr8	90082676	90082694	P05937	0	-	90082676	90082694	255,102,0	1	18	0	.	Interaction with RANBP9. Pubmed:12684061
chr8	91078493	91078514	Q8N6M0	0	+	91078493	91078514	255,102,0	1	21	0	.	Cys-loop.
chr8	91080694	91080727	Q8N6M0	0	+	91080694	91080727	255,102,0	1	33	0	.	Variable-loop.
chr8	91084784	91084817	Q8N6M0	0	+	91084784	91084817	255,102,0	1	33	0	.	His-loop.
chr8	91394024	91395094	Q8TE54	0	+	91394024	91395094	255,102,0	1	1070	0	.	Membrane targeting. Pubmed:16524946
chr8	91970720	91975926	Q06455	0	-	91970720	91975926	255,102,0	1	5206	0	.	Nervy homology region 3 (NHR3). Pubmed:12559562
chr8	91986253	91986955	Q06455	0	-	91986253	91986955	255,102,0	1	702	0	.	Important for oligomerization.
chr8	91986253	91986955	Q06455	0	-	91986253	91986955	255,102,0	1	702	0	.	Nervy homology region 2 (NHR2). Pubmed:12559562
chr8	94250345	94250405	P55040	0	-	94250345	94250405	255,102,0	1	60	0	.	Calmodulin-binding.
chr8	97644506	97644719	Q86UE4	0	+	97644506	97644719	255,102,0	1	213	0	.	Activation of NF-kappa-B.
chr8	97644719	97686691	Q86UE4	0	+	97644719	97686691	255,102,0	1	41972	0	.	Interaction with BCCIP. Pubmed:18440304
chr8	97644806	97687475	Q86UE4	0	+	97644806	97687475	255,102,0	1	42669	0	.	Interaction with RELA. Pubmed:16452207
chr8	97699845	97713718	Q86UE4	0	+	97699845	97713718	255,102,0	1	13873	0	.	Lung-homing for mammary tumors.
chr8	100258558	100259095	Q9NV58	0	-	100258558	100259095	255,102,0	1	537	0	.	Interaction with CASR. Pubmed:16513638
chr8	100712660	100717780	P11940	0	-	100712660	100717780	255,102,0	1	5120	0	.	CSDE1-binding.
chr8	101492769	101552777	Q6ISB3	0	+	101492769	101552777	255,102,0	1	60008	0	.	Transcription activation.
chr8	102551826	102551958	Q14990	0	+	102551826	102551958	255,102,0	1	132	0	.	2 X 5 AA repeats of [RC]-C-L-C-D.
chr8	102560755	102560845	Q14990	0	+	102560755	102560845	255,102,0	1	90	0	.	C-X-P repeat region.
chr8	103140906	103141005	Q8WXS3	0	+	103140906	103141005	255,102,0	1	99	0	.	Interaction with CAMK2A.
chr8	105802566	105802587	Q8WW38	0	+	105802566	105802587	255,102,0	1	21	0	.	Interaction with CTBP2.
chr8	106710644	106710728	Q8N573	0	+	106710644	106710728	255,102,0	1	84	0	.	Mediates oxidative antimutator activity.
chr8	106761039	106761129	Q8N0Z2	0	-	106761039	106761129	255,102,0	1	90	0	.	Interaction with actin.
chr8	106761039	106761285	Q8N0Z2	0	-	106761039	106761285	255,102,0	1	246	0	.	Actin-binding 2.
chr8	106761285	106769596	Q8N0Z2	0	-	106761285	106769596	255,102,0	1	8311	0	.	Actin-binding 1.
chr8	106761327	106761465	Q8N0Z2	0	-	106761327	106761465	255,102,0	1	138	0	.	Interaction with actin.
chr8	108201887	108214617	P60228	0	-	108201887	108214617	255,102,0	1	12730	0	.	Sufficient for interaction with MCM7. Pubmed:17310990
chr8	108229081	108248678	P60228	0	-	108229081	108248678	255,102,0	1	19597	0	.	Sufficient for interaction with TRIM27. Pubmed:10504338
chr8	108235084	108248693	P60228	0	-	108235084	108248693	255,102,0	1	13609	0	.	Sufficient for interaction with EPAS1. Pubmed:17324924
chr8	109575646	109575970	Q9NX95	0	-	109575646	109575970	255,102,0	1	324	0	.	Sufficient for interaction with STX1A. Pubmed:15459722
chr8	109575646	109644656	Q9NX95	0	-	109575646	109644656	255,102,0	1	69010	0	.	Sufficient for interaction with KIF5B. Pubmed:15459722
chr8	115414025	115414382	Q9UHF7	0	-	115414025	115414382	255,102,0	1	357	0	.	Transcriptional repressor domain.
chr8	115414316	115414916	Q9UHF7	0	-	115414316	115414916	255,102,0	1	600	0	.	Mediates interaction with RNF4.
chr8	115587204	115604027	Q9UHF7	0	-	115587204	115604027	255,102,0	1	16823	0	.	Mediates interaction with GLI3. Pubmed:19389374
chr8	116852660	116854322	O60216	0	-	116852660	116854322	255,102,0	1	1662	0	.	Interaction with STAG1. Pubmed:19696148
chr8	116852660	116856244	O60216	0	-	116852660	116856244	255,102,0	1	3584	0	.	Interaction with WAPL and PDS5B. Pubmed:19696148
chr8	117799849	117799891	Q16394	0	-	117799849	117799891	255,102,0	1	42	0	.	Substrate binding.
chr8	117804814	117804829	Q16394	0	-	117804814	117804829	255,102,0	1	15	0	.	Substrate binding.
chr8	117812892	117812901	Q16394	0	-	117812892	117812901	255,102,0	1	9	0	.	Substrate binding.
chr8	117812946	117818437	Q16394	0	-	117812946	117818437	255,102,0	1	5491	0	.	Substrate binding.
chr8	119557559	119557625	Q13822	0	-	119557559	119557625	255,102,0	1	66	0	.	Required for secretion.
chr8	119616276	119616312	Q13822	0	-	119616276	119616312	255,102,0	1	36	0	.	Substrate binding.
chr8	119617178	119617190	Q13822	0	-	119617178	119617190	255,102,0	1	12	0	.	Substrate binding.
chr8	120280712	120300791	Q05707	0	+	120280712	120300791	255,102,0	1	20079	0	.	Nonhelical region (NC4).
chr8	120300791	120342388	Q05707	0	+	120300791	120342388	255,102,0	1	41597	0	.	Triple-helical region 1 (COL2).
chr8	120345445	120371177	Q05707	0	+	120345445	120371177	255,102,0	1	25732	0	.	Triple-helical region 2 (COL1).
chr8	120497505	120523333	Q96DY7	0	+	120497505	120523333	255,102,0	1	25828	0	.	Interaction with MDM2.
chr8	120538879	120538942	Q13884	0	-	120538879	120538942	255,102,0	1	63	0	.	Calmodulin-binding.
chr8	122974042	122974534	Q9Y6X8	0	+	122974042	122974534	255,102,0	1	492	0	.	Required for homodimerization.
chr8	122974246	122974798	Q9Y6X8	0	+	122974246	122974798	255,102,0	1	552	0	.	Required for repressor activity.
chr8	122974246	122974951	Q9Y6X8	0	+	122974246	122974951	255,102,0	1	705	0	.	Required for interaction with NFYA. Pubmed:12741956
chr8	122974408	122974798	Q9Y6X8	0	+	122974408	122974798	255,102,0	1	390	0	.	Required for nuclear localization.
chr8	123247476	123247605	Q9UKY1	0	-	123247476	123247605	255,102,0	1	129	0	.	Required for repressor activity.
chr8	123247791	123247896	Q9UKY1	0	-	123247791	123247896	255,102,0	1	105	0	.	Required for nuclear localization.
chr8	123248403	123249282	Q9UKY1	0	-	123248403	123249282	255,102,0	1	879	0	.	Required for interaction with NFYA.
chr8	123248799	123249282	Q9UKY1	0	-	123248799	123249282	255,102,0	1	483	0	.	Required for dimerization.
chr8	124451803	124451809	Q53H54	0	+	124451803	124451809	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr8	127740874	127740940	P01106	0	+	127740874	127740940	255,102,0	1	66	0	.	Leucine-zipper.
chr8	129752716	129777587	Q9BYG8	0	-	129752716	129777587	255,102,0	1	24871	0	.	Triggers pyroptosis. Pubmed:27281216
chr8	133038526	133038721	Q13239	0	-	133038526	133038721	255,102,0	1	195	0	.	SLA C-terminal.
chr8	133238958	133239048	Q92597	0	-	133238958	133239048	255,102,0	1	90	0	.	3 X 10 AA tandem repeats of G-T-R-S-R-S-H-T-S-E.
chr8	135457866	135557456	O75525	0	+	135457866	135557456	255,102,0	1	99590	0	.	Involved in homodimerization. Pubmed:26758068
chr8	135581899	135582019	O75525	0	+	135581899	135582019	255,102,0	1	120	0	.	Interaction with SIAH1. Pubmed:15163637
chr8	140532450	140532519	Q9UKV8	0	-	140532450	140532519	255,102,0	1	69	0	.	Interaction with guide RNA.
chr8	140532603	140535482	Q9UKV8	0	-	140532603	140535482	255,102,0	1	2879	0	.	Interaction with guide RNA.
chr8	140539358	140539364	Q9UKV8	0	-	140539358	140539364	255,102,0	1	6	0	.	Interaction with guide RNA.
chr8	140541217	140541250	Q9UKV8	0	-	140541217	140541250	255,102,0	1	33	0	.	Interaction with GW182 family members.
chr8	140544281	140544293	Q9UKV8	0	-	140544281	140544293	255,102,0	1	12	0	.	Interaction with GW182 family members.
chr8	140547517	140549132	Q9UKV8	0	-	140547517	140549132	255,102,0	1	1615	0	.	Interaction with guide RNA.
chr8	140557166	140557184	Q9UKV8	0	-	140557166	140557184	255,102,0	1	18	0	.	Interaction with guide RNA.
chr8	140659468	140668400	Q05397	0	-	140659468	140668400	255,102,0	1	8932	0	.	Interaction with ARHGEF28.
chr8	140659468	140717621	Q05397	0	-	140659468	140717621	255,102,0	1	58153	0	.	Interaction with TGFB1I1.
chr8	142542326	142544414	O14514	0	+	142542326	142544414	255,102,0	1	2088	0	.	Necessary for interaction with MAGI1. Pubmed:9647739
chr8	142544402	142544414	O14514	0	+	142544402	142544414	255,102,0	1	12	0	.	Indispensable for interaction with MAGI1. Pubmed:9647739
chr8	142611014	142611074	Q7LC44	0	-	142611014	142611074	255,102,0	1	60	0	.	Required for binding DNM2.
chr8	142611356	142611392	Q7LC44	0	-	142611356	142611392	255,102,0	1	36	0	.	Binds SH3GL1 or SH3GL3.
chr8	143317783	143317792	Q969P6	0	-	143317783	143317792	255,102,0	1	9	0	.	Interaction with DNA.
chr8	143321359	143321377	Q969P6	0	-	143321359	143321377	255,102,0	1	18	0	.	Interaction with DNA.
chr8	143324514	143324520	Q969P6	0	-	143324514	143324520	255,102,0	1	6	0	.	Interaction with DNA.
chr8	143429497	143429563	Q8NHW3	0	-	143429497	143429563	255,102,0	1	66	0	.	Leucine-zipper.
chr8	143429569	143429647	Q8NHW3	0	-	143429569	143429647	255,102,0	1	78	0	.	Basic motif.
chr8	143429584	143429629	Q8NHW3	0	-	143429584	143429629	255,102,0	1	45	0	.	Interaction with DNA.
chr8	143579794	143580601	P29692	0	-	143579794	143580601	255,102,0	1	807	0	.	Catalytic (GEF).
chr8	143581098	143581280	P29692	0	-	143581098	143581280	255,102,0	1	182	0	.	Leucine-zipper.
chr8	143715609	143717589	Q6ZRV2	0	-	143715609	143717589	255,102,0	1	1980	0	.	Mediates interaction with CSNK1A1 and is required for FAM83H activity in keratin cytoskeleton organization. Pubmed:23902688
chr8	143728602	143730582	Q6ZRV2	0	-	143728602	143730582	255,102,0	1	1980	0	.	Mediates interaction with CSNK1A1 and is required for FAM83H activity in keratin cytoskeleton organization. Pubmed:23902688
chr8	143803529	143808672	Q9UHX1	0	-	143803529	143808672	255,102,0	1	5143	0	.	Inhibits transcriptional repression, interaction with ERCC3 and apoptosis induction.
chr8	143803658	143816310	Q9UHX1	0	-	143803658	143816310	255,102,0	1	12652	0	.	Inhibits homodimerization.
chr8	143816522	143821665	Q9UHX1	0	-	143816522	143821665	255,102,0	1	5143	0	.	Inhibits transcriptional repression, interaction with ERCC3 and apoptosis induction.
chr8	143816651	143829303	Q9UHX1	0	-	143816651	143829303	255,102,0	1	12652	0	.	Inhibits homodimerization.
chr8	143916179	143921966	Q15149	0	-	143916179	143921966	255,102,0	1	5787	0	.	Globular 2.
chr8	143916311	143916359	Q15149	0	-	143916311	143916359	255,102,0	1	48	0	.	4 X 4 AA tandem repeats of G-S-R-X.
chr8	143917331	143917484	Q15149	0	-	143917331	143917484	255,102,0	1	153	0	.	Binding to intermediate filaments.
chr8	143921966	143926828	Q15149	0	-	143921966	143926828	255,102,0	1	4862	0	.	Central fibrous rod domain.
chr8	143926828	143950706	Q15149	0	-	143926828	143950706	255,102,0	1	23878	0	.	Globular 1.
chr8	143977916	143983491	Q53GL7	0	-	143977916	143983491	255,102,0	1	5575	0	.	Myc binding.
chr8	144012515	144039931	Q76KD6	0	+	144012515	144039931	255,102,0	1	27416	0	.	Necessary for targeting centrosomes.
chr8	144099197	144099839	Q9H0F6	0	-	144099197	144099839	255,102,0	1	642	0	.	Interaction with SHANK1.
chr8	144099821	144103753	Q9H0F6	0	-	144099821	144103753	255,102,0	1	3932	0	.	Self-association.
chr8	144263701	144264410	Q14137	0	-	144263701	144264410	255,102,0	1	709	0	.	Sufficient for nucleolar localization.
chr8	144291799	144309588	Q00613	0	+	144291799	144309588	255,102,0	1	17789	0	.	DNA-binding domain. Pubmed:7935471
chr8	144309795	144311365	Q00613	0	+	144309795	144311365	255,102,0	1	1570	0	.	Hydrophobic repeat HR-A/B. Pubmed:7935471
chr8	144311362	144311550	Q00613	0	+	144311362	144311550	255,102,0	1	188	0	.	D domain. Pubmed:10747973
chr8	144311538	144312032	Q00613	0	+	144311538	144312032	255,102,0	1	494	0	.	Regulatory domain. Pubmed:7760831
chr8	144312212	144314327	Q00613	0	+	144312212	144314327	255,102,0	1	2115	0	.	Transactivation domain. Pubmed:7623826, Pubmed:7760831
chr8	144313517	144313595	Q00613	0	+	144313517	144313595	255,102,0	1	78	0	.	Hydrophobic repeat HR-C. Pubmed:7935471
chr8	144321335	144326636	O75907	0	-	144321335	144326636	255,102,0	1	5301	0	.	Involved in homomerization.
chr8	144474273	144474519	O75593	0	-	144474273	144474519	255,102,0	1	246	0	.	SMAD-interaction domain (SID).
chr8	144931277	144931370	P17020	0	-	144931277	144931370	255,102,0	1	93	0	.	Required for nuclear localization.
chr8	144931607	144931985	P17020	0	-	144931607	144931985	255,102,0	1	378	0	.	Required for nuclear localization.
chr8	144931667	144931766	P17020	0	-	144931667	144931766	255,102,0	1	99	0	.	Required for nuclear localization.
chr8	144932156	144946023	P17020	0	-	144932156	144946023	255,102,0	1	13867	0	.	Necessary for transcription activation.
chr9	14809	16059	A8K0Z3	0	-	14809	16059	255,102,0	1	1250	0	.	VCA.
chr9	17762	24999	A8K0Z3	0	-	17762	24999	255,102,0	1	7237	0	.	WHD1.
chr9	18479	24999	A8K0Z3	0	-	18479	24999	255,102,0	1	6520	0	.	Required for WASH complex assembly.
chr9	711636	712167	Q14678	0	+	711636	712167	255,102,0	1	531	0	.	Interaction with KIF21A. Pubmed:19559006
chr9	738416	744517	Q14678	0	+	738416	744517	255,102,0	1	6101	0	.	Interaction with KIF21A. Pubmed:19559006
chr9	2651413	2651908	P98155	0	+	2651413	2651908	255,102,0	1	495	0	.	Clustered O-linked oligosaccharides.
chr9	2828739	2828766	Q15397	0	-	2828739	2828766	255,102,0	1	27	0	.	HA-8.
chr9	4679770	4697100	Q7L3B6	0	+	4679770	4697100	255,102,0	1	17330	0	.	Self-association.
chr9	4688536	4701947	Q7L3B6	0	+	4688536	4701947	255,102,0	1	13411	0	.	Self-association and interaction with Hsp90.
chr9	4701914	4706109	Q7L3B6	0	+	4701914	4706109	255,102,0	1	4195	0	.	Interaction with Hsp70.
chr9	4701947	4706109	Q7L3B6	0	+	4701947	4706109	255,102,0	1	4162	0	.	Required for interaction with STIP1.
chr9	4718489	4719200	Q9UIJ7	0	-	4718489	4719200	255,102,0	1	711	0	.	LID.
chr9	4722578	4740979	Q9UIJ7	0	-	4722578	4740979	255,102,0	1	18401	0	.	NMPbind.
chr9	5021987	5054665	O60674	0	+	5021987	5054665	255,102,0	1	32678	0	.	Interaction with cytokine/interferon/growth hormone receptors.
chr9	6014458	6014611	O60518	0	-	6014458	6014611	255,102,0	1	153	0	.	Ran-GTP binding.
chr9	6241694	6250577	O95760	0	+	6241694	6250577	255,102,0	1	8883	0	.	Homeodomain-like HTH domain.
chr9	6250577	6251255	O95760	0	+	6250577	6251255	255,102,0	1	678	0	.	Interaction with RELA.
chr9	6421106	6475460	Q96PU4	0	+	6421106	6475460	255,102,0	1	54354	0	.	Required for interaction with histone H3.
chr9	6434108	6460792	Q96PU4	0	+	6434108	6460792	255,102,0	1	26684	0	.	Interaction with PCNP.
chr9	6481721	6499858	Q96PU4	0	+	6481721	6499858	255,102,0	1	18137	0	.	Methyl-CpG binding and interaction with HDAC1. Pubmed:15361834
chr9	8341962	8375940	P23468	0	-	8341962	8375940	255,102,0	1	33978	0	.	Substrate binding.
chr9	8526627	8528594	P23468	0	-	8526627	8528594	255,102,0	1	1967	0	.	Interaction with IL1RAPL1.
chr9	17579242	17747083	Q99962	0	+	17579242	17747083	255,102,0	1	167841	0	.	Membrane-binding amphipathic helix. Pubmed:16763557
chr9	17579242	17787423	Q99962	0	+	17579242	17787423	255,102,0	1	208181	0	.	Binds and tubulates liposomes.
chr9	17761499	17786454	Q99962	0	+	17761499	17786454	255,102,0	1	24955	0	.	Required for dimerization upon membrane association.
chr9	18928174	18928276	Q8IYX7	0	-	18928174	18928276	255,102,0	1	102	0	.	Mn 12.
chr9	18928276	18928378	Q8IYX7	0	-	18928276	18928378	255,102,0	1	102	0	.	Mn 12.
chr9	18928378	18928480	Q8IYX7	0	-	18928378	18928480	255,102,0	1	102	0	.	Mn 10.
chr9	18928480	18928579	Q8IYX7	0	-	18928480	18928579	255,102,0	1	99	0	.	Mn 9.
chr9	18928579	18928678	Q8IYX7	0	-	18928579	18928678	255,102,0	1	99	0	.	Mn 8.
chr9	18928678	18928780	Q8IYX7	0	-	18928678	18928780	255,102,0	1	102	0	.	Mn 7.
chr9	18928780	18928879	Q8IYX7	0	-	18928780	18928879	255,102,0	1	99	0	.	Mn 6.
chr9	18928879	18928981	Q8IYX7	0	-	18928879	18928981	255,102,0	1	102	0	.	Mn 5.
chr9	18928981	18941664	Q8IYX7	0	-	18928981	18941664	255,102,0	1	12683	0	.	Mn 4.
chr9	18941664	18941766	Q8IYX7	0	-	18941664	18941766	255,102,0	1	102	0	.	Mn 3.
chr9	18941766	18950783	Q8IYX7	0	-	18941766	18950783	255,102,0	1	9017	0	.	Mn 2.
chr9	18950783	18950888	Q8IYX7	0	-	18950783	18950888	255,102,0	1	105	0	.	Mn 1.
chr9	19409084	19409123	Q5QJU3	0	+	19409084	19409123	255,102,0	1	39	0	.	Essential for localization in the Golgi apparatus and for activity.
chr9	21816770	21818038	B4DUC8	0	+	21816770	21818038	255,102,0	1	1268	0	.	Phosphate binding.
chr9	21816770	21818038	J3QSB7	0	+	21816770	21818038	255,102,0	1	1268	0	.	Phosphate binding.
chr9	21816770	21818038	Q13126	0	+	21816770	21818038	255,102,0	1	1268	0	.	Phosphate binding.
chr9	21818131	21818137	B4DUC8	0	+	21818131	21818137	255,102,0	1	6	0	.	Phosphate binding.
chr9	21818131	21818137	J3QSB7	0	+	21818131	21818137	255,102,0	1	6	0	.	Phosphate binding.
chr9	21818131	21818137	Q13126	0	+	21818131	21818137	255,102,0	1	6	0	.	Phosphate binding.
chr9	21854837	21854846	B4DUC8	0	+	21854837	21854846	255,102,0	1	9	0	.	Substrate binding.
chr9	21854837	21854846	J3QSB7	0	+	21854837	21854846	255,102,0	1	9	0	.	Substrate binding.
chr9	21854837	21854846	Q13126	0	+	21854837	21854846	255,102,0	1	9	0	.	Substrate binding.
chr9	21994139	21994331	Q8N726	0	-	21994139	21994331	255,102,0	1	192	0	.	Interaction with CDK5RAP3 and MDM2. Pubmed:16173922
chr9	26961967	26980584	Q96LB3	0	+	26961967	26980584	255,102,0	1	18617	0	.	Basic region.
chr9	32418465	32418474	P21399	0	+	32418465	32418474	255,102,0	1	9	0	.	Substrate binding.
chr9	32440551	32440557	P21399	0	+	32440551	32440557	255,102,0	1	6	0	.	Substrate binding.
chr9	32457124	32491340	O95786	0	-	32457124	32491340	255,102,0	1	34216	0	.	Interaction with ZC3HAV1. Pubmed:21102435
chr9	32541773	32541965	Q9NS56	0	-	32541773	32541965	255,102,0	1	192	0	.	Interaction with UBE2I. Pubmed:14516784
chr9	32541878	32543159	Q9NS56	0	-	32541878	32543159	255,102,0	1	1281	0	.	Interaction with TOP1. Pubmed:10352183
chr9	32542331	32543159	Q9NS56	0	-	32542331	32543159	255,102,0	1	828	0	.	Interaction with p53/TP53. Pubmed:10415337
chr9	32542562	32543216	Q9NS56	0	-	32542562	32543216	255,102,0	1	654	0	.	Interaction with SUMO1. Pubmed:14516784
chr9	32542802	32543216	Q9NS56	0	-	32542802	32543216	255,102,0	1	414	0	.	Required for sumoylation and localization to discrete nuclear foci.
chr9	32543402	32550821	Q9NS56	0	-	32543402	32550821	255,102,0	1	7419	0	.	Required for DNA-binding.
chr9	32543939	32552436	Q9NS56	0	-	32543939	32552436	255,102,0	1	8497	0	.	E3 ubiquitin-protein ligase activity.
chr9	32987738	33001604	Q7Z2E3	0	-	32987738	33001604	255,102,0	1	13866	0	.	Interactions with ADPRT and NCL.
chr9	33113799	33113811	P15291	0	-	33113799	33113811	255,102,0	1	12	0	.	UDP-alpha-D-galactose binding.
chr9	33116004	33116016	P15291	0	-	33116004	33116016	255,102,0	1	12	0	.	N-acetyl-D-glucosamine binding.
chr9	33120504	33120510	P15291	0	-	33120504	33120510	255,102,0	1	6	0	.	UDP-alpha-D-galactose binding.
chr9	33120582	33120591	P15291	0	-	33120582	33120591	255,102,0	1	9	0	.	UDP-alpha-D-galactose binding.
chr9	33135275	33135290	P15291	0	-	33135275	33135290	255,102,0	1	15	0	.	UDP-alpha-D-galactose binding.
chr9	33271196	33276542	Q9NZZ3	0	+	33271196	33276542	255,102,0	1	5346	0	.	Interaction with VTA1.
chr9	33294418	33294472	Q12986	0	+	33294418	33294472	255,102,0	1	54	0	.	Interaction with PABPC1 and PABC4. Pubmed:17267499
chr9	34635634	34635775	Q99720	0	-	34635634	34635775	255,102,0	1	141	0	.	C-terminal hydrophobic region. Pubmed:27042935
chr9	34637253	34637277	Q99720	0	-	34637253	34637277	255,102,0	1	24	0	.	Important for ligand-binding.
chr9	34637673	34637694	Q99720	0	-	34637673	34637694	255,102,0	1	21	0	.	Targeting to endoplasmic reticulum-associated lipid droplets.
chr9	34709396	34709579	O00585	0	-	34709396	34709579	255,102,0	1	183	0	.	C-terminal basic extension.
chr9	35057119	35057149	P55072	0	-	35057119	35057149	255,102,0	1	30	0	.	Interaction with UBXN6. Pubmed:18656546
chr9	35649865	35649877	Q9Y3P8	0	-	35649865	35649877	255,102,0	1	12	0	.	Interaction with GRB2. Pubmed:11433379
chr9	35649922	35649934	Q9Y3P8	0	-	35649922	35649934	255,102,0	1	12	0	.	Interaction with CSK. Pubmed:11433379
chr9	35649985	35650003	Q9Y3P8	0	-	35649985	35650003	255,102,0	1	18	0	.	Interaction with PTPN11.
chr9	35650372	35650384	Q9Y3P8	0	-	35650372	35650384	255,102,0	1	12	0	.	Interaction with GRB2. Pubmed:11433379
chr9	35674070	35674295	Q16790	0	+	35674070	35674295	255,102,0	1	225	0	.	Proteoglycan-like (PG).
chr9	35674295	35680757	Q16790	0	+	35674295	35680757	255,102,0	1	6462	0	.	Catalytic.
chr9	35679270	35679276	Q16790	0	+	35679270	35679276	255,102,0	1	6	0	.	Substrate binding.
chr9	35704704	35711295	Q9Y490	0	-	35704704	35711295	255,102,0	1	6591	0	.	Interaction with SYNM. Pubmed:18342854
chr9	35720197	35722866	Q9Y490	0	-	35720197	35722866	255,102,0	1	2669	0	.	Interaction with LAYN.
chr9	36052272	36091272	O95980	0	+	36052272	36091272	255,102,0	1	39000	0	.	5 X Knot repeats.
chr9	36150915	36150939	Q9H4G4	0	+	36150915	36150939	255,102,0	1	24	0	.	Interaction with CAV1. Pubmed:11865038
chr9	36199020	36204180	P09496	0	+	36199020	36204180	255,102,0	1	5160	0	.	Involved in binding clathrin heavy chain.
chr9	36217367	36227313	Q9Y223	0	-	36217367	36227313	255,102,0	1	9946	0	.	N-acetylmannosamine kinase.
chr9	36643005	36651787	Q14680	0	+	36643005	36651787	255,102,0	1	8782	0	.	UBA-like.
chr9	36651799	36677334	Q14680	0	+	36651799	36677334	255,102,0	1	25535	0	.	Autoinhibitory region.
chr9	37425953	37425959	Q9UBQ7	0	+	37425953	37425959	255,102,0	1	6	0	.	Substrate binding. Pubmed:16756993
chr9	37436671	37436683	Q9UBQ7	0	+	37436671	37436683	255,102,0	1	12	0	.	Substrate binding. Pubmed:16756993
chr9	37744801	37744825	Q5SYB0	0	+	37744801	37744825	255,102,0	1	24	0	.	Important for interaction with GPSM2. Pubmed:23318951
chr9	37948750	38068645	Q15464	0	-	37948750	38068645	255,102,0	1	119895	0	.	Mediates interaction with LAT, PTK2/FAK1, JAK1 and JAK3. Pubmed:10488157, Pubmed:12200137
chr9	68378300	68378306	Q15124	0	+	68378300	68378306	255,102,0	1	6	0	.	Substrate binding.
chr9	68392318	68392324	Q15124	0	+	68392318	68392324	255,102,0	1	6	0	.	Substrate binding.
chr9	68465189	68465198	Q15124	0	+	68465189	68465198	255,102,0	1	9	0	.	Substrate binding.
chr9	69254362	69254371	Q9UDY2	0	+	69254362	69254371	255,102,0	1	9	0	.	Interaction with SCRIB. Pubmed:15975580
chr9	69452166	69452214	Q02410	0	-	69452166	69452214	255,102,0	1	48	0	.	Autoinhibitory helix linker.
chr9	69471683	69516094	Q02410	0	-	69471683	69516094	255,102,0	1	44411	0	.	LIN-2/CASK binding.
chr9	69516268	69516535	Q02410	0	-	69516268	69516535	255,102,0	1	267	0	.	Munc-18-1 binding.
chr9	70300071	70318645	Q8IY18	0	+	70300071	70318645	255,102,0	1	18574	0	.	Flexible hinge.
chr9	74642424	74642808	Q92753	0	+	74642424	74642808	255,102,0	1	384	0	.	Hinge.
chr9	74642808	74685615	Q92753	0	+	74642808	74685615	255,102,0	1	42807	0	.	Ligand-binding.
chr9	75069086	75069092	Q9NWW6	0	-	75069086	75069092	255,102,0	1	6	0	.	Substrate binding. Pubmed:17698003, Pubmed:17914902
chr9	75077159	75077165	Q9NWW6	0	-	75077159	75077165	255,102,0	1	6	0	.	Substrate binding. Pubmed:17698003, Pubmed:17914902
chr9	75077492	75077504	Q9NWW6	0	-	75077492	75077504	255,102,0	1	12	0	.	Substrate binding. Pubmed:17698003, Pubmed:17914902
chr9	76179600	76358520	Q92824	0	+	76179600	76358520	255,102,0	1	178920	0	.	CRM (Cys-rich motif).
chr9	76358757	76358817	Q92824	0	+	76358757	76358817	255,102,0	1	60	0	.	AC 1.
chr9	76358850	76358919	Q92824	0	+	76358850	76358919	255,102,0	1	69	0	.	AC 2.
chr9	76502393	76502408	Q02742	0	+	76502393	76502408	255,102,0	1	15	0	.	Mediates interaction with GOLPH3 and is necessary and sufficient for localization to the Golgi. Pubmed:23027862
chr9	76502477	76502744	Q02742	0	+	76502477	76502744	255,102,0	1	267	0	.	Stem region.
chr9	76502744	76503665	Q02742	0	+	76502744	76503665	255,102,0	1	921	0	.	Catalytic.
chr9	78304777	78304783	Q9Y617	0	+	78304777	78304783	255,102,0	1	6	0	.	Pyridoxal phosphate binding.
chr9	78308563	78308569	Q9Y617	0	+	78308563	78308569	255,102,0	1	6	0	.	Pyridoxal phosphate binding.
chr9	79572790	79652610	Q04727	0	+	79572790	79652610	255,102,0	1	79820	0	.	Q domain. Pubmed:21429299
chr9	79652610	79704785	Q04727	0	+	79652610	79704785	255,102,0	1	52175	0	.	GP domain. Pubmed:21429299
chr9	79704785	79706785	Q04727	0	+	79704785	79706785	255,102,0	1	2000	0	.	CcN domain. Pubmed:21429299
chr9	79706785	79718737	Q04727	0	+	79706785	79718737	255,102,0	1	11952	0	.	SP domain. Pubmed:21429299
chr9	81593255	81616095	Q04724	0	-	81593255	81616095	255,102,0	1	22840	0	.	SP domain. Pubmed:21429299
chr9	81616095	81620554	Q04724	0	-	81616095	81620554	255,102,0	1	4459	0	.	CcN domain. Pubmed:21429299
chr9	81620554	81634280	Q04724	0	-	81620554	81634280	255,102,0	1	13726	0	.	GP domain. Pubmed:21429299
chr9	81634280	81688240	Q04724	0	-	81634280	81688240	255,102,0	1	53960	0	.	Q domain. Pubmed:21429299
chr9	83666397	83679954	Q9UMX0	0	-	83666397	83679954	255,102,0	1	13557	0	.	Interaction with UBXN4. Pubmed:19822669
chr9	83970259	83977048	P61978	0	-	83970259	83977048	255,102,0	1	6789	0	.	2 X 22 AA approximate repeats.
chr9	83970301	83977033	P61978	0	-	83970301	83977033	255,102,0	1	6732	0	.	5 X 4 AA repeats of G-X-G-G.
chr9	83971353	83972864	P61978	0	-	83971353	83972864	255,102,0	1	1511	0	.	Interaction with ZIK1.
chr9	83971692	83972102	P61978	0	-	83971692	83972102	255,102,0	1	410	0	.	2 X 6 AA approximate repeats.
chr9	83972006	83978252	P61978	0	-	83972006	83978252	255,102,0	1	6246	0	.	Necessary for interaction with DDX1. Pubmed:12183465
chr9	83972015	83972129	P61978	0	-	83972015	83972129	255,102,0	1	114	0	.	RNA-binding RGG-box.
chr9	83972897	83977742	P61978	0	-	83972897	83977742	255,102,0	1	4845	0	.	Interaction with ASFV p30.
chr9	87640817	87643459	P53355	0	+	87640817	87643459	255,102,0	1	2642	0	.	Calmodulin-binding.
chr9	87642013	87642043	P53355	0	+	87642013	87642043	255,102,0	1	30	0	.	Autoinhibitory domain.
chr9	88462550	88462742	Q9Y657	0	+	88462550	88462742	255,102,0	1	192	0	.	Tudor-like domain 1.
chr9	88462670	88462688	Q9Y657	0	+	88462670	88462688	255,102,0	1	18	0	.	Histone H3K4me3 and H3R8me2a binding.
chr9	88468409	88468595	Q9Y657	0	+	88468409	88468595	255,102,0	1	186	0	.	Tudor-like domain 2.
chr9	88468439	88468442	Q9Y657	0	+	88468439	88468442	255,102,0	1	3	0	.	Histone H3K4me3 and H3R8me2a binding.
chr9	88475124	88475274	Q9Y657	0	+	88475124	88475274	255,102,0	1	150	0	.	Tudor-like domain 3.
chr9	88475235	88475244	Q9Y657	0	+	88475235	88475244	255,102,0	1	9	0	.	Histone H3K4me3 and H3R8me2a binding.
chr9	89038154	89046954	Q92529	0	-	89038154	89046954	255,102,0	1	8800	0	.	CH1.
chr9	89350755	89350821	Q96T21	0	+	89350755	89350821	255,102,0	1	66	0	.	RNA-binding.
chr9	89605504	89605769	O95257	0	+	89605504	89605769	255,102,0	1	265	0	.	Homodimerization.
chr9	90844219	90845517	P43405	0	+	90844219	90845517	255,102,0	1	1298	0	.	Interdomain A.
chr9	90864648	90874778	P43405	0	+	90864648	90874778	255,102,0	1	10130	0	.	Interdomain B.
chr9	91355943	91356105	Q13825	0	-	91355943	91356105	255,102,0	1	162	0	.	RNA-binding.
chr9	91409645	91409840	Q16649	0	-	91409645	91409840	255,102,0	1	195	0	.	Necessary for transcriptional repression and sufficient for interaction with DR1. Pubmed:8836190
chr9	91410416	91410440	Q16649	0	-	91410416	91410440	255,102,0	1	24	0	.	Leucine-zipper.
chr9	91410449	91410500	Q16649	0	-	91410449	91410500	255,102,0	1	51	0	.	Basic motif.
chr9	92464994	92466463	Q9BXN1	0	-	92464994	92466463	255,102,0	1	1469	0	.	Interaction with TGFB1.
chr9	92713458	92718877	Q8TD16	0	-	92713458	92718877	255,102,0	1	5419	0	.	Interaction with RANBP2.
chr9	92715279	92718649	Q8TD16	0	-	92715279	92718649	255,102,0	1	3370	0	.	Interacts with RAB6A.
chr9	92718847	92720362	Q8TD16	0	-	92718847	92720362	255,102,0	1	1515	0	.	Interaction with KIF5A.
chr9	92719450	92764672	Q8TD16	0	-	92719450	92764672	255,102,0	1	45222	0	.	Interacts with DYNLL1, DYNC1H1, DYNC1I2, DCTN1 and DCTN2.
chr9	93498870	93516066	Q9NZB2	0	+	93498870	93516066	255,102,0	1	17196	0	.	Interaction with YES1, SRC and FYN. Pubmed:19015244
chr9	93557826	93564537	Q9NZB2	0	+	93557826	93564537	255,102,0	1	6711	0	.	RNA binding.
chr9	94563419	94563434	O00757	0	-	94563419	94563434	255,102,0	1	15	0	.	Substrate binding.
chr9	94567326	94567338	O00757	0	-	94567326	94567338	255,102,0	1	12	0	.	Substrate binding.
chr9	94593696	94593720	O00757	0	-	94593696	94593720	255,102,0	1	24	0	.	Important for interaction with ALDOA. Pubmed:18214967
chr9	94603566	94605459	P09467	0	-	94603566	94605459	255,102,0	1	1893	0	.	Substrate binding.
chr9	94605534	94605552	P09467	0	-	94605534	94605552	255,102,0	1	18	0	.	Substrate binding.
chr9	94606871	94606883	P09467	0	-	94606871	94606883	255,102,0	1	12	0	.	Substrate binding.
chr9	94617818	94617830	P09467	0	-	94617818	94617830	255,102,0	1	12	0	.	Substrate binding.
chr9	96523368	96534533	O60729	0	-	96523368	96534533	255,102,0	1	11165	0	.	B.
chr9	96534533	96539110	O60729	0	-	96534533	96539110	255,102,0	1	4577	0	.	Linker.
chr9	96539110	96619249	O60729	0	-	96539110	96619249	255,102,0	1	80139	0	.	A.
chr9	97483016	97495880	Q8NHU6	0	+	97483016	97495880	255,102,0	1	12864	0	.	Interaction with CDK17.
chr9	97483112	97495880	Q8NHU6	0	+	97483112	97495880	255,102,0	1	12768	0	.	Interaction with CABLES1.
chr9	97524302	97562748	P28289	0	+	97524302	97562748	255,102,0	1	38446	0	.	Tropomyosin-binding.
chr9	97689631	97697283	P23025	0	-	97689631	97697283	255,102,0	1	7652	0	.	Interaction with CEP164 and required for UV resistance. Pubmed:19197159
chr9	97931133	97938118	Q9BXL5	0	-	97931133	97938118	255,102,0	1	6985	0	.	Necessary for nuclear localization.
chr9	98220907	98229047	Q9BYX2	0	-	98220907	98229047	255,102,0	1	8140	0	.	Interaction with RAC1. Pubmed:20116244
chr9	98251788	98255541	Q9BYX2	0	-	98251788	98255541	255,102,0	1	3753	0	.	Interaction with CADH1.
chr9	98823286	98826942	Q8IXK2	0	+	98823286	98826942	255,102,0	1	3656	0	.	Catalytic subdomain A.
chr9	98831949	98837034	Q8IXK2	0	+	98831949	98837034	255,102,0	1	5085	0	.	Catalytic subdomain B.
chr9	98987329	99020406	P39059	0	+	98987329	99020406	255,102,0	1	33077	0	.	Nonhelical region 1 (NC1).
chr9	99003458	99020406	P39059	0	+	99003458	99020406	255,102,0	1	16948	0	.	4 X tandem repeats.
chr9	99020406	99022108	P39059	0	+	99020406	99022108	255,102,0	1	1702	0	.	Triple-helical region 1 (COL1).
chr9	99022108	99023449	P39059	0	+	99022108	99023449	255,102,0	1	1341	0	.	Nonhelical region 2 (NC2).
chr9	99024873	99035130	P39059	0	+	99024873	99035130	255,102,0	1	10257	0	.	Triple-helical region 2 (COL2).
chr9	99035130	99035418	P39059	0	+	99035130	99035418	255,102,0	1	288	0	.	Nonhelical region 3 (NC3).
chr9	99036169	99036381	P39059	0	+	99036169	99036381	255,102,0	1	212	0	.	Triple-helical region 3 (COL3).
chr9	99036381	99038724	P39059	0	+	99036381	99038724	255,102,0	1	2343	0	.	Nonhelical region 4 (NC4).
chr9	99038724	99044594	P39059	0	+	99038724	99044594	255,102,0	1	5870	0	.	Triple-helical region 4 (COL4).
chr9	99044594	99044627	P39059	0	+	99044594	99044627	255,102,0	1	33	0	.	Nonhelical region 5 (NC5).
chr9	99044627	99049743	P39059	0	+	99044627	99049743	255,102,0	1	5116	0	.	Triple-helical region 5 (COL5).
chr9	99049743	99052432	P39059	0	+	99049743	99052432	255,102,0	1	2689	0	.	Nonhelical region 6 (NC6).
chr9	99054574	99055109	P39059	0	+	99054574	99055109	255,102,0	1	535	0	.	Triple-helical region 6 (COL6).
chr9	99055109	99055151	P39059	0	+	99055109	99055151	255,102,0	1	42	0	.	Nonhelical region 7 (NC7).
chr9	99055261	99055315	P39059	0	+	99055261	99055315	255,102,0	1	54	0	.	Triple-helical region 7 (COL7).
chr9	99055315	99055336	P39059	0	+	99055315	99055336	255,102,0	1	21	0	.	Nonhelical region 8 (NC8).
chr9	99055336	99056388	P39059	0	+	99055336	99056388	255,102,0	1	1052	0	.	Triple-helical region 8 (COL8).
chr9	99056388	99059902	P39059	0	+	99056388	99059902	255,102,0	1	3514	0	.	Nonhelical region 9 (NC9).
chr9	99059902	99059947	P39059	0	+	99059902	99059947	255,102,0	1	45	0	.	Triple-helical region 9 (COL9).
chr9	99059947	99069883	P39059	0	+	99059947	99069883	255,102,0	1	9936	0	.	Nonhelical region 10 (NC10).
chr9	99828042	99828366	Q92570	0	+	99828042	99828366	255,102,0	1	324	0	.	Activation function (AF)-1 domain.
chr9	99828042	99828456	Q92570	0	+	99828042	99828456	255,102,0	1	414	0	.	Required for DNA-PK heterotrimer. Pubmed:25852083
chr9	99828042	99828915	Q92570	0	+	99828042	99828915	255,102,0	1	873	0	.	Interaction with NCOA1, NCOA2, NCOA3 and KAT2B.
chr9	99833334	99863864	Q92570	0	+	99833334	99863864	255,102,0	1	30530	0	.	Interaction with KAT2B.
chr9	99844711	99847452	Q92570	0	+	99844711	99847452	255,102,0	1	2741	0	.	Ligand-binding.
chr9	99968448	99968589	P56962	0	+	99968448	99968589	255,102,0	1	141	0	.	Necessary and sufficient for localization to autophagosome. Pubmed:23217709
chr9	100007596	100016378	Q9BS26	0	-	100007596	100016378	255,102,0	1	8782	0	.	Interaction with ITPR1.
chr9	101577814	101579276	Q8TCU5	0	-	101577814	101579276	255,102,0	1	1462	0	.	PPP2CB binding site.
chr9	103003155	103005672	Q14093	0	+	103003155	103005672	255,102,0	1	2517	0	.	31 X 3 AA repeats of K-K-X.
chr9	103005099	103005351	Q14093	0	+	103005099	103005351	255,102,0	1	252	0	.	3 X approximate tandem repeats.
chr9	104114070	104120043	O95347	0	+	104114070	104120043	255,102,0	1	5973	0	.	Flexible hinge.
chr9	108862412	108862475	Q9Y615	0	+	108862412	108862475	255,102,0	1	63	0	.	Required for interaction with TES.
chr9	109381771	109382306	P26045	0	-	109381771	109382306	255,102,0	1	535	0	.	Substrate binding.
chr9	110137932	110137974	Q9Y2D5	0	+	110137932	110137974	255,102,0	1	42	0	.	PKA-RII subunit binding domain.
chr9	110472240	110472264	Q4LDE5	0	-	110472240	110472264	255,102,0	1	24	0	.	O-glycosylated at one site.
chr9	110941826	110941844	Q92633	0	-	110941826	110941844	255,102,0	1	18	0	.	Lysophosphatidic acid binding. Pubmed:26091040
chr9	113199954	113207252	Q5T1M5	0	-	113199954	113207252	255,102,0	1	7298	0	.	Important for function in growth cone organization.
chr9	114062683	114062746	P02760	0	-	114062683	114062746	255,102,0	1	63	0	.	Glycopeptide (secretory piece).
chr9	114169427	114302090	Q8IZC6	0	+	114169427	114302090	255,102,0	1	132663	0	.	Triple-helical region.
chr9	114356912	114357929	Q7Z591	0	-	114356912	114357929	255,102,0	1	1017	0	.	PEST.
chr9	114359673	114359775	Q7Z591	0	-	114359673	114359775	255,102,0	1	102	0	.	PEST.
chr9	116187551	116211763	Q13219	0	+	116187551	116211763	255,102,0	1	24212	0	.	Metalloprotease.
chr9	120389238	120402937	Q96SN8	0	-	120389238	120402937	255,102,0	1	13699	0	.	Interaction with PCNT and AKAP9. Pubmed:20466722
chr9	120389755	120389785	Q96SN8	0	-	120389755	120389785	255,102,0	1	30	0	.	Required for centrosomal attachment, Golgi localization and CALM1 interaction.
chr9	120402808	120402937	Q96SN8	0	-	120402808	120402937	255,102,0	1	129	0	.	Interaction with CDK5R1.
chr9	120439496	120453473	Q96SN8	0	-	120439496	120453473	255,102,0	1	13977	0	.	Interaction with MAPRE1. Pubmed:19553473
chr9	120536445	120568344	Q96SN8	0	-	120536445	120568344	255,102,0	1	31899	0	.	Interaction with NCKAP5L. Pubmed:26485573
chr9	120874006	120874027	Q5T6S3	0	-	120874006	120874027	255,102,0	1	21	0	.	Histone H3K36me3 binding.
chr9	121013966	121014056	P01031	0	-	121013966	121014056	255,102,0	1	90	0	.	Involved in C5AR1 binding. Pubmed:9553099
chr9	121167674	121171485	Q7Z7A1	0	+	121167674	121171485	255,102,0	1	3811	0	.	Required for centrosome localization.
chr9	121168203	121177183	Q7Z7A1	0	+	121168203	121177183	255,102,0	1	8980	0	.	Sufficient for interaction with HOOK2. Pubmed:17140400
chr9	121301974	121310707	P06396	0	+	121301974	121310707	255,102,0	1	8733	0	.	Actin-severing.
chr9	121302927	121302939	P06396	0	+	121302927	121302939	255,102,0	1	12	0	.	Actin-actin interfilament contact point.
chr9	121303044	121310686	P06396	0	+	121303044	121310686	255,102,0	1	7642	0	.	Polyphosphoinositide binding.
chr9	121310740	121310767	P06396	0	+	121310740	121310767	255,102,0	1	27	0	.	Polyphosphoinositide binding.
chr9	121318835	121332600	P06396	0	+	121318835	121332600	255,102,0	1	13765	0	.	Actin-binding, Ca-sensitive.
chr9	121341207	121341252	P27105	0	-	121341207	121341252	255,102,0	1	45	0	.	Interaction with LANCL1. Pubmed:9512664
chr9	121341249	121341276	P27105	0	-	121341249	121341276	255,102,0	1	27	0	.	Required for homooligomerization.
chr9	121341261	121341270	P27105	0	-	121341261	121341270	255,102,0	1	9	0	.	Required for lipid raft association.
chr9	121770581	121773357	Q5VWQ8	0	+	121770581	121773357	255,102,0	1	2776	0	.	Necessary for interaction with AKT1. Pubmed:19903888
chr9	121870615	121974091	Q8NHH1	0	-	121870615	121974091	255,102,0	1	103476	0	.	c-MTBD region. Pubmed:25959773
chr9	122217080	122226937	Q9UPM6	0	-	122217080	122226937	255,102,0	1	9857	0	.	Required for interaction with LDB1.
chr9	122883275	122890363	Q9HBD1	0	-	122883275	122890363	255,102,0	1	7088	0	.	ROQ.
chr9	124301964	124312550	Q9HC98	0	+	124301964	124312550	255,102,0	1	10586	0	.	Interaction with ARHGAP33, ANKRA2, CDC42, PRDX3, RAD26L, RBBP6, RPS7 and TRIP4. Pubmed:20873783
chr9	124347789	124347801	Q9HC98	0	+	124347789	124347801	255,102,0	1	12	0	.	Interaction with APBB1. Pubmed:17512906
chr9	124482760	124500272	Q13285	0	-	124482760	124500272	255,102,0	1	17512	0	.	Important for dimerization.
chr9	124491177	124500182	Q13285	0	-	124491177	124500182	255,102,0	1	9005	0	.	Ligand-binding.
chr9	124538156	124540115	Q15406	0	-	124538156	124540115	255,102,0	1	1959	0	.	Sufficient for interaction with UIMC1.
chr9	125019178	125143437	Q8N9R8	0	-	125019178	125143437	255,102,0	1	124259	0	.	Necessary to inhibit MKL1-induced SRF transcriptional activity.
chr9	125020762	125055895	Q8N9R8	0	-	125020762	125055895	255,102,0	1	35133	0	.	Required for interaction with MKL1.
chr9	125438889	125444542	Q9BPZ7	0	-	125438889	125444542	255,102,0	1	5653	0	.	Interaction with ATF2. Pubmed:17054722
chr9	125559679	125672571	Q9BPZ7	0	-	125559679	125672571	255,102,0	1	112892	0	.	Interaction with NBN. Pubmed:23762398
chr9	125585673	125672571	Q9BPZ7	0	-	125585673	125672571	255,102,0	1	86898	0	.	Interaction with MAP3K2. Pubmed:15988011
chr9	127212179	127218766	Q5JS13	0	+	127212179	127218766	255,102,0	1	6587	0	.	Required for stimulation of nucleotide exchange by RALA.
chr9	127403734	127403755	Q9NY64	0	+	127403734	127403755	255,102,0	1	21	0	.	Monosaccharide binding.
chr9	127788276	127788354	P50750	0	+	127788276	127788354	255,102,0	1	78	0	.	T-loop.
chr9	127824426	127843237	P17813	0	-	127824426	127843237	255,102,0	1	18811	0	.	Required for interaction with EGL.
chr9	127868413	127868446	P00568	0	-	127868413	127868446	255,102,0	1	33	0	.	LID.
chr9	127868413	127868446	Q5T9B7	0	-	127868413	127868446	255,102,0	1	33	0	.	LID.
chr9	127868413	127868446	Q6FGX9	0	-	127868413	127868446	255,102,0	1	33	0	.	LID.
chr9	127872695	127872785	P00568	0	-	127872695	127872785	255,102,0	1	90	0	.	NMPbind.
chr9	127872695	127872785	Q5T9B7	0	-	127872695	127872785	255,102,0	1	90	0	.	NMPbind.
chr9	127872695	127872785	Q6FGX9	0	-	127872695	127872785	255,102,0	1	90	0	.	NMPbind.
chr9	128066891	128067101	Q69YI7	0	-	128066891	128067101	255,102,0	1	210	0	.	Required for nuclear localization and apoptosis-inducing activity.
chr9	128124532	128124538	Q9H7Z7	0	-	128124532	128124538	255,102,0	1	6	0	.	Glutathione binding.
chr9	128257069	128257102	Q08379	0	-	128257069	128257102	255,102,0	1	33	0	.	Interaction with GORASP1/GRASP65.
chr9	128268479	128275976	Q08379	0	-	128268479	128275976	255,102,0	1	7497	0	.	Interaction with p115/USO1.
chr9	128504805	128504892	Q53GS7	0	+	128504805	128504892	255,102,0	1	87	0	.	Interaction with NUP155.
chr9	128533529	128533649	Q53GS7	0	+	128533529	128533649	255,102,0	1	120	0	.	Mediates the shuttling between the nucleus and the cytoplasm.
chr9	128540275	128541167	Q53GS7	0	+	128540275	128541167	255,102,0	1	892	0	.	Interaction with NUPL2. Pubmed:16000379
chr9	128683985	128691921	Q01105	0	+	128683985	128691921	255,102,0	1	7936	0	.	Dimerization.
chr9	128691921	128693781	Q01105	0	+	128691921	128693781	255,102,0	1	1860	0	.	Earmuff domain.
chr9	128940376	128940385	Q5SRE7	0	+	128940376	128940385	255,102,0	1	9	0	.	Alpha-ketoglutarate binding.
chr9	128945881	128945929	Q9UPQ8	0	-	128945881	128945929	255,102,0	1	48	0	.	CTP-binding.
chr9	129022405	129028154	Q9NR46	0	-	129022405	129028154	255,102,0	1	5749	0	.	Membrane-binding amphipathic helix.
chr9	129098286	129098310	P43155	0	-	129098286	129098310	255,102,0	1	24	0	.	Coenzyme A binding.
chr9	129634161	129634170	A0A024R8E4	0	+	129634161	129634170	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr9	129634161	129634170	Q9BV86	0	+	129634161	129634170	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding. Pubmed:26543161, Pubmed:26543159
chr9	129634245	129634251	A0A024R8E4	0	+	129634245	129634251	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr9	129634245	129634251	Q9BV86	0	+	129634245	129634251	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding. Pubmed:26543161, Pubmed:26543159
chr9	129739730	129739742	O14684	0	-	129739730	129739742	255,102,0	1	12	0	.	Glutathione binding.
chr9	129739838	129748656	O14684	0	-	129739838	129748656	255,102,0	1	8818	0	.	Glutathione binding.
chr9	129752898	129752931	O14684	0	-	129752898	129752931	255,102,0	1	33	0	.	Glutathione binding.
chr9	129813974	129814037	O14656	0	-	129813974	129814037	255,102,0	1	63	0	.	Interaction with SYNE3. Pubmed:18827015
chr9	129813974	129814220	O14656	0	-	129813974	129814220	255,102,0	1	246	0	.	Interaction with KLC1. Pubmed:14970196
chr9	129814217	129822754	O14656	0	-	129814217	129822754	255,102,0	1	8537	0	.	Interaction with SNAPIN.
chr9	129890541	129900004	Q96RU3	0	-	129890541	129900004	255,102,0	1	9463	0	.	Interaction with ARHGAP17, DAAM1, DIAPH1 and DIAPH2. Pubmed:11431473, Pubmed:16630611
chr9	129890541	129900049	Q96RU3	0	-	129890541	129900049	255,102,0	1	9508	0	.	Interaction with DNM1 and DNM3. Pubmed:15252009
chr9	129890541	129900436	Q96RU3	0	-	129890541	129900436	255,102,0	1	9895	0	.	Required for interaction with TNKS. Pubmed:14596906
chr9	129890541	129900493	Q96RU3	0	-	129890541	129900493	255,102,0	1	9952	0	.	Interaction with PDE6G.
chr9	129890541	129927233	Q96RU3	0	-	129890541	129927233	255,102,0	1	36692	0	.	Required for self-association and induction of membrane tubulation.
chr9	129895853	129899995	Q96RU3	0	-	129895853	129899995	255,102,0	1	4142	0	.	Interaction with FASLG.
chr9	129895856	129899995	Q96RU3	0	-	129895856	129899995	255,102,0	1	4139	0	.	Interaction with DNM2 and WASL.
chr9	129899995	129908987	Q96RU3	0	-	129899995	129908987	255,102,0	1	8992	0	.	Interaction with RND2.
chr9	129924008	130042975	Q96RU3	0	-	129924008	130042975	255,102,0	1	118967	0	.	Interaction with microtubules.
chr9	129978572	130042975	Q96RU3	0	-	129978572	130042975	255,102,0	1	64403	0	.	Required for self-association and induction of membrane tubulation.
chr9	130226433	130226484	P62166	0	+	130226433	130226484	255,102,0	1	51	0	.	Interaction with IL1RAPL1. Pubmed:12783849
chr9	130835449	130854164	P00519	0	+	130835449	130854164	255,102,0	1	18715	0	.	CAP.
chr9	130884894	130885194	P00519	0	+	130884894	130885194	255,102,0	1	300	0	.	DNA-binding.
chr9	130885146	130885680	P00519	0	+	130885146	130885680	255,102,0	1	534	0	.	F-actin-binding.
chr9	131069820	131091784	Q9Y6N6	0	+	131069820	131091784	255,102,0	1	21964	0	.	Domain II and I.
chr9	131127598	131140628	P35658	0	+	131127598	131140628	255,102,0	1	13030	0	.	Seven-bladed beta propeller.
chr9	131144425	131232297	P35658	0	+	131144425	131232297	255,102,0	1	87872	0	.	11 X 5 AA approximate repeats.
chr9	131150705	131151762	P35658	0	+	131150705	131151762	255,102,0	1	1057	0	.	Leucine-zipper 1.
chr9	131163030	131163096	P35658	0	+	131163030	131163096	255,102,0	1	66	0	.	Leucine-zipper 2.
chr9	131197718	131233466	P35658	0	+	131197718	131233466	255,102,0	1	35748	0	.	18 X 4 AA approximate repeats.
chr9	131197772	131233469	P35658	0	+	131197772	131233469	255,102,0	1	35697	0	.	11 X 3 AA approximate repeats.
chr9	131290204	131290270	Q8NBV4	0	+	131290204	131290270	255,102,0	1	66	0	.	Interaction with MTOR.
chr9	132167035	132198016	Q96CW9	0	+	132167035	132198016	255,102,0	1	30981	0	.	NGL discriminant loop I.
chr9	132198352	132198361	Q96CW9	0	+	132198352	132198361	255,102,0	1	9	0	.	NGL discriminant loop II.
chr9	132198541	132198553	Q96CW9	0	+	132198541	132198553	255,102,0	1	12	0	.	NGL discriminant loop III.
chr9	132264241	132264292	Q7Z333	0	-	132264241	132264292	255,102,0	1	51	0	.	Necessary for nuclear localization.
chr9	132402152	132402821	Q15361	0	-	132402152	132402821	255,102,0	1	669	0	.	N-terminal region (NRD).
chr9	132725714	132823289	Q96MA6	0	-	132725714	132823289	255,102,0	1	97575	0	.	Adenylate kinase 2. Pubmed:21080915
chr9	132725855	132727485	Q96MA6	0	-	132725855	132727485	255,102,0	1	1630	0	.	LID 2.
chr9	132792773	132814725	Q96MA6	0	-	132792773	132814725	255,102,0	1	21952	0	.	NMPbind 2.
chr9	132823319	132866951	Q96MA6	0	-	132823319	132866951	255,102,0	1	43632	0	.	Adenylate kinase 1. Pubmed:21080915
chr9	132826992	132828040	Q96MA6	0	-	132826992	132828040	255,102,0	1	1048	0	.	LID 1.
chr9	132854919	132863739	Q96MA6	0	-	132854919	132863739	255,102,0	1	8820	0	.	NMPbind 1.
chr9	132986678	132986738	Q5VTD9	0	+	132986678	132986738	255,102,0	1	60	0	.	SNAG domain.
chr9	132988228	132991047	Q5VTD9	0	+	132988228	132991047	255,102,0	1	2819	0	.	Interaction with ARIH2. Pubmed:17646546
chr9	132988447	132991047	Q5VTD9	0	+	132988447	132991047	255,102,0	1	2600	0	.	Mediates interaction with GATA1.
chr9	133153927	133153939	Q8N5D6	0	-	133153927	133153939	255,102,0	1	12	0	.	Substrate binding.
chr9	133153996	133154005	Q8N5D6	0	-	133153996	133154005	255,102,0	1	9	0	.	Substrate binding.
chr9	133154257	133155191	Q8N5D6	0	-	133154257	133155191	255,102,0	1	934	0	.	Substrate binding.
chr9	133436837	133438329	Q76LX8	0	+	133436837	133438329	255,102,0	1	1492	0	.	Cysteine-rich.
chr9	133438326	133442485	Q76LX8	0	+	133438326	133442485	255,102,0	1	4159	0	.	Spacer.
chr9	133475011	133475032	Q9UGQ3	0	-	133475011	133475032	255,102,0	1	21	0	.	Monosaccharide binding.
chr9	134326631	134408271	P19793	0	+	134326631	134408271	255,102,0	1	81640	0	.	Modulating.
chr9	134409109	134417219	P19793	0	+	134409109	134417219	255,102,0	1	8110	0	.	Hinge.
chr9	134417219	134436611	P19793	0	+	134417219	134436611	255,102,0	1	19392	0	.	Ligand-binding.
chr9	134727301	134731660	P20908	0	+	134727301	134731660	255,102,0	1	4359	0	.	Nonhelical region.
chr9	134731660	134752600	P20908	0	+	134731660	134752600	255,102,0	1	20940	0	.	Interrupted collagenous region.
chr9	134752600	134824611	P20908	0	+	134752600	134824611	255,102,0	1	72011	0	.	Triple-helical region.
chr9	134824611	134824716	P20908	0	+	134824611	134824716	255,102,0	1	105	0	.	Nonhelical region.
chr9	134887193	134887199	Q15485	0	+	134887193	134887199	255,102,0	1	6	0	.	Carbohydrate binding. Pubmed:17215869
chr9	134909800	134909830	O00602	0	-	134909800	134909830	255,102,0	1	30	0	.	P domain. Pubmed:17148457
chr9	134909926	134909935	O00602	0	-	134909926	134909935	255,102,0	1	9	0	.	Carbohydrate-binding. Pubmed:17897951
chr9	134911136	134913021	O00602	0	-	134911136	134913021	255,102,0	1	1885	0	.	B domain; contributes to trimerization.
chr9	134913021	134913141	O00602	0	-	134913021	134913141	255,102,0	1	120	0	.	A domain; contributes to trimerization.
chr9	135821894	135821954	Q5T5Y3	0	-	135821894	135821954	255,102,0	1	60	0	.	Sufficient for interaction with calmodulin.
chr9	135821984	135822050	Q5T5Y3	0	-	135821984	135822050	255,102,0	1	66	0	.	Sufficient for interaction with SPTBN1. Pubmed:24117850
chr9	136377647	136377986	Q5SXM2	0	-	136377647	136377986	255,102,0	1	339	0	.	SNAPC2-binding. Pubmed:11056176
chr9	136395369	136395698	Q5SXM2	0	-	136395369	136395698	255,102,0	1	329	0	.	SNAPC5-binding. Pubmed:11056176
chr9	136407369	136407447	Q96C92	0	-	136407369	136407447	255,102,0	1	78	0	.	Required for interaction with PTPN13. Pubmed:23108400
chr9	136438693	136439392	Q9NRR6	0	-	136438693	136439392	255,102,0	1	699	0	.	13 X 4 AA repeats of P-X-X-P.
chr9	136499127	136499154	P46531	0	-	136499127	136499154	255,102,0	1	27	0	.	HIF1AN-binding.
chr9	136500620	136500647	P46531	0	-	136500620	136500647	255,102,0	1	27	0	.	HIF1AN-binding.
chr9	136517836	136517851	P46531	0	-	136517836	136517851	255,102,0	1	15	0	.	Interaction with DLL4.
chr9	136517929	136517935	P46531	0	-	136517929	136517935	255,102,0	1	6	0	.	Interaction with DLL4.
chr9	136808310	136837373	Q3YEC7	0	+	136808310	136837373	255,102,0	1	29063	0	.	Small GTPase-like.
chr9	136840185	136840411	Q3YEC7	0	+	136840185	136840411	255,102,0	1	226	0	.	Interaction with CDKN2A. Pubmed:16582619
chr9	136850131	136850757	Q9NRX4	0	+	136850131	136850757	255,102,0	1	626	0	.	Substrate binding. Pubmed:18991813
chr9	136862951	136863841	O60869	0	-	136862951	136863841	255,102,0	1	890	0	.	Interaction with NR5A2, PPARG and NR1H3. Pubmed:12040021
chr9	136862966	136863374	O60869	0	-	136862966	136863374	255,102,0	1	408	0	.	Interaction with TBP and NR5A1. Pubmed:10567391
chr9	136920401	136920434	Q12933	0	+	136920401	136920434	255,102,0	1	33	0	.	Important for interaction with BIRC2 and BIRC3.
chr9	136993599	136993802	Q9BUH6	0	+	136993599	136993802	255,102,0	1	203	0	.	Mediates interaction with XRCC5/Ku80 and XRCC6/Ku70 and association with the non-homologous end joining core complex. Pubmed:25670504, Pubmed:25574025
chr9	136995446	136996543	O95833	0	-	136995446	136996543	255,102,0	1	1097	0	.	Required for insertion into the membrane.
chr9	137078090	137078102	Q3KQV9	0	+	137078090	137078102	255,102,0	1	12	0	.	UTP binding.
chr9	137162001	137162010	Q05586	0	+	137162001	137162010	255,102,0	1	9	0	.	Glycine binding.
chr9	137175392	137180894	Q9UJX6	0	-	137175392	137180894	255,102,0	1	5502	0	.	Cullin homology. Pubmed:9469815
chr9	137456415	137459099	Q6X4W1	0	-	137456415	137459099	255,102,0	1	2684	0	.	Necessary and sufficient to elicit dendritic processes and synaptic contacts.
chr9	137811460	137811469	Q9H9B1	0	+	137811460	137811469	255,102,0	1	9	0	.	Histone H3K9me binding.
chr9	137817469	137817478	Q9H9B1	0	+	137817469	137817478	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chr9	137818081	137834351	Q9H9B1	0	+	137818081	137834351	255,102,0	1	16270	0	.	Interaction with histone H3.
chr9	137834405	137834411	Q9H9B1	0	+	137834405	137834411	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chr9	137834779	137834791	Q9H9B1	0	+	137834779	137834791	255,102,0	1	12	0	.	Interaction with histone H3.
chr9	137955761	137956772	Q00975	0	+	137955761	137956772	255,102,0	1	1011	0	.	Binding to the beta subunit.
chrX	1403271	1427802	O95671	0	-	1403271	1427802	255,102,0	1	24531	0	.	ASMT-like.
chrX	1412846	1412855	O95671	0	-	1412846	1412855	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chrX	1427961	1452810	O95671	0	-	1427961	1452810	255,102,0	1	24849	0	.	MAF-like.
chrX	1593708	1593798	Q02040	0	+	1593708	1593798	255,102,0	1	90	0	.	PKA-RI and PKA-RII subunit binding domain.
chrX	1600778	1600868	Q02040	0	+	1600778	1600868	255,102,0	1	90	0	.	PKA-RI-alpha subunit binding domain.
chrX	1636436	1636445	P46597	0	+	1636436	1636445	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chrX	5903585	5903603	Q8N0W4	0	-	5903585	5903603	255,102,0	1	18	0	.	Interaction with NRXN1.
chrX	6533756	6533996	Q9NNX9	0	-	6533756	6533996	255,102,0	1	240	0	.	8 X 10 AA tandem repeats of L-S-Q-E-S-[EQ]-V-E-E-P.
chrX	7843704	7844004	Q9H320	0	+	7843704	7844004	255,102,0	1	300	0	.	10 X 10 AA tandem repeats of L-S-Q-E-S-[EQ]-V-E-E-P.
chrX	8170082	8170142	Q9H322	0	-	8170082	8170142	255,102,0	1	60	0	.	2 X 10 AA tandem repeats of L-S-Q-E-S-[EQ]-V-E-E-P.
chrX	8465951	8466371	Q9H321	0	+	8465951	8466371	255,102,0	1	420	0	.	14 X 10 AA tandem repeats of L-S-Q-E-S-[EQ]-V-E-E-P.
chrX	9743617	9743671	P51810	0	-	9743617	9743671	255,102,0	1	54	0	.	Necessary for its G protein-activation ability and normal distribution of melanosomes.
chrX	10185071	10187559	P51793	0	+	10185071	10187559	255,102,0	1	2488	0	.	Required for localization in the endoplasmic reticulum. Pubmed:17023393
chrX	11763897	11772194	Q8N5Y2	0	+	11763897	11772194	255,102,0	1	8297	0	.	Required for the histone acetyltransferase activity of the MSL complex.
chrX	12819609	12819657	P11908	0	+	12819609	12819657	255,102,0	1	48	0	.	Binding of phosphoribosylpyrophosphate.
chrX	13760284	13760455	O75665	0	+	13760284	13760455	255,102,0	1	171	0	.	Mediates homooligomerization.
chrX	13760302	13769105	O75665	0	+	13760302	13769105	255,102,0	1	8803	0	.	Mediates the interaction with SDCCAG8. Pubmed:20835237
chrX	14607258	14608998	P23416	0	+	14607258	14608998	255,102,0	1	1740	0	.	Strychnine-binding.
chrX	15346243	15353146	O43915	0	-	15346243	15353146	255,102,0	1	6903	0	.	4 X 16 AA repeats of C-X(10)-C-X-C-X(1,3)-C.
chrX	15564184	15566278	Q9BYF1	0	-	15564184	15566278	255,102,0	1	2094	0	.	Essential for cleavage by TMPRSS11D and TMPRSS2.
chrX	15567745	15567769	Q9BYF1	0	-	15567745	15567769	255,102,0	1	24	0	.	Essential for cleavage by ADAM17.
chrX	15581219	15581234	Q9BYF1	0	-	15581219	15581234	255,102,0	1	15	0	.	Interaction with SARS-CoV spike glycoprotein.
chrX	15594937	15594946	Q9BYF1	0	-	15594937	15594946	255,102,0	1	9	0	.	Interaction with SARS-CoV spike glycoprotein.
chrX	15600788	15600824	Q9BYF1	0	-	15600788	15600824	255,102,0	1	36	0	.	Interaction with SARS-CoV spike glycoprotein.
chrX	15776797	15776803	Q9Y2D0	0	+	15776797	15776803	255,102,0	1	6	0	.	Substrate binding.
chrX	17103740	17147478	Q8NFH8	0	+	17103740	17147478	255,102,0	1	43738	0	.	Interaction with RALBP1.
chrX	17135278	17147478	Q8NFH8	0	+	17135278	17147478	255,102,0	1	12200	0	.	Interaction with ASAP1.
chrX	18749916	18806516	O14829	0	+	18749916	18806516	255,102,0	1	56600	0	.	Catalytic.
chrX	18895176	18897270	P46019	0	-	18895176	18897270	255,102,0	1	2094	0	.	Calmodulin-binding.
chrX	18907905	18907998	P46019	0	-	18907905	18907998	255,102,0	1	93	0	.	Calmodulin-binding.
chrX	21856577	21856790	O15391	0	+	21856577	21856790	255,102,0	1	213	0	.	Mediates transcriptional activation.
chrX	21857192	21857600	O15391	0	+	21857192	21857600	255,102,0	1	408	0	.	Mediates transcriptional repression.
chrX	21984315	21984321	P52788	0	+	21984315	21984321	255,102,0	1	6	0	.	S-adenosylmethioninamine binding.
chrX	22273276	22273453	Q8N7E2	0	+	22273276	22273453	255,102,0	1	177	0	.	HYB domain.
chrX	23783669	23783675	P21673	0	+	23783669	23783675	255,102,0	1	6	0	.	Substrate binding. Pubmed:17516632
chrX	23785404	23785413	P21673	0	+	23785404	23785413	255,102,0	1	9	0	.	Acetyl-CoA binding. Pubmed:17516632
chrX	23785518	23785536	P21673	0	+	23785518	23785536	255,102,0	1	18	0	.	Acetyl-CoA binding. Pubmed:17516632
chrX	23785715	23785724	P21673	0	+	23785715	23785724	255,102,0	1	9	0	.	Substrate binding. Pubmed:17516632
chrX	23785736	23785748	P21673	0	+	23785736	23785748	255,102,0	1	12	0	.	Acetyl-CoA binding. Pubmed:17516632
chrX	23785757	23785769	P21673	0	+	23785757	23785769	255,102,0	1	12	0	.	Acetyl-CoA binding. Pubmed:17516632
chrX	24057428	24057452	P41091	0	+	24057428	24057452	255,102,0	1	24	0	.	G1.
chrX	24057512	24057527	P41091	0	+	24057512	24057527	255,102,0	1	15	0	.	G2.
chrX	24060103	24060115	P41091	0	+	24060103	24060115	255,102,0	1	12	0	.	G3.
chrX	24062504	24062516	P41091	0	+	24062504	24062516	255,102,0	1	12	0	.	G4.
chrX	24064235	24064244	P41091	0	+	24064235	24064244	255,102,0	1	9	0	.	G5.
chrX	24737666	24739497	P09884	0	+	24737666	24739497	255,102,0	1	1831	0	.	DNA-binding region.
chrX	24841665	24888104	P09884	0	+	24841665	24888104	255,102,0	1	46439	0	.	DNA-binding region.
chrX	26140538	26141270	Q96M61	0	+	26140538	26141270	255,102,0	1	732	0	.	Interaction with LNX1. Pubmed:20864041
chrX	29955373	29955661	Q9NZN1	0	+	29955373	29955661	255,102,0	1	288	0	.	Interaction with NCS1. Pubmed:12783849
chrX	30304581	30308604	P51843	0	-	30304581	30308604	255,102,0	1	4023	0	.	Ligand-binding.
chrX	30308604	30309363	P51843	0	-	30308604	30309363	255,102,0	1	759	0	.	4 X 67 AA tandem repeats.
chrX	38369846	38369861	P00480	0	+	38369846	38369861	255,102,0	1	15	0	.	Ornithine and carbamoyl phosphate binding.
chrX	38401389	38401401	P00480	0	+	38401389	38401401	255,102,0	1	12	0	.	Ornithine and carbamoyl phosphate binding.
chrX	38408944	38408959	P00480	0	+	38408944	38408959	255,102,0	1	15	0	.	Ornithine binding.
chrX	38411897	38411909	P00480	0	+	38411897	38411909	255,102,0	1	12	0	.	Ornithine binding.
chrX	40052132	40053962	Q6W2J9	0	-	40052132	40053962	255,102,0	1	1830	0	.	Necessary and sufficient for interaction with PCGF1.
chrX	40073803	40073854	Q6W2J9	0	-	40073803	40073854	255,102,0	1	51	0	.	Interaction with BCL6.
chrX	40680895	40697176	O60244	0	-	40680895	40697176	255,102,0	1	16281	0	.	Interaction with SREBF1. Pubmed:15340088
chrX	40692854	40713868	O60244	0	-	40692854	40713868	255,102,0	1	21014	0	.	Interaction with STAT2. Pubmed:12509459
chrX	41334255	41342510	O00571	0	+	41334255	41342510	255,102,0	1	8255	0	.	Interaction with EIF4E.
chrX	41334255	41342627	O00571	0	+	41334255	41342627	255,102,0	1	8372	0	.	Required for TBK1 and IKBKE-dependent IFN-beta activation.
chrX	41341572	41341602	O00571	0	+	41341572	41341602	255,102,0	1	30	0	.	Required for interaction with VACV protein K7.
chrX	41342507	41342540	O00571	0	+	41342507	41342540	255,102,0	1	33	0	.	Required for interaction with IKBKE.
chrX	41342507	41347716	O00571	0	+	41342507	41347716	255,102,0	1	5209	0	.	Interaction with GSK3B. Pubmed:18846110
chrX	41343804	41344041	O00571	0	+	41343804	41344041	255,102,0	1	237	0	.	Involved in stimulation of ATPase activity by DNA and RNA, nucleic acid binding and unwinding and HIV-1 replication.
chrX	41344041	41346558	O00571	0	+	41344041	41346558	255,102,0	1	2517	0	.	Necessary for interaction with XPO1. Pubmed:15507209
chrX	41626673	41636580	O14936	0	-	41626673	41636580	255,102,0	1	9907	0	.	Calmodulin-binding.
chrX	42777638	42777650	O14990	0	-	42777638	42777650	255,102,0	1	12	0	.	Required for binding PPP1CC catalytic center, displacing metal ions and inhibition of PPP1CC catyltic activity.
chrX	42777914	42777953	O14990	0	-	42777914	42777953	255,102,0	1	39	0	.	Required for binding PPP1CC.
chrX	42778028	42778046	O14990	0	-	42778028	42778046	255,102,0	1	18	0	.	Required for binding PPP1CC.
chrX	43744486	43744495	P21397	0	+	43744486	43744495	255,102,0	1	9	0	.	Interaction with membrane phospholipid headgroups.
chrX	44844258	44844516	Q9H596	0	+	44844258	44844516	255,102,0	1	258	0	.	Sufficient for mitochondrial localization.
chrX	44873551	45082790	O15550	0	+	44873551	45082790	255,102,0	1	209239	0	.	Interaction with SUPT6H.
chrX	47199218	47206339	P22314	0	+	47199218	47206339	255,102,0	1	7121	0	.	2 approximate repeats.
chrX	47572866	47574018	P17600	0	-	47572866	47574018	255,102,0	1	1152	0	.	E.
chrX	47574018	47575172	P17600	0	-	47574018	47575172	255,102,0	1	1154	0	.	D; Pro-rich linker.
chrX	47575172	47619392	P17600	0	-	47575172	47619392	255,102,0	1	44220	0	.	C; actin-binding and synaptic-vesicle binding.
chrX	47583484	47583499	P01033	0	+	47583484	47583499	255,102,0	1	15	0	.	Involved in metalloproteinase-binding.
chrX	47585270	47585276	P01033	0	+	47585270	47585276	255,102,0	1	6	0	.	Involved in metalloproteinase-binding.
chrX	47619392	47619644	P17600	0	-	47619392	47619644	255,102,0	1	252	0	.	B; linker.
chrX	47619644	47619728	P17600	0	-	47619644	47619728	255,102,0	1	84	0	.	A.
chrX	47636918	47637792	P19419	0	-	47636918	47637792	255,102,0	1	874	0	.	Sufficient for interaction with MAD2L2. Pubmed:17296730
chrX	48696784	48700192	O43463	0	+	48696784	48700192	255,102,0	1	3408	0	.	Interaction with SIRT1.
chrX	48700684	48700693	O43463	0	+	48700684	48700693	255,102,0	1	9	0	.	S-adenosyl-L-methionine binding.
chrX	48700687	48707462	O43463	0	+	48700687	48707462	255,102,0	1	6775	0	.	Mediates interaction with MECOM.
chrX	48706402	48706408	O43463	0	+	48706402	48706408	255,102,0	1	6	0	.	S-adenosyl-L-methionine binding.
chrX	48792321	48793912	P15976	0	+	48792321	48793912	255,102,0	1	1591	0	.	Interaction with MED1 and CCAR1. Pubmed:24245781
chrX	48792330	48792390	P15976	0	+	48792330	48792390	255,102,0	1	60	0	.	Required for interaction with ZFPM1.
chrX	48793171	48793867	P15976	0	+	48793171	48793867	255,102,0	1	696	0	.	Interaction with CALCOCO1. Pubmed:24245781
chrX	48803163	48815446	Q9UBN7	0	+	48803163	48815446	255,102,0	1	12283	0	.	Histone deacetylase 1.
chrX	48816002	48822682	Q9UBN7	0	+	48816002	48822682	255,102,0	1	6680	0	.	Histone deacetylase 2.
chrX	48824174	48824183	Q9UBN7	0	+	48824174	48824183	255,102,0	1	9	0	.	Ubiquitin binding.
chrX	48824258	48824282	Q9UBN7	0	+	48824258	48824282	255,102,0	1	24	0	.	Ubiquitin binding.
chrX	48831262	48831382	Q9UHG2	0	-	48831262	48831382	255,102,0	1	120	0	.	C-terminal inhibitory domain; interacts with PCSK1.
chrX	48831397	48835433	Q9UHG2	0	-	48831397	48835433	255,102,0	1	4036	0	.	ProSAAS(1-180).
chrX	48902029	48903081	O60828	0	+	48902029	48903081	255,102,0	1	1052	0	.	Intrinsically disordered.
chrX	48902249	48902354	O60828	0	+	48902249	48902354	255,102,0	1	105	0	.	5 X 7 AA approximate tandem repeats of D-R-[SG]-H-D-K-S.
chrX	48902354	48902372	O60828	0	+	48902354	48902372	255,102,0	1	18	0	.	3 X 2 AA tandem repeats of [DE]-R.
chrX	48902387	48902429	O60828	0	+	48902387	48902429	255,102,0	1	42	0	.	7 X 2 AA tandem repeats of [DE]-R.
chrX	48903018	48903051	O60828	0	+	48903018	48903051	255,102,0	1	33	0	.	Important for interaction with TXNL4A.
chrX	48934535	48934553	Q96G74	0	-	48934535	48934553	255,102,0	1	18	0	.	His-loop.
chrX	48934771	48934804	Q96G74	0	-	48934771	48934804	255,102,0	1	33	0	.	Variable-loop.
chrX	48944205	48944226	Q96G74	0	-	48944205	48944226	255,102,0	1	21	0	.	Cys-loop.
chrX	48966577	48966625	Q9NSA2	0	-	48966577	48966625	255,102,0	1	48	0	.	Mediates dendritic targeting.
chrX	48970211	48970268	Q9NSA2	0	-	48970211	48970268	255,102,0	1	57	0	.	Interaction with KCNIP2.
chrX	49030595	49031456	P19532	0	-	49030595	49031456	255,102,0	1	861	0	.	Leucine-zipper.
chrX	49038081	49038199	P19532	0	-	49038081	49038199	255,102,0	1	118	0	.	Strong transcription activation domain.
chrX	49062508	49063887	Q96HB5	0	+	49062508	49063887	255,102,0	1	1379	0	.	Involved in CYTH2-binding. Pubmed:25326380
chrX	49191463	49191619	P08247	0	-	49191463	49191619	255,102,0	1	156	0	.	Repeats, Gly-rich.
chrX	49210996	49211426	O60840	0	-	49210996	49211426	255,102,0	1	430	0	.	Dihydropyridine binding.
chrX	49211029	49211390	O60840	0	-	49211029	49211390	255,102,0	1	361	0	.	Phenylalkylamine binding.
chrX	49215362	49216473	O60840	0	-	49215362	49216473	255,102,0	1	1111	0	.	Dihydropyridine binding.
chrX	49227009	49227063	O60840	0	-	49227009	49227063	255,102,0	1	54	0	.	Binding to the beta subunit.
chrX	49235636	49247549	O60826	0	+	49235636	49247549	255,102,0	1	11913	0	.	Sufficient for interaction with COMMD1. Pubmed:25355947
chrX	49235636	49248644	O60826	0	+	49235636	49248644	255,102,0	1	13008	0	.	Sufficicient and required for interaction with CCDC93. Pubmed:25355947
chrX	49253161	49254052	Q9BZS1	0	-	49253161	49254052	255,102,0	1	891	0	.	Interaction with RUNX1. Pubmed:17377532
chrX	49255464	49255735	Q9BZS1	0	-	49255464	49255735	255,102,0	1	271	0	.	Leucine-zipper.
chrX	49256800	49257436	Q9BZS1	0	-	49256800	49257436	255,102,0	1	636	0	.	Interaction with IKZF4.
chrX	49256803	49257565	Q9BZS1	0	-	49256803	49257565	255,102,0	1	762	0	.	Interaction with ZFP90. Pubmed:23543754
chrX	49256827	49257565	Q9BZS1	0	-	49256827	49257565	255,102,0	1	738	0	.	Essential for transcriptional repressor activity and for interaction with KAT5 and HDAC7. Pubmed:17360565
chrX	50193677	50193707	Q5JQC9	0	-	50193677	50193707	255,102,0	1	30	0	.	PKA-RI-alpha subunit binding domain.
chrX	50194016	50194058	Q5JQC9	0	-	50194016	50194058	255,102,0	1	42	0	.	PKA-RI and PKA-RII subunit binding domain.
chrX	50368951	50371741	Q5KSL6	0	-	50368951	50371741	255,102,0	1	2790	0	.	Required for localization to the plasma membrane.
chrX	50470141	50470537	Q5KSL6	0	-	50470141	50470537	255,102,0	1	396	0	.	33 X 4 AA approximate tandem repeats of E-P-A-P.
chrX	51333013	51333022	Q8NFP7	0	+	51333013	51333022	255,102,0	1	9	0	.	Substrate binding.
chrX	51333229	51333238	Q8NFP7	0	+	51333229	51333238	255,102,0	1	9	0	.	Substrate binding.
chrX	51496171	51496180	Q96G61	0	-	51496171	51496180	255,102,0	1	9	0	.	Substrate binding.
chrX	51496387	51496396	Q96G61	0	-	51496387	51496396	255,102,0	1	9	0	.	Substrate binding.
chrX	51744253	51744277	Q8IYD1	0	+	51744253	51744277	255,102,0	1	24	0	.	G1.
chrX	51744421	51744436	Q8IYD1	0	+	51744421	51744436	255,102,0	1	15	0	.	G2.
chrX	51744484	51744496	Q8IYD1	0	+	51744484	51744496	255,102,0	1	12	0	.	G3.
chrX	51744670	51744682	Q8IYD1	0	+	51744670	51744682	255,102,0	1	12	0	.	G4.
chrX	51744796	51744805	Q8IYD1	0	+	51744796	51744805	255,102,0	1	9	0	.	G5.
chrX	51896540	51896987	Q9Y5V3	0	+	51896540	51896987	255,102,0	1	447	0	.	22 X 6 AA tandem repeats of W-[PQ]-X-P-X-X.
chrX	52704536	52705239	Q16385	0	-	52704536	52705239	255,102,0	1	703	0	.	Interaction with RAB3IP. Pubmed:12007189
chrX	52704536	52705749	Q16385	0	-	52704536	52705749	255,102,0	1	1213	0	.	Interaction with SSX2IP. Pubmed:12007189
chrX	52752680	52753893	Q16385	0	+	52752680	52753893	255,102,0	1	1213	0	.	Interaction with SSX2IP. Pubmed:12007189
chrX	52753190	52753893	Q16385	0	+	52753190	52753893	255,102,0	1	703	0	.	Interaction with RAB3IP. Pubmed:12007189
chrX	53405325	53409097	Q14683	0	-	53405325	53409097	255,102,0	1	3772	0	.	Flexible hinge.
chrX	54022314	54022359	Q9UPP1	0	-	54022314	54022359	255,102,0	1	45	0	.	Linker.
chrX	54539044	54540158	Q9NVN8	0	+	54539044	54540158	255,102,0	1	1114	0	.	Required for nucleolar localization.
chrX	54928974	54931014	Q12816	0	+	54928974	54931014	255,102,0	1	2040	0	.	62 X 10 AA approximate tandem repeats.
chrX	54933405	54952000	P16118	0	-	54933405	54952000	255,102,0	1	18595	0	.	Fructose-2,6-bisphosphatase.
chrX	54952000	54994004	P16118	0	-	54952000	54994004	255,102,0	1	42004	0	.	6-phosphofructo-2-kinase.
chrX	55007045	55007069	Q9UBZ4	0	+	55007045	55007069	255,102,0	1	24	0	.	Required for the colocalization with PCNA in nuclear foci in presence of oxidative-induced DNA damaging agents.
chrX	56565343	56565451	Q9UHD9	0	+	56565343	56565451	255,102,0	1	108	0	.	12 X 3 AA tandem repeats of P-X-X.
chrX	57592858	57593779	P98169	0	+	57592858	57593779	255,102,0	1	921	0	.	Required for interaction with ZXDC.
chrX	57593773	57594157	P98169	0	+	57593773	57594157	255,102,0	1	384	0	.	Required for transcriptional activation.
chrX	57908323	57908707	P98168	0	-	57908323	57908707	255,102,0	1	384	0	.	Required for transcriptional activation.
chrX	57908701	57909622	P98168	0	-	57908701	57909622	255,102,0	1	921	0	.	Required for interaction with ZXDC. Pubmed:17493635
chrX	63706308	63706341	O43307	0	-	63706308	63706341	255,102,0	1	33	0	.	Interaction with GPHN.
chrX	64337336	64337357	Q96EF0	0	-	64337336	64337357	255,102,0	1	21	0	.	Substrate binding.
chrX	64345081	64345087	Q96EF0	0	-	64345081	64345087	255,102,0	1	6	0	.	Substrate binding.
chrX	64345150	64345162	Q96EF0	0	-	64345150	64345162	255,102,0	1	12	0	.	Substrate binding.
chrX	67545146	67643316	P10275	0	+	67545146	67643316	255,102,0	1	98170	0	.	Modulating.
chrX	67643292	67723835	P10275	0	+	67643292	67723835	255,102,0	1	80543	0	.	Interaction with LPXN. Pubmed:18451096
chrX	67643352	67711502	P10275	0	+	67643352	67711502	255,102,0	1	68150	0	.	Interaction with HIPK3.
chrX	67686014	67723835	P10275	0	+	67686014	67723835	255,102,0	1	37821	0	.	Interaction with CCAR1. Pubmed:23887938
chrX	67686113	67723835	P10275	0	+	67686113	67723835	255,102,0	1	37722	0	.	Interaction with KAT7. Pubmed:10930412
chrX	67711586	67723835	P10275	0	+	67711586	67723835	255,102,0	1	12249	0	.	Ligand-binding.
chrX	70062959	70062980	Q7L8S5	0	+	70062959	70062980	255,102,0	1	21	0	.	Cys-loop.
chrX	70063151	70063184	Q7L8S5	0	+	70063151	70063184	255,102,0	1	33	0	.	Variable-loop.
chrX	70063295	70063328	Q7L8S5	0	+	70063295	70063328	255,102,0	1	33	0	.	His-loop.
chrX	70134625	70146756	P78318	0	+	70134625	70146756	255,102,0	1	12131	0	.	Interaction with PPP2CA.
chrX	70146822	70150321	P78318	0	+	70146822	70150321	255,102,0	1	3499	0	.	Interaction with MID1. Pubmed:11806752
chrX	70376162	70420262	O95239	0	+	70376162	70420262	255,102,0	1	44100	0	.	Interaction with PRC1.
chrX	70406279	70420262	O95239	0	+	70406279	70420262	255,102,0	1	13983	0	.	Globular.
chrX	71134830	71140743	Q93074	0	+	71134830	71140743	255,102,0	1	5913	0	.	Interaction with CTNNB1 and GLI3. Pubmed:17000779
chrX	71291783	71297926	Q15233	0	+	71291783	71297926	255,102,0	1	6143	0	.	DBHS.
chrX	71382549	71392718	P21675	0	+	71382549	71392718	255,102,0	1	10169	0	.	Histone acetyltransferase (HAT).
chrX	71406665	71454809	P21675	0	+	71406665	71454809	255,102,0	1	48144	0	.	Interaction with ASF1A and ASF1B. Pubmed:12842904
chrX	71573623	71573683	O15294	0	+	71573623	71573683	255,102,0	1	60	0	.	Required for phosphatidylinositol 3,4,5-triphosphate binding.
chrX	72462036	72572722	Q9BY41	0	-	72462036	72572722	255,102,0	1	110686	0	.	Histone deacetylase.
chrX	72584287	72593211	P46020	0	-	72584287	72593211	255,102,0	1	8924	0	.	Calmodulin-binding.
chrX	72611033	72611126	P46020	0	-	72611033	72611126	255,102,0	1	93	0	.	Calmodulin-binding.
chrX	75299883	75300880	Q96BW1	0	+	75299883	75300880	255,102,0	1	997	0	.	5-phospho-alpha-D-ribose 1-diphosphate binding.
chrX	75303475	75303484	Q96BW1	0	+	75303475	75303484	255,102,0	1	9	0	.	Uracil binding.
chrX	76430156	76430801	Q9HCI5	0	+	76430156	76430801	255,102,0	1	645	0	.	Interaction with DTNA.
chrX	77969074	77969080	Q8N0Y7	0	-	77969074	77969080	255,102,0	1	6	0	.	Substrate binding.
chrX	77969287	77969293	Q8N0Y7	0	-	77969287	77969293	255,102,0	1	6	0	.	Substrate binding.
chrX	77969362	77969374	Q8N0Y7	0	-	77969362	77969374	255,102,0	1	12	0	.	Substrate binding.
chrX	77969566	77969572	Q8N0Y7	0	-	77969566	77969572	255,102,0	1	6	0	.	Substrate binding.
chrX	77969587	77969611	Q8N0Y7	0	-	77969587	77969611	255,102,0	1	24	0	.	Substrate binding.
chrX	78109870	78109879	P00558	0	+	78109870	78109879	255,102,0	1	9	0	.	Substrate binding.
chrX	78109870	78109879	V9HWF4	0	+	78109870	78109879	255,102,0	1	9	0	.	Substrate binding.
chrX	78113813	78113825	P00558	0	+	78113813	78113825	255,102,0	1	12	0	.	Substrate binding.
chrX	78113813	78113825	V9HWF4	0	+	78113813	78113825	255,102,0	1	12	0	.	Substrate binding.
chrX	83874301	83874367	P35663	0	+	83874301	83874367	255,102,0	1	66	0	.	8 X approximate tandem repeats.
chrX	85092522	85092531	Q86VE3	0	-	85092522	85092531	255,102,0	1	9	0	.	Substrate binding.
chrX	85093208	85093226	Q86VE3	0	-	85093208	85093226	255,102,0	1	18	0	.	Acetyl-CoA binding.
chrX	85094143	85094152	Q86VE3	0	-	85094143	85094152	255,102,0	1	9	0	.	Acetyl-CoA binding.
chrX	85103897	85103903	Q86VE3	0	-	85103897	85103903	255,102,0	1	6	0	.	Substrate binding.
chrX	86148824	86149085	Q96NX9	0	+	86148824	86149085	255,102,0	1	261	0	.	DACHbox-N.
chrX	86812971	86814749	Q96NX9	0	+	86812971	86814749	255,102,0	1	1778	0	.	DACHbox-C.
chrX	100823305	100826675	P33240	0	+	100823305	100826675	255,102,0	1	3370	0	.	Interactions with CSTF3 and SYMPK.
chrX	100833199	100833379	P33240	0	+	100833199	100833379	255,102,0	1	180	0	.	12 X 5 AA tandem repeats of M-E-A-R-[AG].
chrX	100837377	100838358	P33240	0	+	100837377	100838358	255,102,0	1	981	0	.	Interaction with RPO2TC1. Pubmed:11389848
chrX	100844038	100849879	Q9Y5S8	0	-	100844038	100849879	255,102,0	1	5841	0	.	Interaction with NOXO1. Pubmed:16329988
chrX	101094578	101094614	Q53FP2	0	+	101094578	101094614	255,102,0	1	36	0	.	Interaction with NGFR.
chrX	101356180	101356198	Q06187	0	-	101356180	101356198	255,102,0	1	18	0	.	Inhibitor-binding.
chrX	101375212	101375251	Q06187	0	-	101375212	101375251	255,102,0	1	39	0	.	Inositol-(1,3,4,5)-tetrakisphosphate 1-binding.
chrX	101400683	101400698	P06280	0	-	101400683	101400698	255,102,0	1	15	0	.	Substrate binding.
chrX	101412687	101413287	P55795	0	+	101412687	101413287	255,102,0	1	600	0	.	2 X 16 AA Gly-rich approximate repeats.
chrX	101413047	101413164	P55795	0	+	101413047	101413164	255,102,0	1	117	0	.	2 X 19 AA perfect repeats.
chrX	102656607	102658098	Q5JY77	0	+	102656607	102658098	255,102,0	1	1491	0	.	OPRD1-binding.
chrX	103377692	103377770	Q00994	0	+	103377692	103377770	255,102,0	1	78	0	.	Interaction with p75NTR/NGFR.
chrX	103377692	103377824	Q00994	0	+	103377692	103377824	255,102,0	1	132	0	.	Interaction with 14-3-3 epsilon.
chrX	103719263	103722161	Q5JXX5	0	-	103719263	103722161	255,102,0	1	2898	0	.	Strychnine-binding.
chrX	104250314	104250719	Q8N693	0	-	104250314	104250719	255,102,0	1	405	0	.	15 X 9 AA tandem repeats of P-P-x-x-P-x-P-P-x.
chrX	106900811	106901484	Q0D2K3	0	-	106900811	106901484	255,102,0	1	673	0	.	Ripply homology domain.
chrX	106928912	106928918	P57739	0	+	106928912	106928918	255,102,0	1	6	0	.	Interactions with TJP1, TJP2 and TJP3.
chrX	107645279	107645327	P60891	0	+	107645279	107645327	255,102,0	1	48	0	.	Binding of phosphoribosylpyrophosphate.
chrX	107714632	107714698	Q99576	0	-	107714632	107714698	255,102,0	1	66	0	.	Leucine-zipper.
chrX	107714743	107716811	Q99576	0	-	107714743	107716811	255,102,0	1	2068	0	.	AP1-binding.
chrX	108084976	108087702	O75832	0	-	108084976	108087702	255,102,0	1	2726	0	.	Interaction with RB1. Pubmed:10613832
chrX	108084976	108088850	O75832	0	-	108084976	108088850	255,102,0	1	3874	0	.	Interaction with RELA.
chrX	108088751	108091520	O75832	0	-	108088751	108091520	255,102,0	1	2769	0	.	Interaction with RB1. Pubmed:10613832
chrX	108091409	108091520	O75832	0	-	108091409	108091520	255,102,0	1	111	0	.	Required for nuclear localization.
chrX	108160601	108310756	Q14031	0	-	108160601	108310756	255,102,0	1	150155	0	.	Triple-helical region.
chrX	108310756	108310828	Q14031	0	-	108310756	108310828	255,102,0	1	72	0	.	7S domain.
chrX	108440203	108539787	P29400	0	+	108440203	108539787	255,102,0	1	99584	0	.	Nonhelical region (NC2).
chrX	108539787	108687552	P29400	0	+	108539787	108687552	255,102,0	1	147765	0	.	Triple-helical region.
chrX	108733653	108733662	O14654	0	-	108733653	108733662	255,102,0	1	9	0	.	GRB2-binding.
chrX	108733944	108734313	O14654	0	-	108733944	108734313	255,102,0	1	369	0	.	CRK-binding.
chrX	111142112	111147784	O75914	0	+	111142112	111147784	255,102,0	1	5672	0	.	GTPase-binding.
chrX	111142112	111147865	O75914	0	+	111142112	111147865	255,102,0	1	5753	0	.	Autoregulatory region.
chrX	111142169	111173052	O75914	0	+	111142169	111173052	255,102,0	1	30883	0	.	Linker.
chrX	111248567	111251045	Q9Y6Q1	0	-	111248567	111251045	255,102,0	1	2478	0	.	Domain III.
chrX	111681218	111685095	Q9NP73	0	+	111681218	111685095	255,102,0	1	3877	0	.	Glycosyltransferase activity.
chrX	111685095	111718224	Q9NP73	0	+	111685095	111718224	255,102,0	1	33129	0	.	Deubiquitinase activity.
chrX	111776315	111776324	Q9UL62	0	-	111776315	111776324	255,102,0	1	9	0	.	Essential for binding to NHERF PDZ domain.
chrX	115289759	115306219	Q9P127	0	+	115289759	115306219	255,102,0	1	16460	0	.	Interaction with DDX39B/UAP56. Pubmed:25662211
chrX	115302050	115303316	Q9P127	0	+	115302050	115303316	255,102,0	1	1266	0	.	Arg-rich; required for RNA-binding. Pubmed:25662211
chrX	115306393	115306570	Q9P127	0	+	115306393	115306570	255,102,0	1	177	0	.	RS-containing His-rich (RS-H); necessary for nuclear localization. Pubmed:25662211
chrX	115306573	115306723	Q9P127	0	+	115306573	115306723	255,102,0	1	150	0	.	Leucine-zipper; required for RNA-binding and for its relocalization to the cytoplasm during cell division. Pubmed:25662211
chrX	115306582	115306801	Q9P127	0	+	115306582	115306801	255,102,0	1	219	0	.	Interaction with NXF1. Pubmed:25662211
chrX	118346506	118392955	Q5JSH3	0	+	118346506	118392955	255,102,0	1	46449	0	.	Binding activity.
chrX	118542817	118543579	Q5JSL3	0	+	118542817	118543579	255,102,0	1	762	0	.	Interaction with activated CDC42.
chrX	119590536	119592497	O15226	0	-	119590536	119592497	255,102,0	1	1961	0	.	Active repression domain.
chrX	119834880	119851585	Q9BZI7	0	-	119834880	119851585	255,102,0	1	16705	0	.	Sufficient for association with EJC core.
chrX	119834988	119837771	Q9BZI7	0	-	119834988	119837771	255,102,0	1	2783	0	.	Necessary for interaction with RBM8A and for activating NMD.
chrX	119841117	119852841	Q9BZI7	0	-	119841117	119852841	255,102,0	1	11724	0	.	Necessary for interaction with UPF2.
chrX	119851858	119852775	Q9BZI7	0	-	119851858	119852775	255,102,0	1	917	0	.	Binds to UPF2.
chrX	119903325	119903379	Q86UN6	0	+	119903325	119903379	255,102,0	1	54	0	.	RII-binding.
chrX	119925222	119932137	Q8N5F7	0	-	119925222	119932137	255,102,0	1	6915	0	.	Necessary for interaction with HDAC3 and transcriptional repression. Pubmed:19409814
chrX	119932137	119936615	Q8N5F7	0	-	119932137	119936615	255,102,0	1	4478	0	.	Necessary for interaction with CIR1. Pubmed:19409814
chrX	120253415	120253724	Q86T24	0	+	120253415	120253724	255,102,0	1	309	0	.	Interaction with NCOR1. Pubmed:14527417
chrX	120253415	120253823	Q86T24	0	+	120253415	120253823	255,102,0	1	408	0	.	Self-association.
chrX	120254306	120255134	Q86T24	0	+	120254306	120255134	255,102,0	1	828	0	.	Interaction with CBFA2T3. Pubmed:23251453
chrX	120254774	120255431	Q86T24	0	+	120254774	120255431	255,102,0	1	657	0	.	Interaction with CTNND1.
chrX	120254954	120255329	Q86T24	0	+	120254954	120255329	255,102,0	1	375	0	.	Required for DNA-binding.
chrX	120431343	120431355	P13473	0	-	120431343	120431355	255,102,0	1	12	0	.	Important for binding and subsequent lysosomal degradation of target proteins. Pubmed:11082038
chrX	120431430	120447897	P13473	0	-	120431430	120447897	255,102,0	1	16467	0	.	Second lumenal domain.
chrX	120447897	120448005	P13473	0	-	120447897	120448005	255,102,0	1	108	0	.	Hinge.
chrX	120448005	120456749	P13473	0	-	120448005	120456749	255,102,0	1	8744	0	.	First lumenal domain.
chrX	123417422	123417431	P42263	0	+	123417422	123417431	255,102,0	1	9	0	.	Glutamate binding.
chrX	123428118	123428124	P42263	0	+	123428118	123428124	255,102,0	1	6	0	.	Glutamate binding.
chrX	123886082	123886109	P98170	0	+	123886082	123886109	255,102,0	1	27	0	.	Interaction with caspase-7.
chrX	124365821	124370250	O60880	0	+	124365821	124370250	255,102,0	1	4429	0	.	Interaction with FYN SH3 domain.
chrX	129558987	129575226	Q01968	0	+	129558987	129575226	255,102,0	1	16239	0	.	5-phosphatase.
chrX	129575226	129576471	Q01968	0	+	129575226	129576471	255,102,0	1	1245	0	.	ASH.
chrX	130071230	130074130	Q99607	0	-	130071230	130074130	255,102,0	1	2900	0	.	RUNX1-binding. Pubmed:10207087
chrX	130133311	130147826	O95831	0	-	130133311	130147826	255,102,0	1	14515	0	.	FAD-dependent oxidoreductase.
chrX	132629041	132629068	Q96MM7	0	-	132629041	132629068	255,102,0	1	27	0	.	3'-phosphate binding.
chrX	132957028	132957049	Q96MM7	0	-	132957028	132957049	255,102,0	1	21	0	.	5'-phosphosulfate-binding.
chrX	133217329	133217500	Q5H9I0	0	-	133217329	133217500	255,102,0	1	171	0	.	DCB2.
chrX	133217341	133217737	Q5H9I0	0	-	133217341	133217737	255,102,0	1	396	0	.	Involved in negatively regulating E2F activity.
chrX	133217536	133217635	Q5H9I0	0	-	133217536	133217635	255,102,0	1	99	0	.	DCB1.
chrX	134377656	134393930	Q8IWS0	0	+	134377656	134393930	255,102,0	1	16274	0	.	Extended PHD1 domain (ePHD1).
chrX	134413861	134425222	Q8IWS0	0	+	134413861	134425222	255,102,0	1	11361	0	.	Extended PHD2 domain (ePHD2).
chrX	136510885	136512010	O43719	0	+	136510885	136512010	255,102,0	1	1125	0	.	Mediates interaction with the P-TEFb complex.
chrX	136874144	136874321	P38159	0	-	136874144	136874321	255,102,0	1	177	0	.	Necessary for RNA-binding.
chrX	136875331	136875571	P38159	0	-	136875331	136875571	255,102,0	1	240	0	.	Necessary for the association to nascent RNAPII transcripts and nuclear localization.
chrX	138632984	138708917	Q92913	0	-	138632984	138708917	255,102,0	1	75933	0	.	Mediates interaction with sodium channels.
chrX	138710817	138711003	Q92913	0	-	138710817	138711003	255,102,0	1	186	0	.	Mediates targeting to the nucleus.
chrX	140783748	140783838	P51861	0	-	140783748	140783838	255,102,0	1	90	0	.	5 X 6 AA approximate repeats.
chrX	140783838	140783946	P51861	0	-	140783838	140783946	255,102,0	1	108	0	.	6 X 6 AA approximate repeats.
chrX	140783946	140784360	P51861	0	-	140783946	140784360	255,102,0	1	414	0	.	23 X 6 AA approximate repeats.
chrX	142202868	142203585	Q9UBF1	0	-	142202868	142203585	255,102,0	1	717	0	.	Interaction with TRIM28.
chrX	147912179	147930166	Q06787	0	+	147912179	147930166	255,102,0	1	17987	0	.	Required for nuclear localization.
chrX	147930127	147932427	Q06787	0	+	147930127	147932427	255,102,0	1	2300	0	.	Necessary for interaction with CYFIP1, CYFIP2, FXR1 and FXR2. Pubmed:14532325, Pubmed:8668200
chrX	147940575	147944870	Q06787	0	+	147940575	147944870	255,102,0	1	4295	0	.	Required for nuclear export. Pubmed:8789445, Pubmed:18936162
chrX	147940641	147948841	Q06787	0	+	147940641	147948841	255,102,0	1	8200	0	.	Interaction with RANBP9. Pubmed:15381419
chrX	147944996	147945041	Q06787	0	+	147944996	147945041	255,102,0	1	45	0	.	RNA-binding RGG-box.
chrX	150732724	150736600	Q13613	0	+	150732724	150736600	255,102,0	1	3876	0	.	Substrate binding. Pubmed:27018598
chrX	150736663	150736669	Q13613	0	+	150736663	150736669	255,102,0	1	6	0	.	Substrate binding. Pubmed:27018598
chrX	150737310	150737331	Q13613	0	+	150737310	150737331	255,102,0	1	21	0	.	Substrate binding. Pubmed:27018598
chrX	150755853	150762726	Q13613	0	+	150755853	150762726	255,102,0	1	6873	0	.	Required for dimerization. Pubmed:27018598
chrX	151671058	151671578	Q8IV76	0	+	151671058	151671578	255,102,0	1	520	0	.	Necessary for transcriptional repression. Pubmed:25936801
chrX	152829688	152829760	P41208	0	-	152829688	152829760	255,102,0	1	72	0	.	Required for self-assembly.
chrX	153445379	153445385	Q9BQ50	0	-	153445379	153445385	255,102,0	1	6	0	.	Substrate binding.
chrX	153565049	153565103	Q16720	0	+	153565049	153565103	255,102,0	1	54	0	.	Calmodulin-binding subdomain A.
chrX	153579977	153580007	Q16720	0	+	153579977	153580007	255,102,0	1	30	0	.	Calmodulin-binding subdomain B.
chrX	153670555	153670770	Q6P2M8	0	-	153670555	153670770	255,102,0	1	215	0	.	Calmodulin-binding.
chrX	153725464	153725824	P33897	0	+	153725464	153725824	255,102,0	1	360	0	.	Interaction with PEX19.
chrX	153933947	153934904	P41227	0	-	153933947	153934904	255,102,0	1	957	0	.	Interaction with NAA15. Pubmed:15496142
chrX	153942893	153942959	P51606	0	-	153942893	153942959	255,102,0	1	66	0	.	Leucine-zipper.
chrX	153956310	153956977	P51610	0	-	153956310	153956977	255,102,0	1	667	0	.	Interaction with GABP2. Pubmed:10675337
chrX	153956340	153957419	P51610	0	-	153956340	153957419	255,102,0	1	1079	0	.	Interaction with ZBTB17. Pubmed:12244100
chrX	153957500	153958225	P51610	0	-	153957500	153958225	255,102,0	1	725	0	.	Interaction with SIN3A. Pubmed:12670868
chrX	153958721	153959438	P51610	0	-	153958721	153959438	255,102,0	1	717	0	.	Required for interaction with OGT.
chrX	154018694	154019305	P51617	0	-	154018694	154019305	255,102,0	1	611	0	.	ProST region.
chrX	154030900	154031023	P51608	0	-	154030900	154031023	255,102,0	1	123	0	.	Interaction with NCOR2.
chrX	154348851	154349652	P21333	0	-	154348851	154349652	255,102,0	1	801	0	.	Self-association site, tail.
chrX	154349464	154349652	P21333	0	-	154349464	154349652	255,102,0	1	188	0	.	Hinge 2.
chrX	154354462	154354708	P21333	0	-	154354462	154354708	255,102,0	1	246	0	.	Hinge 1.
chrX	154357557	154358990	P21333	0	-	154357557	154358990	255,102,0	1	1433	0	.	Interaction with furin.
chrX	154379742	154381098	P50402	0	+	154379742	154381098	255,102,0	1	1356	0	.	Interaction with F-actin.
chrX	154380933	154380990	P50402	0	+	154380933	154380990	255,102,0	1	57	0	.	Interaction with CTNNB1. Pubmed:16858403
chrX	154414099	154419745	Q16635	0	+	154414099	154419745	255,102,0	1	5646	0	.	Hydrophilic.
chrX	154534366	154534381	P11413	0	-	154534366	154534381	255,102,0	1	15	0	.	Substrate binding.
chrX	154552131	154556310	Q9Y6K9	0	+	154552131	154556310	255,102,0	1	4179	0	.	Interaction with CHUK/IKBKB.
chrX	154558579	154562812	Q9Y6K9	0	+	154558579	154562812	255,102,0	1	4233	0	.	Interaction with TANK.
chrX	154561739	154563696	Q9Y6K9	0	+	154561739	154563696	255,102,0	1	1957	0	.	Ubiquitin-binding (UBD).
chrX	154561751	154563998	Q9Y6K9	0	+	154561751	154563998	255,102,0	1	2247	0	.	Self-association.
chrX	154561766	154564458	Q9Y6K9	0	+	154561766	154564458	255,102,0	1	2692	0	.	Required for interaction with TNFAIP3.
chrX	154563609	154563675	Q9Y6K9	0	+	154563609	154563675	255,102,0	1	66	0	.	Leucine-zipper.
chrX	154564344	154564458	Q9Y6K9	0	+	154564344	154564458	255,102,0	1	114	0	.	Interaction with CYLD. Pubmed:12917691
chrX	154762968	154764945	O60832	0	+	154762968	154764945	255,102,0	1	1977	0	.	Nucleolar localization.
chrX	154775270	154776864	O60832	0	+	154775270	154776864	255,102,0	1	1594	0	.	Nuclear and nucleolar localization.
chrX	154779179	154784091	Q00013	0	-	154779179	154784091	255,102,0	1	4912	0	.	Interaction with MPP5. Pubmed:17584769
chrX	154885307	154885394	P0C5Y9	0	+	154885307	154885394	255,102,0	1	87	0	.	Docking domain.
chrX	154928788	154931512	P00451	0	-	154928788	154931512	255,102,0	1	2724	0	.	B.
chrX	155277905	155280043	O15247	0	-	155277905	155280043	255,102,0	1	2138	0	.	C-terminal.
chrX	155279217	155279280	O15247	0	-	155279217	155279280	255,102,0	1	63	0	.	Foot loop.
chrX	155280043	155298795	O15247	0	-	155280043	155298795	255,102,0	1	18752	0	.	Joint loop.
chrX	155298789	155334427	O15247	0	-	155298789	155334427	255,102,0	1	35638	0	.	Required for insertion into the membrane.
chrX	155298795	155334427	O15247	0	-	155298795	155334427	255,102,0	1	35632	0	.	N-terminal.
chrX	155381044	155381131	P0C5Z0	0	+	155381044	155381131	255,102,0	1	87	0	.	Docking domain.
chrX	155459582	155459669	P0C5Z0	0	-	155459582	155459669	255,102,0	1	87	0	.	Docking domain.
chrY	2786991	2787012	Q05066	0	-	2786991	2787012	255,102,0	1	21	0	.	Necessary for interaction with SLC9A3R2. Pubmed:9054412
chrY	2787138	2787192	Q05066	0	-	2787138	2787192	255,102,0	1	54	0	.	Necessary for interaction with ZNF208 isoform KRAB-O.
chrY	2787186	2787285	Q05066	0	-	2787186	2787285	255,102,0	1	99	0	.	Sufficient for interaction with EP300. Pubmed:15297880
chrY	2787195	2787216	Q05066	0	-	2787195	2787216	255,102,0	1	21	0	.	Required for nuclear localization.
chrY	2787195	2787429	Q05066	0	-	2787195	2787429	255,102,0	1	234	0	.	Sufficient for interaction with KPNB1.
chrY	2787372	2787423	Q05066	0	-	2787372	2787423	255,102,0	1	51	0	.	Required for nuclear localization.
chrY	14829992	14830010	Q8NFZ3	0	+	14829992	14830010	255,102,0	1	18	0	.	Interaction with NRXN1.
